Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.7931281653443893,-2.097559560641058,0.0,0.05745399983957548,0.058,3/12,2.24%,FOXP1;SMARCA4;NCOR1
prerank,regulation of T cell proliferation (GO:0042129),0.808352601759349,2.0147393645451275,0.0,0.0010236187466542003,0.001,19/61,11.69%,NCKAP1L;PTPRC;CD86;LILRB1;GPNMB;LGALS3;CD3E;PDCD1LG2;NCK2;TNFSF8;CCDC88B;ANXA1;AIF1;CD80;CEBPB;PNP;CD274;TNFRSF21;TNFRSF1B
prerank,positive regulation of T cell activation (GO:0050870),0.7977279902885653,2.0007259227776064,0.0,0.0005118093733271001,0.001,19/62,8.29%,NCKAP1L;PTPRC;CD86;DOCK8;CD3E;CCR2;PDCD1LG2;SIRPA;CYRIB;THY1;MDK;NCK2;PYCARD;CCDC88B;ANXA1;AIF1;CD80;PRKCQ;PNP
prerank,regulation of immune response (GO:0050776),0.7758467706240608,1.991230949986337,0.0,0.00034120624888473345,0.001,33/135,6.56%,SLAMF7;CD300LB;CD22;CD226;LILRB1;TREM2;ITGAL;TREML2;FGR;LYN;SLAMF6;KLRK1;IRF4;NCR1;TREML4;CD3E;SYK;ITGB2;FCGR2B;ADCY7;PDCD1;TREML1;ITGA4;CD300A;CD200R1;CRTAM;FCGR1A;LAIR1;CD300LF;TRAF3;SAMHD1;TYROBP;RAET1E
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.8847530574694114,1.988824011693153,0.0,0.00025590468666355007,0.001,7/23,2.20%,ARRB2;CD226;LILRB1;SLAMF6;KLRK1;NCR1;CRTAM
prerank,neutrophil chemotaxis (GO:0030593),0.8109325776466816,1.9846072625417353,0.0,0.00020472374933084005,0.001,12/53,3.98%,NCKAP1L;PF4;LGALS3;PIK3CG;SYK;ITGB2;CXCL5;PIK3CD;CXCL2;CCL8;FCER1G;PIP5K1C
prerank,positive regulation of T cell proliferation (GO:0042102),0.8108449284994672,1.9844064099228012,0.0,0.00017060312444236672,0.001,17/55,9.75%,NCKAP1L;PTPRC;CD86;CD3E;SYK;CCR2;PDCD1LG2;NCK2;PYCARD;CCDC88B;IL18;HMGB1;ANXA1;AIF1;CD80;PNP;CD274
prerank,positive regulation of phagocytosis (GO:0050766),0.7993629223543542,1.9628244584390155,0.0,0.0001462312495220286,0.001,14/47,5.11%,NCKAP1L;PTPRC;DOCK2;TREM2;SLC11A1;FCGR2B;STAP1;SIRPA;PTPRJ;CAMK1D;TNF;FCER1G;PYCARD;CD300LF
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.8948786020942718,1.9579468278258294,0.0,0.00012795234333177504,0.001,9/22,2.44%,CD22;LGALS3;FCGR2B;DGKZ;CD300A;LAPTM5;PTPRJ;THY1;DUSP3
prerank,positive regulation of interleukin-12 production (GO:0032735),0.8511509555783727,1.9576934341406502,0.0,0.00011373541629491114,0.001,9/31,5.85%,IRF5;SCIMP;SYK;LAPTM5;PLCG2;TLR2;MDK;MAPK14;HMGB1
prerank,neutrophil migration (GO:1990266),0.7932863743393009,1.9562149908598454,0.0,0.00020472374933084005,0.002,12/58,3.98%,NCKAP1L;PF4;LGALS3;PIK3CG;SYK;ITGB2;CXCL5;PIK3CD;CXCL2;CCL8;FCER1G;PIP5K1C
prerank,negative regulation of T cell activation (GO:0050868),0.8379313700981613,1.9524216884716203,0.0,0.00027916874908750914,0.003,15/35,10.63%,NCKAP1L;CD86;LILRB1;GPNMB;LGALS3;FCGR2B;PDCD1LG2;LAPTM5;HAVCR2;DUSP3;RIPOR2;CD80;CEBPB;CD274;TNFRSF21
prerank,regulation of phagocytosis (GO:0050764),0.7976621089430054,1.9462996871827236,0.0,0.00034120624888473345,0.004,14/53,4.78%,PTPRC;DOCK2;TREM2;FGR;HCK;SLC11A1;SYK;FCGR2B;SIRPA;TLR2;CAMK1D;TNF;FCER1G;PYCARD
prerank,B cell receptor signaling pathway (GO:0050853),0.8544778892562719,1.9441130264204918,0.0,0.0003149596143551385,0.004,13/32,6.13%,NCKAP1L;PTPRC;BTK;BLNK;SYK;RFTN1;PIK3CD;PLCG2;TEC;LAT2;VAV3;NFAM1;PRKCB
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.5970923037676428,-1.9318919365837344,0.005208333333333333,0.30318033761499064,0.463,10/25,13.87%,CDH5;BMPR1A;FOXD1;BMP4;SULF1;ZNF423;ACVRL1;SMAD4;CCN1;UBE2O
prerank,ethanol metabolic process (GO:0006067),-0.7293916751297171,-1.9313635422565754,0.0,0.20329876866311322,0.463,7/12,21.57%,ALDH2;ALDH1A1;ACSS2;SULT1A1;ADH5;ACSS1;ADH1A
prerank,positive regulation of interferon-gamma production (GO:0032729),0.8074395792356451,1.9311969914772593,0.0,0.0005118093733271001,0.007,13/48,5.10%,CD226;LILRB1;SLAMF6;SLC11A1;CCR2;CYRIB;CRTAM;TLR8;TLR7;IL12RB2;PYCARD;IL18;CD14
prerank,dendritic cell differentiation (GO:0097028),0.8729056905150255,1.930486668357493,0.0,0.00047768874843862676,0.007,6/22,1.15%,BATF3;LILRB1;TREM2;LYN;IRF8;FLT3
prerank,regulation of immunoglobulin production (GO:0002637),0.8668384093325567,1.9303204178738032,0.0,0.00044783320166121265,0.007,5/23,1.94%,PTPRC;CD86;CD22;FCGR2B;VAMP3
prerank,B cell activation (GO:0042113),0.7726220929330184,1.928549794441814,0.0,0.00042149007215172953,0.007,22/68,9.95%,PTPRC;CD86;CD22;BTK;BLNK;FLT3;ITGA4;PIK3CD;TPD52;PLCG2;PTPRJ;LAT2;CTPS1;NFAM1;HDAC5;ADGRG3;PRKCB;KLF6;MALT1;MEF2C;GPR183;HDAC4
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.8323770981635165,1.928439464337637,0.0,0.000398073957032189,0.007,11/33,4.09%,CD226;LGALS3;CARD11;DGKZ;CD300A;LAPTM5;KCNN4;PTPRJ;THY1;DUSP3;PRKD2
prerank,granulocyte chemotaxis (GO:0071621),0.7870548134275999,1.9282862785788764,0.0,0.000377122696135758,0.007,12/55,3.98%,NCKAP1L;PF4;LGALS3;PIK3CG;SYK;ITGB2;CXCL5;PIK3CD;CXCL2;CCL8;FCER1G;PIP5K1C
prerank,regulation of interleukin-17 production (GO:0032660),0.8393349164587377,1.9258311783321123,0.0,0.0003582665613289701,0.007,10/31,5.08%,NCKAP1L;SLAMF6;LY9;TGFB1;RFTN1;VSIR;OSM;NR1H4;DDIT3;IL18
prerank,regulation of interleukin-2 production (GO:0032663),0.8130500167550587,1.924588663296863,0.0,0.00034120624888473345,0.007,18/43,8.56%,PTPRC;CD86;RUNX1;CARD11;IRF4;CCR2;IL1A;LAPTM5;HAVCR2;PLCG2;PRKD2;TRAF2;TNFAIP3;ANXA1;CD80;MALT1;PNP;TRIM27
prerank,positive regulation of leukocyte migration (GO:0002687),0.8365103154664366,1.9243047742195771,0.0,0.0003256968739354274,0.007,8/27,6.51%,NCKAP1L;LGALS3;ADAM8;THY1;MDK;TNF;IL6R;AIF1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.7708306325829186,1.9238098679674513,0.0,0.000311536140286061,0.007,17/63,9.75%,NCKAP1L;PTPRC;CD86;CD3E;PDCD1LG2;CD74;NCK2;CCDC88B;VAV3;IL18;ANXA1;AIF1;CD80;MEF2C;PNP;GPR183;CD274
prerank,T cell activation (GO:0042110),0.7769791347689282,1.9194397200660007,0.0,0.00029855546777414173,0.007,18/69,6.22%,PTPRC;TREML2;PIK3CG;IRF4;CD3E;LCP1;CD7;CD74;LAT;PIK3CD;CRTAM;LFNG;MDK;NCK2;NLRC3;CTPS1;CD44;CHD7
prerank,regulation of interferon-gamma production (GO:0032649),0.7769282943216745,1.9098510604973493,0.0,0.0003275579989293441,0.008,21/71,5.85%,CD226;LILRB1;SLAMF6;SLC11A1;CCR2;PDCD1LG2;SIRPA;VSIR;LAPTM5;CYRIB;HAVCR2;CRTAM;TLR8;TLR7;IL12RB2;NR1H4;PYCARD;DDIT3;IL18;CD14;HMGB1
prerank,regulation of B cell proliferation (GO:0030888),0.7941763262323844,1.9073281197865224,0.0,0.0003936995179439231,0.009,14/44,11.78%,NCKAP1L;PTPRC;CD22;LYN;FCGR2B;CD74;CD300A;VAV3;TYROBP;MEF2C;RC3H1;GPR183;TNFRSF21;SASH3
prerank,regulation of B cell activation (GO:0050864),0.8532596453443142,1.9048937731068039,0.0,0.0005307652760429187,0.013,8/25,7.56%,THEMIS2;CD22;FCGR2B;LAPTM5;SLAMF8;TNFAIP3;SAMSN1;SH3KBP1
prerank,regulation of interleukin-6 production (GO:0032675),0.7521409799619511,1.9035523798668728,0.0,0.0005483671857076073,0.014,26/96,6.55%,NCKAP1L;SLAMF1;TREM2;SCIMP;SYK;CD74;IL1A;SIRPA;POU2F2;LPL;CD200R1;TLR1;PLCG2;TLR2;DHX9;TLR8;TLR7;NLRC3;TNF;IL6R;PYCARD;TNFAIP3;RAB7B;HMGB1;AIF1;TYROBP
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.8250421896279474,1.9016833419313337,0.0,0.000529457972407345,0.014,13/31,10.63%,CD86;LILRB1;GPNMB;LYN;FCGR2B;PDCD1LG2;CD300A;TYROBP;CD80;CEBPB;RC3H1;CD274;TNFRSF21
prerank,positive regulation of interleukin-2 production (GO:0032743),0.8511172298490238,1.9014109132900194,0.0,0.0005800506231040468,0.016,14/25,8.29%,PTPRC;CD86;RUNX1;CARD11;IRF4;CCR2;IL1A;PLCG2;PRKD2;TRAF2;ANXA1;CD80;MALT1;PNP
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.8281146943571139,1.9010985146233137,0.0,0.0005613393126813356,0.016,9/30,3.16%,PTPRC;PLD4;MEOX1;SHH;TGFB1;PLEK;FLT3;CSF1R;SP7
prerank,regulation of T cell activation (GO:0050863),0.790720625934591,1.8862499627070692,0.0,0.0016313923774801317,0.042,17/42,12.01%,GPNMB;LGALS3;CCR2;LAT;SIRPA;LAPTM5;CYRIB;CRTAM;THY1;DUSP3;TNFSF8;PYCARD;CCDC88B;PRKCQ;CCL2;TNFRSF1B;METTL3
prerank,regulation of interleukin-12 production (GO:0032655),0.7761762033166144,1.883987141510485,0.0,0.0017990874941195031,0.047,11/47,3.05%,SLAMF1;LILRB1;IRF5;SCIMP;SYK;LAPTM5;PLCG2;TLR2;TLR8;MDK;MAPK14
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.8918896595671068,1.8821791434459796,0.0,0.001806386023507412,0.049,6/17,2.44%,LGALS3;DGKZ;LAPTM5;PTPRJ;THY1;DUSP3
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.8989218145175986,1.8808269322439406,0.0,0.0017840212441687488,0.05,3/16,1.91%,PTPRC;LILRB1;CYRIB
prerank,T cell activation involved in immune response (GO:0002286),0.9366034064387483,1.8782488016612084,0.0,0.0018197666607185782,0.053,7/12,3.89%,LILRB1;ITGAL;SLC11A1;LCP1;CD74;MDK;FCER1G
prerank,regulation of mast cell degranulation (GO:0043304),0.9153723758284111,1.8751991880395837,0.0,0.001936576007183622,0.056,6/14,1.54%,CD84;FGR;LYN;SYK;UNC13D;CD300A
prerank,mononuclear cell differentiation (GO:1903131),0.8320802582122812,1.8733698295857244,0.0,0.001966425486993595,0.059,8/24,2.01%,BATF3;LILRB1;TREM2;LYN;IRF8;IKZF1;FLT3;CSF1R
prerank,defense response to fungus (GO:0050832),0.8678891837665161,1.8717134388932257,0.0,0.0021522240314267803,0.066,3/17,2.02%,CLEC4D;CX3CR1;PLCG2
prerank,toll-like receptor signaling pathway (GO:0002224),0.7459521778780359,1.8704587731668056,0.0,0.0021751898366401752,0.069,30/84,9.31%,CTSS;BTK;SCIMP;RFTN1;ITGB2;CTSB;LGMN;MAPKAPK3;IRAK2;TLR1;PIK3AP1;PLCG2;UNC93B1;TLR2;CTSK;CTSL;TLR8;TLR7;SFTPA1;SFTPA2;NR1H4;UBE2D3;CD14;TRAF3;HMGB1;TICAM1;CNPY3;MAP3K1;LY96;ITGAM
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.9702236941911258,1.8691815152381706,0.0,0.002172069047778425,0.071,5/10,1.05%,ARRB2;PTPRC;LILRB1;CX3CR1;FCGR2B
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.7553059802184656,1.8655756831319037,0.0,0.0023153281174321198,0.079,32/71,11.37%,NCKAP1L;VAV1;FGR;LYN;MYO1G;HCK;SYK;FCGR2B;PLCG2;PRKCD;GRB2;NCKIPSD;PIK3CB;ELMO1;VAV2;FCGR1A;WIPF1;FCER1G;VAV3;ARPC2;PLD2;WIPF2;ACTB;ARPC3;WASF2;ABI1;ACTG1;ACTR2;ACTR3;YES1;CYFIP1;ARPC4
prerank,positive regulation of interleukin-6 production (GO:0032755),0.7456636481223223,1.8637268192657226,0.0,0.0024519239745437816,0.085,19/68,6.55%,SCIMP;SYK;CD74;IL1A;POU2F2;LPL;TLR1;PLCG2;TLR2;DHX9;TLR8;TLR7;TNF;IL6R;PYCARD;RAB7B;HMGB1;AIF1;TYROBP
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.7525974605465784,1.8593328600205339,0.0,0.002698631241179255,0.092,32/73,11.37%,NCKAP1L;VAV1;FGR;LYN;MYO1G;HCK;SYK;FCGR2B;PLCG2;PRKCD;GRB2;NCKIPSD;PIK3CB;ELMO1;VAV2;FCGR1A;WIPF1;FCER1G;VAV3;ARPC2;PLD2;WIPF2;ACTB;ARPC3;WASF2;ABI1;ACTG1;ACTR2;ACTR3;YES1;CYFIP1;ARPC4
prerank,neurotransmitter biosynthetic process (GO:0042136),0.8953183738470525,1.858086039367716,0.0,0.002684155824559903,0.093,4/14,3.73%,SLC6A3;SLC6A4;DAGLB;ALDH9A1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.752779748365115,1.8566016314517702,0.0,0.002692562355329527,0.096,31/70,11.37%,NCKAP1L;VAV1;FGR;LYN;MYO1G;HCK;SYK;FCGR2B;PLCG2;PRKCD;GRB2;NCKIPSD;PIK3CB;ELMO1;VAV2;FCGR1A;WIPF1;VAV3;ARPC2;PLD2;WIPF2;ACTB;ARPC3;WASF2;ABI1;ACTG1;ACTR2;ACTR3;YES1;CYFIP1;ARPC4
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.738527205820041,1.8532105749527743,0.0,0.0030490771176933623,0.112,18/73,6.55%,PTPRC;CD86;PF4;SYK;CCR2;IL1A;LPL;TLR1;HAVCR2;PLCG2;ADAM8;PTPRJ;TLR2;DHX9;PYCARD;CD14;HMGB1;TYROBP
prerank,regulation of myeloid cell differentiation (GO:0045637),0.7454170116931201,1.8470095002429967,0.0,0.003710617956621476,0.136,22/62,12.44%,RUNX1;NFE2;PTK2B;PF4;LYN;LGALS3;ITGA2B;GP1BA;GATA1;SPI1;PRKCB;TNRC6A;LEO1;DPY30;PRKCQ;MEF2C;MOV10;AGO4;RBBP5;THBS1;AGO3;CDK6
prerank,platelet aggregation (GO:0070527),0.7923435046581478,1.846731346479583,0.0,0.003718451773560156,0.14,18/33,10.21%,FERMT3;PIK3CG;UBASH3B;GP1BA;PLEK;GATA1;ITGB3;PIK3CB;MYH9;MYL12A;ACTB;CLIC1;STXBP3;P2RY12;RAP2B;ACTG1;VCL;ACTN1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.8052698417623635,1.8427915742418153,0.0,0.004155892111416053,0.161,9/29,6.56%,CD226;SLAMF6;KLRK1;STAP1;CYRIB;CRTAM;SPI1;TYROBP;RAET1E
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.748105855865369,1.8387531177859768,0.0,0.004455752191318284,0.173,16/49,11.72%,RUNX1;NFE2;PF4;ITGA2B;GP1BA;GATA1;RAB7B;TNRC6A;DPY30;PRKCQ;MEF2C;MOV10;AGO4;RBBP5;THBS1;AGO3
prerank,natural killer cell mediated immunity (GO:0002228),0.8806797090227223,1.837709460216182,0.0,0.004468489528663528,0.177,5/15,1.19%,SLAMF7;TUBB;KLRK1;PLEKHM2;LYST
prerank,negative regulation of T cell proliferation (GO:0042130),0.8079504377921323,1.8360423023131607,0.0,0.004596627579315088,0.186,10/28,10.63%,CD86;LILRB1;GPNMB;PDCD1LG2;CRTAM;CD80;CEBPB;RC3H1;CD274;TNFRSF21
prerank,positive regulation of lymphocyte activation (GO:0051251),0.8088492434907433,1.8342531748066724,0.0,0.004776887484386268,0.194,13/28,12.24%,NCKAP1L;CCR2;SIRPA;CYRIB;THY1;PYCARD;CCDC88B;TYROBP;TICAM1;SH3KBP1;PRKCQ;CCL2;NOD2
prerank,organophosphate catabolic process (GO:0046434),0.9084259176335253,1.8337144338853137,0.0,0.004745868734487655,0.196,3/11,3.09%,PLBD1;ABHD12;ANGPTL3
prerank,regulation of interleukin-4 production (GO:0032673),0.8380081320491501,1.8330423734461092,0.0,0.004807352328036691,0.2,8/21,8.09%,CD86;IRF4;SYK;HAVCR2;FCER1G;DDIT3;CEBPB;PRKCQ
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.8245617000927687,1.8283187230593838,0.0,0.005567049323908808,0.232,7/22,3.81%,BTK;LILRB1;SCIMP;CCR2;LAPTM5;FFAR2;TNF
prerank,lymphocyte proliferation (GO:0046651),0.8342324144500283,1.827345106576813,0.0,0.0055769573093573666,0.237,6/22,8.10%,PTPRC;PIK3CG;FLT3;ELF4;CTPS1;MEF2C
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.7864694077114058,1.827303735751743,0.0,0.005499782079481042,0.237,5/33,0.95%,NCKAP1L;FERMT3;LYN;PIK3CG;SYK
prerank,homotypic cell-cell adhesion (GO:0034109),0.7761018322237506,1.8240778740168855,0.0,0.0060052299803713075,0.258,18/39,10.21%,FERMT3;PIK3CG;UBASH3B;GP1BA;PLEK;GATA1;ITGB3;PIK3CB;MYH9;MYL12A;ACTB;CLIC1;STXBP3;P2RY12;RAP2B;ACTG1;VCL;ACTN1
prerank,positive regulation of immune response (GO:0050778),0.7261475475241791,1.813199474330117,0.0,0.00810504679727834,0.319,10/64,4.78%,PTPRC;CD226;LILRB1;ITGB2;FCGR2B;CD74;ADAM8;DHX9;TLR8;PYCARD
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.8694506679758962,1.8104816777138124,0.0026109660574412533,0.00856867950828274,0.336,6/16,1.76%,SLAMF7;TUBB;KLRK1;PLEKHM2;LYST;CORO1A
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.7368424666186055,1.8087557714340958,0.0,0.008822618721162393,0.352,21/56,8.92%,CTSS;CTSB;LGMN;MAPKAPK3;IRAK2;TLR1;PLCG2;UNC93B1;TLR2;CTSK;CTSL;TLR8;TLR7;SFTPA1;SFTPA2;FFAR2;CD14;TRAF3;HMGB1;CNPY3;LY96
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.7785970661060986,1.808091323122608,0.0,0.008876693818641894,0.357,7/33,3.90%,RUNX1;PF4;HCLS1;CD74;ACIN1;TNF;OCSTAMP
prerank,myeloid dendritic cell activation (GO:0001773),0.9092571787761137,1.8075772727603785,0.0013986013986013986,0.008803121221226121,0.358,6/12,6.68%,DOCK2;BATF3;SLAMF1;PYCARD;HMGB1;TGFBR2
prerank,regulation of lymphocyte differentiation (GO:0045619),0.8336348947978275,1.8070281688183647,0.0,0.00877830622130723,0.36,4/18,2.20%,NCKAP1L;CCR2;SLAMF8;CRTAM
prerank,regulation of cytokine production (GO:0001817),0.7137446472219096,1.806273398810127,0.0,0.008815343534619007,0.366,27/126,6.34%,CLEC9A;PTPRC;PLD4;TREM2;GPNMB;FGR;LYN;PIK3CG;IRF8;SLC11A1;FCGR2B;CCR2;IL1A;SIRPA;SRGN;PIK3CD;CRTAM;MAPK14;TNF;RGCC;CCDC88B;TRAF3;NFAM1;PPP1R11;BTN3A3;PLD3;ANXA1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.9391803257754712,1.8054897429437733,0.0,0.008745918997148387,0.367,3/10,0.52%,LILRB1;FGR;LYN
prerank,outflow tract septum morphogenesis (GO:0003148),-0.550988002791063,-1.8042093804276123,0.0058823529411764705,0.6512189904893421,0.909,11/24,13.22%,ZFPM2;PARVA;BMPR1A;ROBO2;BMP4;ACVR1;ROBO1;SEMA3C;SMAD4;TBX1;SMAD6
prerank,natural killer cell activation (GO:0030101),0.8197621910506172,1.8036479885463381,0.0,0.009064218176894439,0.379,7/23,2.82%,SLAMF7;PTPRC;KLRK1;NCR1;PIK3CD;IL21R;ELF4
prerank,positive regulation of cytokine production (GO:0001819),0.6944701998205756,1.801574002167937,0.0,0.009490408093979656,0.392,71/292,8.85%,CLEC9A;PTPRC;CD86;RUNX1;CD226;LILRB1;IRF5;SCIMP;FGR;SLAMF6;PIK3CG;LY9;CARD11;IRF4;HPSE;SLC11A1;TGFB1;SYK;RFTN1;CCR2;CD74;IL1A;POU2F2;LPL;PIK3CD;LAPTM5;TLR1;CYRIB;HAVCR2;CSF1R;PLCG2;CRTAM;TLR2;DHX9;TLR8;TLR7;MDK;MAPK14;OSM;IL12RB2;FFAR2;NR1H4;TNF;FCER1G;RGCC;PRKD2;TRAF2;IL6R;PYCARD;LRRFIP1;DDIT3;CCDC88B;IL18;CD14;RAB7B;NFAM1;HMGB1;XRCC5;CTNNB1;ANXA1;AIF1;TYROBP;CD80;TICAM1;CEBPB;MALT1;PRKCQ;PNP;TRIM27;LURAP1;SULF2
prerank,regulation of interleukin-10 production (GO:0032653),0.7509478114525128,1.8015238410027905,0.0,0.009371157539791975,0.392,13/44,12.24%,LILRB1;IRF4;SYK;FCGR2B;PDCD1LG2;VSIR;PLCG2;PYCARD;HMGB1;TYROBP;CD274;TNFRSF21;NOD2
prerank,regulation of B cell differentiation (GO:0045577),0.8551007054196594,1.8013168555930117,0.0,0.009312087209145848,0.395,4/17,1.96%,NCKAP1L;BTK;SYK;SLAMF8
prerank,negative regulation of lymphocyte activation (GO:0051250),0.8269908429263592,1.797865458954845,0.0,0.010474564434940926,0.439,7/21,5.42%,GPNMB;LGALS3;FCGR2B;LAPTM5;DUSP3;TNFAIP3;SAMSN1
prerank,positive regulation of interleukin-4 production (GO:0032753),0.8478595438182106,1.7972095595338633,0.0,0.010540506553385143,0.442,7/17,8.09%,CD86;IRF4;SYK;HAVCR2;FCER1G;CEBPB;PRKCQ
prerank,embryonic organ morphogenesis (GO:0048562),-0.4905203664924052,-1.7970224282507994,0.0,0.5577457522888019,0.928,23/42,26.10%,RYR2;NIPBL;EFEMP1;HOXC4;ACVR1;HOXB9;DSCAML1;HOXA3;MFAP5;PDGFRA;FBN1;SIX1;HES1;TBX1;HOXC9;SOX17;FUZ;RBP4;FOXE1;HOXD4;FGFR2;HOXD3;MFAP2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.8249445541715229,1.7969066562835527,0.0,0.010413614715962064,0.443,6/20,6.62%,MRAP;PLEK;GRK3;SNCA;MGRN1;YWHAB
prerank,regulation of calcium-mediated signaling (GO:0050848),0.7947713981354947,1.795359713835012,0.0,0.010747996839869104,0.454,5/25,5.57%,CD22;TREM2;PLEK;PLCG2;P2RX4
prerank,innate immune response (GO:0045087),0.6966546342427431,1.795268316454196,0.0,0.010608412465325349,0.454,56/217,13.13%,CD300LB;SLA;CLEC4D;PTK2B;BTK;TREM2;IRF5;FGR;LYN;CIITA;PIK3CG;HCK;CYBB;SLC11A1;CX3CR1;SYK;CLEC5A;NRROS;TREML1;CD74;PIK3CD;CORO1A;NLRC5;PLCG2;TRIM25;TLR2;NCF2;S100B;TLR8;MASP1;TRIM5;SNCA;FCER1G;GCH1;OTULIN;DMBT1;HMGB1;TYROBP;KYNU;CAPZA1;MALT1;TRIM27;ADAR;SETD2;TRIM8;TRIM56;YES1;MID2;TRIM35;NOD2;DEFA6;FYN;ALPK1;IKBKG;RNF135;B2M
prerank,positive regulation of immune system process (GO:0002684),0.8537253908985866,1.7932628150439833,0.0,0.010971093233370659,0.476,4/16,6.34%,NCKAP1L;PIK3CD;PIK3CB;ANXA1
prerank,positive regulation of chemokine production (GO:0032722),0.7410614093750917,1.7911822300144535,0.0,0.011415292605093044,0.495,13/44,6.51%,SYK;CD74;LPL;CSF1R;TLR2;TLR7;FFAR2;TNF;IL6R;PYCARD;IL18;HMGB1;AIF1
prerank,regulation of microglial cell activation (GO:1903978),0.8612205337970007,1.789815084054392,0.0013513513513513514,0.011554096602859285,0.501,4/15,3.45%,PTPRC;TREM2;STAP1;CST7
prerank,regulation of macrophage cytokine production (GO:0010935),0.8628660287129115,1.7874160422629919,0.001336898395721925,0.012018042321828943,0.515,6/13,2.16%,LILRB1;TGFB1;CD74;LAPTM5;PLCG2;GPRC5B
prerank,negative regulation of interleukin-6 production (GO:0032715),0.7896146593034734,1.7873785345863653,0.0011890606420927466,0.011883963985546324,0.515,7/27,5.09%,NCKAP1L;SLAMF1;SIRPA;CD200R1;NLRC3;TNF;TNFAIP3
prerank,B cell differentiation (GO:0030183),0.7490003039783689,1.78711817092927,0.0,0.01181478023246655,0.517,12/46,6.73%,PTPRC;BLNK;FLT3;ITGA4;TPD52;PLCG2;PTPRJ;FNIP1;NFAM1;HDAC5;ADGRG3;KLF6
prerank,inflammatory response (GO:0006954),0.6964723096116365,1.7867156543203258,0.0,0.011820359336363977,0.521,54/195,14.08%,ITGAL;BLNK;PF4;CIITA;PIK3CG;CYBB;SLC11A1;TGFB1;ITGB2;CXCL5;FCGR2B;CCR2;TMIGD3;NRROS;LAT;IL1A;PIK3CD;IL10RB;TLR1;CSF1R;ADAM8;CXCL2;TLR2;ADGRE5;CCL8;TNF;CXCR4;IL18;CD14;NFAM1;HDAC5;CD44;HMGB1;ANXA1;AIF1;CEBPB;CCL14;HDAC4;NFX1;F11R;CMKLR1;CCL13;THBS1;CCL2;TACR1;TPST1;HDAC9;LTB4R2;IKBKG;ITCH;NFKB1;ADCY8;C3AR1;SIGLEC1
prerank,superoxide anion generation (GO:0042554),0.8738098505438526,1.7842769198305033,0.0,0.01258448929710164,0.551,4/13,2.52%,CYBB;NCF4;ALOX12;NCF2
prerank,phagosome maturation (GO:0090382),0.7656593313692481,1.7813229157468822,0.0,0.0133070437065046,0.57,16/35,10.51%,ATP6V0D2;CORO1A;SLAMF8;ATP6V0E1;RAB39A;RAB34;TCIRG1;RAB32;ATP6V1C1;ATP6V1E1;RAB14;ATP6V0A2;RAB7A;ATP6V0D1;RAB31;ATP6V0A1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.7632639810803595,1.7796277303315537,0.0,0.013671781420829662,0.583,6/34,3.52%,PTPRC;CD86;SCIMP;LAPTM5;VAMP3;FFAR2
prerank,positive regulation of interleukin-17 production (GO:0032740),0.8079885610177739,1.7785228214806454,0.0,0.013795589017407742,0.594,8/22,8.09%,SLAMF6;LY9;TGFB1;RFTN1;OSM;NR1H4;IL18;PRKCQ
prerank,negative regulation of interleukin-17 production (GO:0032700),0.9111764304519583,1.7781009391028342,0.0,0.013801601078483598,0.6,3/10,4.84%,NCKAP1L;VSIR;DDIT3
prerank,regulation of lymphocyte activation (GO:0051249),0.8900274907160511,1.7780360033519005,0.0,0.013659623497018826,0.6,3/12,2.20%,THEMIS2;LAT;CRTAM
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.8492642132695291,1.775714231908361,0.0,0.01410569130004799,0.614,6/14,7.53%,LILRB1;CD74;LAPTM5;PLCG2;GPRC5B;TICAM1
prerank,negative regulation of cytokine production (GO:0001818),0.6893182262138272,1.7754381257614842,0.0,0.014030252603597243,0.615,51/163,13.54%,NCKAP1L;CD84;PTPRC;SLAMF1;LILRB1;TREM2;GPNMB;SLC11A1;FCGR2B;ADCY7;PDCD1LG2;SIRPA;VSIR;SRGN;CD200R1;NLRC5;LAPTM5;HAVCR2;TRIM25;TLR8;NLRC3;NR1H4;TNF;RGCC;PYCARD;DDIT3;TNFAIP3;HMGB1;PPP1R11;ANXA1;TYROBP;ABCD1;TAX1BP1;TMSB4X;ATP2B1;TRIM27;CD274;ANXA4;INHBA;TNFRSF21;CMKLR1;THBS1;RPS6KA4;HDAC9;RNF216;NLRX1;RNF135;ITCH;NPTN;GAS6;GPATCH3
prerank,cholesterol biosynthetic process (GO:0006695),-0.5033145479378741,-1.7749804565070655,0.0,0.5766024496720471,0.958,20/31,31.51%,HMGCR;ACAA2;ACLY;NSDHL;CYP51A1;INSIG2;INSIG1;ACAT2;SQLE;LSS;PMVK;LBR;IDI1;MVK;HSD17B7;FDPS;DHCR7;EBP;SC5D;TM7SF2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.7442297450567548,1.774675372023131,0.001095290251916758,0.014132542695741861,0.621,12/45,5.81%,IRF5;PTAFR;CIITA;HCK;IRF4;IRF8;TRIM25;PRKCD;FCGR1A;TRIM5;CD44;IFNGR2
prerank,T cell proliferation (GO:0042098),0.9024632115499689,1.7746743436469525,0.0,0.01398219649685099,0.621,6/13,4.13%,LILRB1;DOCK8;PIK3CG;SLC11A1;CRTAM;CTPS1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.7024358499100376,1.7738290504670002,0.0,0.014125938703827962,0.628,34/101,13.46%,CD86;LILRB1;PF4;LYN;HCK;TGFB1;CX3CR1;CXCL5;STAP1;PDCD1LG2;IL1A;SIRPA;CXCL2;MAPK14;TNF;PYCARD;CD68;IL18;TNFAIP3;CD14;CASP1;HMGB1;CD80;TICAM1;CD180;MEF2C;LY96;CD274;CCL2;TNFRSF1B;NOD2;DEFA6;SHPK;NFKB1
prerank,neuron fate commitment (GO:0048663),0.8813064966202735,1.7715266618031664,0.0,0.014629217920932944,0.644,4/14,5.19%,ASCL1;SHH;TGFBR1;MYT1L
prerank,negative regulation of B cell activation (GO:0050869),0.8220891921883868,1.771096972434945,0.0,0.01464724557068072,0.65,10/21,10.63%,LYN;FCGR2B;CD300A;LAPTM5;TNFAIP3;SAMSN1;TYROBP;RC3H1;INHBA;TNFRSF21
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.8915695444136217,1.7696789152203636,0.002828854314002829,0.01500959325451108,0.662,4/11,5.09%,TREM2;LYN;TLR1;TNFAIP3
prerank,negative regulation of interleukin-10 production (GO:0032693),0.8427541618844853,1.768806317067509,0.0012987012987012987,0.015240545783518092,0.672,7/16,10.63%,LILRB1;FCGR2B;PDCD1LG2;VSIR;TYROBP;CD274;TNFRSF21
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.7070355562164427,1.7662317155075409,0.0,0.016214120947002534,0.693,16/69,6.55%,PTPRC;PF4;SYK;CCR2;IL1A;LPL;TLR1;HAVCR2;PLCG2;PTPRJ;TLR2;DHX9;PYCARD;CD14;HMGB1;TYROBP
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.6949484263896426,1.7647946055136712,0.0,0.01664140576243759,0.705,29/121,7.60%,PTPRC;PTK2B;TREM2;LYN;TGFB1;CASS4;HCLS1;FLT3;GATA1;CD74;ITGB3;CSF1R;PLCG2;GPRC5B;PTPRJ;ANGPT4;PTPN1;TEC;OSM;FCGR1A;SEMA4D;TNF;IL6R;IL18;CD44;TP53;CD80;NEDD9;EPO
prerank,cellular lipid catabolic process (GO:0044242),0.7746462933697419,1.761679129015775,0.0035671819262782403,0.01797354093389875,0.734,7/27,7.03%,PLBD1;LPIN2;ABHD12;ANGPTL3;CEL;NUDT19;ACADL
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.9113016536434457,1.7608603351079795,0.0,0.018077305826834856,0.744,4/10,1.54%,NCKAP1L;TREM2;STAP1;CD300A
prerank,negative regulation of immune response (GO:0050777),0.6902251848121488,1.7600504750706158,0.0,0.018100335337471865,0.745,41/154,13.49%,TSHB;LILRB1;TREM2;FGR;LYN;LGALS3;CALCR;HCK;SYK;FCGR2B;CCR2;ADCY7;PDCD1;CD300A;PRKAR2B;HAVCR2;PLCG2;CYSLTR2;MAPK14;FCGR1A;NLRC3;ADCY6;RHBDF2;TRAFD1;SPI1;TNFAIP3;MYH9;SAMSN1;RAMP1;PLK2;TRIM27;RC3H1;CYSLTR1;YES1;PRKACB;IAPP;FYN;CREB1;ITCH;ADCY3;ADCY8
prerank,integrin-mediated signaling pathway (GO:0007229),0.7101439984652241,1.7594167082079961,0.0,0.018298403690189848,0.758,17/73,3.11%,PTK2B;FERMT3;FGR;FYB1;ITGA2B;HCK;PLEK;SYK;ITGB2;LAT;ITGB3;ITGB5;THY1;ITGA2;TEC;ANGPTL3;CCM2
prerank,defense response to protozoan (GO:0042832),0.8668225315964785,1.7589119096393584,0.0028530670470756064,0.01831891285285866,0.762,4/12,1.19%,PF4;IRF4;SLC11A1;LYST
prerank,leukocyte cell-cell adhesion (GO:0007159),0.7867132256743754,1.7580242114574247,0.0024154589371980675,0.018587768455599167,0.772,6/24,3.56%,ITGAL;FERMT3;SYK;ITGB2;ITGA4;SEMA4D
prerank,regulation of tumor necrosis factor production (GO:0032680),0.6851643752153307,1.7577216915252973,0.0,0.018548350807428424,0.774,24/112,6.55%,PTPRC;SLAMF1;LILRB1;PF4;CX3CR1;SYK;CCR2;IL1A;SIRPA;VSIR;LPL;TLR1;HAVCR2;PLCG2;PTPRJ;TLR2;DHX9;NLRC3;NR1H4;PYCARD;TNFAIP3;CD14;HMGB1;TYROBP
prerank,positive regulation of immune effector process (GO:0002699),0.7765076528461242,1.7555874544804595,0.0024479804161566705,0.019326673216645357,0.791,4/27,2.35%,PTPRC;LILRB1;CCR2;PTPRJ
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.7714209352984449,1.7550859532616652,0.0011682242990654205,0.01936500556170355,0.794,11/27,8.09%,ITGB2;CCR2;SIRPA;CYRIB;THY1;MDK;TNF;PYCARD;CCDC88B;CD44;PRKCQ
prerank,chemokine-mediated signaling pathway (GO:0070098),0.7318123177185631,1.7543748410593882,0.0,0.019485643348471398,0.8,11/42,11.55%,PTK2B;PF4;CXCL5;CCR2;CXCL2;CCL8;WNK1;CCL14;SH2B3;CCL13;CCL2
prerank,cellular response to chemokine (GO:1990869),0.7154500204521695,1.7539471474610555,0.0,0.019540150717381074,0.806,13/46,11.55%,PTK2B;DOCK8;PF4;CXCL5;CCR2;CXCL2;CCL8;RIPOR2;WNK1;CCL14;SH2B3;CCL13;CCL2
prerank,B cell proliferation (GO:0042100),0.8292768905075834,1.7531470348834433,0.001282051282051282,0.01973863052176551,0.809,4/17,8.10%,PTPRC;CTPS1;CD180;MEF2C
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.8538113566699965,1.7526609099775603,0.0,0.019780983323501783,0.814,3/14,6.74%,CD84;IL18;CD80
prerank,regulation of mast cell activation (GO:0033003),0.8922613278812946,1.7523117841460416,0.00145985401459854,0.019706886131238253,0.814,4/10,5.11%,CD84;CD226;LYN;CD300LF
prerank,B cell homeostasis (GO:0001782),0.8946844872756511,1.7514492162263888,0.0,0.01995174126021678,0.823,6/10,8.10%,NCKAP1L;LYN;TNFAIP3;DOCK11;DOCK10;MEF2C
prerank,vasculature development (GO:0001944),-0.63176446689175,-1.7503840546477123,0.004,0.6221447411199744,0.982,11/16,25.06%,ERRFI1;CDH5;ACVRL1;PDGFRA;FBXW7;STRA6;NOTCH4;FLT4;BMPR2;SOX18;ACVR2B
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.8206342591997424,1.7489593822037848,0.00258732212160414,0.020796083425615675,0.836,5/17,6.56%,CD226;SLAMF6;KLRK1;CRTAM;RAET1E
prerank,positive regulation of interleukin-8 production (GO:0032757),0.7163143057538166,1.7480405128188992,0.0010787486515641855,0.021079606392963614,0.842,13/49,5.85%,SYK;CD74;TLR1;TLR2;TLR8;TLR7;FFAR2;TNF;PRKD2;PYCARD;DDIT3;CD14;HMGB1
prerank,arachidonic acid metabolic process (GO:0019369),0.7421627395545032,1.7454686948670481,0.0011299435028248588,0.022201344412726812,0.857,6/35,3.21%,TBXAS1;CYP1A1;ALOX12;DAGLB;PTGES3;HPGDS
prerank,neutrophil activation (GO:0042119),0.8759426055011017,1.743618671469244,0.0,0.022937590081276202,0.864,5/12,6.55%,PREX1;SYK;PRKCD;FCER1G;TYROBP
prerank,sterol biosynthetic process (GO:0016126),-0.4837090117557938,-1.7420787663217727,0.0,0.5884615445107289,0.988,20/33,31.51%,HMGCR;ACAA2;ACLY;NSDHL;CYP51A1;INSIG2;INSIG1;ACAT2;SQLE;LSS;PMVK;LBR;IDI1;MVK;HSD17B7;FDPS;DHCR7;EBP;SC5D;TM7SF2
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.6840812569458312,1.7397246017340795,0.0,0.024693744805649672,0.883,55/163,15.61%,NCKAP1L;THEMIS2;PTPRC;LCP2;GRAP2;BTK;BLNK;INPP5D;FYB1;CARD11;CD3E;SYK;RFTN1;LAT;PIK3CD;PLCG2;PTPRJ;THY1;PIK3CB;TEC;THEMIS;LAT2;PRKD2;VAV3;NFAM1;BTN3A3;PRKCB;PSMB10;WNK1;NFKBID;RC3H2;MALT1;PRKCQ;MEF2C;DENND1B;RC3H1;SPPL3;BCAR1;EIF2B2;TNFRSF21;PSMA2;TXK;FYN;PSME3;TAB2;IKBKG;NFKB1;PSMB5;BMX;PSMD8;PLEKHA1;PAG1;ICOSLG;PSMD7;PSMB9
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.5009732487131883,-1.739490977959115,0.006896551724137931,0.5358444839738868,0.988,18/30,28.67%,HMGCR;ACAA2;ACLY;NSDHL;CYP51A1;INSIG2;INSIG1;ACAT2;SQLE;LSS;PMVK;LBR;IDI1;MVK;HSD17B7;FDPS;DHCR7;EBP
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.693726478767194,1.7394865750275208,0.0,0.024633972460465017,0.883,32/95,13.46%,CD86;LILRB1;PF4;CX3CR1;CXCL5;FCGR2B;STAP1;PDCD1LG2;IL1A;SIRPA;CYRIB;CXCL2;TLR2;MAPK14;PYCARD;CD68;TNFAIP3;CD14;CASP1;HMGB1;CD80;TICAM1;CD180;MEF2C;LY96;CD274;CCL2;TNFRSF1B;NOD2;DEFA6;SHPK;NFKB1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.8229346263982856,1.7383220633110508,0.001310615989515072,0.02502456561942423,0.887,5/16,6.56%,CD226;SLAMF6;KLRK1;CRTAM;RAET1E
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.8749424585090706,1.7369182915852175,0.0,0.025722548504632965,0.894,3/12,5.08%,SLC11A1;CCR2;IL18
prerank,microglial cell activation (GO:0001774),0.774321835158748,1.7356571276617816,0.0,0.02614731726453489,0.901,10/21,11.64%,TREM2;CX3CR1;ITGB2;TNF;SNCA;AIF1;TYROBP;C1QA;ITGAM;GRN
prerank,positive regulation of neutrophil migration (GO:1902624),0.8172026403933852,1.7341724168778974,0.0,0.02687405407882614,0.912,6/18,5.96%,NCKAP1L;CD74;ADAM8;CAMK1D;MDK;RIPOR2
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.8762853313818422,1.7340659513927665,0.001364256480218281,0.026702747304451692,0.912,4/12,1.54%,PTPRC;RUNX1;LYN;CD300A
prerank,positive regulation of B cell activation (GO:0050871),0.7150168582220117,1.7329310196329215,0.0,0.027029932528837473,0.916,12/50,12.24%,NCKAP1L;PTPRC;BTK;SYK;CD74;MAD2L2;VAV3;SH3KBP1;MEF2C;GPR183;SASH3;NOD2
prerank,peptidyl-tyrosine modification (GO:0018212),0.7115233309037984,1.7326242676209584,0.0,0.02705051401041991,0.919,9/56,2.77%,PTK2B;BTK;FGR;LYN;HCK;SYK;FLT3;CSF1R;TEC
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.8694995988474885,1.73179212654162,0.0,0.027267628612796118,0.919,6/11,9.31%,ITGB2;STAP1;SPI1;TYROBP;TICAM1;ITGAM
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.6956485863794868,1.7316861850128764,0.0,0.027153245378804165,0.921,15/72,5.08%,TREM2;FGR;LYN;PIK3CG;PIK3R5;HCLS1;FLT3;PIK3CD;CBL;PIK3AP1;PIK3CB;OSM;SEMA4D;TNF;IL18
prerank,myeloid cell activation involved in immune response (GO:0002275),0.813149181744329,1.7299284806321342,0.001277139208173691,0.027901365533801608,0.93,7/18,6.55%,DOCK2;SLAMF1;SYK;PLCG2;FCER1G;PYCARD;TYROBP
prerank,positive regulation of immunoglobulin production (GO:0002639),0.7439121803642568,1.7290300613487235,0.0011668611435239206,0.028199542013090148,0.932,4/31,2.40%,PTPRC;CD86;VAMP3;MAD2L2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.8614854522807986,1.7275670944267667,0.002793296089385475,0.028928688011786986,0.94,3/11,5.57%,TREM2;PLCG2;P2RX4
prerank,regulation of chemokine production (GO:0032642),0.7204173762576136,1.7268757178498306,0.0011198208286674132,0.02917692546018787,0.941,12/36,6.51%,TREM2;CD74;LPL;CSF1R;TLR2;TLR7;FFAR2;TNF;IL6R;PYCARD;IL18;AIF1
prerank,plasma membrane invagination (GO:0099024),0.7583174907171432,1.7261350444253583,0.0,0.029519358267483628,0.944,11/29,6.51%,ARHGAP25;BIN2;ITGB2;FCGR2B;ELMO1;MSR1;FCGR1A;SNX9;SNX33;MYH9;AIF1
prerank,T cell differentiation (GO:0030217),0.7366554248640745,1.7260195123819169,0.0,0.029363661856576694,0.944,8/40,6.34%,PTPRC;SHH;PIK3CD;LFNG;FCER1G;SPI1;CHD7;ANXA1
prerank,T cell differentiation in thymus (GO:0033077),0.8392258020723358,1.7257740846966438,0.004092769440654843,0.02927697965974006,0.944,2/14,0.68%,PTPRC;SHH
prerank,cortical actin cytoskeleton organization (GO:0030866),0.78202634446799,1.7249937957158767,0.0,0.02961866618016686,0.947,6/20,5.71%,NCKAP1L;PLEK;LCP1;TNF;FHOD1;FMNL3
prerank,myeloid cell differentiation (GO:0030099),0.7185715431540317,1.7248479376248844,0.0,0.02949484302859317,0.947,15/47,12.56%,RUNX1;LYN;IKZF1;HCLS1;GATA1;ACIN1;CEBPA;SPI1;TAL1;EPO;ATP5IF1;SLC25A38;INHBA;PRDX3;RPS14
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.7369640506083769,1.7247530737418397,0.0,0.029329217989240916,0.948,11/37,7.53%,PLD4;TREM2;ADCY7;SIRPA;MAPK14;NLRC3;TNF;PYCARD;PLD3;ABCD1;TICAM1
prerank,positive regulation of B cell proliferation (GO:0030890),0.7573666643996152,1.7235219624050195,0.0,0.030002121292780147,0.95,7/29,11.78%,NCKAP1L;PTPRC;CD74;VAV3;MEF2C;GPR183;SASH3
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.8541853163567557,1.7234528337281834,0.0014124293785310734,0.029820948940988797,0.95,7/13,3.89%,SYK;ITGB2;LPL;ABCA1;CD9;SREBF2;FCER1G
prerank,regulation of interferon-alpha production (GO:0032647),0.7798002064813698,1.7231568889535378,0.003579952267303103,0.02981289599630358,0.95,6/23,3.58%,IRF5;HAVCR2;DHX9;TLR8;TLR7;NLRC3
prerank,regulation of mononuclear cell migration (GO:0071675),0.7729648770275611,1.7229793302175553,0.0012033694344163659,0.0297131814115002,0.95,10/23,11.24%,LYN;LGALS3;CSF1R;MDK;TNF;AIF1;STK10;AKIRIN1;CMKLR1;THBS1
prerank,macrophage migration (GO:1905517),0.8276075249489767,1.721577897919637,0.005405405405405406,0.030386052383556877,0.953,6/13,11.55%,LGALS3;CCR2;EDNRB;P2RX4;P2RY12;CCL2
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.8628992640311616,1.7212103298750518,0.0028368794326241137,0.030367356150741272,0.953,6/12,9.45%,PTK2B;FCGR2B;LFNG;DOCK11;DOCK10;GPR183
prerank,lymphocyte differentiation (GO:0030098),0.6963364377416893,1.720901875216097,0.0,0.030348912569720474,0.954,15/68,6.73%,PTPRC;BLNK;IKZF1;FLT3;ITGA4;PIK3CD;TPD52;PLCG2;PTPRJ;LFNG;NFAM1;HDAC5;ADGRG3;CHD7;KLF6
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.787637488621343,1.7201481969339614,0.0025380710659898475,0.030653603003832488,0.957,7/19,9.31%,SCIMP;ITGB2;PIK3AP1;NR1H4;CD14;LY96;ITGAM
prerank,negative regulation of organelle assembly (GO:1902116),-0.48423753351100235,-1.717835716280786,0.018018018018018018,0.5848817183668783,0.997,23/35,27.04%,MTM1;FEZ1;TRIM37;SMAD4;CCP110;TMEM39A;EVI5L;CEP97;CDK5RAP2;PINK1;RBM14;CHMP4B;CHMP4A;NUPR1;CDK10;TBC1D7;PHF23;KAT2B;SMCR8;FEZ2;KAT2A;TESK1;STYXL1
prerank,immunoglobulin mediated immune response (GO:0016064),0.8940004525046303,1.7163939116365023,0.0,0.03262614151835821,0.966,4/10,3.89%,FCGR2B;CD74;TLR8;FCER1G
prerank,superoxide metabolic process (GO:0006801),0.7482720817495401,1.7163119069952075,0.00117096018735363,0.03247108474485841,0.966,8/29,4.06%,CYBB;PREX1;NRROS;NCF4;SH3PXD2B;ALOX12;NCF2;ATP7A
prerank,response to thyroid hormone (GO:0097066),0.8468803847337947,1.7155145574119852,0.0013550135501355014,0.03281640889767051,0.968,6/13,2.62%,CTSS;CTSB;GATA1;BRD8;GAS2L1;CTSL
prerank,positive regulation of macrophage migration (GO:1905523),0.7811926642752189,1.7154690614287382,0.0,0.0326420644766395,0.968,8/19,11.24%,TREM2;CSF1R;MDK;P2RX4;P2RY12;AKIRIN1;CMKLR1;THBS1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.8044570572036283,1.7140643843048031,0.003870967741935484,0.03330749051613115,0.972,6/18,8.71%,RUNX1;TGFB1;RGCC;COLGALT1;RB1;SMAD3
prerank,defense response to bacterium (GO:0042742),0.6756476379555454,1.7134935086745346,0.0,0.03350205097920488,0.973,19/105,7.68%,TREM2;FGR;SLC11A1;SYK;LYST;AQP1;MPEG1;SLAMF8;PRKCD;TLR2;FCER1G;IL6R;PYCARD;DMBT1;STAB2;PPP1R11;STAB1;EPX;CEBPB
prerank,regulation of platelet activation (GO:0010543),0.7806532244551603,1.7131971613553325,0.001221001221001221,0.033457897366601076,0.973,8/21,10.99%,LYN;PLEK;SYK;TEC;FCER1G;APOE;PRKCQ;TXK
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.6805770079661797,1.7101586847389574,0.0010416666666666667,0.0351616299408032,0.976,23/67,11.23%,NCKAP1L;VAV1;PTK2B;CYBB;MAPKAPK3;NCF4;ITGB3;NCF2;PIK3CB;ELMO1;VAV2;MAPK14;NCK2;PRKD2;VAV3;SHC2;VEGFB;WASF2;PDCD6;ABI1;BCAR1;CYFIP1;NRP1
prerank,regulation of osteoclast differentiation (GO:0045670),0.7346859870684883,1.7100217369492525,0.0,0.035081617171724644,0.978,8/33,7.68%,LILRB3;UBASH3B;MTOR;TNF;OCSTAMP;GPR137B;TMEM178A;CEBPB
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.7389161339989005,1.709216799694011,0.0011876484560570072,0.03535025495520889,0.979,8/29,8.34%,LGALS3;CCR2;LGMN;CREB3;TNF;HMGB1;AIF1;PLA2G7
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.7941778628715498,1.7086843637525226,0.0038314176245210726,0.035589944297733225,0.979,4/19,3.02%,NCKAP1L;BTK;SYK;MDK
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.8486843902637755,1.7077099243637364,0.0013440860215053765,0.03608732922987106,0.98,5/13,8.29%,NCKAP1L;RUNX1;SHH;TGFBR2;PNP
prerank,negative regulation of interferon-gamma production (GO:0032689),0.7768154567390138,1.7073957830538529,0.0025031289111389237,0.03607940150244125,0.982,10/23,10.54%,LILRB1;PDCD1LG2;VSIR;LAPTM5;HAVCR2;NR1H4;DDIT3;HMGB1;CD274;INHBA
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.7866978974267163,1.706584463133305,0.0025188916876574307,0.03637928465869805,0.982,7/20,7.53%,LYN;HCK;TGFB1;TNF;IL18;CD14;TICAM1
prerank,B cell mediated immunity (GO:0019724),0.8798944877787973,1.7044898495972756,0.0,0.037705371027670874,0.985,4/10,3.89%,FCGR2B;CD74;TLR8;FCER1G
prerank,cellular response to interferon-gamma (GO:0071346),0.6764051456189046,1.7042969946732809,0.0,0.03763194737699623,0.985,24/88,11.55%,IRF5;PTAFR;CIITA;HCK;IRF4;IRF8;SIRPA;TRIM25;PRKCD;TLR2;FCGR1A;CCL8;TRIM5;CASP1;CD44;IFNGR2;AIF1;IRF2;CCL14;EPRS1;TRIM8;CCL13;GBP3;CCL2
prerank,catecholamine biosynthetic process (GO:0042423),0.8519312144155748,1.7042576258930833,0.0014265335235378032,0.0374484135447648,0.985,3/11,4.50%,SNCA;GCH1;DDC
prerank,dendritic cell chemotaxis (GO:0002407),0.8243448084756132,1.7041686152618767,0.002717391304347826,0.03727933662964578,0.985,5/14,9.45%,PIK3CG;CCR2;CXCR4;HMGB1;GPR183
prerank,regulation of tissue remodeling (GO:0034103),0.8044687272960503,1.7027503975828382,0.007407407407407408,0.0381541701877893,0.985,5/18,5.08%,RUNX1;GPNMB;TGFB1;MDK;IL18
prerank,neutrophil activation involved in immune response (GO:0002283),0.6590928448719661,1.7013586762980266,0.0,0.03890356928852028,0.987,126/428,12.57%,ARHGAP45;NCKAP1L;PTPRC;CTSS;HK3;DOCK2;TUBB;CLEC4D;LILRB3;ITGAL;FGR;LGALS3;GMFG;PTAFR;P2RX1;CYBB;MGAM;ITGAX;HPSE;SLC11A1;ARHGAP9;BIN2;SYK;ITGB2;CLEC5A;CTSB;HEXB;TMC6;GUSB;ATP8B4;UNC13D;SIRPA;CD300A;CTSD;IQGAP2;TBC1D10C;CTSC;CTSA;ADAM8;PRKCD;PTPRJ;TLR2;TCIRG1;LPCAT1;OSTF1;ARSB;ADGRE5;MAPK14;GNS;PFKL;ATP8A1;GM2A;PSAP;NPC2;ATG7;FCER1G;SLC2A3;TTR;PPIE;DNAJC3;LAIR1;PYCARD;RAB14;CD68;GYG1;NBEAL2;CD14;CPPED1;RAP1B;RAB7A;NFAM1;CD44;ADGRG3;HMGB1;XRCC5;APAF1;ARL8A;B4GALT1;CDA;TYROBP;STK10;FUCA1;VPS35L;IRAG2;STXBP3;SVIP;EPX;RAP2B;FABP5;DNAJC13;CAP1;PNP;TSPAN14;ACTR10;TMEM179B;RAB31;SLC44A2;PAFAH1B2;CCT8;CTSZ;MAN2B1;FTL;SNAP29;ITGAM;ATP6AP2;VCL;SYNGR1;FGL2;ACTR2;TMEM63A;ATP6V0A1;DIAPH1;PSMA2;CD53;CYFIP1;GPI;CD63;GRN;TNFRSF1B;CD93;GGH;PRDX6;DYNC1H1;SDCBP;ARSA;COTL1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.8548628539395214,1.7010585262818156,0.0014064697609001407,0.03897578910054493,0.987,5/11,8.10%,LYN;PIK3CD;PIK3CB;ANXA1;MEF2C
prerank,cholesterol efflux (GO:0033344),0.7812760794356011,1.7009910888546074,0.003745318352059925,0.03877779088202286,0.987,6/20,5.56%,ABCA1;NPC2;ABCG1;APOE;NPC1;SOAT2
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.8501684813312721,1.6995489451081174,0.005681818181818182,0.03955810354075854,0.988,4/12,5.08%,TREM2;STAP1;TNF;IL18
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.7993641843744281,1.6982772214159918,0.002509410288582183,0.04043589892852488,0.99,5/19,5.96%,NCKAP1L;CD74;CAMK1D;MDK;RIPOR2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.6725463807579107,1.6972369400281857,0.0,0.04096828133160833,0.99,27/116,13.49%,TSHB;TREM2;FGR;LYN;CALCR;HCK;SYK;FCGR2B;ADCY7;PRKAR2B;PLCG2;CYSLTR2;MAPK14;FCGR1A;ADCY6;RHBDF2;MYH9;RAMP1;PLK2;CYSLTR1;YES1;PRKACB;IAPP;FYN;CREB1;ADCY3;ADCY8
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.6781417791424216,1.6962444682426916,0.0,0.04151212711431348,0.99,24/86,8.95%,PTPRC;PTK2B;TREM2;TGFB1;ITGB2;HCLS1;GATA1;CD74;ITGB3;PLCG2;PRKCD;PTPRJ;ANGPT4;TEC;OSM;SEMA4D;PDCL3;IL6R;SAMSN1;CD44;TP53;CD80;RAP2B;NTF3
prerank,neutrophil degranulation (GO:0043312),0.6568425055817434,1.695891695478677,0.0,0.04153798345797897,0.991,125/425,12.57%,ARHGAP45;NCKAP1L;PTPRC;CTSS;HK3;DOCK2;TUBB;CLEC4D;LILRB3;ITGAL;FGR;LGALS3;GMFG;PTAFR;P2RX1;CYBB;MGAM;ITGAX;HPSE;SLC11A1;ARHGAP9;BIN2;ITGB2;CLEC5A;CTSB;HEXB;TMC6;GUSB;ATP8B4;UNC13D;SIRPA;CD300A;CTSD;IQGAP2;TBC1D10C;CTSC;CTSA;ADAM8;PRKCD;PTPRJ;TLR2;TCIRG1;LPCAT1;OSTF1;ARSB;ADGRE5;MAPK14;GNS;PFKL;ATP8A1;GM2A;PSAP;NPC2;ATG7;FCER1G;SLC2A3;TTR;PPIE;DNAJC3;LAIR1;PYCARD;RAB14;CD68;GYG1;NBEAL2;CD14;CPPED1;RAP1B;RAB7A;NFAM1;CD44;ADGRG3;HMGB1;XRCC5;APAF1;ARL8A;B4GALT1;CDA;TYROBP;STK10;FUCA1;VPS35L;IRAG2;STXBP3;SVIP;EPX;RAP2B;FABP5;DNAJC13;CAP1;PNP;TSPAN14;ACTR10;TMEM179B;RAB31;SLC44A2;PAFAH1B2;CCT8;CTSZ;MAN2B1;FTL;SNAP29;ITGAM;ATP6AP2;VCL;SYNGR1;FGL2;ACTR2;TMEM63A;ATP6V0A1;DIAPH1;PSMA2;CD53;CYFIP1;GPI;CD63;GRN;TNFRSF1B;CD93;GGH;PRDX6;DYNC1H1;SDCBP;ARSA;COTL1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.8510034069200498,1.6957782372812407,0.0013908205841446453,0.041366920309703355,0.991,6/12,2.62%,CTSS;CTSB;GATA1;BRD8;GAS2L1;CTSL
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.6033567988416297,-1.6945329642200389,0.0211864406779661,0.6447704821157393,1.0,5/16,20.47%,CLDN5;CLDN11;CLDN14;CLDN12;CLDN1
prerank,negative regulation of B cell proliferation (GO:0030889),0.8498235311619622,1.6936407624039802,0.002758620689655172,0.04268145133521053,0.993,6/11,10.63%,LYN;FCGR2B;CD300A;TYROBP;RC3H1;TNFRSF21
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.8136830017986745,1.6926114274047448,0.009259259259259259,0.043312225626586105,0.993,4/14,3.45%,PTPRC;TREM2;CD200R1;CST7
prerank,monocyte chemotaxis (GO:0002548),0.7308119144747566,1.6920885609408192,0.0034965034965034965,0.04354360412850673,0.994,9/32,11.55%,LGALS3;TNFRSF11A;CCL8;IL6R;ANXA1;CCL14;CCL13;PTPRO;CCL2
prerank,dendritic cell migration (GO:0036336),0.8013381135256016,1.6919327203764707,0.005188067444876783,0.04343310483041026,0.995,5/16,9.45%,PIK3CG;CCR2;CXCR4;HMGB1;GPR183
prerank,prostaglandin metabolic process (GO:0006693),0.7449584492612749,1.6909510436146007,0.0035671819262782403,0.04404372750026946,0.995,6/26,4.51%,TBXAS1;CD74;DAGLB;PTGES3;HPGDS;HPGD
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.8266795912566265,1.6903871863495792,0.005471956224350205,0.044228160818550605,0.995,5/13,9.31%,FGR;SYK;ITGB2;GAB2;ITGAM
prerank,positive regulation of superoxide anion generation (GO:0032930),0.830537030873832,1.6901459554088087,0.003989361702127659,0.04416581103091139,0.995,6/13,9.31%,TGFB1;SYK;ITGB2;PRKCD;TYROBP;ITGAM
prerank,receptor metabolic process (GO:0043112),0.6967725359603556,1.6898981686360208,0.0010604453870625664,0.04417606526101154,0.995,29/53,18.52%,ARRB2;LILRB1;TGFB1;SYK;ITGB2;LGMN;GRB2;CD9;GRK3;SNCA;FCER1G;LDLRAP1;DNM2;RAMP1;RAB31;UVRAG;ARFGEF2;CLTC;BECN1;SNX25;GRK4;LRP1;AP2M1;CD36;SMURF1;PIK3R4;ADM;PICALM;ITGB1
prerank,erythrocyte differentiation (GO:0030218),0.7046744461555827,1.689214887437862,0.002190580503833516,0.0444888921932933,0.997,13/44,12.56%,NCKAP1L;LYN;IKZF1;HCLS1;GATA1;ACIN1;TAL1;EPO;ATP5IF1;SLC25A38;INHBA;SH2B3;RPS14
prerank,neutrophil mediated immunity (GO:0002446),0.6535140717668101,1.6871858932646684,0.0,0.04601905242311156,0.999,125/432,12.57%,ARHGAP45;NCKAP1L;PTPRC;CTSS;HK3;DOCK2;TUBB;CLEC4D;LILRB3;ITGAL;FGR;LGALS3;GMFG;PTAFR;P2RX1;CYBB;MGAM;ITGAX;HPSE;SLC11A1;ARHGAP9;BIN2;ITGB2;CLEC5A;CTSB;HEXB;TMC6;GUSB;ATP8B4;UNC13D;SIRPA;CD300A;CTSD;IQGAP2;TBC1D10C;CTSC;CTSA;ADAM8;PRKCD;PTPRJ;TLR2;TCIRG1;LPCAT1;OSTF1;ARSB;ADGRE5;MAPK14;GNS;PFKL;ATP8A1;GM2A;PSAP;NPC2;ATG7;FCER1G;SLC2A3;TTR;PPIE;DNAJC3;LAIR1;PYCARD;RAB14;CD68;GYG1;NBEAL2;CD14;CPPED1;RAP1B;RAB7A;NFAM1;CD44;ADGRG3;HMGB1;XRCC5;APAF1;ARL8A;B4GALT1;CDA;TYROBP;STK10;FUCA1;VPS35L;IRAG2;STXBP3;SVIP;EPX;RAP2B;FABP5;DNAJC13;CAP1;PNP;TSPAN14;ACTR10;TMEM179B;RAB31;SLC44A2;PAFAH1B2;CCT8;CTSZ;MAN2B1;FTL;SNAP29;ITGAM;ATP6AP2;VCL;SYNGR1;FGL2;ACTR2;TMEM63A;ATP6V0A1;DIAPH1;PSMA2;CD53;CYFIP1;GPI;CD63;GRN;TNFRSF1B;CD93;GGH;PRDX6;DYNC1H1;SDCBP;ARSA;COTL1
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.5979537604397753,-1.6847171338055735,0.008368200836820083,0.6429691853841721,1.0,10/15,32.99%,RAI2;STOX2;RICTOR;UBR3;USP22;TGFB2;CELF4;SCEL;NR5A2;BRCA1
prerank,intracellular pH reduction (GO:0051452),0.730333231220499,1.6836237064501982,0.0011534025374855825,0.04867089349118029,1.0,11/33,7.43%,ATP6V0D2;SLC11A1;SLAMF8;ATP6V0E1;RAB39A;TCIRG1;ATP6V1C1;ATP6V1E1;ATP6V0A2;RAB7A;ATP6V0D1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.6980897389490005,1.6825232376727686,0.0011098779134295228,0.04933950678317335,1.0,7/42,5.04%,TREM2;SLC11A1;AQP1;MPEG1;IL6R;PYCARD;DMBT1
prerank,activation of phospholipase C activity (GO:0007202),0.7460394018599198,1.6811160465254633,0.0011862396204033216,0.05026506792780889,1.0,7/29,7.66%,GNA15;CD86;PLCB2;P2RY6;GNAQ;S1PR4;P2RY12
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.8210432325475652,1.67843790218706,0.004005340453938585,0.052413567237058,1.0,5/14,6.68%,SYK;RASAL3;CCR2;IL18;TGFBR2
prerank,regulation of lymphocyte proliferation (GO:0050670),0.7882704936076581,1.678369498031529,0.010230179028132993,0.05217789934117009,1.0,3/16,4.38%,CD22;LGALS3;TNFSF8
prerank,vesicle transport along actin filament (GO:0030050),0.7754137438845596,1.6772871681414794,0.007653061224489796,0.05283039552032377,1.0,7/19,8.47%,MYO1F;MYO1G;MYO1E;MYO5A;ACTN4;MYO7A;MYO19
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.808875573079793,1.6772793698432138,0.0039946737683089215,0.052579179435098475,1.0,4/14,4.09%,CD226;CARD11;KCNN4;PRKD2
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.7757207826376079,1.6764305672909519,0.0038363171355498722,0.053259670787453924,1.0,5/18,4.50%,PTK2B;LYN;CAMK1D;MDK;IL6R
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.8031338141929608,1.6752597422637703,0.0012804097311139564,0.0541003397785248,1.0,5/17,5.96%,NCKAP1L;CD74;CAMK1D;MDK;RIPOR2
prerank,hyaluronan catabolic process (GO:0030214),0.7887455802850392,1.673291343497168,0.0038314176245210726,0.05582619194950623,1.0,7/18,7.37%,TGFB1;HEXB;GUSB;HEXA;CD44;STAB2;SLC9A1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.7031144407536615,1.6727348646148414,0.003401360544217687,0.05603020190019304,1.0,8/41,5.09%,SLAMF1;LILRB1;SIRPA;VSIR;HAVCR2;NLRC3;NR1H4;TNFAIP3
prerank,phagolysosome assembly (GO:0001845),0.841171599832055,1.6723733069488698,0.005479452054794521,0.056072703302901684,1.0,7/12,5.43%,CORO1A;RAB39A;RAB34;CLN3;RAB14;RAB7A;RAB7B
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.7882203995448249,1.6721552141035656,0.007761966364812419,0.056048244473050735,1.0,5/17,9.61%,NCKAP1L;CD3E;SYK;P2RY12;PODXL
prerank,phagosome acidification (GO:0090383),0.7458981389692443,1.6719069522173284,0.0035671819262782403,0.05595273218651591,1.0,11/26,10.51%,ATP6V0D2;SLAMF8;ATP6V0E1;RAB39A;TCIRG1;ATP6V1C1;ATP6V1E1;ATP6V0A2;RAB7A;ATP6V0D1;ATP6V0A1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.7652944670610405,1.6707721570585523,0.008641975308641974,0.05683111011745968,1.0,8/21,6.13%,PTPRC;CD226;CARD11;STAP1;KCNN4;PRKD2;NFAM1;PRKCB
prerank,positive regulation of calcium ion import (GO:0090280),0.8419035699695263,1.670122704849752,0.00423728813559322,0.057216758218153745,1.0,2/12,0.54%,LGALS3;CALCR
prerank,presynapse organization (GO:0099172),-0.6732956967569355,-1.670019328242017,0.014336917562724014,0.6744895602468506,1.0,4/10,17.63%,NLGN1;WNT5A;LRRTM3;FZD1
prerank,regulation of T cell differentiation (GO:0045580),0.7174457865645826,1.6693085041358713,0.0033783783783783786,0.05773410440687857,1.0,4/33,3.02%,RUNX1;CCR2;CRTAM;MDK
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.6606492470596732,1.6681511810752845,0.0,0.05853601252208385,1.0,26/117,13.49%,TSHB;TREM2;FGR;LYN;CALCR;HCK;SYK;ADCY7;PRKAR2B;PLCG2;CYSLTR2;MAPK14;FCGR1A;ADCY6;RHBDF2;MYH9;RAMP1;PLK2;CYSLTR1;YES1;PRKACB;IAPP;FYN;CREB1;ADCY3;ADCY8
prerank,mesoderm development (GO:0007498),0.7812803591015606,1.6680323922702085,0.010430247718383311,0.05839595878970951,1.0,4/18,2.20%,BTK;HCK;IKZF1;HES7
prerank,positive regulation of lipid kinase activity (GO:0090218),0.7320390463805094,1.6678991308597086,0.003472222222222222,0.05823747816109427,1.0,5/29,1.24%,PTK2B;FGR;TGFB1;FLT3;DGKZ
prerank,negative regulation of interleukin-12 production (GO:0032695),0.795640887113851,1.6673771740208545,0.00804289544235925,0.058503748366466976,1.0,5/14,11.24%,SLAMF1;LILRB1;TLR8;CMKLR1;THBS1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.8358865968750608,1.667175695493784,0.002828854314002829,0.05841973401957559,1.0,2/11,0.65%,PF4;CIITA
prerank,prostaglandin biosynthetic process (GO:0001516),0.7717331028594173,1.6661845025002269,0.007594936708860759,0.05917491230658092,1.0,5/18,3.21%,TBXAS1;CD74;DAGLB;PTGES3;HPGDS
prerank,muscle organ development (GO:0007517),-0.4201426166108082,-1.6653042767610042,0.0,0.6507454685126421,1.0,21/54,18.19%,SGCD;UTRN;TCF12;FHL1;CHD2;MRAS;DMD;VAMP5;COL6A3;MKX;SRI;TEAD4;EVC;SGCE;ITGA11;TBX1;MAPK12;EMD;MEF2B;TAGLN;HBEGF
prerank,negative regulation of leukocyte activation (GO:0002695),0.8042194986442003,1.6644791830094414,0.004054054054054054,0.060660326105043225,1.0,5/15,5.11%,CD84;FCGR2B;CD300A;HAVCR2;CD300LF
prerank,regulation of superoxide anion generation (GO:0032928),0.8155897831428133,1.6644559844822369,0.005270092226613966,0.060383849271969006,1.0,6/14,9.31%,TGFB1;SYK;ITGB2;PRKCD;TYROBP;ITGAM
prerank,positive regulation of T cell differentiation (GO:0045582),0.71191432859237,1.6642940339385348,0.0033594624860022394,0.06025894584177003,1.0,7/36,8.91%,NCKAP1L;SHH;VSIR;ADAM8;MDK;PNP;DUSP10
prerank,negative regulation of phagocytosis (GO:0050765),0.7884885794958413,1.6631128894122489,0.002577319587628866,0.06124014398791461,1.0,6/17,5.85%,FCGR2B;SIRPA;CD300A;TLR2;CD300LF;HMGB1
prerank,myeloid leukocyte differentiation (GO:0002573),0.6691628746279746,1.6622911454201268,0.003157894736842105,0.061683741775124735,1.0,15/65,6.68%,RUNX1;BATF3;TREM2;PIK3CD;CBFA2T3;CSF1R;TNFRSF11A;MAPK14;CEBPA;SPI1;MYH9;EFNA2;TYROBP;GAB2;TGFBR2
prerank,pinocytosis (GO:0006907),0.8596682969041292,1.6617462409629113,0.004405286343612335,0.06189102236714747,1.0,6/10,4.90%,DOCK2;MAPKAPK3;SNX5;RAB34;PYCARD;SNX33
prerank,hyaluronan metabolic process (GO:0030212),0.7465610304285717,1.6599064719584613,0.0036452004860267314,0.06343605947007228,1.0,7/23,7.37%,TGFB1;HEXB;GUSB;HEXA;CD44;STAB2;SLC9A1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.8386512157963631,1.6579789187820404,0.008486562942008486,0.06535664832421932,1.0,4/11,9.75%,RUNX1;VSIR;HMGB1;CD274
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.8584128551332191,1.6575748583074,0.002902757619738752,0.06546953326203371,1.0,2/11,0.35%,PTPRC;LILRB1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.8649199747332875,1.6569664299922575,0.0029411764705882353,0.06583729665980424,1.0,4/10,5.85%,NCKAP1L;RUNX1;IRF4;HMGB1
prerank,protein autoprocessing (GO:0016540),0.7657689798190175,1.6560628431534732,0.00902061855670103,0.06640552927955325,1.0,4/17,5.12%,PCSK9;FAM111A;CTSL;CASP1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.848357267798695,1.655466552863767,0.002824858757062147,0.06677959598104857,1.0,3/11,5.06%,ARRB2;GRK3;SAG
prerank,regulation of chemotaxis (GO:0050920),0.7204617569517576,1.655361980609615,0.005841121495327103,0.06662243268582539,1.0,12/30,13.67%,TREM2;TGFB1;CYRIB;DUSP3;CXCR4;P2RX4;AIF1;P2RY12;GPR183;THBS1;STX3;ZSWIM6
prerank,triglyceride catabolic process (GO:0019433),0.7546054376601127,1.6548522385078388,0.01038961038961039,0.06676370485990119,1.0,4/19,8.57%,LPL;FABP4;FABP5;LIPC
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.7887655995325304,1.6547129264758345,0.008152173913043478,0.06660345978229996,1.0,3/14,7.31%,PTK2B;CCR2;WNK1
prerank,regulation of interleukin-8 production (GO:0032677),0.6635753996477396,1.6538023663440644,0.0020855057351407717,0.06733690224118581,1.0,16/69,7.46%,PTPRC;SYK;CD74;TLR1;TLR2;TLR8;TLR7;FFAR2;TNF;PRKD2;PYCARD;DDIT3;CD14;HMGB1;ANXA1;TMSB4X
prerank,regulation of acute inflammatory response (GO:0002673),0.7635099809504065,1.6521347143399798,0.011479591836734694,0.06901084272597303,1.0,3/18,3.52%,ADAM8;OSM;FFAR2
prerank,regulation of macrophage chemotaxis (GO:0010758),0.7618410692723161,1.6517559565136708,0.006165228113440197,0.06913018184640954,1.0,8/21,11.24%,PTK2B;STAP1;SLAMF8;CSF1R;MDK;AKIRIN1;CMKLR1;THBS1
prerank,T cell receptor signaling pathway (GO:0050852),0.6498617724381712,1.6510963096722018,0.0,0.06948985605015806,1.0,44/138,15.61%,THEMIS2;PTPRC;LCP2;GRAP2;INPP5D;FYB1;CARD11;CD3E;RFTN1;LAT;PIK3CD;PLCG2;PTPRJ;THY1;PIK3CB;TEC;THEMIS;PRKD2;BTN3A3;PSMB10;WNK1;NFKBID;RC3H2;MALT1;PRKCQ;DENND1B;RC3H1;SPPL3;BCAR1;EIF2B2;TNFRSF21;PSMA2;TXK;FYN;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;PAG1;ICOSLG;PSMD7;PSMB9
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.6882267675333784,1.6477395439044373,0.006696428571428571,0.07299291766902408,1.0,10/43,9.75%,SLAMF1;LILRB1;SIRPA;VSIR;HAVCR2;NLRC3;NR1H4;TNFAIP3;TRIM27;CD274
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.6738542769946086,1.6463592977797403,0.004415011037527594,0.07446272475661117,1.0,9/49,7.60%,LYN;HCLS1;FLT3;CSF1R;OSM;TNF;IL6R;IL18;EPO
prerank,vitamin D metabolic process (GO:0042359),0.8264064025807395,1.6429892678997406,0.005509641873278237,0.0780244565337624,1.0,2/13,1.26%,CYP1A1;LGMN
prerank,T cell homeostasis (GO:0043029),0.8491707599170564,1.6417916473774528,0.007062146892655367,0.07924917841585888,1.0,1/10,0.04%,NCKAP1L
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.8247866125599111,1.641483345617147,0.005641748942172073,0.0792167174494056,1.0,3/12,8.09%,SLC11A1;CCR2;PRKCQ
prerank,positive regulation of bone resorption (GO:0045780),0.8475144389197378,1.6398987824654871,0.005649717514124294,0.08092686252803569,1.0,6/11,11.02%,SYK;ADAM8;TNFRSF11A;SPP1;PLEKHM1;ATP6AP1
prerank,response to interferon-gamma (GO:0034341),0.6549534780859435,1.639491043745909,0.0010672358591248667,0.08110009883449253,1.0,17/67,11.55%,CIITA;IRF8;SLC11A1;CD74;SIRPA;TLR2;CCL8;SNCA;GCH1;CASP1;AIF1;KYNU;CCL14;EPRS1;CCL13;GBP3;CCL2
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.6394999914131106,1.6392151263227448,0.0,0.08108615337420234,1.0,27/150,7.98%,CD86;VAV1;CALCR;PIK3CG;PIK3R5;HPSE;TGFB1;CX3CR1;CASS4;HCLS1;FLT3;F10;PIK3CD;PIK3AP1;TGFBR1;ADAM8;PTPRJ;GRB2;PIK3CB;OSM;TNF;IL18;P2RX4;GAB2;CD80;P2RY12;FLT3LG
prerank,receptor internalization (GO:0031623),0.6924051163710936,1.6384773894485716,0.0010695187165775401,0.08173036572550321,1.0,15/44,9.24%,ARRB2;LILRB1;SYK;ITGB2;GRB2;CD9;GRK3;SNCA;FCER1G;LDLRAP1;SAG;DNM2;RAMP1;RAB31;SCYL2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.7298026180107402,1.637339628670948,0.00963855421686747,0.082780347846579,1.0,10/25,13.47%,CD226;SCIMP;LAPTM5;PLCG2;FFAR2;TRAF2;MALT1;NOD2;B2M;LACC1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.764565667633349,1.6372326251630627,0.007585335018963337,0.08257191223010547,1.0,8/21,6.13%,RUNX1;CD22;LYN;FCGR2B;STAP1;CD300A;NFAM1;PRKCB
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.6659350178417853,1.6349552183777898,0.0010460251046025104,0.0849178821653835,1.0,9/67,2.77%,PTK2B;BTK;FGR;LYN;HCK;SYK;FLT3;CSF1R;TEC
prerank,actin filament-based transport (GO:0099515),0.7411505616165773,1.6323537311223306,0.012453300124533,0.0878408698833379,1.0,7/21,8.47%,MYO1F;MYO1G;MYO1E;MYO5A;ACTN4;MYO7A;MYO19
prerank,regulation of monocyte chemotaxis (GO:0090025),0.7269251935767903,1.6308990048186804,0.009925558312655087,0.0892780893686795,1.0,8/24,8.34%,LYN;CCR2;LGMN;SLAMF8;CREB3;HMGB1;AIF1;PLA2G7
prerank,negative regulation of interleukin-2 production (GO:0032703),0.7570496273345664,1.6303701364241996,0.011494252873563218,0.08960020160262464,1.0,5/18,8.56%,PTPRC;LAPTM5;HAVCR2;TNFAIP3;TRIM27
prerank,pyroptosis (GO:0070269),0.7732914943743099,1.6302582114601376,0.016129032258064516,0.08936818363646262,1.0,4/15,5.12%,TREM2;AIM2;DHX9;CASP1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.7681382531208933,1.6302173068316275,0.008108108108108109,0.08905483095891542,1.0,6/17,8.34%,CCR2;LGMN;CREB3;HMGB1;AIF1;PLA2G7
prerank,regulation of cholesterol storage (GO:0010885),0.7825448078350326,1.6297432147402287,0.007905138339920948,0.08929105066968178,1.0,6/15,4.11%,TREM2;LPL;ABCA1;MSR1;SREBF2;ABCG1
prerank,regulation of platelet aggregation (GO:0090330),0.7660328720359589,1.6279590415572807,0.01278772378516624,0.09141988556308016,1.0,8/17,10.93%,LYN;SYK;ALOX12;PRKCD;CD9;PRKCQ;F11R;SH2B3
prerank,negative regulation of complement activation (GO:0045916),-0.6698101457225595,-1.6270780566820036,0.019543973941368076,0.817437831563683,1.0,4/10,8.07%,CD55;SERPING1;CR1L;CD46
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.8175204552715494,1.6264863555626483,0.014084507042253521,0.09309997492159708,1.0,3/12,3.90%,LYN;CSF1R;OCSTAMP
prerank,negative regulation of type I interferon production (GO:0032480),0.6919083681435249,1.6261001516717124,0.0033632286995515697,0.09324757334521101,1.0,15/40,13.54%,LILRB1;SIRPA;NLRC5;HAVCR2;TRIM25;NLRC3;PYCARD;TNFAIP3;YY1;TAX1BP1;RNF216;NLRX1;RNF135;ITCH;GPATCH3
prerank,positive regulation of phospholipase C activity (GO:0010863),0.6852715358476705,1.6257301789941436,0.0011098779134295228,0.09340623017278009,1.0,9/40,10.99%,GNA15;CD86;PLCB2;P2RY6;GNAQ;S1PR4;P2RY12;NTF3;TXK
prerank,regulation of interferon-beta production (GO:0032648),0.6740761778210292,1.6237025543663652,0.00437636761487965,0.09579771635354228,1.0,15/46,13.88%,LILRB1;IRF5;SIRPA;TLR2;DHX9;TLR8;TLR7;NLRC3;PYCARD;TRAF3;YY1;TRIM56;RNF216;RNF135;IRF1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.6256894137421398,1.622486509806777,0.0,0.09706171435665716,1.0,21/151,5.85%,ARRB2;PTPRC;PTK2B;SLAMF1;TREM2;SCIMP;GPNMB;CALCR;TGFB1;CD74;P2RY6;CSF1R;DSTYK;TNFRSF11A;CCL8;TNF;PRKD2;APOE;PYCARD;CD44;HMGB1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.7685801337654067,1.619916951784019,0.01164294954721863,0.10047583697473432,1.0,1/17,0.08%,PLBD1
prerank,cellular response to interleukin-2 (GO:0071352),0.8354904920099924,1.6194807951228263,0.00851063829787234,0.10025865802190398,1.0,3/11,1.35%,PTK2B;SYK;STAT5A
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.8354904920099924,1.6194807951228263,0.00851063829787234,0.10025865802190398,1.0,3/11,1.35%,PTK2B;SYK;STAT5A
prerank,keratan sulfate catabolic process (GO:0042340),0.8143610748239155,1.6189228097166155,0.018387553041018388,0.10070496649962958,1.0,5/11,6.81%,HEXB;PRELP;GNS;HEXA;FMOD
prerank,lymphocyte migration (GO:0072676),0.6971056375281921,1.6185370303331945,0.00683371298405467,0.10081851151639488,1.0,7/32,11.55%,MYO1G;CRTAM;ADAM8;CCL8;CCL14;CCL13;CCL2
prerank,prostanoid biosynthetic process (GO:0046457),0.7772539441970596,1.6179910168360687,0.009308510638297872,0.10125525980417223,1.0,4/15,2.88%,TBXAS1;CD74;DAGLB;PTGES3
prerank,macrophage activation involved in immune response (GO:0002281),0.8038874594126703,1.6172938532829368,0.013831258644536652,0.1019288051956817,1.0,7/13,11.64%,TREM2;CX3CR1;SYK;PLCG2;TYROBP;DYSF;GRN
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.7775283307094154,1.6170523759827404,0.011936339522546418,0.10188732344570678,1.0,6/16,7.24%,TREM2;ADCY7;SIRPA;NLRC3;PYCARD;ABCD1
prerank,regulation of adaptive immune response (GO:0002819),0.7461017919706306,1.6151344457667507,0.015503875968992248,0.10424502060392125,1.0,7/18,13.88%,FCGR2B;ADCY7;PYCARD;SAMSN1;TRIM27;SASH3;IRF1
prerank,response to lipopolysaccharide (GO:0032496),0.6313953828902567,1.6148425857371786,0.0,0.10425342869916125,1.0,38/138,13.46%,CD86;LILRB1;PF4;SLC11A1;CX3CR1;CXCL5;STAP1;PDCD1LG2;MAPKAPK3;IL1A;SIRPA;CXCL2;TNFRSF11A;MAPK14;SNCA;GCH1;IFNAR1;PYCARD;CD68;TNFAIP3;CD14;CASP1;HMGB1;CD80;TICAM1;ERBIN;CD180;MEF2C;LY96;CD274;CCL2;TNFRSF1B;PRDX3;NOD2;DEFA6;TAB2;SHPK;NFKB1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.632452181215574,1.6136079784406125,0.0,0.10585148402901388,1.0,28/138,11.29%,LCP2;SLA;PTK2B;GP6;BLNK;FGR;LYN;HCK;CD3E;SYK;CASS4;STAP1;FLT3;CD7;CSF1R;PIK3CB;GUCY2F;CLNK;SHC2;MTSS1;NEDD9;NTF3;ABI1;BCAR1;NPR2;YES1;RAPGEF1;PTPRU
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.7309210131308848,1.6133656482522296,0.01098901098901099,0.10581127670603209,1.0,7/22,11.85%,NCKAP1L;LGALS3;MGAT5;TNF;PPP1R11;BOD1L1;PPP4R4
prerank,positive regulation of chemotaxis (GO:0050921),0.6671247811195011,1.6126427533490033,0.005488474204171241,0.10647174241514441,1.0,16/43,13.51%,TREM2;TGFB1;CCR2;LGMN;SMOC2;MDK;PRKD2;IL6R;P2RX4;AIF1;TMSB4X;P2RY12;NRP1;THBS1;STX3;MEGF8
prerank,negative regulation of immune effector process (GO:0002698),0.8046262106210449,1.6125009846475944,0.014725568942436412,0.10630299852894258,1.0,5/13,1.96%,LILRB1;LGALS3;CD300A;HAVCR2;SLAMF8
prerank,negative regulation of macrophage activation (GO:0043031),0.7646093838702849,1.6124184861388644,0.015523932729624839,0.1060132907915447,1.0,3/16,3.45%,PTPRC;FCGR2B;CST7
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.7270141205614598,1.611343932927718,0.01090909090909091,0.10736961544830823,1.0,5/23,7.72%,PTK2B;IL10RA;IL10RB;TNF;OCIAD1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.6684700970517885,1.6111126878260429,0.006550218340611353,0.10730178291316234,1.0,13/47,11.24%,TGFB1;SYK;ITGB2;PLCG2;PRKCD;GRB2;MAPK14;XDH;TYROBP;TGFBR2;TP53;ITGAM;THBS1
prerank,negative regulation of inflammatory response (GO:0050728),0.6304112145631058,1.610736722599168,0.0,0.10742331053448508,1.0,42/182,13.49%,TSHB;TREM2;FGR;LYN;CALCR;HCK;SYK;ADCY7;SIRPA;CD200R1;METRNL;PRKAR2B;SLAMF8;PLCG2;CYSLTR2;PRKCD;MDK;MAPK14;FCGR1A;NLRC3;NR1H4;APOE;OTULIN;ADCY6;RHBDF2;TNFAIP3;MYH9;RAMP1;PLK2;RB1;CYSLTR1;YES1;PRKACB;GRN;TNFRSF1B;IAPP;FYN;CREB1;GPS2;FNDC4;ADCY3;ADCY8
prerank,macrophage activation (GO:0042116),0.6835179872326145,1.6095670736464214,0.010392609699769052,0.10880088817838081,1.0,13/34,11.79%,TREM2;SLC11A1;SYK;ITGB2;TLR1;PLCG2;TNF;SNCA;AIF1;C1QA;ITGAM;DYSF;CD93
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.7703525290590149,1.6087204060112519,0.02080624187256177,0.1097409284874547,1.0,3/15,1.16%,SHH;SYK;CCR2
prerank,response to amyloid-beta (GO:1904645),0.6648933074126517,1.6076274578900231,0.006528835690968444,0.11091693645315039,1.0,6/44,1.53%,TREM2;MMP12;CALCR;FCGR2B;LGMN;ITGA4
prerank,positive regulation of interferon-alpha production (GO:0032727),0.7485582113661244,1.6075346369200465,0.014814814814814815,0.11067738113823995,1.0,4/19,2.91%,IRF5;DHX9;TLR8;TLR7
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.7796331496192727,1.604374547710271,0.024226110363391656,0.1152424105608187,1.0,6/14,7.90%,CD86;IL18;ANXA1;CD80;NFKBID;MALT1
prerank,regulation of BMP signaling pathway (GO:0030510),-0.37724149387682954,-1.6029521735801422,0.0,0.9177724032066032,1.0,21/73,13.87%,FSTL1;CDH5;CRIM1;BMPR1A;BMPER;FOXD1;NBL1;BMP4;SULF1;ZNF423;ACVRL1;SMAD9;XIAP;PCSK6;SMAD4;SMAD5;SMAD1;TWSG1;CCN1;SMAD6;UBE2O
prerank,regulation of sequestering of triglyceride (GO:0010889),0.7611980197380205,1.602498064776762,0.027359781121751026,0.11782701710133278,1.0,5/15,8.24%,TREM2;LPL;PLIN2;OSBPL11;PLIN3
prerank,fibrinolysis (GO:0042730),0.7912356710853604,1.6022860284505025,0.017980636237897647,0.11773824835616802,1.0,1/13,0.82%,GP1BA
prerank,negative regulation of transport (GO:0051051),0.6707190032079797,1.6020571102352665,0.005382131324004306,0.11774550694040592,1.0,10/51,5.43%,LILRB1;LGALS3;FCGR2B;SIRPA;ITGB3;TLR2;SNCA;MCTP1;SNX33;RAB7A
prerank,negative regulation of bone mineralization (GO:0030502),0.7838454581912366,1.5997287487262368,0.015047879616963064,0.12106850726052554,1.0,2/13,1.55%,PTK2B;SRGN
prerank,"phagocytosis, engulfment (GO:0006911)",0.6806926375424861,1.5991567285526516,0.004419889502762431,0.12159570734276585,1.0,11/36,11.24%,ARHGAP25;BIN2;ITGB2;FCGR2B;ELMO1;MSR1;FCGR1A;MYH9;AIF1;ITGAM;THBS1
prerank,platelet degranulation (GO:0002576),0.6291370894519466,1.5984549120184655,0.0,0.1222389535898115,1.0,33/118,13.40%,FERMT3;PF4;LYN;MMRN1;ITGA2B;LY6G6F;TGFB1;PLEK;SRGN;ITGB3;CYRIB;F13A1;CD9;PSAP;TUBA4A;TTN;CYB5R1;TIMP1;LHFPL2;ACTN4;VEGFB;TMSB4X;SYTL4;VCL;ACTN1;BRPF3;THBS1;CD63;TLN1;F5;TEX264;NHLRC2;GAS6
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.7520460514666728,1.5979800109334168,0.01507537688442211,0.12252318524439709,1.0,4/18,7.06%,GNA15;RGS10;GNAQ;AGRN
prerank,glycosaminoglycan catabolic process (GO:0006027),0.6579787112817328,1.596667551850508,0.0021598272138228943,0.12411377303182178,1.0,16/55,9.07%,HPSE;TGFB1;HEXB;GUSB;PRELP;ARSB;GNS;IDS;HEXA;CD44;STAB2;FUCA1;FMOD;AGRN;SLC9A1;BCAN
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.736235279968949,1.5962272481974906,0.013447432762836185,0.12434633202777215,1.0,11/20,19.16%,MRAP;TGFB1;BCL2L1;CLTC;NUMB;PPFIA1;PID1;AP2M1;PICALM;CSK;TMEM59
prerank,response to peptide (GO:1901652),0.6938852485433566,1.5948883647352117,0.009101251422070534,0.12599458300163568,1.0,14/33,13.80%,IRF5;MMP12;CALCR;STAT5A;ANXA1;STAT4;CACNA1A;ERBIN;STAT5B;EIF2B2;NOD2;FYN;KAT7;CACNA1B
prerank,receptor-mediated endocytosis (GO:0006898),0.6280793883528207,1.5946022669422923,0.0,0.12605847031967266,1.0,48/132,18.52%,CLEC9A;ARRB2;LILRB1;SYK;ITGB2;FCGR2B;GRB2;CTSL;CD9;MSR1;FCGR1A;MASP1;GRK3;SNX9;SNCA;FCER1G;PIP5K1C;APOE;LDLRAP1;CLN3;STAB2;STAB1;DNM2;MICALL1;AP2S1;RAMP1;GPR107;DNAJC13;RAB31;ITGAM;CLTC;ARHGAP27;GRK4;SORL1;FNBP1L;CUBN;GAK;EPS15;LRP1;AP2M1;CD36;CXCL16;HSP90AA1;VLDLR;ADM;PICALM;LRP1B;ITGB1
prerank,stem cell differentiation (GO:0048863),0.6728771085412107,1.5943548618689245,0.012443438914027148,0.12602594971827996,1.0,10/39,12.31%,PTPRC;MEOX1;SHH;SP7;EEF1AKMT4-ECE2;TP53;SETD6;MEF2C;SETD2;MTF2
prerank,positive regulation of interleukin-10 production (GO:0032733),0.6904608043973388,1.5939346430495014,0.01527614571092832,0.12625575724302984,1.0,7/30,12.24%,IRF4;SYK;PLCG2;PYCARD;HMGB1;CD274;NOD2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.8074767144836349,1.593929650455898,0.018544935805991442,0.12583451144214566,1.0,4/10,9.61%,FERMT3;CD3E;WNK1;PODXL
prerank,cellular response to cytokine stimulus (GO:0071345),0.6133568977522549,1.5921245179231773,0.0,0.12843777077864196,1.0,121/416,16.88%,CD86;SLA;GRAP2;VAV1;DOCK8;IRF5;INPP5D;PTPN7;PF4;PTAFR;IL10RA;HCK;ITGAX;IRF4;IRF8;TGFB1;SYK;ITGB2;HCLS1;FLT3;CCR2;CSF3R;AIM2;STAT5A;NFE2L2;IL1A;SIRPA;IRAK2;CSF2RB;PIK3CD;IL10RB;CBL;CSF1R;F13A1;TYK2;CXCL2;PTPRJ;TLR2;GRB2;PIK3CB;TEC;DHX9;OSM;PTPN18;IL12RB2;CCL8;TNF;OCSTAMP;LDLRAP1;MYLK3;TANK;IL6R;CEBPA;IFNAR1;CXCR4;FOXO3;PYCARD;IL18;CASP1;TIMP1;IFNGR2;RIPOR2;ANXA1;BCL2L1;AIF1;GAB2;TP53;CD80;PIM1;WNK1;STAT4;ERBIN;FLT3LG;SMAD3;RC3H1;CCL14;ITGAM;EPRS1;STAT5B;TPR;NPR2;TNFRSF21;IL18BP;SH2B3;CCL13;RAPGEF1;SOX9;GBP3;CCL2;TNFRSF1B;CDC34;FYN;STX3;LRP8;PRLR;SHPK;UBE2G2;GAS6;NFKB1;TRADD;IRF1;PID1;IL2RG;PTPRT;SOX2;RO60;MAOA;IL3RA;SELPLG;GSK3A;IL13RA1;CD36;IRGM;HIF1A;SBNO2;CD47;HSP90AA1;ASAH1;PTPN12;CCL25;IL20RB
prerank,regulation of protein processing (GO:0070613),0.7378797721140147,1.591904116272714,0.009626955475330927,0.1283484697645556,1.0,4/21,4.53%,RUNX1;BAG2;ADAM8;CLN3
prerank,vacuolar acidification (GO:0007035),0.7405414519612591,1.5915999111100103,0.015037593984962405,0.1284449380187315,1.0,10/21,11.64%,ATP6V0D2;SLC11A1;ATP6V0E1;TCIRG1;CLN3;ATP6V0A2;ATP6V0D1;ATP6AP2;ATP6V0A1;GRN
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.7122297190806542,1.591290815774061,0.013173652694610778,0.12858253038328663,1.0,4/27,1.15%,PTK2B;FGR;TGFB1;FLT3
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.7530924377064787,1.591288996958411,0.012706480304955527,0.1281466573989365,1.0,3/17,2.52%,PTPRC;CD300A;MTOR
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.6939222090461423,1.5896417452666916,0.013953488372093023,0.13053559739850032,1.0,4/29,6.35%,PLBD1;DBI;LPCAT1;LPCAT2
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.7208803428773746,1.5889482332011124,0.010948905109489052,0.13121620512666232,1.0,3/22,3.02%,RUNX1;VSIR;MDK
prerank,positive regulation of acute inflammatory response (GO:0002675),0.7672313991887871,1.5884108270503552,0.020134228187919462,0.13173423675481621,1.0,4/14,3.81%,ADAM8;OSM;FFAR2;TNF
prerank,regulation of erythrocyte differentiation (GO:0045646),0.6725592035248396,1.5873118374903263,0.012443438914027148,0.13325530466477623,1.0,10/35,12.44%,NCKAP1L;LYN;GATA1;MAPK14;FOXO3;SPI1;TAL1;STAT5B;INHBA;CDK6
prerank,regulation of leukocyte migration (GO:0002685),0.7440028117457981,1.5854690216939147,0.020969855832241154,0.13610034855514247,1.0,2/16,6.34%,NCKAP1L;ANXA1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.7163227418198596,1.584659766260089,0.012269938650306749,0.13700507789520852,1.0,2/22,1.26%,CYP1A1;LGMN
prerank,lipid oxidation (GO:0034440),0.78880784171645,1.5843251492827313,0.027142857142857142,0.1371039016627894,1.0,5/12,16.65%,ALOX12;PLA2G7;PPARGC1A;ADIPOR1;ADIPOR2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.630574848653172,1.5843171695782834,0.0,0.1366784397760252,1.0,18/100,5.08%,TREM2;FGR;LYN;PIK3CG;PIK3R5;HCLS1;FLT3;PIK3CD;CBL;PIK3AP1;PIK3CB;OSM;SEMA4D;NLRC3;TNF;PIP5K1C;PIP4K2A;IL18
prerank,iron ion transport (GO:0006826),0.6652384981700377,1.5841029149892005,0.008611410118406888,0.13658239217281026,1.0,18/47,15.44%,ATP6V0D2;SLC11A1;ATP6V0E1;TCIRG1;ATP6V1C1;ATP6V1E1;ATP6V0A2;IREB2;DNM2;ATP6V0D1;HFE;ARHGAP1;ATP6V0A1;ATP6AP1;CLTC;FTH1;ATP6V0B;STEAP3
prerank,leukocyte tethering or rolling (GO:0050901),0.7447111644409832,1.5837709686110988,0.019329896907216496,0.136768889061154,1.0,4/17,3.81%,CX3CR1;ITGA4;GCNT1;TNF
prerank,positive regulation of lipid transport (GO:0032370),0.7811825457685748,1.5824011901499886,0.025936599423631124,0.1385598434809269,1.0,6/12,15.26%,DBI;APOE;SPP1;ABCB4;LRP1;ABCA3
prerank,response to molecule of bacterial origin (GO:0002237),0.6277310747933451,1.5823987657148626,0.001040582726326743,0.138108508485875,1.0,14/69,8.92%,IRF5;SLC11A1;FCGR2B;MAPKAPK3;CYRIB;CXCL2;TNFRSF11A;SNCA;GCH1;IFNAR1;TNFAIP3;CD14;ERBIN;LY96
prerank,cellular defense response (GO:0006968),0.6676329858901346,1.58140106573867,0.009142857142857144,0.13928858860722138,1.0,6/40,2.52%,PTK2B;NCR1;CX3CR1;CLEC5A;TCIRG1;NCF2
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.7234552772162559,1.5811599954148758,0.011002444987775062,0.1392452763652513,1.0,6/23,8.45%,NCKAP1L;CD74;CAMK1D;MDK;RIPOR2;MPP1
prerank,negative regulation of immune system process (GO:0002683),0.7623474316022386,1.5808056104769546,0.02560819462227913,0.13942017529025902,1.0,3/16,1.25%,LYN;FCGR2B;PDCD1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.6180000747154222,1.580768092523557,0.0,0.13906732888628062,1.0,27/140,9.01%,ARHGAP45;ARHGAP30;FGD2;VAV1;ARHGAP25;PREX1;ARHGAP9;ABR;ARHGAP15;ARHGAP39;ARHGAP22;CYRIB;ARHGAP24;NUP62;VAV2;ARHGEF18;ARAP1;VAV3;FAM13B;TAGAP;MYO9B;GNA13;FLCN;ITSN1;ARHGAP21;ARHGAP10;ARHGAP1
prerank,eosinophil migration (GO:0072677),0.7635660679928116,1.5806288007823368,0.03471295060080107,0.13842726616095524,1.0,4/14,11.55%,LGALS3;CCL8;CCL13;CCL2
prerank,eosinophil chemotaxis (GO:0048245),0.7635660679928116,1.5806288007823368,0.03471295060080107,0.13842726616095524,1.0,4/14,11.55%,LGALS3;CCL8;CCL13;CCL2
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.7590842607629599,1.5800858323249216,0.013315579227696404,0.13895461489215058,1.0,4/15,7.81%,LILRB1;TGFB1;TNF;HFE
prerank,regulation of neutrophil migration (GO:1902622),0.8146419969398333,1.5796886335326887,0.024926686217008796,0.1392024007950031,1.0,3/10,8.45%,NCKAP1L;SLAMF8;MPP1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.7427270439045676,1.5796786492537578,0.025974025974025976,0.13877160476793018,1.0,4/18,7.29%,LILRB1;LILRB3;GPR137B;TMEM178A
prerank,cellular response to zinc ion (GO:0071294),0.7613176645874622,1.578479397851139,0.021333333333333333,0.14065231976897052,1.0,13/15,22.27%,P2RX4;GLRA2;HVCN1;ATP13A2;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,positive regulation of locomotion (GO:0040017),0.6976803201526018,1.577249431617564,0.016548463356973995,0.1423860114449745,1.0,7/27,12.76%,TREM2;TGFB1;CSF1R;AIF1;P2RY12;THBS1;STX3
prerank,lipid translocation (GO:0034204),0.7227498405375861,1.5770797951453037,0.021303258145363407,0.1421995760438272,1.0,8/21,12.70%,ATP8B4;ABCA1;RFT1;ATP8A1;ATP8A2;ABCB4;ABCC1;ABCA4
prerank,response to acidic pH (GO:0010447),0.7656448534564335,1.575664592363495,0.01977401129943503,0.14420229093491047,1.0,5/13,12.59%,CTSS;LGMN;SLC9A1;IMPACT;RAB11FIP5
prerank,regulation of macrophage differentiation (GO:0045649),0.7555579561791812,1.5747018110516182,0.02464332036316472,0.14536023971179146,1.0,5/15,12.90%,PF4;C1QC;HSF1;INHBA;CASP8
prerank,lipid modification (GO:0030258),0.6750854983030949,1.574696741226453,0.007865168539325843,0.14491834721653732,1.0,9/37,8.67%,CYP1A1;DGKZ;ALOX12;DGKK;DGKE;DGKG;DGKD;PLA2G7;PLPPR1
prerank,negative regulation of interferon-beta production (GO:0032688),0.8192498390406936,1.5744905827808906,0.01908957415565345,0.14483729900413905,1.0,5/10,7.16%,LILRB1;SIRPA;NLRC3;PYCARD;YY1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.7188718519740888,1.5728472559869038,0.022727272727272728,0.14736634702989249,1.0,7/19,11.24%,CSF1R;CAMK1D;MDK;MPP1;AKIRIN1;CMKLR1;THBS1
prerank,transferrin transport (GO:0033572),0.6851897131261863,1.5722752669482398,0.012600229095074456,0.1479018853050295,1.0,13/33,11.11%,ATP6V0D2;ATP6V0E1;TCIRG1;ATP6V1C1;ATP6V1E1;ATP6V0A2;DNM2;ATP6V0D1;HFE;ARHGAP1;ATP6V0A1;ATP6AP1;CLTC
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.7132307521055802,1.5721232262445715,0.018844221105527637,0.1477433524120248,1.0,8/21,12.98%,CX3CR1;MDK;FZD9;FZD3;CTNNB1;DISC1;NAP1L1;SMARCD3
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.59863937488174,-1.5719915170140215,0.03643724696356275,1.0,1.0,10/13,23.07%,MTM1;FEZ1;TMEM39A;PINK1;CHMP4B;CHMP4A;NUPR1;PHF23;SMCR8;FEZ2
prerank,tryptophan metabolic process (GO:0006568),0.7764268066105711,1.5711615218349848,0.03730272596843615,0.14903513311378125,1.0,4/11,7.82%,ATP7A;HAAO;KYNU;KMO
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.6860495095382732,1.5709735704358085,0.010550996483001172,0.1489646147379419,1.0,10/34,8.92%,TREM2;LYN;CD300A;TNFAIP3;CD14;CD300LF;RAB7B;TICAM1;GRAMD4;LY96
prerank,positive regulation of response to external stimulus (GO:0032103),0.6085419480298184,1.5700924267400944,0.0010090817356205853,0.15003948461596398,1.0,31/128,13.66%,TREM2;SCIMP;TGFB1;CCR2;LPL;GPRC5B;ADAM8;TLR2;DHX9;TLR8;TLR7;LY86;MDK;OSM;TNF;SNCA;CEBPA;IL18;AIF1;USF1;P2RY12;CD180;PLA2G7;LY96;PUM2;ABCC1;THBS1;GRN;STX3;NINJ1;TRADD
prerank,negative regulation of cilium assembly (GO:1902018),-0.5869161235762655,-1.5681091593664627,0.033210332103321034,1.0,1.0,6/12,18.91%,MAP4;CCP110;EVI5L;CEP97;CDK10;TBC1D7
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.6889581565295284,1.5671703827504748,0.018495684340320593,0.15506893449314177,1.0,2/25,0.45%,ARRB2;NPAS4
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.623817526784936,1.5670065663390855,0.0,0.15489114364024853,1.0,22/76,12.90%,ARRB2;TMIGD3;AIM2;IRAK2;NLRC5;HAVCR2;NLRC3;OTULIN;PYCARD;DDIT3;SPI1;TNFAIP3;TRAF3;SETD6;TAX1BP1;TMSB4X;ERBIN;ANXA4;CMKLR1;USP7;DAP;ITCH
prerank,cellular response to copper ion (GO:0071280),0.747143318697437,1.5657660593713836,0.01703800786369594,0.1565180893792183,1.0,12/16,22.27%,AQP1;SNCA;HSF1;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,excitatory postsynaptic potential (GO:0060079),0.7125424423739997,1.564712271601286,0.028423772609819122,0.15796927144312115,1.0,2/19,0.45%,ARRB2;NPAS4
prerank,stem cell development (GO:0048864),0.745787534828858,1.564635401758424,0.029411764705882353,0.15761276917045572,1.0,2/16,0.68%,PTPRC;SHH
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.734449632611946,1.5633460992003774,0.017135862913096694,0.15960202386265324,1.0,10/20,19.16%,MRAP;TGFB1;BCL2L1;CLTC;NUMB;PPFIA1;PID1;AP2M1;PICALM;TMEM59
prerank,macrophage chemotaxis (GO:0048246),0.7994198806616095,1.5631006671208532,0.029154518950437316,0.15959312994710395,1.0,2/10,2.42%,LGALS3;EDNRB
prerank,regulation of innate immune response (GO:0045088),0.6318511893876825,1.5629065191800897,0.0053533190578158455,0.15947797826211313,1.0,18/57,13.88%,TREM2;FGR;FCGR2B;ADAM8;PTPN1;DHX9;TLR8;NLRC3;TRAFD1;TNFAIP3;SAMHD1;RNASEL;USP18;RNF135;CASP8;LRP8;ERAP1;IRF1
prerank,inorganic ion transmembrane transport (GO:0098660),0.7710248120711863,1.5623560133299597,0.03319502074688797,0.15998434180325868,1.0,2/12,4.10%,KCNJ11;PKD2
prerank,regulation of neuroinflammatory response (GO:0150077),0.7129430711936244,1.5617117162524017,0.03291139240506329,0.1607172017976887,1.0,4/19,5.08%,TREM2;CD200R1;TNF;IL18
prerank,erythrocyte development (GO:0048821),0.8083443322410462,1.5612510163763904,0.024390243902439025,0.16110253750650855,1.0,2/10,1.17%,NCKAP1L;GATA1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.6714240788363934,1.5606773798887514,0.01839080459770115,0.16162970027814885,1.0,4/29,4.28%,TGFB1;MYL3;PKP2;TTN
prerank,negative regulation of lipid storage (GO:0010888),0.7181551097179091,1.5606422972846206,0.024081115335868188,0.16122893170984928,1.0,5/19,4.11%,TREM2;ABCA1;ITGB3;TNF;ABCG1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.614161463601723,1.5601829341390658,0.0010111223458038423,0.16159149934427108,1.0,22/109,8.63%,LCP2;GRAP2;VAV1;BTK;LYN;CARD11;SYK;LAT;PLCG2;NFATC1;GRB2;PIK3CB;TEC;VAV2;LAT2;FCER1G;VAV3;GAB2;PSMB10;MALT1;PRKCQ;MAP3K1
prerank,melanocyte differentiation (GO:0030318),0.7841208103676387,1.5584070949540225,0.027472527472527472,0.16440388300187372,1.0,3/11,8.10%,LRMDA;MITF;MEF2C
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.686828130185574,1.558306758153362,0.02035928143712575,0.1640994366375377,1.0,7/27,5.08%,PF4;LPL;ABCA1;ITGB3;MSR1;ABCG1;IL18
prerank,Fc receptor signaling pathway (GO:0038093),0.6151239921010445,1.5581794833511213,0.0010141987829614604,0.163888461584979,1.0,22/110,8.63%,LCP2;GRAP2;VAV1;BTK;LYN;CARD11;SYK;LAT;PLCG2;NFATC1;GRB2;PIK3CB;TEC;VAV2;LAT2;FCER1G;VAV3;GAB2;PSMB10;MALT1;PRKCQ;MAP3K1
prerank,positive regulation of type 2 immune response (GO:0002830),0.7714209627406666,1.55817337475136,0.03212290502793296,0.1634368099124764,1.0,5/14,12.24%,CD86;CD74;IL18;DENND1B;NOD2
prerank,negative regulation of ossification (GO:0030279),0.7043305399518097,1.5571903820984712,0.024600246002460024,0.16497616276894864,1.0,6/23,12.22%,PTK2B;SRGN;MDK;MEF2C;SOX9;CHSY1
prerank,inositol lipid-mediated signaling (GO:0048017),0.6419555530519826,1.5568448880713024,0.009615384615384616,0.1651311147718571,1.0,9/50,6.59%,PTAFR;PIK3CG;PLCB2;PLCL2;PIK3CD;CSF1R;PIK3CB;ADAP2;GAB2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.7880109674087702,1.5567237933358349,0.034532374100719423,0.16490205546100123,1.0,3/11,8.09%,LYN;SYK;PRKCQ
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.7151649859400908,1.5565869471515992,0.018427518427518427,0.16471512942956093,1.0,5/22,7.72%,IL10RA;IL10RB;MGAT5;TNF;OCIAD1
prerank,regulation of defense response (GO:0031347),0.6190803153840029,1.5565248884881864,0.003134796238244514,0.16439258911110396,1.0,27/76,14.52%,TREM2;FGR;HCK;FCGR2B;CCR2;PIK3AP1;DAGLB;APOE;CASP1;TRAF3;SAMHD1;ANXA1;SETD6;AKNA;TMSB4X;ZMPSTE24;GRN;USP18;NOD2;RNF135;CASP8;LRP8;SHPK;LACC1;ERAP1;IRF1;AREL1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.6817615592594898,1.556214948716605,0.022300469483568074,0.16459093501442607,1.0,3/27,5.93%,GNA15;LPAR6;GPR17
prerank,negative regulation of biomineral tissue development (GO:0070168),0.7076071089610912,1.5548293894618326,0.03194103194103194,0.16687009675329728,1.0,3/21,1.55%,PTK2B;TGFB1;SRGN
prerank,positive regulation of lipid storage (GO:0010884),0.7125030574258923,1.5543202682780928,0.02753441802252816,0.16740347485775464,1.0,8/21,13.46%,LPL;MSR1;SREBF2;PLIN2;OSBPL11;PLIN3;VSTM2A;NFKB1
prerank,positive regulation of endocytosis (GO:0045807),0.6544856401666618,1.5541723109951273,0.006543075245365322,0.16718626973092268,1.0,18/45,18.32%,NCKAP1L;TREM2;STAP1;CBL;SNCA;APOE;LDLRAP1;CLN3;HFE;RAB31;NEDD4L;B2M;TOR1A;LRP1;APPL2;VPS28;CDC42;FLOT1
prerank,positive regulation of macrophage differentiation (GO:0045651),0.798522634219425,1.5531823992631546,0.029577464788732393,0.16874512738961622,1.0,4/11,12.90%,PF4;TGFB1;HSF1;CASP8
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.7880430790901154,1.5531117955019749,0.017045454545454544,0.1684110172567944,1.0,5/13,7.46%,GATA1;MAD2L2;DDIT3;TAF1;TMSB4X
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.732938841157875,1.5530392567499112,0.021628498727735368,0.16808447107316185,1.0,4/18,7.31%,GPNMB;LAPTM5;DUSP3;WNK1
prerank,negative regulation of bone remodeling (GO:0046851),0.7908043545868872,1.5528620968202758,0.033478893740902474,0.1679729929405469,1.0,4/11,5.09%,UBASH3B;P2RX7;GPR137B;TNFAIP3
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5626150764141877,-1.552777485682847,0.05179282868525897,1.0,1.0,6/15,12.21%,FOXC1;EDA;GLI2;WNT6;HDAC2;TBX1
prerank,intracellular cholesterol transport (GO:0032367),0.744048323423141,1.5522171491229468,0.021361815754339118,0.16865891044248887,1.0,7/15,14.52%,ABCA1;NPC2;ABCG1;LDLRAP1;NPC1;OSBP;STARD4
prerank,T cell migration (GO:0072678),0.7723479882669095,1.552152529191394,0.033921302578018994,0.16830328121783977,1.0,3/13,1.59%,MYO1G;PIK3CG;PIK3CD
prerank,regulation of protein kinase B signaling (GO:0051896),0.6028719668557663,1.5518058419396914,0.0,0.1685276880855141,1.0,34/193,9.56%,ARRB2;CD86;VAV1;CALCR;PIK3CG;PIK3R5;HPSE;TGFB1;CX3CR1;CASS4;HCLS1;FLT3;F10;PIK3CD;PIK3AP1;TGFBR1;ADAM8;PTPRJ;GRB2;PIK3CB;OSM;TNF;DDIT3;IL18;XDH;P2RX4;OTUD3;GAB2;CD80;P2RY12;FLT3LG;FLCN;PDCD6;STRN
prerank,heterotypic cell-cell adhesion (GO:0034113),0.6902584580444329,1.551216656225504,0.015834348355663823,0.16920080425464262,1.0,6/25,3.69%,ITGAX;ITGB2;ITGA4;CD200R1;ITGB3;PKP2
prerank,phospholipid catabolic process (GO:0009395),0.6948335919246077,1.550971532628116,0.023514851485148515,0.16923082095370154,1.0,3/24,3.09%,PLBD1;ABHD12;ANGPTL3
prerank,negative regulation of endocytosis (GO:0045806),0.6978217234839794,1.550928715204769,0.025974025974025976,0.16882437711211512,1.0,5/24,4.90%,LILRB1;LGALS3;CD300A;MCTP1;SNX33
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.6193374604506436,1.5500452968305993,0.004140786749482402,0.1701187417293723,1.0,22/72,15.15%,PTPRC;RUNX1;SYK;CD74;IRAK2;PTPN1;TNF;OTULIN;TRAF2;PYCARD;TNFAIP3;IFNGR2;CFLAR;TAX1BP1;RNASEL;USP18;IKBKG;CASP8;GAS6;TRADD;SPPL2A;PIAS1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.7201546061411284,1.549795193169005,0.02763819095477387,0.17012932989568166,1.0,4/18,3.81%,CX3CR1;ITGA4;GCNT1;TNF
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.6897408341390059,1.5495623199426725,0.019464720194647202,0.1701731490880811,1.0,7/25,10.54%,NCKAP1L;GATA1;MAPK14;FOXO3;TAL1;STAT5B;INHBA
prerank,somite development (GO:0061053),0.7892861845710721,1.5493666505903698,0.036931818181818184,0.17006180533940632,1.0,2/11,0.68%,MEOX1;SHH
prerank,positive chemotaxis (GO:0050918),0.7417817418915307,1.5487342241276743,0.02099737532808399,0.17076774955975313,1.0,4/17,2.35%,GPNMB;LGALS3;CORO1A;PTPRJ
prerank,negative regulation of cholesterol transport (GO:0032375),0.7977890276760542,1.5479945772227883,0.033045977011494254,0.17174781637410905,1.0,2/10,3.88%,SHH;SREBF2
prerank,secretory granule organization (GO:0033363),0.8033598636850875,1.547125788332893,0.036231884057971016,0.1729586367503511,1.0,3/10,1.71%,LYST;SRGN;ABCA1
prerank,lymphocyte chemotaxis (GO:0048247),0.6559937931789974,1.5468272395761318,0.02402745995423341,0.17307367664017378,1.0,12/34,18.57%,PIK3CG;PIK3CD;ADAM8;CCL8;CCL14;GPR183;CCL13;CCL2;GAS6;CXCL16;CCL25;CKLF
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.7378989706622668,1.5468096811271876,0.03316326530612245,0.1726503619356751,1.0,1/16,0.06%,MRAP
prerank,regulation of collagen biosynthetic process (GO:0032965),0.7172118275894308,1.546611728808129,0.021546261089987327,0.1725777648614443,1.0,5/19,7.23%,RUNX1;CIITA;TGFB1;RGCC;CREB3L1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.7864591663161338,1.5464390195227453,0.022922636103151862,0.17246482538124175,1.0,3/11,9.57%,TREM2;KCNIP2;NOS1AP
prerank,negative regulation of signaling (GO:0023057),0.6857515357078401,1.5461889759644538,0.020506634499396863,0.17250954665835758,1.0,4/25,3.12%,UBASH3B;PCSK9;PTPN1;OSM
prerank,positive regulation of leukocyte activation (GO:0002696),0.7169611618076832,1.5460091537567526,0.037037037037037035,0.1723892806370562,1.0,3/18,4.57%,CLEC4D;CD226;CEBPA
prerank,response to ATP (GO:0033198),0.7313995414588388,1.5454369424394039,0.025606469002695417,0.17306429899024317,1.0,6/18,7.66%,KCNJ11;P2RX7;P2RY2;P2RX4;TAF1;P2RY12
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.7944722327976066,1.5444676245364233,0.026239067055393587,0.17449878633908217,1.0,2/10,0.52%,LILRB1;LYN
prerank,phagosome-lysosome fusion (GO:0090385),0.799248847170163,1.5442510073910185,0.03056768558951965,0.1744332092466016,1.0,5/10,5.43%,RAB39A;RAB34;CLN3;RAB7A;RAB7B
prerank,positive regulation of dendrite development (GO:1900006),-0.6419611642590902,-1.5438436082732356,0.030821917808219176,1.0,1.0,6/10,11.30%,COBL;PTN;ALK;DAB2IP;BMP5;PACSIN1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.6669193574760769,1.543789151703307,0.014806378132118452,0.1749158645229176,1.0,11/35,11.23%,PTK2B;HCK;HCLS1;STAP1;IQGAP2;CSF1R;MDK;NTF3;ARHGDIB;F11R;NRP1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.6462720940295121,1.5405321616205043,0.006557377049180328,0.1811245390075858,1.0,6/44,4.78%,NCKAP1L;PTK2B;HCK;NCK2;SNX9;PYCARD
prerank,intracellular sterol transport (GO:0032366),0.7652832085792005,1.5401897042561512,0.023415977961432508,0.18131877315734152,1.0,7/13,14.79%,ABCA1;NPC2;ABCG1;NPC1;OSBP;STARD4;ARV1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.6987936643426745,1.5399382586446282,0.03288672350791717,0.18089221210253423,1.0,5/21,6.37%,PF4;GATA1;IL1A;TNF;BCL2L1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.6987936643426745,1.5399382586446282,0.03288672350791717,0.18089221210253423,1.0,5/21,6.37%,PF4;GATA1;IL1A;TNF;BCL2L1
prerank,positive regulation of T cell migration (GO:2000406),0.694299610214321,1.5398349424575213,0.025839793281653745,0.1806634323991743,1.0,5/20,7.31%,DOCK8;CCR2;PYCARD;AIF1;WNK1
prerank,regulation of protein kinase activity (GO:0045859),0.610036497168695,1.53886576147942,0.0,0.1820909862460771,1.0,27/106,14.54%,PTPRC;LCP2;PTK2B;FGR;UBASH3B;LAT;MMD;THY1;GNAQ;SNX9;TNF;SNCA;TTN;XRCC5;MAP2K3;RAP2B;RB1;TRIM27;UVRAG;QARS1;DUSP19;DTNBP1;TAB2;CAMKK2;GAS6;RTRAF;RAP1A
prerank,acylglycerol homeostasis (GO:0055090),0.704134224794434,1.5381204043139527,0.042131350681536554,0.18318838569930745,1.0,7/20,12.23%,LPL;MLXIPL;ANGPTL3;APOE;IL18;LIPC;ANGPTL4
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.621226032730256,1.538089648343027,0.014973262032085561,0.18278270402212174,1.0,12/57,12.34%,LYN;HCLS1;FLT3;CSF1R;OSM;TNF;IL6R;IL18;EPO;SH2B3;NF2;PPP2CA
prerank,anterior/posterior axis specification (GO:0009948),0.7403116835390094,1.5379216439677157,0.03557312252964427,0.18262194047451058,1.0,3/15,4.84%,SHH;SKI;DDIT3
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.7551296709280285,1.5359733318941255,0.030683403068340307,0.1859157315965144,1.0,4/13,2.91%,IRAK2;PIK3AP1;UNC93B1;TLR7
prerank,renal water homeostasis (GO:0003091),0.6924958464662894,1.5348350540555604,0.033210332103321034,0.1876911490692539,1.0,10/23,14.21%,ADCY7;PRKAR2B;AQP1;ADCY6;TFAP2B;RAB11A;PRKACB;ADCY3;ADCY8;WFS1
prerank,phospholipid homeostasis (GO:0055091),0.7901153871103415,1.5347487791824432,0.02318840579710145,0.18737665087488253,1.0,3/11,4.11%,ABCA1;ANGPTL3;ABCG1
prerank,regulated exocytosis (GO:0045055),0.598343556201553,1.5343852778049631,0.0,0.18765309730330382,1.0,44/173,13.40%,FERMT3;PF4;LYN;MMRN1;ITGA2B;LY6G6F;SYT17;TGFB1;PLEK;SRGN;ITGB3;CYRIB;F13A1;SDF4;CD9;PSAP;SNCA;PIP5K1C;TUBA4A;TTN;CYB5R1;TIMP1;MYH9;LHFPL2;ACTN4;SYT2;VEGFB;TMSB4X;RAB31;SYTL4;SYT10;VCL;SYNGR1;ACTN1;SYNGR2;BRPF3;THBS1;CD63;TLN1;F5;RAB11FIP5;TEX264;NHLRC2;GAS6
prerank,response to copper ion (GO:0046688),0.7096458427857804,1.5338853343374081,0.026515151515151516,0.1882246653010158,1.0,13/20,22.27%,IL1A;AQP1;SNCA;HSF1;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,regulation of MAP kinase activity (GO:0043405),0.6099182495265552,1.5333133462718296,0.0020470829068577278,0.1888370835065109,1.0,13/92,4.14%,LYN;PIK3CG;PIK3R5;TGFB1;FLT3;CD300A;ADAM8;PRKCD;PTPRJ;PTPN1;PIK3CB;TNF;APOE
prerank,regulation of T cell migration (GO:2000404),0.7083890904454349,1.5331448873706737,0.0374331550802139,0.18866909740963206,1.0,5/18,6.51%,DOCK8;CD200R1;PYCARD;RIPOR2;AIF1
prerank,negative regulation of cell development (GO:0010721),0.6908708606332493,1.5329092634877277,0.027479091995221028,0.18867084833643558,1.0,9/25,16.65%,HOOK3;LILRB1;TNF;PCM1;SORL1;B2M;RFLNA;GSK3A;APPL2
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.6129473963609338,1.5327091673262616,0.003105590062111801,0.18862664255677172,1.0,18/76,12.21%,NCKAP1L;PTK2B;HCK;PLEK;HCLS1;STAP1;P2RX7;NUP62;NCK2;SNX9;MYLK3;PYCARD;PLK4;NTF3;PFN2;PFN1;NRP1;DYNC1H1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.5115262466453578,-1.5306071480739556,0.038461538461538464,1.0,1.0,7/19,11.70%,DLG2;CLIC4;PRKCI;SYNJ2BP;PARD3;DLG1;MTCL1
prerank,zymogen activation (GO:0031638),0.6510202643942371,1.5304965126988996,0.021205357142857144,0.1927968085116155,1.0,7/39,8.96%,KLK3;LGMN;VSIR;CTSL;ASPH;TBC1D10A;BAK1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.7339383468831837,1.5299499004373305,0.03800786369593709,0.19344108314563419,1.0,7/15,16.03%,PF4;LPL;MSR1;IL18;PRKCH;NFKB1;CD36
prerank,cellular response to hydrogen peroxide (GO:0070301),0.6493946366041417,1.5286428776266618,0.03125,0.19569107400454744,1.0,9/33,11.27%,NFE2L2;SIRPA;AQP1;PRKCD;TNFAIP3;ANXA1;MAP3K5;IMPACT;HDAC6
prerank,transepithelial transport (GO:0070633),-0.5558137665593879,-1.5276479717510183,0.0321285140562249,1.0,1.0,4/15,8.42%,SLC12A2;ABCG2;CXADR;GPLD1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.6433523235195147,1.5275853134844946,0.02040816326530612,0.19736885907710242,1.0,10/38,8.02%,PTPRC;CASS4;CSF1R;GPRC5B;THY1;PTPN1;FCGR1A;NCK2;NEDD9;RAP2B
prerank,phosphatidylinositol metabolic process (GO:0046488),0.6004357611647242,1.5265490377917126,0.0020325203252032522,0.19907871885360173,1.0,15/109,4.84%,PLBD1;INPP5D;PIK3CG;PLCB2;PIK3R5;PLEK;PIK3CD;CSF1R;PLCG2;PIK3CB;PIP5K1C;INPP4B;PIP4K2A;PI4K2A;RAB14
prerank,calcium-mediated signaling (GO:0019722),0.6012104761427108,1.5254885391259336,0.0020387359836901123,0.2008455672489217,1.0,17/93,7.66%,PTPRC;BTK;CX3CR1;CCR2;LAT;PLCG2;PTPRJ;EDNRB;P2RX7;SLC8A1;LAT2;CXCR4;MCTP1;P2RX4;NUDT4;SLC9A1;P2RY12
prerank,positive regulation of MAP kinase activity (GO:0043406),0.6161678857618537,1.5245283402105996,0.012552301255230125,0.20225753063485702,1.0,11/66,6.91%,PIK3CG;PIK3R5;TGFB1;FLT3;TAOK3;FZD10;ADAM8;TNFRSF11A;TNF;TRAF2;MAP3K5
prerank,angiogenesis involved in wound healing (GO:0060055),0.7540350918667585,1.52446574599151,0.03907380607814761,0.20189565841710105,1.0,2/11,1.74%,HPSE;ITGB3
prerank,mesenchyme development (GO:0060485),0.7270376899530483,1.5238017779295614,0.05089408528198074,0.20277388045001826,1.0,3/15,4.10%,MEOX1;TGFBR1;PKD2
prerank,hemopoiesis (GO:0030097),0.6069322789317708,1.5236642760926389,0.007157464212678937,0.20255198400947153,1.0,17/87,11.96%,PTPRC;RUNX1;PLD4;TGFB1;PLEK;FLT3;CSF1R;CEBPA;TGFBR2;TP53;TAL1;FLT3LG;FLCN;INHBA;SH2B3;ETV6;PRDX3
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.5645026209575821,-1.5235153389801595,0.06666666666666667,1.0,1.0,7/13,15.60%,NFIB;BMP4;REST;PPARA;NFATC4;RELA;PPARG
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6748550708428089,1.5229685473717087,0.02564102564102564,0.20345913296664833,1.0,4/26,1.40%,HPSE;TGFB1;CCR2;IL1A
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.7303663964031435,1.5229222376103972,0.04657534246575343,0.20305324319223247,1.0,2/14,2.40%,CD226;MAD2L2
prerank,regulation of cellular biosynthetic process (GO:0031326),0.659071598331983,1.522781150018288,0.03146853146853147,0.20281991736242522,1.0,10/28,16.65%,CX3CR1;SIRPA;NR1H4;MITF;NOS1AP;ADIPOR1;TNFRSF1B;CTNS;CD47;ADIPOR2
prerank,endothelial cell differentiation (GO:0045446),-0.5740231113320968,-1.521779721134159,0.05136986301369863,1.0,1.0,8/12,25.30%,FSTL1;ACVRL1;JAG1;SCUBE1;BMPR2;SOX18;ACVR2B;EDF1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.6603128134809367,1.5213657876060374,0.01611047180667434,0.20525652438933958,1.0,10/35,11.48%,PTPRC;IL10RA;IL10RB;TNF;OCIAD1;DOT1L;SH2B3;NF2;NLK;ADIPOR1
prerank,lysosome localization (GO:0032418),0.646695009735915,1.519871631261139,0.026077097505668934,0.20801360092765894,1.0,13/37,12.67%,PIK3CG;PLEKHM2;PIK3CD;RAB34;KLC2;PLEKHM1;MYH9;TFEB;FLCN;SYTL4;HDAC6;BORCS5;PIP4P1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.6132823750471867,1.518792351673882,0.007268951194184839,0.20985166194897104,1.0,8/69,2.72%,PTAFR;PIK3CG;PLCB2;PIK3R5;PLCL2;PIK3CD;CSF1R;PIK3CB
prerank,negative regulation of ion transport (GO:0043271),0.6908165861351835,1.5187823968396623,0.024242424242424242,0.20937411296695563,1.0,4/24,7.31%,PTK2B;LILRB1;SNCA;WNK1
prerank,acylglycerol catabolic process (GO:0046464),0.6523405322753338,1.5183273753094553,0.029411764705882353,0.20983451405160516,1.0,8/30,17.09%,LPL;FABP4;ABHD12;FABP5;LIPC;LIPE;ABHD16A;PNPLA3
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.7187188452192358,1.5179802155974058,0.042801556420233464,0.21012943118817104,1.0,3/17,1.83%,SCIMP;LYN;TAOK3
prerank,positive regulation of collagen metabolic process (GO:0010714),0.7176591533397316,1.5169611890443053,0.033942558746736295,0.21170915707225932,1.0,5/17,7.23%,RUNX1;TGFB1;VSIR;RGCC;CREB3L1
prerank,negative regulation of protein localization to membrane (GO:1905476),0.6877628667730067,1.5167953206770055,0.024734982332155476,0.21158102467868703,1.0,11/24,19.95%,MRAP;TGFB1;BCL2L1;CLTC;NUMB;PPFIA1;PID1;AP2M1;PICALM;TMEM59;INPP5K
prerank,positive regulation of cellular component movement (GO:0051272),0.6700711768305823,1.5165630079870052,0.04316546762589928,0.21161563157781677,1.0,4/24,6.77%,LYN;CSF1R;TGFBR1;ACTN4
prerank,regulation of response to external stimulus (GO:0032101),0.5926673083275027,1.5164205396673476,0.0010111223458038423,0.21140382733082158,1.0,41/121,16.65%,TREM2;FGR;HCK;GP1BA;FCGR2B;CCR2;CYRIB;PIK3AP1;DAGLB;TRIM5;GUCY2F;CXCR4;SAG;CASP1;TRAF3;P2RX4;SAMHD1;ANXA1;CNGB1;SETD6;AKNA;TMSB4X;P2RY12;ZMPSTE24;GRN;USP18;NOD2;GRK4;RNF135;CASP8;LRP8;SHPK;LACC1;STK24;ERAP1;IRF1;AREL1;METAP2;CD36;SBNO2;APPL2
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.5762981696259744,-1.516025968494849,0.05985915492957746,1.0,1.0,6/12,26.19%,CAV1;SRI;CALM3;GJD3;PDE4D;CALM2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.6548895517879973,1.5158240219781598,0.02870264064293915,0.2121805108358786,1.0,4/33,2.72%,PIK3CG;PIK3R5;PIK3CD;PIK3CB
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.629594538048418,1.515555539900981,0.017758046614872364,0.2122735383026417,1.0,13/48,13.40%,PTPRC;TREM2;STAP1;NLRC5;RFFL;SAMHD1;YTHDF3;SH2B3;TTLL12;USP18;METTL3;GPS2;GAS6
prerank,regulation of viral entry into host cell (GO:0046596),0.6523018738813329,1.5154999867853716,0.04312354312354312,0.21188908055741942,1.0,8/30,11.21%,CIITA;CD74;TRIM25;TRIM5;P4HB;TRIM27;LGALS1;MID2
prerank,cellular protein catabolic process (GO:0044257),0.6192669450680843,1.515035286345405,0.016877637130801686,0.21239610666557526,1.0,22/59,16.53%,CTSS;CTSB;PCSK9;LGMN;CTSC;MYLIP;TCIRG1;CTSK;CTSL;RAB7A;LONP1;AP2S1;MALT1;CHEK2;CTSZ;CLTC;CASP8;UBE2G2;CAPN2;AP2M1;IDE;YME1L1
prerank,positive regulation of MAPK cascade (GO:0043410),0.5816707087348753,1.514922600098966,0.0,0.21214916084503085,1.0,30/245,5.85%,ARRB2;PTPRC;PTK2B;SLAMF1;TREM2;SCIMP;GPNMB;CALCR;PIK3CG;PIK3R5;TGFB1;FLT3;CD74;P2RY6;LAPTM5;TAOK3;CSF1R;PLCG2;ADAM8;PTPRJ;DSTYK;OSM;CCL8;TRIM5;TNF;PRKD2;APOE;PYCARD;CD44;HMGB1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5015642484350972,-1.5143687131224375,0.0625,1.0,1.0,7/17,10.62%,FSTL1;SULF1;XIAP;SLIT2;PCSK6;TMEM204;TWSG1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.6827413118283758,1.5139289454186176,0.0387409200968523,0.21387918584161225,1.0,6/25,8.46%,TGFB1;GATA1;MAD2L2;NSD1;DOT1L;RB1
prerank,regulation of sequestering of calcium ion (GO:0051282),0.7440062947014001,1.5127143691250695,0.0403899721448468,0.21614980452841168,1.0,2/12,0.77%,PTK2B;UBASH3B
prerank,osteoclast differentiation (GO:0030316),0.6787386464404406,1.5124213730633718,0.03201970443349754,0.21632002281724202,1.0,9/22,9.45%,TREM2;CSF1R;TNFRSF11A;MAPK14;OCSTAMP;EFNA2;TYROBP;GAB2;GPR183
prerank,mammary gland development (GO:0030879),-0.4673323391341444,-1.511099639327144,0.047337278106508875,0.9977026205760127,1.0,8/21,16.40%,CAV1;ARHGAP35;WNT4;GLI2;TBX3;GPAT4;TGFB3;NOTCH4
prerank,positive regulation of endothelial cell migration (GO:0010595),0.5946558869764268,1.5108411084446918,0.007238883143743537,0.21943029026140767,1.0,23/84,11.64%,PTK2B;PIK3CG;TGFB1;RIN2;LGMN;STAT5A;SMOC2;PIK3CD;ITGB3;ANGPT4;PIK3CB;MAPK14;PRKD2;P2RX4;HMGB1;MAP2K3;TMSB4X;PDCD6;BCAR1;NRP1;THBS1;GPI;GRN
prerank,positive regulation of transport (GO:0051050),0.5931107371712727,1.510199232861822,0.006185567010309278,0.22036577589261575,1.0,35/85,22.71%,DOCK2;TREM2;SLC11A1;FCGR2B;SIRPA;CAMK1D;TNF;SNCA;FCER1G;APOE;PYCARD;ANXA1;ACTB;BAK1;NEDD4L;DYNC1H1;MERTK;GAS6;IL2RG;LRP1;GSK3A;CD47;LMAN2;RXRA;FLOT1;PLAA;SMPD1;INPP5K;PLA2G5;GSK3B;CYBA;CDH3;CHP1;BID;SGK1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.6149719607474744,1.509311157004255,0.02074235807860262,0.2219558414727911,1.0,14/51,13.40%,CCR2;LGMN;CSF1R;MDK;CREB3;IL6R;HMGB1;AIF1;VEGFB;PLA2G7;AKIRIN1;CMKLR1;THBS1;GAS6
prerank,positive regulation of protein kinase activity (GO:0045860),0.5944054690030698,1.5089247020523406,0.0,0.22228491498444877,1.0,44/148,16.74%,PTPRC;LCP2;PTK2B;SLC11A1;CASS4;LAT;ITGB3;TAOK3;CSF1R;GPRC5B;MMD;PRKCD;PTPN1;FCGR1A;SNX9;TNF;SNCA;IL6R;XRCC5;MAP2K3;TGFBR2;NEDD9;TNIK;KIF14;STRADB;DUSP19;MAP2K2;PARP16;PPP2CA;TAB2;LRP8;GAS6;STK3;RAP1A;PIH1D1;SRC;STRADA;SYAP1;ALS2;INCENP;IRGM;EPHA4;HSP90AA1;STK4
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.7765084523288773,1.5087837038355212,0.038011695906432746,0.2220549967141225,1.0,3/10,7.53%,TREM2;CD68;TICAM1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.666520603147561,1.5081450239811154,0.03407755581668625,0.22307176481025126,1.0,10/27,16.03%,BTK;IRAK2;TLR1;TLR2;CD14;MAP3K1;LY96;TAB2;TAB3;CD36
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.45517935770343715,-1.5074686923044867,0.027624309392265192,0.9847047346131197,1.0,5/26,2.24%,FOXP1;SMARCA4;KANK2;CLOCK;NCOR1
prerank,base conversion or substitution editing (GO:0016553),0.7636005770625173,1.5053949604101613,0.041666666666666664,0.22861440463430005,1.0,4/11,13.05%,APOBEC1;ADAR;METTL3;ADARB1
prerank,phospholipid metabolic process (GO:0006644),0.6000466262501039,1.5052683338812751,0.010427528675703858,0.22838562722224884,1.0,9/71,4.92%,PLBD1;PLCB2;LPL;ABHD12;LPCAT1;ANGPTL3;CLN8;PIP4K2A;SMPD3
prerank,positive regulation of glucose import (GO:0046326),-0.4743231701938386,-1.5050868740500158,0.04975124378109453,0.9653186360314031,1.0,6/21,15.10%,SORBS1;PRKCI;IRS1;ARPP19;AKT1;OCLN
prerank,regulation of activated T cell proliferation (GO:0046006),0.6631385511297259,1.5050376485041548,0.031070195627157654,0.22842017514624308,1.0,7/30,9.75%,PDCD1LG2;CRTAM;PYCARD;IL18;HMGB1;RC3H1;CD274
prerank,cyclooxygenase pathway (GO:0019371),0.7698383856057103,1.5048147129282883,0.06427503736920777,0.22840824915444302,1.0,3/10,3.21%,TBXAS1;PTGES3;HPGDS
prerank,regulation of nervous system process (GO:0031644),-0.49937846014266607,-1.5031995832548484,0.0430622009569378,0.9445437573626206,1.0,7/18,12.61%,APP;DLGAP1;HTR2C;DLGAP2;SLC8A3;CHRNA7;NOS3
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.6797258169006961,1.5029569897498238,0.04228855721393035,0.23222281638260445,1.0,8/20,13.14%,SMOC2;DSTYK;PRKD2;FGFBP3;CREB3L1;SULF2;THBS1;NPTN
prerank,second-messenger-mediated signaling (GO:0019932),0.5958158115334765,1.5023755072277671,0.006166495375128468,0.23303003530250732,1.0,19/82,14.53%,BTK;CX3CR1;CCR2;LAT;PLCG2;EDNRB;LAT2;APOE;CXCR4;MCTP1;P2RX4;NUDT4;P2RY12;DGKD;RCAN1;PPP2CA;CAMKK2;DDAH1;LRRK2
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.6409965741568538,1.5022834701421963,0.028538812785388126,0.23272489765223686,1.0,8/33,10.54%,NCKAP1L;GATA1;MAPK14;FOXO3;RAB7B;TAL1;STAT5B;INHBA
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.5847964419228554,-1.5021275310712139,0.050335570469798654,0.9192069711306372,1.0,3/11,2.48%,ZFPM2;BMPR1A;BMP4
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.685816001152287,1.5006756326475834,0.03676470588235294,0.23585002162259852,1.0,9/21,19.36%,HK3;RPE;GPI;SHPK;HK2;PGLS;GCK;PGD;RBKS
prerank,Golgi localization (GO:0051645),0.7604620083096162,1.5001976633304088,0.0496551724137931,0.2364284507792235,1.0,4/11,9.42%,HOOK3;RIPOR1;ARHGAP21;UVRAG
prerank,cellular component maintenance (GO:0043954),0.7413032115944848,1.4996533444124647,0.054945054945054944,0.23702029170574432,1.0,1/12,0.36%,TREM2
prerank,regulation of macrophage migration (GO:1905521),0.7747238355114496,1.49961672819052,0.05,0.2365790382996577,1.0,4/10,7.66%,PTK2B;CX3CR1;CD200R1;P2RY12
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.7690034405584325,1.4986171582654655,0.043227665706051875,0.23833938897096396,1.0,3/10,8.09%,NCKAP1L;TGFBR2;PRKCQ
prerank,cellular response to lipid (GO:0071396),0.5863877089218716,1.498310378207417,0.0,0.238516785958189,1.0,48/191,13.92%,CD86;PTK2B;LILRB1;PF4;LYN;CX3CR1;CXCL5;STAP1;PDCD1LG2;IL1A;SIRPA;LPL;MAP4K1;AQP1;FZD10;CXCL2;MAPK14;FFAR2;NR1H4;ADCY6;PYCARD;CD68;SPP1;TNFAIP3;CD14;CASP1;HMGB1;ABCB4;CD80;TICAM1;CD180;MEF2C;LY96;CD274;SOX9;CCL2;TNFRSF1B;NRIP1;TWF2;NOD2;DEFA6;CREB1;SHPK;NFKB1;ADCY3;ADCY8;MGST1;PID1
prerank,regulation of cell killing (GO:0031341),-0.5053671201744014,-1.497493741867096,0.07531380753138076,0.9151206801370844,1.0,5/16,8.72%,MAPK8;CD55;WNT5A;CR1L;CFH
prerank,heart process (GO:0003015),-0.5613041541670318,-1.4970177119274666,0.055350553505535055,0.8904164646466235,1.0,4/14,9.66%,SGCD;SGCZ;SOD1;ACE
prerank,cytokine-mediated signaling pathway (GO:0019221),0.5750938394907631,1.4958166168522593,0.0,0.24391340068228018,1.0,118/532,14.01%,CD86;SLA;GRAP2;VAV1;PTK2B;IRF5;INPP5D;PF4;PTAFR;IL10RA;CIITA;HCK;ITGAX;IRF4;IRF8;TGFB1;SYK;ITGB2;CXCL5;LCP1;FLT3;CCR2;CSF3R;AIM2;STAT5A;IL1A;IRAK2;CSF2RB;PIK3CD;IL10RB;CBL;CSF1R;F13A1;TYK2;CXCL2;TRIM25;PRKCD;PTPRJ;IL21R;GRB2;PIK3CB;TEC;TNFRSF11A;OSM;FCGR1A;IL12RB2;CCL8;TRIM5;TNF;FCER1G;AIP;UBE2V1;TNFSF8;TRAF2;IL6R;CEBPA;IFNAR1;FOXO3;PYCARD;SPI1;IL18;CD300LF;CASP1;TRAF3;TIMP1;RAP1B;CD44;MAP3K14;IFNGR2;SAMHD1;ANXA1;BCL2L1;GAB2;TP53;CD80;ACTN4;PSMB10;PIM1;STAT4;TMSB4X;P4HB;EPO;CAPZA1;ST18;FLT3LG;IL18RAP;ADAR;IRF2;CCL14;ITGAM;STAT5B;TRAF5;TRIM8;RNASEL;IL18BP;SH2B3;PSMA2;CCL13;RAPGEF1;LIMS1;RPS6KA4;ADIPOR1;CCL2;TNFRSF1B;NOD2;FYN;PSME3;TAB2;STX3;IKBKG;LRP8;B2M;PRLR;NFKB1;TRADD;PSMB5;IRF1;IL2RG
prerank,regulation of hemopoiesis (GO:1903706),0.7945357371674782,1.4957074412830837,0.036671368124118475,0.24360996348353792,1.0,3/10,6.13%,RUNX1;LGALS3;PRKCB
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.6287973393491566,1.4954820978659416,0.017524644030668127,0.24359646036842827,1.0,10/40,8.27%,PTK2B;RPL23;LAPTM5;PDCL3;XPO1;TAF1;GNA12;HFE;CSNK2A2;CSNK2A1
prerank,vesicle organization (GO:0016050),0.6257783818756352,1.4949530293507192,0.03791982665222102,0.24422868381709886,1.0,23/46,19.71%,HOOK3;SRGN;CORO1A;PI4K2A;SNX33;VPS18;VPS11;DNAJC13;ARFGEF2;WASHC4;EXOC8;PI4K2B;SAR1A;FNBP1L;HOOK2;USP8;EPS15;ALS2;LAMTOR1;SNX10;VPS33B;LAPTM4B;SORT1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.6343458805113706,1.4949058567034856,0.030197444831591175,0.2437963543840484,1.0,9/38,11.64%,SCIMP;ADAM8;DHX9;TLR8;LY86;CD180;LY96;PUM2;GRN
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.6493313737258232,1.4940563538787295,0.029239766081871343,0.24516900908649628,1.0,6/32,12.29%,PF4;CXCL5;CXCL2;CXCL14;CCL13;DEFA6
prerank,retinol metabolic process (GO:0042572),0.7419654572482967,1.4938996045671136,0.04851752021563342,0.24497789178933085,1.0,2/14,3.05%,CYP1A1;DHRS3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.7561040367753575,1.4931232799456915,0.039492242595204514,0.24632638052655706,1.0,6/11,12.18%,ATF3;DDIT3;TP53;CREB3L1;CEBPB;ATF6B
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.6894248331597365,1.492656448269881,0.0392638036809816,0.24683898498122564,1.0,5/22,9.17%,TREM2;LYN;TNFAIP3;RAB7B;WDFY1
prerank,regulation of response to cytokine stimulus (GO:0060759),0.6888404944376263,1.491592363335434,0.05562579013906448,0.2487793231971437,1.0,3/19,2.82%,RUNX1;IRAK2;DHX9
prerank,myeloid cell development (GO:0061515),0.6942165025781286,1.4912346871184767,0.05037783375314862,0.24903846481099298,1.0,4/18,2.43%,NCKAP1L;GATA1;NRROS;TLR2
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.7337166767763257,1.4909455785392087,0.04526748971193416,0.2491903667205937,1.0,3/13,8.18%,PTPRC;MGAT5;DOT1L
prerank,cellular component disassembly (GO:0022411),0.6186293339175188,1.4902088764418875,0.017316017316017316,0.25040494197516877,1.0,9/53,5.65%,CTSS;MMP12;LCP1;SH3PXD2B;ADAM8;CTSK;CTSL;TIMP1;CD44
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.5525821093156372,-1.4893038038805417,0.046153846153846156,0.905329452675736,1.0,12/15,30.69%,SIK1;GPLD1;FBXW7;SCARB1;CTDNEP1;SLC27A1;NR1H2;NR1H3;MFSD2A;LDLR;CNEP1R1;FITM2
prerank,sulfur compound catabolic process (GO:0044273),0.6270033370697907,1.4887175955441694,0.029115341545352745,0.2535316522358227,1.0,9/38,9.55%,HEXB;PRELP;ARSB;GNS;IDS;HEXA;FMOD;BCAN;TXN2
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.7686159236652113,1.4882932482152622,0.056179775280898875,0.25399583539564774,1.0,4/10,9.75%,PDCD1LG2;CRTAM;RC3H1;CD274
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7434686291560675,1.4868266703123074,0.059065934065934064,0.2568537807048804,1.0,3/12,3.87%,CBL;PTPRJ;SNCA
prerank,triglyceride homeostasis (GO:0070328),0.6595275337627894,1.4862579179975675,0.053204353083434096,0.2577353894219893,1.0,8/26,12.23%,LPL;MLXIPL;ANGPTL3;NR1H4;APOE;IL18;LIPC;ANGPTL4
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.7076707272731897,1.4860137672842098,0.0692410119840213,0.25778386734770625,1.0,2/15,3.58%,TREM2;NLRC3
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.6266168547542273,1.4853904011860026,0.025612472160356347,0.2587991320131318,1.0,14/40,19.19%,ARRB2;PCSK9;CBL;LDLRAP1;HFE;DGKD;NTF3;SCYL2;CD63;B2M;AHI1;GREM1;ANGPT1;TBC1D5
prerank,lipid phosphorylation (GO:0046834),0.7679198866642474,1.4851863993953198,0.06599713055954089,0.25876690723540474,1.0,6/10,12.73%,DGKZ;DGKK;DGKE;DGKG;DGKD;DGKI
prerank,endosome organization (GO:0007032),0.6249728172096165,1.4850735710847347,0.04061470911086718,0.258474576949112,1.0,19/41,19.29%,HOOK3;PI4K2A;SNX33;VPS18;VPS11;DNAJC13;ARFGEF2;WASHC4;TMCC1;EXOC8;PI4K2B;HOOK2;USP8;ALS2;CORO1C;LAMTOR1;SNX10;VPS33B;LAPTM4B
prerank,extracellular matrix disassembly (GO:0022617),0.6183763017102916,1.48483832132762,0.013015184381778741,0.2584583232831102,1.0,9/53,5.65%,CTSS;MMP12;LCP1;SH3PXD2B;ADAM8;CTSK;CTSL;TIMP1;CD44
prerank,positive regulation of phospholipid transport (GO:2001140),0.7568148529844525,1.4846314729999928,0.05943536404160475,0.25835143780270453,1.0,3/10,6.00%,DBI;APOE;ABCB4
prerank,ganglion development (GO:0061548),0.7442720781467427,1.4840623259955283,0.05865921787709497,0.25916087177132796,1.0,5/11,11.23%,ASCL1;TUBB3;FZD3;CTNNB1;NRP1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.6357915684478223,1.4838943688330475,0.04,0.2590099502563414,1.0,5/34,3.03%,PTK2B;FGR;TGFB1;FLT3;WDR91
prerank,response to hydrogen peroxide (GO:0042542),0.6134796163291952,1.4836724021420844,0.02925243770314193,0.2589390617322483,1.0,14/45,14.89%,NFE2L2;SIRPA;AQP1;PRKCD;TNFAIP3;ANXA1;MAP3K5;IMPACT;APTX;HDAC6;PRDX3;FYN;STK24;PLEKHA1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.7157973822342873,1.483497905445091,0.04417670682730924,0.25881279180571826,1.0,4/14,11.02%,TNF;OCSTAMP;TYROBP;ATP6AP1
prerank,positive regulation of neuron death (GO:1901216),0.614393698668285,1.4831848797340286,0.02643171806167401,0.25900973476143846,1.0,16/46,12.48%,ITGB2;FCGR2B;PCSK9;TNF;SNCA;FOXO3;DDIT3;CTNNB1;TYROBP;MAP3K5;C1QA;TFAP2B;ITGAM;GRN;FYN;DDIT4
prerank,lysosome organization (GO:0007040),0.6422807705361926,1.4822353138849074,0.02983425414364641,0.2607434177805467,1.0,15/36,17.34%,HOOK3;ABCA1;CORO1A;MTOR;ARSB;CLN3;VPS18;TFEB;MYO7A;GRN;HOOK2;LRRK2;GNPTAB;TMEM165;LAMTOR1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.5746758015325057,1.4818911718100836,0.0,0.26107598303438107,1.0,26/214,5.85%,ARRB2;PTPRC;PTK2B;SLAMF1;TREM2;SCIMP;GPNMB;LYN;CALCR;TGFB1;SYK;CD74;SIRPA;P2RY6;CSF1R;DUSP3;PTPN1;DUSP29;DSTYK;CCL8;TNF;PRKD2;APOE;PYCARD;CD44;HMGB1
prerank,regulation of B cell apoptotic process (GO:0002902),0.7411246733923041,1.4810687337255035,0.06027397260273973,0.2625624558974939,1.0,3/12,3.86%,BTK;LYN;FNIP1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.7148687375653063,1.480965477866644,0.05473965287049399,0.2622816407187933,1.0,4/16,6.92%,TREM2;TNF;APOE;MYOCD
prerank,reverse cholesterol transport (GO:0043691),0.7265060373449209,1.4805251048349348,0.051094890510948905,0.26283949218065566,1.0,4/13,8.57%,ABCA1;ABCG1;APOE;LIPC
prerank,sterol homeostasis (GO:0055092),0.5945621794690837,1.48030812615001,0.02332979851537646,0.26275132421849073,1.0,16/65,12.14%,PCSK9;LPL;ABCA1;ANGPTL3;NPC2;ABCG1;APOE;LDLRAP1;IL18;NPC1;SOAT2;ABCD1;LIPC;LRP5;TTC39B;HDAC9
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.701273726016545,1.4795485889082873,0.06615776081424936,0.26408310557971926,1.0,5/17,8.92%,SCIMP;LY86;TRIM5;CD180;LY96
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.6901714213267401,1.4785806201463563,0.06901041666666667,0.26580247039659854,1.0,5/18,8.96%,FCGR2B;ERN1;DDIT3;ATXN3;BAK1
prerank,cholesterol transport (GO:0030301),0.6076530048790616,1.4777157194614792,0.0390625,0.26740361692821873,1.0,10/45,8.57%,ABCA1;MSR1;NPC2;ABCG1;APOE;LDLRAP1;CEL;NPC1;SOAT2;LIPC
prerank,cellular response to ATP (GO:0071318),0.7220089599982388,1.4774827192088322,0.05890603085553997,0.2674910460965378,1.0,5/14,7.66%,P2RX7;P2RY2;P2RX4;TAF1;P2RY12
prerank,receptor catabolic process (GO:0032801),0.6629680679671562,1.4761250557449317,0.05620608899297424,0.2702249040274573,1.0,14/24,17.85%,TGFB1;PCSK9;LGMN;MYLIP;AP2S1;UVRAG;CLTC;BECN1;SNX25;AP2M1;SMURF1;ZNRF3;PIK3R4;VLDLR
prerank,phosphatidylcholine metabolic process (GO:0046470),0.5876518782308006,1.4755106492358507,0.016666666666666666,0.2711130344371598,1.0,14/70,9.94%,PLBD1;DBI;LPIN2;LPCAT1;PCYT1A;CHKB;LPCAT2;CSNK2A2;CSNK2A1;PLA2G7;LIPC;SLC44A2;ABHD4;STARD10
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.44318986290963786,-1.4751282008060014,0.03597122302158273,0.955984048319688,1.0,12/26,20.43%,STMN2;SLAIN2;CLIP1;PAK1;DRG1;MET;CDK5RAP2;MAPT;NAV3;OCLN;RAC1;TRPV4
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.5672676074599522,-1.4747091547113185,0.06390977443609022,0.9316141520995778,1.0,8/13,25.26%,CPSF6;FIP1L1;CPSF7;CSTF2;TUT1;CSTF2T;NCBP2;CPSF1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.7090579590654267,1.4746759618461933,0.05614973262032086,0.27260298759982365,1.0,5/14,11.24%,CSF1R;MDK;AKIRIN1;CMKLR1;THBS1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.6552805226772526,1.4746665141555764,0.04232164449818621,0.2720791086441509,1.0,11/24,17.01%,NFE2L2;ATF3;DDIT3;TP53;CREB3L1;CEBPB;HSF1;ATF6B;RBPJ;HIF1A;GCN1
prerank,acylglycerol metabolic process (GO:0006639),0.6231929818770152,1.4740487052113787,0.03945885005636979,0.27306584144045304,1.0,10/37,8.24%,DGKZ;LPL;ABHD12;APOE;SEL1L;PGS1;DGKK;DGKE;DGKG;DGKD
prerank,metanephric mesenchyme development (GO:0072075),0.7535180459506327,1.4735196598502232,0.07264957264957266,0.2739100370213644,1.0,3/10,4.10%,SHH;BASP1;PKD2
prerank,regulation of neurogenesis (GO:0050767),0.607728277681001,1.4733314505898976,0.01812366737739872,0.27379118601284835,1.0,12/55,13.13%,HOOK3;ASCL1;CX3CR1;HES7;TNF;BHLHE41;CTNNB1;NAP1L1;PCM1;NUMB;SORL1;B2M
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.6862879652734224,1.4731341114456595,0.06447534766118837,0.27371606477434585,1.0,5/18,13.98%,LYN;FCER1G;BCAR1;CMKLR1;C3AR1
prerank,cortical cytoskeleton organization (GO:0030865),0.6068401008232388,1.4728400128598285,0.037694013303769404,0.27381184835200667,1.0,6/41,5.71%,NCKAP1L;PLEK;LCP1;TNF;FHOD1;FMNL3
prerank,defense response to symbiont (GO:0140546),0.5825510118751142,1.4727404300499367,0.014329580348004094,0.2734703125705639,1.0,21/92,13.88%,PTPRC;LILRB1;LYST;NLRC5;TLR2;TLR8;TLR7;TRIM5;ATG7;PYCARD;MAP3K14;SAMHD1;BCL2L1;MOV10;IRF2;SETD2;TRIM56;RNASEL;DDIT4;AGBL5;IRF1
prerank,water transport (GO:0006833),0.7293823474972335,1.4717120693335277,0.06456241032998565,0.2755233635619245,1.0,2/12,8.14%,AQP1;AQP11
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.6256684369741646,1.4714413662871284,0.04805491990846682,0.2756435703190914,1.0,8/34,11.87%,IL1A;NUP62;ESPL1;RGCC;CDC23;RB1;LRP5;PHIP
prerank,regulation of calcium ion import (GO:0090279),0.6870200258267875,1.4713170847249122,0.05641025641025641,0.27536567733699163,1.0,6/21,12.33%,LGALS3;PKD2;CTNNB1;TRIM27;CCL2;FYN
prerank,chondroitin sulfate catabolic process (GO:0030207),0.7222287749101981,1.4711186296727994,0.07372654155495978,0.2753615829592972,1.0,5/13,9.07%,HEXB;ARSB;IDS;HEXA;BCAN
prerank,megakaryocyte differentiation (GO:0030219),0.7394052449206423,1.4703380321868582,0.06032171581769437,0.27680153841816324,1.0,3/11,10.93%,GATA1;TAL1;SH2B3
prerank,glycoprotein catabolic process (GO:0006516),0.7004613791012251,1.4699155777766413,0.05974025974025974,0.2772973049847153,1.0,4/17,6.91%,MMP12;EDEM1;CTSL;OGA
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.6877245320593319,1.4697979757901323,0.07672301690507152,0.277048684964004,1.0,5/15,11.09%,TREM2;MAPK14;RIPOR2;TYROBP;CD53
prerank,negative regulation of nervous system development (GO:0051961),0.7049777123208523,1.468700604237431,0.05121638924455826,0.27916122382865804,1.0,6/17,13.13%,HOOK3;TLR2;TNF;PCM1;SORL1;B2M
prerank,response to axon injury (GO:0048678),0.6773014145599537,1.4683779391127725,0.06413612565445026,0.279425752863736,1.0,5/18,7.66%,TREM2;RTN4RL1;P2RX4;TYROBP;P2RY12
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.5985742412746627,1.4681490459369801,0.021208907741251327,0.2794056860219017,1.0,13/61,13.12%,VAV1;LPAR6;LYN;PIK3CG;GRB2;PIK3CB;GPR17;EPO;ERBIN;F11R;RAPGEF1;ADGRG1;ARHGEF3
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.5886227999696608,1.4673491276824224,0.02845100105374078,0.2807705938249205,1.0,20/54,18.47%,TGFB1;STAT5A;ANGPT4;MAPK14;TNF;RGCC;PRKD2;APOE;P2RX4;HMGB1;MAP2K3;TMSB4X;MEF2C;THBS1;ATP5F1A;PRCP;NF1;HIF1A;PDPK1;ANGPT1
prerank,androgen metabolic process (GO:0008209),0.6871692657475329,1.466214457338399,0.06314432989690721,0.2830375945371922,1.0,3/18,11.50%,SHH;SPP1;HSD17B11
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.46972999219499667,-1.465370135099035,0.03763440860215054,0.9568181295528801,1.0,7/21,10.09%,CACNA1C;ANK2;RYR2;DMD;SRI;ATP1A2;CALM3
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.7507324756489613,1.464156362745697,0.07025411061285501,0.287492921423582,1.0,5/10,12.98%,CX3CR1;FZD3;CTNNB1;DISC1;SMARCD3
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.7644494715946628,1.4639330916376432,0.05531914893617021,0.28744730878267205,1.0,4/11,7.53%,SCIMP;RFTN1;UNC93B1;TICAM1
prerank,regulation of T cell mediated immunity (GO:0002709),0.7489536678336259,1.4638560190128438,0.0766016713091922,0.28707726300864383,1.0,3/10,11.69%,CCR2;HMGB1;TNFRSF1B
prerank,acetyl-CoA metabolic process (GO:0006084),-0.5315089450960944,-1.4635026011704897,0.06299212598425197,0.9417803827954379,1.0,9/15,24.90%,DIP2A;ACACB;HMGCS2;ACLY;MLYCD;ACSS1;PMVK;MVK;PPCS
prerank,protein trimerization (GO:0070206),-0.5297630577652724,-1.4629790082469065,0.0823045267489712,0.8969895236492489,1.0,7/14,28.43%,DISP1;SLC1A5;SCARA5;SIGMAR1;MLKL;MIF;PNPT1
prerank,protein homotrimerization (GO:0070207),-0.5297630577652724,-1.4629790082469065,0.0823045267489712,0.8969895236492489,1.0,7/14,28.43%,DISP1;SLC1A5;SCARA5;SIGMAR1;MLKL;MIF;PNPT1
prerank,cell projection organization (GO:0030030),0.6323252990193053,1.4624806366526022,0.044340723453908985,0.29004783778981386,1.0,6/30,11.18%,NCKAP1L;PLEK;NEFH;P2RY12;PARVB;CYFIP1
prerank,embryonic appendage morphogenesis (GO:0035113),0.7330380813779217,1.4620709921408042,0.06954102920723226,0.2905529909834382,1.0,2/12,4.36%,SHH;SKI
prerank,positive regulation of protein maturation (GO:1903319),0.7501190275613365,1.4614118898796167,0.059154929577464786,0.29162838694571974,1.0,4/11,14.60%,BAG2;ADAM8;CCBE1;SOX4
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6446800214381148,1.4612571789417161,0.05497076023391813,0.291438880297403,1.0,5/26,6.37%,PF4;GATA1;IL1A;TNF;BCL2L1
prerank,cellular response to type I interferon (GO:0071357),0.6055410310903717,1.461112015691447,0.033482142857142856,0.29070969254738255,1.0,9/41,10.76%,IRF5;IRF4;IRF8;TYK2;IFNAR1;SAMHD1;ADAR;IRF2;RNASEL
prerank,type I interferon signaling pathway (GO:0060337),0.6055410310903717,1.461112015691447,0.033482142857142856,0.29070969254738255,1.0,9/41,10.76%,IRF5;IRF4;IRF8;TYK2;IFNAR1;SAMHD1;ADAR;IRF2;RNASEL
prerank,positive regulation of kinase activity (GO:0033674),0.5742503111120988,1.4602358435664293,0.005060728744939271,0.2923207585814687,1.0,14/107,6.25%,PTPRC;LCP2;PTK2B;TREM2;FLT3;CD74;LAT;CSF1R;MMD;DSTYK;SNX9;TNF;XRCC5;MAP2K3
prerank,small GTPase mediated signal transduction (GO:0007264),0.5723336818928616,1.459808312650321,0.00508646998982706,0.29287261887030286,1.0,19/103,9.01%,ARHGAP30;GRAP2;ABR;RIN2;LAT;RREB1;GRB2;MAPK14;ARHGEF18;RASGRP2;RGS19;PLD2;RGL2;SHC2;TP53;PLK2;RASGRP3;RB1;ARHGAP1
prerank,cell chemotaxis (GO:0060326),0.5881497032560096,1.4594307251238159,0.02014846235418876,0.2933245084939165,1.0,11/60,11.23%,ARRB2;CX3CR1;BIN2;CCR2;PRKCD;CXCR4;DOCK4;PRKCQ;BCAR1;ABCC1;NRP1
prerank,defense response to virus (GO:0051607),0.5741620733647298,1.4591165004858262,0.0163265306122449,0.2935070478359674,1.0,24/100,14.25%,PTPRC;LILRB1;LYST;NLRC5;TLR2;TLR8;TLR7;TRIM5;ATG7;PYCARD;MAP3K14;SAMHD1;BCL2L1;MOV10;IRF2;SETD2;TRIM56;RNASEL;DDIT4;RNF135;AGBL5;IRF1;ATAD3A;ZDHHC1
prerank,positive regulation of nuclear division (GO:0051785),0.6499086685751628,1.4590973301566992,0.05562273276904474,0.2929791827923684,1.0,5/25,11.87%,IL1A;NUP62;RGCC;LRP5;PHIP
prerank,regulation of actin filament polymerization (GO:0030833),0.58509783429872,1.4588459919204082,0.02,0.2929612421270278,1.0,10/69,5.03%,NCKAP1L;PTK2B;HCK;HCLS1;CYRIB;PRKCD;NCK2;SNX9;PYCARD;ARFGEF1
prerank,negative regulation of receptor binding (GO:1900121),0.7531703045075419,1.4587785409333724,0.07101449275362319,0.29257820764187636,1.0,4/10,13.41%,PCSK9;HFE;B2M;ATP2A3
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.6191314244543724,1.4584047612358437,0.04788418708240535,0.292911993964463,1.0,8/39,8.47%,MYO1F;MYO1G;MYO1E;MYO5A;CLN3;ACTN4;MYO7A;MYO19
prerank,positive regulation of macrophage activation (GO:0043032),0.6810771140036744,1.457656538996153,0.07593307593307594,0.2941462316354347,1.0,3/17,4.57%,TREM2;STAP1;CEBPA
prerank,regulation of epidermal cell differentiation (GO:0045604),0.6692517934678056,1.4570171223442567,0.05759803921568627,0.29523289145245474,1.0,4/21,5.47%,RUNX1;CTSK;CTSL;MAFG
prerank,steroid metabolic process (GO:0008202),0.5905243144692381,1.456968477785658,0.02198952879581152,0.2948021990364097,1.0,7/72,5.97%,CYP1A1;SHH;LGMN;TSPO;LIPA;NPC1;DHRS11
prerank,response to sterol (GO:0036314),0.7289354853453355,1.4568487100146255,0.08647140864714087,0.29450204015581183,1.0,3/11,6.68%,TGFB1;TGFBR1;TGFBR2
prerank,cholesterol homeostasis (GO:0042632),0.5857425782080754,1.4564266599117506,0.03184713375796178,0.29502497534900235,1.0,15/64,12.14%,PCSK9;LPL;ABCA1;ANGPTL3;NPC2;ABCG1;APOE;LDLRAP1;IL18;NPC1;SOAT2;LIPC;LRP5;TTC39B;HDAC9
prerank,regulation of endocytosis (GO:0030100),0.5873170883336353,1.455578231585718,0.023206751054852322,0.2966098253998833,1.0,12/61,11.64%,CD22;LILRB1;LGALS3;PTPN1;SNCA;APOE;MCTP1;SNX33;AP2S1;STON2;NEDD4L;STON1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.7346223422894989,1.455201788552306,0.07779349363507779,0.29701015423947313,1.0,4/12,7.03%,WDTC1;ERLIN1;ERLIN2;ACADL
prerank,cellular response to glucagon stimulus (GO:0071377),0.6868919559264366,1.4550546043843482,0.07643312101910828,0.2968303391650417,1.0,7/17,13.49%,ADCY7;PRKAR2B;CYSLTR2;ADCY6;PRKACB;ADCY3;ADCY8
prerank,negative regulation of protein metabolic process (GO:0051248),0.6039528467137429,1.453895392640923,0.036519871106337275,0.2991387589035201,1.0,6/48,4.14%,CD84;TREM2;ITGB3;MAD2L2;EDNRB;APOE
prerank,glycogen catabolic process (GO:0005980),-0.5013650063889987,-1.4530923218968395,0.04954954954954955,0.9268526683313427,1.0,7/15,21.94%,PHKA2;PYGB;PHKG2;PHKB;PYGM;AGL;PHKA1
prerank,regulation of cellular component size (GO:0032535),0.6393826950711746,1.4529770177319932,0.05509964830011723,0.3008430717513299,1.0,6/30,4.99%,VAV1;PEX11A;RIN3;MTOR;VAV2;VAV3
prerank,response to organic cyclic compound (GO:0014070),0.5978604016678142,1.4526022756829124,0.027600849256900213,0.30120788740832916,1.0,13/52,14.53%,CYP1A1;TGFB1;TNF;SPP1;IL18;ABCB4;CTNNB1;ANXA1;KYNU;STAT5B;CCL2;TIPARP;LRRK2
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.6650043376923626,1.4513961916391416,0.05961070559610705,0.3037474895280044,1.0,7/21,16.50%,BAG2;RPL23;MAD2L2;UBE2S;FZR1;RPL11;PTEN
prerank,response to glucagon (GO:0033762),0.6801876902264022,1.4506724685888746,0.07421383647798742,0.30503649441654374,1.0,8/19,13.49%,ADCY7;PRKAR2B;CYSLTR2;ADCY6;PRKACB;CREB1;ADCY3;ADCY8
prerank,macromolecule catabolic process (GO:0009057),0.6454726443430895,1.450314111501522,0.06481481481481481,0.30545954329354924,1.0,13/26,17.55%,TGFB1;LGMN;MTOR;CLN8;UVRAG;TRIM24;BECN1;SNX25;CAPN3;SMURF1;IDE;PIK3R4;USE1
prerank,regulation of microtubule polymerization (GO:0031113),-0.3967847069373304,-1.4501337082478163,0.03260869565217391,0.918990406957781,1.0,15/40,15.12%,CDH5;STMN2;SLAIN2;EML2;CLIP1;PAK1;DYRK1A;ABL1;DRG1;MET;CDK5RAP2;MAPT;NAV3;OCLN;TUBB4A
prerank,negative regulation of cell communication (GO:0010648),0.6594088218866032,1.449625826401397,0.057001239157372985,0.3067858903301127,1.0,3/21,3.12%,UBASH3B;PTPN1;OSM
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.5893860929977329,1.4492347639247092,0.027513227513227514,0.3072305112085622,1.0,17/54,14.82%,SYK;LAPTM5;RFFL;TNF;OTULIN;TRAF2;PYCARD;TNFAIP3;CASP1;CFLAR;TAX1BP1;IKBKG;CASP8;GPS2;GAS6;TRADD;SPPL2A
prerank,regulation of GTPase activity (GO:0043087),0.5614863527235988,1.4478162345004773,0.002004008016032064,0.31030485799949914,1.0,52/177,17.17%,FGD2;VAV1;DOCK8;RGS10;KLRK1;ARHGAP9;ARHGAP15;FZD10;THY1;PLXNC1;VAV2;RASA4;SNX9;CCL8;ARAP1;SEMA4D;ITGA6;GPR137B;PLXNB2;RASGRP2;VAV3;ARFGEF1;RAB3GAP2;FGD6;USP6NL;DOCK11;DOCK10;AGRN;WNK1;FLCN;CCL14;F11R;TBC1D2;CCL13;RAPGEF1;LIMS1;CCL2;ARHGAP27;ADAP1;MMUT;LRRK2;RAP1A;BCAR3;NF1;GNB5;ALS2;RGS1;EPHA4;CPEB2;SNX13;CCL25;SNX18
prerank,regulation of glucose import (GO:0046324),-0.4160490032875084,-1.447654455718356,0.050359712230215826,0.9101576926285806,1.0,8/30,15.10%,SORBS1;GRB10;PRKCI;IRS1;SELENOS;ARPP19;AKT1;OCLN
prerank,positive regulation of interleukin-13 production (GO:0032736),0.7546233448497746,1.4474369321201823,0.08408408408408409,0.310808896580244,1.0,2/10,5.08%,IRF4;IL18
prerank,amyloid-beta metabolic process (GO:0050435),-0.5177652096973006,-1.4473398367957302,0.0912863070539419,0.8910191289806051,1.0,9/16,23.91%,MGAT3;BACE1;DYRK1A;MME;ACE;BACE2;PSEN2;APEH;PSENEN
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.5983868133867991,1.4465049065280065,0.018259935553168637,0.3125742415171683,1.0,15/57,9.02%,SYK;LGMN;AIM2;CTSD;TNF;PYCARD;CASP1;HMGB1;ASPH;MAP3K5;TBC1D10A;MALT1;GRAMD4;BAK1;PDCD6
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.578635983723191,1.4461987938662249,0.01981230448383733,0.3122708402702953,1.0,22/78,12.21%,CTSS;FCGR2B;LGMN;CD74;CTSD;CTSL;KLC2;AP1S3;FCER1G;RAB7A;CAPZB;DNM2;AP2S1;CAPZA1;AP1B1;ACTR10;KIF23;CTSE;CLTC;DCTN5;SEC24D;DYNC1H1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.578635983723191,1.4461987938662249,0.01981230448383733,0.3122708402702953,1.0,22/78,12.21%,CTSS;FCGR2B;LGMN;CD74;CTSD;CTSL;KLC2;AP1S3;FCER1G;RAB7A;CAPZB;DNM2;AP2S1;CAPZA1;AP1B1;ACTR10;KIF23;CTSE;CLTC;DCTN5;SEC24D;DYNC1H1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.5730163595158781,1.4455092676396966,0.013265306122448979,0.31359583922498074,1.0,15/91,11.64%,PTPRC;CD22;FGR;HCK;SYK;RAB8B;PTPN1;AP2S1;STON2;DNAJC13;RAB11A;MAP2K2;USP7;NRP1;STON1
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.6419346577755459,1.445160312064919,0.0761904761904762,0.31397415087937036,1.0,3/23,3.69%,TGFB1;MYL3;PKP2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.5706911912673529,-1.444966085523803,0.06640625,0.8824934375358793,1.0,4/12,4.78%,NFIB;GLI2;PAFAH1B1;EPHB2
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.6027562521048803,1.4448387525799307,0.057803468208092484,0.31429731476752487,1.0,4/34,8.10%,ARRB2;NPAS4;GABRA5;MEF2C
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.6374667282142343,1.4438727697162395,0.057432432432432436,0.3162722783174984,1.0,4/28,2.00%,TREM2;BAG2;LAPTM5;CTSC
prerank,regulation of stem cell proliferation (GO:0072091),0.6747648697268496,1.4435372749999003,0.08322496749024708,0.3165679550573239,1.0,1/17,0.11%,PTPRC
prerank,regulation of store-operated calcium entry (GO:2001256),0.7384178546603154,1.4433759372208508,0.0944206008583691,0.31646418494533507,1.0,1/10,0.09%,CD84
prerank,sensory perception of pain (GO:0019233),0.649474173845534,1.4432401031229165,0.0670807453416149,0.3162889875115916,1.0,7/21,13.51%,CCR2;P2RX7;PRDM12;P2RX4;CCL2;SCN9A;RETREG1
prerank,cell proliferation in forebrain (GO:0021846),0.7351699518135895,1.441325046784489,0.09292649098474341,0.32054152428890287,1.0,5/10,12.61%,HOOK3;AKNA;KIF14;PCM1;NUMB
prerank,regulation of Golgi organization (GO:1903358),0.702526236248578,1.441162307390874,0.06979695431472081,0.3203724888385833,1.0,9/17,17.70%,MYO5A;ARMH3;RBSN;USP6NL;MAP2K2;STX5;RAB33B;CAMSAP2;AKAP9
prerank,regulation of phospholipase C activity (GO:1900274),-0.5070463251726371,-1.4406700969303823,0.05976095617529881,0.8838692590704992,1.0,4/15,6.80%,NTRK3;PLCG1;ABL1;PDGFRA
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.6917235511845524,1.4406641420779542,0.08049113233287858,0.32103906737641213,1.0,3/15,2.40%,BAG2;RPL23;MAD2L2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.653387514051581,1.4404825817747582,0.057285180572851806,0.3209501743415674,1.0,6/23,12.71%,PTK2B;UBASH3B;NOS1AP;DIAPH1;FYN;CACNB1
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.7500275155962397,1.4404263069979815,0.08131241084165478,0.32051126880531816,1.0,2/10,3.12%,HK3;PFKL
prerank,positive regulation of interferon-beta production (GO:0032728),0.619105785753584,1.440224707026131,0.0489749430523918,0.32049284391462585,1.0,5/33,2.91%,IRF5;TLR2;DHX9;TLR8;TLR7
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.6290796562201946,1.4400705280400623,0.056140350877192984,0.32033266873537636,1.0,6/29,11.04%,VAV1;LYN;GRB2;EPO;ERBIN;RAPGEF1
prerank,regulation of response to biotic stimulus (GO:0002831),0.6295578715942728,1.439896212055393,0.059371362048894066,0.32021843472461076,1.0,14/28,16.65%,TREM2;FGR;FCGR2B;TRIM5;TRAF3;SAMHD1;ZMPSTE24;RNF135;CASP8;LRP8;ERAP1;IRF1;CD36;APPL2
prerank,positive regulation of receptor internalization (GO:0002092),0.6581788659290854,1.4396742201455446,0.0725,0.3202223665307549,1.0,9/22,19.19%,ARRB2;PCSK9;NTF3;SCYL2;CD63;AHI1;GREM1;ANGPT1;TBC1D5
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6812437352930596,1.4388198509280155,0.08409986859395532,0.3220854365134861,1.0,5/15,4.90%,ADAM8;SNX9;TNF;APOE;SNX33
prerank,regulation of cholesterol metabolic process (GO:0090181),0.6629563284433074,1.4384005675190412,0.07633587786259542,0.3225987737140723,1.0,10/20,14.79%,NR1H4;SREBF2;APOE;LDLRAP1;FMO5;ACADL;SEC14L2;TTC39B;SREBF1;ARV1
prerank,phospholipid translocation (GO:0045332),0.6276326892241457,1.4379927822022978,0.0533175355450237,0.32311931411770795,1.0,8/28,12.70%,ATP8B4;ABCA1;P2RX7;ATP8A1;ATP8A2;ABCB4;ABCC1;ABCA4
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.6337464791688614,1.4372136275754,0.054906542056074766,0.32448714268938145,1.0,10/30,12.34%,PTPRC;CD300A;PRKCD;THY1;SEMA4D;SAMSN1;NTF3;SH2B3;NF2;PPP2CA
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.6387401013847883,1.437201827393431,0.0821256038647343,0.3239358252240782,1.0,12/25,20.49%,HK3;PFKL;ALDOB;ENO3;GPI;FOXK1;HK2;GAPDHS;GCK;PGAM1;ENO1;PKM
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.6829751219836087,1.4369550070059256,0.07105263157894737,0.32398160768665557,1.0,4/16,7.23%,RUNX1;TGFB1;RGCC;CREB3L1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.6072905948960529,1.436828224005444,0.04703247480403135,0.323776694013819,1.0,12/41,16.34%,CASS4;STAP1;CSF1R;GPRC5B;PTPN1;FCGR1A;NEDD9;FYN;LRP8;GAS6;SRC;EPHA4
prerank,sympathetic nervous system development (GO:0048485),0.6842373961890983,1.4349965533109441,0.08597883597883597,0.328009963227605,1.0,7/15,16.02%,ASCL1;FZD3;CTNNB1;TFAP2B;NRP1;SOX4;NF1
prerank,regulation of leukocyte activation (GO:0002694),0.7040165537852628,1.4344645329819141,0.08743169398907104,0.3289525457235663,1.0,3/14,4.54%,LYN;CD74;GPR137B
prerank,cell projection assembly (GO:0030031),0.6445387225156145,1.4342822233682746,0.08487084870848709,0.32883618720777485,1.0,2/22,1.31%,NCKAP1L;NEFH
prerank,indolalkylamine catabolic process (GO:0046218),0.7238835197842919,1.4323425215665648,0.09530791788856305,0.333283866293441,1.0,3/10,7.82%,HAAO;KYNU;KMO
prerank,positive regulation of lymphocyte migration (GO:2000403),0.7012581777058235,1.431838947668203,0.08882521489971347,0.33396049469481204,1.0,3/12,6.51%,DOCK8;PYCARD;AIF1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.6118020976105895,1.4312979868893063,0.04888888888888889,0.3347977107568914,1.0,12/38,16.50%,ARRB2;PTPRJ;PIK3CB;DDIT3;XDH;OTUD3;FLCN;PDCD6;SH2B3;PLEKHA1;PHLPP1;PTEN
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.6200376577509513,1.431180904236733,0.056712962962962965,0.33452532445708877,1.0,2/33,0.14%,RUNX1;KLK3
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.5721026718811361,1.4310777793750706,0.020833333333333332,0.3342415234010328,1.0,22/79,12.21%,CTSS;FCGR2B;LGMN;CD74;CTSD;CTSL;KLC2;AP1S3;FCER1G;RAB7A;CAPZB;DNM2;AP2S1;CAPZA1;AP1B1;ACTR10;KIF23;CTSE;CLTC;DCTN5;SEC24D;DYNC1H1
prerank,protein-DNA complex disassembly (GO:0032986),0.6746737394792275,1.430493382940522,0.08571428571428572,0.33518140394960694,1.0,5/16,13.09%,NFE2;RPL23;ARID1A;SMARCD3;SMARCB1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.5749467357257063,1.4304690027894769,0.034957627118644065,0.3346512195569324,1.0,12/66,7.90%,CX3CR1;AIM2;SIRPA;LPL;P2RX7;TLR8;TNF;PYCARD;TNFAIP3;CASP1;TYROBP;MALT1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.5632047593355823,1.43016465965284,0.013211382113821139,0.334907686877019,1.0,31/98,19.41%,ARRB2;TGFB1;PCSK9;IL10RB;VAMP3;GRB2;MAPK14;SNCA;APOE;IFNAR1;XDH;TGFBR2;TP53;NTF3;SCYL2;RAB1B;INHBA;THBS1;CD63;PID1;STARD4;FASN;AHI1;ACACA;PPARD;GREM1;ANGPT1;GHITM;TBC1D5;SCRIB;RAB29
prerank,neuronal action potential (GO:0019228),-0.4394589160216986,-1.4295835483007806,0.06557377049180328,0.917872312985375,1.0,12/22,28.36%,SCN1A;CACNA1G;KCNA1;KCNA2;SCN8A;ANK3;SCN3A;KCNMB2;GPER1;CACNA1H;MYH14;CACNA1I
prerank,canonical glycolysis (GO:0061621),0.6398427276520859,1.4287543792326778,0.08118081180811808,0.3375159720698723,1.0,12/24,20.49%,HK3;PFKL;ALDOB;ENO3;GPI;FOXK1;HK2;GAPDHS;GCK;PGAM1;ENO1;PKM
prerank,glucose catabolic process to pyruvate (GO:0061718),0.6398427276520859,1.4287543792326778,0.08118081180811808,0.3375159720698723,1.0,12/24,20.49%,HK3;PFKL;ALDOB;ENO3;GPI;FOXK1;HK2;GAPDHS;GCK;PGAM1;ENO1;PKM
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.6470692300846245,1.4275735481831855,0.07161125319693094,0.3400161028562003,1.0,3/23,4.51%,CYP1A1;ALOX12;HPGD
prerank,regulation of cell development (GO:0060284),0.6102515159991149,1.4274417775926949,0.06292906178489703,0.33982224193653143,1.0,8/36,12.14%,ASCL1;CX3CR1;SLAMF8;HES7;BHLHE41;CTNNB1;GRN;HDAC9
prerank,carboxylic acid catabolic process (GO:0046395),0.7170410908051259,1.4272729360418224,0.08391608391608392,0.33968997009504664,1.0,4/12,7.33%,NPL;RENBP;NAGK;PON3
prerank,lytic vacuole organization (GO:0080171),0.6282830946258812,1.4269260004084916,0.05411499436302142,0.3399943584387795,1.0,13/32,17.34%,HOOK3;ABCA1;MTOR;ARSB;CLN3;VPS18;TFEB;MYO7A;GRN;HOOK2;LRRK2;GNPTAB;LAMTOR1
prerank,regulation of neuron death (GO:1901214),0.5678696796273299,1.426675804709773,0.0296220633299285,0.3400444126914971,1.0,21/82,13.27%,GPNMB;ITGB2;FCGR2B;PCSK9;CD200R1;SNCA;TRAF2;TYROBP;MAP3K5;C1QA;MEF2C;KIF14;CTSZ;PPARGC1A;ITGAM;TNFRSF1B;FYN;DDIT4;SORL1;IKBKG;RRAS2
prerank,actin crosslink formation (GO:0051764),0.7284839760351088,1.4264532842320652,0.06805555555555555,0.3400613893389831,1.0,4/12,6.51%,LCP1;GAS2L1;GAS2L3;AIF1
prerank,high-density lipoprotein particle assembly (GO:0034380),0.7307964037287158,1.426382439736316,0.10310734463276836,0.33967888983144867,1.0,3/10,11.47%,ABCA1;APOE;PRKACB
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6780656151718217,1.4260989992777393,0.0858974358974359,0.33988285196663076,1.0,3/16,3.81%,ITGB2;MDK;TNF
prerank,regulation of cell size (GO:0008361),0.6499170017840601,1.425893240830896,0.07600950118764846,0.33987588916685957,1.0,5/23,4.99%,VAV1;PLEK;MTOR;VAV2;VAV3
prerank,estrogen metabolic process (GO:0008210),0.6883396591477703,1.425597378786093,0.08544726301735647,0.34007195315314687,1.0,1/15,0.47%,CYP1A1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.5526020030348994,1.4249766905597385,0.008056394763343404,0.34119995145396537,1.0,48/132,17.02%,LAPTM5;ADAM8;DAGLB;PRKCD;P2RX7;PTPN1;MLXIPL;PIK3CB;SNX9;TRIM5;TNF;SNCA;APOE;CNOT8;FOXO3;SNX33;PFKFB4;HMGB1;TFEB;GTPBP1;ABCD1;PIM2;SVIP;TICAM1;PLK2;GRSF1;VPS11;FLCN;MOV10;TRIM27;RC3H1;AMER1;TRIM8;ZC3H18;MID2;TNFRSF1B;ITCH;LRRK2;RNF152;MTDH;GSK3A;PFKFB3;IRGM;HIF1A;FAF1;HSP90AA1;GAPDHS;FURIN
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.46070683931525397,-1.4247145671419819,0.07954545454545454,0.9043638392330539,1.0,8/20,16.92%,ACADSB;AUH;MCCC1;HIBCH;DLD;IVD;BCKDK;SLC25A44
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.46070683931525397,-1.4247145671419819,0.07954545454545454,0.9043638392330539,1.0,8/20,16.92%,ACADSB;AUH;MCCC1;HIBCH;DLD;IVD;BCKDK;SLC25A44
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.7119740007871679,1.4242667200876948,0.09286675639300135,0.34191091396395185,1.0,8/12,24.42%,TNF;SLC9A1;SPPL3;CHERP;LMCD1;PTBP1;IGF1;CAMTA1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.7119740007871679,1.4242667200876948,0.09286675639300135,0.34191091396395185,1.0,8/12,24.42%,TNF;SLC9A1;SPPL3;CHERP;LMCD1;PTBP1;IGF1;CAMTA1
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5962197978358378,1.4242143016242381,0.05649717514124294,0.3415007457639878,1.0,6/40,5.90%,FGR;MPEG1;TLR2;DMBT1;STAB2;PPP1R11
prerank,fluid transport (GO:0042044),0.7113821746683497,1.4239098865538142,0.09237536656891496,0.34172488238303816,1.0,2/12,8.14%,AQP1;AQP11
prerank,pre-miRNA processing (GO:0031054),0.6991164818225691,1.4226580068053747,0.0638002773925104,0.34460695675631337,1.0,11/14,25.04%,ADAR;AGO4;AGO3;PRKRA;TUT7;TARBP2;AGO2;DICER1;LIN28B;DROSHA;AGO1
prerank,activation of GTPase activity (GO:0090630),0.5606605747215627,1.4215312568225613,0.016477857878475798,0.347105376191033,1.0,19/89,12.62%,ARHGAP45;ARHGAP25;TBC1D9;ABR;SIPA1L2;ARHGAP22;TBC1D10C;ARHGAP24;TBC1D16;TBC1D22A;USP6NL;TBC1D10A;SIPA1;NTF3;RAP1GAP2;TBC1D2;TBC1D17;TBC1D2B;TBC1D8
prerank,protein processing (GO:0016485),0.5586061859823047,1.4215131580859306,0.016227180527383367,0.3465653937988086,1.0,19/102,9.46%,CTSS;KLK3;PCSK9;LGMN;FAM111A;VSIR;SRGN;CTSL;ECE2;EEF1AKMT4-ECE2;CLN3;CASP1;DDI2;SPCS2;ATP23;SEC11C;ZMPSTE24;SPPL3;SPCS1
prerank,positive regulation of cation channel activity (GO:2001259),0.5994640779855597,1.4213875133848095,0.043668122270742356,0.34632208297397205,1.0,7/40,7.46%,CTSS;CCR2;P2RY6;PKD2;KCNIP2;STAC;TMSB4X
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.6979787955396808,1.4213079888403088,0.09190672153635117,0.34598821216455766,1.0,2/13,1.20%,ANAPC15;PCID2
prerank,cellular response to drug (GO:0035690),0.6342782186333698,1.4211073163956385,0.07645631067961164,0.34595104271204635,1.0,5/25,8.10%,AIM2;SLAMF8;RAP2A;TP53;MEF2C
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5870147752294441,1.4205594119822824,0.058305830583058306,0.34691400547645596,1.0,13/45,16.03%,AIM2;LPL;P2RX7;TLR8;TNF;PYCARD;CASP1;TYROBP;MALT1;NOD2;CASP8;TMEM106A;CD36
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6774940101852931,1.420169487108216,0.08839050131926121,0.347424283815067,1.0,5/15,7.46%,LGMN;SMOC2;PRKD2;P2RX4;TMSB4X
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.5486587597963893,1.419731390758748,0.002,0.3480017999401076,1.0,43/190,12.90%,ARRB2;CD22;TREM2;LYN;ARHGAP25;PLEK;CYRIB;PTPRJ;DUSP3;P2RX7;PIK3CB;RFFL;MAPK14;TSPAN6;NLRC3;NR1H4;FNIP1;HERPUD1;TANK;PYCARD;DDIT3;SPI1;MGRN1;TNFAIP3;WWC2;XDH;ADGRG3;MAP2K3;BCL2L1;OTUD3;TMSB4X;DGKG;DGKD;FLCN;PDCD6;PDE11A;SH2B3;THBS1;ADIPOR1;CDC34;DDIT4;NLRX1;CASP8
prerank,substrate-dependent cell migration (GO:0006929),0.6804926990669968,1.4193318651456697,0.1077127659574468,0.34843982136108975,1.0,5/14,12.29%,PTPRC;ITGA2;P2RY12;NRP1;SDCBP
prerank,regulation of cellular respiration (GO:0043457),0.6782629489971825,1.419308432416254,0.08118556701030928,0.3479198029339843,1.0,4/17,7.84%,IL10RB;CBFA2T3;IFNAR1;TRAP1
prerank,lipid homeostasis (GO:0055088),0.5778580472351316,1.4184489066850792,0.04068522483940043,0.3496076164736943,1.0,12/57,9.00%,TREM2;ABCA1;MLXIPL;ANGPTL3;CLN8;ABCG1;APOE;CEBPA;ABCB4;USF1;ABCD1;ABHD4
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.6226133911815368,1.4181818136917501,0.07934655775962661,0.3497403014261702,1.0,7/26,11.19%,PTPRC;PLCG2;PKD2;ITPR2;IBTK;SLC8B1;CHERP
prerank,regulation of hydrolase activity (GO:0051336),0.5665626468753009,1.4177896145912936,0.031545741324921134,0.3502743328738231,1.0,11/71,5.92%,FGD2;VAV1;ARHGAP9;ARHGAP15;PLXNC1;VAV2;GPR137B;PLXNB2;VAV3;RAB3GAP2;FGD6
prerank,glycine transport (GO:0015816),0.7106822483604609,1.4176840296673472,0.09601181683899557,0.3499527798012665,1.0,3/10,9.26%,SLC7A8;SLC36A1;SLC25A38
prerank,cellular response to amyloid-beta (GO:1904646),0.603029967355014,1.416703864893774,0.0625,0.3518822379123379,1.0,11/35,16.34%,TREM2;FCGR2B;LGMN;ITGA4;CACNA1A;ABCC1;FYN;CACNB1;LRP1;CD36;EPHA4
prerank,granulocyte differentiation (GO:0030851),0.6593204821334058,1.4155984246207247,0.09718670076726342,0.35434628402209184,1.0,5/18,6.87%,GATA1;CBFA2T3;CEBPA;SPI1;TAL1
prerank,cellular response to fluid shear stress (GO:0071498),0.7119133303462503,1.414908660963489,0.10082872928176796,0.3555435367019482,1.0,5/12,8.10%,NFE2L2;SREBF2;PKD2;MTSS1;MEF2C
prerank,protein-containing complex subunit organization (GO:0043933),0.5530852495429008,1.4138986536422558,0.021105527638190954,0.35766131987295163,1.0,27/109,13.71%,NCKAP1L;PTK2B;CD3E;CD74;VAMP3;SKAP2;SNX9;WIPF1;MITF;TRAF2;TEAD1;TP53;SEH1L;CAPZA1;HFE;PPARGC1A;EPRS1;TUBGCP4;TPR;SOX9;NUP205;DET1;MDN1;RANBP9;IKBKG;DARS1;TSPAN4
prerank,negative regulation of innate immune response (GO:0045824),0.6016253513190694,1.4126072852633302,0.06995412844036697,0.36053007955745864,1.0,11/34,12.01%,NLRC5;SLAMF8;NLRC3;TRAFD1;TNFAIP3;SAMHD1;YTHDF3;TTLL12;GRN;USP18;METTL3
prerank,growth hormone receptor signaling pathway (GO:0060396),0.68858043573454,1.4118562993194312,0.09825033647375504,0.3619802699219039,1.0,3/14,2.55%,LYN;STAT5A;PTPN1
prerank,serine family amino acid metabolic process (GO:0009069),0.6556184134389028,1.4106982157991692,0.0847457627118644,0.3645465117103727,1.0,1/16,0.19%,SEPSECS
prerank,positive regulation of phosphatase activity (GO:0010922),0.6462683274923057,1.4099642470857796,0.0874384236453202,0.36599217183742605,1.0,4/21,8.10%,PLEK;CD300A;MTOR;MEF2C
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.5516604241663724,1.4098338937434538,0.002008032128514056,0.3657944241949895,1.0,21/152,7.66%,GNA15;CNR2;PF4;CALCR;ADCY7;ABCA1;ADGRE1;ADGRG5;GNAQ;ADGRE5;PSAP;GNAZ;ADCY6;AKAP5;S1PR4;ADGRG3;GNA13;GNA12;RAMP1;WASF2;P2RY12
prerank,wound healing (GO:0042060),0.5669984374787895,1.4096925826309803,0.04756871035940803,0.365582569235057,1.0,18/62,17.18%,MMP12;HPSE;SLC11A1;ITGB3;TGFBR1;MYH9;MACF1;CFLAR;SMAD3;SYTL4;DYSF;NRG1;PRCP;DST;AHNAK2;NF1;ARL8B;DCBLD2
prerank,regulation of chromatin binding (GO:0035561),-0.5732498451206641,-1.4096477377750016,0.1178343949044586,0.9577139819412311,1.0,5/10,16.92%,WAPL;BTAF1;DTX3L;KDM4D;HMBOX1
prerank,positive regulation of proteolysis (GO:0045862),0.5775069881788747,1.409480130672913,0.04741379310344827,0.365521827109968,1.0,18/55,14.80%,BAG2;CTSC;ADAM8;SNX9;TNF;AURKAIP1;APOE;TANK;SNX33;ASPH;TBC1D10A;ATP5IF1;BAK1;TNFRSF1B;CCBE1;CASP8;STUB1;CAPN3
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.6493447249396571,1.4093960375225338,0.10611735330836454,0.3651641517669509,1.0,2/19,5.09%,CX3CR1;TNFAIP3
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7313001604698811,1.40906739364897,0.09428571428571429,0.36547427167563395,1.0,5/10,13.17%,LYN;STAT5A;PTPN1;STAT5B;PRLR
prerank,cellular response to osmotic stress (GO:0071470),0.6392747940173631,1.4088001551018057,0.09236453201970443,0.36558812053596096,1.0,7/21,17.28%,AQP1;LRRC8D;PKD2;EPO;CAPN3;RCSD1;ARHGEF2
prerank,negative regulation of GTPase activity (GO:0034260),0.6443181082262556,1.40822146555489,0.09595959595959595,0.36657087151016,1.0,8/22,16.45%,KLRK1;FZD10;RASA4;ARFGEF1;WNK1;F11R;LRRK2;CPEB2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5914763990741486,1.4076182516152589,0.06256742179072276,0.36763161841999176,1.0,6/46,2.60%,PTPRC;LYN;SIRPA;DUSP3;PTPN1;DUSP29
prerank,dopaminergic neuron differentiation (GO:0071542),0.6546456028552775,1.4075179271746447,0.0949367088607595,0.36731068645763626,1.0,2/19,6.29%,SHH;CTNNB1
prerank,diacylglycerol metabolic process (GO:0046339),0.6318386497570556,1.4071607160847106,0.07913669064748201,0.36776050392234577,1.0,8/23,12.79%,DGKZ;PGS1;DGKK;DGKE;DGKG;DGKD;DGKI;LIPE
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.6959002473881484,1.4071167025744429,0.1136986301369863,0.3673047596629925,1.0,3/12,5.65%,THY1;TNF;CD44
prerank,response to purine-containing compound (GO:0014074),0.6603755299264111,1.407085391386709,0.09986859395532194,0.36679080689165894,1.0,5/17,10.39%,KCNJ11;P2RY6;P2RX7;P2RX4;VGF
prerank,"wound healing, spreading of cells (GO:0044319)",0.6372155976395261,1.4067842376132995,0.08752997601918465,0.36705101277431385,1.0,5/24,6.17%,MMP12;LCP1;ARHGAP24;CD44;MRTFA
prerank,negative regulation of cyclase activity (GO:0031280),0.6778924734439901,1.4067365673065062,0.10187667560321716,0.3666033494885336,1.0,6/14,18.16%,CCR2;EDNRB;AKAP5;LTB4R2;GNAI3;GNAI2
prerank,positive regulation of GTPase activity (GO:0043547),0.5428103000334297,1.4067055802584103,0.004012036108324975,0.3661217923377772,1.0,55/188,17.22%,ARHGAP45;DOCK8;ARHGAP25;RGS10;TBC1D9;ABR;SIPA1L2;ARHGAP22;FZD10;TBC1D10C;THY1;ARHGAP24;SNX9;CCL8;ARAP1;SEMA4D;ITGA6;RASGRP2;TBC1D16;TBC1D22A;USP6NL;DOCK11;DOCK10;AGRN;TBC1D10A;FLCN;SIPA1;NTF3;CCL14;RAP1GAP2;F11R;TBC1D2;TBC1D17;CCL13;RAPGEF1;LIMS1;CCL2;TBC1D2B;ARHGAP27;TBC1D8;MMUT;RAP1A;TBC1D14;BCAR3;SIPA1L3;TBC1D22B;NF1;GNB5;ALS2;RGS1;ARHGEF26;SNX13;CCL25;SNX18;CORO1C
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.6659272114153041,1.40613955969844,0.09433962264150944,0.3671539428726907,1.0,6/15,11.24%,LGMN;SMOC2;PRKD2;P2RX4;TMSB4X;THBS1
prerank,cell differentiation in spinal cord (GO:0021515),0.709123326424301,1.4052556268700949,0.09388335704125178,0.36887860880404916,1.0,3/10,14.60%,DRAXIN;SOX6;SOX4
prerank,regulation of nervous system development (GO:0051960),0.6003668526941535,1.4050948117256383,0.07366071428571429,0.3687822078917125,1.0,6/37,8.15%,ASCL1;CX3CR1;HES7;BHLHE41;CTNNB1;KIF14
prerank,ventricular septum morphogenesis (GO:0060412),-0.4266580193919225,-1.4050865522192697,0.06329113924050633,0.961466256742217,1.0,9/27,7.15%,ZFPM2;BMPR1A;ROBO2;BMP4;ACVR1;TGFBR3;ROBO1;SLIT2;SMAD4
prerank,positive regulation of cellular component organization (GO:0051130),0.5586134449372205,1.4039185354153685,0.013091641490433032,0.3714301070803362,1.0,18/107,10.05%,RUNX1;TREM2;LGALS3;PLEKHM2;TGFB1;SYK;FNIP2;TGFBR1;TNF;FNIP1;SNCA;ASAP1;APOE;ABCB4;TAL1;RB1;BAK1;NEDD4L
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.7170276288791699,1.4038982035061638,0.09812409812409813,0.3709065813109831,1.0,3/11,6.68%,TGFB1;TGFBR1;TGFBR2
prerank,regulation of proteolysis (GO:0030162),0.5782848471957192,1.4034064619588829,0.0625,0.3716880468829267,1.0,16/48,14.80%,GSAP;SHH;CLN8;AURKAIP1;CLN3;TRAF3;ASPH;TBC1D10A;BAK1;HDAC6;SPOP;PARL;CASP8;ITCH;STUB1;CAPN3
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.6609593464719593,1.403047142533094,0.10411311053984576,0.37211001299883767,1.0,3/17,7.57%,TREM2;NFE2L2;P4HB
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.6814174137148205,1.402776862148664,0.11036339165545088,0.37227872940429996,1.0,6/13,18.16%,CCR2;EDNRB;AKAP5;LTB4R2;GNAI3;GNAI2
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5145481826333747,-1.4017865917029233,0.08550185873605948,0.9589548523519676,1.0,8/13,28.97%,BMP4;NR3C2;AR;CALCOCO1;GPER1;PLPP1;PGR;BMP7
prerank,pancreas development (GO:0031016),-0.5314058637292131,-1.4015632630622126,0.12709030100334448,0.9418786922902364,1.0,5/12,20.28%,TCF7L2;NPHP3;MET;CCDC39;ZIC3
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.6950476781942457,1.4015227594567023,0.11424541607898449,0.3739615230361441,1.0,7/12,21.60%,ESPL1;CDC23;RB1;ANAPC11;CUL3;NSMCE2;CDC16
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6950476781942457,1.4015227594567023,0.11424541607898449,0.3739615230361441,1.0,7/12,21.60%,ESPL1;CDC23;RB1;ANAPC11;CUL3;NSMCE2;CDC16
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6950476781942457,1.4015227594567023,0.11424541607898449,0.3739615230361441,1.0,7/12,21.60%,ESPL1;CDC23;RB1;ANAPC11;CUL3;NSMCE2;CDC16
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.6448786327521283,1.4014211279871562,0.09036860879904875,0.373663362076721,1.0,3/23,4.96%,HOOK3;TUBB;CCDC88B
prerank,positive regulation of defense response (GO:0031349),0.5503351566437171,1.4013638332830338,0.03115264797507788,0.37323089253005765,1.0,20/89,13.66%,CCR2;LPL;GPRC5B;ADAM8;TLR2;DHX9;TLR8;TLR7;MDK;OSM;TNF;SNCA;CEBPA;IL18;MEF2C;PLA2G7;ABCC1;GRN;NINJ1;TRADD
prerank,regulation of inflammatory response (GO:0050727),0.5391741674524227,1.4011626978083995,0.002002002002002002,0.37323306058028066,1.0,44/190,13.66%,HCK;CCR2;SIRPA;LPL;CD200R1;METRNL;PIK3AP1;VAMP3;GPRC5B;DAGLB;PRKCD;TLR2;DHX9;TLR7;MDK;OSM;FFAR2;NLRC3;NR1H4;TNF;SNCA;APOE;OTULIN;CEBPA;IL18;TNFAIP3;CASP1;ANXA1;SETD6;AKNA;TMSB4X;PLA2G7;RB1;ABCC1;GRN;TNFRSF1B;USP18;NOD2;NINJ1;SHPK;GPS2;FNDC4;LACC1;TRADD
prerank,lipoxygenase pathway (GO:0019372),0.6752354174442875,1.4009896967711137,0.10739191073919108,0.37310041155804924,1.0,3/14,7.33%,ALOX12;HPGD;PON3
prerank,regulation of hormone secretion (GO:0046883),0.6779329625484398,1.400682159856178,0.10121457489878542,0.37342363157759284,1.0,4/15,6.34%,VAMP3;OSM;FFAR2;ANXA1
prerank,response to fatty acid (GO:0070542),0.664783730491518,1.4005283742367958,0.09961190168175937,0.3732660922150571,1.0,7/17,16.03%,LPL;FFAR2;NR1H4;FOXO3;SOX9;PID1;CD36
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.6305991460062176,1.4004680785317647,0.08787128712871287,0.3728749739908247,1.0,5/22,10.54%,PLEK;STAP1;CDA;TP53;INHBA
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.7079314175907888,1.400310365471594,0.11874105865522175,0.372701611082016,1.0,5/11,13.40%,LILRB1;HCLS1;NOD2;MERTK;GAS6
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5520332902006084,-1.4003070241744877,0.09696969696969697,0.9306074794528161,1.0,4/11,15.07%,GHR;IRS1;EIF2AK3;AKT1
prerank,regulation of protein kinase A signaling (GO:0010738),0.6536516484358187,1.4000287879658218,0.09316770186335403,0.37293635582889273,1.0,5/20,14.53%,CALCR;PRKAR2B;AKAP5;IAPP;LRRK2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.6538666254120817,1.399662378866278,0.09305210918114144,0.37337076268324243,1.0,2/19,2.35%,PTPRC;PTPRJ
prerank,regulation of plasminogen activation (GO:0010755),0.6871638681288286,1.3994794386697547,0.12021857923497267,0.3732966965923426,1.0,4/12,15.23%,RUNX1;CTSZ;THBS1;PLGRKT
prerank,activation of protein kinase activity (GO:0032147),0.547357161107972,1.3994294979308501,0.022267206477732792,0.3728728730058875,1.0,25/106,13.59%,CD86;PTK2B;SLC11A1;ADCY7;PRKAR2B;ITGB3;TAOK3;PRKCD;MTOR;TRAF2;ADCY6;IL18;TGFBR2;TNIK;MALT1;KIF14;STRADB;NTF3;PRKACB;NRG1;PRLR;GAS6;ADCY3;ADCY8;STK3
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.6364812583584947,1.3993121311512304,0.09914320685434516,0.3726853601394692,1.0,2/20,0.51%,PTK2B;PF4
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.6573130115004231,1.398811769133322,0.09504685408299866,0.37345101136417985,1.0,6/18,8.44%,PTK2B;CYRIB;ARFGEF1;RAP1B;RIPOR2;KIF20B
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.7125898567167126,1.398804966660785,0.11392405063291139,0.3729086258707195,1.0,2/10,6.71%,SAG;CNGB1
prerank,TOR signaling (GO:0031929),0.6129765953477789,1.3987835232765844,0.08805790108564536,0.3723986571380411,1.0,7/26,9.29%,CARD11;MTOR;FNIP1;EIF4EBP2;FLCN;LARP1;SMG1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.7227369046317362,1.398477729624134,0.11911764705882352,0.37268021989672245,1.0,3/10,6.70%,MEOX1;SP7;TP53
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.6310166230146801,1.3980041171306667,0.09270704573547589,0.3733415342650784,1.0,4/22,4.11%,GSAP;LYN;TNF;ABCG1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.6161822689747694,1.3978986300793985,0.09265944645006016,0.37306765934383973,1.0,4/26,4.78%,LYN;AIM2;VSIR;PYCARD
prerank,regulation of neuroblast proliferation (GO:1902692),0.6687487941179878,1.397341874170141,0.11580381471389646,0.37401560132794115,1.0,8/15,16.02%,CX3CR1;FZD3;CTNNB1;DISC1;TAFA1;SMARCD3;LRRK2;NF1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.6341676479838714,1.3970769217277734,0.08780487804878048,0.3741739022098112,1.0,1/23,0.08%,PLBD1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.648539169007406,1.3970734024664573,0.10794044665012408,0.3736223680410732,1.0,5/18,7.95%,CBL;IL6R;CEBPA;SPI1;ST18
prerank,negative regulation of MAP kinase activity (GO:0043407),0.58916017430074,1.3969835731419318,0.05263157894736842,0.37329334545954107,1.0,11/44,12.78%,LYN;CD300A;PRKCD;PTPRJ;PTPN1;PIK3CB;APOE;DUSP10;DUSP19;SH2B3;SORL1
prerank,regulation of receptor internalization (GO:0002090),0.5993249323388122,1.3966896268709816,0.06455266138165346,0.37349764324426743,1.0,13/35,19.19%,ARRB2;PCSK9;RIN3;NTF3;SCYL2;CD63;SDCBP;ANKRD13A;AHI1;FLOT1;GREM1;ANGPT1;TBC1D5
prerank,digestive tract morphogenesis (GO:0048546),-0.5038286956085988,-1.3962207778247009,0.08196721311475409,0.9346600622853231,1.0,5/14,14.15%,NIPBL;PDGFRA;GLI1;SOX17;STRA6
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.6201061352319114,1.3957067392191338,0.09917355371900827,0.3755572133032402,1.0,6/24,11.19%,PTPRC;PLCG2;PKD2;ITPR2;IBTK;CHERP
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.6210333084124955,1.395313148180035,0.10824108241082411,0.3760820769374049,1.0,9/24,11.64%,PCSK9;TNF;FOXO3;DDIT3;CTNNB1;TYROBP;TFAP2B;ITGAM;GRN
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.6530618506872486,1.3952160364607022,0.10841836734693877,0.37576953335940777,1.0,2/18,1.16%,PTK2B;CCR2
prerank,T cell mediated immunity (GO:0002456),0.6959530720077862,1.3951550480213792,0.10340136054421768,0.3753777775119621,1.0,3/13,6.12%,MYO1G;CRTAM;BTN3A3
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.629293539224215,1.3948710068914492,0.09158415841584158,0.3755397502382189,1.0,4/23,4.54%,PTPRC;CBL;THY1;ZFYVE28
prerank,regulation of cholesterol efflux (GO:0010874),0.609076599070098,1.3943958784322763,0.07838479809976247,0.3763057688730999,1.0,12/30,18.30%,TREM2;SHH;SREBF2;APOE;EEPD1;TTC39B;GPS2;LRP1;ABCA3;LAMTOR1;NAXE;RXRA
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6256242715516103,1.3938904093892093,0.09777227722772278,0.3771177048059562,1.0,3/24,1.40%,HPSE;TGFB1;IL1A
prerank,positive regulation of stem cell proliferation (GO:2000648),0.662346260806091,1.3932609905031155,0.10878112712975098,0.378333096230341,1.0,1/17,0.11%,PTPRC
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.7124258160363621,1.393244534850526,0.12028985507246377,0.37781137557960204,1.0,2/11,5.65%,CD74;CD44
prerank,cellular response to nutrient levels (GO:0031669),0.5646129525662357,1.3927718804370304,0.0550935550935551,0.3784946465758101,1.0,12/62,8.33%,PCSK9;LPL;GAS2L1;MTOR;ATG7;FNIP1;SREBF2;MAP1LC3B;CD68;TFEB;RIPOR1;FLCN
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.661243307795129,1.3914734793457266,0.10064516129032258,0.381504502700383,1.0,8/18,16.02%,CD300A;NLRC3;SKI;MORC3;TP53;B4GALT7;FTH1;NF1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.5662090003316792,1.3914534620305314,0.0582010582010582,0.3810028521761871,1.0,18/59,14.63%,CARD11;IRAK2;TLR2;TLR8;TLR7;NLRC3;TNF;TANK;TRAF2;CD14;MAP3K14;TICAM1;LY96;IRAK1BP1;TAB2;IKBKG;TRADD;TAB3
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.7203356820252076,1.3911493095360303,0.1235632183908046,0.3812412812156096,1.0,4/10,11.17%,SHH;TGFBR2;LRP5;SOX9
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.7000890351510721,1.3910091055202487,0.11596180081855388,0.3810588407577464,1.0,3/11,2.08%,STAP1;SLAMF8;RIN3
prerank,regulation of fibroblast proliferation (GO:0048145),0.580764739309689,1.3905259714380653,0.06578947368421052,0.3817964021405052,1.0,13/45,14.05%,CD74;CD300A;AQP1;DHX9;NLRC3;SKI;MORC3;CTNNB1;TP53;CDK6;B4GALT7;GAS6;FTH1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5946466425017197,1.390191235153081,0.09389140271493213,0.38217229319023677,1.0,9/33,11.24%,TGFB1;ANGPT4;TNF;RGCC;APOE;HDAC5;HMGB1;MEF2C;THBS1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.4599184796240747,-1.3891106625218326,0.09012875536480687,0.9502323347093744,1.0,15/18,46.05%,NPHP3;CCDC39;SPEF2;OFD1;NEK10;CABYR;CFAP53;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;ODAD4;CCDC40;DNAAF4
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.5469498426113076,-1.387236916140162,0.115625,0.9421990759116777,1.0,5/11,18.57%,PPIP5K2;IP6K1;IP6K2;ITPKC;IPMK
prerank,inositol phosphate metabolic process (GO:0043647),0.5795067637688635,1.3864942588355729,0.06526548672566372,0.3916958726870944,1.0,6/46,6.79%,PLD4;INPP5D;PLCB2;PLCG2;INPP4B;NUDT4
prerank,regulation of establishment of protein localization (GO:0070201),0.6900451109237884,1.386166294757357,0.11650485436893204,0.3920474613270922,1.0,3/13,7.13%,TREM2;CTSD;GAPVD1
prerank,regulation of metal ion transport (GO:0010959),-0.4828222405007002,-1.3861490308996454,0.08968609865470852,0.9310900727317515,1.0,6/16,14.13%,ANK2;SRI;CAMK2G;DLG1;CACNA2D1;IL16
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.6916038982580237,1.3859998254752104,0.1,0.39191728801630593,1.0,4/13,9.57%,ITGB2;MDK;TNF;FUT9
prerank,regulation of interleukin-13 production (GO:0032656),0.6897688034655115,1.3857398369512015,0.10845070422535211,0.3920829070517713,1.0,3/13,10.63%,IRF4;IL18;TNFRSF21
prerank,positive regulation of JUN kinase activity (GO:0043507),0.626055021749233,1.3847787782681962,0.10253317249698432,0.3942082639492432,1.0,7/23,10.57%,TAOK3;FZD10;TNFRSF11A;TNF;TRAF2;MAP3K5;DUSP19
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.7075904321140285,1.384608302743361,0.1093525179856115,0.39414476660738207,1.0,3/11,8.09%,NFKBID;MALT1;PRKCQ
prerank,polyol metabolic process (GO:0019751),0.5799681656384359,1.3842275413165936,0.0664451827242525,0.3946859162476453,1.0,6/46,6.79%,PLD4;INPP5D;PLCB2;PLCG2;INPP4B;NUDT4
prerank,response to cytokine (GO:0034097),0.5402387410763863,1.383976743494545,0.012048192771084338,0.39480696023213097,1.0,28/141,10.79%,PTPN7;CIITA;SLC11A1;HCLS1;FLT3;MAPKAPK3;CD74;IRAK2;CSF1R;TNFRSF11A;PTPN18;SNCA;GCH1;LDLRAP1;IL6R;CXCR4;CASP1;TIMP1;ANXA1;BCL2L1;KYNU;ADAR;SMAD3;CD274;HDAC4;SETD2;TRIM56;IL18BP
prerank,regulation of calcium ion transport (GO:0051924),0.5630117789090032,1.383514049314646,0.05644302449414271,0.39552745690918484,1.0,9/54,10.60%,CD84;LILRB1;PKD2;P2RX4;CTNNB1;ATP2B1;EPB41;CACNB2;SLC8B1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6230856773177229,1.3833882050298938,0.1262135922330097,0.3953189240297491,1.0,3/21,1.91%,ARHGAP25;RASAL3;CYRIB
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6551839910141014,1.3826761977544524,0.10817610062893082,0.39678094782808193,1.0,3/17,1.15%,HCK;HCLS1;STAP1
prerank,lipoprotein localization (GO:0044872),0.6977729454133752,1.3819582003372388,0.13702623906705538,0.398215436751175,1.0,5/11,16.03%,PRKCB;VMP1;ZDHHC3;LRP1;CD36
prerank,cellular response to oxygen-containing compound (GO:1901701),0.5372484840387161,1.381877601309407,0.0,0.3978843980050308,1.0,66/291,14.54%,CD86;PTK2B;LILRB1;PF4;LYN;CX3CR1;CXCL5;STAP1;PDCD1LG2;IL1A;SIRPA;LPL;P2RY6;AQP1;FZD10;HCN4;CXCL2;PRKCD;TLR2;P2RX7;MTOR;MAPK14;P2RY2;FFAR2;NR1H4;PKD2;ADCY6;PYCARD;CD68;TNFAIP3;CD14;CASP1;RAP1B;P2RX4;HMGB1;TAF1;ABCB4;ACTB;CD80;TICAM1;P2RY12;CD180;MEF2C;LY96;CD274;IMPACT;CPEB3;RAPGEF1;SOX9;GLRA2;CCL2;TNFRSF1B;NRIP1;PRDX3;TWF2;NOD2;DEFA6;CREB1;CAMKK2;SHPK;NFKB1;PID1;LAMTOR3;GNG2;CAPN2;RAP1A
prerank,positive regulation of interleukin-1 production (GO:0032732),0.5631910388399405,1.3816093402499152,0.07319698600645856,0.398068294529244,1.0,14/51,16.03%,AIM2;LPL;P2RX7;TLR8;TNF;PYCARD;CASP1;HMGB1;TYROBP;MALT1;NOD2;CASP8;TMEM106A;CD36
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.6928048497364168,1.381581197709078,0.13049645390070921,0.3975668327825445,1.0,3/12,10.47%,CD74;CD44;RPL26
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.6831780018811009,1.3815738693289388,0.11901504787961696,0.3970188795533681,1.0,2/12,0.90%,PF4;TGFB1
prerank,regulation of mitochondrion organization (GO:0010821),0.5677673865681006,1.381326831919825,0.07934782608695652,0.3971191272696112,1.0,22/47,20.78%,TREM2;CYRIB;SREBF2;CSNK2A2;FLCN;MYO19;PPARGC1A;HDAC6;IAPP;PARL;PID1;LRRK2;SREBF1;VDAC1;GSK3A;GOLPH3;DNM1L;FIS1;INF2;ATP13A2;GSK3B;PRKN
prerank,embryonic digestive tract development (GO:0048566),-0.47219083840816506,-1.3812311374401005,0.11013215859030837,0.9380357997275982,1.0,9/18,14.15%,PCSK5;NIPBL;GLI2;SALL1;GLI3;PDGFRA;PKDCC;RARB;STRA6
prerank,response to zinc ion (GO:0010043),0.6168336634392911,1.380786740058059,0.0983009708737864,0.3980631787112671,1.0,15/25,22.27%,HAAO;P2RX4;GLRA2;HVCN1;ATP13A2;SLC30A4;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.658493897816818,1.3798881470023987,0.12953367875647667,0.39997613367674834,1.0,6/16,18.03%,KLK3;DDAH1;KLK2;GSK3A;PRCP;ADM
prerank,positive regulation of protein transport (GO:0051222),0.553091641747174,1.3796448212730965,0.05408271474019088,0.4000862236922783,1.0,23/67,19.99%,TREM2;TGFB1;IL1A;ADAM8;TNF;ABCG1;TTN;CLN3;RIPOR1;ATP2C1;KIF20B;SYTL4;TPR;EXOC1;PCM1;ARF6;MYH10;CD33;VPS28;GOLPH3;RAB29;DNM1L;ATP13A2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6775774061221809,1.3795328124252966,0.124,0.39981827386040764,1.0,4/13,6.47%,PLEK;APOE;ERLIN1;ERLIN2
prerank,apoptotic cell clearance (GO:0043277),0.5992781169232365,1.3793217781728022,0.09942196531791908,0.3998519727173056,1.0,13/30,22.31%,TREM2;ITGB3;HMGB1;ANXA1;TYROBP;THBS1;GAS6;LRP1;TXNDC5;XKR4;MEGF10;RHOG;TGM2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.4835306526394523,-1.3789625421282177,0.09170305676855896,0.9322132450893581,1.0,6/16,10.09%,CACNA1C;ANK2;RYR2;DMD;ATP1A2;CALM3
prerank,positive regulation of defense response to virus by host (GO:0002230),0.6159451063031331,1.378357139880559,0.11217183770883055,0.40184942973461907,1.0,2/24,1.30%,LILRB1;AIM2
prerank,negative regulation of leukocyte migration (GO:0002686),0.7160817749900015,1.3783488762620504,0.1276595744680851,0.40130305385134446,1.0,3/10,1.96%,CD300A;CD200R1;SLAMF8
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.6303617898851365,1.3779806545734796,0.09669211195928754,0.40173595070894486,1.0,5/19,9.97%,RUNX1;TNF;SNAI1;PRKCH;F11R
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.6731704614103354,1.3777870388081253,0.12745098039215685,0.4016851758024366,1.0,4/12,11.30%,BASP1;MYO1E;PODXL;PTPRO
prerank,dendrite morphogenesis (GO:0048813),-0.38560103872670587,-1.3776841096909278,0.06779661016949153,0.9225532932626108,1.0,11/35,11.11%,PTN;DCDC2;BTBD3;TAOK2;FARP1;EPHB2;DIP2A;CHRNA7;MAP6;SHANK3;SHANK1
prerank,activation of adenylate cyclase activity (GO:0007190),0.5902549810418262,1.3776501603932407,0.09049773755656108,0.40150873483462596,1.0,8/35,15.71%,CALCR;ADCY7;TMIGD3;ADCY6;CAP1;ADCY3;ADCY8;LGR4
prerank,regulation of T cell cytokine production (GO:0002724),0.6665450915648071,1.377232748024485,0.1152317880794702,0.40208087002467074,1.0,6/15,13.13%,CCR2;TRAF2;HFE;MALT1;TNFRSF1B;B2M
prerank,histone H2A ubiquitination (GO:0033522),-0.4635185949475299,-1.3771278430213516,0.0942622950819672,0.9102966113540282,1.0,7/17,12.26%,DDB2;RYBP;DDB1;UBR2;UBE2B;TRIM37;DTX3L
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.5506837436071248,1.3770936655832453,0.044897959183673466,0.40190722073542096,1.0,25/88,16.38%,LGALS3;TGFB1;PLEK;SYK;FNIP2;TNF;FNIP1;RGCC;SMPD3;RAB7A;TAL1;SMAD3;BAK1;TPR;PFN2;PFN1;SDCBP;NRG1;SLX4;SYNPO;BMF;SLF2;PIH1D1;PDCD6IP;FAF1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.5380827833397498,1.3768121116693133,0.003009027081243731,0.40214834245292336,1.0,46/198,16.82%,PLBD1;PTPRC;HK3;PLD4;INPP5D;PIK3CG;PLCB2;TGFB1;LPL;PIK3CD;PLCG2;DUSP3;MTOR;PIK3CB;ANGPTL3;PFKL;CLN8;ALDOB;INPP4B;PIP4K2A;PFKFB4;NADK;NUDT4;CERK;PLPPR1;DUSP10;PPA2;AGK;FRA10AC1;GPI;SYNJ1;PIP4P1;SHPK;THNSL2;PXYLP1;PLCH1;HK2;LRRK2;GDE1;XYLB;PFKFB3;PTEN;PLAAT3;GK;GCK;PPP3CB
prerank,positive regulation of integrin activation (GO:0033625),0.6988999257696034,1.3766491170373933,0.1332378223495702,0.40202341936302977,1.0,3/11,7.66%,PLEK;RAP1B;P2RY12
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.6894777447864294,1.3763992737714914,0.11852861035422343,0.4021373559064478,1.0,2/13,2.21%,SHH;ADAM8
prerank,sterol transport (GO:0015918),0.6332772360141522,1.3761705534038848,0.12020460358056266,0.40218434237482487,1.0,7/19,16.03%,MSR1;NPC2;LDLRAP1;NPC1;OSBP;ARV1;CD36
prerank,negative regulation of developmental growth (GO:0048640),0.6005251847983618,1.3760675850983002,0.09080188679245282,0.40191406110850303,1.0,5/30,8.91%,SLC6A4;FGF13;DIP2B;WWC2;DUSP10
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.6916399407719681,1.3760199422702908,0.13204747774480713,0.40147345207172197,1.0,3/11,8.57%,ABCG1;PLA2G7;LIPC
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.4110286023722473,-1.375467058630885,0.08982035928143713,0.9035781435087521,1.0,7/26,15.10%,SORBS1;PRKCI;IRS1;C2CD5;ARPP19;AKT1;OCLN
prerank,positive regulation of epithelial cell migration (GO:0010634),0.5381291371621129,1.3754118700199338,0.034623217922606926,0.4026309037529263,1.0,22/92,11.64%,PTK2B;PIK3CG;RIN2;SMOC2;PIK3CD;ITGB3;PLCG2;RREB1;ANGPT4;MTOR;PIK3CB;PRKD2;PDCD6;BCAR1;RAB11A;PFN1;SOX9;NRP1;THBS1;HDAC6;GPI;GRN
prerank,negative regulation of secretion by cell (GO:1903531),0.5836424013532502,1.3749800462612998,0.08700440528634361,0.40326348788643857,1.0,7/38,6.34%,LILRB1;VAMP3;OSM;SNCA;APOE;RHBDF2;ANXA1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.4998487932002431,-1.3741793499685533,0.1449814126394052,0.895232757115693,1.0,3/13,0.51%,CACNA1C;ANK2;KCNN2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5638329522688207,1.3738945878850501,0.07142857142857142,0.40579232085381994,1.0,13/48,13.07%,TGFB1;STAT5A;ANGPT4;MAPK14;PRKD2;P2RX4;HMGB1;MAP2K3;ANXA1;TMSB4X;THBS1;HDAC9;ATP5F1A
prerank,regulation of cell projection organization (GO:0031344),0.6911695952861948,1.372534278861696,0.11234396671289876,0.4090355202375459,1.0,4/13,8.46%,TREM2;SEMA4D;MACF1;MOV10
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.6101800920530495,1.3720690951629655,0.10223266745005875,0.4097943214743325,1.0,14/28,17.04%,IRAK2;MAP2K6;UBE2V1;OTULIN;TNFAIP3;NOD2;TAB2;IKBKG;CASP8;ITCH;LACC1;TAB3;IRGM;UBE2N
prerank,ruffle organization (GO:0031529),0.6460594511673557,1.3719633480481535,0.12057667103538663,0.40948255409820933,1.0,9/16,20.37%,PLEK;CSF1R;AIF1;CYFIP1;ARF6;PLEKHA1;ARFIP2;INPP5K;AIF1L
prerank,lipid catabolic process (GO:0016042),0.6353776759670037,1.371912353846456,0.1251564455569462,0.4090526142751459,1.0,6/18,16.78%,LPL;CEL;ACADL;LIPC;LIPE;PLAAT3
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.5120861370028155,-1.371063779982719,0.12837837837837837,0.8958880386819105,1.0,6/12,10.73%,CACNA1C;CAV1;RYR2;JUP;DLG1;CTNNA3
prerank,regulation of establishment of cell polarity (GO:2000114),0.6501334292446134,1.370237900100427,0.12516823687752354,0.4130930916569362,1.0,6/16,8.44%,PTK2B;CYRIB;ARFGEF1;RAP1B;RIPOR2;KIF20B
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.6781620733945315,1.3698814158737056,0.13212795549374132,0.4134721497228771,1.0,6/12,20.11%,HOOK3;BICD2;PCM1;NINL;CCDC120;KIF3A
prerank,response to retinoic acid (GO:0032526),0.5575034246020548,1.3694610214401863,0.07021276595744681,0.4140579667494713,1.0,6/59,3.60%,PTK2B;LYN;ASCL1;AQP1;FZD10;RXRB
prerank,response to organophosphorus (GO:0046683),0.6521470888832056,1.3694149269586815,0.13090418353576247,0.4136255343623095,1.0,4/16,10.39%,KCNJ11;P2RX7;P2RX4;VGF
prerank,regulation of defense response to virus by host (GO:0050691),0.5927406997823215,1.3693763563164079,0.11926605504587157,0.4131720244817072,1.0,4/30,5.09%,LILRB1;AIM2;DHX9;TNFAIP3
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5991530843567989,1.3685895327175335,0.09584295612009237,0.4148030941665628,1.0,9/29,12.90%,UBE2D3;TANK;CD14;CD300LF;TRAF3;TICAM1;LY96;IKBKG;CASP8
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5410534612709565,1.368525188331961,0.024365482233502538,0.41440747242595577,1.0,14/110,7.48%,CNR2;PF4;CALCR;ADCY7;ABCA1;ADGRE1;ADGRG5;GNAQ;ADGRE5;ADCY6;S1PR4;ADGRG3;GNA13;RAMP1
prerank,activation of protein kinase A activity (GO:0034199),0.651855835940574,1.3685175442532482,0.12694300518134716,0.41386194107790053,1.0,6/16,13.49%,ADCY7;PRKAR2B;ADCY6;PRKACB;ADCY3;ADCY8
prerank,positive regulation of lipid localization (GO:1905954),0.6978032787961244,1.3683471546148198,0.14305750350631136,0.41375223047193393,1.0,4/11,15.03%,LPL;VSTM2A;NFKB1;LRP1
prerank,positive regulation of TOR signaling (GO:0032008),0.5706605184591123,1.368248074444677,0.1019036954087346,0.4134798105665163,1.0,18/40,21.78%,NCKAP1L;TREM2;FNIP1;GPR137B;SEH1L;FLCN;PIP4P1;GAS6;LAMTOR3;PIH1D1;LAMTOR1;GOLPH3;RPTOR;SEC13;TELO2;RRAGA;PIK3CA;RRAGB
prerank,glycolytic process (GO:0006096),0.5970715976213342,1.3678857877349337,0.11529411764705882,0.4139696310761444,1.0,11/28,16.87%,HK3;PFKL;ALDOB;ENO3;GPI;HK2;GAPDHS;GCK;LDHA;PGAM4;PGAM1
prerank,positive regulation of wound healing (GO:0090303),0.5882241231561749,1.3677549159749036,0.07311586051743532,0.4138133772729145,1.0,8/36,11.24%,HPSE;SMOC2;RREB1;MTOR;ARFGEF1;ANXA1;ACTG1;THBS1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.6976412150910356,1.3675218874888526,0.13916786226685796,0.41387905240223544,1.0,4/10,16.79%,PTPRJ;SNCA;LRP1;PTPN12
prerank,aminoglycan catabolic process (GO:0006026),0.6012452640529744,1.3673373494919454,0.08922363847045191,0.4138002828085264,1.0,6/28,7.06%,HPSE;GUSB;GNS;IDS;FUCA1;AGRN
prerank,response to laminar fluid shear stress (GO:0034616),0.7104090450030051,1.3672148322354223,0.15519765739385066,0.41358176579796574,1.0,3/10,3.88%,NFE2L2;ABCA1;SREBF2
prerank,keratan sulfate metabolic process (GO:0042339),0.5961553179263707,1.3668591918210584,0.11421911421911422,0.4140339135814279,1.0,7/31,8.51%,HEXB;PRELP;GNS;HEXA;B4GALT1;FMOD;ST3GAL1
prerank,regulation of transmembrane transport (GO:0034762),0.605321858163211,1.3666924899647053,0.1064327485380117,0.4138964084816972,1.0,7/31,13.74%,KCNJ11;SNCA;PRKCB;ACTB;PIM1;NEDD4L;CTTNBP2NL
prerank,aromatic amino acid family catabolic process (GO:0009074),0.6536310546002049,1.365907624051845,0.14209115281501342,0.4154593796583848,1.0,4/15,9.08%,HAAO;KYNU;KMO;QDPR
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.5913570124275117,1.3658725182488773,0.09234234234234234,0.4149996067435324,1.0,5/32,5.57%,CALCR;THY1;P2RX7;SNCA;P2RX4
prerank,endoderm development (GO:0007492),-0.5139054554585976,-1.3657079487172232,0.10037174721189591,0.905978597004103,1.0,11/13,48.65%,KIF16B;DUSP1;SOX17;LAMC1;SOX7;LHX1;DUSP4;TBX20;DUSP5;DUSP2;GATA4
prerank,tryptophan catabolic process (GO:0006569),0.6841241565733709,1.3653592588554309,0.1389290882778582,0.4158509086107899,1.0,3/11,7.82%,HAAO;KYNU;KMO
prerank,positive regulation of lipid catabolic process (GO:0050996),0.6266596064020012,1.3652334673823232,0.12020460358056266,0.4156695216549731,1.0,4/19,7.24%,DAGLB;PRKCD;ANGPTL3;ABCD1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.6327150414013893,1.3648673577392065,0.13565891472868216,0.41608674694675196,1.0,9/18,18.54%,PCSK9;CTSC;APOE;VPS11;ATP5IF1;AMER1;FAF1;HSP90AA1;DACT1
prerank,positive regulation of myelination (GO:0031643),0.6909877918429332,1.3645656305245044,0.1350210970464135,0.41636574950113603,1.0,4/11,11.69%,ITGAX;CST7;RNF10;TNFRSF1B
prerank,cellular response to interferon-beta (GO:0035458),0.651829390983497,1.3644819786221816,0.15352697095435686,0.4160678037476569,1.0,7/14,20.52%,AIM2;CDC34;UBE2G2;IRF1;IRGM;UBE2K;IFITM2
prerank,sodium ion import across plasma membrane (GO:0098719),0.6471445776174592,1.3644459548922678,0.12369791666666667,0.4156095210373722,1.0,5/17,7.37%,HCN4;SLC9A4;SLC8A1;SLC9A9;SLC9A1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5738320053894264,1.3631744446238963,0.07536557930258718,0.4184531801051635,1.0,5/42,2.38%,PTK2B;CD3E;RIN2;PTPRJ;THY1
prerank,regulation of extracellular matrix organization (GO:1903053),0.6494738017311587,1.3628719682050188,0.1422924901185771,0.418674922007179,1.0,2/15,8.46%,RUNX1;RB1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6768946585982034,1.3622268979550298,0.14383561643835616,0.41997499264900906,1.0,2/12,6.74%,IL18;CD80
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.5952036582058937,1.3617584857882847,0.10229885057471265,0.42074771087803375,1.0,9/30,12.90%,UBE2D3;TANK;CD14;CD300LF;TRAF3;TICAM1;LY96;IKBKG;CASP8
prerank,cellular response to interleukin-12 (GO:0071349),0.5676377890499494,1.361654680743279,0.08081896551724138,0.420459807043885,1.0,9/48,7.75%,LCP1;SIRPA;TYK2;IL12RB2;AIP;RAP1B;STAT4;P4HB;CAPZA1
prerank,endocytic recycling (GO:0032456),0.5626693593866062,1.361449228225048,0.0755939524838013,0.4204426685322374,1.0,15/50,15.18%,DENND1C;MICALL2;CCDC93;RAB14;RAB7A;MICALL1;VPS35L;DENND1A;SNX27;DENND1B;ACAP2;ARF6;VPS29;EPS15;VPS39
prerank,integrated stress response signaling (GO:0140467),0.6582917919173477,1.3599015241941992,0.13746630727762804,0.4242329537165634,1.0,5/14,11.55%,NFE2L2;HERPUD1;DDIT3;IMPACT;CCL2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.6522833945573604,1.359886628749242,0.14766839378238342,0.4237312675858691,1.0,7/15,11.37%,IQGAP2;ARPC2;ARPC3;TRIM27;ACTR2;ACTR3;ARPC4
prerank,regulation of type I interferon production (GO:0032479),0.5415396776125357,1.3595242693651761,0.043121149897330596,0.4242464834172297,1.0,22/84,14.78%,IRF5;IRF8;NLRC5;TRIM25;DHX9;LRRFIP1;TNFAIP3;CD14;TRAF3;XRCC5;CTNNB1;TAX1BP1;TRIM56;POLR2L;RNF216;NLRX1;RNF135;ITCH;NFKB1;GPATCH3;IRF1;DTX4
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.6793874588069049,1.3589353920203704,0.12225274725274725,0.4252841902629842,1.0,4/13,11.23%,SHH;CTNNB1;TGFBR2;NRP1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.5259016417127436,1.3589060716012995,0.0,0.424787099540485,1.0,75/390,12.63%,NCKAP1L;LCP2;SLA;VAV1;PTK2B;BLNK;FGR;LYN;ATP6V0D2;HCK;CYBB;UBASH3B;CD3E;SYK;CASS4;STAP1;FLT3;CD7;MAPKAPK3;NCF4;ITGB3;CBL;CSF1R;ATP6V0E1;PTPRJ;TCIRG1;GRB2;NCF2;PIK3CB;ELMO1;VAV2;MAPK14;ATP6V1C1;NCK2;PRKD2;ATP6V1E1;CLNK;RAB14;ATP6V0A2;VAV3;ARPC2;SHC2;EFNA2;MTSS1;ACTB;NEDD9;AP2S1;VEGFB;ATP6V0D1;ARPC3;WASF2;ITSN1;AP3S1;SULF2;NTF3;ABI1;ACTG1;BCAR1;ACTR2;FLRT1;ATP6V0A1;ACTR3;POLR2L;YES1;ATP6AP1;RAPGEF1;CYFIP1;NRP1;ARPC4;ZNF106;PHIP;SDCBP;FYN;DDIT4;NRG1
prerank,positive regulation of isotype switching (GO:0045830),0.6476283701507833,1.3585855487085434,0.1529255319148936,0.42513765476273896,1.0,2/15,2.40%,TGFB1;MAD2L2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.5244950255230987,1.3584943161095837,0.0,0.42485236180216,1.0,97/509,12.90%,PTPRC;CD86;VAV1;TREM2;FGR;LYN;CALCR;PIK3CG;PIK3R5;CARD11;HPSE;TGFB1;CX3CR1;CASS4;HCLS1;FLT3;F10;CD74;PIK3CD;RPL23;CBL;LAPTM5;PIK3AP1;PLCG2;TGFBR1;GPRC5B;ADAM8;TRIM25;PTPRJ;TLR2;GRB2;PIK3CB;S100B;TLR7;NUP62;OSM;TSPAN6;SEMA4D;TRIM5;NEK6;TNF;FNIP1;PRKD2;UBE2V1;TRAF2;DDIT3;IL18;CD14;CASP1;P2RX4;MAP3K14;HMGB1;PRKCB;CFLAR;BCL2L1;GAB2;TP53;CD80;ACTN4;SEH1L;PIM2;TICAM1;EPO;PLK2;P2RY12;MALT1;FLT3LG;ATP2C1;FLCN;TRIM27;ZDHHC13;SLC44A2;LURAP1;NTF3;PUM2;STRN;NOS1AP;TRAF5;LITAF;TRIM8;DUSP19;RPS20;LGALS1;GPR37;LIMS1;SOX9;MID2;THBS1;BECN1;IAPP;NOD2;FYN;ALPK1;TAB2;NRG1;IKBKG;CASP8
prerank,negative regulation of neurogenesis (GO:0050768),0.6006290056615718,1.3580954778468852,0.09828571428571428,0.4254146217344899,1.0,14/34,17.75%,HOOK3;THY1;TNF;PCM1;SORL1;B2M;ARHGDIA;EFNB3;YWHAH;NF1;RTN4;PTEN;APPL2;RHOA
prerank,negative regulation of cell activation (GO:0050866),0.6622502238881796,1.3578173255114698,0.13611859838274934,0.42565678695986575,1.0,2/14,4.14%,TREM2;APOE
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.43648617847058796,-1.3568179853110087,0.11707317073170732,0.9320872552619256,1.0,7/20,10.09%,CACNA1C;ANK2;RYR2;ATP1B1;DMD;ATP1A2;CALM3
prerank,response to organonitrogen compound (GO:0010243),0.5783840269335384,1.3568139840096876,0.10022026431718062,0.42783551003292414,1.0,9/38,15.36%,IRF5;MTOR;NR1H4;SEL1L;KYNU;DERL1;GLRA2;KAT7;CCDC47
prerank,vasoconstriction (GO:0042310),0.6892353267265889,1.355707373755454,0.13963328631875882,0.4303793764474019,1.0,2/11,3.19%,EDNRB;SLC8A1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.6917270554747293,1.3554957605266165,0.15450643776824036,0.429902703215788,1.0,3/10,4.92%,PRKCD;TNF;SMPD3
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6917270554747293,1.3554957605266165,0.15450643776824036,0.429902703215788,1.0,3/10,4.92%,PRKCD;TNF;SMPD3
prerank,PERK-mediated unfolded protein response (GO:0036499),0.7029169445725764,1.3554253474628086,0.12130177514792899,0.4295650366838749,1.0,4/10,11.55%,NFE2L2;HERPUD1;DDIT3;CCL2
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.4665408623692289,-1.3543664516203593,0.11059907834101383,0.9295979182188325,1.0,5/17,13.93%,BMP4;AR;TFPI;ATP1A2;UBE2L3
prerank,negative regulation of MAPK cascade (GO:0043409),0.5431638228708219,1.3532621352615932,0.05344295991778006,0.43493257543648767,1.0,12/87,4.14%,PTPRC;LYN;SIRPA;CD300A;PRKCD;PTPRJ;DUSP3;P2RX7;PTPN1;DUSP29;PIK3CB;APOE
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.5310911163403951,1.3532308213856306,0.02004008016032064,0.43445116275090423,1.0,44/149,17.33%,BTK;CARD11;CX3CR1;AIM2;IRAK2;ADAM8;TRIM25;TLR2;TNFRSF11A;DHX9;TRIM5;TNF;PRKD2;UBE2V1;TRAF2;PYCARD;IL18;RAB7B;PRKCB;CFLAR;TICAM1;MALT1;IL18RAP;PRKCQ;TRIM27;PRKCH;TRAF5;TRIM8;MID2;RPS6KA4;PRDX3;NOD2;TAB2;IKBKG;NFKB1;TRADD;TAB3;CAPN3;MTDH;CD36;UBE2N;TRIM62;ARHGEF2;RPS6KA5
prerank,heterochromatin organization (GO:0070828),-0.4785031542429311,-1.3532196430645975,0.1037037037037037,0.9208652794800185,1.0,5/14,10.17%,SMCHD1;EZH1;MECOM;SETDB2;SETD7
prerank,filopodium assembly (GO:0046847),0.6453228751142958,1.3531457391910058,0.15197956577266922,0.43410632972677987,1.0,2/16,5.92%,FGD2;FGD6
prerank,response to iron ion (GO:0010039),0.6813172116392722,1.3529872230435545,0.1408839779005525,0.43400122526411616,1.0,5/12,16.30%,SNCA;HFE;ACO1;B2M;HIF1A
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.6480339147027538,1.3523056652502794,0.13915416098226466,0.43531582542571845,1.0,6/15,12.01%,NLRC5;SAMHD1;YTHDF3;TTLL12;USP18;METTL3
prerank,negative regulation of signaling receptor activity (GO:2000272),0.6022354759397678,1.352249659625893,0.1234866828087167,0.4349240864700314,1.0,5/25,7.81%,CALCR;CBL;TNF;ZFYVE28;HFE
prerank,plasma membrane tubulation (GO:0097320),0.6751787369311293,1.3520406109883412,0.14589235127478753,0.4349255392153758,1.0,6/13,13.31%,BIN2;SNX9;SNX33;MICALL1;BIN3;FNBP1L
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6284146788466752,1.3519637082669043,0.15394402035623408,0.43458099467327876,1.0,4/17,5.61%,CCND3;RGCC;PKD2;CCND2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.6431050881255356,1.3518930033167444,0.12317880794701987,0.4342490637080022,1.0,5/16,9.89%,PLEKHN1;ZC3H12D;MOV10;RC3H1;CPEB3
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.5126779826693142,-1.3517648901496244,0.11068702290076336,0.9140741965685778,1.0,6/12,18.57%,SEC61G;SGTB;CHMP4B;CHMP4A;SEC61B;SEC61A1
prerank,negative regulation of lyase activity (GO:0051350),0.64086927333656,1.3511735444459316,0.12924281984334204,0.4357086590004612,1.0,5/16,14.14%,CCR2;EDNRB;AKAP5;LTB4R2;GNAI3
prerank,positive regulation of cell adhesion (GO:0045785),0.5442150187287739,1.350804867700418,0.06314699792960662,0.4361656388062425,1.0,14/74,13.82%,NCKAP1L;SYK;ADAM8;PTPRJ;MDK;TNF;PRKD2;P4HB;P2RY12;FLCN;LIMS1;ADGRG1;STX3;ZFHX3
prerank,regulation of Rac protein signal transduction (GO:0035020),0.6418400146639469,1.35017497790614,0.13959390862944163,0.4373138303282105,1.0,3/16,2.72%,PIK3CG;ARHGAP24;PIK3CB
prerank,urogenital system development (GO:0001655),0.6825695776527838,1.3500236882358896,0.15481171548117154,0.43714228875651806,1.0,3/11,11.17%,SHH;ANXA1;SOX9
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.541617152955824,1.3497294785197336,0.05447070914696814,0.43736896748655524,1.0,24/78,15.42%,MRAP;TREM2;LGALS3;TGFB1;PLS1;TNF;LDLRAP1;CLN3;AKAP5;STAC;BCL2L1;ACTB;ZDHHC7;PRKCH;CLTC;NUMB;STX3;STAC3;PPFIA1;STX8;PID1;ARF6;LRP1;AP2M1
prerank,receptor clustering (GO:0043113),0.5961614326553604,1.349644654772788,0.11786148238153099,0.4370748521665101,1.0,4/27,2.38%,ITGAL;ITGB2;ITGA4;THY1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.5237270457359646,1.348787778436341,0.02920443101711984,0.4389269430965736,1.0,23/140,13.98%,GNA15;LPAR6;CALCR;CX3CR1;CCR2;CD52;P2RX7;SLC8A1;CXCR4;P2RX4;S1PR4;HMGB1;GPR17;CCKBR;CACNA1A;SPPL3;CYSLTR1;CMKLR1;TACR1;IAPP;NPTN;ADCY8;C3AR1
prerank,actin nucleation (GO:0045010),0.6189364601814583,1.3483677428045373,0.12639405204460966,0.4396164990990092,1.0,7/21,11.37%,IQGAP2;ARPC2;ARPC3;TRIM27;ACTR2;ACTR3;ARPC4
prerank,regulation of lipid storage (GO:0010883),0.6047584487291193,1.3482279700524458,0.11206896551724138,0.43944313767730137,1.0,5/22,13.46%,LPL;ITGB3;TNF;VSTM2A;NFKB1
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.5039007216949457,-1.3481041357502797,0.1206896551724138,0.9168612624453336,1.0,4/12,13.17%,REST;HES1;HNRNPU;JAG1
prerank,cAMP-mediated signaling (GO:0019933),-0.4109152098993493,-1.3478140922669268,0.10429447852760736,0.9053301748225413,1.0,9/24,16.49%,PDE7A;RAPGEF3;ADGRG6;ADCY2;RIMS2;RAPGEF2;CAP2;DGKQ;PDE2A
prerank,ceramide catabolic process (GO:0046514),0.6596237427996481,1.3477137704508533,0.145748987854251,0.44030284412686405,1.0,4/14,9.80%,HEXB;GM2A;HEXA;ACER3
prerank,negative regulation of autophagy (GO:0010507),0.5536422437129167,1.3473004163912277,0.07013815090329437,0.4409122015425029,1.0,15/54,15.12%,TREM2;IL10RA;CTSA;MTOR;ATG7;SNCA;SMG1;EIF4G3;DAP;TAB2;FOXK1;BMF;LRRK2;TAB3;TBC1D14
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.5317729605692647,1.3471682052705398,0.04334677419354839,0.44076997544135715,1.0,25/105,15.61%,CLEC4D;LYN;CARD11;SYK;PLCG2;PRKCD;FFAR2;FCER1G;MUC13;TYROBP;PSMB10;MALT1;PSMA2;PRKACB;FYN;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;TAB3;SRC;PSMD7;PSMB9
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.6715534671336026,1.3461904038575034,0.1310344827586207,0.4428664700984995,1.0,5/13,12.90%,LGMN;ASPH;TBC1D10A;BAK1;CASP8
prerank,phospholipid transport (GO:0015914),0.5419576686859929,1.345962826606172,0.0967391304347826,0.44291816621498126,1.0,13/52,15.26%,ATP8B4;ABCA1;ATP8A1;NPC2;ABCG1;APOE;ATP8A2;PRELID3B;ABCB4;ABCC1;ABCA4;OSBPL8;ABCA3
prerank,positive regulation of inflammatory response (GO:0050729),0.5301603203214629,1.3457816150681554,0.061601642710472276,0.4428264264666403,1.0,13/86,5.08%,CCR2;LPL;GPRC5B;ADAM8;TLR2;DHX9;TLR7;MDK;OSM;TNF;SNCA;CEBPA;IL18
prerank,carbohydrate catabolic process (GO:0016052),0.5669115981643728,1.3454769742071013,0.12416107382550336,0.44309656884663856,1.0,13/38,16.87%,HK3;PFKL;ALDOB;ENO3;MAN2B1;MAN2B2;GPI;HK2;GAPDHS;GCK;LDHA;PGAM4;PGAM1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.6650000192158448,1.3450126388376773,0.14327062228654125,0.44384849127835174,1.0,3/12,4.11%,ABCA1;ITGB3;ABCG1
prerank,regulation of neuron apoptotic process (GO:0043523),0.5323805323598143,1.344989731425852,0.04918032786885246,0.44335566635906704,1.0,25/96,16.02%,PTK2B;TREM2;PCSK9;LGMN;ADAM8;MDK;TNF;APOE;CLN3;FOXO3;DDIT3;FZD9;CTNNB1;MEF2C;KIF14;TFAP2B;NTF3;PPARGC1A;CCL2;GRN;RETREG1;WFS1;CPEB4;RASA1;NF1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.5348027137399495,1.3448956545570199,0.061855670103092786,0.44308686996030855,1.0,11/86,6.54%,NCKAP1L;PTK2B;HCK;PLEK;NCK2;SNX9;APOE;COLGALT1;MYLK3;PYCARD;MAPRE1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.5317377035818251,1.3448620385546397,0.041456016177957536,0.442620375509773,1.0,33/110,16.71%,LGALS3;HCK;TGFB1;SYK;FNIP2;ABCA1;TNF;FNIP1;APOE;TRAF2;TAL1;TFIP11;SVIP;RB1;BAK1;HSF1;ATF7IP;IMPACT;GFAP;HDAC6;IAPP;NRG1;SORL1;SAR1A;HCFC1;BMF;SLF2;PIH1D1;SRC;CD36;IRGM;FAF1;HSP90AA1
prerank,ureteric bud development (GO:0001657),-0.4615756348927973,-1.3448086009376288,0.10328638497652583,0.9054605074822875,1.0,7/17,14.63%,ROBO2;FOXC1;BMP4;SALL1;SLIT2;SIX1;GPC3
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6962830580365414,1.3447590795731699,0.1402002861230329,0.44235823836490207,1.0,1/10,0.11%,PTPRC
prerank,regulation of lipase activity (GO:0060191),0.6629553341258709,1.3446936634509337,0.1471004243281471,0.44198386107856596,1.0,6/13,17.75%,LPL;ANGPTL3;SNCA;LIPC;FURIN;RHOA
prerank,negative regulation of protein kinase activity (GO:0006469),0.5348166994922753,1.3441010520709955,0.042008196721311473,0.4430774284249009,1.0,22/88,14.08%,PTPRC;UBASH3B;THY1;DUSP3;PTPN1;GNAQ;SLC8A1;SNCA;PYCARD;RB1;TRIM27;ADAR;DUSP10;QARS1;LRP5;DUSP19;DTNBP1;PTPRO;SORL1;ADARB1;RTRAF;PTPRT
prerank,positive regulation of protein polymerization (GO:0032273),0.5463849086713408,1.344077949516902,0.07539267015706806,0.44257782407873025,1.0,7/65,6.54%,NCKAP1L;PTK2B;HCK;NCK2;SNX9;PYCARD;MAPRE1
prerank,early endosome to late endosome transport (GO:0045022),0.6325023077134302,1.3438630856386875,0.14104193138500634,0.4426152735069716,1.0,7/20,14.27%,HOOK3;WDR91;RAB7A;BECN1;WDR81;STX8;HOOK2
prerank,positive regulation of cell migration (GO:0030335),0.5176015104889005,1.3436433682858682,0.002,0.44269301997718147,1.0,46/253,11.64%,NCKAP1L;PTPRC;PTK2B;FERMT3;GPNMB;FGR;ITGAX;TGFB1;CASS4;CCR2;F10;VSIR;PIK3CD;CSF1R;PLCG2;TGFBR1;MGAT5;RREB1;MTOR;MDK;ANGPTL3;SEMA4D;ITGA6;LGR6;AIF1;MAPRE1;CCAR1;ACTN4;RIPOR1;NEDD9;SNAI1;FAM89B;KIF20B;PTP4A1;NTF3;PODXL;ACTG1;BCAR1;RAB11A;SEMA4A;PFN1;SOX9;NRP1;THBS1;HDAC6;GRN
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.6018446583905743,1.342911551919506,0.12965186074429771,0.44415220813876155,1.0,6/26,12.44%,LILRB3;C1QC;GPR137B;TMEM178A;INHBA;CDK6
prerank,thymus development (GO:0048538),0.6708498528395418,1.3428487297529248,0.15289256198347106,0.44378468249778513,1.0,2/13,2.10%,SHH;TGFBR1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5955271848296124,1.3424145177971314,0.13484486873508353,0.44443287599665127,1.0,13/26,24.42%,PLCG2;TNF;SLC9A1;SPPL3;CHERP;RCAN1;LMCD1;GSK3B;PTBP1;CHP1;IGF1;ATP2B4;CAMTA1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.5230022651389283,1.3418188375062154,0.012012012012012012,0.4455404212660994,1.0,32/172,9.94%,INPP5D;PIK3CG;PIK3R5;DGKZ;PIK3CD;LPIN2;PLCG2;DDHD1;LPCAT1;PIK3CB;PIP5K1C;INPP4B;CLN3;PIP4K2A;PI4K2A;RAB14;PCYT1A;CHKB;PLD2;PGS1;CDS2;DGKE;LPCAT2;MTMR3;DGKG;DGKD;CSNK2A2;CSNK2A1;SLC44A2;ABHD4;AGK;STARD10
prerank,retina homeostasis (GO:0001895),0.614049841717611,1.3417821416069156,0.14389359129383314,0.4451022972353962,1.0,11/23,22.05%,WHRN;POTEF;ACTB;CNGB1;ACTG1;PRDX1;B2M;ATP1B2;CCDC66;HSPB1;CDH3
prerank,chondroitin sulfate metabolic process (GO:0030204),0.5828606956603548,1.3417054477605883,0.12249705535924617,0.4447930414546564,1.0,8/30,12.83%,HEXB;ARSB;IDS;HEXA;CHSY3;BCAN;CHSY1;CHST15
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.6009680435046718,1.3406056562773119,0.13776137761377613,0.4473001190376495,1.0,8/24,16.47%,PTK2B;CTSC;APOE;ATP5IF1;PSME3;RHBDF1;EPHA4;TMF1
prerank,B cell activation involved in immune response (GO:0002312),0.644639649160724,1.340189589222933,0.16073968705547653,0.4480088041446129,1.0,3/13,9.45%,FCGR2B;CD180;GPR183
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.6038118843903182,1.340077257661654,0.12823529411764706,0.4478082353503186,1.0,7/25,12.29%,NCKAP1L;PTGES3;SNCA;ITGA6;NRP1;THBS1;SDCBP
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5887590467125772,1.3398658576718891,0.1242603550295858,0.44784878659949906,1.0,9/25,16.37%,RPL23;PDCL3;TAF1;HFE;CSNK2A2;CSNK2A1;PSME3IP1;EPHA4;RPL11
prerank,positive regulation of biosynthetic process (GO:0009891),0.5607073056500553,1.339080231876442,0.10279329608938548,0.4495056103920601,1.0,8/40,7.23%,RUNX1;TGFB1;PLCG2;MTOR;MLXIPL;RGCC;APOE;CREB3L1
prerank,"phototransduction, visible light (GO:0007603)",0.6446773241312896,1.338978544914524,0.16216216216216217,0.4492417657323983,1.0,4/14,12.70%,GNAQ;SAG;CNGB1;ABCA4
prerank,mesonephric tubule development (GO:0072164),-0.4805298845554954,-1.3389015032997922,0.10121457489878542,0.9181411957731411,1.0,6/15,10.33%,ROBO2;FOXC1;BMP4;SALL1;SLIT2;SIX1
prerank,focal adhesion assembly (GO:0048041),-0.43224510350692247,-1.3383645108012652,0.1388888888888889,0.9083388983867899,1.0,7/21,5.31%,SORBS1;PEAK1;TAOK2;ACTN2;PTPRK;BCR;WHAMM
prerank,hydrogen peroxide catabolic process (GO:0042744),0.6704306121690712,1.338337378614857,0.16895604395604397,0.4504965980117303,1.0,5/11,16.91%,PRDX1;PRDX3;PRDX2;PXDN;PRDX5
prerank,regulation of fibroblast migration (GO:0010762),0.6209780675153225,1.3382162810664655,0.14212548015364918,0.45028058102821306,1.0,8/20,18.52%,TGFB1;RFFL;CLN3;GNA12;THBS1;APPL2;CORO1C;ITGB1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.5738990730021092,1.3376887068187735,0.12428078250863062,0.4512175876141335,1.0,9/32,12.50%,LPIN2;LPCAT1;PCYT1A;CHKB;CSNK2A2;CSNK2A1;SLC44A2;STARD10;ABHD3
prerank,positive regulation of secretion by cell (GO:1903532),0.533863294156977,1.3369781334906163,0.07015706806282722,0.4527117908872556,1.0,17/70,14.20%,TREM2;TGFB1;UNC13D;IL1A;ADAM8;SNCA;RGCC;ABCG1;TTN;P2RX4;SYTL4;ATP6AP1;DTNBP1;EXOC1;ARF6;NMB;MYH10
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5779780207651668,1.3367582202521384,0.11941964285714286,0.45278440103361606,1.0,12/38,18.51%,LGALS3;RFFL;TRAF2;TNFAIP3;CFLAR;BCL2L1;THBS1;CASP8;TRADD;FEM1B;ARHGEF2;TNFSF10
prerank,response to glucocorticoid (GO:0051384),0.5812952160240517,1.3357298607994064,0.15256257449344457,0.4551893038122288,1.0,3/26,6.34%,CALCR;TNF;ANXA1
prerank,cellular response to interleukin-6 (GO:0071354),0.5836372751645552,1.33508752274428,0.15063731170336037,0.4564735305034528,1.0,11/26,16.43%,CBL;IL6R;CEBPA;SPI1;ST18;NFKB1;PID1;PTPRT;SRC;SELPLG;SBNO2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.5314940987316751,1.3349585196471496,0.05015353121801433,0.4562580397090362,1.0,18/93,12.29%,PTK2B;SLAMF1;SCIMP;FCGR2B;TAOK3;TRAF2;PYCARD;SPI1;TRAF3;XDH;HMGB1;MAP3K5;GADD45B;TRAF5;DUSP19;RELL1;NOD2;SDCBP
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.6063105586022526,1.3343629822198566,0.159846547314578,0.45745300331997363,1.0,4/19,8.10%,RUNX1;TGFBR1;PIM1;MEF2C
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.690410863685943,1.3341935181936102,0.15028901734104047,0.45738062765416554,1.0,4/10,8.51%,NPL;RENBP;NAGK;ST3GAL1
prerank,Golgi to lysosome transport (GO:0090160),0.6671755292431042,1.3341562588212226,0.18723404255319148,0.45692671640217297,1.0,6/11,19.71%,LAPTM5;RBSN;CLN3;GAK;CCDC91;SORT1
prerank,import into cell (GO:0098657),0.5560676745088957,1.3340125510345173,0.10188261351052048,0.4567656543528244,1.0,6/41,7.46%,TREM2;IL10RA;LRRC8D;SLC7A8;SLC36A1;SLC16A2
prerank,regulation of bone mineralization (GO:0030500),0.5426157905344156,1.3339451573478134,0.0864461045891142,0.45640662087661055,1.0,9/55,8.52%,PTK2B;TGFB1;SRGN;P2RX7;BMP2K;SLC8A1;FZD9;MEF2C;ATP2B1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.6233957008821218,1.3338351909751436,0.15849056603773584,0.456191531797423,1.0,4/17,8.05%,CD74;RFFL;CD44;SNAI1
prerank,regulation of T cell chemotaxis (GO:0010819),0.6575317176455288,1.3337241121531502,0.15517241379310345,0.4559586335260619,1.0,2/11,7.31%,CCR2;WNK1
prerank,gene silencing by miRNA (GO:0035195),0.5687929446212491,1.333698913062136,0.1352601156069364,0.45551156230730105,1.0,19/32,26.28%,CNOT8;TNRC6A;MOV10;ADAR;PUM2;AGO4;SNIP1;AGO3;PRKRA;TARBP2;AGO2;ZC3H7A;DICER1;CNOT7;CNOT1;ZC3H7B;AGO1;PUM1;LIMD1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.5174321946985379,1.333127379508581,0.006,0.45663754147618474,1.0,66/234,17.33%,BTK;SHH;CARD11;CX3CR1;HCLS1;AIM2;IRAK2;PLCG2;ADAM8;TRIM25;TLR2;CAMK1D;TNFRSF11A;DHX9;TRIM5;TNF;RGCC;PRKD2;UBE2V1;TRAF2;PYCARD;DDIT3;IL18;RAB7B;NFAM1;HDAC5;TAF1;PRKCB;CFLAR;CTNNB1;MYOCD;TICAM1;MALT1;IL18RAP;PRKCQ;TRIM27;SMAD3;HSF1;PPARGC1A;PRKCH;TRAF5;HDAC4;TRIM8;MID2;RPS6KA4;PRDX3;NOD2;TAB2;IKBKG;LRP8;SMARCB1;NFKB1;ADCY8;STK3;TRADD;TAB3;CAPN3;BUD31;MTDH;FANK1;CD36;PTEN;UBE2N;TRIM62;ARHGEF2;RPS6KA5
prerank,protein kinase A signaling (GO:0010737),0.6671652946941716,1.3327774319379644,0.14738292011019283,0.45707072184876557,1.0,3/12,11.47%,LCP1;TTN;PRKACB
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.5377170383889315,1.3325265817726284,0.06632124352331606,0.45720502697945153,1.0,7/76,7.66%,GNA15;LPAR6;CX3CR1;P2RY6;GPR17;CCKBR;P2RY12
prerank,cellular response to hormone stimulus (GO:0032870),0.5350825838126632,1.3319792102291126,0.09014675052410902,0.4581877791963178,1.0,13/69,11.20%,CTSS;CTSB;GATA1;BRD8;GAS2L1;CTSL;OCSTAMP;RAMP1;LMO2;MEF2C;STAT5B;TRIM24;SRA1
prerank,regulation of mitotic nuclear division (GO:0007088),0.5423784166649662,1.3318298135928397,0.10043196544276457,0.45807545321985566,1.0,9/55,11.87%,ANAPC15;IL1A;NUP62;NME6;AURKAIP1;RGCC;KIF20B;LRP5;PHIP
prerank,regulation of cell adhesion (GO:0030155),0.5226529340682651,1.331430138988508,0.031313131313131314,0.45868416606731316,1.0,34/129,16.80%,PTK2B;LYN;PIK3CG;ADAM8;PTPRJ;PLXNC1;MDK;SEMA4D;TNF;PRKD2;TGFBI;CXCR4;PLXNB2;CYTIP;IL18;RIPOR2;ATXN3;P4HB;KIF14;FLCN;SIPA1;PODXL;ARHGDIB;CYTH1;PPP2CA;ADGRG1;STX3;ARHGDIA;ZFHX3;SRC;RASA1;EPHA4;LPXN;EPHA8
prerank,retrograde axonal transport (GO:0008090),-0.46377485668423446,-1.331422313117835,0.12955465587044535,0.9261608034868245,1.0,6/16,10.38%,DLG2;KIF5B;PAFAH1B1;SOD1;NEFL;KIF5A
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.589850824962797,1.3312989518094496,0.14496314496314497,0.4585134412317996,1.0,5/24,8.26%,CD74;CD44;BCL2L1;SNAI1;TPT1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.6080601442470132,1.3312389837675982,0.14231738035264482,0.45814492179796223,1.0,8/20,13.98%,P2RX7;PSTPIP1;PYCARD;IL18;CASP1;P2RX4;ENTPD1;C3AR1
prerank,chromatin disassembly (GO:0031498),0.637489824111725,1.331057358733364,0.15730337078651685,0.4575816932702498,1.0,4/14,13.09%,NFE2;ARID1A;SMARCD3;SMARCB1
prerank,nucleosome disassembly (GO:0006337),0.637489824111725,1.331057358733364,0.15730337078651685,0.4575816932702498,1.0,4/14,13.09%,NFE2;ARID1A;SMARCD3;SMARCB1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5528193765297351,1.3306475579903854,0.11231101511879049,0.45823437238456827,1.0,14/45,17.77%,PTK2B;TGFB1;CBL;GRB2;NCK2;ERBIN;DGKD;BCAR1;SOX9;BRAF;SRC;IQGAP1;RPS6KA5;PDPK1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6751802858497481,1.330493320433799,0.14138438880706922,0.4581505809789875,1.0,2/10,7.31%,CCR2;WNK1
prerank,cytosolic transport (GO:0016482),0.52111140987311,1.330229918080317,0.053643724696356275,0.45831327950988,1.0,37/108,19.71%,HOOK3;LAPTM5;TBC1D10C;VAMP3;SNX5;WDR91;TMEM87B;HEATR5A;RBSN;CLN3;RAB14;RAB7A;TMEM87A;TBC1D10A;TRIM27;VPS54;TBC1D17;CLTC;BECN1;YKT6;WDR81;STX5;STX8;VPS29;HOOK2;VTI1A;SNX2;GAK;EPS15;HEATR5B;CCDC91;MON2;TBC1D23;DENND5A;TBC1D5;RAB29;SORT1
prerank,protein insertion into membrane (GO:0051205),-0.3876930549642871,-1.3297896985398285,0.10948905109489052,0.9211236473780648,1.0,12/32,19.11%,APP;EGFR;OXA1L;ALDH3A2;TRAM1;SEC61G;COX18;EMD;SERP1;SEC61B;GET4;VAPA
prerank,sodium ion transmembrane transport (GO:0035725),0.5238847956389677,1.328808105526192,0.07700205338809035,0.46173725630143403,1.0,10/84,9.15%,SLC6A3;SLC6A4;SCN4B;HCN4;SLC9A4;SLC8A1;PKD2;SLC9A9;SLC9A1;SLC6A15
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.5326735412427882,1.3283297838685109,0.07083333333333333,0.46250427128538985,1.0,16/75,10.93%,LYN;CD300A;PRKAR2B;PRKCD;PTPRJ;PTPN1;PIK3CB;SLC8A1;PKIB;APOE;CEBPA;PYCARD;MYOCD;RB1;LRP5;SH2B3
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.45229675742601505,-1.3271264156850533,0.14349775784753363,0.9203632159705722,1.0,4/18,4.76%,UNC13B;GRIK4;GRIA2;SLC17A6
prerank,cellular response to retinoic acid (GO:0071300),0.5542569329651119,1.3268559173790924,0.1141602634467618,0.46611287748962155,1.0,4/42,1.89%,PTK2B;LYN;AQP1;FZD10
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.6046445076827905,1.3265362175185311,0.16170763260025872,0.4664867400129169,1.0,13/20,28.33%,CNOT8;TNRC6A;MOV10;AGO4;AGO3;NRDE2;AGO2;CNOT7;CNOT1;AGO1;LIMD1;EIF6;TNRC6C
prerank,regulation of myelination (GO:0031641),0.592806322420958,1.326496217842383,0.12574850299401197,0.4660534959095633,1.0,7/25,11.69%,ITGAX;CST7;KIF14;TMEM98;RNF10;TNFRSF21;TNFRSF1B
prerank,negative regulation of secretion (GO:0051048),0.6873523854963928,1.3256845753238937,0.17138810198300283,0.4677257645769609,1.0,2/10,1.94%,CD74;VAMP3
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.5300019309573543,-1.3247043338725126,0.14626865671641792,0.9187045621864738,1.0,3/10,7.23%,ERRFI1;CAV1;MVP
prerank,triglyceride metabolic process (GO:0006641),0.5464286904501944,1.324568102096677,0.11038251366120219,0.47034864334765936,1.0,14/48,20.89%,LPL;LPIN2;FABP4;APOE;SEL1L;FABP5;LIPC;AGMO;PLAAT3;GK;PNPLA3;DGAT2;MOGAT1;LPIN1
prerank,secondary alcohol metabolic process (GO:1902652),0.5483323650865164,1.3239096141488946,0.13743016759776536,0.4716299570122096,1.0,7/42,5.56%,ABCA1;ANGPTL3;CLN8;ABCG1;APOE;LDLRAP1;SOAT2
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.606919740065563,1.3236018100144196,0.13878562577447337,0.471922719494059,1.0,7/22,16.65%,MDK;FZD9;SLC16A2;NAP1L1;TAFA1;LRRK2;APPL2
prerank,carbohydrate derivative transport (GO:1901264),0.6192141562192712,1.3235983307235384,0.159846547314578,0.4713883077617146,1.0,4/18,4.53%,SLC15A3;NPC2;ABCG1;CLN3
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.4621017786133326,-1.3233190426700618,0.15879828326180256,0.91307664360433,1.0,6/17,15.60%,CAV1;PANK2;NCOR1;PPARA;PRKAB2;PPARG
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.4790155763204261,-1.3232257325908312,0.1450381679389313,0.902196940310872,1.0,7/14,19.56%,IRS1;DDB1;GPLD1;ARPP19;AKT1;NNMT;IRS2
prerank,response to interleukin-1 (GO:0070555),0.533374580848769,1.3232242464637805,0.0766839378238342,0.4718336808375444,1.0,22/73,16.84%,SIRPA;IRAK2;TNFRSF11A;CCL8;SNCA;MYLK3;TANK;PYCARD;ANXA1;RC3H1;CCL14;HDAC4;CCL13;SOX9;GBP3;CCL2;NFKB1;SRC;TLE5;HIF1A;CD47;CCL25
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5912699231472799,1.32319755097865,0.15330188679245282,0.4713693243707408,1.0,12/26,17.04%,IRAK2;MAP2K6;UBE2V1;TNFAIP3;NOD2;ALPK1;TAB2;IKBKG;CASP8;ITCH;TAB3;UBE2N
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.6583822699799183,1.3230756797652883,0.19429347826086957,0.4711817677662538,1.0,2/12,3.81%,TGFB1;TNF
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5730350056780398,1.322979480080844,0.1400462962962963,0.47094145396732073,1.0,10/33,13.80%,CX3CR1;ABR;CEL;BTBD9;CACNA1A;FABP5;EIF4EBP2;NTF3;LRP8;CACNA1B
prerank,amyloid precursor protein metabolic process (GO:0042982),0.6263995166125954,1.3229539665987249,0.14637305699481865,0.47048681723379326,1.0,4/18,4.53%,ABCG1;APOE;LDLRAP1;CLN3
prerank,cilium-dependent cell motility (GO:0060285),-0.40880495320892896,-1.3227663468287378,0.13812154696132597,0.8930917063242977,1.0,15/22,48.20%,CCDC39;CFAP54;DNAH2;CFAP44;GAS8;DNAH3;DRC1;CCDC65;DNAAF2;TEKT2;DNAH8;DNAH17;TEKT5;EFHC2;DNAH1
prerank,response to lipid (GO:0033993),0.5174948422585903,1.3226459468607696,0.06205493387589013,0.4708080178159558,1.0,20/105,12.55%,ASCL1;SLC11A1;TGFB1;MAPKAPK3;TNFRSF11A;RXRB;SNCA;GCH1;ABCG1;IFNAR1;FOXO3;SPP1;CTNNB1;ANXA1;ERBIN;LY96;STAT5B;SOX9;PRDX3;TAB2
prerank,cellular response to lectin (GO:1990858),0.5227182145324344,1.3224257699294373,0.051515151515151514,0.4703457546479729,1.0,27/104,17.85%,CLEC4D;LYN;CARD11;SYK;PLCG2;PRKCD;FCER1G;MUC13;TYROBP;PSMB10;MALT1;PSMA2;PRKACB;FYN;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;TAB3;SRC;PSMD7;PSMB9;RPS6KA5;PDPK1;PSMD2
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.5227182145324344,1.3224257699294373,0.051515151515151514,0.4703457546479729,1.0,27/104,17.85%,CLEC4D;LYN;CARD11;SYK;PLCG2;PRKCD;FCER1G;MUC13;TYROBP;PSMB10;MALT1;PSMA2;PRKACB;FYN;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;TAB3;SRC;PSMD7;PSMB9;RPS6KA5;PDPK1;PSMD2
prerank,long-term memory (GO:0007616),0.6093099731081094,1.3220658871212352,0.15889029003783103,0.4707976357817596,1.0,3/19,9.89%,NPAS4;APOE;CPEB3
prerank,bone development (GO:0060348),0.5654571021445982,1.3219801656862067,0.12181616832779624,0.47051128717338286,1.0,6/39,9.91%,PTPRC;SH3PXD2B;SKI;TP53;SULF2;LRP5
prerank,autonomic nervous system development (GO:0048483),0.6222361355112211,1.3217132204675626,0.1517509727626459,0.4707450253943127,1.0,6/17,16.02%,ASCL1;EDNRB;TFAP2B;NRP1;SOX4;NF1
prerank,neurotransmitter uptake (GO:0001504),-0.5205453882454745,-1.321661368329313,0.13356164383561644,0.8869640935382248,1.0,10/12,42.75%,SNAP25;ATP1A2;GLUL;SLC29A1;SLC22A2;SLC1A6;SLC38A1;SLC22A3;SLC29A2;SLC29A4
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.656075564102376,1.3215120826270947,0.15855354659248957,0.4707357927262273,1.0,4/12,5.85%,CD74;LPL;TNF;HMGB1
prerank,actin filament organization (GO:0007015),0.517054607991627,1.3210109221396475,0.035246727089627394,0.47164257370838936,1.0,26/151,11.37%,MYO1F;ARHGAP25;MYO1G;CASS4;LCP1;MYO1E;CORO1A;GAS2L1;MYO5A;MAD2L2;ELMO1;PLS1;TTN;GAS2L3;FHOD1;FLII;AIF1;NEDD9;MYO7A;MYO19;ABI1;TPM4;BCAR1;ACTN1;BIN3;ARPC4
prerank,response to cholesterol (GO:0070723),0.6273494271293297,1.3208225379995142,0.16141732283464566,0.47164051712277955,1.0,3/17,6.68%,TGFB1;TGFBR1;TGFBR2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.6736183259803458,1.3206701092453272,0.19176136363636365,0.4715287501049985,1.0,4/10,8.99%,NFKBID;RC3H2;MALT1;RC3H1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5371217797712646,1.3203325546809699,0.08254963427377221,0.47191622267446526,1.0,12/74,6.37%,PF4;LGALS3;GATA1;IL1A;TGFBR1;RFFL;TNF;ITGA6;TRAF2;TNFAIP3;CFLAR;BCL2L1
prerank,modulation by host of viral genome replication (GO:0044827),-0.47826454534448637,-1.320041991495003,0.16304347826086957,0.8828869869120698,1.0,10/13,19.11%,NUCKS1;PPIB;IFI27;CCNK;FMR1;FBXL2;TBC1D20;EIF2AK4;ZC3H12A;VAPA
prerank,positive regulation of cell death (GO:0010942),0.5330739671650492,1.3198350995393466,0.10253699788583509,0.4727721177806358,1.0,15/59,16.38%,CALCR;ITGB2;FCGR2B;TNF;SNCA;TYROBP;MAP3K5;C1QA;ITGAM;FYN;DDIT4;LRRK2;LRP1;CD36;FAF1
prerank,regulation of cell junction assembly (GO:1901888),0.5809878300236796,1.3195170365167186,0.13286713286713286,0.47314450157848,1.0,12/27,21.21%,RUNX1;RAP1B;SNAI1;MEF2C;PRKCH;F11R;RAPGEF1;RAP1A;MYO1C;FLOT1;ROCK2;SETD5
prerank,regulation of transposition (GO:0010528),0.6505390429618318,1.3186529662911401,0.16666666666666666,0.47500905940794175,1.0,1/13,0.89%,SMYD5
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.6654107436632111,1.3184628825009062,0.1826086956521739,0.474997397108138,1.0,3/11,8.10%,TGFB1;MYOCD;MEF2C
prerank,sodium ion transport (GO:0006814),0.5253835124867351,1.3182527446790524,0.07135470527404343,0.47499967223705386,1.0,7/85,4.10%,SLC6A3;SLC6A4;SCN4B;HCN4;FGF13;SLC8A1;PKD2
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.5150696365819296,1.3180323042115774,0.044444444444444446,0.47507489242341483,1.0,28/136,11.72%,ARRB2;TMIGD3;AIM2;IRAK2;NLRC5;HAVCR2;MAD2L2;NLRC3;PKD2;OTULIN;PYCARD;DDIT3;SPI1;TNFAIP3;TRAF3;ADGRG3;TAF1;SETD6;PIM1;TAX1BP1;TMSB4X;ERBIN;RB1;ANXA4;HDAC4;CMKLR1;USP7;DAP
prerank,microtubule anchoring at centrosome (GO:0034454),0.679627013230728,1.31799250895663,0.18037518037518038,0.47465374777058084,1.0,1/10,0.15%,HOOK3
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.5816280564281382,1.317813624269463,0.14285714285714285,0.47462867524038965,1.0,6/26,11.48%,WDTC1;MLXIPL;ERLIN1;ERLIN2;ACADL;ADIPOR1
prerank,blood vessel endothelial cell migration (GO:0043534),-0.42001480459416357,-1.3176964522104173,0.11363636363636363,0.8817239179000188,1.0,8/22,8.42%,CDH5;PIK3R3;EPHB4;EFNB2;ID1;ROBO1;SLIT2;GPLD1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.57310109990242,1.3176503997250295,0.1148105625717566,0.4745655764716649,1.0,9/36,13.35%,TREM2;SIRPA;TAOK3;DUSP3;DUSP10;QARS1;DUSP19;ITCH;GPS2
prerank,carbohydrate transport (GO:0008643),0.6712344295751946,1.3176015544096054,0.17073170731707318,0.4741798571494203,1.0,2/11,8.14%,AQP1;AQP11
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.61805712669917,1.3170724102047828,0.1527777777777778,0.47510532969707087,1.0,4/20,7.06%,RGS10;GNAQ;LY6G6D;AGRN
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5963063272436849,1.3169526816348465,0.16029593094944514,0.4748831896416172,1.0,6/22,5.21%,ADAM8;SNX9;TNF;APOE;SNX33;TIMP1
prerank,eye morphogenesis (GO:0048592),-0.4466971542601028,-1.3160574930922664,0.12690355329949238,0.8782547918232064,1.0,7/19,9.04%,COL5A2;NIPBL;EFEMP1;SHROOM2;MFAP5;FBN1;TENM3
prerank,positive regulation of JNK cascade (GO:0046330),0.5332070993724726,1.3155374682811471,0.08654848800834203,0.47825053246456833,1.0,14/70,12.29%,PTK2B;SLAMF1;FCGR2B;TAOK3;TRAF2;PYCARD;TRAF3;HMGB1;MAP3K5;GADD45B;TRAF5;DUSP19;NOD2;SDCBP
prerank,hematopoietic stem cell proliferation (GO:0071425),0.6726738924721162,1.3154923980180577,0.1991643454038997,0.47784405083441955,1.0,1/11,0.13%,RUNX1
prerank,regulation of phospholipase activity (GO:0010517),0.681200470370353,1.3150603009291126,0.16714697406340057,0.47855723870034567,1.0,5/10,20.31%,ANGPTL3;SNCA;LRP1;PDPK1;PLA2G5
prerank,gas transport (GO:0015669),0.6746244755105347,1.3149843117648694,0.18722786647314948,0.4782417773587989,1.0,2/10,13.10%,AQP1;IPCEF1
prerank,embryonic skeletal system development (GO:0048706),-0.36212498502912066,-1.314719607317197,0.12195121951219512,0.8730264813819417,1.0,11/35,14.20%,PCSK5;HOXC4;WNT5A;SULF1;HOXB9;DSCAML1;HOXA3;PDGFRA;SIX1;HOXC9;COL1A1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.5654176516534528,1.3146205271129505,0.11402508551881414,0.4788019576528652,1.0,15/37,22.31%,PCSK9;ITGB3;RIN3;EDNRB;APOE;TRAP1;SDCBP;NFKB1;ANKRD13A;OPTN;PRKN;SIRT5;ABCA2;MT3;AATF
prerank,mesoderm formation (GO:0001707),0.6077956844819831,1.314386732704619,0.15870967741935485,0.47889477543663794,1.0,3/17,8.05%,ITGB3;ITGA2;SNAI1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.5258884638872476,1.3138237454946171,0.09345794392523364,0.47998475838095483,1.0,19/69,16.30%,PTK2B;CX3CR1;LGMN;ADAM8;MDK;APOE;CLN3;FZD9;MEF2C;KIF14;NTF3;PPARGC1A;CCL2;GRN;RETREG1;WFS1;CPEB4;RASA1;HIF1A
prerank,negative regulation of kinase activity (GO:0033673),0.534680625349608,1.313622855866512,0.10725552050473186,0.48001563826955107,1.0,11/62,11.96%,PTPRC;UBASH3B;THY1;GNAQ;SNCA;RB1;TRIM27;QARS1;DUSP19;DTNBP1;PRDX3
prerank,inner ear morphogenesis (GO:0042472),-0.4006235929056363,-1.313460634304102,0.14534883720930233,0.8682183283449694,1.0,8/22,15.27%,MYO6;TTC39C;ZIC1;EPHB2;TBX18;SIX1;TBX1;PAX2
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.526352558501673,1.3130342443239114,0.09307135470527404,0.48111219712042913,1.0,20/71,16.53%,CTSS;CTSB;LGMN;CTSC;CTSK;CTSL;TNFAIP3;DDI2;ATXN3;LONP1;MALT1;CTSZ;HDAC6;CASP8;STUB1;USP9X;CAPN2;PDCD6IP;IDE;YME1L1
prerank,negative regulation of neuron death (GO:1901215),0.5218053987412169,1.312968029561258,0.07464212678936605,0.48075960467858936,1.0,25/93,15.93%,PTK2B;GPNMB;LGMN;CD200R1;ADAM8;MDK;SNCA;APOE;TRAF2;CLN3;FZD9;MEF2C;KIF14;NTF3;PPARGC1A;CCL2;GRN;TNFRSF1B;SORL1;IKBKG;RETREG1;WFS1;LRRK2;CPEB4;RASA1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5559482171711227,1.3117082164601603,0.11955307262569832,0.48373654399322075,1.0,11/40,12.93%,TGFB1;TGFBR1;MTOR;MDK;RGCC;CTNNB1;TGFBR2;SNAI1;SMAD3;SDCBP;BAMBI
prerank,regulation of defense response to virus (GO:0050688),0.6463366518537671,1.3110385670247569,0.17289073305670816,0.485052297042607,1.0,6/14,12.90%,DHX9;TNFAIP3;TRAF3;ZMPSTE24;RNF216;ITCH
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.6861007806296653,1.3105936560253242,0.19913419913419914,0.4857484707960037,1.0,2/10,6.55%,LILRB1;TYROBP
prerank,protein localization to organelle (GO:0033365),-0.26150733079891153,-1.3104864857653262,0.0,0.8701922233264933,1.0,41/133,16.77%,APP;ANK2;RAB6A;UBAC2;LMBRD1;BMP4;SSB;ZNF423;CEP250;ATP6V1D;ARL3;YBX1;TOLLIP;PAF1;CALR;GCC2;BBS4;ARL6;EHD1;ALDH3A2;TRAM1;SCG3;ARL1;SIX1;TOPORS;SEC61G;BBS2;XPA;WDR35;GBP2;COL1A1;CTDNEP1;EMD;DNAJA1;SERP1;IFT20;SEC61B;AUP1;MTCH2;LAMP2;LMNA
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.6169555161143327,1.310318208165587,0.17408376963350786,0.4859346919335214,1.0,7/17,14.65%,SREBF2;ABCG1;APOE;ERLIN1;ERLIN2;SEC14L2;SREBF1
prerank,positive regulation of signal transduction (GO:0009967),0.5093110857634495,1.3101295875023777,0.006006006006006006,0.4858875010223256,1.0,53/238,13.40%,PTPRC;CD226;PTK2B;TREM2;SCIMP;SHH;CD74;SMOC2;P2RY6;ITGB3;SNX5;RAB34;TGFBR1;MGAT5;TLR2;BMP2K;DSTYK;LY86;MAML3;ERN1;PRKD2;PKD2;SKI;TNFAIP3;LGR6;FGFBP3;PRKCB;MACF1;CD80;CRADD;ASXL2;DISC1;CD180;CSNK2A1;TSPAN14;SULF2;LY96;NTF3;BAK1;POGLUT1;ATP6AP2;LIMS1;NRP1;CD63;PHIP;NOD2;CCBE1;SORL1;SMARCB1;TXNDC15;NPTN;GPS2;GAS6
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.3964478963757633,-1.3097143870072065,0.10303030303030303,0.8634108526318971,1.0,16/24,31.28%,LEPR;NDUFS1;SLC25A13;NDUFS4;COQ10B;GFPT1;COX15;SDHAF4;GFPT2;MRAP2;ACADVL;LYRM7;CYCS;COX10;MTLN;NR4A3
prerank,negative regulation of interleukin-1 production (GO:0032692),0.5914118072972732,1.3095964746170816,0.16990291262135923,0.4868504751677868,1.0,4/23,15.67%,CX3CR1;TNFAIP3;GAS6;CD33
prerank,regulation of receptor recycling (GO:0001919),0.6252112605601801,1.309377849627143,0.16302952503209242,0.48694232209911914,1.0,4/16,5.41%,PCSK9;VAMP3;SNCA;TBC1D16
prerank,microvillus organization (GO:0032528),0.640395030606491,1.309273295395311,0.1829105473965287,0.4867047853653794,1.0,9/13,22.13%,RAP2A;RAP1B;TNIK;RAP2B;RAP1A;FXYD5;MINK1;MAP4K4;RAPGEF6
prerank,ganglioside metabolic process (GO:0001573),0.6105875076247809,1.308951586223441,0.15403726708074533,0.48706347458372706,1.0,5/20,7.47%,HEXB;GM2A;ST8SIA4;HEXA;ST6GALNAC4
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5795869252265811,1.3089465800961724,0.1588447653429603,0.4865484874000525,1.0,3/24,2.62%,RUNX1;CTSK;CTSL
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.3781550591588734,-1.308674042291502,0.11510791366906475,0.85774985018316,1.0,9/28,15.10%,SLAIN2;CLIP1;PAK1;DRG1;MET;CDK5RAP2;MAPT;NAV3;OCLN
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5593584748370654,1.3086698847586284,0.13028571428571428,0.48687285209274594,1.0,7/33,8.71%,TGFB1;TNF;FOXO3;SPI1;TEAD1;TP53;SMAD3
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6448551189207892,1.3086412624188462,0.16916780354706684,0.4864243018434619,1.0,3/13,5.85%,ITGA4;MDK;HMGB1
prerank,catecholamine metabolic process (GO:0006584),0.653029972934276,1.3083914976363902,0.1816976127320955,0.4865496467530375,1.0,3/14,4.50%,RNF180;ATP7A;DDC
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.6306547364695325,1.3077146481675597,0.1802403204272363,0.48796600011455316,1.0,5/16,11.17%,WDTC1;ERLIN1;ERLIN2;ACADL;SOX9
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.6469603225032523,1.3074205479952612,0.18989071038251365,0.4882829227892445,1.0,4/13,13.92%,TREM2;TMSB4X;PPARGC1A;PID1
prerank,receptor signaling pathway via STAT (GO:0097696),0.586628193668999,1.306604531504551,0.15173237753882915,0.490090999592139,1.0,7/25,11.55%,CCR2;STAT5A;PKD2;IFNAR1;STAT4;STAT5B;CCL2
prerank,protein K63-linked ubiquitination (GO:0070534),0.5521823122803875,1.3055357496120266,0.12791991101223582,0.4924320583618108,1.0,16/41,14.99%,UBE2V2;TRIM5;UBE2V1;TRAF2;TRAF3;HECTD1;UBE2S;TRIM27;UBE2E3;RNF4;TRAF5;TRIM56;RNF135;ITCH;STUB1;RNF152
prerank,rRNA 3'-end processing (GO:0031125),-0.5277857318151604,-1.3049190191103353,0.15517241379310345,0.8623384206690796,1.0,5/10,19.27%,RPS21;ERI1;EXOSC7;EXOSC8;EXOSC9
prerank,atrial septum development (GO:0003283),-0.4857934139527228,-1.3039310860598234,0.18518518518518517,0.8569817706426802,1.0,6/13,26.25%,ANK2;NPHP3;HEY2;BMPR2;DAND5;TGFB2
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.669592837327545,1.3034431675303841,0.16666666666666666,0.49782883754763346,1.0,5/11,18.40%,TGFB1;MYOCD;MEF2C;SOX6;GREM1
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.6368799700116639,1.3031016340899422,0.17287234042553193,0.49823166655700796,1.0,4/13,12.76%,TNF;SNX33;TYROBP;STX3
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5890293350912148,1.3026036722870298,0.1552346570397112,0.49916545654777583,1.0,11/24,17.04%,IRAK2;MAP2K6;UBE2V1;TNFAIP3;NOD2;TAB2;IKBKG;CASP8;ITCH;TAB3;UBE2N
prerank,negative regulation of platelet activation (GO:0010544),0.6254371921608168,1.3024854719434134,0.17305151915455746,0.4989657921801555,1.0,4/16,4.14%,ALOX12;PRKCD;CD9;APOE
prerank,peptidyl-proline hydroxylation (GO:0019511),0.6606299168802974,1.3024303133251123,0.18246110325318246,0.4986011388054678,1.0,3/11,9.78%,CRTAP;P4HB;P3H2
prerank,cellular response to peptide (GO:1901653),0.5343802272451121,1.3021381430413974,0.12197686645636173,0.4988893750621799,1.0,16/56,17.28%,TREM2;FCGR2B;LGMN;ITGA4;RPL23;TP53;CACNA1A;ABCC1;NOD2;FYN;CACNB1;LRP1;SRC;CD36;EPHA4;ARHGEF2
prerank,cellular response to fatty acid (GO:0071398),0.64809616938891,1.3020649164806595,0.19889502762430938,0.4985588280579108,1.0,3/12,3.77%,LPL;FFAR2;NR1H4
prerank,lipoprotein transport (GO:0042953),0.6697332890602978,1.3019347943272752,0.2153392330383481,0.4983960945939157,1.0,4/10,16.03%,PRKCB;VMP1;LRP1;CD36
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.579018914961427,1.3016835102974855,0.1722488038277512,0.4985752873282404,1.0,9/25,17.39%,CBL;NUP62;ARAP1;DOK1;DGKD;BCAR3;RBPJ;RTN4;PDE6H
prerank,neurogenesis (GO:0022008),0.5549847663119076,1.3016681286276934,0.10857763300760044,0.49807609786632523,1.0,7/43,6.34%,ASCL1;PCSK9;DAGLB;PRDM12;CXCR4;THOC2;ANXA1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.5187653455923817,1.30150904938276,0.06903553299492386,0.49795522304910794,1.0,25/101,17.87%,PIK3CG;PIK3R5;TGFB1;FLT3;CSF1R;ADAM8;CCND3;TNF;SNCA;RGCC;PKD2;CCND2;MAP2K2;PARP16;NOD2;PPP2CA;LRRK2;PIH1D1;SRC;SYAP1;INCENP;IRGM;CEMIP;RHOA;CCNYL1
prerank,icosanoid metabolic process (GO:0006690),0.5403145731829336,1.300998487613422,0.1739606126914661,0.49884831055326434,1.0,6/40,10.31%,TBXAS1;ALOX12;DAGLB;HPGD;PON3;ABCC1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.5402873656081468,1.3009724053204754,0.11974110032362459,0.4983790551048694,1.0,10/50,13.66%,CD86;LAPTM5;TLR2;TLR7;TNF;CD14;ACTN4;LIMS1;NOD2;TRADD
prerank,cellular glucose homeostasis (GO:0001678),0.5422278157866258,1.300074961037714,0.13968957871396895,0.5003791472366413,1.0,12/41,16.81%,HK3;LRRC8D;ERN1;PPARGC1A;TRA2B;GAS6;FOXK1;ADCY8;HK2;SOX4;HIF1A;GCK
prerank,microvillus assembly (GO:0030033),0.6254099472083675,1.299954625154749,0.19245773732119636,0.5001805371794878,1.0,9/14,22.13%,RAP2A;RAP1B;TNIK;RAP2B;RAP1A;FXYD5;MINK1;MAP4K4;RAPGEF6
prerank,regulation of steroid metabolic process (GO:0019218),0.5932013073985533,1.2996017533557407,0.1668726823238566,0.5006494055983042,1.0,10/23,17.34%,NR1H4;ABCG1;APOE;FMO5;ACADL;TTC39B;STUB1;ARV1;ASAH1;LAMTOR1
prerank,regulation of autophagy (GO:0010506),0.5081082804161363,1.29914214117846,0.0160481444332999,0.5014033133704817,1.0,57/216,15.64%,TREM2;ATP6V0D2;IL10RA;ATP6V0E1;SNX5;DRAM2;CTSA;MTOR;PIK3CB;ATP6V1C1;PSAP;ERN1;TRIM5;SREBF2;ATP6V1E1;GPR137B;PIP4K2A;FOXO3;DDIT3;ATP6V0A2;DCAF12;HMGB1;TFEB;PIM2;SVIP;ATP6V0D1;TICAM1;PLK2;MTMR3;CSNK2A2;FLCN;RAB39B;TRIM27;TRIM8;GFAP;ATP6V0A1;EIF4G3;MID2;HDAC6;DAP;EXOC8;EXOC7;EXOC1;TAB2;FOXK1;LAMTOR3;VPS29;BMF;LRRK2;ATP6V0B;TAB3;SREBF1;VDAC1;RNF152;TBC1D14;MTDH;GSK3A
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.33291667399923,-1.2988808441957551,0.028169014084507043,0.8667655226207118,1.0,14/52,15.39%,RBFOX2;FXR2;YTHDC1;MBNL2;RBFOX3;REST;SRRM4;KHDRBS3;FMR1;HNRNPA1;NOVA2;HNRNPU;KHDRBS2;PUF60
prerank,ERBB signaling pathway (GO:0038127),0.5263718842620486,1.2985366939742382,0.10703043022035677,0.5025639612249667,1.0,19/64,17.77%,PTK2B;TGFB1;CBL;GRB2;PTPN18;NCK2;ERBIN;DGKD;BCAR1;SOX9;NRG1;BRAF;STUB1;SRC;HSP90AA1;PTPN12;IQGAP1;RPS6KA5;PDPK1
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.655803724113287,1.2985327239637758,0.19187675070028012,0.5020368764039144,1.0,4/12,14.95%,TREM2;APOE;IAPP;PFDN1
prerank,collagen fibril organization (GO:0030199),-0.2976770781439642,-1.297900948721912,0.0,0.8614936516835842,1.0,33/88,17.78%,COL5A2;COL8A1;COL12A1;COL25A1;SERPINH1;PLOD2;COL4A1;COL4A5;COL3A1;TLL1;COL6A3;PLOD1;COL4A2;COL4A3;PPIB;PLEC;COL4A6;ITGB4;COL5A3;COL1A2;COL20A1;LOXL1;ADAMTS2;COL6A2;COL1A1;COL16A1;COL6A1;COL26A1;COL9A2;COL14A1;DPT;PLOD3;CD151
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.5357429591910456,1.29667789811087,0.11956521739130435,0.5068212802670967,1.0,18/49,21.15%,TREM2;NLRC3;HMGB1;TFIP11;SVIP;KIF14;HSF1;IMPACT;HDAC6;IAPP;SORL1;SRC;LDLRAD4;CDC42;DACT1;RIOK3;GSK3B;CRYAB
prerank,regulation of protein transport (GO:0051223),0.5744126020350615,1.2958269251111556,0.15312131919905772,0.5087057787476923,1.0,5/27,7.13%,LCP1;PTPN1;TNF;RHBDF2;GAPVD1
prerank,cell-matrix adhesion (GO:0007160),0.5156926833223677,1.2954565207157647,0.07581967213114754,0.5092225285072807,1.0,10/95,3.09%,ITGAL;FERMT3;HPSE;ITGB2;ITGA4;ITGB3;ITGB5;THY1;ITGA2;ANGPTL3
prerank,negative regulation of response to stimulus (GO:0048585),0.5317563135894727,1.2949129098923093,0.1144385026737968,0.5101683164641131,1.0,14/60,15.37%,LYN;UBASH3B;FCGR2B;PDCD1;THY1;PTPN1;MCTP1;AQP11;CASK;SH2B3;CDK6;DDAH1;WFS1;TLE5
prerank,positive regulation of secretion (GO:0051047),0.6573388644698942,1.2944102288210202,0.19627507163323782,0.5110207191386578,1.0,1/11,1.86%,AQP1
prerank,glycolipid metabolic process (GO:0006664),0.5361783731545732,1.2941588570853728,0.13867822318526543,0.5111823796786717,1.0,13/47,12.72%,HEXB;CTSA;GM2A;PSAP;HEXA;SMPD3;FUCA1;CERK;ST6GALNAC4;PGAP1;B3GALNT1;ARSA;SUMF2
prerank,protein localization to synapse (GO:0035418),-0.5027262607114573,-1.2937185110988438,0.17525773195876287,0.8680710103966628,1.0,3/12,11.11%,NLGN1;BSN;SHANK1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.5149645530508585,1.2936186916385384,0.09342915811088295,0.5122262021698522,1.0,28/87,18.76%,ARRB2;TGFB1;NRROS;CBL;TGFBR1;ITGB5;ARHGEF18;SKI;HPGD;ZMIZ2;TGFBR2;FMOD;TGFBRAP1;ZFYVE9;SMAD3;F11R;NLK;BAMBI;ZYX;USP9X;SRC;SMURF1;LPXN;APPL2;FURIN;RHOA;ITGB1;LTBP2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.6724009630232035,1.2935614388731065,0.19247467438494936,0.5118516626609131,1.0,2/10,10.81%,LYN;MAP2K2
prerank,Rap protein signal transduction (GO:0032486),0.6720110194815779,1.292886268840591,0.2055800293685756,0.5132131933225116,1.0,6/10,14.54%,RAP2A;RAP1B;PLK2;RAP2B;RAPGEF1;RAP1A
prerank,regulation of ATP biosynthetic process (GO:2001169),0.6155282912064233,1.292811458702188,0.2033898305084746,0.5129141457798844,1.0,4/16,9.18%,TREM2;TMSB4X;FLCN;PPARGC1A
prerank,positive regulation of multicellular organismal process (GO:0051240),0.4976697111471867,1.292777557252748,0.009,0.5124914255226004,1.0,52/308,13.61%,CLEC9A;TREM2;FGR;PIK3CG;SHH;ITGAX;IRF4;SLC11A1;TGFB1;SYK;CCR2;IL1A;PIK3CD;ABCA1;TGFBR1;CRTAM;FABP4;RREB1;MAD2L2;MTOR;MDK;TNF;RGCC;APOE;CXCR4;CCDC88B;IL18;NFAM1;CTNNB1;TGFBR2;ACADL;CEBPB;SNAI1;FABP5;SMAD3;LURAP1;HSF1;PPARGC1A;PRKCH;INHBA;CMKLR1;TXK;SOX9;ADIPOR1;NR2C2;DYNC1H1;SDCBP;SORL1;BAMBI;PRLR;GAS6;SOX6
prerank,cellular response to organic substance (GO:0071310),0.5091393645059235,1.2925951415194548,0.06760847628657922,0.5124917858248695,1.0,26/116,14.53%,PTPN7;CYP1A1;TGFB1;HCLS1;FLT3;CSF1R;TGFBR1;PTPN18;NR1H4;TNF;LDLRAP1;CXCR4;IL18;CASP1;CTNNB1;TGFBR2;RAMP1;SMAD3;STAT5B;IL18BP;HDAC6;CCL2;TWF2;TIPARP;PID1;LRRK2
prerank,regulation of ERBB signaling pathway (GO:1901184),0.6258184235010753,1.2918063421136268,0.1864406779661017,0.5141780422076614,1.0,7/15,16.79%,LGMN;PTPN18;RHBDF2;MVB12B;RBPJ;RHBDF1;PTPN12
prerank,positive regulation of translational initiation (GO:0045948),0.5950450822642929,1.291246721579733,0.1951530612244898,0.5152271824475076,1.0,3/18,8.61%,MTOR;YTHDF3;LARP1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.5033162441855565,1.2910069858153796,0.004,0.5153505990647366,1.0,60/348,13.40%,PTPRC;LCP2;PTK2B;TREM2;GPNMB;LYN;CALCR;TGFB1;CX3CR1;HCLS1;GATA1;CD74;LAT;FNIP2;ITGB3;CSF1R;PLCG2;NIBAN1;TGFBR1;MMD;PTPRJ;ANGPT4;MAD2L2;TEC;OSM;SNX9;RAP2A;SEMA4D;CCND3;TNF;FNIP1;SNCA;PRKD2;IL6R;BRAT1;CCND2;CD44;XRCC5;MAP2K3;TP53;CD80;VEGFB;TNIK;HFE;FLCN;NTF3;PFN2;INHBA;DUSP19;SOX9;NRP1;RPS6KA4;HDAC6;SDCBP;TAB2;LRP8;CAMKK2;NPTN;BRAF;GAS6
prerank,ear morphogenesis (GO:0042471),-0.4289798984763097,-1.289537527837177,0.14814814814814814,0.8750868378420479,1.0,7/20,15.27%,NIPBL;MYO6;ZIC1;EPHB2;SIX1;TBX1;PAX2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.5821466893740811,1.288910625107927,0.15782983970406905,0.5208660337294828,1.0,6/23,12.63%,TGFB1;MAPK14;MYLK3;MYOCD;MEF2C;NRG1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5678217540468615,1.2888229979368788,0.18298368298368298,0.5205761899170178,1.0,8/26,18.32%,TREML4;TLR1;TLR2;HMGB1;WDFY1;NINJ1;RTN4;FLOT1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.5202411492220981,-1.2876800050661348,0.18412698412698414,0.8732827586291014,1.0,8/10,42.94%,BMP5;LIN7C;ARHGAP12;BMP7;SOX11;DLL4;LRP6;TBX20
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.5561867618967375,1.2875727276533506,0.16143497757847533,0.5236775567199116,1.0,5/34,3.37%,UBASH3B;PTPRJ;DUSP3;PTPN1;PTPN18
prerank,mRNA polyadenylation (GO:0006378),-0.39247480484508673,-1.2872389239842987,0.12994350282485875,0.8576556314513858,1.0,10/26,15.25%,WDR33;APP;SCAF8;AHCYL1;FIP1L1;PAPOLA;PAF1;PAPOLG;TUT1;CSTF3
prerank,RNA polyadenylation (GO:0043631),-0.39247480484508673,-1.2872389239842987,0.12994350282485875,0.8576556314513858,1.0,10/26,15.25%,WDR33;APP;SCAF8;AHCYL1;FIP1L1;PAPOLA;PAF1;PAPOLG;TUT1;CSTF3
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.5219416381494275,-1.2871493395879647,0.15547703180212014,0.8494352899358774,1.0,9/11,30.49%,GPLD1;SCARB1;CTDNEP1;SLC27A1;NR1H2;NR1H3;MFSD2A;LDLR;CNEP1R1
prerank,rRNA catabolic process (GO:0016075),0.6090020961525198,1.2868242992893293,0.19473684210526315,0.5252975600369393,1.0,1/16,0.36%,SLFN14
prerank,eye development (GO:0001654),-0.3212049749767756,-1.2868066245993752,0.06153846153846154,0.8425026806038018,1.0,13/54,11.18%,COL5A2;CACNA1C;FOXC1;PBX1;NIPBL;EFEMP1;SHROOM2;MEIS2;FBN1;PBX4;SMG9;PBX3;PBX2
prerank,regulation of JUN kinase activity (GO:0043506),0.5636887742441228,1.286069058672784,0.16589861751152074,0.5269238108038478,1.0,8/33,10.57%,TAOK3;FZD10;TNFRSF11A;TNF;TRAF2;MAP3K5;DUSP10;DUSP19
prerank,membrane fusion (GO:0061025),0.5554212118648506,1.2845431142126944,0.16319444444444445,0.5308313542994076,1.0,17/33,23.88%,VAMP3;RABEP1;STX11;DNM2;SNAP29;DYSF;SNAP23;HUWE1;VPS33B;UBXN2A;DNM1L;USO1;NSFL1C;RIMS1;CHP1;NAPA;NSF
prerank,inhibitory synapse assembly (GO:1904862),0.636748337547124,1.2845124702935693,0.21137026239067055,0.5303541822696162,1.0,2/11,2.79%,NPAS4;FGF13
prerank,glutathione derivative biosynthetic process (GO:1901687),0.5936009413890043,1.2841806051021027,0.17747858017135862,0.53015134174371,1.0,3/20,3.21%,ESD;AKR1A1;HPGDS
prerank,glutathione derivative metabolic process (GO:1901685),0.5936009413890043,1.2841806051021027,0.17747858017135862,0.53015134174371,1.0,3/20,3.21%,ESD;AKR1A1;HPGDS
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5202826225135168,1.284156755506753,0.11375387797311272,0.5296742366141804,1.0,9/75,8.19%,MRAP;CALCR;PLEK;GUCY2F;MGRN1;SAG;YWHAB;CNGB1;ZDHHC7
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.5788804115618509,1.2840985918345547,0.18810679611650485,0.5293098489260831,1.0,3/23,3.02%,ITGAX;PIK3CD;MDK
prerank,bicellular tight junction assembly (GO:0070830),-0.3288728019551887,-1.2834168742260221,0.058823529411764705,0.8463201589512971,1.0,10/46,10.37%,CDH5;AFDN;PRKCI;PARD3;CLDN5;CLDN11;MPP7;PARD6G;CLDN14;DLG1
prerank,blood vessel morphogenesis (GO:0048514),0.5235046679680009,1.2826746126278388,0.13719185423365488,0.53292164284532,1.0,14/54,16.11%,SHH;TGFB1;SYK;TGFBR1;ANGPTL3;CCM2;TGFBR2;LOX;LRP5;NRP1;CCBE1;RASA1;NF1;RBPJ
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5391573913515072,1.282663039085384,0.15783540022547915,0.5324027986098921,1.0,11/36,17.81%,CD74;NLRC5;LAPTM5;CXCR4;CD300LF;CASP1;TXK;GAS6;IRGM;HIF1A;UBE2K
prerank,positive regulation of catabolic process (GO:0009896),0.5165084759571872,1.2819470978032974,0.1225130890052356,0.5338474076073981,1.0,25/65,20.78%,VSIR;ANGPTL3;ATG7;TNF;TNFAIP3;RAB7A;PLK2;CSNK2A1;NEDD4L;FZR1;SORL1;ITCH;STX5;TIPARP;HUWE1;AREL1;GSK3A;SMURF1;IDE;VPS28;DACT1;SEC22B;WWP1;GSK3B;PRKN
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5926178527757376,1.281447646586451,0.2113022113022113,0.534734830453253,1.0,9/20,13.76%,SLC8A1;KCNMA1;SLC9A1;TFAP2B;NEDD4L;ATP6AP1;ATP1B3;LACC1;ATP1B2
prerank,regulation of ion transport (GO:0043269),0.520511005163019,1.2811100454501858,0.09240246406570841,0.5351483041711868,1.0,16/76,14.29%,KCNJ11;SYT17;ITGB3;VAMP3;P2RX7;SNCA;P2RX4;WNK1;SYT2;HFE;SYT10;NEDD4L;DTNBP1;B2M;TOR1A;KCNA5
prerank,cellular response to organic cyclic compound (GO:0071407),0.5036091966084647,1.280523049627877,0.06237424547283702,0.5362525007330008,1.0,34/141,14.54%,CYP1A1;TGFB1;P2RY6;AQP1;HCN4;P2RX7;P2RY2;NR1H4;TNF;PKD2;ADCY6;SPP1;IL18;RAP1B;P2RX4;TAF1;ABCB4;CTNNB1;ACTB;P2RY12;MEF2C;LARP1;IMPACT;DIAPH1;RAPGEF1;CCL2;CASP7;NRIP1;TIPARP;ADCY3;ADCY8;GNG2;LRRK2;RAP1A
prerank,cellular response to mechanical stimulus (GO:0071260),0.5329997219613055,1.2800881012176266,0.1381936887921654,0.5370491284497098,1.0,14/46,13.88%,AQP1;TLR8;TLR7;CASP1;MAP3K14;CRADD;SLC9A1;MAP3K1;BAK1;F11R;SOX9;CASP8;NFKB1;IRF1
prerank,lymphocyte mediated immunity (GO:0002449),0.6489020585506133,1.2799741414474872,0.19405099150141644,0.5368416004295581,1.0,2/12,6.12%,MYO1G;BTN3A3
prerank,negative regulation of calcium ion transport (GO:0051926),0.6143172572092326,1.2799569821203318,0.19350473612990526,0.5363287846849065,1.0,3/15,8.56%,LILRB1;EPO;TRIM27
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.6168021817411437,1.27942752165252,0.17828418230563003,0.5373482398138398,1.0,2/15,2.77%,PTK2B;TEC
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.6565594939041213,1.2789914217392024,0.20719424460431654,0.5380478883942146,1.0,4/10,10.93%,ALOX12;PRKCD;CD9;SH2B3
prerank,vasculogenesis (GO:0001570),0.5512435267071437,1.278943738233146,0.17036172695449242,0.5376426098892222,1.0,4/32,6.68%,SHH;TGFB1;CCM2;TGFBR2
prerank,membrane raft organization (GO:0031579),0.6216981810999097,1.2787261234984866,0.2038961038961039,0.5377200509347162,1.0,3/15,5.51%,RFTN1;CLN3;NPC1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5626453891306037,1.2783335349427571,0.17053364269141533,0.5383049475040725,1.0,7/29,11.55%,CCR2;STAT5A;PKD2;IFNAR1;STAT4;STAT5B;CCL2
prerank,regulation of integrin activation (GO:0033623),0.6060740059992649,1.2775141934321914,0.20917678812415655,0.54010399755652,1.0,7/15,22.43%,PLEK;RAP1B;KIF14;SRC;FBLIM1;PIEZO1;SELP
prerank,non-motile cilium assembly (GO:1905515),-0.3836260812935561,-1.2772195176937713,0.12244897959183673,0.8599486919775275,1.0,15/30,25.28%,TTC8;IFT57;CEP250;BBS4;PIBF1;TBC1D32;CEP89;FUZ;TMEM216;BBS1;VANGL2;RPGRIP1L;GORAB;ARL13B;IFT122
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.45833047968900986,-1.2762306695361465,0.17928286852589642,0.8554542803952615,1.0,4/15,9.80%,TJP1;BMPER;SMAD1;KLF4
prerank,regulation of myoblast fusion (GO:1901739),0.6436808491132551,1.2760332683473699,0.19772403982930298,0.5439424194835731,1.0,4/11,11.09%,MAPK14;RIPOR2;CFLAR;CD53
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5443693312222204,1.2759446205684537,0.16989737742303307,0.5436262461163619,1.0,6/38,5.09%,TREM2;NLRC3;NR1H4;TANK;PYCARD;TNFAIP3
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.5607157707301763,1.2757558267589109,0.1879432624113475,0.5436846521961269,1.0,5/26,8.46%,ANAPC15;ESPL1;NEK6;CDC23;RB1
prerank,response to alcohol (GO:0097305),0.5664667866565478,1.275623302174672,0.18127250900360145,0.5435112945919807,1.0,4/27,6.68%,TGFB1;TGFBR1;SDF4;TGFBR2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.5423519543658879,1.2754103463267081,0.16071428571428573,0.5435311306572229,1.0,8/39,7.56%,LGMN;CBL;PTPRJ;DUSP3;GRB2;PTPN18;ZFYVE28;SH3KBP1
prerank,phosphate ion homeostasis (GO:0055062),0.6442368762051276,1.275359797139565,0.2276657060518732,0.5431406458086175,1.0,2/10,9.60%,TFAP2B;XPR1
prerank,regulation of coagulation (GO:0050818),0.6457967628579914,1.2752425242512437,0.20689655172413793,0.5429475643266938,1.0,1/11,0.82%,GP1BA
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.61338021316093,1.2751180266779525,0.22162883845126835,0.5427496788541413,1.0,2/14,3.38%,PRKAR2B;PKIB
prerank,negative regulation of multicellular organismal process (GO:0051241),0.4952031402608244,1.2745486050234949,0.03907815631262525,0.5438332754346479,1.0,43/199,13.91%,SLC6A4;GPNMB;SHH;SLC11A1;TGFB1;PLCL2;FCGR2B;SRGN;SLAMF8;MAD2L2;MDK;TLE3;MAP2K6;NR1H4;TNF;RGCC;DDIT3;SPI1;TIMP1;WWC2;PPP1R11;NKX2-1;MYOCD;MEF2C;FLCN;RB1;ATP2B1;DUSP10;ARHGDIB;PFN2;SOX9;RPS6KA4;PTPRO;ADIPOR1;GRN;HDAC9;CHSY1;PPP2CA;RAB11FIP5;NPTN;VASN;GAS6;TRPV3
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.4392614186764794,-1.2742703181510566,0.1596244131455399,0.8552223836787896,1.0,4/16,3.14%,ANK2;RYR2;UBAC2;BCAP31
prerank,embryonic eye morphogenesis (GO:0048048),-0.502226216110243,-1.2737865695207082,0.21212121212121213,0.8489396407640046,1.0,3/11,8.21%,EFEMP1;MFAP5;FBN1
prerank,steroid catabolic process (GO:0006706),0.6594814371637343,1.2737745225666608,0.20029027576197386,0.5455286401051832,1.0,3/10,15.73%,SPP1;HSD17B11;YWHAH
prerank,glucose homeostasis (GO:0042593),0.5088183128498193,1.273657912619937,0.12149532710280374,0.5452935173282308,1.0,20/83,16.81%,HK3;LRRC8D;MLXIPL;FFAR2;CEBPA;USF1;TFAP2B;PPARGC1A;SLC8B1;ADIPOR1;FOXK1;ADCY8;MBD5;WFS1;HK2;SOX4;HIF1A;ADIPOR2;APPL2;GCK
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.6001028015220372,1.2733860093179856,0.21578947368421053,0.5455473918151558,1.0,4/17,10.79%,MYO1G;IL18;BTN3A3;IL18BP
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.6276962918470346,1.27329479857056,0.21052631578947367,0.5447066825724982,1.0,4/14,14.98%,BLVRB;SLCO2B1;ABCC1;SLCO1B1
prerank,heme catabolic process (GO:0042167),0.6276962918470346,1.27329479857056,0.21052631578947367,0.5447066825724982,1.0,4/14,14.98%,BLVRB;SLCO2B1;ABCC1;SLCO1B1
prerank,regulation of kinase activity (GO:0043549),0.5039282173909263,1.2732691401714364,0.0998980632008155,0.5442298142556569,1.0,9/89,4.28%,TREM2;FGR;FLT3;CD74;NLRC5;SLAMF8;CSF1R;DSTYK;TTN
prerank,cellular response to interleukin-15 (GO:0071350),0.6419818913317255,1.2729921884316295,0.1885245901639344,0.5439442053083318,1.0,4/13,14.01%,STAT5A;GRB2;STAT5B;IL2RG
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.6419818913317255,1.2729921884316295,0.1885245901639344,0.5439442053083318,1.0,4/13,14.01%,STAT5A;GRB2;STAT5B;IL2RG
prerank,hexose metabolic process (GO:0019318),0.5403256131608252,1.272850559471436,0.15916575192096596,0.5437853711999703,1.0,11/39,17.26%,KCNJ11;AKR1A1;ALDOB;BRAT1;SORD;FUCA1;TFAP2B;CHST15;PMM1;GALM;PPARD
prerank,protein-containing complex assembly (GO:0065003),0.49314810595072495,1.2728138191359588,0.014,0.5433339530809866,1.0,62/259,15.85%,NCKAP1L;PTK2B;FERMT3;CD3E;BIN2;AIM2;CD74;SH3PXD2B;VAMP3;CTSC;P2RX7;SKAP2;DHX9;TLE3;SNX9;WIPF1;TNF;PPP6R1;MITF;TRAF2;TEAD1;CTNNB1;TRAPPC9;TP53;LEO1;SLC9A1;CAPZA1;HFE;MCFD2;CTSZ;PDCD6;HSF1;PPARGC1A;EPRS1;AMER1;TUBGCP4;RAB1B;RBBP5;SOX9;PYGO2;DET1;SEC24D;SEC16A;MDN1;CSNK1A1;F5;SEC16B;RANBP9;IKBKG;CASP8;STX5;TRAPPC6A;ADCY8;DARS1;TRADD;TSPAN4;PDZD11;LRRK2;CAPN3;AP2M1;GRIA1;BCL9
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.5753169070990833,1.2725756520188054,0.2222222222222222,0.5434737923497303,1.0,4/20,5.61%,CCND3;RGCC;PKD2;CCND2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.5056709874074289,1.272519702168429,0.07630522088353414,0.5430984649958708,1.0,15/113,6.87%,LGALS3;TGFB1;PLEK;SYK;LCP1;FNIP2;ABCA1;GTF2H1;TNF;FNIP1;SNCA;ASAP1;RAP1B;TP53;TAL1
prerank,mesonephros development (GO:0001823),-0.49763269329197424,-1.2719638156701014,0.19682539682539682,0.8482485620189631,1.0,7/11,35.32%,BMP4;PAX2;ZBTB16;FGF10;BMP7;FGF1;OSR1
prerank,lipoprotein catabolic process (GO:0042159),0.6461108720003608,1.2714605832979813,0.22510822510822512,0.5455611265951574,1.0,4/11,11.66%,CTSD;APOE;ABHD17B;ABHD17C
prerank,nitrogen compound transport (GO:0071705),0.49230453763948206,1.2705664764235187,0.07028112449799197,0.5476227224162906,1.0,18/141,9.15%,SLC6A3;SLC6A4;SLC11A1;SLC16A10;SLC15A3;AQP1;SLC52A1;LRRC8D;SLC7A7;SLC7A8;MYH9;RAB7A;SLC36A1;SLC38A4;RAMP1;SLC43A2;SLC44A2;SLC6A15
prerank,regulation of adenylate cyclase activity (GO:0045761),0.5751204859785806,1.2704538350645838,0.20947630922693267,0.5473640188839631,1.0,9/22,18.16%,CCR2;EDNRB;AKAP5;CAP1;LTB4R2;GNAI3;NF1;CACNA1D;GNAI2
prerank,endocardial cushion development (GO:0003197),-0.42822425078820503,-1.270292533059635,0.1650485436893204,0.8464835248065047,1.0,4/21,5.20%,BMPR1A;BMP4;ACVR1;ACVRL1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.532779415980759,1.2701927017244012,0.15502183406113537,0.5475532818367645,1.0,8/46,7.75%,LCP1;TYK2;IL12RB2;AIP;RAP1B;STAT4;P4HB;CAPZA1
prerank,regulation of protein localization (GO:0032880),0.5196580930614075,1.269579976575193,0.148109243697479,0.5488117112108901,1.0,11/58,10.11%,PLEKHM2;CTSD;ITGB3;MMD;TRIM25;TRIM5;RAB14;ZDHHC7;TRIM27;ATCAY;TPR
prerank,glycosphingolipid metabolic process (GO:0006687),0.5329806911119565,1.269072686166414,0.19141914191419143,0.5497536152536233,1.0,19/42,21.48%,HEXB;CTSA;GM2A;PSAP;HEXA;SMPD3;CERK;B3GALNT1;ST8SIA1;ARSA;SUMF2;LARGE1;ASAH1;B4GALNT1;GBA2;SMPD1;ABCA2;SUMF1;B4GALT6
prerank,regulation of cholesterol esterification (GO:0010872),0.64772712474037,1.26893851566093,0.22492401215805471,0.5495264139314302,1.0,5/10,21.23%,ABCG1;APOE;STARD4;LAMTOR1;ABCA2
prerank,positive regulation of cell population proliferation (GO:0008284),0.4879662201562915,1.2684239017674543,0.006,0.5504789626390745,1.0,74/423,13.40%,PTPRC;CD86;PTK2B;SLAMF1;LYN;SHH;HCK;ITGAX;HPSE;TGFB1;CXCL5;HCLS1;FLT3;LGMN;CD74;RPL23;AQP1;CSF1R;TGFBR1;TCIRG1;MLXIPL;S100B;TNFRSF11A;DHX9;MDK;OSM;IL12RB2;TNF;IL6R;CNOT8;IL18;TIMP1;CCND2;FZD9;AIF1;GAB2;CCAR1;TGFBR2;RPS15A;PIM1;CCKBR;EPO;FLT3LG;MEF2C;AQP11;KIF14;DOT1L;CSNK2A1;TFAP2B;KIF20B;GID8;NTF3;HSF1;CCL14;PRKCH;ACER3;LRP5;HDAC4;NAP1L1;SOX9;THBS1;GRN;PHIP;PRDX3;CIAO1;NOD2;SDCBP;CDK6;TBC1D8;NRG1;STX3;BAMBI;PRLR;GAS6
prerank,cardiac atrium morphogenesis (GO:0003209),-0.43917456086123696,-1.2678100405821087,0.14342629482071714,0.847474621969324,1.0,12/16,49.50%,HEY2;BMPR2;TGFB2;PROX1;DLL4;TBX20;NOG;MYH6;GATA4;NOTCH2;ZFPM1;ISL1
prerank,regulation of cell division (GO:0051302),0.5130635039125435,1.2675149032829873,0.14035087719298245,0.5525548885613474,1.0,14/72,11.28%,SHH;SMYD5;ZFYVE26;KLHL21;BCL2L1;TAL1;PLK4;PLK2;FLCN;MYO19;UVRAG;RAB11A;SETD2;BECN1
prerank,dendritic spine organization (GO:0097061),0.5646023636098221,1.2667096711634063,0.18160377358490565,0.5543332175891483,1.0,3/26,6.43%,TREM2;LGMN;DOCK10
prerank,negative regulation of protein binding (GO:0032091),0.5066736957910136,1.2664102086675835,0.140625,0.5546633902707737,1.0,15/71,15.37%,ARRB2;BAG2;ITGA4;PRKCD;ACTB;TFIP11;HFE;DISC1;CTSZ;PSME3IP1;SORL1;B2M;ATP2A3;LRRK2;TLE5
prerank,basement membrane organization (GO:0071711),0.6093204513251737,1.2658454521726679,0.21389645776566757,0.5557033613643213,1.0,1/14,0.14%,CTSS
prerank,cellular response to tumor necrosis factor (GO:0071356),0.4901503166315885,1.2646927252007671,0.054,0.558466543538098,1.0,42/175,18.27%,PTK2B;AIM2;NFE2L2;TNFRSF11A;DHX9;CCL8;TNF;OCSTAMP;TNFSF8;TANK;TRAF2;FOXO3;PYCARD;TRAF3;MAP3K14;TP53;ACTN4;PSMB10;TMSB4X;ERBIN;ST18;CCL14;TRAF5;TNFRSF21;PSMA2;CCL13;LIMS1;GBP3;CCL2;TNFRSF1B;PSME3;TRADD;PSMB5;PID1;PSMD8;PSMD7;PSMB9;ASAH1;CCL25;ARHGEF2;PSMD2;BIRC2
prerank,plasma membrane repair (GO:0001778),0.6245221163535871,1.2644982287503566,0.22038567493112948,0.5585317025222095,1.0,6/13,19.88%,MYH9;SYTL4;DYSF;AHNAK2;ARL8B;SMPD1
prerank,phosphorylation (GO:0016310),0.48817597405244545,1.2640512190289175,0.006,0.559311143970207,1.0,104/384,17.40%,PTK2B;BTK;FGR;LYN;GMFG;PIK3CG;HCK;TGFB1;SYK;DGKZ;RSKR;FNIP2;PIK3CD;MAP4K1;TAOK3;TGFBR1;TYK2;PRKCD;MTOR;BMP2K;PIK3CB;TEC;GRK3;ERN1;NEK6;CDK14;PRKD2;MYLK3;CDK8;DGKK;MORC3;TLK1;DGKE;TAF1;PRKCB;MKNK1;CDK11B;STK10;TGFBR2;NADK;MAP3K5;PIM1;PLK4;WNK1;CDK17;PIM2;CERK;TNIK;PLK2;CSNK1G2;CHEK2;DGKG;DGKD;CSNK2A1;MAP3K1;STRADB;PRKCH;AGK;CDK7;STK17B;FAM20C;RNASEL;PKN1;TXK;RPS6KA4;POMK;NLK;PRKACB;CCL2;CSNK1A1;FYN;GRK4;MAP3K12;CDK6;CREB1;DGKI;LIPE;MERTK;CAMKK2;SHPK;BRAF;GAS6;STK3;STK24;BMX;LRRK2;NIM1K;WNK4;TESK2;STRADA;SGK3;GSK3A;CDK15;XYLB;MAP3K11;GNPTAB;COQ8B;STK4;GK;PPP3CB;PIK3R4;RPS6KA5;CDK18;SIK2
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.5762391639048058,1.2637015256823858,0.1906519065190652,0.5598104299379554,1.0,6/23,19.98%,GUCY2F;SAG;CNGB1;GRK4;METAP2;NMT1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.5219610149151636,1.2632614107807218,0.17252747252747253,0.560530600193712,1.0,11/45,11.59%,TGFB1;NABP1;NME6;AURKAIP1;RGCC;FZD3;CTNNB1;PLK2;SMAD3;ANGEL2;TRIM35
prerank,negative regulation of hydrolase activity (GO:0051346),0.519092553227237,1.2629204290361105,0.16666666666666666,0.5610105755838499,1.0,8/49,9.97%,KLRK1;FZD10;RASA4;CST7;ARFGEF1;WNK1;ATP5IF1;F11R
prerank,glycerophospholipid metabolic process (GO:0006650),0.5074840580587082,1.262739830218198,0.13617463617463618,0.5609601838043514,1.0,18/75,15.84%,PLCB2;PLEK;PIGM;CSF1R;ABHD12;CLN3;PIGL;PIGX;PIGV;PLA2G7;AGK;PIGH;PRDX6;ABHD3;SYNJ1;GDE1;ABCA3;GDPD3
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.6005860402635785,1.2619448667584738,0.21324503311258278,0.5627007210733304,1.0,3/15,10.88%,NPAS4;CLN3;ZDHHC3
prerank,striated muscle tissue development (GO:0014706),-0.37009374786554716,-1.2618566531263538,0.14093959731543623,0.8613720253148827,1.0,6/29,10.33%,SGCD;CAV1;SGCZ;PGM5;BMP5;SIX1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5941295955414168,1.2615066831931847,0.2134387351778656,0.5634323050155784,1.0,4/16,8.78%,MAPK14;RIPOR2;MEF2C;AKIRIN1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.537462528961283,1.261242919870356,0.18008948545861297,0.5636717196097888,1.0,9/36,9.43%,CX3CR1;TGFBR1;TNF;PYCARD;CRADD;CSNK2A2;CSNK2A1;RB1;QARS1
prerank,negative regulation of cell adhesion (GO:0007162),0.5052187798250135,1.2605646363145502,0.14511041009463724,0.5651287815575705,1.0,14/72,11.30%,PTPRC;TGFB1;PLXNC1;MDK;SEMA4D;TGFBI;PLXNB2;RIPOR2;SIPA1;SPINT2;PODXL;ARHGDIB;NF2;PTPRO
prerank,calcium import into the mitochondrion (GO:0036444),-0.5245338772880079,-1.260535970512187,0.2079207920792079,0.8585190198555684,1.0,4/10,17.88%,AFG3L2;MICU1;MCUR1;SLC25A23
prerank,dopamine metabolic process (GO:0042417),0.5832732184182966,1.2599734911084262,0.23008849557522124,0.5662664915994441,1.0,5/18,14.71%,SNCA;GCH1;ATP7A;COMT;MAOA
prerank,amino acid transport (GO:0006865),0.5141533403611371,1.259547898864023,0.16902944383860413,0.5669497039936426,1.0,13/49,16.72%,SLC16A10;SLC7A7;SLC7A8;SLC38A6;SLC36A1;SLC38A4;SLC43A2;SLC6A15;SLC36A4;SLC38A10;SLC25A45;SLC1A4;SLC43A1
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.47356778565174174,-1.2594252188818218,0.19285714285714287,0.8548873577218793,1.0,4/13,11.64%,SESN3;CASTOR2;KPTN;ATM
prerank,positive regulation of gene expression (GO:0010628),0.4845626805587838,1.25846499900254,0.005,0.5695938511289486,1.0,83/442,14.36%,CLEC9A;LILRB1;TREM2;FGR;PF4;CALCR;PIK3CG;ITGAX;SLC11A1;TGFB1;CD3E;STAP1;CD74;NFE2L2;IL1A;VSIR;PIK3CD;RPL23;PLCG2;NIBAN1;TGFBR1;CRTAM;TLR2;TAF1A;P2RX7;MTOR;PIK3CB;MAPK14;POLR1E;ERN1;TNF;SF3B1;RGCC;MITF;TTN;PDCL3;PLXNB2;TENT4B;CCDC88B;NFAM1;CIRBP;ACTB;TYROBP;TP53;NKX2-1;TNRC6A;YTHDF3;TICAM1;HFE;MEF2C;LARP4B;MOV10;SMAD3;LURAP1;PPARGC1A;AGO4;NOS1AP;ACTG1;CPEB3;RPL26;INHBA;MAP2K2;POLR1B;POLR2L;TXK;LIMS1;DTNBP1;SOX9;THBS1;AGO3;ZCCHC4;METTL3;VSTM2A;SEC16B;BRAF;GAS6;PCIF1;POLDIP3;HCFC1;UPF3B;PID1;CADM1;HNRNPD
prerank,regulation of cell-matrix adhesion (GO:0001952),0.5146675545680554,1.258445699967214,0.14705882352941177,0.5690980689569195,1.0,25/64,20.52%,PTK2B;CD3E;THY1;DUSP3;PIK3CB;MACF1;SLC9A1;CASK;ACTG1;VCL;NF2;THBS1;CDK6;PTPRA;RASA1;NF1;CD36;CCL25;CORO1C;RHOA;MINK1;PLEKHA2;ROCK2;GSK3B;MAP4K4
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.4319638960726511,-1.2584079126156709,0.18846153846153846,0.8511333231295166,1.0,6/17,8.42%,PIK3R3;EPHB4;EFNB2;ROBO1;SLIT2;GPLD1
prerank,blood circulation (GO:0008015),-0.3339897613163876,-1.258145890654309,0.14285714285714285,0.8446698745645681,1.0,15/49,12.61%,SGCD;ELN;SGCZ;SERPING1;COL4A3;ACVRL1;SOD1;HTR7;SCPEP1;ROCK1;ACE;CYB5R3;CXCL12;GUCY1A1;NOS3
prerank,positive regulation of coagulation (GO:0050820),0.6536387616938055,1.258088614147968,0.23019431988041852,0.5690612568972695,1.0,2/10,11.24%,HPSE;THBS1
prerank,positive regulation of hemostasis (GO:1900048),0.6536387616938055,1.258088614147968,0.23019431988041852,0.5690612568972695,1.0,2/10,11.24%,HPSE;THBS1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.6223009927143051,1.2580240614596463,0.22462787550744248,0.5687048515032425,1.0,5/13,14.39%,ZMIZ2;SPI1;ARID1A;ARID1B;ELOF1
prerank,regulation of immune effector process (GO:0002697),0.5208929304118085,1.2580167971358722,0.17738359201773837,0.5681750540102103,1.0,5/41,8.94%,IRF4;FCGR2B;C1QC;C1QA;C1QB
prerank,intestinal lipid absorption (GO:0098856),0.63108682065508,1.2567669649010662,0.20480225988700565,0.5713531764395141,1.0,3/11,16.03%,CEL;SOAT2;CD36
prerank,RNA catabolic process (GO:0006401),0.5155597367429909,1.2567418059664102,0.1634199134199134,0.5708685014985114,1.0,24/46,26.89%,SLFN14;ERN1;SND1;ZC3H12D;AGO4;AGO3;RNASEH1;METTL3;DNA2;HNRNPD;PABPC4;RNASEH2A;DIS3L2;RNASE6;NUDT12;ZPR1;DCP2;SIDT2;XRN2;NCBP1;DXO;RNASE3;SUPV3L1;LSM6
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.6159979435764471,1.2562385791715522,0.21534320323014805,0.57175157460283,1.0,4/15,9.24%,BMP2K;PIK3CB;DGKD;SCYL2
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.5070355767072183,1.2560622540357935,0.1375387797311272,0.5717232748556121,1.0,13/70,12.01%,FERMT3;ITGA4;ITGB3;VAMP3;MICALL2;SPI1;MEF2C;KIF14;RB1;ACTN1;PARVB;NRP1;METTL3
prerank,protein depolymerization (GO:0051261),-0.3639599873462359,-1.2557067279365892,0.1509433962264151,0.8458082204499837,1.0,11/27,18.47%,NCKAP5;GSN;CFL2;STMN2;WDR1;MICAL3;MICAL2;KIF24;STMN4;STMN3;KIF18A
prerank,regulation of ruffle assembly (GO:1900027),0.563039555980062,1.2551739422383417,0.20606060606060606,0.573717518337513,1.0,7/23,11.10%,STAP1;ARHGAP24;PLEKHM1;P2RX4;P2RY12;PFN2;PFN1
prerank,mRNA stabilization (GO:0048255),0.5265476989362659,1.2549518417333019,0.18826135105204872,0.5737931972005867,1.0,7/40,9.54%,SLC11A1;DHX9;MAPK14;CIRBP;LARP1;TENT5C;ANGEL2
prerank,protein autophosphorylation (GO:0046777),0.4883508530701418,1.2549086009157873,0.06827309236947791,0.5733677891309579,1.0,40/157,18.94%,PTK2B;FGR;LYN;HCK;FLT3;MAPKAPK3;MAP4K1;TAOK3;CSF1R;MTOR;TEC;ERN1;NEK6;PRKD2;TAF1;MKNK1;STK10;PIM1;PIM2;TNIK;CHEK2;SMG1;STK17B;MAP2K2;TXK;MAP3K12;CAMKK2;STK24;BMX;LRRK2;SRC;MAP3K11;EPHA4;STK4;EPHA8;SIK2;PDPK1;VRK1;MINK1;TAOK1
prerank,positive regulation of programmed cell death (GO:0043068),0.48393841748611577,1.2543976848448408,0.031,0.5742659104120097,1.0,63/272,17.54%,FGD2;VAV1;LILRB1;IRF5;PREX1;SYK;ABR;PLEKHN1;CTSD;LAPTM5;TNFAIP8;VAV2;ARHGEF18;MTCH1;ATG7;TNF;SNCA;ITGA6;FOXO3;PYCARD;VAV3;HMGB1;FZD9;APAF1;CTNNB1;DNM2;GNA13;CCAR1;TP53;CRADD;MAP3K5;KCNMA1;FLCN;GADD45B;ITSN1;BAK1;STK17B;ARHGEF17;HDAC6;TRIM35;IAPP;UTP11;CTNNBL1;CASP8;ARHGEF3;STK3;TRADD;ARHGEF11;BMF;LRRK2;SOX4;PTPA;RPS6KA2;TOP2A;FANK1;NF1;MAP3K11;FAF1;ARHGEF26;STK4;BIN1;ARHGEF2;UBE2Z
prerank,regulation of dendrite extension (GO:1903859),0.57881584628652,1.2543748171045275,0.22681704260651628,0.5737895870515347,1.0,9/18,21.68%,SYT17;SYT2;NEDD4L;SMURF1;RASAL1;PLAA;UNC13A;RIMS1;ITSN2
prerank,chemical homeostasis (GO:0048878),0.5088013843150928,1.2541273940791386,0.16631578947368422,0.5739663803965516,1.0,13/61,11.13%,TREM2;ANGPTL3;CLN8;CEBPA;TENT4B;ABCB4;USF1;WNK1;AQP11;ABHD4;NEDD4L;VGF;SLC66A1
prerank,positive regulation of cell motility (GO:2000147),0.4846176640859884,1.2540424691885284,0.04804804804804805,0.5736890950599363,1.0,36/205,12.61%,PTK2B;FERMT3;GPNMB;FGR;ITGAX;TGFB1;CASS4;F10;VSIR;PIK3CD;CSF1R;TGFBR1;MGAT5;MDK;ANGPTL3;SEMA4D;ITGA6;LGR6;AIF1;MAPRE1;CCAR1;ACTN4;RIPOR1;NEDD9;SNAI1;FAM89B;PTP4A1;NTF3;PODXL;ACTG1;BCAR1;SEMA4A;THBS1;GRN;SDCBP;NUMB
prerank,positive regulation of innate immune response (GO:0045089),0.543797444264699,1.2534589802405876,0.20591715976331362,0.574792900300627,1.0,5/30,4.97%,NLRC5;ADAM8;DHX9;TLR8;SPI1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.600978721925559,1.2534562448846172,0.21510883482714468,0.5742501168730063,1.0,5/16,9.74%,PIGM;PIGL;PIGX;PIGV;PIGH
prerank,negative regulation of apoptotic process (GO:0043066),0.48328781906091667,1.2532277165149028,0.005,0.5743619985001573,1.0,97/444,16.32%,NCKAP1L;PTK2B;TREM2;ASCL1;SHH;HCK;CX3CR1;CLEC5A;HCLS1;GATA1;PCID2;LGMN;CD74;CBL;AQP1;ALOX12;ADAM8;PRKCD;ANGPT4;TNFAIP8;DSTYK;NUP62;MDK;SEMA4D;NR1H4;TNF;FNIP1;SNCA;APOE;DNAJC3;CLN3;CCND2;CD44;FZD9;FZD3;CFLAR;CTNNB1;ANXA1;BCL2L1;TP53;PIM1;TAX1BP1;PIM2;PLK2;MALT1;MEF2C;KIF14;TPT1;CSNK2A2;CSNK2A1;TFAP2B;RB1;TRIM27;ARHGAP10;NTF3;PPARGC1A;PRKCH;QARS1;BABAM2;MGMT;ANXA4;SON;BNIP1;MAEA;SOX9;THBS1;CCL2;GRN;PHIP;PRDX3;ANGPTL4;PRDX2;ITCH;MERTK;PRLR;BRAF;GAS6;NFKB1;RETREG1;ARHGDIA;RNF144B;ATAD3A;WFS1;BAG1;MIEN1;AREL1;CAPN3;VDAC1;CPEB4;ERCC5;SRC;AHI1;MTDH;FANK1;RASA1;TXNDC5;NAA38
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.5461142102391549,1.252398567146197,0.20385050962627407,0.5762699009899677,1.0,4/32,2.52%,TGFB1;CD300A;PRKCD;MTOR
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.48228967474878626,1.2522193609763372,0.016,0.5762366229191448,1.0,56/348,11.72%,ARRB2;LILRB1;TREM2;PF4;CALCR;ITGAX;SLC11A1;TGFB1;CD3E;PCSK9;STAP1;CD74;NFE2L2;IL1A;VSIR;PIK3CD;RPL23;LAPTM5;VAMP3;PLCG2;TGFBR1;TLR2;P2RX7;MTOR;PTPN1;PIK3CB;MAPK14;TNF;SNCA;RGCC;MITF;TTN;PDCL3;TYROBP;TP53;NKX2-1;TNRC6A;TICAM1;RESF1;HFE;MEF2C;MOV10;SMAD3;NTF3;PPARGC1A;SCYL2;AGO4;NOS1AP;ACTG1;ATF7IP;INHBA;LIMS1;DTNBP1;SOX9;CD63;AGO3
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.49160817823765907,1.2518702178732573,0.0963855421686747,0.5767827414584185,1.0,39/122,17.20%,CIITA;SMOC2;PPP1R3E;NLRC5;NIBAN1;TLR2;MTOR;DHX9;RGCC;PRKD2;PLXNB2;SLC25A37;CIRBP;YTHDF3;LARP4B;CPEB3;RPL26;BRPF3;THBS1;CCL2;STN1;ZCCHC4;METTL3;NOD2;KAT7;DNA2;PCIF1;NFKB1;POLDIP3;UPF3B;HNRNPD;TMEM106A;SOX4;BCAR3;FAF1;NOX1;GCK;RPS4X;IL33
prerank,regulation of cellular component movement (GO:0051270),0.5122400464025524,1.2516883944660602,0.1581798483206934,0.5767197070869972,1.0,13/49,14.01%,LYN;TGFBR1;CD9;ARAP1;ACTN4;ACTN1;PKN1;DIAPH1;HDAC6;CDK6;NRG1;ZSWIM6;ARHGAP18
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.5907304864294389,1.250612147352205,0.23226703755215578,0.5792636999136322,1.0,3/15,8.57%,ABCG1;APOE;LIPC
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5199006363689331,1.2500173065575202,0.16720955483170466,0.5804494018086538,1.0,8/46,11.23%,FERMT3;ITGA4;ITGB3;VAMP3;MICALL2;KIF14;PARVB;NRP1
prerank,calcium ion transport into cytosol (GO:0060402),-0.40338022718842065,-1.2499213038876755,0.1504424778761062,0.8586672146964245,1.0,13/21,27.72%,CACNA1C;RYR2;JPH1;ITPR3;GRIN2B;CACNA2D1;GRIN1;TRPV4;JPH2;JPH4;TRPM2;CACNB3;GRIN2D
prerank,double-strand break repair via break-induced replication (GO:0000727),0.625462311600983,1.2498154377689015,0.24043715846994534,0.580462995227699,1.0,3/12,10.17%,MCM5;MCM6;MCM2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.49841310574519176,1.2498068336053352,0.13655030800821355,0.5799360219567049,1.0,25/80,17.07%,GSAP;NIBAN1;PRKCD;MTOR;TNF;ABCG1;PLXNB2;SMPD3;CIRBP;YTHDF3;LARP4B;CPEB3;RPL26;THBS1;ZCCHC4;METTL3;PCIF1;POLDIP3;NSMAF;UPF3B;HNRNPD;SOX4;GSK3A;EPHA4;RPS4X
prerank,metal ion export (GO:0070839),0.538693103308214,1.2491522535477506,0.20436280137772675,0.5812500344237955,1.0,7/31,14.29%,SLC11A1;ATP7A;KCNIP2;SLC9A1;ATP1B3;ATP1B2;KCNA5
prerank,entry into host (GO:0044409),0.6187300764489689,1.2490684066403435,0.24360699865410498,0.5809284272144255,1.0,4/13,6.29%,CBL;GRB2;CXCR4;CTNNB1
prerank,prostanoid metabolic process (GO:0006692),0.6153942123912426,1.2487103329496714,0.23601637107776263,0.5814037939962083,1.0,2/13,4.51%,HPGDS;HPGD
prerank,piRNA metabolic process (GO:0034587),-0.40488601394209633,-1.2484082100557674,0.16826923076923078,0.8568885793544404,1.0,19/19,59.57%,TDRKH;MYBL1;EXD1;TEX15;PIWIL2;TDRD9;DDX4;TDRD12;PIWIL4;FKBP6;MAEL;MOV10L1;HENMT1;ASZ1;GPAT2;BTBD18;TDRD1;PIWIL1;PLD6
prerank,presynapse assembly (GO:0099054),-0.4277479522993417,-1.2483494021964356,0.21551724137931033,0.8498289631086631,1.0,5/16,8.58%,NLGN1;IL1RAPL1;WNT5A;BSN;LRRTM3
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.5327032620073492,1.2479721419435665,0.18940248027057496,0.5830901077742068,1.0,11/38,16.71%,CX3CR1;SIRPA;TNF;PKD2;P2RX4;SMAD3;NOS1AP;DDAH1;CD36;CD47;HSP90AA1
prerank,positive regulation of type I interferon production (GO:0032481),0.5019393371576965,1.2479001796374474,0.1499482936918304,0.5827414996577513,1.0,21/73,19.16%,IRF5;TLR2;DHX9;TLR8;TLR7;LRRFIP1;CD14;XRCC5;CTNNB1;SETD2;TRIM56;POLR2L;RNF135;NFKB1;IRF1;HSP90AA1;DDX41;FLOT1;POLR2E;RIOK3;CRCP
prerank,cellular response to chemical stress (GO:0062197),0.49055276491564015,1.2477419492605408,0.13719512195121952,0.5826443716468933,1.0,29/96,18.38%,CYBB;NCF4;NFE2L2;LRRC8D;NCF2;ATG7;SNCA;PKD2;FOXO3;TXNRD1;AIF1;LONP1;PPARGC1A;PRDX1;PYCR2;MSRA;PRDX3;PRDX6;PRDX2;LRRK2;CPEB2;NOX1;ERO1A;PRDX5;GPX8;PYROXD1;STX2;KEAP1;GSR
prerank,cellular response to heat (GO:0034605),0.5379695270023529,1.247608772439335,0.2022857142857143,0.5824410018533225,1.0,12/35,18.35%,IL1A;ATXN3;HSBP1;PDCD6;HSF1;TPR;THBS1;RBBP7;STUB1;IER5;HSP90AA1;SLU7
prerank,negative regulation of biosynthetic process (GO:0009890),0.5919548289627024,1.2474530519720406,0.22236340533672172,0.5823327419528198,1.0,3/16,7.84%,CIITA;ABCD1;TRAP1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.485211354707721,1.2471502506011913,0.1228600201409869,0.5826785550058344,1.0,25/114,15.61%,PTK2B;AIM2;TNFRSF11A;TNF;TNFSF8;TRAF2;FOXO3;PYCARD;TRAF3;MAP3K14;TP53;ACTN4;PSMB10;TMSB4X;ST18;TRAF5;PSMA2;LIMS1;TNFRSF1B;PSME3;TRADD;PSMB5;PSMD8;PSMD7;PSMB9
prerank,protein localization to membrane (GO:0072657),0.48056029937672,1.2469407301054865,0.05110220440881764,0.5827284972175841,1.0,42/187,14.80%,MRAP;ITGAL;FYB1;RFTN1;ITGB2;RAB8B;ITGA4;SH3PXD2B;RAB34;MYO5A;THY1;RAB32;RABEP1;FGF13;RAP2A;PKP2;TNF;TTC7A;NPC1;AP3D1;TSPAN32;AGRN;RAMP1;TNIK;PACS1;TSPAN14;ARL5B;RAB11A;RAB40C;F11R;CACNB2;DENND4C;TM9SF2;ZDHHC3;SEC16A;ATP1B3;BRAF;GAS6;PDZD11;RAP1A;GAK;CAPN3
prerank,positive regulation of ATP metabolic process (GO:1903580),0.541684011263432,1.246691308979517,0.21830985915492956,0.5828843699168184,1.0,10/32,16.72%,TREM2;P2RX7;MLXIPL;PFKFB4;TMSB4X;PPARGC1A;PID1;PFKFB3;HIF1A;GAPDHS
prerank,digestive tract development (GO:0048565),-0.35784424360290684,-1.2464613184719038,0.1487603305785124,0.8492879719875708,1.0,13/32,14.15%,COBL;PCSK5;NIPBL;GLI2;SALL1;GLI3;SMO;GLI1;PKDCC;CCDC39;CHD8;RARB;STRA6
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.5450730840669856,1.2463895433760233,0.19143876337693222,0.5832267621752739,1.0,3/29,8.12%,RUNX1;VPS18;VPS11
prerank,detection of visible light (GO:0009584),0.5890308271775245,1.2459179419781554,0.23927178153446033,0.5839966220631884,1.0,4/16,12.70%,GNAQ;REEP6;CNGB1;ABCA4
prerank,positive regulation of organelle organization (GO:0010638),0.529269519189492,1.2458742248513583,0.21593533487297922,0.5835712949059194,1.0,7/32,12.52%,TREM2;P2RX7;RAB3GAP2;ANXA1;PPARGC1A;UVRAG;SYNJ1
prerank,regulation of lipid catabolic process (GO:0050994),0.5769693745776974,1.2455339294516277,0.20887728459530025,0.5839917793353017,1.0,3/19,7.24%,ANGPTL3;TNF;ABCD1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5147251424345306,1.2454829638227636,0.17853231106243153,0.5835883594971225,1.0,13/44,18.45%,PCID2;AQP1;CST7;TNF;FNIP1;SNCA;CD44;CSNK2A1;THBS1;GAS6;SRC;DNAJB6;MAP2K5
prerank,positive regulation of dendrite extension (GO:1903861),0.58199900022744,1.24545601944519,0.23173803526448364,0.5831233962330481,1.0,9/17,21.68%,SYT17;SYT2;NEDD4L;SMURF1;RASAL1;PLAA;UNC13A;RIMS1;ITSN2
prerank,neutral amino acid transport (GO:0015804),0.5408145878630874,1.2433879376439365,0.20425029515938606,0.5886774916679912,1.0,9/28,16.72%,SLC7A8;SLC38A6;SLC36A1;SLC43A2;SLC6A15;SLC36A4;CTNS;SLC1A4;SLC43A1
prerank,positive regulation of protein catabolic process (GO:0045732),0.49273585905513095,1.243200767627484,0.1463917525773196,0.5886659214462139,1.0,33/84,20.78%,ADAM8;SNX9;ATG7;TNF;APOE;SNX33;TNFAIP3;RAB7A;PLK2;VPS11;CSNK2A1;AMER1;NEDD4L;FZR1;TNFRSF1B;SORL1;ITCH;STX5;TIPARP;HUWE1;AREL1;GSK3A;SMURF1;IDE;FAF1;HSP90AA1;VPS28;FURIN;DACT1;SEC22B;WWP1;GSK3B;PRKN
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.4871292377032446,1.2431951628067843,0.05105105105105105,0.5881353952589935,1.0,66/208,20.84%,TREM2;CARD11;CD74;PLCG2;GPRC5B;TRIM25;S100B;NUP62;TSPAN6;NLRC3;TRIM5;NEK6;NR1H4;TNF;UBE2V1;TANK;TRAF2;PYCARD;TNFAIP3;CASP1;TRAF3;MAP3K14;PRKCB;CFLAR;PIM2;TICAM1;PLK2;MALT1;ATP2C1;TRIM27;ZDHHC13;SLC44A2;LURAP1;TRAF5;LITAF;TRIM8;LGALS1;MID2;NOD2;ALPK1;TAB2;NLRX1;IKBKG;CASP8;TRADD;DDX1;TMEM106A;TAB3;CAPN3;MTDH;UBE2N;TRIM62;REL;RHOA;PDPK1;BIRC2;TNFSF10;PER1;RIOK3;EDA2R;OPTN;HSPB1;ZMYND11;PRKN;CARD19;BIRC3
prerank,positive regulation of protein processing (GO:0010954),0.5826518473817773,1.2430583055037618,0.23491655969191272,0.5879820769435605,1.0,5/19,15.23%,BAG2;ADAM8;MYH9;CCBE1;PLGRKT
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6314714002082777,1.242263426041001,0.25968436154949787,0.5896330174226792,1.0,2/10,11.69%,TGFB1;TNFRSF1B
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.3302217897132227,-1.24209904894641,0.03636363636363636,0.8507973771956303,1.0,20/51,22.38%,SPAST;NUP93;IST1;NUP188;NUP98;PPP2R2A;AHCTF1;NDC1;NUP37;VPS4A;RCC1;EMD;CHMP4B;CHMP4A;NUP133;LMNA;CHMP2A;RAN;NUP43;LBR
prerank,mitotic nuclear membrane organization (GO:0101024),-0.3302217897132227,-1.24209904894641,0.03636363636363636,0.8507973771956303,1.0,20/51,22.38%,SPAST;NUP93;IST1;NUP188;NUP98;PPP2R2A;AHCTF1;NDC1;NUP37;VPS4A;RCC1;EMD;CHMP4B;CHMP4A;NUP133;LMNA;CHMP2A;RAN;NUP43;LBR
prerank,positive regulation of cholesterol efflux (GO:0010875),0.5658224418152124,1.2416849003319093,0.2182741116751269,0.5907824174125442,1.0,6/21,15.26%,TREM2;APOE;EEPD1;GPS2;LRP1;ABCA3
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.49625898261831547,1.2416475145913977,0.17927461139896372,0.5903423557738956,1.0,22/73,18.19%,CALCR;TGFB1;HCLS1;FNIP2;MAD2L2;OSM;TNF;FNIP1;SNCA;PRKD2;CD44;NTF3;PFN2;HDAC6;BRAF;GAS6;BCAR3;IRGM;HSP90AA1;STK4;AKAP9;CREBL2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.49766555513117183,1.241330445171349,0.1628630705394191,0.5907174407620251,1.0,21/70,16.54%,CYBB;NCF4;VAMP3;ITGB5;NCF2;FCGR1A;FCER1G;PSMB10;TAP1;PSMA2;PSME3;IKBKG;SNAP23;B2M;PSMB5;PSMD8;PSMD7;PSMB9;CD36;PDIA3;TAP2
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.48237614259216743,-1.2412968915476439,0.21926910299003322,0.8466829594870272,1.0,8/11,31.11%,UQCRC2;UQCRH;UQCRC1;UQCRQ;CYC1;UQCRFS1;CYCS;UQCC3
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.4955041530298696,1.24106536744659,0.15416666666666667,0.5909711239388257,1.0,15/76,12.24%,CD86;LAPTM5;TLR2;TLR7;TSPAN6;NLRC3;TNF;SPI1;CD14;ADGRG3;ACTN4;TMSB4X;LIMS1;ADIPOR1;NOD2
prerank,pentose-phosphate shunt (GO:0006098),0.6276615073200801,1.2405564468725419,0.22571819425444598,0.5919118132438488,1.0,5/11,19.36%,RPE;SHPK;PGLS;PGD;RBKS
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.513014212727302,1.2403858797761238,0.20129171151776104,0.5919106234417872,1.0,9/46,14.53%,PTK2B;CCR2;DGKZ;TNF;CLN3;MEF2C;CCL2;DGKI;LRRK2
prerank,protein localization to microtubule organizing center (GO:1905508),0.6009504493831614,1.240172278860241,0.2542372881355932,0.5919511388290376,1.0,2/15,6.40%,HOOK3;CEP192
prerank,epithelial tube morphogenesis (GO:0060562),0.5322910617975287,1.2401696141469576,0.21016166281755197,0.591408277547728,1.0,9/32,9.61%,SHH;CSF1R;CCM2;PRKD2;PKD2;CTNNB1;MTSS1;MEF2C;PODXL
prerank,response to muramyl dipeptide (GO:0032495),0.6258574241141454,1.2401600844192926,0.2637215528781794,0.5909004772622058,1.0,3/12,12.24%,IRF5;ERBIN;NOD2
prerank,heart morphogenesis (GO:0003007),-0.31194406369135774,-1.2401252257718212,0.05970149253731343,0.84374691625449,1.0,14/50,13.76%,BMPR1A;RYR2;NIPBL;EPHB4;ACVR1;TGFBR3;ACVRL1;TBX3;FKBP1A;HES1;OLFM1;TBX1;NOS3;SOX17
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.632278124346581,1.2400580646037191,0.2470414201183432,0.590655426739744,1.0,2/11,7.45%,IL12RB2;STAT4
prerank,endomembrane system organization (GO:0010256),0.483257902043046,1.2399955772933093,0.07307307307307308,0.590295624016132,1.0,63/178,20.78%,HOOK3;PLEKHM2;SPTBN5;ATP8B4;SRGN;LMAN1L;TMED3;REEP6;PI4K2A;SNX33;VPS18;ARFGEF1;AP3D1;SYNE1;USP6NL;VMP1;VPS11;DNAJC13;ARHGAP21;ARFGEF2;VAPB;WASHC4;SYNGR1;SYNGR2;DYSF;TMCC1;BNIP1;ATL1;EXOC8;SEC16A;CSNK1A1;PI4K2B;SEC16B;TOR1AIP2;TOR1A;HUWE1;TRAPPC11;HOOK2;LRRK2;GAK;USP8;ALS2;LAMTOR1;LMAN2;CDC42;SNX10;VPS33B;LYSMD3;GOLGB1;GOLPH3;UBXN2A;TMEM170A;ATL2;LAPTM4B;RAB29;DNM1L;OPTN;ATL3;TRAPPC12;SEC31A;NSFL1C;COG7;SPTSSB
prerank,negative regulation of blood coagulation (GO:0030195),0.5181014484583789,1.2399727425791383,0.1995540691192865,0.5898176126688967,1.0,3/38,4.14%,GP1BA;F10;APOE
prerank,synaptic vesicle membrane organization (GO:0048499),0.5861954585028395,1.239775632190737,0.2544987146529563,0.5898419228648606,1.0,9/17,17.72%,STX11;AP3D1;SNAP29;SYNGR1;SYNGR2;STX3;SNAP23;TOR1A;STX2
prerank,glycoprotein metabolic process (GO:0009100),0.5049757559727399,1.2390911455060962,0.19871106337271752,0.5913229852049664,1.0,18/53,19.21%,HPSE;MAN1C1;GCNT1;ST8SIA4;OGA;MAN2B1;ST8SIA1;MAN2A2;STT3B;B4GALT7;LARGE1;HIF1A;MGAT4B;ERP44;FBXO44;GOLPH3;MAN1A2;GANC
prerank,regulation of glucose metabolic process (GO:0010906),-0.3660559921381414,-1.2384416801888107,0.1590909090909091,0.8430640833075134,1.0,13/34,21.57%,OGT;IRS1;RORA;PDK3;GPLD1;SELENOS;ZNF692;MLYCD;DGKQ;AKT1;BCKDK;IRS2;PDK2
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.29565775098464936,-1.2382330222642126,0.057692307692307696,0.8369974460145627,1.0,25/61,22.04%,CAV1;PANK2;PSME4;PSMD11;PSMA5;PSMA4;PPARA;PSMD14;AZIN1;PSMC6;PSMC3;PSMB3;PSMC1;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;ODC1;PSME2;FGFR4;PSMB4;PSMC4;PDK2;PSMB6
prerank,skeletal muscle contraction (GO:0003009),0.567296721906583,1.2382315010276945,0.23261694058154236,0.593292436204147,1.0,4/19,15.11%,STAC;TNNT3;STAC3;RCSD1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.49721220861042176,1.2381871757134646,0.16199376947040497,0.5928688865091187,1.0,20/67,16.54%,CYBB;NCF4;VAMP3;ITGB5;NCF2;FCGR1A;PSMB10;TAP1;PSMA2;PSME3;IKBKG;SNAP23;B2M;PSMB5;PSMD8;PSMD7;PSMB9;CD36;PDIA3;TAP2
prerank,protein dephosphorylation (GO:0006470),0.4857514372509102,1.237242904141886,0.10953346855983773,0.595099070812887,1.0,32/135,18.68%,PTPRC;PTPN7;PPM1H;UBASH3B;DAPP1;PPP2CB;PTPRJ;DUSP3;PTPN1;DUSP29;PTPN18;PTPRE;MTMR3;DUSP10;RPAP2;PTPRU;PTPRO;TIMM50;PPP2CA;ILKAP;SSH2;CTTNBP2NL;PTPRT;PPP1CC;PTPRA;PTEN;PTPN12;PPP3CB;PPM1M;PPP2R5C;PTPN3;PPP4R2
prerank,bile acid and bile salt transport (GO:0015721),0.5531321182194634,1.2367665628184081,0.2359952324195471,0.5959881762141898,1.0,3/24,3.77%,SLCO2B1;ABCC3;NR1H4
prerank,positive regulation of calcium ion transport (GO:0051928),0.5227736326928164,1.2364103840855982,0.19506726457399104,0.5964491454062159,1.0,8/36,16.60%,LGALS3;P2RX7;P2RX4;ATP2B1;CACNB2;CCL2;WFS1;CACNA1D
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.5846547685138991,1.2362668766237477,0.24570673712021135,0.5963408021393185,1.0,5/15,13.79%,PTTG1;NEK6;CDC23;TPR;CDC6
prerank,cellular response to organonitrogen compound (GO:0071417),0.4872470280520681,1.2361702291218166,0.1263902932254803,0.5960885643564697,1.0,36/99,21.78%,P2RY6;AQP1;HCN4;P2RX7;MTOR;P2RY2;NR1H4;PKD2;RAP1B;P2RX4;TAF1;CTNNB1;ACTB;P2RY12;MEF2C;LARP1;IMPACT;CPEB3;DIAPH1;RAPGEF1;SOX9;GLRA2;LAMTOR3;CAPN2;RAP1A;CPEB4;LAMTOR1;AKAP9;GOLPH3;RPTOR;INPP5K;P2RY1;HCN1;ZFP36L1;RRAGA;RRAGB
prerank,negative regulation of actin filament polymerization (GO:0030837),0.5604383731760456,1.235972388225263,0.2266500622665006,0.5961004041646002,1.0,9/22,13.44%,CYRIB;PRKCD;ARFGEF1;TMSB4X;PFN2;PFN1;TWF2;TMSB10;SSH2
prerank,response to tumor necrosis factor (GO:0034612),0.4857453153405178,1.2358512224437743,0.15902140672782875,0.5958946099877062,1.0,26/91,21.76%,NFE2L2;TNFRSF11A;DHX9;CCL8;OCSTAMP;GCH1;TANK;PYCARD;ERBIN;CCL14;TNFRSF21;CCL13;GBP3;CCL2;CASP8;TRADD;PID1;CXCL16;ASAH1;CCL25;ARHGEF2;SMPD1;INPP5K;BAG4;ZFP36L1;CX3CL1
prerank,neural tube development (GO:0021915),0.5964288153625031,1.2351546992522997,0.23513870541611626,0.5974490314393844,1.0,2/15,4.10%,TGFB1;PKD2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.5226993045491338,1.2349564827515496,0.19839449541284404,0.5974689224323593,1.0,6/39,5.28%,PIK3CG;PIK3CD;PIK3CB;PIP4K2A;PI4K2A;TTC7A
prerank,regulation of brown fat cell differentiation (GO:0090335),0.582817482900364,1.234764612595059,0.24010554089709762,0.5974813259531238,1.0,6/16,16.20%,METRNL;RREB1;PIM1;FLCN;VSTM2A;ZBTB7B
prerank,protein localization to centrosome (GO:0071539),0.5862713755237907,1.2347060320466732,0.26163522012578616,0.597121481923249,1.0,6/17,18.33%,HOOK3;CEP192;PCM1;NUDCD3;SNX10;GOLGB1
prerank,regulation of translational initiation (GO:0006446),0.4995995772552922,1.2344791240369606,0.18210526315789474,0.5972587605988902,1.0,15/63,10.94%,NCK2;DNAJC3;ATF3;EIF5B;YTHDF3;CEBPB;EIF4EBP2;EIF1;LARP1;EIF4H;IMPACT;TPR;EIF2B2;CTIF;EIF4G3
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.5513153948768879,1.2342866452989163,0.22958579881656804,0.5972787520518185,1.0,11/26,20.84%,TREM2;TLR2;GPS2;IRF1;LGR4;CD36;APPL2;BIRC2;FLOT1;NFKBIL1;BIRC3
prerank,regulation of intracellular signal transduction (GO:1902531),0.4752288601327138,1.234206275736423,0.015,0.5969906007968636,1.0,101/420,18.94%,ARHGAP45;ARHGAP30;FGD2;VAV1;TREM2;LYN;ARHGAP25;PREX1;ARHGAP9;ABR;ARHGAP15;ARHGAP39;PRKAR2B;TAOK3;ARHGAP22;PLCG2;MTOR;ARHGAP24;RFFL;VAV2;MAPK14;ARHGEF18;MAP2K6;ARAP1;TNF;PIP5K1C;PRKD2;TRAF2;PIP4K2A;PYCARD;AKAP5;RMI1;EXO1;VAV3;TRAF3;FAM13B;WWC2;TAGAP;TAF1;BRIP1;MYO9B;GNA13;TP53;GNA12;TMSB4X;TNIK;CHEK2;CSNK2A2;CSNK2A1;FLCN;ITSN1;ARHGAP21;ARHGAP10;ARHGAP1;ATP6AP2;ARHGDIB;TRAF5;ARHGEF17;CMKLR1;USP7;NF2;RBBP7;DDIT4;PIP4P1;IKBKG;RRS1;ARHGEF3;DNA2;ARHGDIA;STK3;ARHGAP18;BRD7;ARHGEF11;LBH;LRRK2;NOC2L;TMEM127;CAPN3;PHLPP1;A2M;TAF3;TTI1;RPL11;ARHGEF26;PTEN;STK4;ARHGAP23;SGMS1;ARHGEF2;MEAF6;RHOA;PDPK1;CDC42;PTPMT1;BIRC2;PPP2R5C;CHN2;MINK1;CHD4;TAF11;TAOK1
prerank,cellular response to increased oxygen levels (GO:0036295),0.6287425225257919,1.2340724411627804,0.23300970873786409,0.5968429773800017,1.0,4/11,11.02%,ATG7;ATP6V0A2;ATP6V0D1;ATP6AP1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5732419402641131,1.2330489664697744,0.23393316195372751,0.5993218285274823,1.0,5/18,11.55%,ITGA4;MDK;HMGB1;MEF2C;CCL2
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6428430688747321,1.2329082207782909,0.25677603423680456,0.5986329558346365,1.0,6/10,17.85%,PCSK9;MYLIP;AP2S1;CLTC;AP2M1;VLDLR
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6428430688747321,1.2329082207782909,0.25677603423680456,0.5986329558346365,1.0,6/10,17.85%,PCSK9;MYLIP;AP2S1;CLTC;AP2M1;VLDLR
prerank,positive regulation of cellular process (GO:0048522),0.4747521899742622,1.232767484981088,0.005,0.5985028599570913,1.0,109/565,16.67%,CD86;DOCK2;PTK2B;SLAMF1;TREM2;LYN;CALCR;SHH;HCK;ITGAX;SLC11A1;TGFB1;CXCL5;FCGR2B;HCLS1;FLT3;LGMN;SIRPA;RPL23;CSF1R;TGFBR1;ADAM8;PRKCD;PTPRJ;TLR2;CAMK1D;TCIRG1;P2RX7;MLXIPL;S100B;TNFRSF11A;MDK;OSM;IL12RB2;CST7;TNF;FCER1G;PRKD2;IL6R;CNOT8;BRAT1;PYCARD;TIMP1;P2RX4;CCND2;AIF1;GAB2;CCAR1;TGFBR2;ACTN4;TAL1;RPS15A;CCKBR;P4HB;EPO;FLT3LG;AQP11;KIF14;DOT1L;CSNK2A1;FLCN;TFAP2B;KIF20B;GID8;NTF3;HSF1;CCL14;ACER3;LRP5;HDAC4;RNF10;NAP1L1;SOX9;THBS1;GRN;TNFRSF1B;PHIP;PRDX3;CIAO1;DYNC1H1;SDCBP;ADGRG1;TBC1D8;NRG1;STX3;BAMBI;MERTK;PRLR;GAS6;HCFC1;CDC6;ZFHX3;INO80;IL2RG;SOX4;MEIS1;LRP1;FASN;IER5;ACACA;IL13RA1;CD36;CXCL16;COPS9;EPHA4;FAF1;PTEN;CD47;NOX1
prerank,regulation of protein export from nucleus (GO:0046825),-0.3939502269949779,-1.2326713456861842,0.1774193548387097,0.8497136860586616,1.0,7/23,7.63%,RAPGEF3;PTPN14;TCF7L2;SP100;ANP32B;BAG3;IFI27
prerank,positive regulation of protein secretion (GO:0050714),0.494103011631338,1.2325411399673647,0.1638830897703549,0.5986351337060607,1.0,7/69,4.28%,TREM2;TGFB1;IL1A;ADAM8;TLR2;ABCG1;TTN
prerank,embryonic hemopoiesis (GO:0035162),0.6177842710459371,1.2319802900871577,0.2472972972972973,0.5997382236646959,1.0,4/12,10.93%,TGFBR2;TAL1;FLT3LG;SH2B3
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.48887668231354153,1.231887759939567,0.16205128205128205,0.5994812594266744,1.0,31/93,19.10%,CALCR;TGFB1;HCLS1;FNIP2;MAD2L2;NSD1;MLXIPL;OSM;NCK2;TNF;FNIP1;SNCA;PRKD2;CD44;NTF3;PFN2;HDAC6;DDIT4;BRAF;GAS6;BCAR3;IRGM;PTEN;HSP90AA1;STK4;AKAP9;SPTBN4;CREBL2;PAQR3;CNKSR3;RPTOR
prerank,ureteric bud morphogenesis (GO:0060675),0.5824079900662884,1.2316104106669021,0.24738219895287958,0.5997733875461008,1.0,2/16,4.10%,SHH;PKD2
prerank,transcription by RNA polymerase I (GO:0006360),0.51966077602833,1.2313724799999533,0.21828571428571428,0.5998681763411579,1.0,8/34,10.96%,GTF2H1;TAF1A;POLR1E;TAF1;TTF1;CDK7;POLR1B;POLR2L
prerank,regulation of blood coagulation (GO:0030193),0.5423511264157033,1.2312996708244892,0.220462850182704,0.5995419534992692,1.0,3/27,4.14%,HPSE;GP1BA;APOE
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.4106998780811663,-1.2312891775684862,0.1888412017167382,0.8476191358544101,1.0,8/17,20.79%,SPRED2;PARD3;CALM3;SPRY2;DGKQ;DMTN;PPEF2;SMAD7
prerank,regulation of intracellular protein transport (GO:0033157),0.5283750326375121,1.2309999921956836,0.2160919540229885,0.5998745531569633,1.0,7/32,12.39%,TGFB1;LCP1;PTPN1;RIPOR1;KIF20B;TPR;PCM1
prerank,negative regulation of heart contraction (GO:0045822),0.6280073772836959,1.230805864115614,0.24861111111111112,0.5998433372026588,1.0,1/11,0.66%,PIK3CG
prerank,response to nutrient levels (GO:0031667),0.5843465769150407,1.229771048887964,0.2336448598130841,0.6022937882115129,1.0,2/17,4.87%,MTOR;CD68
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.484950025684505,1.2297515747993915,0.08726178535606821,0.6018026740671609,1.0,46/158,18.51%,CARD11;CD74;GPRC5B;TRIM25;S100B;NUP62;TSPAN6;TRIM5;NEK6;TNF;UBE2V1;TRAF2;CASP1;MAP3K14;PRKCB;CFLAR;PIM2;TICAM1;PLK2;MALT1;ATP2C1;TRIM27;ZDHHC13;SLC44A2;LURAP1;TRAF5;LITAF;TRIM8;LGALS1;MID2;NOD2;ALPK1;TAB2;IKBKG;CASP8;TRADD;DDX1;TMEM106A;TAB3;MTDH;UBE2N;TRIM62;REL;RHOA;BIRC2;TNFSF10
prerank,dephosphorylation (GO:0016311),0.48283688036377526,1.2297354384047259,0.11178247734138973,0.6013051195995878,1.0,35/147,18.68%,PTPRC;PTPN7;PPM1H;DAPP1;PPP2CB;PTPRJ;DUSP3;PTPN1;DUSP29;PTPN18;PTPRE;MTMR3;PLPPR1;DUSP10;FRA10AC1;PTPRU;PTPRO;TIMM50;PPP2CA;ILKAP;SSH2;CTTNBP2NL;THNSL2;PXYLP1;PTPRT;PPP1CC;PTPRA;PTEN;PTPN12;PPP3CB;PPM1M;DUSP23;PPP2R5C;PTPN3;PPP4R2
prerank,presynaptic endocytosis (GO:0140238),0.5523480788618076,1.2297298609294376,0.22668240850059032,0.6007828631534688,1.0,7/24,12.52%,SNCA;PIP5K1C;CEL;SYT2;STON2;STON1;SYNJ1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.48556531120701385,1.2293097107921247,0.17956656346749225,0.6014549994056277,1.0,21/80,15.15%,TBC1D10C;VAMP3;SNX5;TMEM87B;HEATR5A;RBSN;RAB7A;RAB7B;TMEM87A;TBC1D10A;TRIM27;VPS54;TBC1D17;CLTC;YKT6;STX5;VPS29;VTI1A;SNX2;TBC1D14;HEATR5B
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.33047534657734196,-1.2289080714775367,0.1557377049180328,0.8487912021618856,1.0,7/35,9.28%,RBFOX2;UBR5;NR3C2;AR;KDM3A;TADA3;CALCOCO1
prerank,endochondral bone morphogenesis (GO:0060350),-0.4964090731413446,-1.228743880609415,0.21518987341772153,0.8427991829721583,1.0,8/11,25.38%,FOXC1;BMP4;INPPL1;TMEM119;COL13A1;TRPV4;BMPR2;FGFR3
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.5142842479070381,1.2286225618595292,0.22321428571428573,0.6028685629191699,1.0,8/39,10.93%,TGFB1;MAD2L2;RGCC;AKNA;WNK1;SPINT2;PODXL;NF2
prerank,embryonic heart tube development (GO:0035050),-0.44652888140296015,-1.228541347027316,0.211864406779661,0.8371078139867401,1.0,6/14,25.28%,RYR2;ACVR1;HES1;SOX17;SOX18;IFT122
prerank,positive regulation of ERAD pathway (GO:1904294),0.6043887059561832,1.228509935088605,0.2389261744966443,0.6026261410957061,1.0,3/13,6.40%,NFE2L2;HERPUD1;ATXN3
prerank,cellular iron ion homeostasis (GO:0006879),0.5101115077717767,1.2282401841959925,0.20300751879699247,0.6028722819874145,1.0,9/55,11.45%,SLC11A1;FRRS1;ATP6V0A2;IREB2;ATP6V0D1;HFE;FTL;ATP6AP1;ACO1
prerank,chondrocyte differentiation (GO:0002062),0.5260797623233592,1.228097112778122,0.20554272517321015,0.602759491263154,1.0,8/32,13.61%,RUNX1;TGFB1;MEF2C;SULF2;CREB3L2;SOX9;SNX19;SOX6
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.5390795347356755,1.2279789738808056,0.2350835322195704,0.6025578115018386,1.0,5/26,9.15%,LGMN;SMOC2;DUSP3;TAL1;HSF1
prerank,negative regulation of viral entry into host cell (GO:0046597),0.6089612539212778,1.2273411214433143,0.25783475783475784,0.603850591543335,1.0,3/12,11.21%,CIITA;TRIM5;MID2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4946125042745019,1.2270800702089433,0.14549180327868852,0.6040339740396176,1.0,20/85,13.97%,VAV1;LYN;RASAL3;GRB2;NUP62;ARHGEF18;MYO9B;EPO;ERBIN;DENND1A;KIF14;FLCN;DENND4B;ARHGDIB;DENND4C;RAPGEF1;DENND4A;SYNGAP1;ARHGDIA;ARF6
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.6271112095923113,1.2268021681274903,0.25877192982456143,0.6043113242813913,1.0,2/10,4.05%,MAD2L2;RGCC
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6252584687304342,1.2267093207668618,0.24964539007092199,0.6040609746903894,1.0,3/11,10.81%,TGFB1;TP53;MAP2K2
prerank,carboxylic acid metabolic process (GO:0019752),0.5259566108638827,1.2262653335464042,0.22887323943661972,0.6047450859709431,1.0,5/33,11.55%,TBXAS1;SLC2A3;PON3;ST3GAL1;CYB5A
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.636776633601431,1.2262455500907479,0.2445414847161572,0.6042759653559151,1.0,3/10,6.13%,ITGB3;PRKD2;PRKCB
prerank,actin filament polymerization (GO:0030041),0.5392056320459778,1.2261923812571485,0.22105263157894736,0.603896211800377,1.0,6/29,10.91%,PREX1;PSTPIP1;MICALL2;AIF1;WASHC3;DIAPH1
prerank,actin cytoskeleton reorganization (GO:0031532),0.5033332524593516,1.2261900105477024,0.18124341412012646,0.6033690914306058,1.0,16/63,11.23%,PLEK;CASS4;GRB2;PTPN1;RAP2A;MICALL2;MYH9;ANXA1;NEDD9;TNIK;THSD7B;ATP2C1;BCAR1;PARVB;DTNBP1;NRP1
prerank,placenta development (GO:0001890),-0.47255821636841056,-1.225923867321518,0.19767441860465115,0.8396788239957537,1.0,8/12,43.90%,SOD1;PPARG;PTK2;ADAM19;ANG;E2F7;PLAC1;E2F8
prerank,positive regulation of cellular respiration (GO:1901857),0.631684049458169,1.2258715544371597,0.2581120943952802,0.603709593841693,1.0,2/11,4.57%,IL10RB;IFNAR1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.5806035641247516,1.2256622789299056,0.24566088117489987,0.6037638566863088,1.0,3/15,11.89%,SLFN14;ZC3H12D;RNASEH1
prerank,actin filament depolymerization (GO:0030042),-0.47652868751593014,-1.2246656337205029,0.20923076923076922,0.8374726294718825,1.0,5/11,8.52%,GSN;CFL2;WDR1;MICAL3;MICAL2
prerank,positive regulation of autophagy (GO:0010508),0.48959112869772115,1.2246490986812606,0.1592554291623578,0.6061560521249192,1.0,24/81,16.29%,PIK3CB;TRIM5;FOXO3;HMGB1;TFEB;SCOC;PIM2;SVIP;TICAM1;PLK2;FLCN;TRIM27;LARP1;PAFAH1B2;TRIM8;MID2;IKBKG;CAMKK2;GNAI3;LRRK2;RNF152;MTDH;GSK3A;IRGM
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.5203141123700614,1.2246249086654262,0.19956616052060738,0.6056953609540996,1.0,8/46,9.00%,DGKZ;DDHD1;LPCAT1;PLD2;DGKE;DGKG;DGKD;ABHD4
prerank,regulation of RNA metabolic process (GO:0051252),0.5003075241167829,1.2244444412088575,0.2012779552715655,0.6056902206771771,1.0,20/59,15.96%,RBM38;ZNF326;MITF;RC3H2;GRSF1;METTL4;RC3H1;PCBP3;HNRNPL;SON;PTBP2;TNFRSF1B;TRA2B;PRX;BRDT;FAM50A;PCBP1;IGF2BP3;RASA1;AHNAK2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.6034264106924503,1.2242121783968145,0.2536912751677852,0.6058943027235214,1.0,3/13,8.05%,CD74;CD44;SNAI1
prerank,sensory perception (GO:0007600),0.505051969668286,1.2241527791097997,0.1926006528835691,0.6055220732891957,1.0,10/45,13.51%,CCR2;P2RX7;PRDM12;WHRN;P2RX4;MYO7A;CCL2;SCN9A;CDH23;RETREG1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6173742716413371,1.2235355940343013,0.24517906336088155,0.6067352224914315,1.0,3/12,9.69%,APOBEC1;RESF1;ATF7IP
prerank,aromatic amino acid family metabolic process (GO:0009072),0.628848481843756,1.2231222949093632,0.25178826895565093,0.6073229430444321,1.0,3/10,9.08%,ATP7A;KYNU;QDPR
prerank,organic hydroxy compound transport (GO:0015850),0.5236782850303416,1.2223330895328715,0.2277339346110485,0.6090978928408337,1.0,9/36,18.30%,SLCO2B1;ABCC3;NPC2;NR1H4;SLC16A1;OSBP;SLCO1B1;STARD5;RXRA
prerank,glycerophospholipid catabolic process (GO:0046475),0.5413496538323151,1.2222394423576721,0.24019024970273484,0.608827868735968,1.0,12/27,23.51%,ABHD12;PLA2G7;LIPC;PRDX6;GDE1;ABHD16A;GDPD3;PLA2G5;GPCPD1;PLA2G6;INPP5F;PLA2G4E
prerank,negative regulation of hippo signaling (GO:0035331),0.6048491626157895,1.2222029666153742,0.2622478386167147,0.6083859263327651,1.0,3/12,6.25%,MAPK14;WWC2;MAP2K3
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.509783004272907,1.2217511665557572,0.21349557522123894,0.6091700627647519,1.0,7/41,11.19%,PTPRC;PLCG2;SLC8A1;PKD2;ITPR2;IBTK;CHERP
prerank,regulation of mRNA metabolic process (GO:1903311),0.6137098405194324,1.2216650402796136,0.2539454806312769,0.608896223162201,1.0,4/11,13.52%,DHX9;CDK11B;SRPK3;SAFB2
prerank,regulation of inclusion body assembly (GO:0090083),-0.47122567118530034,-1.2204828780252672,0.21656050955414013,0.84512788902942,1.0,9/11,39.13%,SNCAIP;SACS;DNAJB2;BAG5;DNAJA4;DNAJB1;HSPA1A;HSPA1B;HSPA2
prerank,regulation of myoblast differentiation (GO:0045661),0.5351122893904371,1.2201912935437835,0.2119815668202765,0.6125685585884897,1.0,7/32,11.20%,TGFB1;MAPK14;RIPOR2;MEF2C;AKIRIN1;SOX9;SRA1
prerank,actin filament network formation (GO:0051639),0.6138773092725286,1.2201613143088559,0.276657060518732,0.6121249006024697,1.0,4/11,10.21%,LCP1;PLS1;FHOD1;ACTN1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.5489487762690233,1.2199827438200364,0.23894862604540024,0.6121284571488497,1.0,9/26,16.71%,TNF;PKD2;P2RX4;SMAD3;NOS1AP;DDAH1;TMEM106A;CD36;HSP90AA1
prerank,fatty acid biosynthetic process (GO:0006633),0.48991039173028655,1.2199654611003108,0.19851380042462846,0.6116477434434767,1.0,12/63,16.13%,CYP1A1;LPL;ALOX12;HPGD;ABCD1;LIPC;HACD4;ABHD3;NDUFAB1;DEGS1;ACACA;FADS1
prerank,regulation of keratinocyte migration (GO:0051547),0.60619382215905,1.219231955646093,0.2543978349120433,0.6132328568258129,1.0,6/12,20.52%,MTOR;ARF6;PTEN;MAPRE2;IQSEC1;MAP4K4
prerank,negative regulation of potassium ion transport (GO:0043267),0.6076882911751331,1.2184267477365596,0.278393351800554,0.6150023838379404,1.0,1/13,0.31%,PTK2B
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5519860485065184,1.2182082152406752,0.2506234413965087,0.6150450904896639,1.0,3/21,4.32%,P2RY6;ERN1;LDLRAP1
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4158132140406011,-1.2181662779485694,0.2017167381974249,0.8470454654411258,1.0,8/17,14.15%,ROBO2;BMP4;ROBO1;SLIT2;NOS3;JAG1;SMAD6;STRA6
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.5615915592147676,1.2181096219548226,0.23566084788029926,0.6137345747102687,1.0,4/20,10.11%,IK;MAD2L2;TRIP13;TPR
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.5615915592147676,1.2181096219548226,0.23566084788029926,0.6137345747102687,1.0,4/20,10.11%,IK;MAD2L2;TRIP13;TPR
prerank,spindle assembly checkpoint signaling (GO:0071173),0.5615915592147676,1.2181096219548226,0.23566084788029926,0.6137345747102687,1.0,4/20,10.11%,IK;MAD2L2;TRIP13;TPR
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.6337887103626363,1.2178676570069364,0.26440177252584934,0.6133894150532653,1.0,2/10,6.71%,REEP6;CNGB1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.6337887103626363,1.2178676570069364,0.26440177252584934,0.6133894150532653,1.0,2/10,6.71%,REEP6;CNGB1
prerank,primary alcohol metabolic process (GO:0034308),0.5456846722137807,1.2178213960764048,0.2497027348394768,0.6130065620628644,1.0,5/25,15.84%,CYP1A1;DHRS3;RETSAT;GDE1;GDPD3
prerank,positive regulation of protein import into nucleus (GO:0042307),0.5278366878267942,1.2172314880157737,0.2467986030267753,0.6141633197922448,1.0,5/28,10.11%,TGFB1;HCLS1;PRKCD;SMAD3;TPR
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.5916740764552508,1.2161582595584528,0.2550335570469799,0.6167641807763923,1.0,5/13,16.20%,METRNL;RREB1;PIM1;VSTM2A;ZBTB7B
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.5610175259960856,1.2161527146013236,0.2546816479400749,0.6162510231951295,1.0,6/21,13.49%,ADCY7;GUCY2F;ADCY6;NPR2;ADCY3;ADCY8
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6141214770712271,1.216090091558988,0.25245441795231416,0.6159162323966878,1.0,2/12,3.81%,TGFB1;TNF
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.4161181656240532,-1.216019341560073,0.22321428571428573,0.8481939195773526,1.0,9/18,26.44%,ACSL1;HACD1;ELOVL5;ACSL6;ELOVL1;ACSBG1;HACD2;ACSL4;ACSL3
prerank,positive regulation of monooxygenase activity (GO:0032770),0.5429627884235027,1.215976355852259,0.2546728971962617,0.6157057982233534,1.0,11/26,22.05%,PIK3CB;TNF;GCH1;ATP7A;APOE;NOS1AP;POR;HIF1A;GDNF;TERF2;CDH3
prerank,zinc ion transmembrane transport (GO:0071577),-0.39492267587364926,-1.2157360475196695,0.21505376344086022,0.842860823250136,1.0,9/22,26.16%,SLC39A13;SLC39A8;SLC30A1;SLC39A1;SLC39A14;SLC39A3;SLC39A10;TRPM2;SLC39A12
prerank,apical junction assembly (GO:0043297),-0.3015924559661919,-1.2149691286173905,0.07352941176470588,0.839353618169156,1.0,11/53,10.37%,CDH5;AFDN;PRKCI;PARD3;CLDN5;CLDN11;MPP7;WDR1;PARD6G;CLDN14;DLG1
prerank,defense response to tumor cell (GO:0002357),0.6321465593749427,1.2143370897250712,0.2579250720461095,0.6198533407438706,1.0,3/10,12.89%,LAPTM5;SPI1;PRDX2
prerank,tRNA modification (GO:0006400),-0.29778105298287516,-1.2141836009641556,0.14634146341463414,0.8359159536150209,1.0,23/62,22.88%,NSUN6;DTWD2;METTL6;SSB;THADA;TYW5;THUMPD3;TPRKB;NSUN2;TRMT6;QTRT2;PUS10;TARBP1;DUS2;TYW1;URM1;MTO1;ANKRD16;TRMT5;WDR4;LCMT2;WDR6;DTWD1
prerank,positive regulation of cell division (GO:0051781),0.5093486907383291,1.2141728451951959,0.23841059602649006,0.6197818706090272,1.0,9/38,17.93%,SHH;TAL1;KIF14;KIF20B;KIF23;CDC6;RHOA;GIPC1;CDC42
prerank,fatty acid metabolic process (GO:0006631),0.4750012313018751,1.2133246512126241,0.14732593340060546,0.6216229122645708,1.0,24/115,17.98%,CYP1A1;LPL;LPIN2;SGPL1;ALOX12;ANGPTL3;CEL;HPGD;NUDT19;PON3;ACSF2;LIPC;PPARGC1A;ADIPOR1;NDUFAB1;FASN;ACACA;CD36;ADIPOR2;CPT2;PNPLA3;PPARD;ACOT2;ABCD2
prerank,negative regulation of response to wounding (GO:1903035),0.562746500698304,1.2133088626658286,0.2589395807644883,0.6211379796844922,1.0,7/19,23.28%,MDK;RTN4RL1;CASK;EPHA4;CRK;FGF2;INPP5F
prerank,negative regulation of lymphocyte migration (GO:2000402),0.6129480403650812,1.2132515400334258,0.28823529411764703,0.6207631429272078,1.0,2/10,5.96%,CD200R1;RIPOR2
prerank,positive regulation of protein metabolic process (GO:0051247),0.4760500960892446,1.212386054474673,0.1619718309859155,0.6227156696636106,1.0,36/110,21.23%,CD86;TGFB1;ATG7;TNF;APOE;SLC25A37;IL18;TNFAIP3;RAB7A;CD80;PLK2;CSNK2A1;NEDD4L;RAB1B;INHBA;FZR1;RANBP9;SORL1;ITCH;STX5;TIPARP;HUWE1;WFS1;AREL1;GSK3A;SMURF1;IDE;VPS28;MAP2K5;DACT1;ROCK2;SEC22B;WWP1;GSK3B;PRKN;ABCA2
prerank,mesenchyme morphogenesis (GO:0072132),-0.4189048707280973,-1.2121729132897967,0.18181818181818182,0.8365996875541348,1.0,4/17,12.61%,BMPR1A;ACVR1;ACVRL1;NOS3
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.547385729093517,1.2118577350087272,0.2655860349127182,0.6237023340547172,1.0,10/21,22.61%,PCID2;AIM2;PYCARD;FYN;SOX2;PSMB9;BIRC2;BIRC3;MT3;DELE1
prerank,regulation of ion transmembrane transport (GO:0034765),0.5258920431233767,1.211842145227932,0.24510932105868816,0.623219898207833,1.0,4/33,10.05%,KCNJ11;P2RX7;WNK1;NEDD4L
prerank,regulation of transport (GO:0051049),0.5224289694536912,1.2116307015396546,0.21630804077010193,0.6232862462446417,1.0,11/36,14.58%,SNCA;REEP6;ACTB;GAPVD1;ACTG1;RAB11A;EPB41;NRP1;ICA1L;LRRK2;YRDC
prerank,regulation of cell migration (GO:0030334),0.46616633424960974,1.21149530886889,0.026,0.6231461909319347,1.0,62/382,9.76%,PTK2B;FERMT3;GPNMB;FGR;SHH;ITGAX;TGFB1;CASS4;F10;TMIGD3;CD74;VSIR;PIK3CD;CYRIB;CSF1R;TGFBR1;MGAT5;PTPRJ;THY1;DUSP3;SLURP1;ARSB;RFFL;PLXNC1;MDK;ANGPTL3;RAP2A;SEMA4D;ITGA6;MITF;CLN3;PLXNB2;FOXO3;MCTP1;LGR6;ADGRG3;MACF1;ANXA1;DOCK10;AIF1;MAPRE1;CCAR1;ACTN4;NKX2-1;GNA12;RIPOR1;NEDD9;YTHDF3;TMSB4X;RAP2B;SNAI1;KIF14;FLCN;FAM89B;PTP4A1;DUSP10;PODN;NTF3;PODXL;ACTG1;BCAR1;VCL
prerank,phosphatidic acid metabolic process (GO:0046473),0.5106757519909745,1.211423677368007,0.2145922746781116,0.6228298276371159,1.0,8/48,9.00%,DGKZ;DDHD1;LPCAT1;PLD2;DGKE;DGKG;DGKD;ABHD4
prerank,alcohol catabolic process (GO:0046164),0.622039111357503,1.2111962329090977,0.2892086330935252,0.6229328335803931,1.0,2/10,4.47%,APOE;CEL
prerank,mRNA catabolic process (GO:0006402),0.4997795871014428,1.2111115047748153,0.21232123212321233,0.6226519162854108,1.0,9/44,16.57%,SLFN14;ERN1;ZC3H12D;RC3H1;AGO4;AGO3;METTL3;THRAP3;TUT7
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.576185396599191,1.2098185723820896,0.2604828462515883,0.6258587186481743,1.0,3/18,5.85%,PYCARD;IL18;HMGB1
prerank,axonal fasciculation (GO:0007413),-0.46781697678371403,-1.2094826229816624,0.24324324324324326,0.8399066396624288,1.0,4/12,4.78%,SEMA5A;ARHGAP35;EPHA3;EPHB2
prerank,monocarboxylic acid catabolic process (GO:0072329),0.5593587052619262,1.209130591996959,0.24783147459727387,0.6272884758603141,1.0,3/21,6.19%,LPIN2;CEL;NUDT19
prerank,peptidyl-amino acid modification (GO:0018193),0.6037852741159955,1.208630370541558,0.25663716814159293,0.6281944784193996,1.0,5/10,28.72%,ATP7A;METAP2;TTLL4;METAP1D;FKBP10
prerank,positive regulation of hydrolase activity (GO:0051345),0.4729756495214093,1.2083984017848017,0.13004032258064516,0.6283591402908201,1.0,38/137,18.52%,DOCK8;RGS10;FZD10;THY1;SNX9;CCL8;PSAP;ARAP1;SEMA4D;ITGA6;RASGRP2;USP6NL;DOCK11;DOCK10;AGRN;FLCN;CCL14;F11R;TBC1D2;CCL13;RAPGEF1;LIMS1;CCL2;ARHGAP27;MMUT;RAP1A;BCAR3;NF1;GNB5;ALS2;RGS1;SNX13;CCL25;SNX18;RHOA;PICALM;MAPRE2;ITGB1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.523260308975499,1.2082387451244003,0.26322115384615385,0.6282909619877535,1.0,10/27,21.91%,SLFN14;ERN1;ZC3H12D;RNASEH1;ZC3H12C;PCF11;TRIR;DICER1;TOE1;RNASE6
prerank,positive regulation of establishment of protein localization (GO:1904951),0.5547511339753313,1.2080066312678783,0.26848249027237353,0.6283887509049095,1.0,3/18,8.87%,TREM2;TNF;CCT8
prerank,stabilization of membrane potential (GO:0030322),0.5778107856760842,1.2076729387039693,0.2490118577075099,0.6287314910414715,1.0,3/16,7.51%,KCNN4;KCNK6;KCNK13
prerank,microtubule-based transport (GO:0099111),-0.4588657288153355,-1.2076496667749093,0.2354948805460751,0.8399052711109163,1.0,11/12,46.05%,DYNC1I1;SPEF2;CABYR;ROPN1L;ADCY10;SPAG17;DYNC1I2;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,regulation of oxidoreductase activity (GO:0051341),0.5907411348115383,1.2072259498002282,0.2612859097127223,0.6294574029236005,1.0,4/13,12.24%,SLAMF8;ATP7A;HDAC6;NOD2
prerank,positive regulation of cholesterol transport (GO:0032376),0.525426471508415,1.207177389813986,0.25728155339805825,0.629043876936963,1.0,7/27,15.26%,TREM2;APOE;ABCB4;EEPD1;GPS2;LRP1;ABCA3
prerank,lipid transport (GO:0006869),0.47180425479887544,1.2064533280920526,0.16869918699186992,0.6305465652171707,1.0,25/97,18.30%,ABCA1;SLCO2B1;ABCC3;ATP8A1;GM2A;MFSD2B;NPC2;CLN8;NR1H4;ABCG1;APOE;CLN3;PRELID3B;ABCD1;FABP5;ABCA4;OSBP;SLCO1B1;OSBPL8;ABCA3;CD36;PPARD;ABCD2;STARD5;RXRA
prerank,positive regulation of vasculature development (GO:1904018),0.4780553227853225,1.2063190243189656,0.1673469387755102,0.6304011963218239,1.0,24/94,18.59%,RUNX1;ITGAX;IL1A;SMOC2;PIK3CD;AQP1;ANGPT4;ANGPTL3;PRKD2;PDCL3;PRKCB;VEGFB;PDCD6;THBS1;GRN;ANGPTL4;NINJ1;HK2;MTDH;HIF1A;PDPK1;AGO2;ITGB1;VEGFD
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.5422664789600906,1.2062295128935696,0.2517985611510791,0.6301237144548616,1.0,3/25,2.08%,PCSK9;ITGB3;RIN3
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5370039942325564,1.205738486096709,0.24760765550239233,0.6309888231053354,1.0,5/25,10.39%,STAP1;PRKCD;ARHGAP24;CAPZB;PFN2
prerank,cAMP biosynthetic process (GO:0006171),0.6209866740869837,1.2057305314688698,0.2857142857142857,0.6304770741965573,1.0,4/10,13.49%,ADCY7;ADCY6;ADCY3;ADCY8
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.5775832778090592,1.2057296727150033,0.2723684210526316,0.6299498937481068,1.0,4/14,11.55%,ITGA4;RGCC;THBS1;CCL2
prerank,termination of RNA polymerase I transcription (GO:0006363),0.5159619747327655,1.20566620457861,0.2558411214953271,0.6295906296314508,1.0,7/30,10.96%,GTF2H1;TAF1A;POLR1E;TTF1;CDK7;POLR1B;POLR2L
prerank,regulation of apoptotic process (GO:0042981),0.4637577265542061,1.204910627433148,0.007,0.6312526718601827,1.0,143/676,16.74%,NCKAP1L;FGD2;VAV1;PTK2B;LILRB1;IRF5;ASCL1;SHH;HCK;PREX1;CD3E;CLEC5A;ABR;CTSB;PCSK9;FLT3;GATA1;PCID2;CD74;PLEKHN1;CTSD;CBL;AQP1;ANGPT4;TNFAIP8;DSTYK;NUP62;VAV2;ARHGEF18;MTCH1;SEMA4D;NR1H4;ATG7;TNF;TMEM219;SNCA;ITGA6;TRAF2;DNAJC3;CLN3;FOXO3;PYCARD;VAV3;CASP1;CCND2;CD44;HMGB1;ANP32A;FZD9;APAF1;CFLAR;CTNNB1;ANXA1;BCL2L1;DNM2;GNA13;CCAR1;TP53;ACTN4;CRADD;MAP3K5;PIM1;KCNMA1;TAX1BP1;PIM2;PLK2;MALT1;MEF2C;KIF14;TPT1;FLCN;GADD45B;TFAP2B;ITSN1;ARHGAP10;NTF3;BAK1;BABAM2;BCAR1;MGMT;ANXA4;STK17B;ACTN1;SON;ARHGEF17;LGALS1;BNIP1;NF2;TRIM24;SOX9;SRA1;THBS1;TRIM35;IAPP;PHIP;PRDX3;ANGPTL4;UTP11;CTNNBL1;PRDX2;CASP8;ITCH;LRP8;ARHGEF3;PRLR;BRAF;GAS6;NFKB1;ARHGDIA;STK3;TRADD;RNF144B;ATAD3A;WFS1;BAG1;ARHGEF11;MIEN1;BMF;AREL1;SOX4;CAPN3;VDAC1;PHLPP1;ERCC5;SRC;AHI1;PTPA;STEAP3;MTDH;RPS6KA2;TOP2A;FANK1;RASA1;NF1;MAP3K11;RTN4;TXNDC5;NAA38;FAF1;ARHGEF26;YME1L1;HSP90AA1;STK4
prerank,negative regulation of programmed cell death (GO:0043069),0.4658503251079941,1.204892157477398,0.033,0.6307749084645652,1.0,73/355,16.53%,NCKAP1L;PTK2B;TREM2;ASCL1;SHH;HCK;CLEC5A;GATA1;PCID2;CD74;CBL;LAPTM5;AQP1;ANGPT4;TNFAIP8;DSTYK;NUP62;SEMA4D;NR1H4;SNCA;DNAJC3;CLN3;RAB7A;CCND2;CD44;CFLAR;CTNNB1;ANXA1;BCL2L1;TP53;PIM1;TAX1BP1;PIM2;PLK2;MALT1;KIF14;TPT1;TFAP2B;ARHGAP10;BABAM2;MGMT;ANXA4;SON;BNIP1;SOX9;THBS1;PHIP;PRDX3;ANGPTL4;PRDX2;ITCH;PRLR;BRAF;GAS6;NFKB1;ARHGDIA;RNF144B;ATAD3A;WFS1;BAG1;MIEN1;AREL1;CAPN3;VDAC1;ERCC5;SRC;AHI1;MTDH;FANK1;RASA1;TXNDC5;NAA38;YME1L1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5678312727958122,1.204558514505035,0.26666666666666666,0.6312130475768424,1.0,7/17,19.71%,LPL;ANGPTL3;LIPC;HDAC9;ANGPTL4;FURIN;SORT1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.5495184660548584,1.2044650809873816,0.2589395807644883,0.6309427161143065,1.0,4/21,10.11%,IK;MAD2L2;TRIP13;TPR
prerank,regulation of ERAD pathway (GO:1904292),0.6016505119692315,1.204398320733843,0.27,0.6305926517357202,1.0,3/11,8.14%,HERPUD1;ATXN3;AQP11
prerank,positive regulation of fat cell differentiation (GO:0045600),0.5007752260715379,1.2037160467537504,0.22234392113910187,0.6319545994903885,1.0,15/47,18.19%,LPL;METRNL;RREB1;PIM1;CEBPB;ASXL2;LRP5;CMKLR1;VSTM2A;CREB1;SYAP1;WDFY2;ZBTB7B;PPARD;CREBL2
prerank,histone lysine demethylation (GO:0070076),-0.37312015510378055,-1.2032229268490184,0.19753086419753085,0.8489469772960359,1.0,11/25,18.26%,PHF2;KDM5C;JMJD1C;KDM3A;KDM4B;KDM4A;KDM1B;KDM2A;KDM4D;KDM6A;KDM8
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.5576283133307828,1.2031857960213872,0.2688311688311688,0.6329472431058577,1.0,3/18,4.11%,GSAP;TNF;ABCG1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.578761788227357,1.203086156497474,0.2855245683930943,0.6326976411520396,1.0,2/15,5.65%,CD74;CD44
prerank,response to chemokine (GO:1990868),0.5818337582148639,1.202782092623271,0.26164383561643834,0.6330316784541288,1.0,4/13,10.93%,DOCK8;RIPOR2;WNK1;SH2B3
prerank,organic cation transport (GO:0015695),-0.38451658410521783,-1.202486421101824,0.2191780821917808,0.8455497790492906,1.0,9/20,28.74%,SLC47A1;RALBP1;SEC14L1;SLC25A42;SLC5A7;SLC25A19;SLC22A2;SLC25A29;SLC25A26
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.5220138809992672,1.2022844938541128,0.2713270142180095,0.633909675542111,1.0,8/29,12.01%,NLRC5;PTPN1;SAMHD1;YTHDF3;RNASEL;TTLL12;USP18;METTL3
prerank,negative regulation of myoblast differentiation (GO:0045662),0.6037564060853949,1.2017212827378054,0.2817824377457405,0.6350391505673461,1.0,3/13,11.20%,TGFB1;SOX9;SRA1
prerank,cellular response to starvation (GO:0009267),0.47035695828384755,1.201391225954308,0.1487437185929648,0.6354382631622363,1.0,44/147,19.41%,ATP6V0D2;PCSK9;ATP6V0E1;GAS2L1;TCIRG1;MTOR;ATP6V1C1;ATG7;FNIP1;SREBF2;MAP1LC3B;ATP6V1E1;FOXO3;TFEB;TP53;MAP3K5;RIPOR1;SEH1L;ATP6V0D1;MTMR3;CEBPB;FLCN;XPR1;IMPACT;BECN1;DAP;TBL2;STK24;LAMTOR3;LRRK2;NIM1K;ATP6V0B;SREBF1;RNF152;CPEB4;FADS1;GCN1;PIK3R4;LAMTOR1;SIK2;ATP6V1F;ATG14;RPTOR;SEC13
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.5281712465993541,1.2013419162123764,0.2517241379310345,0.6350554430504998,1.0,9/28,16.70%,ERN1;TRAF2;DDIT3;MAP3K5;CEBPB;BAK1;ATP2A3;SELENOK;ERO1A
prerank,mitotic chromosome condensation (GO:0007076),0.5336449801994352,1.2008225394949466,0.27036599763872493,0.636010141252403,1.0,8/26,19.91%,TTN;NCAPG2;CSNK2A2;CSNK2A1;RB1;AKAP8L;SMC4;MCPH1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.5004480481951665,1.2001251933506294,0.25,0.637390474223444,1.0,10/47,13.46%,PLEK;WDTC1;SIRPA;ERLIN1;ERLIN2;ACADL;SNAI1;PRMT3;FYN;NFKB1
prerank,cartilage development (GO:0051216),0.49029451509917676,1.1996770038918099,0.2118918918918919,0.6381261243593079,1.0,10/49,13.61%,RUNX1;TGFB1;ATP7A;CD44;MEF2C;SULF2;CREB3L2;SOX9;SNX19;SOX6
prerank,homeostasis of number of cells (GO:0048872),0.5929495119496373,1.1991420046846066,0.27801418439716313,0.6391798079819406,1.0,2/12,7.72%,CX3CR1;OCIAD1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.5716179168522084,1.1991239767326891,0.27631578947368424,0.6387068745868902,1.0,4/16,11.23%,PTPRJ;PTPN1;BCAR1;NRP1
prerank,chromosome condensation (GO:0030261),0.5138261928468753,1.1987063458057243,0.24859392575928008,0.6393367546750911,1.0,11/36,19.91%,ACIN1;TTN;NCAPG2;CSNK2A2;CSNK2A1;RB1;AKAP8L;TOP2A;INCENP;SMC4;MCPH1
prerank,negative regulation of viral life cycle (GO:1903901),0.5718936695935567,1.1969611457443232,0.2884097035040431,0.643845239346145,1.0,2/15,3.63%,CIITA;TRIM5
prerank,regulation of macrophage activation (GO:0043030),0.5243607050916398,1.1966838624967295,0.24793388429752067,0.6441297739585369,1.0,4/30,4.57%,FCGR2B;CD74;GPR137B;CEBPA
prerank,phosphate ion transport (GO:0006817),0.5641222821326215,1.1964279305462076,0.2759067357512953,0.6443053390659631,1.0,4/16,13.02%,SLC37A2;XPR1;SLC20A2;SLC25A30
prerank,positive regulation of organelle assembly (GO:1902117),0.5009653195024167,1.196284867770798,0.23227917121046893,0.6441999191228167,1.0,10/44,12.29%,LCP1;NUP62;KCTD17;TNF;ASAP1;PIP4K2A;RAB3GAP2;PLK4;DYNC1H1;SDCBP
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5188311533030847,1.1959513626334202,0.2546948356807512,0.6446388107364531,1.0,18/29,25.87%,ADAR;SMAD3;PUM2;AGO4;SNIP1;AGO3;METTL3;PRKRA;TUT7;TARBP2;AGO2;ZC3H7A;DICER1;LIN28B;DROSHA;ZC3H7B;AGO1;PUM1
prerank,regulation of melanin biosynthetic process (GO:0048021),0.6207797053443406,1.1958030553470955,0.29172714078374457,0.6445752418634285,1.0,5/10,22.05%,ZEB2;ATP7A;CTNS;GIPC1;CDH3
prerank,positive regulation of ATPase activity (GO:0032781),0.49497342389014676,1.1955542585299879,0.2616407982261641,0.6447993293113281,1.0,12/41,13.76%,MYL3;DHX9;ALDOB;VMP1;TNNT3;AHSA1;PFN2;PFN1;ATP1B3;TOR1AIP2;DNAJC9;ATP1B2
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.5967481352351719,1.19550457319419,0.2859078590785908,0.6444333383856268,1.0,3/12,9.57%,MDK;WNK1;FUT9
prerank,myelin maintenance (GO:0043217),0.6177661941775173,1.194728401400642,0.2863187588152327,0.6461043028094438,1.0,6/10,17.98%,CXCR4;ABCD1;PRX;DEGS1;PTEN;ABCD2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.47208586419880766,1.1946715288963106,0.17479674796747968,0.6457462066515691,1.0,24/108,13.66%,SYK;CTSD;LAPTM5;MTCH1;TNF;SNCA;TRAF2;PYCARD;CASP1;XDH;HMGB1;APAF1;CFLAR;CRADD;MAP3K5;MALT1;ST18;SMAD3;GRAMD4;PDCD6;DAP;CASP8;ATP2A3;TRADD
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.5312942752921112,1.1940767865977182,0.2646370023419204,0.6469345683497157,1.0,7/25,17.77%,CALCR;THY1;SNCA;CACNB2;CAPN3;CEMIP;PDPK1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.5177229508741547,1.1939113509400956,0.2511467889908257,0.6469086795229534,1.0,5/34,7.37%,PIK3CG;HCN4;SLC8A1;P2RX4;SLC9A1
prerank,regulation of dopamine secretion (GO:0014059),0.532193686828142,1.1936858811561404,0.27036599763872493,0.6470605271026221,1.0,5/25,11.08%,SYT17;SNCA;SYT2;SYT10;DTNBP1
prerank,iron ion homeostasis (GO:0055072),0.49455190410537936,1.193534737858287,0.23504273504273504,0.6469778953964854,1.0,11/58,14.05%,SLC11A1;FRRS1;ATP6V0A2;IREB2;ATP6V0D1;HFE;FTL;ATP6AP1;ACO1;B2M;FTH1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.4659705524046234,1.19351128814856,0.1606060606060606,0.6465205987818197,1.0,43/119,23.28%,INPP5D;PIK3CG;PIK3R5;PIK3CD;PIGM;PLCG2;PIK3CB;PIP5K1C;INPP4B;PIP4K2A;PI4K2A;RAB14;TTC7A;PIGL;MTMR3;PIGV;SMG1;PIGH;PI4K2B;SYNJ1;BMX;PLEKHA1;EFR3A;PTEN;PIK3R4;PGAP2;PLEKHA2;INPP5K;PIGU;PIGC;SOCS3;PIGN;PIK3CA;ITPKB;SOCS4;SOCS7;FGF2;MTMR9;MTMR14;DPM2;PIGP;OCRL;INPP5F
prerank,positive regulation of glial cell differentiation (GO:0045687),0.5668154032460793,1.1934240590128529,0.2737789203084833,0.6462338166529643,1.0,3/17,4.58%,TGFB1;MDK;CXCR4
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.5453268387197712,1.193395647274,0.26054590570719605,0.6458078026921186,1.0,13/20,25.87%,PUM2;AGO4;SNIP1;AGO3;PRKRA;TARBP2;AGO2;ZC3H7A;DICER1;DROSHA;ZC3H7B;AGO1;PUM1
prerank,retinoic acid metabolic process (GO:0042573),-0.4387360816198068,-1.19300556344067,0.22393822393822393,0.871319625153286,1.0,5/14,37.02%,SCPEP1;ALDH1A2;ADH1A;CYP2S1;BCO2
prerank,protein transport (GO:0015031),0.4612615458327178,1.192528419217268,0.054,0.6477471060858991,1.0,100/332,19.53%,ATP6V0D2;IL10RA;TBC1D9;RAB8B;CD74;ABCA1;LAPTM5;TBC1D10C;ATP6V0E1;RAB34;UNC93B1;CTSA;TCIRG1;RAB32;ATP6V1C1;TMED3;SNX9;ABCG1;APOE;ATP6V1E1;SEL1L;RAB14;ATP6V0A2;SNX33;RAB3GAP2;MYH9;TBC1D16;RAB7A;TBC1D22A;STX11;TLK1;AP3D1;USP6NL;PRKCB;MACF1;DNM2;STXBP3;ATP6V0D1;RAMP1;VMP1;TBC1D10A;HFE;RAB28;PPY;SNX27;RAB31;ARHGAP1;PDCD6;SYNRG;ARL5B;ARL4A;RAB1B;TBC1D2;ATP6V0A1;TBC1D17;COPA;ATP6AP1;CLTC;HDAC6;TBC1D2B;WDR11;ARRDC4;TBC1D8;STX3;STX5;SAR1A;RPGR;STX8;GGA2;ARF6;VPS29;SCAMP2;NEURL1B;ATP6V0B;LRP1;TBC1D14;STEAP3;TBC1D22B;YWHAH;SVBP;CD36;SNX13;ARFIP2;IFT27;ARHGEF2;MON1A;STX2;VLDLR;VPS33B;LRP1B;SLU7;GOLPH3;ATP6V1F;TBC1D12;LTBP2;TBC1D5;MCOLN1;RAB29;SEC13;OPTN
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.5427053995699369,1.1922439488876027,0.2871287128712871,0.6480162512882204,1.0,4/22,7.31%,THY1;TNF;CD44;WNK1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.4772680446208938,1.1922404746112891,0.19917864476386038,0.6474977526647885,1.0,19/77,15.27%,LGALS3;CX3CR1;TGFBR1;TNF;ITGA6;HERPUD1;FZD9;CFLAR;BCL2L1;CSNK2A2;CSNK2A1;RB1;QARS1;THBS1;PHIP;PSME3;NOC2L;PIH1D1;SRC
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.5761601031382438,1.1920202531568116,0.30548302872062666,0.6476133283083126,1.0,5/16,9.57%,PIK3CB;TNF;GCH1;APOE;NOS1AP
prerank,proteolysis (GO:0006508),0.4602066725099564,1.1919626151799825,0.083,0.6472458935306502,1.0,49/252,17.05%,CTSS;KLK3;MMP12;CTSB;NAPSA;LGMN;FAM111A;SRGN;CTSD;CTSC;CTSA;CTSK;CTSL;ECE2;EEF1AKMT4-ECE2;CLN3;CAPN15;CASP1;DDI2;LONP1;MALT1;ZMPSTE24;CTSZ;SPPL3;SPCS1;NLN;TINAGL1;CTSE;TBL1X;MMP19;CASP7;PARL;CASP8;LRP8;PCSK7;ERAP1;PSMB5;CAPN2;ECEL1;CAPN3;SPPL2A;METAP2;PRCP;SVBP;IDE;YME1L1;FURIN;ATG4A;PITRM1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.5830310542745442,1.1919480436293417,0.2866666666666667,0.6467714776959873,1.0,2/13,2.10%,TGFB1;TGFBR1
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.30899508715442175,-1.191902457649675,0.18055555555555555,0.8692263463611221,1.0,10/51,9.52%,FSTL1;CRIM1;BMPR1A;BMPER;NBL1;SMAD9;SMAD4;SMAD5;FBN1;SMAD1
prerank,regulation of cholesterol transport (GO:0032374),0.5443484330026508,1.1912628639272054,0.28697850821744625,0.6481755650966402,1.0,9/20,21.23%,TSPO;ABCB4;TTC39B;NFKB1;ARV1;LRP1;LAMTOR1;NAXE;ABCA2
prerank,nucleoside salvage (GO:0043174),0.6101918843092073,1.190934841392006,0.2875536480686695,0.6485545934309822,1.0,4/10,16.32%,UCK1;CDA;UCK2;DCK
prerank,Ras protein signal transduction (GO:0007265),0.4662850354132365,1.1906449530472225,0.15725806451612903,0.6488537625263342,1.0,33/137,14.78%,GRAP2;LAT;RREB1;GRB2;ELMO1;MAPK14;RAP2A;RASGRP2;RAP1B;RGL2;SHC2;MYO9B;AIF1;GNA13;TP53;GNA12;RIPOR1;PLK2;RAP2B;RASGRP3;RB1;ARHGAP1;ARHGDIB;RAPGEF1;CYFIP1;RASSF1;ADGRG1;ARHGEF3;RRAS2;ARHGDIA;ARHGEF11;RAP1A;USP8
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.477066212612751,1.1906054987490773,0.19648397104446744,0.6484331944055114,1.0,15/80,9.02%,SYK;CTSD;AQP1;TNF;FNIP1;SNCA;PYCARD;CASP1;CD44;HMGB1;MAP3K5;MALT1;CSNK2A1;GRAMD4;PDCD6
prerank,camera-type eye development (GO:0043010),-0.36697002086444386,-1.1901094948329582,0.22485207100591717,0.8692781156261546,1.0,7/25,15.27%,CACNA1C;EFEMP1;SHROOM2;FBN1;TENM3;STRA6;PAX2
prerank,negative regulation of transposition (GO:0010529),0.5667970073847794,1.1900244653855807,0.2713375796178344,0.649516589030372,1.0,2/16,8.46%,SMYD5;MOV10
prerank,positive regulation of apoptotic process (GO:0043065),0.46044577266730874,1.1899535899896747,0.08008008008008008,0.6491941616501681,1.0,65/293,17.54%,FGD2;VAV1;LILRB1;IRF5;PREX1;ABR;PCSK9;PLEKHN1;CTSD;TGFBR1;TNFAIP8;VAV2;ARHGEF18;MTCH1;ATG7;TNF;SNCA;ITGA6;FOXO3;PYCARD;DDIT3;VAV3;HMGB1;FZD9;APAF1;CTNNB1;DNM2;GNA13;CCAR1;TP53;CRADD;MAP3K5;KCNMA1;FLCN;GADD45B;TFAP2B;ITSN1;BAK1;STK17B;ARHGEF17;TRIM35;GRN;IAPP;UTP11;CTNNBL1;CASP8;ARHGEF3;STK3;TRADD;ARHGEF11;BMF;SOX4;TLE5;PTPA;RPS6KA2;TOP2A;FANK1;NF1;MAP3K11;FAF1;ARHGEF26;STK4;BIN1;ARHGEF2;UBE2Z
prerank,ventricular septum development (GO:0003281),-0.32954574612851306,-1.189823831178068,0.1889763779527559,0.8642885225347365,1.0,9/37,7.15%,ZFPM2;BMPR1A;ROBO2;ACVR1;SALL1;TGFBR3;ROBO1;SLIT2;SMAD4
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.48652799611703484,1.1896665483863729,0.2245762711864407,0.6494893861306966,1.0,14/59,13.46%,CSF1R;MED17;MITF;CDK8;CTNNB1;TP53;TNRC6A;CEBPB;MOV10;AGO4;MED27;SOX9;AGO3;NFKB1
prerank,tRNA aminoacylation (GO:0043039),0.5025990672282619,1.189365955186549,0.251685393258427,0.6498079796832669,1.0,17/37,22.57%,VARS1;FARSB;GATB;GARS1;PPA2;RARS1;EPRS1;QARS1;LARS2;DARS1;DARS2;FARS2;AIMP1;TARS1;YARS1;SARS1;SARS2
prerank,modulation by symbiont of entry into host (GO:0052372),0.5676810228697112,1.1891238842578926,0.28532608695652173,0.6499962610776696,1.0,6/16,17.06%,TRIM25;TRIM5;TRIM27;EXOC7;EXOC2;TRIM62
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5096333032533349,1.1889460605983126,0.26225769669327254,0.6499970832603437,1.0,5/33,8.24%,CBL;NUP62;ARAP1;DOK1;DGKD
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.5143535235696428,1.1889082442803114,0.2593856655290102,0.6495935419121955,1.0,9/35,18.32%,CBL;BMP2K;PIK3CB;LDLRAP1;HFE;B2M;ARF6;PICALM;FLOT1
prerank,regulation of anoikis (GO:2000209),-0.3867882811198412,-1.1888861058209057,0.2636363636363636,0.8615430456067679,1.0,4/19,7.55%,ANKRD13C;CAV1;TLE1;SIK1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.4671056470040332,-1.1888020126360181,0.29553264604810997,0.85605281217381,1.0,3/11,15.95%,MLLT3;RSPO3;WNT5B
prerank,ncRNA catabolic process (GO:0034661),0.5186951326075577,1.1888000788977984,0.26985981308411217,0.6493758651913014,1.0,3/28,6.86%,SLFN14;TENT4B;SND1
prerank,regulation of postsynapse organization (GO:0099175),0.5273743546707197,1.1883087066017295,0.27164887307236063,0.6502083601397292,1.0,8/28,16.34%,FCGR2B;ARHGAP22;ABHD17B;ABHD17C;LZTS3;TANC2;LRRK2;EPHA4
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5770620126705017,1.1873481426673644,0.300132802124834,0.6523307075200703,1.0,4/14,7.23%,CREB3;HERPUD1;BCL2L1;CREB3L1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4863817373202613,1.1871076198691373,0.2507970244420829,0.6524980847382514,1.0,4/48,3.87%,PTK2B;UBASH3B;THY1;SNCA
prerank,regulation of protein secretion (GO:0050708),0.4624008419786463,1.1870006499656387,0.1870576339737108,0.6522787848442188,1.0,26/119,16.82%,TREM2;KCNJ11;TGFB1;IL1A;ADAM8;TNF;ABCG1;APOE;TTN;RHBDF2;CACNA1A;TFAP2B;ITPR2;SYTL4;ENSA;SLC8B1;EXOC1;ARF6;MYH10;KCNA5;RAP1A;CD33;RHBDF1;CACNA1D;GCK;PPP3CB
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.5544324918290845,1.1869528424825528,0.2824427480916031,0.6518924967179086,1.0,1/18,0.63%,KCNJ11
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.4941903657923543,1.186899913695059,0.270032930845225,0.6515092710876086,1.0,15/41,24.02%,CD3E;THY1;MDK;TNF;CD44;PODXL;PTPRU;DENND6A;CD47;FLOT1;PIEZO1;MEGF10;CX3CL1;PTPN23;MAGI1
prerank,tight junction assembly (GO:0120192),-0.30189305185412946,-1.1865354102261845,0.11842105263157894,0.8580226580219351,1.0,11/49,11.60%,CDH5;AFDN;PRKCI;PARD3;CLDN5;CLDN11;MPP7;PARD6G;CLDN14;DLG1;CLDN12
prerank,positive regulation of blood coagulation (GO:0030194),0.5549383339737393,1.1856864965757443,0.3032679738562091,0.6545569194668053,1.0,3/17,11.24%,HPSE;USF1;THBS1
prerank,regulation of stem cell population maintenance (GO:2000036),-0.40502969955919677,-1.1856497590167145,0.24019607843137256,0.8551923202841748,1.0,3/18,6.04%,PTN;CNOT3;REST
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5260175923200968,1.1856460808111138,0.25029239766081873,0.6541534542162496,1.0,10/30,20.45%,RFFL;TRAF2;TNFAIP3;CFLAR;BCL2L1;CASP8;TRADD;ARHGEF2;TNFSF10;GSK3B
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.5687559777890405,1.1855917429680125,0.3010471204188482,0.6537905010873847,1.0,6/15,23.23%,TGFB1;LRP1;DPP4;CLASP1;DDR1;PDPN
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.5015424363889112,1.185393559979047,0.2765714285714286,0.6538070016854448,1.0,7/32,10.96%,GTF2H1;TAF1A;POLR1E;TAF1;CDK7;POLR1B;POLR2L
prerank,regulation of microtubule-based movement (GO:0060632),0.5844772278983654,1.185387315663161,0.296398891966759,0.653302730364615,1.0,2/11,11.27%,NEFH;HDAC6
prerank,regulation of exit from mitosis (GO:0007096),0.5036538357998895,1.185302072619766,0.24807056229327454,0.6530403490599611,1.0,4/38,6.58%,ANAPC15;RGCC;CDC23;UBE2S
prerank,protein-containing complex disassembly (GO:0032984),0.4913961311016044,1.185294890238856,0.2470713525026624,0.6525464065834103,1.0,18/54,21.74%,RPL23;LIX1;FRAT2;MAP1LC3B;CLN3;CTNNB1;TECPR1;SNAP29;UVRAG;AMER1;CSNK1A1;SNX14;VPS33B;PYM1;FZD2;GSK3B;EPG5;VAMP8
prerank,RNA interference (GO:0016246),0.5571250452942107,1.184397668967152,0.2975420439844761,0.6546240449060206,1.0,10/17,25.04%,DHX9;AGO4;AGO3;PRKRA;NRDE2;TARBP2;AGO2;DICER1;DROSHA;AGO1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4687715407325871,1.184067118261397,0.21450777202072538,0.6550390644876976,1.0,11/75,9.02%,STAT5A;ITGA4;PIK3CD;ITGB3;TGFBR1;MDK;PRKD2;PDCL3;HMGB1;VEGFB;PDCD6
prerank,response to exogenous dsRNA (GO:0043330),0.5511470550342087,1.1840172162795968,0.2833545108005083,0.6546927942187671,1.0,3/18,7.53%,RFTN1;DHX9;TICAM1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.5129185360367433,1.1840143669515535,0.2967818831942789,0.6541877874944235,1.0,11/26,21.76%,PLEK;FHOD1;SLC9A1;ACTG1;PFN2;PFN1;SYNPO;CDC42;ROCK2;PRKN;CX3CL1
prerank,miRNA metabolic process (GO:0010586),0.5453136340374858,1.183996780706753,0.2857142857142857,0.6537150863301179,1.0,10/20,21.57%,TENT4B;SND1;BCDIN3D;PRKRA;TUT7;TARBP2;AGO2;DIS3L2;DICER1;LIN28B
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.6176613128372197,1.1831706997511404,0.3058321479374111,0.6555390074984727,1.0,2/10,5.56%,PLS1;WHRN
prerank,regulation of JNK cascade (GO:0046328),0.47211555935888116,1.182921330491216,0.20326864147088866,0.6557508189411285,1.0,20/101,13.35%,PTK2B;SLAMF1;FCGR2B;SIRPA;TAOK3;DUSP3;RAP2A;TRAF2;PYCARD;TRAF3;HMGB1;MAP3K5;GADD45B;DUSP10;TRAF5;DUSP19;NOD2;SDCBP;ITCH;GPS2
prerank,sterol metabolic process (GO:0016125),0.47806257602768626,1.182791704742232,0.24046610169491525,0.6555689693040581,1.0,8/60,5.56%,ABCA1;ANGPTL3;CLN8;ABCG1;APOE;LDLRAP1;LIPA;SOAT2
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5394947777123753,1.1826529053071282,0.28431372549019607,0.6554614993868664,1.0,5/21,7.23%,CREB3;HERPUD1;DDIT3;BCL2L1;CREB3L1
prerank,cellular response to oxygen levels (GO:0071453),0.611190823757321,1.1821961195393467,0.2841068917018284,0.6562796399244601,1.0,4/10,15.08%,ATP6V0A2;ATP6V0D1;ATP6AP1;CPEB4
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.3272677292918704,-1.1815090829444055,0.19834710743801653,0.8632196281578207,1.0,13/37,16.40%,EFNA5;PHLDB2;CYLD;EPHA3;STMN2;PHLDB1;ROCK1;MAP6;MAPT;TPPP;STMN4;TRIM36;STMN3
prerank,negative regulation of protein ubiquitination (GO:0031397),0.4893693136806432,1.18115431246321,0.2611050920910076,0.6586821794308888,1.0,5/50,5.94%,ARRB2;BAG2;IVNS1ABP;TNFAIP3;TAF1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.47907964132346115,1.1811251227609827,0.25616291532690244,0.6582503281025641,1.0,9/54,9.39%,HPSE;GUSB;GNS;IDS;HEXA;FUCA1;AGRN;NDST1;XYLT1
prerank,mRNA 3'-end processing (GO:0031124),-0.27394853123688356,-1.1810470737474,0.06818181818181818,0.8590147830160223,1.0,24/78,15.25%,WDR33;APP;SARNP;SRRM1;RPRD2;CPSF6;SCAF8;AHCYL1;FIP1L1;CPSF7;THOC7;CSTF2;THOC1;PAPOLA;THOC5;U2AF2;PAF1;SRSF11;PAPOLG;RPRD1B;EIF4A3;SRSF1;TUT1;CSTF3
prerank,cellular response to sterol (GO:0036315),-0.45286135867099375,-1.1810449603133002,0.23616236162361623,0.8534841574183686,1.0,6/13,20.76%,RORA;GPLD1;SMO;INSIG2;INSIG1;PTCH1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5760175553101514,1.180887860873426,0.2891891891891892,0.6583554501275114,1.0,3/12,8.96%,PTPN1;ERN1;BAK1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.5168097265273283,1.1807445389826474,0.2538552787663108,0.6582381954777932,1.0,3/27,2.82%,CD74;AQP1;DHX9
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5071612436200397,1.1802653397921719,0.2819634703196347,0.6591303147602106,1.0,4/31,3.69%,TGFB1;TGFBR1;MYL3;PKP2
prerank,quinone biosynthetic process (GO:1901663),0.5573677695978216,1.179448076662829,0.3087431693989071,0.6609293193479027,1.0,8/14,21.43%,COQ9;PDSS1;COQ7;COQ8B;FDXR;COQ3;COQ6;UBIAD1
prerank,ceramide metabolic process (GO:0006672),0.4837915658804881,1.178706366069006,0.2773019271948608,0.6625246286153558,1.0,16/49,21.23%,CERS6;SGPL1;CLN8;CERK;AGK;ACER3;ORMDL2;PPP2CA;NSMAF;DEGS1;ASAH1;SGMS1;SPTSSA;SMPD1;SPTSSB;ABCA2
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.5627680268781534,1.178663099214826,0.2883116883116883,0.6621405815076026,1.0,5/15,13.75%,PRKCD;TNF;SMPD3;ORMDL2;NSMAF
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5967856501181198,1.1784319628656608,0.3090909090909091,0.6623037032655222,1.0,3/12,12.24%,MUC13;SOX9;NOD2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.45753416111424855,1.178340954880527,0.18655967903711135,0.6620393973534141,1.0,26/142,13.98%,CALCR;CX3CR1;CCR2;CD52;SLC8A1;CLN3;CXCR4;S1PR4;HMGB1;FZD9;CCKBR;TMEM178A;CACNA1A;ATP2B1;SMAD3;SPPL3;CYSLTR1;SLC8B1;CMKLR1;ATP2B3;TACR1;IAPP;NPTN;CDH23;ADCY8;C3AR1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.4411189603622797,-1.178033390738327,0.26811594202898553,0.8579740648627255,1.0,6/13,16.05%,RHOT1;BNIP3;BCL2L11;BLOC1S2;BAD;BAX
prerank,regulation of intracellular transport (GO:0032386),0.5000231402627615,1.1779654073999373,0.27262443438914025,0.6626092381303766,1.0,4/38,4.64%,LCP1;NEFH;PTPN1;REEP6
prerank,synaptic vesicle recycling (GO:0036465),0.5134057566602599,1.1776198120418635,0.2796803652968037,0.6631239809662749,1.0,8/31,12.52%,SNCA;PIP5K1C;CEL;PLD2;SYT2;STON2;STON1;SYNJ1
prerank,cellular response to cAMP (GO:0071320),0.5134219597230844,1.1775859827190314,0.29161882893226176,0.6626923697648579,1.0,10/30,21.24%,AQP1;HCN4;PKD2;RAP1B;RAPGEF1;RAP1A;AKAP9;INPP5K;HCN1;ZFP36L1
prerank,regulation of protein localization to membrane (GO:1905475),-0.3392968857230877,-1.1775042231851467,0.20512820512820512,0.854299597222638,1.0,6/28,4.10%,SPTBN1;GPC6;GPC5;GSN;MMP14;AR
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.523081489498893,1.1767550695373667,0.29389788293897884,0.664540294872985,1.0,12/24,22.83%,SMYD5;DNMT3A;SPI1;TRIM27;RBBP7;MTF2;TASOR;PHF1;RBBP4;EED;AEBP2;H3-3A
prerank,regulation of catecholamine secretion (GO:0050433),0.5169215604949704,1.1758218318346134,0.27526132404181186,0.6666525867632873,1.0,5/29,11.08%,SYT17;SNCA;SYT2;SYT10;DTNBP1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.534295613453057,1.1756782930279832,0.2905982905982906,0.6664759406884048,1.0,8/25,16.71%,TNF;PKD2;P2RX4;SMAD3;NOS1AP;DDAH1;CD36;HSP90AA1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.4513966561970469,1.1754213361947237,0.049,0.6667140985529352,1.0,98/476,14.80%,CD86;RUNX1;NFE2;CIITA;SHH;IRF4;TGFB1;GATA1;PCID2;CD74;SNX5;TGFBR1;NFATC1;MED17;RREB1;GTF2H1;MAD2L2;NSD1;MLXIPL;SS18L1;ELF4;NUP62;YAF2;RXRB;NR1H4;TNF;APOE;UBE2V1;MITF;FOXO3;DDIT3;CXXC1;SPP1;NDP;HIVEP3;RNF111;FLI1;TEAD1;MAP2K3;CTNNB1;TFEB;DNM2;TP53;KLF6;CD80;TBL1XR1;NKX2-1;TAL1;MAP3K5;MYOCD;PIM2;ZFP90;EPO;CEBPB;CHEK2;SNAI1;MEF2C;TFAP2B;BICRA;SMAD3;MMS19;ARID1A;MDFIC;PPARGC1A;RNF4;ATF7IP;LRP5;HDAC4;ARID1B;RNF10;ATAD2;SEC14L2;TBL1X;INHBA;TRIM56;MAP2K2;CREB3L2;ELF2;SOX9;PHIP;MAP3K12;CREB1;BAMBI;SMARCD3;CAMKK2;NFKB1;FOXK1;GPATCH3;HCFC1;ZFHX3;IRF1;SOX2;BRD7;HNRNPD;ARHGEF11;LBH;SOX4;CAPN3
prerank,regulation of phosphorylation (GO:0042325),0.4648441913649255,1.175317396293287,0.17338709677419356,0.6665075255540119,1.0,21/120,12.34%,NCKAP1L;LYN;STAP1;FNIP2;NLRC5;SLAMF8;PTGES3;NUP62;FNIP1;ITGA6;PLXNB2;SEH1L;FLCN;TPR;INHBA;NRP1;THBS1;NUP205;PHIP;SDCBP;PPP2CA
prerank,smooth muscle tissue development (GO:0048745),0.6100733288238415,1.1752862937805972,0.27890173410404623,0.6660784709735146,1.0,1/10,0.68%,SHH
prerank,regulation of microtubule-based process (GO:0032886),-0.31981005389953976,-1.1748382456339357,0.13157894736842105,0.8576086388906603,1.0,11/36,14.99%,EFNA5;PHLDB2;CYLD;EPHA3;PHLDB1;ROCK1;MAP6;MAPT;TPPP;MARK4;TRIM36
prerank,protein localization to mitochondrion (GO:0070585),-0.46655036934887983,-1.1742995424295712,0.25666666666666665,0.8538659467207967,1.0,6/11,16.31%,HK1;PINK1;COX18;DNAJA1;AKT1;MTCH2
prerank,action potential (GO:0001508),0.491215512175013,1.173640672842279,0.27410617551462624,0.6702310121378436,1.0,3/44,4.53%,GNA15;GNAQ;CLN3
prerank,negative regulation of cellular component organization (GO:0051129),0.47424689667489806,1.173570079205864,0.21436004162330904,0.669903449187964,1.0,15/74,12.78%,LILRB1;LGALS3;NR1H4;TNF;MCTP1;SNX33;XRCC5;DNM2;TFIP11;SVIP;HSF1;IMPACT;HDAC6;IAPP;SORL1
prerank,positive regulation of cell cycle (GO:0045787),0.4704749026129208,1.1733991067158382,0.24156118143459915,0.6698089612283598,1.0,10/62,9.15%,LGMN;SMOC2;DUSP3;CCND3;RGCC;PKD2;CCND2;TAL1;RPS15A;HSF1
prerank,positive regulation of vascular permeability (GO:0043117),0.5818209366034913,1.1727812475850412,0.3024193548387097,0.6711168583131444,1.0,2/12,5.38%,TGFB1;FGFBP3
prerank,genitalia development (GO:0048806),0.5839517035785021,1.1726950199676898,0.31232876712328766,0.6708525564299369,1.0,2/12,6.22%,SHH;CHD7
prerank,ubiquinone biosynthetic process (GO:0006744),0.5497382728980018,1.172332148567838,0.3252361673414305,0.6713668333346763,1.0,8/15,21.43%,COQ9;PDSS1;COQ7;COQ8B;FDXR;COQ3;COQ6;UBIAD1
prerank,cytoskeleton organization (GO:0007010),0.45943398246756795,1.1720482514211612,0.19328585961342828,0.6716587177728369,1.0,30/114,17.75%,FGD2;THY1;NCKIPSD;MDK;APOE;TNFAIP3;PLD2;FMNL3;FGD6;CAPZB;NEDD9;RANBP10;MICAL1;TNIK;SH3KBP1;SIPA1;ARHGAP10;DIAPH1;CCL13;CCL2;PHIP;RANBP9;DES;SIPA1L3;DST;PDZD8;WDPCP;BIN1;ANK1;RHOA
prerank,vesicle transport along microtubule (GO:0047496),-0.36764782810581237,-1.1717384558725294,0.2155688622754491,0.8570534693376826,1.0,8/23,11.16%,KIF5B;DYNC1I1;PAFAH1B1;NDEL1;KIF3B;NDE1;KIF5A;KIFAP3
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.4830280441776286,1.171663275761417,0.2641711229946524,0.6722385627132295,1.0,12/54,16.97%,ARRB2;BAG2;IVNS1ABP;TNFAIP3;CTNNB1;PRMT3;SOX4;CAPN3;SVBP;COPS9;RPL11;VPS28
prerank,transition metal ion homeostasis (GO:0055076),0.5149202393651513,1.1712437822378998,0.29350348027842227,0.6729151530649329,1.0,10/28,22.07%,SLC11A1;IREB2;HFE;FTL;B2M;PICALM;ATP13A2;HMOX2;PRKN;MT3
prerank,neuron projection organization (GO:0106027),0.5640252791883994,1.1710657187328508,0.3050397877984085,0.6729061926938904,1.0,3/15,7.24%,LGMN;PLS1;ABCD1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5499780826252442,1.1707572696469952,0.3163265306122449,0.6732769756219078,1.0,4/18,10.81%,TGFB1;TNF;TP53;MAP2K2
prerank,regulation of macromolecule metabolic process (GO:0060255),0.4514059548126521,1.1702898621439808,0.1523046092184369,0.6740305554666646,1.0,43/170,19.71%,PTPRC;TREM2;ASCL1;SHH;CAVIN4;SIRPA;SLC8A1;PRDM12;TRIM5;APOE;ZUP1;TBC1D16;TFEB;AIF1;NFKBID;MTMR3;TRIM27;PCBP3;TXK;NELL1;AFF1;CDK6;ZFP64;COQ7;ZNF445;MEGF8;PCBP1;SOX2;HNRNPD;RO60;IGF2BP3;C1D;RASA1;HIF1A;MARF1;LAMTOR1;FLOT1;PRDM10;FUBP3;GDNF;ROCK2;ATRAID;SORT1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3482702460605821,-1.1702322428323786,0.21787709497206703,0.8566822349705873,1.0,10/25,10.73%,CACNA1C;ANK2;CAV1;RYR2;CXADR;JUP;CALM3;TBX18;DLG1;CTNNA3
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5979609117724209,1.1698701401683107,0.30428571428571427,0.674715470915791,1.0,5/10,20.52%,MTOR;ARF6;MAPRE2;IQSEC1;MAP4K4
prerank,regulation of aerobic respiration (GO:1903715),0.5765187839357591,1.169855882256151,0.3257372654155496,0.6742376666754974,1.0,3/15,7.24%,CBFA2T3;ATP7A;ABCD1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.49842566185353515,1.1697388475565045,0.27335640138408307,0.674049809545461,1.0,12/36,17.89%,PLCB2;NFATC1;FZD3;CTNNB1;TNRC6A;MOV10;AGO4;NLK;AGO3;GNG2;PPP3CB;AGO2
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5941731260597124,1.1689610589572461,0.3137535816618911,0.6757575400827265,1.0,5/11,18.96%,VAPB;BNIP1;ATL1;RTN4;ATL2
prerank,organelle fission (GO:0048285),0.5309131447720407,1.1687385293518162,0.29594272076372313,0.6758826240522783,1.0,13/24,25.18%,PEX11A;MTFR2;DNM2;TMCC1;SEC16B;CORO1C;DNM1L;FIS1;PRKN;ACOT8;MTFR1;MFF;WASHC5
prerank,nuclear membrane reassembly (GO:0031468),-0.3037895713265088,-1.1685215031076273,0.18867924528301888,0.8570685421462825,1.0,20/54,22.38%,SPAST;NUP93;IST1;NUP188;NUP98;PPP2R2A;AHCTF1;NDC1;NUP37;VPS4A;RCC1;EMD;CHMP4B;CHMP4A;NUP133;LMNA;CHMP2A;RAN;NUP43;LBR
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.46393815516467996,1.1681820012646857,0.20930232558139536,0.6769537191108388,1.0,31/104,20.69%,CSF1R;GTF2H1;THY1;SLC8A1;CCND3;SNCA;BCCIP;PYCARD;CCND2;ACTB;RB1;UVRAG;CDK7;LRP5;DUSP19;MAP2K2;PARP16;PPP2CA;CDC6;CCNE2;PIH1D1;SRC;SYAP1;INCENP;IRGM;KSR1;RHOA;RPTOR;CNPPD1;CDK5R1;TELO2
prerank,brain morphogenesis (GO:0048854),0.5820241516823033,1.1679831965405807,0.3451202263083451,0.6770284715322941,1.0,1/12,0.40%,SLC6A4
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.459084744056692,1.167704837142946,0.24539877300613497,0.6773193893908053,1.0,8/87,3.02%,PTK2B;IQGAP2;CORO1A;FZD10;CSF1R;PRKCD;MTOR;MDK
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.4568969424096767,1.1673333320392263,0.21580547112462006,0.6778876139856669,1.0,31/112,18.76%,ARRB2;TGFB1;NRROS;CBL;TGFBR1;ITGB5;ARHGEF18;SKI;HPGD;ZMIZ2;TGFBR2;TGFBRAP1;MEF2C;ZFYVE9;SMAD3;F11R;LIMS1;SOX9;NLK;BAMBI;SOX6;ZYX;USP9X;SRC;SMURF1;LPXN;APPL2;FURIN;RHOA;ITGB1;LTBP2
prerank,cardiac muscle tissue development (GO:0048738),-0.30430111889226436,-1.1669709293256596,0.2153846153846154,0.8567722660362025,1.0,12/50,10.26%,SGCD;BMPR1A;BMP4;SGCZ;AKAP13;BMP5;CACNA1G;SMAD4;SIK1;SMAD5;SMAD1;TBX18
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.31887446515616613,-1.166577355548702,0.18085106382978725,0.8528146199452032,1.0,6/39,3.85%,UTRN;ANK2;FHL1;TCAF1;AHCYL1;FGF12
prerank,negative regulation of ATP metabolic process (GO:1903579),0.551770093652213,1.1664872785171574,0.30038510911424904,0.6797202687226688,1.0,7/17,19.60%,CBFA2T3;MLXIPL;FLCN;HDAC4;PID1;TIGAR;FIS1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.5907317055068939,1.165512269788577,0.3244005641748942,0.6819256167065605,1.0,4/10,17.20%,TLR2;CCL2;NOD2;IL33
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.4876751579911528,1.1651348261062329,0.3075221238938053,0.6825092809868311,1.0,5/41,9.57%,CTSS;KCNN4;STAC;KCNMA1;NOS1AP
prerank,cellular response to ketone (GO:1901655),0.4972919543766892,1.164906045951266,0.28888888888888886,0.6826238071105314,1.0,12/35,19.65%,MAP4K1;AQP1;ADCY6;SPP1;LARP1;ADCY3;ADCY8;GNG2;SRC;NCOA4;GOLPH3;ROCK2
prerank,negative regulation of protein phosphorylation (GO:0001933),0.4618151379820151,1.1648475734574897,0.17119838872104734,0.6822687092591168,1.0,42/150,20.08%,PTPRC;LYN;UBASH3B;TGFB1;SIRPA;NIBAN1;PRKCD;THY1;GNAQ;MLXIPL;NCK2;SEMA4D;SNCA;DNAJC3;XDH;SAMSN1;RB1;TRIM27;NTF3;QARS1;IBTK;IMPACT;DUSP19;DTNBP1;SNX25;DDIT4;PID1;RTRAF;LRRK2;NF1;PTEN;TARBP2;CORO1C;LDLRAD4;PDPK1;PAQR3;GREM1;ATG14;CNKSR3;INPP5K;HSPB1;PTPN6
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.34315743328458287,-1.1648193232966384,0.21951219512195122,0.8534637661950252,1.0,11/31,13.30%,DLG2;PRKCI;LIN7A;SYNJ2BP;PARD3;MYO9A;WDR1;DLG1;LIN7C;MTCL1;EZR
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.5986821972206808,1.1647333476622457,0.30597014925373134,0.6820896721303475,1.0,3/10,8.33%,DIP2B;MYOCD;FLCN
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.5463072127387479,1.1647278714461957,0.3178893178893179,0.6815841866178907,1.0,6/18,16.02%,MDK;CXCR4;TMEM98;TNFRSF21;TNFRSF1B;NF1
prerank,response to amino acid starvation (GO:1990928),0.4645500558672411,1.1641576963145692,0.2578616352201258,0.6826497912061912,1.0,23/72,19.41%,ATP6V0D2;ATP6V0E1;TCIRG1;MTOR;ATP6V1C1;ATP6V1E1;TFEB;MAP3K5;SEH1L;ATP6V0D1;CEBPB;FLCN;LARP1;IMPACT;DAP;LAMTOR3;ATP6V0B;RNF152;GCN1;LAMTOR1;ATP6V1F;RPTOR;SEC13
prerank,cellular biogenic amine metabolic process (GO:0006576),0.5774836171974562,1.1637462351992653,0.3090128755364807,0.6833178179074993,1.0,4/12,14.71%,ATP7A;DDC;AMD1;MAOA
prerank,regulation of hippo signaling (GO:0035330),0.5400456335401504,1.1635226828055696,0.3222811671087533,0.6834288897574458,1.0,4/17,10.93%,MAPK14;WWC2;MAP2K3;NF2
prerank,organic substance transport (GO:0071702),0.45656975768324354,1.1634620481885412,0.20121951219512196,0.6831065159219603,1.0,25/121,18.21%,SLC6A3;SLC6A4;ABCA1;SLCO2B1;ATP8A1;GM2A;MFSD2B;CLN8;ABCG1;MYH9;RAB7A;ABCD1;RAMP1;TAP1;ARRDC4;ABCA4;CUBN;SCAMP2;SLCO1B1;ABCA3;SLC18A1;TAP2;ABCD2;VPS33B;LRP1B
prerank,cardiac muscle cell development (GO:0055013),0.5358717796916448,1.1633180989211205,0.29213483146067415,0.6829933730602419,1.0,3/20,4.39%,SLC8A1;TTN;MYLK3
prerank,regulation of cell-cell adhesion (GO:0022407),0.49507840340838877,1.162748150550849,0.2972677595628415,0.684061618386718,1.0,7/39,10.93%,FERMT3;TGFB1;ADAM8;SPINT2;FUT9;PODXL;NF2
prerank,regulation of angiogenesis (GO:0045765),0.45371039931945095,1.1625902815194358,0.1624874623871615,0.6839610492067129,1.0,20/192,7.43%,RUNX1;KLK3;GPNMB;PF4;ITGAX;CCR2;IL1A;SMOC2;PIK3CD;AQP1;ANGPT4;ANGPTL3;RGCC;PRKD2;PDCL3;TNFAIP3;PRKCB;CTNNB1;STAB1;VEGFB
prerank,regulation of MAPK cascade (GO:0043408),0.45179173056920785,1.1615948882977485,0.19157472417251756,0.6861523959533616,1.0,32/157,17.34%,PTPRC;LYN;SYK;FLT3;CD74;LAPTM5;TAOK3;PLCG2;PTPRJ;DUSP3;P2RX7;OSM;TRIM5;HMGB1;TNIK;ATP6AP2;DUSP19;MAP2K2;GPR37;IAPP;STK3;SOX2;LBH;TMEM106A;PHLPP1;BCAR3;NF1;STK4;EPHA8;IQGAP1;KSR1;LAMTOR1
prerank,mitochondrial fusion (GO:0008053),-0.39170581330348153,-1.161529355614386,0.25510204081632654,0.8589133362486154,1.0,9/18,25.71%,AFG3L2;SPG7;GDAP1;BAX;MFN2;MIGA2;MIEF1;STOML2;MIEF2
prerank,regulation of macroautophagy (GO:0016241),0.460447795750968,1.1612974157308131,0.22278738555442523,0.6864758839337078,1.0,24/105,14.61%,ATP6V0D2;ATP6V0E1;SNX5;MTOR;ATP6V1C1;ERN1;ATP6V1E1;CLN3;ATP6V0A2;SCOC;ATP6V0D1;LARP1;PAFAH1B2;SMG1;ATP6V0A1;HDAC6;EXOC8;EXOC7;EXOC1;IKBKG;LAMTOR3;GNAI3;LRRK2;ATP6V0B
prerank,protein kinase B signaling (GO:0043491),0.5150863068807384,1.160969719986707,0.31476997578692495,0.6868990133445313,1.0,9/23,24.65%,TGFB1;TNF;CCL2;GAS6;PTEN;ZFP36L1;MT3;IGF1;KDR
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.5645000514302794,1.160533374121989,0.31039136302294196,0.6876232046274351,1.0,1/13,1.91%,CYRIB
prerank,regulation of microtubule nucleation (GO:0010968),-0.46422763233382314,-1.160417456667926,0.267515923566879,0.8574433877486161,1.0,2/10,4.47%,EML2;PAK1
prerank,regulation of endothelial cell migration (GO:0010594),0.4583517548714594,1.159828521528103,0.26202661207778916,0.689107677034773,1.0,16/85,11.64%,PTK2B;PIK3CG;RIN2;SMOC2;PIK3CD;ITGB3;ANGPT4;PIK3CB;PRKD2;APOE;PDCD6;BCAR1;NRP1;THBS1;GPI;GRN
prerank,autophagosome maturation (GO:0097352),0.5144750505825256,1.1594027244001095,0.28132118451025057,0.6897930041079554,1.0,12/32,21.74%,LIX1;MAP1LC3B;CLN3;VMP1;TECPR1;SNAP29;UVRAG;SNX14;VPS33B;ATG14;EPG5;VAMP8
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.47130796249216983,1.1592279747943128,0.2623294858342078,0.6897523996350104,1.0,20/65,18.67%,CBL;PTPRJ;DUSP3;GRB2;NUP62;ARAP1;DOK1;ZFYVE28;RHBDF2;SH3KBP1;DGKD;MVB12B;EPS15;BCAR3;RHBDF1;EPN1;PTPN12;PDE6H;CDC42;PTPN3
prerank,cardiac myofibril assembly (GO:0055003),0.5504059485326208,1.1591133954484911,0.3218543046357616,0.6895599246201677,1.0,3/15,6.76%,TTN;MYLK3;MEF2A
prerank,regulation of actin filament-based movement (GO:1903115),-0.4730693388549606,-1.1587755465639298,0.291970802919708,0.857674572330454,1.0,2/10,5.88%,ANK2;SRI
prerank,positive regulation of phosphorylation (GO:0042327),0.45154462705458215,1.1586076660732663,0.129,0.6904542306645299,1.0,23/240,5.61%,NCKAP1L;TREM2;GPNMB;LYN;TGFB1;FLT3;CD74;ITGB3;CSF1R;NIBAN1;P2RX7;MLXIPL;DSTYK;PTGES3;RAP2A;SEMA4D;CCND3;TNF;FNIP1;ITGA6;BRAT1;PFKFB4;CCND2
prerank,regulation of neuron migration (GO:2001222),-0.34826530609768347,-1.1585214853351764,0.22424242424242424,0.8534416407667482,1.0,8/26,4.32%,SEMA6A;NIPBL;COL3A1;NTNG1;SEMA3A;ULK4;DAB2IP;NEXMIF
prerank,regulation of gluconeogenesis (GO:0006111),-0.3453129045818566,-1.1584845518849523,0.2080536912751678,0.848494188219048,1.0,11/27,23.11%,OGT;DDB1;SIK1;SELENOS;ZNF692;DGKQ;ARPP19;C1QTNF3;NNMT;PDK2;CRY1
prerank,cellular response to insulin stimulus (GO:0032869),0.45315649602381153,1.1581513255984401,0.21148036253776434,0.6911786379541371,1.0,32/124,16.81%,ATP6V0D2;PCSK9;RAB8B;LPIN2;ATP6V0E1;MYO5A;TCIRG1;GRB2;ATP6V1C1;ATP6V1E1;ATP6V0A2;HDAC5;USF1;ATP6V0D1;ZDHHC7;RAB31;AP3S1;EPRS1;BCAR1;DENND4C;ATP6V0A1;ATP6AP1;ZNF106;PHIP;HDAC9;ATP6V0B;BCAR3;GSK3A;SYAP1;IDE;CPEB2;GCK
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.4607718688790951,1.1578683502699714,0.23243801652892562,0.6914632678642291,1.0,21/82,18.10%,TUBB;PRKAR2B;HAUS2;TUBA4A;CNTRL;CEP192;MAPRE1;TP53;CEP70;PLK4;CEP76;KIF14;HAUS1;DYNC1H1;PCM1;CEP152;HAUS8;NINL;HSP90AA1;AKAP9;CEP63
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.4499811418391032,1.1574032647908297,0.18756268806419257,0.6922432159267959,1.0,47/166,17.07%,SMOC2;PPP1R3E;NIBAN1;MTOR;MLXIPL;DHX9;ZEB2;TNF;SNCA;RGCC;ATP7A;PRKD2;PKD2;PLXNB2;SLC25A37;P2RX4;CIRBP;YTHDF3;LARP4B;SMAD3;PPARGC1A;NOS1AP;CPEB3;RPL26;BRPF3;THBS1;STN1;ZCCHC4;METTL3;KAT7;DNA2;PCIF1;DDAH1;POLDIP3;UPF3B;HNRNPD;STARD4;SOX4;SREBF1;BCAR3;PAOX;CD36;HIF1A;FAF1;HSP90AA1;GCK;RPS4X
prerank,positive regulation of signaling receptor activity (GO:2000273),0.48427510481020686,1.157210274483832,0.3055872291904219,0.6922926993288453,1.0,11/36,19.92%,CCR2;TAF1;HFE;NRP1;HDAC6;CCL2;BUD31;HIF1A;GREM1;ITGB1;RELN
prerank,generation of neurons (GO:0048699),0.45129853817213444,1.15719009145171,0.1686746987951807,0.6918364106584399,1.0,28/190,13.00%,RUNX1;ASCL1;SHH;CX3CR1;PCSK9;FZD10;HES7;FGF13;IER2;PLXNB2;MYT1L;BHLHE41;THOC2;FZD3;CTNNB1;LRP12;DISC1;MEF2C;PEX13;FUT9;MAP1B;OLIG1;ARTN;NRP1;CDK6;DDIT4;TAFA1;NAV1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.5346269841196561,1.157041790368657,0.32697201017811706,0.6917349852809417,1.0,5/20,9.69%,WDTC1;ERLIN1;ERLIN2;ACADL;PRMT3
prerank,pyruvate metabolic process (GO:0006090),0.47527984044193666,1.1570291742750416,0.2843243243243243,0.6912553840110547,1.0,15/52,16.87%,HK3;PFKL;ALDOB;ENO3;SLC16A1;GPI;PDHA1;HK2;VDAC1;ME3;GAPDHS;GCK;LDHA;PGAM4;PGAM1
prerank,protein export from nucleus (GO:0006611),0.5060282393444933,1.156244218803017,0.3022432113341204,0.6929662636508308,1.0,11/27,22.38%,TGFB1;XPO1;CSE1L;STRADB;TPR;XPO6;STRADA;SMURF1;DESI1;CHP1;XPO7
prerank,positive regulation of sodium ion transport (GO:0010765),0.5780468961891547,1.1560371564295322,0.32878581173260574,0.6930279725394566,1.0,3/12,8.16%,SCN4B;PKP2;PRSS8
prerank,nuclear migration (GO:0007097),0.5664521930670737,1.1558847942801929,0.3125,0.6929252018243243,1.0,1/13,0.15%,HOOK3
prerank,transcription by RNA polymerase III (GO:0006383),0.5152615885074707,1.155207115243391,0.31585220500595945,0.6943473650827968,1.0,10/27,19.16%,IVNS1ABP;GTF3C4;GTF3A;POLR2L;SNAPC3;ELL;RO60;SNAPC4;ICE2;CRCP
prerank,phosphate ion transmembrane transport (GO:0035435),0.5784423659929379,1.1546388204458249,0.30374479889042993,0.6954322898900507,1.0,4/12,13.02%,SLC37A2;XPR1;SLC20A2;SLC25A30
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5228101200214988,1.154589798166127,0.3088942307692308,0.6950591504497546,1.0,2/27,1.05%,TREM2;FCGR2B
prerank,regulation of oxidative phosphorylation (GO:0002082),0.550626005431581,1.1544584767814234,0.3195739014647137,0.6949179976637285,1.0,3/16,7.24%,MLXIPL;ATP7A;ABCD1
prerank,amino acid transmembrane transport (GO:0003333),0.47633444184865814,1.1535429668192254,0.2743169398907104,0.6969334774858924,1.0,10/45,13.28%,LRRC8D;SLC7A7;SLC7A8;SLC38A6;SLC36A1;SLC38A4;SLC16A2;SLC36A4;SLC25A18;SLC38A10
prerank,protein localization to cell periphery (GO:1990778),0.44561937499799636,1.1535214202526034,0.21471774193548387,0.6964774689022506,1.0,40/133,19.95%,MRAP;FYB1;RAB8B;RAB34;MYO5A;RABEP1;FGF13;RAP2A;PKP2;TNF;TTC7A;TSPAN32;RAMP1;TNIK;PACS1;TSPAN14;RAB11A;RAB40C;F11R;CACNB2;DENND4C;ZDHHC3;SEC16A;ATP1B3;GAS6;PDZD11;RAP1A;GAK;EFR3A;SMURF1;ANK1;SPTBN4;FLOT1;TESC;PACS2;RAB29;ROCK2;FCHO2;INPP5K;P2RY1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.4541652607788719,1.1534730146857777,0.23529411764705882,0.6961129886224294,1.0,25/102,16.81%,PCSK9;ADCY7;RAB8B;LPIN2;PRKAR2B;MYO5A;CYSLTR2;PRKCD;ADCY6;HDAC5;USF1;RAB31;EPRS1;DENND4C;PRKACB;HDAC9;NR4A1;NFKB1;ADCY3;ADCY8;SRC;GSK3A;SYAP1;CPEB2;GCK
prerank,cellular response to nitrogen compound (GO:1901699),0.5282743093478685,1.1528693035453528,0.3046192259675406,0.6973143591536854,1.0,10/20,24.44%,NR1H4;DDI2;HSF1;ATRX;RIOK3;ROCK2;SPIDR;EPG5;ATP2B4;DDX11
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.5658357813393189,1.152139627170818,0.3161559888579387,0.6988813692490561,1.0,2/13,2.82%,CD74;DHX9
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.45271314832570425,1.1521244371456396,0.23293172690763053,0.6984026061120354,1.0,32/128,18.76%,ARRB2;TGFB1;NRROS;CBL;TGFBR1;ITGB5;ARHGEF18;SKI;HPGD;ZMIZ2;RNF111;TGFBR2;HFE;TGFBRAP1;ZFYVE9;SMAD3;F11R;INHBA;NLK;BAMBI;MEGF8;STUB1;ZYX;USP9X;SRC;SMURF1;LPXN;APPL2;FURIN;RHOA;ITGB1;LTBP2
prerank,positive regulation of protein import (GO:1904591),0.4976180039806772,1.1517388696835897,0.3089430894308943,0.6989911960836405,1.0,5/30,10.11%,TGFB1;HCLS1;PRKCD;SMAD3;TPR
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.4572692207629397,1.1516340857987488,0.23469387755102042,0.6987680194136859,1.0,31/101,17.07%,TGFB1;NIBAN1;MTOR;ATG7;AURKAIP1;PLXNB2;ASPH;CIRBP;YTHDF3;TBC1D10A;VPS11;LARP4B;BAK1;CPEB3;AMER1;RPL26;INHBA;THBS1;ZCCHC4;METTL3;CASP8;PCIF1;STUB1;POLDIP3;UPF3B;HNRNPD;SOX4;CAPN3;FAF1;HSP90AA1;RPS4X
prerank,cAMP metabolic process (GO:0046058),0.5626532237245442,1.1515139248876598,0.31412894375857336,0.6986069805129254,1.0,4/13,13.49%,ADCY7;ADCY6;ADCY3;ADCY8
prerank,negative regulation of cellular catabolic process (GO:0031330),0.46543860318938834,1.151240083492009,0.2946145723336853,0.6988536677488397,1.0,15/63,16.01%,TREM2;IL10RA;MTOR;TIMP1;EIF4G3;NELL1;DAP;TAB2;SORL1;FOXK1;BMF;TAB3;TBC1D14;GSK3A;NRDE2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5336395309815027,1.1509802957760595,0.3068181818181818,0.6990932182618191,1.0,5/21,10.29%,HPSE;SULF2;HS3ST4;XYLT1;EXTL3
prerank,protein phosphorylation (GO:0006468),0.44322101083478244,1.1505085678574976,0.07,0.6998807033561983,1.0,107/478,17.40%,PTK2B;BTK;FGR;LYN;GMFG;HCK;TGFB1;SYK;FLT3;MAPKAPK3;RSKR;FNIP2;PIK3CD;MAP4K1;TAOK3;CSF1R;TGFBR1;TYK2;PRKCD;GTF2H1;TLR2;CAMK1D;MTOR;BMP2K;TEC;TLR7;MAPK14;GRK3;MAP2K6;ERN1;NEK6;CDK14;PRKD2;MYLK3;CDK8;MORC3;TLK1;TAF1;PRKCB;MKNK1;CDK11B;STK10;TGFBR2;MAP3K5;PIM1;PLK4;WNK1;CDK17;PIM2;TNIK;PLK2;CSNK1G2;CHEK2;PRKCQ;CSNK2A2;CSNK2A1;MAP3K1;STRADB;ABI1;SMG1;PRKCH;CDK7;STK17B;STK32C;FAM20C;RNASEL;PKN1;TXK;RPS6KA4;NLK;PRKACB;CCL2;CSNK1A1;FYN;GRK4;MAP3K12;CDK6;CREB1;LIPE;MERTK;CAMKK2;BRAF;GAS6;STK3;STK24;BMX;LRRK2;NIM1K;WNK4;TESK2;SRC;STRADA;SGK3;GSK3A;RPS6KA2;CDK15;MAP3K11;INCENP;EPHA4;COQ8B;STK4;EPHA8;PPP3CB;PIK3R4;RPS6KA5;CDK18;SIK2
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4902668997962798,1.150130268154227,0.3162684869169511,0.7004250311770008,1.0,8/36,11.24%,TGFB1;ANGPT4;TNF;RGCC;APOE;HMGB1;MEF2C;THBS1
prerank,organelle organization (GO:0006996),0.4414090695202114,1.1500095051727839,0.082,0.700222062086713,1.0,113/388,20.78%,FGD2;PLEKHM2;SPTBN5;ATP8B4;LMAN1L;PEX11A;RAB34;THY1;RAB32;NCKIPSD;MTFR2;MDK;TMED3;ATXN7;ATP7A;PKD2;APOE;PYROXD2;REEP6;PI4K2A;RAB14;VPS18;ARFGEF1;TNFAIP3;NDP;PLD2;RAB7A;FMNL3;SYNE1;TTC29;FGD6;USP6NL;CAPZB;LONP1;NEDD9;ABCD1;YTHDF3;IRAG2;RANBP10;VMP1;MICAL1;TNIK;SH3KBP1;VPS11;MSTO1;RAB31;SIPA1;ARHGAP21;ARHGAP10;PPARGC1A;VAPB;TMCC1;BNIP1;DIAPH1;CCL13;ATL1;CCL2;PEX7;PHIP;PRDX3;SEC16A;CSNK1A1;PI4K2B;WDR81;SEC16B;RANBP9;SAR1A;FNBP1L;TOR1AIP2;TOR1A;HCFC1;ATAD3A;DES;HUWE1;TRAPPC11;LRRK2;GAK;EPS15;ABCA3;SIPA1L3;AGTPBP1;TWNK;DST;PDCD6IP;PDZD8;YME1L1;PLAAT3;WDPCP;PNPLA3;BIN1;LMAN2;ANK1;CDC42;ABCD2;LYSMD3;GOLGB1;GOLPH3;UBXN2A;ATL2;MCOLN1;RAB29;DNM1L;PALLD;OPTN;SORT1;ATL3;TRAPPC12;SEC31A;KIF3A;NSFL1C;COG7;PRKN;SPTSSB
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.509189586523111,1.1493673103496336,0.31235154394299286,0.7015202978582208,1.0,6/27,8.09%,PRKCD;PTPN1;PTPRE;PIP4K2A;PRKCB;PRKCQ
prerank,negative regulation of macroautophagy (GO:0016242),-0.341240301195676,-1.1485111728085182,0.22981366459627328,0.8754562917525595,1.0,16/26,23.76%,MTM1;FEZ1;NRBP2;TMEM39A;LZTS1;PINK1;CHMP4B;CHMP4A;AKT1;NUPR1;CLEC16A;PHF23;USP36;SMCR8;FEZ2;UBQLN4
prerank,neuron differentiation (GO:0030182),0.44866743636622153,1.1481868780239923,0.20402010050251257,0.7043081901978986,1.0,18/165,11.07%,RUNX1;ASCL1;SHH;PCSK9;FZD10;TGFBR1;IER2;ATP8A2;MYT1L;THOC2;FZD3;CTNNB1;WNK1;MEF2C;MYO7A;FUT9;INHBA;OLIG1
prerank,macrophage differentiation (GO:0030225),0.5621403918827365,1.1476165585216431,0.35956580732700133,0.7054441693541416,1.0,6/13,24.08%,CSF1R;CASP8;CDC42;PARP1;VEGFA;IL15
prerank,alanine transport (GO:0032328),0.5846380555654757,1.1476029736900915,0.32220609579100146,0.7049663057014167,1.0,3/10,15.10%,SLC36A1;SLC36A4;SLC1A4
prerank,regulation of cytoplasmic transport (GO:1903649),0.5789159479488577,1.1471025092194065,0.3314993122420908,0.7058539656753022,1.0,5/11,15.27%,DNAJC13;MAP2K2;USP7;LRRK2;SRC
prerank,positive regulation of signaling (GO:0023056),0.4839627660127377,1.1459828142281945,0.30502793296089387,0.7085333440089604,1.0,5/37,6.74%,CLSTN1;VAMP3;TNF;SNCA;CD80
prerank,lipoprotein biosynthetic process (GO:0042158),0.5811296003689026,1.1459376703334574,0.32409972299168976,0.7081424376032491,1.0,2/11,4.14%,ATG7;APOE
prerank,negative regulation of viral release from host cell (GO:1902187),0.5681652180623342,1.1457457932377813,0.33511348464619495,0.7081679698953481,1.0,4/13,11.59%,TRIM5;TRIM8;MID2;TRIM35
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.5435865581897222,1.1457192441782864,0.3187250996015936,0.7077264202632563,1.0,2/16,4.10%,SHH;PKD2
prerank,extracellular matrix organization (GO:0030198),0.4419370811991685,1.1457087571406772,0.143,0.707243763893693,1.0,34/276,7.70%,CTSS;ITGAL;MMP12;ITGA2B;ITGAX;TGFB1;ITGB2;LCP1;SMOC2;ITGA4;SH3PXD2B;ITGB3;TGFBR1;ITGB5;ADAM8;ITGA2;CTSK;CTSL;ADAMTS8;ITGA6;ATP7A;COLGALT1;TTR;TGFBI;CRTAP;SPP1;TIMP1;CD44;ITGAE;TNR;AGRN;CREB3L1;P4HB;LOX
prerank,carboxylic acid transmembrane transport (GO:1905039),0.4856621942982645,1.1455774788271933,0.3112359550561798,0.7070948214196854,1.0,10/40,13.28%,SLC7A7;SLC7A8;SLC38A6;SLC36A1;SLC38A4;SLC36A4;SLC16A1;ABCC1;SLC25A30;SLC38A10
prerank,negative regulation of myotube differentiation (GO:0010832),0.5683801983363808,1.1453572290227523,0.3291492329149233,0.7071939974384661,1.0,3/12,9.95%,BHLHE41;HDAC5;HDAC4
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.5871067876556325,1.1451282246244021,0.3422222222222222,0.7073398955713467,1.0,5/10,22.07%,SNCA;HDAC6;ETFBKMT;PRKN;MT3
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.47718535693439273,1.1449499227891768,0.3068432671081678,0.7073435983688049,1.0,18/42,22.57%,VARS1;FARSB;GARS1;PPA2;RARS1;EPRS1;QARS1;LARS2;CARS2;DARS1;DARS2;TARS2;FARS2;AIMP1;TARS1;YARS1;SARS1;SARS2
prerank,cellular response to amino acid starvation (GO:0034198),0.4566487358421799,1.1448757508060088,0.2879581151832461,0.7070375359827002,1.0,22/71,19.41%,ATP6V0D2;ATP6V0E1;TCIRG1;MTOR;ATP6V1C1;ATP6V1E1;TFEB;MAP3K5;SEH1L;ATP6V0D1;CEBPB;FLCN;IMPACT;DAP;LAMTOR3;ATP6V0B;RNF152;GCN1;LAMTOR1;ATP6V1F;RPTOR;SEC13
prerank,striated muscle contraction (GO:0006941),0.4689157178914553,1.1448708032783148,0.2980769230769231,0.7065396642197926,1.0,10/53,15.11%,SCN4B;MYL3;SLC8A1;TTN;STAC;TNNT3;DTNA;STAC3;ARHGEF11;RCSD1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.48715782431320753,1.144478375063659,0.3150984682713348,0.7071788791694937,1.0,11/36,16.71%,IL1A;PIK3CB;TNF;GCH1;APOE;DNM2;NOS1AP;SPR;DDAH1;HIF1A;HSP90AA1
prerank,cellular response to reactive oxygen species (GO:0034614),0.4640600103648143,1.1435728526386657,0.29758149316508936,0.7092343726229626,1.0,12/59,13.08%,NFE2L2;SIRPA;AQP1;PRKCD;PKD2;TNFAIP3;ANXA1;MAP3K5;IMPACT;HDAC6;PRDX3;CAMKK2
prerank,membrane lipid catabolic process (GO:0046466),0.5911645824858045,1.143479831176597,0.3413597733711048,0.7089944890809166,1.0,2/10,6.72%,SGPL1;FUCA1
prerank,positive regulation of dephosphorylation (GO:0035306),0.5089023893605324,1.1432541137283359,0.32593457943925236,0.7091087411339428,1.0,13/27,24.55%,TGFB1;PRKCD;SPPL3;SRC;PTPA;SMPD1;ANKLE2;PTBP1;PIN1;MTMR9;PPP1R16B;CAMTA1;PPIA
prerank,cellular response to metal ion (GO:0071248),0.4462705159592424,1.1431421658923622,0.23737373737373738,0.7089077546825032,1.0,42/123,22.27%,SLFN14;SYT17;ADCY7;LGMN;AQP1;PLCG2;RASA4;SNCA;PKD2;RASGRP2;P2RX4;MEF2A;SYT2;HFE;MEF2C;SYT10;HSF1;GLRA2;B2M;BRAF;ADCY8;LRRK2;CAPN3;IQGAP1;SCN5A;ADD1;TIGAR;MCOLN1;HVCN1;SMPD1;ATP13A2;PRKN;ITPKB;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,neuron projection fasciculation (GO:0106030),-0.46187076699316226,-1.1430815096838807,0.30952380952380953,0.8882963942996402,1.0,3/10,4.78%,SEMA5A;ARHGAP35;EPHB2
prerank,purine ribonucleotide transport (GO:0015868),0.5372296248718023,1.1427578753742975,0.3398184176394293,0.7094889997161631,1.0,2/16,2.47%,ABCC6;LRRC8D
prerank,positive regulation of metabolic process (GO:0009893),0.45189928403767743,1.1426590539832404,0.26299694189602446,0.7092503633067446,1.0,24/103,16.91%,IRF4;SYK;CCR2;FABP4;CAMK1D;TNF;CXCR4;IL18;ACADL;CEBPB;FABP5;HSF1;PPARGC1A;CMKLR1;ADIPOR1;DYNC1H1;PRLR;FASN;ACACA;CD36;ZBTB7B;ADIPOR2;APPL2;CPT2
prerank,regulation of peptide hormone secretion (GO:0090276),0.45863996125986334,1.1424821728167673,0.2928870292887029,0.7092423298690456,1.0,16/67,16.82%,KCNJ11;FFAR2;TNF;RASL10B;CHD7;CACNA1A;HFE;TFAP2B;ITPR2;ENSA;SLC8B1;KCNA5;RAP1A;CACNA1D;GCK;PPP3CB
prerank,negative regulation of angiogenesis (GO:0016525),0.4553731389383251,1.1424171079803744,0.25925925925925924,0.7088972807970917,1.0,10/84,7.23%,KLK3;PF4;CCR2;ANGPT4;PIK3CB;TNF;RGCC;CTNNB1;STAB1;CREB3L1
prerank,cGMP-mediated signaling (GO:0019934),0.5664185997437837,1.1422926399811646,0.3310719131614654,0.7087273848864778,1.0,2/13,4.14%,AQP1;APOE
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4667742961366025,1.142269175882891,0.28511087645195354,0.7082852593755465,1.0,14/60,13.46%,CSF1R;MED17;CDK8;CTNNB1;TP53;TNRC6A;CEBPB;MOV10;AGO4;ATF7IP;MED27;SOX9;AGO3;NFKB1
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.3287933303067315,-1.141885126163582,0.1774193548387097,0.8870294678655879,1.0,13/33,22.05%,WDR33;SCAF8;FIP1L1;CPSF7;CSTF2;PAPOLA;SNRPD3;MAZ;CSTF3;SNRPG;SNRPF;CSTF2T;NCBP2
prerank,negative regulation of cell motility (GO:2000146),0.4479128232897741,1.1417004667811184,0.2515400410677618,0.7094443236741013,1.0,26/108,16.50%,SHH;TMIGD3;CD74;PTPRJ;THY1;DUSP3;SLURP1;RAP2A;MITF;FOXO3;MCTP1;NKX2-1;RAP2B;FLCN;SPINT2;DUSP10;PODN;VCL;NF2;PTPRU;ADARB1;STK24;PTPRT;NF1;EPHA4;PTEN
prerank,negative regulation of chemokine production (GO:0032682),0.5568958388672569,1.141495999200875,0.32849604221635886,0.709536188480918,1.0,1/14,1.41%,SIRPA
prerank,cellular component assembly (GO:0022607),0.44130723940543315,1.1409496160100094,0.169,0.7105405807491355,1.0,44/253,14.80%,NCKAP1L;PTK2B;TGFB1;CD3E;LCP1;NEFH;CD74;VAMP3;SKAP2;SNX9;PLS1;WIPF1;PKP2;MITF;TRAF2;TEAD1;AIF1;ACTB;TP53;NEDD9;YTHDF3;VMP1;MICAL1;CAPZA1;HFE;TRIP13;PPARGC1A;EPRS1;ACTG1;TUBGCP4;PARVB;LIMS1;SOX9;CYFIP1;DET1;MDN1;RANBP9;IKBKG;GAS6;DARS1;TSPAN4;NOC2L;JHY;CAPN3
prerank,lung epithelium development (GO:0060428),0.5883756473057878,1.1407504180842802,0.324438202247191,0.7105815947227663,1.0,1/10,0.60%,ASCL1
prerank,proteoglycan metabolic process (GO:0006029),0.5001689126650799,1.1404309130354815,0.3337349397590361,0.7109740290201967,1.0,5/26,12.61%,HPSE;SULF2;HS3ST4;XYLT1;B4GALT7
prerank,regulation of sister chromatid cohesion (GO:0007063),0.5729367718454316,1.1402241069493566,0.3328550932568149,0.7110711340878635,1.0,3/12,8.46%,ESPL1;CTNNB1;RB1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.5029393154685196,1.1401490371253997,0.31220657276995306,0.710790746052694,1.0,9/28,16.65%,PRKCD;PTPN1;PTPRE;PIP4K2A;PRKCB;PRKCQ;PID1;GSK3A;APPL2
prerank,L-glutamate transmembrane transport (GO:0015813),-0.4778650202885987,-1.1396376586246082,0.3300653594771242,0.8894702123705099,1.0,3/10,6.22%,SLC25A12;ARL6IP5;SLC25A13
prerank,membrane protein proteolysis (GO:0033619),0.48422958162654484,1.1395677741587353,0.2945823927765237,0.7118931569944583,1.0,9/37,14.82%,TGFB1;NAPSA;MYH9;PRKCQ;SPPL3;PARL;NFKB1;ERAP1;SPPL2A
prerank,regulation of organelle assembly (GO:1902115),0.4544998340916252,1.1394980962169738,0.29002079002079,0.7115840467448815,1.0,27/72,19.79%,HCK;TBC1D10C;TBC1D16;TBC1D22A;USP6NL;PLK2;MTMR3;TBC1D10A;CEP76;VPS11;RNF4;RAB1B;TBC1D2;TBC1D17;TBC1D2B;TBC1D8;ATXN2L;TBC1D14;TBC1D22B;PDCD6IP;ATG3;RABEP2;DYNC2LI1;TBC1D12;TBC1D5;TRAPPC12;SENP6
prerank,glycogen metabolic process (GO:0005977),-0.3327417058769351,-1.1388141380651526,0.24812030075187969,0.8871503683360629,1.0,11/27,21.94%,PGM1;PHKA2;PYGB;PHKG2;UGP2;PHKB;PYGM;PER2;AGL;PPP1R3C;PHKA1
prerank,metanephros development (GO:0001656),0.5080758432570208,1.138533832731458,0.3237410071942446,0.7138102967918399,1.0,3/26,4.10%,SHH;BASP1;PKD2
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.3328148228006119,-1.1384746775406092,0.275,0.8834004473585216,1.0,11/33,13.59%,TJP1;SEMA6A;BMPER;EPN2;SYNJ2BP;KLF2;SMAD1;RHOJ;KLF4;ADAMTS9;GLUL
prerank,regulation of sensory perception of pain (GO:0051930),-0.45449737681884245,-1.1378181991086938,0.2966666666666667,0.8804469665116065,1.0,7/11,39.42%,ATPSCKMT;CCN3;ZFHX2;ACP3;SPX;F2R;TMEM100
prerank,apical protein localization (GO:0045176),-0.46478968614721844,-1.137114561643988,0.3146417445482866,0.8775812943516694,1.0,6/10,21.36%,SHROOM3;SHROOM2;ATP8B1;JAM3;GOPC;VANGL2
prerank,positive regulation of chromatin organization (GO:1905269),0.5656658779408277,1.1369755024886705,0.33810888252148996,0.7177766623487363,1.0,7/12,22.85%,TAL1;ATRX;UBE2N;TINF2;TERF2;H3-3A;TERF2IP
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5014149125095213,1.1362171645927381,0.33454545454545453,0.7194397034214426,1.0,9/24,20.52%,PTPRJ;THY1;DUSP3;LIMS1;NRP1;ARF6;MAPRE2;IQSEC1;MAP4K4
prerank,neuropeptide signaling pathway (GO:0007218),0.4632935691022927,1.1359276023672467,0.2914466737064414,0.7197477086862782,1.0,9/58,12.78%,CYSLTR2;GALR1;SORCS3;PPY;CYSLTR1;GPR37;GLRA2;LTB4R2;SORL1
prerank,carbohydrate homeostasis (GO:0033500),0.458875750595472,1.135902025086282,0.2998955067920585,0.719313078698533,1.0,19/67,20.09%,MLXIPL;FFAR2;CEBPA;TENT4B;USF1;TFAP2B;VGF;SLC8B1;ADIPOR1;ADCY8;MBD5;WFS1;SOX4;ADIPOR2;APPL2;GCK;KLF7;INPP5K;PYGL
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5662177118232284,1.1356895170612986,0.35607094133697137,0.7193970694857676,1.0,3/11,13.59%,PRKCD;MAP3K5;STK24
prerank,transition metal ion transport (GO:0000041),0.4896071610742881,1.135651474975147,0.31483578708946774,0.7189851482189156,1.0,7/35,14.34%,SLC11A1;ATP7A;ATOX1;IREB2;ATP2C1;FTH1;SLC31A2
prerank,cytosolic calcium ion transport (GO:0060401),-0.3379658876531438,-1.135285339984419,0.2265193370165746,0.8782931476980158,1.0,9/28,12.43%,CACNA1C;RYR2;AFG3L2;MICU1;JPH1;ITPR3;SLC35G1;MCUR1;CACNA2D1
prerank,copper ion transport (GO:0006825),0.5823185538325871,1.1352023296256848,0.35492957746478876,0.7197240194758685,1.0,4/11,15.44%,ATP7A;ATOX1;SLC31A2;STEAP3
prerank,regulation of glycogen metabolic process (GO:0070873),0.5576245253466022,1.134362897737452,0.33052039381153303,0.7215872402195452,1.0,1/12,1.62%,PPP1R3E
prerank,regulation of amyloid fibril formation (GO:1905906),0.5556458202532737,1.134353174409943,0.33065595716198126,0.7210998135319417,1.0,2/15,4.14%,TREM2;APOE
prerank,regulation of protein import into nucleus (GO:0042306),0.4802759412435443,1.1343487054871646,0.3096846846846847,0.7205963809026377,1.0,6/36,10.11%,TGFB1;HCLS1;PRKCD;SMAD3;MDFIC;TPR
prerank,glucose metabolic process (GO:0006006),0.4645157110064518,1.1335700063819332,0.31329113924050633,0.722235208659855,1.0,14/58,17.26%,KCNJ11;AKR1A1;ALDOB;BRAT1;SORD;ENO3;TFAP2B;PPARGC1A;LRP5;GPI;GAPDHS;PGAM1;GALM;PPARD
prerank,BMP signaling pathway (GO:0030509),-0.2660395425255284,-1.133487628560184,0.17857142857142858,0.879291727459349,1.0,15/62,14.77%,BMPR1A;SLC33A1;RGMA;BMP4;ACVR1;TGFBR3;ACVRL1;SMAD9;BMP5;SMAD4;SMAD5;SMAD1;RGMB;SMAD6;TGFB3
prerank,activin receptor signaling pathway (GO:0032924),0.5455784837205508,1.1332927507734156,0.3403416557161629,0.7225399958412098,1.0,3/15,10.54%,TGFBR1;SMAD3;INHBA
prerank,epithelial cell differentiation (GO:0030855),0.4461044160687154,1.1332584013364988,0.2882051282051282,0.7221387573795326,1.0,9/88,9.80%,LGALS3;ASCL1;CTSB;BASP1;DMBT1;ANXA1;ZDHHC7;TDRD7;ANXA4
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.5294354649684797,1.1329549504747196,0.35435056746532156,0.7225090581272686,1.0,10/19,20.78%,SREBF2;CSNK2A2;HDAC6;CAMKK2;SREBF1;VDAC1;GSK3A;DNM1L;ATP13A2;PRKN
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.4712348328043974,1.1328976545657725,0.33763440860215055,0.7221720683329717,1.0,10/51,14.53%,NCKAP1L;TAOK3;ATP7A;DNM2;TNIK;KIF20B;NTF3;DTNBP1;LRRK2;SNX2
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.4940286493837936,1.1322316969829582,0.3287037037037037,0.7234909831357272,1.0,7/33,8.66%,PLCG2;CCND3;RGCC;CCND2;ANXA1;AIF1;LSM11
prerank,respiratory chain complex IV assembly (GO:0008535),-0.3565356591734057,-1.1320855996427734,0.27450980392156865,0.8789900376646586,1.0,13/21,30.05%,COX16;OXA1L;COX18;COX15;COA8;COX14;COX17;TIMM21;COA5;SCO1;COA3;COX10;SURF1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.5345755378894942,1.131922792048662,0.348,0.7238689366115558,1.0,3/15,15.56%,DDC;SMOX;PAOX
prerank,protein localization to plasma membrane (GO:0072659),0.43968760610489177,1.1319020912583164,0.25783619817997977,0.7234205320104279,1.0,37/129,19.95%,MRAP;FYB1;RAB8B;RAB34;MYO5A;FGF13;RAP2A;PKP2;TNF;TTC7A;TSPAN32;RAMP1;TNIK;PACS1;TSPAN14;RAB11A;RAB40C;F11R;CACNB2;DENND4C;ZDHHC3;SEC16A;ATP1B3;GAS6;RAP1A;GAK;EFR3A;SMURF1;ANK1;SPTBN4;FLOT1;TESC;PACS2;ROCK2;FCHO2;INPP5K;P2RY1
prerank,positive regulation of angiogenesis (GO:0045766),0.446106800223578,1.1318720887506815,0.2591093117408907,0.7229799730729145,1.0,13/108,7.43%,RUNX1;ITGAX;IL1A;SMOC2;PIK3CD;AQP1;ANGPT4;MDK;ANGPTL3;PRKD2;PDCL3;PRKCB;VEGFB
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5118880800605421,1.1314669608356376,0.3575757575757576,0.7235910460019481,1.0,2/22,3.44%,GPNMB;RAP2A
prerank,cation transmembrane transport (GO:0098655),0.4660820191742457,1.131300430230503,0.33187294633077763,0.7235270103505971,1.0,6/44,10.22%,KCNJ11;SLC25A20;SLC7A8;PKD2;SLC25A38;SLC36A4
prerank,regulation of cellular pH (GO:0030641),0.49645631947890784,1.1311194168082033,0.3356643356643357,0.723530730137705,1.0,10/29,22.06%,SLC9A4;CLN3;SLC9A9;SLC9A1;ATP6AP1;LACC1;SLC9A8;SLC9B1;SLC9A7;CHP1
prerank,mRNA destabilization (GO:0061157),0.4780163587421336,1.1310906895177981,0.33560864618885095,0.7231085962792796,1.0,15/38,22.43%,PLEKHN1;YTHDF3;RC3H2;ZC3H12D;MOV10;RC3H1;CPEB3;METTL3;MEX3D;TUT7;ROCK2;FTO;DIS3L2;ZFP36L1;CNOT1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.46036842712224507,1.1309217852782107,0.29947089947089944,0.7230673181685346,1.0,10/67,12.44%,PTK2B;CD3E;CASS4;RREB1;MDK;NEDD9;P4HB;LIMS1;NRP1;CDK6
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.2874394093291143,-1.1307516212345947,0.1044776119402985,0.878511967623074,1.0,21/53,22.04%,PSME4;PSMD11;PSMA5;PSMA4;PSMD14;AZIN1;PSMC6;PSMC3;PSMB3;PSMC1;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;BCKDK;ODC1;PSME2;PSMB4;PSMC4;PSMB6
prerank,anion transport (GO:0006820),0.4887383238147887,1.1307002121490912,0.3262092238470191,0.7231733554257095,1.0,8/33,17.02%,TSPO;SLCO2B1;LRRC8D;VDAC2;VDAC1;SLCO1B1;LRRC8C;SLC13A3
prerank,negative regulation of JNK cascade (GO:0046329),0.5025532350750479,1.1304770582349468,0.3472222222222222,0.7232756548369884,1.0,11/31,20.78%,SIRPA;TAOK3;DUSP3;DUSP10;DUSP19;ITCH;GPS2;DACT1;PER1;ZMYND11;PRKN
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.4008223787222355,-1.1303125468097417,0.30434782608695654,0.8750782731345581,1.0,5/15,19.88%,RSPO3;NPHP3;GPC3;WNT5B;SPEF1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.4490305605351446,1.1302260300983566,0.2786220871327254,0.7234524123777906,1.0,33/107,20.86%,NIBAN1;ERN1;HERPUD1;TRAF2;ATF3;SEL1L;DDIT3;TP53;MAP3K5;CREB3L1;P4HB;CEBPB;TMX1;BAK1;DERL1;CREB3L2;THBS1;SEC16A;ATF6B;ATP2A3;WFS1;CCDC47;SELENOK;PDIA3;ERO1A;ERP44;FLOT1;ERLEC1;OS9;QRICH1;GSK3B;PRKN;TMEM259
prerank,endocardial cushion morphogenesis (GO:0003203),-0.3906128234826526,-1.1301185378537058,0.2602739726027397,0.8710718129523863,1.0,4/18,5.20%,BMPR1A;BMP4;ACVR1;ACVRL1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.5348432702550378,1.1300644490474476,0.3462532299741602,0.7234131595839814,1.0,8/18,20.79%,CAMK1D;PRKD2;RPS6KA4;LRP8;ADCY8;RPS6KA5;RELN;CRTC3
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.5120963845311173,1.129945798589053,0.3565426170468187,0.7232450244467084,1.0,7/23,20.69%,PLEK;CBFA2T3;HDAC4;GSK3A;GCK;TIGAR;CLK2
prerank,regulation of protein localization to cell surface (GO:2000008),0.48599028630647545,1.1299161031416394,0.3381858902575588,0.7228137036951038,1.0,15/33,25.14%,TNF;SNX33;CTNNB1;TYROBP;HFE;NEDD4L;RAB11FIP5;STX3;TOR1A;PICALM;LEPROTL1;ABCA2;GPM6B;GPD1L;HSP90AB1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.49490996975161394,1.1298865593480596,0.35079726651480636,0.7224037299631749,1.0,4/32,4.10%,P2RY6;THY1;SNCA;PKD2
prerank,regulation of dephosphorylation (GO:0035303),0.5396941202515181,1.1298641876259128,0.35131396957123096,0.7219593027597921,1.0,7/15,26.03%,MTMR3;SRC;SMG7;INPP5K;MTMR9;PPP1R16B;CDK5RAP3
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.4720549375493627,1.1295472722484505,0.3273542600896861,0.7223819644566872,1.0,8/39,13.40%,NFE2L2;ITGA4;TNF;RGCC;TNFAIP3;THBS1;CCL2;GAS6
prerank,epithelium development (GO:0060429),0.44617157427149085,1.1294261617183996,0.26417004048583,0.7221951476917345,1.0,7/107,5.04%,LGALS3;MEOX1;SHH;TGFB1;CTSB;PKD2;DMBT1
prerank,regulation of regulated secretory pathway (GO:1903305),0.4888403801392792,1.1292206297467813,0.3405714285714286,0.7222782274562349,1.0,6/34,11.08%,SYT17;UNC13D;VPS18;SYT2;SYT10;DTNBP1
prerank,central nervous system neuron differentiation (GO:0021953),0.487665887793271,1.1284903248210476,0.3321718931475029,0.7237647467420675,1.0,3/33,6.29%,DRAXIN;ATP7A;CTNNB1
prerank,ion transport (GO:0006811),0.44432410129237077,1.1280475654100872,0.2785065590312815,0.7244399898032857,1.0,21/111,14.90%,P2RX1;TSPO;SLC15A3;HCN4;SLC9A4;KCNN4;SLC8A1;SLC36A1;SLC9A9;CNGB1;WNK1;SLC9A1;AQP11;SLC8B1;SLC20A2;SLC25A18;CTNS;WNK4;SLC9A8;VDAC2;VDAC1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.4710956563008663,1.1272208504955927,0.3165938864628821,0.7263044818619193,1.0,10/47,14.70%,TGFB1;EDNRB;WDR91;APOE;FOXO3;INHBA;CYFIP1;PCIF1;NFKB1;PUM3
prerank,glutamate metabolic process (GO:0006536),0.5170960373006407,1.127115698297067,0.33250311332503113,0.7260771759754241,1.0,2/19,2.77%,DGLUCY;MTHFS
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.4885610453676213,1.1269799353804255,0.3416289592760181,0.7259347765074183,1.0,5/30,13.12%,LPAR6;GPR17;F11R;ADGRG1;ARHGEF3
prerank,N-glycan processing (GO:0006491),0.5286875646517832,1.1266175345488096,0.34096692111959287,0.7264446787801234,1.0,8/18,19.21%,MAN1C1;ST8SIA4;ST8SIA1;MAN2A2;GNPTAB;MGAT4B;MAN1A2;GANC
prerank,regulation of centrosome cycle (GO:0046605),-0.361862547447119,-1.1266172828904655,0.3081081081081081,0.8778158935988362,1.0,12/21,37.49%,NAT10;CHMP5;CHMP4B;MARK4;CHMP2A;NPM1;ATF5;CHMP4C;CHMP1B;GEN1;CEP131;XRCC3
prerank,melanosome organization (GO:0032438),0.49488697517908276,1.1265375572353504,0.33774038461538464,0.7261623794529223,1.0,5/26,13.34%,LYST;RAB32;AP3D1;DTNBP1;TRAPPC6A
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.44100022029195557,1.1264720809406341,0.27947154471544716,0.7258549341269511,1.0,46/110,25.69%,RPL23;RPL17;RPL10A;PNRC2;RPS2;RPL18A;RPS15A;GSPT1;CASC3;SMG1;RPL6;RPLP2;RPL26;CTIF;RPS20;RPS16;PPP2CA;RPS14;RPL19;UPF3B;RPL9;RPS11;RPL11;SMG7;RPS23;RPS4X;UPF2;RPS27;RPL4;PYM1;RPL7A;RPL15;RPL29;RPL22;RPS7;RPS13;EIF3E;RPLP1;RPS15;RPS5;RPL41;RPL10;NCBP1;RPS8;RPL5;RPL18
prerank,limb development (GO:0060173),-0.3393777600729935,-1.126251957166036,0.2535211267605634,0.8742179705945528,1.0,13/28,26.28%,PCSK5;KREMEN1;SALL1;GLI3;MAP3K20;RSPO2;PTCH1;FGF10;KAT2B;LRP4;IFT122;SMOC1;KAT2A
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.2899758632100732,-1.1261824055165728,0.14285714285714285,0.8697698935812789,1.0,20/50,22.04%,PSME4;PSMD11;PSMA5;PSMA4;PSMD14;AZIN1;PSMC6;PSMC3;PSMB3;PSMC1;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;ODC1;PSME2;PSMB4;PSMC4;PSMB6
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.4304810463253807,1.1257609929323111,0.041,0.7273364119231825,1.0,199/1082,14.68%,CD86;RUNX1;NFE2;LILRB1;IRF5;NPAS4;MMP12;PF4;ASCL1;CIITA;SHH;IRF4;IRF8;SLC11A1;TGFB1;HCLS1;GATA1;PCID2;CD74;NFE2L2;POU2F2;BRD8;LPIN2;NLRC5;SNX5;TGFBR1;NFATC1;MED17;RREB1;GTF2H1;MAD2L2;TLR2;MTOR;NSD1;MLXIPL;SS18L1;ELF4;DHX9;NUP62;ZEB2;IER2;OSM;SP7;MAML3;CREB3L4;CREB3;BARX2;NCK2;YAF2;RXRB;FOXD2;NR1H4;TNF;SREBF2;TET3;ITGA6;RGCC;PRKD2;PKD2;MLXIP;APOE;UBE2V1;BPTF;MITF;SKI;ATF3;CEBPA;CDK8;FOXO3;FHOD1;ZMIZ2;DDIT3;CXXC1;SPP1;SPI1;IL18;FIZ1;NDP;HIVEP3;HDAC5;GALR1;HMGB1;RNF111;FLI1;TEAD1;MRTFA;MAP2K3;CTNNB1;TFEB;DNM2;TP53;KLF6;CD80;MEF2A;AKNA;TBL1XR1;NKX2-1;NRL;TAL1;USF1;MAP3K5;MYOCD;AGRN;YY1;TCF20;SLC9A1;PIM2;ZFP90;EPO;CEBPB;ASXL2;ST18;LMO2;CHEK2;SNAI1;MEF2C;DOT1L;NKRF;CDC5L;FLCN;TFAP2B;BICRA;SMAD3;MMS19;AKIRIN1;ARID1A;IRF2;HSF1;MDFIC;PPARGC1A;ATRX;CDK7;CREBRF;RNF4;ATF7IP;STAT5B;MCRS1;LRP5;HDAC4;ACTR2;LITAF;ARID1B;RNF10;DDX39B;NFIC;ATAD2;SEC14L2;TBL1X;INHBA;ACTR3;TRIM56;RNASEL;MAP2K2;CREB3L2;TXK;ELF2;SOX9;RPS6KA4;PTOV1;NR2C2;NRIP1;PHIP;ATF6B;NOD2;MTF2;MAP3K12;ELL;HEATR1;CREB1;LAGE3;IKBKG;ZFP64;KAT7;BAMBI;SMARCD3;NR4A1;MAX;CAMKK2;SMARCB1;GPS2;NFKB1;FOXK1;GPATCH3;HCFC1;PCBP1;ZFHX3;IRF1;INO80;PID1;RTRAF;SOX2;BRD7;HNRNPD;ELOF1;ARHGEF11;LBH;SOX4;SREBF1;MEIS1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.5532544721390651,1.1256737453699883,0.36439499304589706,0.7270831254218993,1.0,1/13,2.15%,TYK2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.5276954173006503,1.1256000250657778,0.3564993564993565,0.7267940865118493,1.0,3/17,11.18%,GMFG;WASF2;CYFIP1
prerank,sphingolipid metabolic process (GO:0006665),0.4449505766764609,1.125465696346039,0.2857142857142857,0.7266518804686808,1.0,33/108,21.46%,HEXB;CERS6;SGPL1;CTSA;GM2A;PSAP;CLN8;PRKD2;HEXA;SMPD3;CERK;CSNK1G2;HACD4;AGK;B3GALNT1;ACER3;VAPB;ORMDL2;PPP2CA;ARSA;SUMF2;NSMAF;ARV1;DEGS1;ASAH1;SGMS1;B4GALNT1;GBA2;SPTSSA;SMPD1;SPTSSB;ABCA2;SUMF1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.45696964578399557,1.1248355937626118,0.33121693121693124,0.7278784660730322,1.0,9/60,8.87%,SMOC2;PTGES3;PKIB;RGCC;PRKD2;XRCC5;CTNNB1;PRKCQ;CCT8
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.4316067324199462,1.1248003519510732,0.059,0.7274870441801072,1.0,145/834,13.98%,RUNX1;LILRB1;IRF5;NPAS4;MMP12;PF4;ASCL1;CIITA;SHH;IRF4;IRF8;SLC11A1;TGFB1;HCLS1;GATA1;NFE2L2;POU2F2;BRD8;LPIN2;NLRC5;NFATC1;MED17;RREB1;TLR2;MLXIPL;SS18L1;ELF4;DHX9;ZEB2;IER2;OSM;SP7;MAML3;CREB3L4;CREB3;BARX2;NCK2;RXRB;FOXD2;NR1H4;TNF;SREBF2;TET3;ITGA6;RGCC;PRKD2;PKD2;MLXIP;BPTF;MITF;SKI;ATF3;CEBPA;CDK8;FOXO3;FHOD1;ZMIZ2;DDIT3;SPI1;IL18;FIZ1;HDAC5;GALR1;HMGB1;RNF111;TEAD1;MRTFA;CTNNB1;TFEB;TP53;KLF6;MEF2A;AKNA;TBL1XR1;NKX2-1;NRL;TAL1;USF1;MYOCD;AGRN;LEO1;YY1;TCF20;SLC9A1;CEBPB;ASXL2;ST18;LMO2;MEF2C;DOT1L;NKRF;CDC5L;FLCN;TFAP2B;SMAD3;AKIRIN1;IRF2;HSF1;PPARGC1A;ATRX;CDK7;CREBRF;RNF4;STAT5B;MCRS1;LRP5;HDAC4;ACTR2;LITAF;RNF10;NFIC;ATAD2;TBL1X;INHBA;ACTR3;RNASEL;TXK;SOX9;RPS6KA4;PTOV1;NR2C2;NRIP1;PHIP;ATF6B;NOD2;MTF2;ELL;CREB1;LAGE3;IKBKG;ZFP64;KAT7;SMARCD3;NR4A1;MAX;SMARCB1;GPS2;NFKB1;HCFC1;PCBP1;ZFHX3;IRF1;INO80;PID1;RTRAF
prerank,long-chain fatty acid metabolic process (GO:0001676),0.4528860492030242,1.1246857413900972,0.31104033970276007,0.7272754719461036,1.0,6/64,7.24%,CYP1A1;ALOX12;DAGLB;HPGD;ACADL;ABCD1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.31886067398963536,-1.1239384454175891,0.23976608187134502,0.8721677031293592,1.0,10/30,10.62%,FSTL1;LTBP4;LATS1;TGFBR3;XIAP;PCSK6;SMAD4;FKBP1A;LATS2;TWSG1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.49855068970921895,1.123661502431185,0.35460122699386504,0.729622885472667,1.0,6/23,11.48%,TSPAN6;NLRC3;SPI1;ADGRG3;TMSB4X;ADIPOR1
prerank,endodermal cell differentiation (GO:0035987),0.48959957915675884,1.1234840568270663,0.334867663981588,0.7296152804276798,1.0,6/31,10.54%,ITGB2;ITGA4;ITGB5;LEO1;SETD2;INHBA
prerank,AMP metabolic process (GO:0046033),-0.4122823068438509,-1.1232980079562425,0.2915129151291513,0.8695921266724316,1.0,10/13,29.58%,ADSS2;NT5E;AK3;AMPD3;AMPD2;ADSL;AK4;NUDT2;NT5C1A;ADSS1
prerank,transcription preinitiation complex assembly (GO:0070897),0.5579916070471238,1.1231955497152863,0.3418803418803419,0.7298887759263988,1.0,5/12,18.83%,POLR1E;TAF1;BDP1;GTF2B;TAF11
prerank,positive regulation of heart contraction (GO:0045823),-0.3654074865729167,-1.123187811562449,0.3018867924528302,0.8653363240615185,1.0,8/19,29.71%,RYR2;ATP1A2;EDN1;EDN3;TGFB2;CHGA;ATP2A2;SCN3B
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.5407467395079415,1.1231836524516108,0.36426592797783935,0.729419877236692,1.0,4/13,8.99%,CNOT8;GTPBP1;MOV10;RC3H1
prerank,sensory perception of light stimulus (GO:0050953),0.4499633762530565,1.1231317821550388,0.3114754098360656,0.7290796633643531,1.0,14/87,14.21%,CABP4;DRAM2;DHRS3;ATXN7;GUCY2F;WHRN;RP2;CNGB1;MYO7A;CRYBB1;RPGR;CDH23;OAT;WFS1
prerank,plasma membrane organization (GO:0007009),0.46192840705162513,1.122989387142596,0.3108252947481243,0.728978245634089,1.0,20/61,17.98%,BIN2;P2RX7;SNX9;CLN3;CXCR4;SNX33;MYH9;MICALL1;ABCD1;SYTL4;DYSF;BIN3;FNBP1L;ARV1;DEGS1;AHNAK2;ARL8B;BIN1;STX2;ABCD2
prerank,positive regulation of response to stimulus (GO:0048584),0.4783781034106495,1.1229706258968146,0.32075471698113206,0.7285362292376156,1.0,7/40,15.19%,FCGR2B;PRKCD;DHX9;CD80;YPEL3;B2M;IER5
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.5119875901694497,1.122629301767868,0.3614163614163614,0.72898504453082,1.0,2/21,2.09%,SHH;RAB34
prerank,regulation of lymphocyte migration (GO:2000401),0.584617760349266,1.122529859275747,0.3497822931785196,0.7287512998155707,1.0,2/10,10.60%,STK10;SLC8B1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.43945016223066924,1.1225157468603228,0.2682186234817814,0.7282872105261988,1.0,33/124,17.93%,ARRB2;PLCB2;FZD10;NFATC1;FZD9;FZD3;CTNNB1;PSMB10;TNRC6A;AP2S1;MOV10;DAAM1;AGO4;PSMA2;PFN1;CLTC;NLK;AGO3;PSME3;PSMB5;PSMD8;GNG2;AP2M1;PSMD7;PSMB9;VANGL1;SMURF1;FZD8;PPP3CB;RHOA;PSMD2;AGO2;CDC42
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.4605447754979863,1.1225045561289393,0.34141201264488935,0.7278237565404401,1.0,13/52,15.03%,TREM2;LGALS3;PLS1;TNF;CLN3;AKAP5;STAC;ATP2C1;PRKCH;STX3;STAC3;ARF6;LRP1
prerank,cardiac muscle contraction (GO:0060048),0.47774021168601305,1.1222626704869219,0.3344594594594595,0.7279889707651604,1.0,4/34,4.28%,SCN4B;MYL3;SLC8A1;TTN
prerank,negative regulation of peptidase activity (GO:0010466),-0.2958223167926866,-1.122072328836083,0.2191780821917808,0.864355281517254,1.0,12/47,18.09%,SERPINH1;SERPINE2;SERPING1;TIMP2;SPOCK2;TIMP3;SERPINB9;SERPINF1;ECM1;AKT1;GAPDH;PARK7
prerank,regulation of protein dephosphorylation (GO:0035304),0.4809324507927106,1.1219479816720275,0.3447136563876652,0.7283512663693114,1.0,18/37,26.62%,TGFB1;PRKCD;PPP6R1;YWHAB;ENSA;SPPL3;PTPA;SMPD1;ANKLE2;PTBP1;PIN1;PPP1R16B;CAMTA1;PPIA;HTT;MFHAS1;TIPRL;TSC1
prerank,V(D)J recombination (GO:0033151),0.5610366341054536,1.121917197151525,0.35673352435530087,0.7279432553947228,1.0,2/11,6.22%,HMGB1;LIG3
prerank,anterior/posterior pattern specification (GO:0009952),0.4541374671445662,1.1218756171316373,0.33190578158458245,0.7275686410775009,1.0,9/53,10.28%,BASP1;TGFBR1;HES7;SKI;DDIT3;BHLHE41;ATP6AP2;LRP5;HOXA6
prerank,peptidyl-serine phosphorylation (GO:0018105),0.43686904044273417,1.1216436848618703,0.25728643216080405,0.7277231049457166,1.0,48/153,21.32%,MAPKAPK3;MAP4K1;TGFBR1;PRKCD;CAMK1D;MTOR;MAPK14;ERN1;NEK6;PRKD2;MORC3;TLK1;TAF1;PRKCB;MKNK1;TGFBR2;WNK1;PLK2;CSNK1G2;PRKCQ;CSNK2A2;CSNK2A1;SMG1;PRKCH;STK32C;MAP2K2;PKN1;RPS6KA4;NLK;CSNK1A1;MAP3K12;GAS6;LRRK2;SGK3;RPS6KA2;STK4;RPS6KA5;PDPK1;VRK1;TOP1;ROCK2;TLK2;DCLK3;CDK5R1;GSK3B;CSNK1G3;MARK1;BRSK1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.44694563448974145,1.121546474561031,0.30340557275541796,0.7274928906563707,1.0,16/73,13.66%,LAPTM5;MTCH1;TNF;SNCA;TRAF2;PYCARD;CASP1;XDH;APAF1;CFLAR;CRADD;SMAD3;DAP;CASP8;ATP2A3;TRADD
prerank,respiratory system development (GO:0060541),0.4866582695691861,1.1214707287219732,0.3352601156069364,0.727196050364913,1.0,5/32,6.82%,SHH;BASP1;CEBPA;CHD7;NKX2-1
prerank,retinoid metabolic process (GO:0001523),0.4487968607225264,1.121462188762617,0.3159541188738269,0.7267288949527286,1.0,10/71,15.03%,CYP1A1;LPL;DHRS3;APOE;TTR;AGRN;ABCA4;LRP8;RETSAT;LRP1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.44043688223113925,1.121402835179553,0.3085539714867617,0.7263995539649765,1.0,26/88,16.83%,MYO5A;RABEP1;AP1S3;EXOC6;CCDC93;RAB14;RP2;DNM2;VPS35L;CLINT1;AP1B1;FTL;ARFGEF2;DTNBP1;CLTC;EXOC8;EXOC1;SORL1;EXOC2;SNAP23;EXOC5;FTH1;SCAMP2;EPS15;TXNDC5;MON2
prerank,pulmonary valve development (GO:0003177),-0.36622639529005374,-1.1212979688738818,0.2833333333333333,0.862459117303358,1.0,8/18,14.15%,ROBO2;BMP4;ROBO1;SLIT2;NOS3;JAG1;SMAD6;STRA6
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.5183316736897793,1.121255541100848,0.35218508997429304,0.7263211724814874,1.0,5/18,15.64%,BHLHE41;HDAC5;HDAC4;SOX6;GSK3A
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.399814034387872,-1.1212327501829036,0.3034188034188034,0.8582652071690939,1.0,4/15,7.60%,ATF2;RAD17;TIPIN;MRE11
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.5078060089905889,1.1212242171430455,0.32515337423312884,0.7259035456274818,1.0,3/24,5.78%,LPCAT1;PGS1;CDS2
prerank,negative regulation of insulin secretion (GO:0046676),0.5255893437121121,1.12098117764709,0.34023285899094435,0.7261001011271786,1.0,1/17,0.63%,KCNJ11
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5662766896858059,1.1208073250541166,0.35497237569060774,0.7260658326547667,1.0,4/11,14.39%,ZMIZ2;ARID1A;ARID1B;ELOF1
prerank,response to muscle stretch (GO:0035994),0.5345601397049071,1.1203429801124287,0.3546284224250326,0.7268130307895935,1.0,4/15,7.37%,SLC8A1;TTN;CTNNB1;SLC9A1
prerank,positive regulation of cell cycle process (GO:0090068),0.44028974971008095,1.1201825298849932,0.3119266055045872,0.72679705046992,1.0,16/91,13.89%,PCID2;IL1A;NUP62;RGCC;PLK4;KIF14;KIF20B;KIF23;ATRX;LRP5;TPR;DBF4;PHIP;DYNC1H1;CDC6;INO80
prerank,regulation of synapse organization (GO:0050807),0.4964552034477465,1.1201140911403549,0.3486682808716707,0.726490015368286,1.0,6/26,11.66%,ARHGAP22;TNF;CLN3;ABHD17B;MEF2C;ABHD17C
prerank,negative regulation of nuclear division (GO:0051784),0.5604774790106435,1.1200761378505304,0.3548387096774194,0.7261002873171291,1.0,2/11,4.03%,NME6;AURKAIP1
prerank,positive regulation of potassium ion transport (GO:0043268),-0.3035628592775657,-1.1200238014269142,0.2523364485981308,0.857518033450184,1.0,8/38,10.54%,ANK2;KCNN2;FHL1;KIF5B;ACTN2;GABBR2;DLG1;KCNJ3
prerank,ceramide transport (GO:0035627),0.5534275870427585,1.1194397162975087,0.36023054755043227,0.7273389100085229,1.0,2/12,6.00%,PSAP;ABCB4
prerank,muscle tissue development (GO:0060537),0.5475956223446976,1.1188394672904691,0.371994342291372,0.7284651973993443,1.0,5/13,16.02%,SHH;SRPK3;POGLUT1;CSRP1;NF1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5811969114829073,1.1187303544571159,0.3743016759776536,0.7282511727800032,1.0,2/10,10.05%,PCSK9;NEDD4L
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.2734578146206499,-1.1177440991958667,0.20967741935483872,0.8601736351524418,1.0,25/55,22.47%,FBXL7;FHL1;PSME4;PSMD11;PSMA5;PSMA4;RBX1;PSMD14;PSMC6;PINX1;PSMC3;PSMB3;PSMC1;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;USP47;PSME2;PSMB4;PSMC4;SKP1;PSMB6;CUL1
prerank,smooth muscle cell differentiation (GO:0051145),0.5572509887016638,1.1176939332862803,0.36083916083916084,0.7305412277867483,1.0,4/12,8.10%,EDNRB;MRTFA;MYOCD;MEF2C
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.44380256183919053,1.117382441398469,0.3175745118191161,0.7309121015725054,1.0,20/90,16.91%,IRF4;SYK;CCR2;FABP4;CXCR4;IL18;ACADL;CEBPB;FABP5;HSF1;PPARGC1A;CMKLR1;ADIPOR1;DYNC1H1;PRLR;CD36;ZBTB7B;ADIPOR2;APPL2;CPT2
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4540767290784404,1.1172905117776233,0.3115942028985507,0.7306809960491965,1.0,17/66,16.65%,GPNMB;CCND3;RGCC;PKD2;CCND2;ANXA1;AIF1;KIF14;RB1;LSM11;CCL2;CDK6;PSME3;INO80;BRD7;PTEN;APPL2
prerank,negative regulation of protein modification process (GO:0031400),0.44928928840222365,1.1172181460883592,0.3363914373088685,0.7303923001126401,1.0,24/79,20.78%,LYN;TGFB1;SIRPA;DBI;NIBAN1;CRTAP;XDH;YWHAB;ENSA;IBTK;IMPACT;CDYL;PID1;LRRK2;PTPA;PTEN;CORO1C;PAQR3;ATG14;TINF2;INPP5K;FXYD1;GSK3B;PRKN
prerank,DNA replication initiation (GO:0006270),0.47457727224790297,1.1172106095028616,0.3490460157126824,0.7299193831584321,1.0,10/37,16.90%,MCM5;ORC3;MCM6;MCM2;DBF4;ORC4;CDC34;CDC6;NOC3L;LRWD1
prerank,cellular response to purine-containing compound (GO:0071415),0.5719013665304633,1.1169663905013383,0.34502923976608185,0.7300907361181651,1.0,2/10,3.19%,P2RY6;SLC8A1
prerank,nucleosome organization (GO:0034728),0.44894925326795226,1.1167379533702655,0.317937701396348,0.7302130167412503,1.0,13/55,15.28%,NFE2;BPTF;SRCAP;ARID1A;ATRX;SETD2;NAP1L1;SOX9;BRDT;SMARCD3;SMARCB1;INO80;SPTY2D1
prerank,regulation of monooxygenase activity (GO:0032768),0.5048175003740356,1.1162762630435332,0.34933973589435774,0.7310603969052851,1.0,10/23,20.67%,IL1A;SNCA;DNM2;NOS1AP;SPR;DDAH1;POR;HSP90AA1;GDNF;ZDHHC21
prerank,regulation of gene expression (GO:0010468),0.4265559790060198,1.1161771827252858,0.058,0.7308314964660703,1.0,175/903,16.43%,PTPRC;RUNX1;LILRB1;TREM2;PF4;LYN;CALCR;ASCL1;SHH;ITGAX;SLC11A1;TGFB1;CD3E;HCLS1;STAP1;LGMN;CD74;CAVIN4;NFE2L2;IL1A;SIRPA;VSIR;PIK3CD;RPL23;RBM38;HAVCR2;PLCG2;TGFBR1;RREB1;TLR2;P2RX7;MTOR;NSD1;MLXIPL;PIK3CB;MAPK14;MSR1;SLC8A1;PRDM12;YAF2;TRIM5;TNF;RGCC;APOE;UBE2V1;ZNF326;MITF;TTN;PDCL3;PPIE;NFXL1;CEBPA;DDIT3;CXXC1;SPI1;TRAF3;WWC2;XDH;ZUP1;HDAC5;TAF1;BACH1;BTN3A3;CHD7;SBNO1;TFEB;CDK11B;AIF1;TYROBP;DNM2;CCAR1;TP53;NKX2-1;TNRC6A;YY1;CREB3L1;NFKBID;GCFC2;TICAM1;CEBPB;HINT1;FOXN2;HFE;TGFBRAP1;CHEK2;GRSF1;PRKCQ;MEF2C;FLCN;MOV10;RB1;METTL4;TRIM27;LARP1;SMAD3;RC3H1;GTF2IRD1;IRF2;PPARGC1A;TDRD7;PCBP3;PUM2;ATRX;AGO4;RPL6;NOS1AP;ACTG1;HNRNPL;HDAC4;NFX1;SON;INHBA;MAP2K2;TXK;HCFC2;ZSCAN26;LIMS1;DTNBP1;SOX9;NELL1;RPS6KA4;HDAC6;NLK;AFF1;DENND4A;NR2C2;PTBP2;AGO3;ZNF628;GZF1;VSTM2A;TRA2B;PRX;MTF2;PPP2CA;CDK6;BRDT;SEC16B;ZFP64;KAT7;CASP8;COQ7;TIPARP;BRAF;FOXN3;FAM50A;GAS6;NFKB1;MEGF8;SOX6;HCFC1;PCBP1;ZFHX3;PID1;SOX2;HNRNPD;RO60;SOX4;IGF2BP3;ZBTB11;C1D;ICOSLG;SPTY2D1;TLE5;REXO4;GSK3A;AHNAK2;OGG1;CD36;RBPJ;FADS1;ZBTB7B;HIF1A;RPL11;SBNO2
prerank,glycerolipid metabolic process (GO:0046486),0.5714158164815937,1.1159835701249021,0.37765205091937765,0.7308390699703347,1.0,2/11,8.19%,DGKZ;DGKG
prerank,positive regulation of lipid metabolic process (GO:0045834),0.49827243753967854,1.1159270679602467,0.3580097087378641,0.7305042836209872,1.0,4/22,4.14%,MTOR;MLXIPL;ANGPTL3;APOE
prerank,response to UV-B (GO:0010224),-0.4357436533037751,-1.1152996956407462,0.3120567375886525,0.8634019333819657,1.0,5/12,22.36%,MSH2;MME;RELA;HYAL1;CDKN1A
prerank,response to ethanol (GO:0045471),0.5513423111152925,1.1147738407547727,0.35714285714285715,0.7332113206694004,1.0,2/14,2.97%,ADCY7;SDF4
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.5070420975715854,1.1147728050035457,0.36810551558752996,0.73223317473873,1.0,5/23,12.29%,ZEB2;RNF111;FLCN;THBS1;SDCBP
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.5070420975715854,1.1147728050035457,0.36810551558752996,0.73223317473873,1.0,5/23,12.29%,ZEB2;RNF111;FLCN;THBS1;SDCBP
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.4514265940470456,1.1142419103236263,0.33608247422680415,0.7331696642395914,1.0,17/78,15.64%,BAG2;NFE2L2;CBFA2T3;RNF180;RNF19B;HERPUD1;CEBPA;TAF1;HECTD1;FZR1;DET1;CSNK1A1;STUB1;RNF144B;LRRK2;PIAS1;GSK3A
prerank,regulation of amyloid-beta formation (GO:1902003),0.47789324670580957,1.114110083594656,0.3456221198156682,0.7330491461761002,1.0,18/34,25.48%,GSAP;TNF;ABCG1;APOE;SORL1;RTN1;GSK3A;RTN4;EPHA4;BIN1;PICALM;ROCK2;ABCA2;PIN1;EFNA1;IGF1;IFNGR1;GGA3
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.36934659081607196,-1.1138588926223598,0.31343283582089554,0.8635374314037247,1.0,6/20,8.55%,SEMA6A;SEMA5A;SEMA3A;SEMA6D;SEMA3C;SEMA3D
prerank,Golgi organization (GO:0007030),0.43619451363891487,1.113683043686865,0.3214649033570702,0.7336913781509222,1.0,36/112,20.57%,PLEKHM2;SPTBN5;ATP8B4;LMAN1L;TMED3;PI4K2A;ARFGEF1;SYNE1;USP6NL;VMP1;ARHGAP21;SEC16A;CSNK1A1;PI4K2B;SEC16B;STX5;HUWE1;TRAPPC11;VTI1A;LRRK2;GAK;LMAN2;CDC42;VRK1;LYSMD3;GOLGB1;GOLPH3;UBXN2A;ATL2;RAB29;OPTN;ATL3;TRAPPC12;SEC22B;NSFL1C;COG7
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.45793361109183617,-1.1136050193853222,0.3419354838709677,0.8600020045916875,1.0,4/10,13.25%,OGT;SELENOS;ZNF692;DGKQ
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.44761146863794676,1.1130547688563226,0.31611570247933884,0.7348804131750215,1.0,15/72,13.44%,TREM2;CORO1A;CYRIB;PRKCD;FGF13;SNCA;ATXN7;APOE;ARFGEF1;MAPRE1;PFN2;PFN1;IAPP;TWF2;SSH2
prerank,organophosphate biosynthetic process (GO:0090407),-0.30655711492541116,-1.113035324500523,0.3025210084033613,0.8575103863184322,1.0,12/37,20.85%,PPIP5K2;IP6K1;AGPAT4;GK5;AGPAT3;AGPAT5;IP6K2;GPHN;MBOAT1;ITPKC;IPMK;NFS1
prerank,calcium-ion regulated exocytosis (GO:0017156),0.48849120872811125,1.1122361823534732,0.33726415094339623,0.7366199345297845,1.0,4/27,9.11%,SYT17;SDF4;SYT2;SYT10
prerank,positive regulation of vacuole organization (GO:0044090),0.5702757914003859,1.1120490977477127,0.37735849056603776,0.7366290568527476,1.0,3/10,11.64%,PIP4K2A;RAB3GAP2;GRN
prerank,negative regulation of signal transduction (GO:0009968),0.43403669222625524,1.111977820337412,0.214,0.7363267197803267,1.0,30/249,9.43%,PTPRC;SLAMF1;LYN;UBASH3B;PLEK;CX3CR1;LGMN;NFATC1;PRKCD;PTPRJ;PTPN1;PIK3CB;PTPN18;TNF;SNCA;PTPRE;PIP4K2A;MGRN1;TNFAIP3;XDH;PRKCB;YWHAB;CREB3L1;PRKCQ;CSNK2A2;CSNK2A1;RB1;SULF2;PDCD6;QARS1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.3689949698840559,-1.1118197078515837,0.32057416267942584,0.8570678328376424,1.0,6/19,9.80%,APP;MAPK8;MTPN;KLF2;CHRNA7;KLF4
prerank,response to interferon-beta (GO:0035456),0.49268541349860145,1.1115480093062746,0.3565217391304348,0.7369850660791148,1.0,7/22,20.52%,AIM2;CDC34;UBE2G2;IRF1;IRGM;UBE2K;IFITM2
prerank,intracellular lipid transport (GO:0032365),0.5090237852289339,1.1114755540234584,0.3675,0.7366788107569856,1.0,7/21,17.98%,SLC25A20;NPC2;ABCD1;ARV1;ACACA;CPT2;ABCD2
prerank,O-glycan processing (GO:0016266),0.4514440808241716,1.110944041062556,0.3414893617021277,0.737675440757439,1.0,8/54,8.51%,GCNT1;GALNT10;MUC13;GALNT15;GALNT7;ST6GALNAC4;GALNT6;ST3GAL1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.35713690248397584,-1.110700891521006,0.3081395348837209,0.8563614322816356,1.0,7/22,7.97%,SCAF8;CDK12;THOC1;BRD4;THOC5;CCNK;CCNT1
prerank,rRNA metabolic process (GO:0016072),0.43061452352799706,1.110200326296481,0.27738693467336684,0.7392199397401605,1.0,45/160,21.04%,SLFN14;RPL23;RPL17;EMG1;RPL10A;UTP20;NOB1;TEX10;FBL;RPS2;EXOSC1;LAS1L;RPL18A;KRR1;RPL6;DDX27;RPLP2;RPL26;RPS16;MDN1;UTP11;HEATR1;RPS14;RPL19;IMP3;RPL9;PES1;C1D;PIH1D1;RPL11;WDR12;RPS27;RPL4;FCF1;WDR75;RPL7A;RPL15;EXOSC3;RPL29;RRP7A;UTP3;TRIR;RPL22;IMP4;RPS7
prerank,regulation of vasculature development (GO:1901342),0.4908439671592111,1.1099169576113446,0.35251798561151076,0.7394976390518565,1.0,2/26,6.29%,GPNMB;CTNNB1
prerank,regulation of biomineral tissue development (GO:0070167),0.49706217265300473,1.1097786706733188,0.3496420047732697,0.7393758402059555,1.0,5/26,13.40%,TGFB1;BMP2K;CEBPB;SOX9;GAS6
prerank,synaptic vesicle endocytosis (GO:0048488),0.47797422331755646,1.1092918558406428,0.3580931263858093,0.7401950637585311,1.0,10/33,14.65%,SNCA;PIP5K1C;CEL;DNM2;SYT2;STON2;ITSN1;STON1;SYNJ1;GAK
prerank,renal filtration (GO:0097205),0.5720348827324357,1.1092020866546002,0.3671071953010279,0.7399597561989175,1.0,2/10,8.85%,MYO1E;SULF2
prerank,limb morphogenesis (GO:0035108),0.5137760931098985,1.1090335568217737,0.3682896379525593,0.7399381551385199,1.0,4/20,13.51%,SHH;SKI;TFAP2B;MEGF8
prerank,negative regulation of defense response (GO:0031348),0.44151563356222456,1.108940851546502,0.32987551867219916,0.7396911428079403,1.0,9/77,5.09%,SIRPA;METRNL;PRKCD;NLRC3;NR1H4;APOE;OTULIN;TRAFD1;TNFAIP3
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.45438953425518164,1.1088201966859872,0.3351409978308026,0.7395290256313547,1.0,10/56,9.82%,ESPL1;CCND3;RGCC;CDC23;CCND2;ANXA1;AIF1;RB1;LSM11;RAB11A
prerank,organonitrogen compound catabolic process (GO:1901565),0.4521082193711246,1.108806431505077,0.35232067510548526,0.7390655810263315,1.0,15/57,17.55%,SGPL1;NPL;MTOR;CLN8;RENBP;NAGK;PLA2G7;LIPC;TXN2;NAALADL1;TRIM24;ERAP1;CAPN3;IDE;USE1
prerank,adenine nucleotide transport (GO:0051503),0.5181308827000145,1.1080237491718143,0.37017994858611825,0.7406912007349177,1.0,2/17,2.47%,ABCC6;LRRC8D
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.4435670648057308,1.1079664367172002,0.33436853002070394,0.7403511644047918,1.0,16/74,13.30%,TGFB1;TGFBR1;MAD2L2;MTOR;MDK;RGCC;CTNNB1;TGFBR2;NKX2-1;SNAI1;SMAD3;ADIPOR1;SDCBP;PPP2CA;BAMBI;VASN
prerank,chloride transport (GO:0006821),-0.26815458448645846,-1.1079400119112996,0.2894736842105263,0.8608429500715798,1.0,17/74,17.41%,SLC12A2;CLIC4;SLC12A7;SLC4A10;GABRB2;CLCN6;GABRB1;SLC26A7;GABRA2;CLIC5;CLCN2;GABRB3;TTYH3;ANO4;TTYH1;SLC12A8;GLRB
prerank,positive regulation of nervous system process (GO:0031646),0.5194971729092568,1.1073535706421163,0.3560606060606061,0.7415095550293345,1.0,4/18,11.69%,ITGAX;CST7;RNF10;TNFRSF1B
prerank,ubiquinone metabolic process (GO:0006743),0.5148392130958576,1.1071287555528253,0.37967914438502676,0.741613130592268,1.0,8/15,21.43%,COQ9;PDSS1;COQ7;COQ8B;FDXR;COQ3;COQ6;UBIAD1
prerank,regulation of receptor binding (GO:1900120),0.5659705818887841,1.107093821004799,0.37175792507204614,0.7412300307857412,1.0,3/10,13.41%,HFE;B2M;ATP2A3
prerank,cardiac ventricle morphogenesis (GO:0003208),0.45975508988001396,1.1064576464594689,0.3511111111111111,0.7425135092547641,1.0,8/41,16.11%,TGFB1;MYL3;PKP2;TGFBR2;MEF2C;SOX4;GSK3A;RBPJ
prerank,regulation of cell population proliferation (GO:0042127),0.4251512665525958,1.1063686337046066,0.109,0.7422703032814093,1.0,110/691,14.77%,CD86;RUNX1;PTK2B;SLAMF1;GPNMB;PF4;LYN;SHH;HCK;ITGAX;TGFB1;CXCL5;HCLS1;FLT3;TMIGD3;LGMN;STAT5A;IL1A;TSPO;CBFA2T3;RPL23;CSF1R;TGFBR1;PTPRJ;TCIRG1;SLURP1;MLXIPL;S100B;TNFRSF11A;ADAMTS8;NUP62;OSM;UTP20;NCK2;IL12RB2;RGCC;PKD2;SKI;IL6R;CNOT8;CEBPA;ATP8A2;TIMP1;CCND2;XRCC5;SPEG;CTNNB1;AIF1;GAB2;CCAR1;TGFBR2;TP53;RPS15A;MYOCD;CCKBR;PIM2;STAT4;EPO;ST18;FLT3LG;AQP11;KIF14;DOT1L;CSNK2A1;TFAP2B;KIF20B;GID8;PODN;NTF3;HSF1;CCL14;ABI1;STRN;P3H2;ACER3;STAT5B;LRP5;HDAC4;NAP1L1;INHBA;SH2B3;NF2;LIMS1;SOX9;CHERP;THBS1;PTPRU;AGO3;PHIP;PRDX3;CIAO1;SDCBP;CDK6;ADGRG1;TBC1D8;NRG1;STX3;BAMBI;ADARB1;PRLR;DDAH1;CDC6;RAB33B;IRF1;FTH1;BRD7;SOX4;MEIS1;TMEM127;PRKRA
prerank,protein deneddylation (GO:0000338),0.5759759853349233,1.1061957773642774,0.37695590327169276,0.7422574284665975,1.0,3/10,13.52%,COPS6;COPS4;TOR1A
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.5563075522646509,1.1059172726737094,0.3881019830028329,0.7425691981719851,1.0,6/12,19.31%,ACTB;ZDHHC7;ACTG1;AHI1;LAMA3;SCRIB
prerank,positive regulation of peptidase activity (GO:0010952),0.5148810315512418,1.1054834731734686,0.35406091370558374,0.7432351982965476,1.0,4/20,12.47%,VSIR;TANK;GRN;PSME3
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5376484725396065,1.1052793657636386,0.38114209827357237,0.7433344819596814,1.0,3/13,11.83%,SULT4A1;BPNT1;TPST1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5311537599130959,1.1047447564383672,0.3669724770642202,0.7442949241440328,1.0,6/15,23.65%,TNF;TICAM1;NOD2;HIF1A;GBP5;STAT3
prerank,regulation of lipid kinase activity (GO:0043550),0.5536189173229819,1.1043180406896196,0.38095238095238093,0.7449859698758429,1.0,3/11,12.33%,WDR91;RB1;WDR81
prerank,regulation of protein phosphorylation (GO:0001932),0.4320244039067457,1.1041947896434445,0.23023023023023023,0.744844085912098,1.0,56/256,18.59%,TREM2;GPNMB;FGR;LYN;TGFB1;ITGB2;CD74;SIRPA;FNIP2;ITGB3;CSF1R;NIBAN1;NSD1;RAP2A;SEMA4D;CCND3;TNF;FNIP1;TTN;PDCL3;ATF3;PLXNB2;BRAT1;XDH;CCND2;VEGFB;TNIK;CEBPB;FLCN;IBTK;IMPACT;SOX9;PHIP;FYN;PPP2CA;PPIL4;CAMKK2;NPTN;GAS6;MOB1B;PID1;LRRK2;AKAP8L;WDFY2;IRGM;PTEN;HSP90AA1;STK4;PECAM1;CORO1C;SPTBN4;FLOT1;PAQR3;ANGPT1;PPP2R5C;VEGFD
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.478943355048631,1.103886050038869,0.35260115606936415,0.7452011422584806,1.0,7/34,11.23%,CASS4;RREB1;MDK;NEDD9;P4HB;LIMS1;NRP1
prerank,establishment of spindle orientation (GO:0051294),-0.3237543364951131,-1.103725265733325,0.3049645390070922,0.8700960879077444,1.0,6/28,11.09%,PAFAH1B1;MAP4;GPSM2;NDEL1;NDE1;CDK5RAP2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5361718331887643,1.1031275396472555,0.37551581843191195,0.7468121666030877,1.0,3/13,11.23%,PLXNC1;PLXNB2;NRP1
prerank,protein stabilization (GO:0050821),0.4282621988622118,1.1031203675694594,0.2796780684104628,0.7463410877670742,1.0,63/168,22.44%,BAG2;RPL23;PRKCD;GNAQ;PTGES3;PDCL3;SEL1L;CRTAP;MORC3;TAF1;OTUD3;TYROBP;PIM2;CHEK2;CCT8;PPARGC1A;CDK7;ATF7IP;PFN2;TBL1X;USP7;PFN1;NLK;GRN;SEC16A;WDR81;CREB1;ATP1B3;STK3;HCFC1;ATP1B2;CCT5;USP9X;WFS1;BAG1;SOX4;PRKRA;RTN4;IRGM;EPHA4;RPL11;PTEN;STXBP4;HSP90AA1;STK4;VHL;CREBL2;FLOT1;TESC;COG7;TELO2;NAA15;PRKN;BAG4;RPS7;CRYAB;PIN1;FLNA;WIZ;CHP1;MT3;MTMR9;MDM4
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5644360195481934,1.1030800544427453,0.3764367816091954,0.7459594889904451,1.0,5/11,15.93%,PCBP3;ZNF445;PCBP1;IGF2BP3;RASA1
prerank,regulation of cellular catabolic process (GO:0031329),0.45177871228732774,1.1029995330357818,0.34635691657866946,0.7457119325796896,1.0,21/62,21.78%,DRAM2;WDR91;PSAP;GPR137B;PIP4K2A;DDIT3;DCAF12;ABCD1;MTMR3;RAB39B;HDAC6;VPS29;LRRK2;KEAP1;RPTOR;HSPB1;OSBPL7;PRKN;RRAGA;SCARB2;RRAGB
prerank,regulation of p38MAPK cascade (GO:1900744),0.4717491502281657,1.1026344941691142,0.345372460496614,0.7462127280123636,1.0,6/35,10.77%,TREM2;SPI1;XDH;GADD45B;DUSP10;RELL1
prerank,glial cell development (GO:0021782),0.48825523296758355,1.1023998191490285,0.3730814639905549,0.7463374329269713,1.0,7/25,16.02%,NRROS;TLR2;MDK;EIF2B2;CDK6;SOX4;NF1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.4326699228422824,1.102394563757717,0.32175689479060265,0.7458701958774787,1.0,23/94,18.10%,TUBB;MKS1;PRKAR2B;HAUS2;TUBA4A;CNTRL;CEP192;MAPRE1;CEP70;PLK4;CEP76;HAUS1;RAB11A;DYNC1H1;PCM1;CEP152;HAUS8;CEP162;AHI1;NINL;HSP90AA1;AKAP9;CEP63
prerank,intermediate filament organization (GO:0045109),0.5166386379054146,1.1021323192703794,0.37789203084832906,0.7461121747164305,1.0,5/17,17.62%,BFSP2;PKP2;GFAP;DES;DNAJB6
prerank,fatty acid oxidation (GO:0019395),0.4438516615619633,1.1020137439416027,0.36264929424538545,0.7459631599520248,1.0,16/57,18.65%,ALOX12;EHHADH;ACAD10;ACADL;ABCD1;PEX13;PPARGC1A;ECHS1;ILVBL;ECI1;ADIPOR1;ADIPOR2;CPT2;PPARD;ABCD2;ECHDC1
prerank,response to estradiol (GO:0032355),0.4793993273234786,1.10186551255488,0.3648960739030023,0.7458349575402344,1.0,5/31,11.82%,TGFB1;CTNNB1;ANXA1;STAT5B;NRIP1
prerank,tube closure (GO:0060606),0.474164941103669,1.1013929487293823,0.37284234752589185,0.7466069084971411,1.0,3/31,4.59%,TGFB1;SKI;PLXNB2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.4522352526153078,1.1013414765467393,0.3704918032786885,0.7462785136217137,1.0,7/43,6.51%,P2RY6;ERN1;TNF;LDLRAP1;IL6R;IL18;AIF1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.44132223274616206,1.1010831806404,0.3495248152059134,0.7464776220372037,1.0,26/73,22.83%,SMYD5;TAF1A;POLR1E;DNMT3A;SF3B1;SPI1;HDAC5;ACTB;TRIM27;HDAC4;POLR1B;POLR2L;HDAC6;RBBP7;MTF2;ERCC6;TASOR;MYO1C;PHF1;POLR2E;RBBP4;EED;TAF1C;SMARCA5;AEBP2;H3-3A
prerank,negative regulation of gene expression (GO:0010629),0.422851998330069,1.1007004175782835,0.241,0.7470559344100852,1.0,48/302,13.46%,RUNX1;SLFN14;GPNMB;SLC11A1;SMYD5;TGFB1;CD3E;FCGR2B;LGMN;SRGN;HAVCR2;MSR1;ERN1;DNMT3A;TNF;RGCC;APOE;CNOT8;SPI1;XDH;PPP1R11;TAF1;TNRC6A;YY1;CREB3L1;ZC3H12D;MEF2C;FLCN;MOV10;RB1;ATP2B1;TRIM27;LARP1;EPRS1;AGO4;CPEB3;MAP2K2;RPS6KA4;PTBP2;AGO3;RBBP7;METTL3;HDAC9;MTF2;NPTN;TIPARP;PCIF1;NFKB1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.5505697648368058,1.1005711450791735,0.3755334281650071,0.7469334060956527,1.0,2/11,6.70%,MAD2L2;TP53
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.4418861050661574,1.1004369147103168,0.34332988624612204,0.746803085957058,1.0,7/75,6.60%,KLK3;PF4;CCR2;ANGPT4;RGCC;CTNNB1;STAB1
prerank,primary neural tube formation (GO:0014020),0.4768578502177246,1.1002005688639067,0.380897583429229,0.7469437365219942,1.0,3/30,4.59%,TGFB1;SKI;PLXNB2
prerank,positive regulation of synaptic transmission (GO:0050806),0.4402333415383139,1.1001941393744596,0.3667711598746082,0.7464767831369894,1.0,12/72,13.49%,PTK2B;CCR2;LGMN;CLSTN1;TNF;AKAP5;PLK2;ZDHHC3;DTNBP1;CCL2;NPTN;ADCY8
prerank,organic acid transport (GO:0015849),0.43283861140185764,1.1000747038055385,0.3319672131147541,0.7462874978150454,1.0,21/94,18.30%,SLC16A10;SLCO2B1;LRRC8D;ABCC3;SLC7A7;SLC7A8;NR1H4;SLC36A1;SLC38A4;SLC43A2;SLC6A15;SLC16A1;SLC25A30;SLC25A45;SLCO1B1;SLC1A4;SLC43A1;SLC13A3;PPARD;STARD5;RXRA
prerank,regulation of vasoconstriction (GO:0019229),-0.3264055199511817,-1.1000582616010404,0.3352941176470588,0.8772133889533372,1.0,11/27,27.30%,CAV1;ECE1;ACE;CHRM3;PER2;TBXA2R;BMPR2;KCNMB2;AGTR1;ACE2;AGT
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.41583973868979457,-1.100053043663073,0.34545454545454546,0.8729429227407829,1.0,7/13,23.42%,NOS3;GLUL;NOS1;GAD1;GLS;GLS2;ALDH4A1
prerank,fat cell differentiation (GO:0045444),0.44909766270624224,1.0997016598216545,0.3572938689217759,0.7467434226076131,1.0,13/57,15.24%,METRNL;SDF4;FFAR2;CEBPA;OSBPL11;BBS9;TFAP2B;PPARGC1A;NR4A1;TMEM120A;ERAP1;PID1;OSBPL8
prerank,regulation of vasculogenesis (GO:2001212),0.5459958089419956,1.0995026487633701,0.3925233644859813,0.7467681788373397,1.0,2/14,5.36%,RIN2;XDH
prerank,nuclear body organization (GO:0030575),-0.41621838870476424,-1.0992873060678607,0.3242320819112628,0.8709193957758142,1.0,4/12,22.96%,AFF2;PML;WRAP53;USP50
prerank,glutamate receptor signaling pathway (GO:0007215),0.4680036061832026,1.098610672545258,0.360529217199559,0.7487365248133185,1.0,4/37,4.53%,PTK2B;DAGLB;GNAQ;CLN3
prerank,cellular response to calcium ion (GO:0071277),0.44359620287530294,1.098521653129698,0.35548523206751054,0.7484704232824481,1.0,18/67,19.88%,SYT17;LGMN;PLCG2;RASA4;PKD2;RASGRP2;MEF2A;SYT2;MEF2C;SYT10;BRAF;ADCY8;CAPN3;IQGAP1;SCN5A;ADD1;MCOLN1;SMPD1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.4980474987023125,1.098170792839545,0.3982947624847747,0.748927063766642,1.0,7/24,14.53%,CREB3;HERPUD1;BCL2L1;CREB3L1;AQP11;WFS1;LRRK2
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4600221002784065,1.0972386756742356,0.36577181208053694,0.75087111832273,1.0,8/40,11.23%,TGFB1;P2RX7;SLC8A1;FZD9;CEBPB;MEF2C;ATP2B1;NELL1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5335142073888265,1.0971053103599464,0.38154269972451793,0.7507397622406661,1.0,3/14,13.40%,RFFL;GPS2;GAS6
prerank,regulation of cellular protein localization (GO:1903827),0.4566951010509409,1.097019567624205,0.37093275488069416,0.7504750309057701,1.0,14/45,21.61%,SHH;LCP1;PTPN1;CTNNB1;HFE;SETD2;RAB11FIP5;TOR1A;HSP90AA1;CCDC66;ATP13A2;SPIDR;ABCA2;PIN1
prerank,negative regulation of hormone secretion (GO:0046888),0.5644911905120211,1.0969479918768732,0.38619676945668135,0.750175138395762,1.0,2/10,12.59%,OSM;RAB11FIP5
prerank,I-kappaB phosphorylation (GO:0007252),0.5713714910003387,1.0966651915335466,0.3875181422351234,0.7504682522365256,1.0,2/10,2.91%,TLR2;TLR7
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.3313641273204885,-1.096371613534085,0.29411764705882354,0.8758841992637355,1.0,4/26,4.70%,ANK2;FHL1;ATP1B1;ACTN2
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.4831187262529904,1.0959441329238302,0.3726190476190476,0.751922492013883,1.0,5/27,10.81%,TGFB1;DHX9;TP53;PUM2;MAP2K2
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.551660671562004,1.0959229111375293,0.4052924791086351,0.7514995453441298,1.0,2/11,4.62%,FBL;TENT4B
prerank,carboxylic acid transport (GO:0046942),0.44493781200638377,1.095337879339701,0.36989247311827955,0.7525742075737686,1.0,14/55,17.42%,PSAP;SLC7A8;SLC38A6;CLN3;SLC36A1;SLC16A2;SLC6A15;SLC36A4;SLC16A1;SLC66A1;SLC1A4;SLC16A6;SLC13A3;SLC16A13
prerank,regulation of protein catabolic process (GO:0042176),0.4327163033119119,1.0951760506587478,0.33537206931702346,0.7525321294504851,1.0,38/99,22.74%,CTSA;MAD2L2;WDR91;ATG7;TNF;TNFAIP3;RAB7A;PLK2;CHEK2;CSNK2A1;NEDD4L;GFAP;FZR1;SORL1;ITCH;STX5;TIPARP;HUWE1;AREL1;GSK3A;SMURF1;IDE;FAF1;VPS28;FURIN;DACT1;SEC22B;WWP1;SF3B3;ATP13A2;GSK3B;PRKN;AZIN2;ZDHHC2;PIN1;FLNA;MDM4;NKD1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.3269538690950864,-1.0950701587717602,0.3284671532846715,0.8758080357202269,1.0,10/29,17.36%,RAB6A;GOSR1;COG2;COPZ2;TRAPPC3;COG1;RAB6B;COPB1;VTI1B;COPG2
prerank,long-chain fatty acid transport (GO:0015909),0.47393566619265814,1.0949775896610066,0.35259433962264153,0.7525811371634341,1.0,9/30,17.98%,FABP4;SLC25A20;APOE;ABCD1;FABP5;ACACA;CD36;CPT2;ABCD2
prerank,secretion (GO:0046903),0.5408853398984176,1.0946381829549712,0.38633193863319387,0.752997904288272,1.0,1/14,1.60%,TPD52
prerank,cardiac cell development (GO:0055006),0.559806152381346,1.0942473999816051,0.38202247191011235,0.7535770021055486,1.0,2/11,4.28%,SLC8A1;TTN
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.43995260764420496,1.093092815056101,0.3730407523510972,0.75624573884758,1.0,13/70,13.66%,TGFB1;P2RX7;TNF;TRAF2;IL6R;BCL2L1;CRADD;SMAD3;BAK1;INHBA;TNFRSF1B;CASP8;TRADD
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.4740873875042751,1.0930582881868958,0.39273153575615477,0.7558558908087651,1.0,6/30,10.33%,CD74;CD44;BCL2L1;SNAI1;TPT1;DDX39B
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.4506002430190692,1.0928235434579499,0.3639274279615795,0.7559724740357252,1.0,20/52,25.39%,EDEM1;ERN1;DNAJC3;CXXC1;ATP6V0D1;VAPB;EXTL3;PARP16;TLN1;TATDN2;WFS1;GSK3A;ADD1;SEC31A;HYOU1;DDX11;PPP2R5B;PDIA6;EXTL2;XBP1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.44849348497321945,1.092619050214548,0.36921420882669537,0.7560621601721389,1.0,13/50,18.45%,AQP1;RFFL;TNF;FNIP1;SNCA;CD44;CSNK2A1;THBS1;GAS6;PIH1D1;SRC;DNAJB6;MAP2K5
prerank,cellular response to light stimulus (GO:0071482),0.4448188924931771,1.092585469477393,0.348326359832636,0.755681649818992,1.0,14/66,16.15%,AQP1;PRKCD;SAG;TAF1;TP53;CNGB1;YY1;BAK1;RPL26;METTL3;INO80;BMF;NOC2L;COPS9
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.4270210576301639,1.0923734182108265,0.3209255533199195,0.7557720584701676,1.0,23/151,10.54%,CERS6;LPIN2;SGPL1;LPCAT1;ESD;AKR1A1;HPGDS;GCNT1;GCH1;PRKD2;APOE;PCYT1A;CHKB;LPCAT2;CSNK1G2;CSNK2A2;CSNK2A1;SLC44A2;HACD4;ACER3;VAPB;STARD10;INHBA
prerank,sodium ion homeostasis (GO:0055078),0.5025841399878463,1.0923522763882976,0.3805418719211823,0.7553524961951774,1.0,6/21,13.76%,SLC8A1;SLC9A1;TFAP2B;NEDD4L;ATP1B3;ATP1B2
prerank,visual perception (GO:0007601),0.4389120160829506,1.0920139152318005,0.3556701030927835,0.7558321434648021,1.0,13/84,14.21%,CABP4;DRAM2;DHRS3;ATXN7;GUCY2F;REEP6;RP2;CNGB1;MYO7A;CRYBB1;RPGR;OAT;WFS1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.5497107544398095,1.0919998190324651,0.41304347826086957,0.7553851119607453,1.0,3/12,15.71%,CTPS1;CDA;DPYSL5
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.5121424378569402,1.0918854658435797,0.38083228247162676,0.7552012144482163,1.0,5/19,11.83%,SULT4A1;SLC35B3;BPNT1;PAPSS1;TPST1
prerank,positive regulation of neuron differentiation (GO:0045666),0.455661840299234,1.0918790129712175,0.36017897091722595,0.7547369644588285,1.0,5/40,9.84%,ASCL1;GPRC5B;MMD;MEF2C;IMPACT
prerank,positive regulation of telomere capping (GO:1904355),0.5195354998245818,1.091794925036607,0.3877005347593583,0.7544790655427877,1.0,4/17,14.36%,PKIB;PRKCQ;TNKS2;HNRNPD
prerank,regulation of cell differentiation (GO:0045595),0.4266712622531292,1.091495232733977,0.32665330661322645,0.7547313568249105,1.0,31/148,19.29%,RUNX1;LGALS3;SHH;SMYD5;TGFB1;TGFBR1;MDK;TNF;PRKCB;TRPS1;CEBPB;OCIAD1;TFAP2B;NTF3;TAF8;PPP2CA;CDK6;GPS2;ZFHX3;YWHAH;NF1;FADS1;MCRIP1;TRIP4;BIN1;VHL;CASZ1;BIRC2;GREM1;MAFB;GDNF
prerank,regulation of stem cell differentiation (GO:2000736),0.43045732871623826,1.0912784543732255,0.32991803278688525,0.7548705295228142,1.0,18/89,16.28%,RUNX1;SMYD5;GATA1;OSM;SP7;PSMB10;TAL1;OCIAD1;LMO2;PSMA2;METTL3;PSME3;ITCH;PSMB5;PSMD8;PSMD7;PSMB9;PUS7
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.5559024737773255,1.0912021737417457,0.36046511627906974,0.7546013742740165,1.0,2/10,9.48%,PRDM12;ATRX
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.49187352646581206,1.091168676105519,0.3921085080147966,0.7542205506301061,1.0,3/21,8.40%,TGFB1;TGFBR1;FAM89B
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.5518599899434432,1.0909065142382357,0.39260312944523473,0.7544445446579167,1.0,7/11,23.23%,RREB1;CD44;SRC;CORO1C;ARPIN;ARHGEF7;PDPN
prerank,negative regulation of cell population proliferation (GO:0008285),0.42055451739307376,1.0908007234260775,0.234,0.7542369520198562,1.0,62/351,14.77%,PTK2B;TREM2;GPNMB;LYN;TGFB1;TMIGD3;IL1A;CD300A;CBFA2T3;PTPRJ;SLURP1;ADAMTS8;NUP62;OSM;UTP20;NCK2;NLRC3;RGCC;PKD2;SKI;CEBPA;ATP8A2;TNFAIP3;MORC3;SPEG;CTNNB1;MTSS1;AIF1;TP53;MYOCD;PIM2;SLC16A2;ST18;AQP11;FLCN;TFAP2B;DUSP10;PODN;ABI1;STRN;P3H2;INHBA;SH2B3;NF2;SOX9;CHERP;NELL1;PTPRU;CDK6;ADGRG1;B4GALT7;ADARB1;B2M;DDAH1;CDC6;IRF1;FTH1;SOX2;BRD7;SOX4;TMEM127;PRKRA
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.42211916444291,1.0903125596382155,0.3049147442326981,0.7550597024799288,1.0,21/182,8.46%,RUNX1;APOBEC1;TGFB1;CD3E;PCSK9;LGMN;HAVCR2;RIN3;MSR1;TNF;APOE;SPI1;XDH;TAF1;TNRC6A;YY1;CREB3L1;MEF2C;FLCN;MOV10;RB1
prerank,negative regulation of transmembrane transport (GO:0034763),0.561834949190258,1.0902815442800655,0.3905160390516039,0.754653072273089,1.0,4/10,19.95%,PRKCB;THBS1;CTTNBP2NL;INPP5K
prerank,protein K11-linked ubiquitination (GO:0070979),0.47714146905028565,1.0900469524122585,0.3688622754491018,0.7547832897578526,1.0,7/27,11.25%,CDC23;UBE2D3;UBE2S;UBE2E3;RNF4;UBE2H;FZR1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.27224547093978735,-1.090006798509841,0.2876712328767123,0.8872826101099194,1.0,28/57,26.66%,DLG2;APP;DLGAP1;NLGN1;GRIA3;GRIA2;DLGAP2;ACTN2;NEFL;GRIN2B;DLG1;SHANK1;PRRT1;GRIN1;CACNG8;CAMK2A;OPRM1;DLG3;SHISA9;GSG1L;DLGAP3;SHISA7;GRIA4;CAMK2B;CACNG2;LRRC7;NPTX1;NPTXR
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.49314679649523835,1.089865155777517,0.39707673568818513,0.7547927276959283,1.0,4/22,13.13%,CYRIB;TRAF2;MALT1;B2M
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.5550756219713142,1.0892580284482944,0.385049365303244,0.7559392214231865,1.0,3/11,8.99%,ANXA1;RC3H2;RC3H1
prerank,protein oxidation (GO:0018158),0.548575248902755,1.0889702473935372,0.3845070422535211,0.7562468244279117,1.0,5/11,21.46%,LOX;CHCHD4;PRDX3;LOXL3;SUMF1
prerank,carnitine metabolic process (GO:0009437),0.5411119055427503,1.0887894959257138,0.4031117397454031,0.7562785003700095,1.0,5/12,23.85%,ALDH9A1;ACADL;CPT2;CROT;CPT1A
prerank,cholesterol metabolic process (GO:0008203),0.4368723641428011,1.08861889689002,0.3411016949152542,0.7562650998418685,1.0,8/68,5.56%,ABCA1;ANGPTL3;CLN8;ABCG1;APOE;LDLRAP1;CEL;SOAT2
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5519807478331619,1.088607258548537,0.386094674556213,0.7558189928969926,1.0,3/10,14.53%,NFE2L2;GPR37;LRRK2
prerank,protein localization to cell junction (GO:1902414),-0.3532057826954282,-1.0884933412224649,0.32432432432432434,0.8876285203054237,1.0,6/22,12.45%,NLGN1;TJP1;BSN;SHANK1;JAM3;HEG1
prerank,inner dynein arm assembly (GO:0036159),-0.4436619845706134,-1.0872709144840695,0.4046920821114369,0.8871835941687912,1.0,9/10,52.94%,DNAAF5;CCDC39;CFAP100;CCDC40;DNAAF4;DNAH1;DNAAF1;DNAI3;CFAP73
prerank,insulin receptor signaling pathway (GO:0008286),0.43849889941996006,1.0872459954557858,0.37017726798748696,0.7589422963305269,1.0,18/69,16.08%,ATP6V0D2;ATP6V0E1;TCIRG1;GRB2;ATP6V1C1;ATP6V1E1;ATP6V0A2;ATP6V0D1;AP3S1;BCAR1;ATP6V0A1;ATP6AP1;ZNF106;PHIP;ATP6V0B;BCAR3;GSK3A;IDE
prerank,negative regulation of cell division (GO:0051782),-0.41693067233067727,-1.0871399392070844,0.3602941176470588,0.88344071973933,1.0,7/11,43.90%,ZFYVE19;VPS4A;ORC6;CHMP4C;E2F7;MYC;E2F8
prerank,proteasome assembly (GO:0043248),-0.4282556868605053,-1.0866206016028503,0.3591549295774648,0.8808409866340289,1.0,8/11,40.65%,PSMD11;PSMD5;OTUD6B;PSMG1;ADRM1;PSMD10;PSMD9;POMP
prerank,pteridine-containing compound metabolic process (GO:0042558),0.5330675108126962,1.0863734899327935,0.3958904109589041,0.7608139449136117,1.0,5/13,17.43%,GCH1;QDPR;SPR;HSP90AA1;FPGS
prerank,regulation of transferase activity (GO:0051338),0.5136411284903666,1.0856669262085017,0.37792207792207794,0.7622462031119708,1.0,2/17,1.96%,NLRC5;SLAMF8
prerank,anterograde axonal transport (GO:0008089),-0.29449810155556955,-1.0852612966089128,0.3364485981308411,0.8809585772669802,1.0,8/37,10.38%,DLG2;KIF5B;SPAST;SOD1;NEFL;MAPK8IP3;KIF3B;KIF5A
prerank,regulation of TOR signaling (GO:0032006),0.4298518167014135,1.0852494199437268,0.37552301255230125,0.762897407868236,1.0,23/67,21.95%,TREM2;RFFL;FNIP1;GNA12;SEH1L;FLCN;PDCD6;DDIT4;GAS6;LAMTOR3;TMEM127;PIH1D1;GSK3A;TTI1;LAMTOR1;GOLPH3;RPTOR;SEC13;TELO2;RRAGA;PIK3CA;RRAGB;NPRL3
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.47992777846282175,1.0850419177040669,0.3870967741935484,0.762985031116001,1.0,6/26,8.66%,CCND3;RGCC;CCND2;ANXA1;AIF1;LSM11
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.4560981421898372,-1.085025430573117,0.3741258741258741,0.8776011112525809,1.0,2/10,5.30%,UPP2;NT5E
prerank,response to cAMP (GO:0051591),0.4643394977721138,1.0846144437856546,0.39120631341600903,0.7636503320001782,1.0,11/37,21.24%,AQP1;HCN4;PKD2;RAP1B;VGF;RAPGEF1;RAP1A;AKAP9;INPP5K;HCN1;ZFP36L1
prerank,negative regulation of blood pressure (GO:0045776),-0.4160245132014832,-1.0843103711405873,0.35984848484848486,0.8755842257602996,1.0,6/13,26.63%,SCPEP1;NOS3;NOS1;DRD2;BMPR2;GPR37L1
prerank,regulation of histone acetylation (GO:0035065),0.47210377193217773,1.0842131018150845,0.40578034682080927,0.7642232575982141,1.0,13/33,21.79%,SNCA;SPI1;HDAC5;MYOCD;FLCN;PPARGC1A;RPS6KA4;BRD7;NOC2L;RPS6KA5;SETD5;IWS1;CTBP1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.43292243654990137,1.083603350962767,0.36279547790339156,0.7653411837835624,1.0,38/87,25.69%,RPL23;RPL17;RPL10A;RPS2;RPL18A;RPS15A;RPL6;RPLP2;RPL26;RPS20;RPS16;RPS14;RPL19;SRP19;RPL9;RPS11;RPL11;RPS23;RPS4X;RPS27;SEC63;RPL4;RPL7A;RPL15;RPL29;RPL22;RPS7;SRP14;RPS13;RPLP1;RPS15;SRP9;RPS5;RPL41;RPL10;RPS8;RPL5;RPL18
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.47616451767081397,1.0834406772938812,0.3936545240893067,0.7653049435400612,1.0,4/29,8.98%,SLC11A1;CIRBP;LARP1;TENT5C
prerank,DNA strand elongation (GO:0022616),-0.36971875570453283,-1.08312786591777,0.358974358974359,0.8752437651562638,1.0,13/18,37.94%,MRE11;POLA1;GINS3;TERT;MCM4;DCLRE1B;MCMDC2;POLD2;RFC3;GINS1;RFC4;MCM3;MCM7
prerank,glucan catabolic process (GO:0009251),0.5296663198414253,1.082814455891412,0.403921568627451,0.7665211160455793,1.0,1/15,0.75%,MGAM
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.48359303144436505,1.0824505685735768,0.41973840665873957,0.7669867351294904,1.0,6/25,16.70%,PTGES3;SDF2L1;DNAJC7;BAG1;GAK;ERO1A
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.44747570159629174,1.0822799201708657,0.37513397642015006,0.7669482604295622,1.0,10/55,13.92%,GRB2;MAPK14;SNCA;XDH;TGFBR2;TP53;THBS1;PARL;COQ7;PID1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4418480742732128,1.0822511785819384,0.37874097007223945,0.7665482188262366,1.0,17/76,16.50%,BAG2;CBFA2T3;LAPTM5;RNF180;RNF19B;CEBPA;TAF1;HECTD1;DET1;CSNK1A1;STUB1;RNF144B;LRRK2;PIAS1;GSK3A;SMURF1;PTEN
prerank,regulation of signal transduction (GO:0009966),0.42224450859688933,1.0818387601297035,0.3306613226452906,0.7671984263878835,1.0,26/190,12.36%,RUNX1;TREM2;UBASH3B;TGFB1;CD3E;IRAK2;LFNG;PTPN1;NUP62;DHRS3;GRK3;NCK2;MTCH1;TRIM5;SREBF2;TIMP1;CD80;ZDHHC7;MDFIC;ZDHHC3;DTNBP1;CD63;WDR11;FYN;PPP2CA;GRK4
prerank,t-circle formation (GO:0090656),0.5574378014373454,1.0815176256478083,0.4080717488789238,0.7665962861324329,1.0,4/10,18.75%,EXO1;DNA2;SLX4;ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.5574378014373454,1.0815176256478083,0.4080717488789238,0.7665962861324329,1.0,4/10,18.75%,EXO1;DNA2;SLX4;ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.5574378014373454,1.0815176256478083,0.4080717488789238,0.7665962861324329,1.0,4/10,18.75%,EXO1;DNA2;SLX4;ERCC1
prerank,neural tube closure (GO:0001843),0.4606932789070284,1.0810851110856465,0.3914027149321267,0.7672365831715587,1.0,3/34,4.59%,TGFB1;SKI;PLXNB2
prerank,positive regulation of bone mineralization (GO:0030501),0.46236362641801515,1.0801598347219583,0.38434982738780205,0.7692262962520016,1.0,7/35,11.23%,TGFB1;P2RX7;SLC8A1;FZD9;MEF2C;ATP2B1;NELL1
prerank,peptidyl-serine modification (GO:0018209),0.41978599628697766,1.0801121749178448,0.3453815261044177,0.7688837285584771,1.0,51/166,21.32%,MAPKAPK3;MAP4K1;TGFBR1;PRKCD;CAMK1D;MTOR;MAPK14;NEK6;PRKD2;MORC3;TLK1;TAF1;PRKCB;MKNK1;TGFBR2;WNK1;PLK2;CSNK1G2;POGLUT2;PRKCQ;CSNK2A2;CSNK2A1;POGLUT1;SMG1;PRKCH;HPF1;STK32C;PKN1;RPS6KA4;CSNK1A1;MAP3K12;GAS6;GALNT2;LRRK2;MGAT5B;SGK3;RPS6KA2;STK4;RPS6KA5;GALNT1;PDPK1;VRK1;TOP1;ROCK2;TLK2;DCLK3;CDK5R1;GSK3B;CSNK1G3;MARK1;BRSK1
prerank,positive regulation of protein modification process (GO:0031401),0.4217436635349008,1.079874265876636,0.31431431431431434,0.7690327703164701,1.0,25/203,9.57%,TREM2;GPNMB;LYN;TGFB1;CD74;ITGB3;CSF1R;NIBAN1;PRKCD;RAP2A;SEMA4D;CCND3;ATG7;TNF;FNIP1;BRAT1;RAB3GAP2;CCND2;SVIP;VEGFB;RAMP1;TNIK;FLCN;SPPL3;NOS1AP
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.4292268423824215,1.0797245077995044,0.3498964803312629,0.7689672636110892,1.0,16/73,16.28%,RUNX1;GATA1;OSM;SPI1;PSMB10;TAL1;LMO2;PSMA2;METTL3;PSME3;ITCH;PSMB5;PSMD8;PSMD7;PSMB9;PUS7
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.5136985705214066,1.0793406061991448,0.387434554973822,0.7695166430962133,1.0,1/17,2.53%,LPCAT1
prerank,positive regulation of telomerase activity (GO:0051973),0.46747376616767883,1.078879445462761,0.40046296296296297,0.7702091306856197,1.0,5/33,8.09%,PTGES3;PKIB;XRCC5;CTNNB1;PRKCQ
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.44048334845265963,1.0783121814490904,0.39125799573560766,0.7712141144434955,1.0,13/52,15.03%,TREM2;LGALS3;PLS1;TNF;AKAP5;STAC;PRKCH;EPB41;STX3;EPB41L2;STAC3;ARF6;LRP1
prerank,negative regulation of cellular process (GO:0048523),0.41496492422824927,1.077517613369775,0.228,0.7728005215006006,1.0,88/521,14.77%,PTK2B;LILRB1;TREM2;GPNMB;LYN;SHH;SMYD5;TGFB1;FCGR2B;TMIGD3;IL1A;SIRPA;CBFA2T3;VAMP3;PTPRJ;TLR2;SLURP1;ADAMTS8;PLXNC1;NUP62;MDK;OSM;CD9;UTP20;NCK2;SEMA4D;NME6;RGCC;PKD2;SKI;TGFBI;HPGD;CEBPA;PLXNB2;ATP8A2;MYH9;RIPOR2;SPEG;CTNNB1;CDA;TP53;MYOCD;PIM2;EPO;ST18;AQP11;FLCN;TFAP2B;RB1;SMAD3;SIPA1;PODN;TMEM98;CASK;ABI1;STRN;PODXL;P3H2;IMPACT;ARHGDIB;ACTN1;INHBA;TNFRSF21;DYSF;SH2B3;NF2;CHERP;BECN1;PTPRU;PARP16;TNFRSF1B;RBBP7;PPP2CA;CDK6;ADGRG1;NR4A1;ADARB1;ARHGDIA;DDAH1;CTTNBP2NL;CDC6;IRF1;FTH1;WFS1;BRD7;SOX4;TMEM127;PRKRA
prerank,sulfate transport (GO:0008272),-0.3892630289650105,-1.077358940845339,0.36398467432950193,0.8891016611730381,1.0,7/14,30.79%,SLC26A2;SLC26A7;SLC25A14;SLC25A11;SLC26A6;RACGAP1;SLC26A8
prerank,oligodendrocyte differentiation (GO:0048709),0.5073504823602475,1.0772746242058329,0.3933002481389578,0.7729649270017453,1.0,4/19,13.61%,SHH;EIF2B2;SOX9;SOX6
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.5310092898791158,1.077202619621232,0.4128686327077748,0.7726678692337173,1.0,5/13,13.26%,EDEM1;SEC16A;SEC16B;SORL1;SAR1A
prerank,endoderm formation (GO:0001706),0.4535500443347457,1.0771252311315334,0.38202247191011235,0.7724027516586992,1.0,5/35,10.54%,ITGB2;ITGA4;ITGB5;SETD2;INHBA
prerank,GPI anchor biosynthetic process (GO:0006506),0.4679771028152832,1.0770084012010004,0.40820980615735464,0.7722212641143272,1.0,13/30,24.47%,PIGM;PIGL;PIGX;PIGV;PGAP1;PIGH;PGAP2;PIGU;PIGC;PIGN;DPM2;PIGP;PIGK
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5331015269302941,1.0769910296848313,0.4065934065934066,0.7717883527222498,1.0,3/13,14.21%,PTPN1;ATF6B;WFS1
prerank,vasodilation (GO:0042311),-0.39852486703890555,-1.0769412049804608,0.3460207612456747,0.88632531863512,1.0,7/13,26.87%,SOD2;SOD1;KLF2;NOS3;NOS1;GPER1;ADRB2
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.41294084676140486,-1.0766832306320728,0.37282229965156793,0.8790921927420348,1.0,3/12,7.04%,EFNA5;KANK1;AP1AR
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.41294084676140486,-1.0766832306320728,0.37282229965156793,0.8790921927420348,1.0,3/12,7.04%,EFNA5;KANK1;AP1AR
prerank,embryonic axis specification (GO:0000578),-0.3894760452774842,-1.0764949884505717,0.31666666666666665,0.8756897372638165,1.0,10/15,44.05%,COBL;TBX3;SMAD6;PTCH1;STIL;FZD5;CXXC4;RIPPLY2;WNT7A;HOXD8
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.4865212738227229,1.0760898150256524,0.4059880239520958,0.7736893713935331,1.0,5/22,7.50%,P2RY6;PKD2;STAC;SLC9A1;VMP1
prerank,regulation of viral release from host cell (GO:1902186),0.49152810504243677,1.0758970581724994,0.3972772277227723,0.7737417570901788,1.0,5/21,11.59%,TRIM25;TRIM5;TRIM8;MID2;TRIM35
prerank,regulation of execution phase of apoptosis (GO:1900117),0.5470752446241247,1.0758549555995531,0.41109530583214793,0.7733779578157719,1.0,3/11,6.70%,FZD3;BCL2L1;TP53
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.25521964715196077,-1.0753761330035239,0.18181818181818182,0.8753143630612715,1.0,21/84,15.79%,RBFOX2;FXR2;YTHDC1;DAZAP1;MBNL2;RBFOX3;REST;NUP98;U2AF2;SRRM4;KHDRBS3;FMR1;HNRNPA1;NOVA2;METTL16;QKI;HNRNPU;SNW1;KHDRBS2;PUF60;LARP7
prerank,positive regulation of vasoconstriction (GO:0045907),-0.3922502204732307,-1.0753411769750503,0.36486486486486486,0.871509306083033,1.0,1/13,1.12%,CAV1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.3440413297725122,-1.075259235129225,0.3575418994413408,0.8678912824997287,1.0,10/23,26.44%,FAR1;ACSL1;HACD1;ELOVL5;ACSL6;ELOVL1;ACSBG1;HACD2;ACSL4;ACSL3
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.49929301915005075,1.0750850904555926,0.4119897959183674,0.7749196564906075,1.0,4/17,11.23%,MDK;AIF1;DOCK4;NRP1
prerank,autophagosome organization (GO:1905037),0.4401986126650579,1.0750257140250972,0.3907074973600845,0.7746033662603616,1.0,18/50,22.33%,ATG7;MAP1LC3B;RAB7A;VMP1;EMC6;RAB1B;BECN1;ATG2B;IRGM;ATG3;UBXN2A;ATG14;PACS2;TMEM41B;ATP13A2;NSFL1C;TP53INP2;RB1CC1
prerank,cell cycle checkpoint signaling (GO:0000075),0.533435105953021,1.0746937055520345,0.41596638655462187,0.7750056940828388,1.0,7/12,27.37%,NABP1;PLK2;PRCC;ZWINT;BUB1B;ZWILCH;WEE1
prerank,positive regulation of vasculogenesis (GO:2001214),0.5695097907895487,1.0742979239658086,0.4005805515239477,0.7755726888223253,1.0,1/10,1.10%,RIN2
prerank,negative regulation of response to external stimulus (GO:0032102),0.4250564435676728,1.0738233268256743,0.38071065989847713,0.7763191100429958,1.0,16/105,13.40%,SIRPA;METRNL;PRKCD;DUSP3;NLRC3;RTN4RL1;NR1H4;APOE;OTULIN;TRAFD1;TNFAIP3;RB1;CASK;ITCH;GPS2;FNDC4
prerank,actin filament bundle assembly (GO:0051017),0.46235987744852275,1.0737721254440247,0.3901345291479821,0.7759720038745038,1.0,5/33,7.51%,LCP1;PLS1;AIF1;NEDD9;MICAL1
prerank,pseudouridine synthesis (GO:0001522),-0.39237611090048485,-1.0735277506692416,0.34532374100719426,0.8693584128210236,1.0,10/13,40.34%,PUS10;TRUB2;GAR1;NOP10;PUS1;PUS7L;NHP2;TRUB1;PUSL1;RPUSD2
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.48371884781137015,1.0734993991053208,0.4017094017094017,0.7762013826052845,1.0,5/24,9.02%,ITGB3;PTPN1;PRKD2;PRKCB;PDCD6
prerank,long-chain fatty acid import into cell (GO:0044539),-0.43200135296122427,-1.072905012197266,0.3584905660377358,0.8673120309228981,1.0,6/10,28.89%,ACSL1;SLC27A1;SLC27A4;ACSL3;SLC2A1;SLC27A2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.46373925576137026,1.0726946535598296,0.4066666666666667,0.7778130549813554,1.0,6/35,11.85%,CD300A;MTOR;PPP6R1;PPP1R11;BOD1L1;PPP4R4
prerank,extracellular transport (GO:0006858),-0.4067729468794936,-1.0726508292078427,0.38047138047138046,0.8642136062238976,1.0,9/12,46.05%,SPEF2;CABYR;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,regulation of sodium ion transport (GO:0002028),0.45729657313222905,1.072437450216161,0.3991130820399113,0.7780109759088285,1.0,12/34,18.95%,SCN4B;P2RX7;PKP2;P2RX4;WNK1;PRSS8;WNK4;YWHAH;SCN5A;SPTBN4;PER1;CNKSR3
prerank,negative regulation of protein polymerization (GO:0032272),0.471163037743182,1.0722254876848707,0.4068801897983393,0.778059742127525,1.0,9/27,13.44%,CYRIB;PRKCD;SNCA;ARFGEF1;MAPRE1;PFN2;PFN1;TWF2;SSH2
prerank,C21-steroid hormone metabolic process (GO:0008207),0.4904703951174994,1.0718980481256462,0.39575530586766544,0.778450488750609,1.0,4/20,20.61%,TSPO;FDXR;FDX1;STARD3
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.5093494192917944,1.071844460343104,0.4010416666666667,0.7781158512226765,1.0,4/16,11.27%,TNF;CLN3;GSPT1;HDAC6
prerank,cellular protein-containing complex assembly (GO:0034622),0.41790385106633526,1.0717081762936949,0.34734734734734735,0.7779796007708546,1.0,47/159,21.81%,TGFB1;CD3E;VAMP3;TBCEL;DHX9;PTGES3;NCK2;SNX9;SNCA;TRAF2;DNAI4;FMOD;LONP1;AP2S1;TBCC;PSMG3;CHCHD4;SMAD3;HSF1;UVRAG;EIF4H;TPR;IMMP2L;CLTC;NUP205;NRG1;PRLR;BBS12;SRP19;EPS15;SRC;AP2M1;RTN4;HSP90AA1;GTF2B;BIN1;MIS12;PICALM;ANGPT1;TMEM170A;FCHO2;GPX4;CYBA;PDE4DIP;DNAJB14;VAMP8;PSMG2
prerank,macroautophagy (GO:0016236),0.4231161426992538,1.0708312469857328,0.3941532258064516,0.7797734123102269,1.0,40/118,22.54%,LIX1;TCIRG1;VTA1;ATG7;MAP1LC3B;CLN3;PIP4K2A;PLEKHM1;MTMR3;FUNDC1;CSNK2A2;CSNK2A1;TECPR1;SNAP29;UVRAG;VPS37C;BECN1;TOMM40;VDAC1;VPS39;SRC;SNX14;ATG3;ARL8B;VPS28;PIK3R4;VPS33B;ATG14;PLAA;TBC1D5;TOMM20;MFN1;ATP13A2;EPG5;STAM2;PRKN;VAMP8;RB1CC1;ATG10;MTMR14
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.504483313563449,1.0707753222568008,0.4050632911392405,0.779422985946437,1.0,1/18,0.31%,PTK2B
prerank,sphingoid metabolic process (GO:0046519),-0.4028376477488527,-1.068898832735089,0.4006849315068493,0.8713322695186729,1.0,7/12,40.94%,SGPP1;SPHK1;PLPP3;PLPP1;PLPP2;ASAH2;SPTLC3
prerank,fatty acid catabolic process (GO:0009062),0.4251034229671719,1.0679540726278764,0.3960084033613445,0.7863243464972688,1.0,25/67,24.25%,LPIN2;EHHADH;CEL;ACAD10;NUDT19;ACADL;ABCD1;PEX13;ECHS1;ILVBL;ECI1;ABHD3;MMUT;CPT2;PPARD;PCCA;ABCD2;ECHDC1;LPIN1;ACOT8;CROT;MMAA;ABHD2;HADHA;HADH
prerank,positive regulation of mitochondrion organization (GO:0010822),0.4383093901254138,1.0673255950356448,0.3932702418506835,0.7875135753702427,1.0,14/57,20.78%,TREM2;DDHD1;PYCARD;TP53;BAK1;PPARGC1A;CAMKK2;BMF;GSK3A;TNFSF10;DNM1L;FIS1;GSK3B;PRKN
prerank,determination of left/right symmetry (GO:0007368),0.45263837834665116,1.0668952744219629,0.40540540540540543,0.7881658878321043,1.0,3/36,5.50%,SHH;PKD2;ODAD2
prerank,actin polymerization or depolymerization (GO:0008154),0.4419320245620907,1.0666034157919628,0.4169381107491857,0.7884508956941463,1.0,10/50,12.18%,PREX1;PSTPIP1;MICALL2;FLII;AIF1;MICAL1;WASHC3;ABI1;DIAPH1;TWF2
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.4249345837056351,1.065201513915042,0.3862928348909657,0.791673952500427,1.0,15/70,16.28%,RUNX1;GATA1;OSM;PSMB10;TAL1;LMO2;PSMA2;METTL3;PSME3;ITCH;PSMB5;PSMD8;PSMD7;PSMB9;PUS7
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.44577888643072205,1.0651840077910983,0.41202185792349727,0.7912374030034703,1.0,7/43,7.56%,CBL;PTPRJ;DUSP3;GRB2;ZFYVE28;RAB7A;SH3KBP1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.5169297295418692,1.064929886995093,0.42207792207792205,0.7914399027604907,1.0,1/16,0.75%,MGAM
prerank,fatty acid transport (GO:0015908),0.5008382879086508,1.0644757372682192,0.4023136246786632,0.7921126863322169,1.0,5/17,17.26%,FABP4;APOE;FABP5;CD36;PPARD
prerank,actin-myosin filament sliding (GO:0033275),0.45476921878900256,1.064250968529149,0.4166666666666667,0.7917539105556228,1.0,6/38,13.93%,MYL3;TTN;TNNT3;TPM4;TPM3;DES
prerank,muscle filament sliding (GO:0030049),0.45476921878900256,1.064250968529149,0.4166666666666667,0.7917539105556228,1.0,6/38,13.93%,MYL3;TTN;TNNT3;TPM4;TPM3;DES
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.4352769907056706,1.0639653897505295,0.4032258064516129,0.7920095146252212,1.0,8/50,14.41%,GTF2H1;CCND3;BCCIP;CCND2;ACTB;CDK7;CDC6;CCNE2
prerank,glutamine family amino acid metabolic process (GO:0009064),0.4570344582281552,1.0633449618021713,0.4151376146788991,0.7932240262752356,1.0,6/33,13.99%,DGLUCY;MTHFS;ART4;PYCR2;DDAH1;OAT
prerank,negative regulation of phosphorylation (GO:0042326),0.42508647398642835,1.063229879403351,0.3940936863543788,0.7930557410293421,1.0,22/85,20.78%,LYN;TGFB1;STAP1;SIRPA;CBFA2T3;NIBAN1;XDH;IBTK;IMPACT;HDAC4;INHBA;PRDX3;PID1;LRRK2;PTEN;CORO1C;PAQR3;TIGAR;ATG14;INPP5K;ANKLE2;PRKN
prerank,autophagosome assembly (GO:0000045),0.4340827590320078,1.0631064398282073,0.3804004214963119,0.7929000291643696,1.0,18/52,22.33%,ATG7;MAP1LC3B;RAB7A;VMP1;EMC6;RAB1B;BECN1;ATG2B;SMURF1;IRGM;ATG3;UBXN2A;ATG14;PACS2;TMEM41B;NSFL1C;TP53INP2;RB1CC1
prerank,protein targeting to ER (GO:0045047),0.4230864716665639,1.0628861811043793,0.40551583248212464,0.792982484353257,1.0,41/99,25.69%,RPL23;RPL17;EDEM1;RPL10A;RPS2;RPL18A;RPS15A;SPCS2;SPCS1;RPL6;RPLP2;RPL26;RPS20;RPS16;RPS14;RPL19;SRP19;RPL9;RPS11;RPL11;RPS23;RPS4X;RPS27;SEC63;RPL4;RPL7A;RPL15;RPL29;RPL22;RPS7;SRP14;RPS13;RPLP1;RPS15;SRP9;RPS5;RPL41;RPL10;RPS8;RPL5;RPL18
prerank,negative regulation of cell differentiation (GO:0045596),0.4159944423970874,1.0626620213264768,0.3613613613613614,0.7930629867560144,1.0,31/181,14.68%,PTK2B;ASCL1;SHH;TGFB1;ABCA1;ITGB3;TGFBR1;MAD2L2;SEMA4D;PKP2;TNF;ABCG1;SKI;XDH;NKX2-1;MYOCD;LEO1;RB1;SMAD3;LRP5;SOX9;SRA1;ADIPOR1;PPP2CA;CDK6;BAMBI;VASN;GPS2;SOX2;BBS12;MEIS1
prerank,peptide cross-linking (GO:0018149),0.4771637135997773,1.0625559669236568,0.42117930204572807,0.7928587791183536,1.0,3/25,11.24%,F13A1;ANXA1;THBS1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.493909964863691,1.0623141171404151,0.4189723320158103,0.7930021940060946,1.0,3/18,5.80%,PCID2;NXF1;THOC2
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.4301876618144716,1.0622734773911264,0.4016393442622951,0.7926354766448849,1.0,16/85,15.64%,TREM2;BAG2;CBFA2T3;RNF180;RNF19B;CEBPA;TAF1;HECTD1;ATXN3;DET1;CSNK1A1;STUB1;RNF144B;LRRK2;PIAS1;GSK3A
prerank,cellular respiration (GO:0045333),-0.28142202804852334,-1.0619300372729588,0.3333333333333333,0.8886500467494578,1.0,27/41,32.99%,UQCRC2;UQCRH;NDUFS1;SLC25A13;NDUFS4;OXA1L;SLC25A14;COQ10B;MTFR1L;COX15;ATP5F1D;UQCRC1;ETFA;NDUFS7;ETFRF1;ETFB;SDHAF4;UQCRFS1;LYRM7;MDH2;CYCS;COX10;MTLN;SURF1;NR4A3;NDUFS8;SIRT3
prerank,histone H2A acetylation (GO:0043968),0.5036138116920078,1.0619049277496606,0.4096228868660598,0.7931011606940936,1.0,7/16,25.07%,BRD8;EP400;NAA40;MEAF6;MORF4L2;MORF4L1;SPHK2
prerank,potassium ion transport (GO:0006813),0.41747770669787354,1.061582451118791,0.40606060606060607,0.7934929927583747,1.0,13/120,7.51%,KCNJ11;AQP1;HCN4;SLC9A4;KCNN4;KCNK6;PKD2;KCNIP2;SLC9A9;CCDC51;KCNMA1;SLC9A1;KCNK13
prerank,cellular response to oxidative stress (GO:0034599),0.41817820694210533,1.0613310858845708,0.4101522842639594,0.7936713817977183,1.0,30/118,18.38%,CYBB;NCF4;NFE2L2;PRKCD;NCF2;SNCA;PKD2;FOXO3;TXNRD1;AIF1;TP53;LONP1;PPARGC1A;PRDX1;PYCR2;MSRA;PRDX3;PRDX6;PRDX2;CAMKK2;LRRK2;HIF1A;CPEB2;ERO1A;PRDX5;GPX8;PYROXD1;STX2;KEAP1;GSR
prerank,positive regulation of lamellipodium organization (GO:1902745),0.46059256126407405,1.0609956274600443,0.4217687074829932,0.7940605547625568,1.0,11/32,17.93%,RREB1;ARPC2;WASF2;AKIRIN1;ACTR2;ACTR3;CYFIP1;TWF2;SRC;CORO1C;CDC42
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.45889154188970593,1.0609392637366697,0.42289719626168226,0.7937428710992661,1.0,7/32,14.04%,PKIB;XRCC5;CTNNB1;PRKCQ;CCT8;TNKS2;CCT5
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.30624309974164454,-1.0608349161006823,0.31125827814569534,0.8880785096747966,1.0,14/29,23.27%,ARRDC3;ABL1;DCUN1D4;TOPORS;PINK1;FBXW7;DTX3L;UBE2L3;FEM1A;DCUN1D3;PARK7;BMI1;SMAD7;BAG5
prerank,renal absorption (GO:0070293),-0.4260514441924951,-1.0606197709608058,0.3871951219512195,0.8849325655662039,1.0,2/10,5.49%,GSN;KLHL3
prerank,artery morphogenesis (GO:0048844),0.46341118701024636,1.0603024561991485,0.42719614921780985,0.7949179877378658,1.0,8/30,16.02%,TGFBR1;ANGPTL3;PKD2;HPGD;TFAP2B;NRP1;LRP1;NF1
prerank,neuron development (GO:0048666),0.41510469366434743,1.0596439763812393,0.3971774193548387,0.7961616960404377,1.0,19/141,9.82%,RUNX1;LYN;ASCL1;PRDM12;MICALL2;ATP7A;APOE;ATP8A2;MYT1L;THOC2;HMGB1;GPRIN3;MICALL1;LRP12;WNK1;MEF2C;RB1;ATCAY;RAB11A
prerank,regulation of protein metabolic process (GO:0051246),0.4438943761077035,1.0596283831522069,0.41774891774891776,0.7957248837749933,1.0,13/44,19.65%,GSAP;SHH;APOE;TRAF3;CHEK2;NEDD4L;SPOP;PARL;WFS1;FAF1;FURIN;MAP2K5;ROCK2
prerank,outer dynein arm assembly (GO:0036158),0.5089271390326953,1.0595445354222004,0.41733333333333333,0.7954750419849914,1.0,3/14,13.03%,ODAD2;ODAD1;CCDC63
prerank,regulation of histone modification (GO:0031056),0.5164963690755958,1.0590900212242462,0.436241610738255,0.7961620799126351,1.0,6/13,21.21%,MYOCD;FLCN;HPF1;AKAP8L;UBE2N;SETD5
prerank,regulation of protein acetylation (GO:1901983),-0.4070306472049724,-1.0588699999545728,0.35587188612099646,0.8864266370759037,1.0,2/12,1.83%,CEP295;RAPGEF3
prerank,cytoplasmic translation (GO:0002181),0.4187911236759311,1.058392770515457,0.4177732379979571,0.797490277846645,1.0,40/91,25.69%,RPL23;RPL17;RPL10A;RPS2;RPL18A;RPS15A;GSPT1;EIF4A1;RPL6;RPL26;RPS20;RPS16;RPS14;RPL19;RWDD1;RPL9;TMA7;RPS11;RPL11;RPS23;RPS4X;RPS27;RPL4;RPL7A;RPL15;RPL29;RPL22;RPS7;RPS13;RPL22L1;RPLP1;EIF3M;RPS15;RPS5;RPL41;DRG2;RPL10;RPS8;RPL5;RPL18
prerank,positive regulation of neurogenesis (GO:0050769),0.42304983241913185,1.0581015950988006,0.40436590436590436,0.797732659275755,1.0,14/68,13.64%,CX3CR1;SS18L1;PLXNC1;SLITRK1;PLXNB2;FZD3;CTNNB1;DISC1;NAP1L1;NUMB;SMARCD3;NPTN;ARHGDIA;CUX1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.3859964193727286,-1.0579944975892,0.3956043956043956,0.8853959788558483,1.0,8/14,25.56%,ECE1;ACE;NOS3;ENPEP;EDN1;EDN3;AGTR1;ACE2
prerank,regulation of centriole replication (GO:0046599),0.4960173808924196,1.05781920863111,0.43170103092783507,0.7979447704828423,1.0,5/17,7.73%,NUP62;MDM1;PLK4;PLK2;CEP76
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.2637319654222906,-1.0569076895099503,0.3275862068965517,0.8810724435633152,1.0,29/56,24.08%,NDUFAF7;TIMMDC1;NDUFS5;NDUFA7;NDUFS1;NDUFS4;NDUFS3;NDUFAF2;OXA1L;NDUFAF6;NUBPL;NDUFAF4;NDUFAF5;NDUFB5;NDUFB2;TMEM126B;NDUFA8;NDUFS2;NDUFB7;ACAD9;NDUFA10;NDUFB6;NDUFB3;NDUFB10;NDUFS7;NDUFC1;NDUFA3;FOXRED1;TIMM21
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.2637319654222906,-1.0569076895099503,0.3275862068965517,0.8810724435633152,1.0,29/56,24.08%,NDUFAF7;TIMMDC1;NDUFS5;NDUFA7;NDUFS1;NDUFS4;NDUFS3;NDUFAF2;OXA1L;NDUFAF6;NUBPL;NDUFAF4;NDUFAF5;NDUFB5;NDUFB2;TMEM126B;NDUFA8;NDUFS2;NDUFB7;ACAD9;NDUFA10;NDUFB6;NDUFB3;NDUFB10;NDUFS7;NDUFC1;NDUFA3;FOXRED1;TIMM21
prerank,regulation of cell cycle (GO:0051726),0.4104502712254056,1.0568747580540943,0.351,0.7998883417067219,1.0,47/271,14.24%,PTPRC;LILRB1;TGFB1;RPL23;GAS2L1;TGFBR1;MLXIPL;MAP2K6;ERN1;NEK6;RGCC;PKD2;HPGD;FBXL22;FZD9;CDK11B;TP53;SND1;RPS15A;PIM2;CSNK2A2;CSNK2A1;GADD45B;KIF20B;RB1;SMAD3;SIPA1;CDK7;SON;INHBA;NF2;MAEA;TTLL12;SOX9;SRA1;THBS1;RASSF1;RNF40;METTL3;SDCBP;CDK6;FBXL3;NR4A1;ADARB1;HCFC1;IRF1;SOX2
prerank,regulation of DNA biosynthetic process (GO:2000278),0.4628150940182044,1.0565046142255543,0.4236453201970443,0.8004130261263077,1.0,3/27,4.09%,SMOC2;RGCC;PRKD2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.3356791416362652,-1.0561653045692385,0.3763440860215054,0.8795702018932788,1.0,11/22,22.13%,NTRK3;STMN2;NGF;EHD1;MAPT;RAPGEF2;AKT1;MAGI2;WASF1;BDNF;NTRK2
prerank,regulation of filopodium assembly (GO:0051489),0.44444187032020005,1.0559229546188331,0.40898876404494383,0.8014348465301918,1.0,10/38,14.40%,PRKCD;ARAP1;RIPOR2;DOCK11;CAPZB;AGRN;NRP1;FNBP1L;ARF6;MIEN1
prerank,histone lysine methylation (GO:0034968),0.4628051975888488,1.0558627589865028,0.43592677345537756,0.8011083245281881,1.0,10/33,18.42%,WDR5B;CXXC1;SETD6;DPY30;DOT1L;RBBP5;SMYD3;SUV39H1;SETD1B;WDR82
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.5198334600914536,1.055264429383061,0.42398884239888424,0.8022041555312234,1.0,2/12,7.57%,SOAT2;P4HB
prerank,extracellular structure organization (GO:0043062),0.40672792726619644,1.0549550923306572,0.37,0.8025207553354873,1.0,26/204,10.54%,ITGAL;MMP12;ITGA2B;ITGAX;ITGB2;SMOC2;ITGA4;ITGB3;TGFBR1;ITGB5;ITGA2;ADAMTS8;ITGA6;ATP7A;TTR;TGFBI;SPP1;CD44;ITGAE;TNR;AGRN;LOX;BCAN;ITGAM;F11R;MMP19
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.414049084961238,1.054925520622842,0.4026639344262295,0.8021210544094376,1.0,17/94,13.59%,FNIP2;PRKCD;ERN1;TRAF2;PYCARD;DDIT3;APAF1;BCL2L1;TP53;MAP3K5;CEBPB;HINT1;CHEK2;BAK1;TNFRSF1B;ATP2A3;STK24
prerank,positive regulation of exocytosis (GO:0045921),0.4553832046703248,1.0546939549094596,0.44685714285714284,0.80228143975943,1.0,11/35,19.99%,UNC13D;SNCA;SMPD3;RAB7A;SYTL4;ATP6AP1;SDCBP;PDCD6IP;RAB27B;STXBP5;ATP13A2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.49606946683902936,1.0542496044989174,0.4106699751861042,0.8029327523138517,1.0,10/20,22.31%,KCTD17;HERPUD1;BAK1;WFS1;CCDC47;SELENOK;PACS2;FIS1;RAP1GDS1;TGM2
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5318280329623927,1.0539867901982483,0.4330935251798561,0.8030875990907146,1.0,4/11,17.23%,NOS1AP;CACNB2;CACNB1;BIN1
prerank,cellular biogenic amine catabolic process (GO:0042402),0.5458839263016764,1.0535782628559731,0.44084507042253523,0.803648305504876,1.0,4/10,20.02%,SMOX;ALDH7A1;COMT;SLC44A1
prerank,regulation of muscle contraction (GO:0006937),-0.32272623194018263,-1.0535706732973507,0.33544303797468356,0.8836514308875263,1.0,7/26,13.05%,CHRM2;CAV1;SRI;KCNA1;ATP1A2;PLCE1;KCNB2
prerank,ceramide biosynthetic process (GO:0046513),0.44334443974388366,1.0532880613581124,0.4141749723145072,0.8038906297129079,1.0,14/40,22.59%,CERS6;CLN8;ST8SIA4;ST6GALNAC4;AGK;DEGS1;ASAH1;SGMS1;B4GALNT1;SPTSSA;SMPD1;SPTSSB;B4GALT6;CERS4
prerank,cellular response to alcohol (GO:0097306),0.44245886082724567,1.0531511648018952,0.4315443592552026,0.8037471398328369,1.0,13/42,20.41%,ADCY7;MAP4K1;ADCY6;CTNNB1;LARP1;GLRA2;ADCY3;ADCY8;GNG2;GOLPH3;GRAMD1C;SPIDR;OSBPL7
prerank,nucleoside catabolic process (GO:0009164),-0.4259002656156235,-1.0531314118186577,0.41544117647058826,0.8812078881091501,1.0,2/11,5.30%,UPP2;NT5E
prerank,negative regulation of cell migration (GO:0030336),0.40922402534771074,1.0531113863070585,0.4167507568113017,0.8033762818139186,1.0,34/137,17.38%,SHH;TMIGD3;CD74;PTPRJ;THY1;DUSP3;SLURP1;RAP2A;MITF;FOXO3;MCTP1;TIMP1;NKX2-1;RAP2B;FLCN;DUSP10;PODN;VCL;ARHGDIB;PFN2;NF2;PTPRU;ADIPOR1;ADGRG1;ADARB1;STK24;ATP1B2;PTPRT;LRP1;NF1;EPHA4;PTEN;CORO1C;LDLRAD4
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.428967907427805,-1.052905137839606,0.37540453074433655,0.878195436394034,1.0,4/11,11.23%,BMPR1A;CD200;CD46;PTGS2
prerank,eye photoreceptor cell development (GO:0042462),0.5112545589249228,1.0527478399133334,0.40867279894875164,0.8038457399562291,1.0,3/15,8.12%,THY1;NRL;MYO7A
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.4377725486246576,1.052489787719402,0.4355362946912243,0.8040407075184492,1.0,7/46,10.11%,TGFB1;HCLS1;PRKCD;DHX9;TP53;SMAD3;TPR
prerank,positive regulation of T cell cytokine production (GO:0002726),0.48592952846753035,1.0515524818206232,0.4396551724137931,0.8059035189227768,1.0,5/20,13.13%,TRAF2;IL18;MALT1;DENND1B;B2M
prerank,neurotrophin signaling pathway (GO:0038179),0.48632404233021154,1.0515524436345356,0.4398496240601504,0.8054275402709873,1.0,8/21,19.71%,GRB2;NTF3;BCAR1;RAPGEF1;DDIT4;RAP1A;KIDINS220;SORT1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.4512302844445844,1.0514190331155118,0.41359447004608296,0.8052854658075606,1.0,4/26,7.84%,PLCG2;SNCA;ABCD1;TRAP1
prerank,"transcription, DNA-templated (GO:0006351)",0.40844396517478504,1.0512311136353885,0.3953953953953954,0.8052983414611278,1.0,70/207,25.39%,ARRB2;IVNS1ABP;RREB1;GTF2H1;TAF1A;FOXO3;EAF1;TAF1;GTF3C4;BTF3;TP53;MEF2A;TTF1;LEO1;GTF3A;TRIP13;GMEB2;MMS19;HSF1;CDK7;NFX1;NFIC;KLF13;POLR2L;TRIM24;MBD1;PMF1;SNAPC3;ELL;MLLT1;NFKB1;RO60;TWNK;MAF;ERCC6;TAF3;ZBTB7B;GTF2B;RSF1;NFYA;TCEA1;CREBL2;GTF2H5;POLR2E;TAF11;FUBP3;ELOB;MED4;CRCP;GLIS3;IWS1;TAF1C;IRF9;SMARCA5;ELOC;POLR3A;NELFE;GTF2A1;CTR9;PARP1;MNT;TFAM;MRPL12;PAX8;PWP1;THRA;NCBP1;XAB2;NFIX;XBP1
prerank,negative regulation of neuron differentiation (GO:0045665),0.4829277900178539,1.0511640370355582,0.4441687344913151,0.8049758368574927,1.0,6/22,20.45%,ASCL1;SOX9;B2M;SOX2;CNTN4;GSK3B
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.3293483455650125,-1.0507915186626313,0.37272727272727274,0.8807681670906486,1.0,12/20,25.78%,ADSS2;NT5C2;GMPS;PFAS;AK3;AMPD3;AMPD2;PAICS;ADSL;IMPDH1;AK4;PPAT
prerank,'de novo' posttranslational protein folding (GO:0051084),0.45832357799919804,1.0507662325289127,0.4379391100702576,0.8055118616038299,1.0,7/30,16.70%,PTGES3;SDF2L1;DNAJC7;CHCHD4;BAG1;GAK;ERO1A
prerank,odontogenesis (GO:0042476),-0.2851849599937153,-1.0506473108620848,0.3467741935483871,0.8775924981217189,1.0,9/35,14.77%,FOXC1;EDA;BMP4;GLI2;WNT6;HDAC2;COL1A2;TBX1;TGFB3
prerank,thyroid hormone generation (GO:0006590),0.539733286522453,1.0505505086540037,0.43459302325581395,0.8056205452514779,1.0,2/10,14.25%,CTSK;TG
prerank,cotranslational protein targeting to membrane (GO:0006613),0.41685186162267507,1.0499739222920044,0.42213114754098363,0.8065675392648027,1.0,38/91,25.69%,RPL23;RPL17;RPL10A;RPS2;RPL18A;RPS15A;RPL6;RPLP2;RPL26;RPS20;RPS16;RPS14;RPL19;SRP19;RPL9;RPS11;RPL11;RPS23;RPS4X;RPS27;SEC63;RPL4;RPL7A;RPL15;RPL29;RPL22;RPS7;SRP14;RPS13;RPLP1;RPS15;SRP9;RPS5;RPL41;RPL10;RPS8;RPL5;RPL18
prerank,regulation of cellular localization (GO:0060341),0.44160266085928035,1.0496925409728226,0.4108695652173913,0.8068183457616855,1.0,9/46,16.71%,LYN;UNC13D;NR1H4;REEP6;LRP5;DYNC1H1;LRRK2;STXBP4;HSP90AA1
prerank,regulation of response to interferon-gamma (GO:0060330),0.5123784421058302,1.049400745905762,0.4272363150867824,0.807125490427604,1.0,9/14,30.33%,IFNGR2;PIAS1;SOCS3;IFNGR1;PARP9;HSP90AB1;CDC37;SUMO1;JAK2
prerank,cell-substrate junction assembly (GO:0007044),-0.3057253450435807,-1.0492750996055178,0.2992125984251969,0.8780513467094094,1.0,9/33,8.60%,SORBS1;PEAK1;TAOK2;ACTN2;PTPRK;BCR;WHAMM;PLEC;ITGB4
prerank,mitotic cell cycle phase transition (GO:0044772),0.40345792069968894,1.0480192814837448,0.4044044044044044,0.8101797868886114,1.0,37/203,14.41%,TUBB;GPR132;PRKAR2B;HAUS2;CDK14;CCND3;CDC23;TUBA4A;FBXL22;CCND2;CNTRL;CEP192;MAPRE1;UBE2S;DNM2;CEP70;GSPT1;PLK4;PIM2;PLK2;CEP76;CHEK2;RB1;ENSA;HAUS1;CDK7;DBF4;INHBA;CDC34;DYNC1H1;PCM1;CDK6;FBXL3;MAX;CEP152;HAUS8;CCNE2
prerank,regulation of protein sumoylation (GO:0033233),0.49124776720458013,1.0476749247417423,0.4256410256410256,0.8105724533690819,1.0,6/17,20.00%,CTNNB1;HDAC4;UBA2;CAPN3;PIAS1;RWDD3
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.523766256928862,1.0476349194029302,0.4410112359550562,0.8101876223444768,1.0,4/12,16.32%,UCK1;CDA;UCK2;DCK
prerank,regulation of chromosome segregation (GO:0051983),0.49711068036330247,1.0474567917433215,0.4313984168865435,0.8101644851124662,1.0,4/16,13.79%,CSNK2A2;CSNK2A1;PUM2;CDC6
prerank,regulation of cell communication (GO:0010646),0.45409701934642854,1.0474050995596493,0.4359861591695502,0.8098266002579307,1.0,6/35,6.34%,PTPN1;NUP62;SLC8A1;GRK3;MTCH1;ANXA1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.3646775555738501,-1.0473494459187438,0.37446808510638296,0.8801873078827976,1.0,8/17,23.33%,SOD2;PRKG1;TGFB3;PPARG;TAFA5;PDCD4;CDKN1A;GPER1
prerank,peptide hormone secretion (GO:0030072),-0.3116035395390728,-1.0473148374649468,0.3620689655172414,0.8767173713667641,1.0,9/26,24.67%,LTBP4;CDK16;RIMS2;CAMK2G;PARK7;PTPRN;EDN1;EDN3;ADCYAP1
prerank,polyol biosynthetic process (GO:0046173),-0.36198241665022135,-1.0471535317142107,0.42386831275720166,0.8736169921823028,1.0,7/16,23.13%,PPIP5K2;IP6K1;IP6K2;ITPKC;IPMK;ISYNA1;CYP2R1
prerank,regulation of wound healing (GO:0061041),0.44362116311635713,1.046961578264416,0.45154185022026433,0.8105433490038841,1.0,6/42,9.65%,GP1BA;ARFGEF1;TNFAIP3;ANXA1;CASK;ACTG1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.5449301142136754,1.0469300533868908,0.4334763948497854,0.8101474371196841,1.0,6/10,24.65%,FZD9;ABCD1;LRRK2;SRC;RACK1;KDR
prerank,regulation of membrane depolarization (GO:0003254),0.49958076392244805,1.0465348676691413,0.4389937106918239,0.8106838599490568,1.0,6/18,18.67%,HCN4;ABCD1;NEDD4L;LRRK2;SCN5A;PTPN3
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.44620969477218353,1.046379197419483,0.44932432432432434,0.8105819905113926,1.0,7/39,11.23%,SHH;PKD2;CTNNB1;TGFBR2;NKX2-1;LRP5;NRP1
prerank,positive regulation of filopodium assembly (GO:0051491),0.4673930543482431,1.0460137234012292,0.44878048780487806,0.8110121147459957,1.0,8/24,17.93%,ARAP1;RIPOR2;DOCK11;AGRN;NRP1;FNBP1L;MIEN1;CDC42
prerank,negative regulation of axonogenesis (GO:0050771),0.4635579541831507,1.0459762807073572,0.42655699177438305,0.8106318200258077,1.0,8/27,17.75%,THY1;FGF13;DIP2B;ARHGDIA;EFNB3;RTN4;PTEN;RHOA
prerank,SNARE complex assembly (GO:0035493),0.5459144703159882,1.0455617089101257,0.45942028985507244,0.8112127715338883,1.0,3/10,9.42%,VAMP3;SNCA;UVRAG
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.3258330795241309,-1.0453102463504966,0.3559322033898305,0.875519513220254,1.0,13/24,30.40%,DMD;JPH1;SRI;FKBP1A;CALM3;SELENON;NOS1;JPH2;JPH4;PDE4D;CALM2;GSTO1;CASQ2
prerank,modulation of chemical synaptic transmission (GO:0050804),0.4153021751532109,1.0452694723211837,0.4200404858299595,0.8115239856944158,1.0,14/107,8.95%,NPAS4;CX3CR1;ABR;DGKZ;CLSTN1;TNF;CEL;CLN3;MCTP1;BTBD9;CACNA1A;MEF2C;EIF4EBP2;NTF3
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.511570983633937,1.0452606212910385,0.4535809018567639,0.8110795217906746,1.0,4/15,9.46%,EDEM1;RAB3GAP2;SPCS2;SPCS1
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.4649673014963602,1.045175596234499,0.42098765432098767,0.8108404197060176,1.0,4/24,11.77%,PRKAR2B;MGRN1;PDE11A;CDC34
prerank,cardiac muscle cell action potential (GO:0086001),0.46007972613893583,1.0447227396015637,0.4407744874715262,0.8115064396179186,1.0,5/30,4.32%,SCN4B;HCN4;SLC8A1;PKP2;KCNIP2
prerank,positive regulation of cell projection organization (GO:0031346),0.40904321429168355,1.0447073182742348,0.4262626262626263,0.8110669385749084,1.0,20/115,14.54%,PTK2B;LYN;CAMK1D;ARSB;SS18L1;PLXNC1;MDK;SLITRK1;ITGA6;APOE;PLXNB2;CBFA2T2;FUT9;RAPGEF1;TWF2;NPTN;ARHGDIA;CUX1;ATP1B2;RAP1A
prerank,ncRNA export from nucleus (GO:0097064),-0.295373827642479,-1.0442811988710408,0.34615384615384615,0.8749795093434602,1.0,17/36,22.05%,NUP93;NUP188;RANBP2;SSB;NUP98;NUP42;PHAX;NDC1;RAE1;NUP153;NUP37;NUP133;NUP50;RAN;NUP43;NPM1;NCBP2
prerank,amino acid import (GO:0043090),0.4714748033629267,1.0442547069480694,0.4224464060529634,0.8117386086018477,1.0,4/21,9.26%,SLC7A8;SLC36A1;SLC16A2;SLC25A38
prerank,regulation of transforming growth factor beta production (GO:0071634),0.49136665315208206,1.043964826848642,0.45118733509234826,0.8119912310733706,1.0,1/18,0.35%,LILRB1
prerank,regulation of endothelial cell proliferation (GO:0001936),0.40942363887642796,1.0437797288632749,0.4329580348004094,0.8119630916632081,1.0,16/88,13.07%,STAT5A;PIK3CD;ITGB3;TGFBR1;RGCC;PRKD2;APOE;PDCL3;XDH;VEGFB;ATP5IF1;PDCD6;NRP1;THBS1;NR4A1;ATP5F1A
prerank,ephrin receptor signaling pathway (GO:0048013),0.4176127352404924,1.0434902086500069,0.4567901234567901,0.8122099337296586,1.0,25/82,17.93%,LYN;VAV2;NCK2;VAV3;ARPC2;EFNA2;ACTB;AP2S1;ARPC3;ITSN1;ACTG1;ACTR2;ACTR3;YES1;ARPC4;SDCBP;FYN;EFNB3;SRC;AP2M1;RASA1;EPHA4;EPHA8;RHOA;CDC42
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5437707383871193,1.0432968507239904,0.45314685314685316,0.8122608058648005,1.0,2/10,10.05%,PCSK9;NEDD4L
prerank,regulation of heart contraction (GO:0008016),0.41130094007367346,1.0431510344029857,0.44012282497441146,0.8121695487172942,1.0,15/90,13.93%,KCNJ11;TMIGD3;HCN4;SLC8A1;KCNIP2;P2RX4;ASPH;ATP2B1;ITPR2;NPR2;ATP2B3;ATP1B3;ATP2A3;ATP1B2;DES
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.3684991996389383,-1.0429710195770727,0.38188976377952755,0.8753419498573616,1.0,3/16,1.09%,SOX5;FOXC1;PTN
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.385461721000967,-1.0426494520170433,0.40725806451612906,0.8727527747938466,1.0,7/14,21.50%,AUTS2;SMAD4;DNMT1;SNW1;PAXIP1;KMT2E;PRDM9
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.432889271124356,1.0420351355289825,0.4402583423035522,0.8145492218551214,1.0,5/53,6.99%,TREM2;BAG2;APOE;XPO1;GNA12
prerank,striated muscle cell differentiation (GO:0051146),0.5030373750593006,1.0419032640768684,0.43365253077975374,0.814402712266988,1.0,5/16,12.63%,SKI;PLD3;MYOCD;MEF2C;NRG1
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.27714732780476115,-1.0414978165415363,0.3488372093023256,0.8725014069416523,1.0,6/43,4.03%,SUCO;BMPR1A;WNT4;PRKD1;BMP4;ACVR1
prerank,protein polymerization (GO:0051258),0.42594713716064503,1.041474258710641,0.4440894568690096,0.8150188943360297,1.0,9/55,12.84%,PREX1;FGF13;PSTPIP1;MICALL2;AIF1;UBE2S;WASHC3;DIAPH1;RNF135
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.3518349737357034,-1.0413868774367834,0.38860103626943004,0.8693793340804332,1.0,6/18,12.66%,SLC25A12;FOLH1;MTHFD1;SLC25A13;SMS;GOT1
prerank,regulation of axon guidance (GO:1902667),0.5363422328780492,1.0410372666042782,0.4334319526627219,0.8156456305140215,1.0,5/10,28.43%,NRP1;ZSWIM6;MYCBP2;VEGFA;ZSWIM5
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5037720618480348,1.0409801938734737,0.4590395480225989,0.8153203333621144,1.0,4/13,13.40%,IL18;TYROBP;TICAM1;GAS6
prerank,negative regulation of DNA binding (GO:0043392),0.46032137795008243,1.0409360240341077,0.44770857814336074,0.8149675712294265,1.0,2/28,2.40%,GATA1;MAD2L2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.42953468092584446,1.0402874324666957,0.4358695652173913,0.8161544934608602,1.0,17/48,21.97%,TAF1A;POLR1E;SF3B1;ZMIZ2;ACTB;ARID1A;ARID1B;ATAD2;POLR1B;POLR2L;ELOF1;ERCC6;MYO1C;POLR2E;PADI2;TAF1C;SMARCA5
prerank,cell junction maintenance (GO:0034331),0.5139180124810916,1.0401697223439585,0.461118690313779,0.8159833049231953,1.0,1/14,2.01%,CSF1R
prerank,mesenchymal to epithelial transition (GO:0060231),0.5327626591424998,1.0400842926582328,0.4408284023668639,0.8157307085230443,1.0,1/10,1.62%,BASP1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.3826114745620287,-1.0399555946676358,0.4279661016949153,0.8701844115562629,1.0,7/14,29.97%,UPP2;NT5E;DHODH;NT5C1A;UMPS;UPB1;CAD
prerank,actin filament bundle organization (GO:0061572),0.4476465837854031,1.0399072594764927,0.43687150837988825,0.8156899831991653,1.0,5/33,7.51%,LCP1;PLS1;AIF1;NEDD9;MICAL1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.4595038215599315,1.039761397334417,0.4511904761904762,0.8155872852741602,1.0,6/25,14.62%,CTSS;STAC;WNK1;ATP1B3;ATP1B2;WNK4
prerank,DNA geometric change (GO:0032392),0.47097673923115996,1.0396496717359291,0.45883777239709445,0.8153914348888776,1.0,6/24,14.15%,DHX9;HMGB1;ANXA1;MCM9;DNA2;DDX1
prerank,chordate embryonic development (GO:0043009),0.4193600040641571,1.0394903771272779,0.45405982905982906,0.8153191165029158,1.0,7/55,9.39%,TGFB1;TGFBR1;PKD2;CHD7;FLCN;SULF2;XYLT1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.47825273444969946,1.0394230211816036,0.45454545454545453,0.8150104349368636,1.0,5/19,12.46%,SMOC2;PIK3CB;XDH;CD63;CCBE1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4076857524210967,1.0391614470559492,0.43478260869565216,0.8152071411825647,1.0,16/113,12.98%,MMP12;STAT5A;PIK3CD;ITGB3;TGFBR1;RREB1;MDK;PRKD2;PDCL3;VEGFB;PDCD6;SOX9;NRP1;GRN;NOD2;NR4A1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.44273149477073626,1.0388934836315473,0.44004524886877827,0.8154077438141889,1.0,12/38,15.64%,SREBF2;MICALL2;UBE2D3;VPS11;CSNK2A2;ATP5IF1;PARL;HUWE1;LRRK2;SREBF1;UBE2J2;GSK3A
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.47223088222746024,1.038849655017835,0.4426829268292683,0.8150506879303765,1.0,3/22,4.59%,EDEM1;MAN1C1;SEL1L
prerank,cellular sodium ion homeostasis (GO:0006883),0.5038425797046255,1.038689446783479,0.43693107932379716,0.814983479480542,1.0,5/15,13.76%,SLC8A1;SLC9A1;NEDD4L;ATP1B3;ATP1B2
prerank,regulation of cellular protein catabolic process (GO:1903362),0.47864375445621626,1.0383615507151078,0.4269081500646831,0.8153449628648317,1.0,8/18,19.66%,WDR91;VPS11;AMER1;NELL1;FAF1;HSP90AA1;DACT1;ATRAID
prerank,regulation of intracellular pH (GO:0051453),0.4496581308257043,1.0383523112252575,0.44419134396355353,0.8149004162442814,1.0,11/34,22.06%,SLC9A4;CLN3;SLC9A9;SLC9A1;LRRK2;SLC9A8;NOX1;TMEM165;SLC9B1;SLC9A7;CHP1
prerank,regulation of cellular component organization (GO:0051128),0.4019667188172381,1.0382735270788637,0.42900302114803623,0.8146360855902929,1.0,36/135,19.65%,CD22;MAD2L2;MTOR;PTPN1;SEMA4D;TNF;APOE;TRAF2;RASGRP2;RAP1B;CDK11B;AP2S1;PRKCQ;STON2;KIF14;METTL4;BCAR1;GFAP;RAPGEF1;STON1;ITCH;HCFC1;RAB33B;ATAD3A;ARHGEF11;RAP1A;SGK3;CAMSAP2;CD36;IRGM;HSP90AA1;LAMTOR1;PICALM;DCUN1D5;RPTOR;ROCK2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.47254790138652925,1.0378926560817519,0.4632352941176471,0.8151139468841706,1.0,6/21,17.70%,SCN4B;NOS1AP;KCNA5;CACNA1D;SCN5A;AKAP9
prerank,error-free translesion synthesis (GO:0070987),-0.3266956920274538,-1.0375906999938997,0.421875,0.8735095946536353,1.0,15/22,39.93%,REV1;RFC1;RCHY1;RFC2;UBC;RPA3;UBA52;RPA2;RFC3;RPS27A;RFC4;PCNA;POLD1;UFD1;RFC5
prerank,hydrogen peroxide metabolic process (GO:0042743),0.47479681091660525,1.0372410307480178,0.4535031847133758,0.8162975280911626,1.0,7/19,20.99%,PRDX1;PRDX3;PRDX2;PXDN;NOX1;PRDX5;CYBA
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4765398164201555,1.0372361799561673,0.4566831683168317,0.8158440740945008,1.0,2/21,4.27%,MED17;MITF
prerank,cellular transition metal ion homeostasis (GO:0046916),0.41465733197053617,1.0371101831923732,0.441025641025641,0.8157063692642346,1.0,25/91,22.27%,SLC11A1;FRRS1;ATP7A;ATOX1;ATP6V0A2;IREB2;ATP6V0D1;HFE;FTL;ATP6AP1;ACO1;FTH1;SLC31A2;ATP13A2;SLC39A6;HMOX2;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.3377078559459391,-1.0369435629790205,0.40476190476190477,0.8719766691791208,1.0,4/21,3.95%,AFG3L2;BCAP31;MICU1;SLC8A3
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.452249045767806,1.0369061765566203,0.4342258440046566,0.8157351307576016,1.0,4/31,9.11%,SYT17;SYT2;STXBP3;SYT10
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.4779951358246908,1.0368496863540888,0.44221105527638194,0.8154074363677785,1.0,4/20,11.55%,ITGA4;RGCC;THBS1;CCL2
prerank,diol biosynthetic process (GO:0034312),0.5108061771198793,1.036564629149012,0.45170068027210886,0.8156966274338144,1.0,6/15,21.23%,GCH1;QDPR;ACER3;SPR;ASAH1;ABCA2
prerank,apoptotic process (GO:0006915),0.4018845400334596,1.036486483265403,0.4214214214214214,0.8154301267857134,1.0,38/203,14.99%,PTK2B;ITGB2;IL1A;PRKCD;TLR2;MTOR;ELMO1;ESPL1;CXCR4;BRAT1;PYCARD;CD14;CASP1;APAF1;CFLAR;BCL2L1;CDK11B;TGFBR2;BAK1;ATCAY;MCM2;TNFRSF21;BNIP1;CASP7;DAP;IAPP;PPP2CA;DDIT4;IKBKG;CASP8;STK3;TRADD;IRF1;HK2;BMF;CAPN3;VDAC1;RNF152
prerank,regulation of RNA export from nucleus (GO:0046831),0.5157488182012889,1.0362913807109198,0.44813278008298757,0.8154677441453501,1.0,5/11,16.01%,DHX9;TPR;SETD2;AKAP8L;NRDE2
prerank,regulation of small molecule metabolic process (GO:0062012),0.4608633430143384,1.0359421984964607,0.4495192307692308,0.8159123136052143,1.0,8/28,14.79%,NR1H4;APOE;FMO5;ACADL;ADIPOR1;TTC39B;FOXK1;ARV1
prerank,response to histamine (GO:0034776),-0.42451421671490847,-1.0351857801918265,0.43322475570032576,0.873663337824958,1.0,3/10,10.55%,GABRB2;GABRB1;GABRB3
prerank,regulation of interleukin-1 production (GO:0032652),0.501971975464335,1.034981914258723,0.44823066841415465,0.8178923878554286,1.0,3/15,6.34%,SIRPA;HMGB1;ANXA1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.5216953987073087,1.0349208639758658,0.44866385372714485,0.8175622515478019,1.0,4/11,16.71%,GCH1;QDPR;SPR;HSP90AA1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.46391502546846125,1.0348023306571168,0.44471744471744473,0.8174149472107435,1.0,8/20,25.14%,PTGES3;LONP1;PSMG3;BBS12;HSP90AA1;PSMG2;HSPA4;HSP90AB1
prerank,negative regulation of chemotaxis (GO:0050922),-0.30325455283721436,-1.0344002650193482,0.37735849056603776,0.872581977689265,1.0,9/31,8.55%,SEMA6A;ROBO2;SEMA5A;SEMA3A;SEMA6D;ROBO1;SLIT2;SEMA3C;SEMA3D
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.4341045312909805,-1.0341842404332697,0.44256756756756754,0.8698199827829539,1.0,4/10,17.07%,SOX5;ACVRL1;PKDCC;ZBTB16
prerank,myofibril assembly (GO:0030239),0.4257889894885464,1.0338877637838186,0.4611171960569551,0.8192363977704513,1.0,7/42,14.80%,TTN;MYLK3;FLII;CFLAR;TNNT3;CSRP1;CAPN3
prerank,positive regulation of translation (GO:0045727),0.40867875421219013,1.0332161457376179,0.454638124362895,0.8204735129218697,1.0,24/94,17.95%,NIBAN1;MTOR;DHX9;PLXNB2;CIRBP;FASTKD3;YTHDF3;LARP4B;LARP1;CPEB3;RPL26;THBS1;ZCCHC4;METTL3;PCIF1;POLDIP3;UPF3B;RCC1L;HNRNPD;SOX4;USP16;RPS4X;AGO2;CNBP
prerank,gland development (GO:0048732),0.4248687824053474,1.032029434664738,0.4574468085106383,0.8229481551235004,1.0,14/59,16.02%,SHH;PCSK9;TGFBR1;MDK;PKD2;CEBPA;ANXA1;NKX2-1;SOX9;NRG1;SOX2;TG;IGSF3;NF1
prerank,mRNA metabolic process (GO:0016071),0.4081417280502201,1.0316881761160717,0.4635897435897436,0.8233384332463363,1.0,16/90,12.06%,SLFN14;ERN1;SF3B2;AURKAIP1;SCAF11;TP53;ZC3H12D;LSM11;HSF1;PPARGC1A;PCBP3;AGO4;SON;AGO3;METTL3;PRPF8
prerank,establishment of skin barrier (GO:0061436),0.4836094562595386,1.0316030772241946,0.44621513944223107,0.8226072128688313,1.0,1/15,1.99%,ALOX12
prerank,regulation of water loss via skin (GO:0033561),0.4836094562595386,1.0316030772241946,0.44621513944223107,0.8226072128688313,1.0,1/15,1.99%,ALOX12
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.37159862127273324,-1.0315041528999191,0.4196078431372549,0.8740584327242669,1.0,4/15,10.54%,KCNN2;ATP1B1;KCND3;KCNJ3
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.45170091199367157,1.0314881486067198,0.45794392523364486,0.8224256981732776,1.0,8/29,13.44%,CORO1A;CYRIB;PRKCD;ARFGEF1;PFN2;PFN1;TWF2;SSH2
prerank,cellular response to BMP stimulus (GO:0071773),-0.24009302610292865,-1.029815692361255,0.3902439024390244,0.875694147614036,1.0,12/66,9.52%,BMPR1A;SLC33A1;RGMA;BMP4;ACVR1;TGFBR3;ACVRL1;SMAD9;BMP5;SMAD4;SMAD5;SMAD1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.4798119079411495,1.0295825511825236,0.4543239951278928,0.8268164369552062,1.0,3/20,10.05%,PCSK9;EPO;NEDD4L
prerank,mitochondrial genome maintenance (GO:0000002),0.5183186019981743,1.0294097879109223,0.46924177396280403,0.8267638127084049,1.0,7/11,27.01%,MEF2A;LONP1;MGME1;MPV17;PARP1;AKT3;TOP3A
prerank,endothelial cell migration (GO:0043542),-0.2786852217256822,-1.0293340072531414,0.4344262295081967,0.8736462327506799,1.0,10/37,16.08%,FSTL1;CDH5;STARD13;ID1;ABL1;FAP;CCN3;NOS3;SCG2;STAT1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.5017314623402491,1.0293338471094182,0.4700520833333333,0.8264921495953854,1.0,2/14,5.17%,LPIN2;CHKB
prerank,external encapsulating structure organization (GO:0045229),0.3971714458813278,1.0291131372388416,0.432,0.8265886479030514,1.0,25/205,10.54%,ITGAL;MMP12;ITGA2B;ITGAX;ITGB2;SMOC2;ITGA4;ITGB3;ITGB5;ITGA2;ADAMTS8;ITGA6;ATP7A;TTR;TGFBI;SPP1;CD44;ITGAE;TNR;AGRN;LOX;BCAN;ITGAM;F11R;MMP19
prerank,positive regulation of cell differentiation (GO:0045597),0.3994573449158727,1.0290551803049477,0.4244244244244244,0.8262548624293943,1.0,38/237,13.61%,PF4;ASCL1;TGFB1;RIN2;LPL;TGFBR1;GPRC5B;MMD;MTOR;MDK;MAPK14;SP7;MSR1;RGCC;IL6R;IL18;RIPOR2;CTNNB1;TGFBR2;MEF2A;CEBPB;ASXL2;SNAI1;MEF2C;SMAD3;AKIRIN1;PRKCH;IMPACT;LRP5;CMKLR1;ATP6AP1;SOX9;NELL1;SDCBP;CREB1;BAMBI;NFKB1;SOX6
prerank,acute-phase response (GO:0006953),0.5138849027894621,1.0289022431075883,0.454172366621067,0.8261679560721995,1.0,2/12,7.68%,IL6R;CEBPB
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.3176398104893046,-1.0287292216188966,0.3793103448275862,0.872187478715566,1.0,12/27,26.75%,ANK2;DMD;JPH1;FKBP1A;SELENON;AHNAK;NOS1;JPH2;JPH4;PDE4D;CALM2;CACNB3
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.393509966150162,1.0286435119669044,0.304,0.8263506430193296,1.0,270/1668,14.33%,RUNX1;BATF3;SPIC;NFE2;LILRB1;IRF5;NPAS4;MMP12;AHRR;PF4;ASCL1;CIITA;MEOX1;SHH;IRF4;IRF8;SLC11A1;TGFB1;IKZF1;HCLS1;TOX4;UXT;GATA1;STAT5A;NFE2L2;POU2F2;BRD8;FNIP2;LPIN2;NLRC5;RPL23;CSF1R;NFATC1;HES7;MED17;RREB1;GTF2H1;MAD2L2;EDNRB;TLR2;BCL11A;NSD1;MLXIPL;SS18L1;ELF4;DHX9;ZEB2;MAPK14;IER2;OSM;MED13L;SP7;MAML3;CREB3L4;CREB3;BARX2;NCK2;PRDM12;SEMA4D;RXRB;FOXD2;NR1H4;DNMT3A;TNF;FNIP1;SNCA;SREBF2;TET3;ITGA6;RGCC;RFX1;PRKD2;PKD2;MLXIP;APOE;CIR1;BPTF;UBE2D3;MITF;ZFP30;CRYM;SKI;ATF3;CEBPA;CDK8;FOXO3;SRCAP;FHOD1;ZMIZ2;LRRFIP1;DDIT3;SPI1;IL18;FIZ1;MYT1L;ZBTB12;PGBD1;WWC2;ZBTB39;HIVEP3;MAFG;MAFK;HOXC8;BHLHE41;HDAC5;GALR1;HMGB1;TAF1;RNF111;BRIP1;BACH1;FLI1;PRKCB;TEAD1;PCGF6;MRTFA;CTNNB1;TRPS1;TFEB;MTA3;ZFP69;ZNF177;TP53;KLF6;MEF2A;AKNA;TBL1XR1;NKX2-1;PHF21A;NRL;TAL1;USF1;MYOCD;RCOR1;TNRC6A;AGRN;KDM7A;HSBP1;YY1;TCF20;CREB3L1;SLC9A1;STAT4;ZFP90;EPO;CEBPB;ASXL2;DBX2;ST18;LMO2;SNAI1;MEF2C;DOT1L;NKRF;CDC5L;FLCN;TFAP2B;MOV10;RB1;TRIM27;GMEB2;SMAD3;AKIRIN1;ARID1A;ZFP14;TADA1;GTF2IRD1;IRF2;HSF1;PPARGC1A;ZNF32;ARID3B;ATRX;AGO4;CDK7;CREBRF;RNF4;ARID4A;ANXA4;IMPACT;GMEB1;CPEB3;STAT5B;MCRS1;LRP5;MIDEAS;HDAC4;NFX1;NFE2L1;NEDD4L;TPR;ACTR2;LITAF;CCNL1;ZNF83;TGIF1;ARID1B;HOXA6;RNF10;RPAP2;NFIC;ATAD2;TBL1X;INHBA;MED27;ACTR3;KLF13;CHD1;RNASEL;CREB3L2;PKN1;BAZ1A;TXK;HCFC2;ZSCAN26;ELF2;OLIG1;SOX9;SRA1;RPS6KA4;PTOV1;JDP2;NR2C2;AGO3;ETV6;ZNF740;NRIP1;E2F6;PHIP;GZF1;CIAO1;HDAC9;HSF5;ATF6B;NOD2;SDCBP;MTF2;CREB1;RPS14;LAGE3;IKBKG;ZFP64;KAT7;ZSCAN18;SMARCD3;NR4A1;PPIL4;MAX;SMARCB1;ZFX;ZNF445;GPS2;NFKB1;FOXK1;SAFB2;RFX7;SOX6;CUX1;HCFC1;PCBP1;ZFHX3;IRF1;INO80;PID1;RTRAF;USP9X;WFS1;SOX2;KDM3B;BRD7
prerank,positive regulation of cell killing (GO:0031343),0.5124207441181627,1.028540770873722,0.4530386740331492,0.8261181274627942,1.0,1/13,0.95%,SYK
prerank,intracellular protein transport (GO:0006886),0.398638501285007,1.0282593043168846,0.43,0.8263537813283257,1.0,79/304,19.41%,MMP12;TBC1D9;TGFB1;SYK;CD74;LAPTM5;TBC1D10C;UNC93B1;CTSA;RAB32;NUP62;AP1S3;TMED3;SNX9;XPO1;RAB14;RAB3GAP2;TBC1D16;RAB7A;TBC1D22A;STX11;TLK1;AP3D1;USP6NL;STXBP3;TBC1D10A;RAB28;SNX27;CSE1L;RAB31;STRADB;PDCD6;SYNRG;ARL5B;ARL4A;TPR;RAB1B;TBC1D2;TBC1D17;COPA;CLTC;HDAC6;TBC1D2B;WDR11;XPO6;SEC16A;TBC1D8;STX3;SORL1;STX5;SAR1A;RPGR;STX8;GGA2;ARF6;VPS29;TBC1D14;STRADA;TBC1D22B;YWHAH;SMURF1;RPL11;SNX13;APPL2;ARFIP2;VPS28;IFT27;ARHGEF2;MYO1C;STX2;GIPC1;VPS33B;SLU7;TBC1D12;LTBP2;TBC1D5;DESI1;RAB29;SEC13
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.4304560130398255,1.028191101384708,0.4498346196251378,0.8260793806755117,1.0,8/43,11.17%,TGFB1;TNF;FOXO3;SPI1;TEAD1;TP53;SMAD3;SOX9
prerank,regulation of Wnt signaling pathway (GO:0030111),0.40838861946626603,1.0278832112334477,0.47585513078470826,0.8263840321107474,1.0,19/108,12.34%,RUNX1;NFATC1;TLR2;GNAQ;CDK14;OTULIN;SKI;TNFAIP3;LGR6;MACF1;CTNNB1;DISC1;CSNK2A1;SULF2;MDFIC;ATP6AP2;AMER1;NLK;PPP2CA
prerank,maintenance of blood-brain barrier (GO:0035633),-0.2941586528480942,-1.0278647018752722,0.42857142857142855,0.8714422388068654,1.0,9/30,15.10%,SLC12A2;TJP1;CDH5;DMD;CLDN5;CLDN12;JAM3;LAMC1;OCLN
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.44965968194804645,1.0278561071896468,0.47591743119266056,0.8259813224832964,1.0,8/31,18.54%,GPNMB;PKD2;RB1;CCL2;CDK6;BRD7;PTEN;DACT1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.40122836105929727,1.0277722710768344,0.4607645875251509,0.825730649539193,1.0,23/128,14.26%,TUBB;PRKAR2B;HAUS2;CDK14;TUBA4A;FBXL22;BACH1;CNTRL;CEP192;MAPRE1;DNM2;CEP70;PLK4;CEP76;CHEK2;ENSA;HAUS1;CDK7;DYNC1H1;PCM1;FBXL3;CEP152;HAUS8
prerank,establishment of protein localization to extracellular region (GO:0035592),0.4271152785112091,1.0277061295413379,0.45230078563411896,0.8254405121338451,1.0,9/39,18.76%,RAB8B;ABCA1;SEL1L;PPY;STEAP3;SVBP;MON1A;GOLPH3;LTBP2
prerank,T-helper cell differentiation (GO:0042093),0.4946035630866832,1.0276302000697624,0.4573333333333333,0.8251685482132874,1.0,4/14,9.45%,ATP7A;HMGB1;TMEM98;GPR183
prerank,regulation of lysosomal lumen pH (GO:0035751),0.518322613509206,1.0276051088303026,0.4609164420485175,0.8247536179408044,1.0,5/12,17.27%,CLN3;ATP6AP2;GRN;LRRK2;TMEM165
prerank,mitotic sister chromatid segregation (GO:0000070),0.40995265863458286,1.0270118303332356,0.4506172839506173,0.8257940726624672,1.0,26/98,20.56%,NUP62;ESPL1;CDC23;TTN;NCAPG2;SEH1L;KIF14;CSNK2A2;CSNK2A1;RB1;KIF23;RAB11A;BECN1;PDS5A;RRS1;INO80;AKAP8L;PDCD6IP;NAA50;EML4;CENPK;MIS12;SMC4;MCPH1;DIS3L2;CUL3
prerank,positive regulation of neuron projection development (GO:0010976),0.40695848024878956,1.026809888349634,0.4595701125895599,0.8258074412683406,1.0,16/85,14.54%,PTK2B;LYN;CAMK1D;ARSB;MDK;ITGA6;APOE;PLXNB2;CBFA2T2;FUT9;RAPGEF1;TWF2;LRP8;NPTN;ATP1B2;RAP1A
prerank,regulation of secretion (GO:0051046),-0.37945070563492944,-1.0267819260122113,0.4069767441860465,0.8711646873111014,1.0,7/13,27.26%,MYO6;GPLD1;FGF10;EGF;ERBB3;ACSL3;POFUT2
prerank,microtubule depolymerization (GO:0007019),-0.3545289066455398,-1.0266360580715255,0.42592592592592593,0.868250849476954,1.0,7/17,21.11%,NCKAP5;STMN2;KIF24;STMN4;STMN3;KIF18A;STMN1
prerank,peroxisome organization (GO:0007031),0.46226582836972296,1.0262295474048928,0.47205707491082044,0.8267685900059579,1.0,11/25,25.03%,PEX11A;ABCD1;PEX7;SEC16B;PLAAT3;ABCD2;DNM1L;FIS1;ACOT8;TMEM135;MFF
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.4246195930762412,1.0256028583991337,0.4580152671755725,0.8278222387762333,1.0,9/48,13.64%,CASS4;RREB1;SS18L1;MDK;NEDD9;P4HB;LIMS1;NRP1;CUX1
prerank,muscle cell migration (GO:0014812),0.5253498584414763,1.025525702209028,0.4552129221732746,0.8275452642653774,1.0,1/10,1.74%,ITGB3
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.43445905878691093,1.0254449255983367,0.4564732142857143,0.8272708939136297,1.0,9/36,13.05%,UXT;YAF2;APAF1;PCGF6;RING1;PHC1;E2F6;RBBP7;MAX
prerank,artery development (GO:0060840),0.4553137186809764,1.025288124592885,0.47051442910915936,0.8272071712778538,1.0,5/23,11.23%,TGFBR1;ANGPTL3;PKD2;HECTD1;NRP1
prerank,positive regulation of dendritic spine development (GO:0060999),-0.33881504050777106,-1.024649867832052,0.405,0.8707288255617883,1.0,10/20,19.35%,NLGN1;CAPRIN1;DLG5;FMR1;SHANK3;SHANK1;DBN1;DHX36;CAPRIN2;CAMK1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.467794347455295,1.0245579045995703,0.4586374695863747,0.8285366037831718,1.0,7/24,12.18%,ARPC2;WASF2;AKIRIN1;ACTR2;ACTR3;CYFIP1;TWF2
prerank,epiboly involved in wound healing (GO:0090505),0.49820725908119684,1.0243508850151946,0.4765625,0.8285644160207816,1.0,8/16,23.23%,LCP1;CD44;MRTFA;TOR1A;RHOA;FLNA;DDR1;PDPN
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.31715237889397707,-1.0241530927278273,0.42134831460674155,0.8689772640674253,1.0,5/23,11.09%,PAFAH1B1;GPSM2;NDEL1;NDE1;CDK5RAP2
prerank,sodium-independent organic anion transport (GO:0043252),0.5327101598842892,1.0237205126582578,0.4666666666666667,0.8296409915552845,1.0,3/10,14.98%,SLCO2B1;SLC16A2;SLCO1B1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.40952558029371944,1.0230738409285522,0.45320715036803366,0.8307809837195655,1.0,16/66,14.24%,TGFB1;NLRC3;RGCC;APOE;XDH;MTSS1;AQP11;ATP5IF1;DUSP10;CASK;SOX9;THBS1;CDK6;ATP5F1A;B2M;SOX2
prerank,triglyceride biosynthetic process (GO:0019432),0.47805830632582824,1.022853613074169,0.4593241551939925,0.8308435029166336,1.0,7/18,20.89%,LPIN2;AGMO;GK;PNPLA3;DGAT2;MOGAT1;LPIN1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.5119027131635575,1.0227988667160326,0.45850340136054424,0.8305163831496324,1.0,4/12,20.61%,TSPO;FDXR;FDX1;STARD3
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.4571160841580951,1.0227301195872798,0.4644149577804584,0.8302244529995189,1.0,6/24,12.63%,MAPK14;CTNNB1;MEF2A;MYOCD;MEF2C;NRG1
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.3386101009128545,-1.0227026185399604,0.4385026737967914,0.8698509190407552,1.0,8/22,18.42%,SP100;GDI1;LMAN1;RAB23;INSIG1;DMTN;PARK7;CABP1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3936464276955392,1.022638635775984,0.401,0.8300041706775171,1.0,98/572,14.24%,RUNX1;BATF3;ASCL1;CIITA;SHH;IRF8;UXT;GATA1;FNIP2;RPL23;RREB1;MAD2L2;EDNRB;BCL11A;NSD1;ZEB2;PRDM12;SEMA4D;NR1H4;DNMT3A;TNF;FNIP1;SNCA;SREBF2;CIR1;BPTF;UBE2D3;MITF;CRYM;SKI;ATF3;FOXO3;LRRFIP1;DDIT3;SPI1;MYT1L;WWC2;MAFK;BHLHE41;HDAC5;HMGB1;TAF1;BACH1;TRPS1;MTA3;ZFP69;ZNF177;TP53;MEF2A;TBL1XR1;NKX2-1;PHF21A;HSBP1;YY1;ZFP90;EPO;CEBPB;SNAI1;MEF2C;FLCN;TFAP2B;RB1;TRIM27;SMAD3;GTF2IRD1;IRF2;HSF1;ATRX;IMPACT;CPEB3;HDAC4;NFX1;NEDD4L;TPR;TGIF1;NFIC;TBL1X;HCFC2;SOX9;JDP2;NR2C2;ETV6;NRIP1;E2F6;GZF1;HDAC9;SDCBP;MTF2;RPS14;MAX;GPS2;NFKB1;CUX1;HCFC1;ZFHX3;USP9X;WFS1;SOX2
prerank,cardiac muscle cell differentiation (GO:0055007),0.4701119882170872,1.0222571392119677,0.4557739557739558,0.8304895468258522,1.0,5/21,12.63%,SLC8A1;TTN;MYOCD;MEF2C;NRG1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.4092444401289216,1.0220421073058787,0.46469968387776606,0.8305429351437231,1.0,15/65,17.77%,TGFB1;NRROS;TGFBR1;SKI;TGFBR2;NKX2-1;FAM89B;SMAD3;SNX25;BAMBI;VASN;STUB1;SMURF1;LDLRAD4;PDPK1
prerank,regulation of smooth muscle contraction (GO:0006940),-0.33183316003640834,-1.0218631403404803,0.41025641025641024,0.8690126952000575,1.0,6/20,14.95%,CHRM2;CAV1;SETD3;PLCE1;KCNB2;CHRM3
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.4126098485978223,1.02177091767075,0.45265348595213317,0.8307181641044145,1.0,15/64,18.91%,PCID2;GTF2H1;POLR1E;EAF1;LEO1;CDK7;SETD2;POLR2L;ELL;MLLT1;ELOF1;TCEA1;GTF2H5;POLR2E;ELOB
prerank,COPII-coated vesicle budding (GO:0090114),0.40826054352978075,1.0215187685284777,0.4801670146137787,0.8308778267891986,1.0,27/68,24.69%,CTSC;PPP6R1;TRAPPC9;MCFD2;CTSZ;PDCD6;VAPB;RAB1B;SEC24D;SEC16A;F5;SEC16B;STX5;SAR1A;TRAPPC6A;GRIA1;TRAPPC2L;SEC13;SEC22B;SEC31A;USO1;CUL3;NAPA;TRAPPC10;NSF;SEC24C;TRAPPC4
prerank,regulation of viral life cycle (GO:1903900),0.46553802266028,1.0215071441531796,0.4585427135678392,0.8304461280492229,1.0,3/21,8.56%,TRIM25;TRIM5;TRIM27
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3999949226493844,1.0212994252914775,0.4695740365111562,0.830511364066641,1.0,27/124,17.60%,LYN;PLEK;CSF1R;PRDM12;MICALL2;PKD2;APOE;HMGB1;TTC29;GPRIN3;MICALL1;LRP12;RB1;ATCAY;RAB11A;DTNBP1;CYFIP1;STX3;TOR1A;ATP1B2;PLEKHA1;ERCC6;EPHA8;ARFIP2;WDPCP;TBC1D23;MANF
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.4848102933748687,1.0211565050668836,0.4666666666666667,0.8304139763008397,1.0,4/13,14.19%,UTP20;NOP9;RRS1;TSR1
prerank,cellular protein modification process (GO:0006464),0.39140767649281294,1.0211335271749222,0.382,0.830021312745511,1.0,210/982,18.94%,PTPRC;PTK2B;BTK;PTPN7;FGR;LYN;GMFG;PPM1H;HCK;DAPP1;TGFB1;SYK;PCSK9;WDTC1;RSKR;FNIP2;PIK3CD;MAP4K1;TAOK3;COPS6;F13A1;TGFBR1;TYK2;PPP2CB;PRKCD;PTPRJ;MTOR;PTPN1;DUSP29;BMP2K;TEC;GRK3;PTPN18;ERN1;NEK6;CDK14;ATG7;ART4;PTPRE;PRKD2;ST8SIA4;APOE;UBE2D3;MYLK3;DNAJC3;CEL;CDK8;FBXL22;SPP1;RNF7;TIMP1;OARD1;NPC1;MORC3;FBXL18;TLK1;PARP8;TAF1;PTP4A2;KLHL21;PRKCB;ANXA1;MKNK1;CDK11B;UBE2S;STK10;TGFBR2;PSMB10;MAP3K5;OGA;PIM1;PLK4;WNK1;CDK17;PIM2;TNIK;P4HB;PLK2;MTMR3;CSNK1G2;LOX;CHEK2;CSNK2A1;ST3GAL1;MAP3K1;STRADB;DUSP10;MAN2B1;CHML;PRKCH;PGAP1;FUT9;CDK7;B3GALNT1;PIGH;RAB11A;MCRS1;STK17B;RAB1B;VGF;ST8SIA1;FAM20C;MSRA;RNASEL;LGALS1;CHGB;PKN1;PSMA2;TXK;YES1;RBBP5;THBS1;RPS6KA4;PTPRU;PTPRO;TIMM50;NLK;FBXO40;PRKACB;PARP16;CCL2;CDC34;KLHL11;RBBP7;FBXO32;MAN2A2;CSNK1A1;F5;FYN;PPP2CA;TNKS2;GRK4;MAP3K12;CDK6;PSME3;CREB1;STT3B;B4GALT7;SUMF2;FBXL3;LIPE;ILKAP;MERTK;CAMKK2;COPS4;TIPARP;BRAF;GAS6;SSH2;STK3;STK24;PSMB5;CTTNBP2NL;PTPRT;BMX;WFS1;PSMD8;LRRK2;NIM1K;WNK4;PPP1CC;CCDC8;DCAF17;TESK2;LARGE1;METAP2;PTPRA;PSMD7;STRADA;GAN;PSMB9;SGK3;GSK3A;CDK15;MAP3K11;HIF1A;ATG3;APLP2;COQ8B;PTEN;WSB2;ERO1A;STK4;PTPN12;PPP3CB;MACROD1;DCAF5;FEM1B;PIK3R4;RPS6KA5;CDK18;SIK2;VHL;PPM1M;PDPK1;PSMD2;KEAP1;DDOST;VRK1;FBXO44;PPP2R5C;CSK;MINK1;PTPN3;PPP4R2;MXRA8;SPSB2;IGFBP4;ELOB;TAOK1
prerank,organic anion transport (GO:0015711),0.4088634307018061,1.0208615109058166,0.4797086368366285,0.8302149830080735,1.0,12/76,15.17%,AQP1;ABCC6;SLC52A1;SLCO2B1;LRRC8D;CYB5R1;SLC16A2;CYB5RL;MGST1;SLC35A3;SLCO1B1;LRRC8C
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.408742951648015,-1.0208378978679418,0.44242424242424244,0.8687666784858883,1.0,2/10,13.44%,CAV1;ANK3
prerank,manganese ion transport (GO:0006828),0.49355311586487965,1.020541155839264,0.4532650448143406,0.8305553993431738,1.0,2/14,8.01%,SLC11A1;ATP2C1
prerank,regulation of cytoplasmic translation (GO:2000765),0.49676293884149575,1.02049303392882,0.4727272727272727,0.8302166176326148,1.0,6/14,20.49%,DHX9;CPEB3;CPEB4;CPEB2;CNBP;PKM
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4288215307078999,1.0204776707824763,0.47368421052631576,0.8297863914738071,1.0,11/39,20.21%,PCSK9;SCN4B;FGF13;WNK1;NEDD4L;WNK4;FXYD5;YWHAH;FXYD6;PTPN3;FXYD1
prerank,heart looping (GO:0001947),0.42921895064587,1.0200607013574687,0.4582857142857143,0.8303247457745178,1.0,4/39,8.10%,SHH;PKD2;TGFBR2;MEF2C
prerank,liver development (GO:0001889),0.442536943276231,1.019941799710419,0.47586206896551725,0.8301689575568364,1.0,5/32,7.68%,PCSK9;PKD2;CEBPA;ANXA1;CEBPB
prerank,positive regulation of cilium assembly (GO:0045724),-0.3518380435200932,-1.0197891628102242,0.4263157894736842,0.868525739045218,1.0,10/18,22.65%,ARHGAP35;CEP135;CCP110;BBS4;MARK4;CEP120;FUZ;CCDC88A;WRAP73;CROCC
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4099533514732356,1.0194103122004219,0.46673596673596673,0.8309741512121535,1.0,14/72,13.57%,LPAR6;ABCA1;ARHGEF18;APOE;GPR17;RIPOR2;MYO9B;FLCN;ARHGDIB;F11R;NRP1;ADGRG1;ARHGEF3;ARHGDIA
prerank,regulation of urine volume (GO:0035809),0.522403534640773,1.0186560457900424,0.4528301886792453,0.8324033715678808,1.0,4/10,19.95%,ADCY6;TFAP2B;ADM;INPP5K
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4357888457392282,1.0185825465926845,0.4738675958188153,0.8321065183527887,1.0,6/34,14.32%,TGFB1;TNF;FLCN;SMAD3;GPS2;BBS12
prerank,epithelial to mesenchymal transition (GO:0001837),0.4216810388008667,1.0180552159547793,0.4807480748074808,0.832940944628443,1.0,13/47,20.45%,TGFB1;TGFBR1;CTNNB1;AKNA;SNAI1;LIMS1;SOX9;RBPJ;HIF1A;TASOR;LOXL3;ROCK2;GSK3B
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.3881436554754508,-1.0180184384203976,0.4305555555555556,0.8703143594477141,1.0,6/12,18.49%,ANKRD13C;RER1;KDELR3;INSIG2;INSIG1;KDELR1
prerank,rRNA transcription (GO:0009303),0.48334252356162505,1.0176715400800258,0.47066326530612246,0.8334068961900193,1.0,3/17,7.94%,POLR1E;GTF3C4;GTF3A
prerank,cGMP biosynthetic process (GO:0006182),0.527460094257266,1.0175288651981387,0.48444444444444446,0.8333266673595681,1.0,2/10,10.24%,GUCY2F;NPR2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.3590699378388492,-1.0171707810748651,0.4581497797356828,0.8695644258616391,1.0,3/15,7.10%,PIEZO2;SCN1A;KCNA1
prerank,Golgi to plasma membrane transport (GO:0006893),0.41631475489227787,1.0169863212286776,0.47194719471947194,0.8341635539779989,1.0,13/47,13.78%,RAB34;RABEP1;EXOC6;CCDC93;MACF1;VPS35L;RAB31;ARFGEF2;EXOC8;EXOC1;EXOC2;EXOC5;GGA2
prerank,cellular protein localization (GO:0034613),0.3940336178951238,1.0168006736652035,0.457,0.8341404908480056,1.0,97/285,23.15%,TBC1D9;CD74;SH3PXD2B;LAPTM5;TBC1D10C;UNC93B1;CTSA;RAB32;TMED3;SNX9;RAP2A;RAB14;RAB3GAP2;TBC1D16;TBC1D22A;STX11;TLK1;AP3D1;USP6NL;CTNNB1;STXBP3;TBC1D10A;MYO7A;RAB28;SNX27;RAB31;ITSN1;PDCD6;SYNRG;ARL5B;ARL4A;VCL;RAB1B;TBC1D2;TM9SF2;TBC1D17;COPA;CLTC;HDAC6;PTPRU;CD63;TBC1D2B;BICD2;WDR11;TBC1D8;STX3;STX5;SAR1A;RPGR;STX8;GGA2;ARF6;LAMTOR3;VPS29;LRRK2;CAPN3;TBC1D14;AHI1;TBC1D22B;YWHAH;SMURF1;SNX13;MESD;ARFIP2;IFT27;ARHGEF2;LAMTOR1;STX2;VPS33B;SLU7;ANGPT1;TBC1D12;PACS2;TBC1D5;RAB29;SEC13;HHEX;SEC31A;USO1;ARCN1;COG7;AMOT;PIGU;HERC2;RRAGA;RRAGB;ERP29;UNC50;FLNA;NAPA;ABHD17A;NPHP1;ADPRH;ARL5A;CEP68;TBC1D9B;STX7
prerank,regulation of histone methylation (GO:0031060),0.5048707486238839,1.0167961886316508,0.47275204359673023,0.8336904288827323,1.0,3/13,15.10%,NSD1;TTLL12;PIH1D1
prerank,cell cycle G1/S phase transition (GO:0044843),0.4073675167302895,1.0166143550716755,0.48187633262260127,0.8336682144161616,1.0,14/61,16.10%,GPR132;GSPT1;PIM2;PLK2;RB1;CDK7;DBF4;INHBA;CDC34;CDK6;MAX;CCNE2;USP29;MAP3K11
prerank,protein maturation (GO:0051604),0.3991708752151036,1.016551564192257,0.48778004073319753,0.8333612794125518,1.0,22/95,17.05%,CTSS;SRGN;ECE2;EEF1AKMT4-ECE2;CLN3;DDI2;TSPAN32;TSPAN14;MMS19;CIAO2A;CIAO1;NAA40;SORL1;NDUFAB1;STUB1;PCSK7;GALNT2;ECEL1;METAP2;NAA50;FURIN;PITRM1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5282215709350666,1.016211174873674,0.47391304347826085,0.83374028128926,1.0,3/10,9.69%,HMGB1;TP53;ATF7IP
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.40939798685645956,1.0159580820311,0.49385245901639346,0.8339013268459744,1.0,19/80,14.40%,P2RX7;KCTD17;ARAP1;ARPC2;PLEKHM1;RIPOR2;DOCK11;AGRN;WASF2;P2RY12;AKIRIN1;ACTR2;ACTR3;PFN1;CYFIP1;NRP1;TWF2;FNBP1L;MIEN1
prerank,negative regulation of cell cycle (GO:0045786),0.40761971378803286,1.0157760453747529,0.47708333333333336,0.8338919670397087,1.0,21/73,20.95%,LILRB1;TGFB1;HPGD;CEBPA;MYOCD;RB1;SMAD3;SIPA1;ANGEL2;INHBA;TRIM35;CDK6;NR4A1;RPS6KA2;PTEN;PTPN3;SCRIB;HHEX;NPPC;HEXIM1;TFAP4
prerank,long-term synaptic potentiation (GO:0060291),0.47073804386292195,1.0153825355938964,0.4864516129032258,0.8344227827429845,1.0,2/21,7.63%,PTK2B;PLK2
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.512425439121867,1.0152190690473026,0.46277372262773725,0.834345242780672,1.0,3/10,11.77%,MGRN1;PDE11A;CDC34
prerank,neuron projection development (GO:0031175),0.39775777342348,1.0148301406630393,0.477432296890672,0.8348359663089269,1.0,42/168,20.52%,NCKAP1L;LYN;NEFH;TAOK3;PRDM12;MICALL2;ATP7A;APOE;WHRN;HMGB1;DOCK10;DNM2;GPRIN3;MICALL1;LRP12;TNIK;KIF20B;RB1;NTF3;ATCAY;RAB11A;DTNBP1;STX3;TOR1A;LRRK2;ERCC6;SVBP;CAMSAP2;ALS2;EPHA4;PTEN;EPHA8;TBC1D23;MANF;CDC42;MINK1;TAOK1;GDNF;CNTN4;CDK5R1;GSK3B;MAP4K4
prerank,nuclear membrane disassembly (GO:0051081),0.5043591352431662,1.0143962042205221,0.47593582887700536,0.8354371471563388,1.0,5/14,20.89%,NEK6;PRKCB;AKAP8L;VRK1;LPIN1
prerank,negative regulation of proteolysis (GO:0045861),0.440051774689739,1.0143860033304861,0.47586980920314254,0.8350078881471303,1.0,9/34,19.16%,CST7;CLN8;CLN3;TIMP1;HDAC6;LRRK2;EPHA4;PTPN3;TMEM59
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.44439523384829627,1.014337288299532,0.4811320754716981,0.8346670135259107,1.0,12/27,27.02%,CHSY3;BCAN;XYLT1;CHSY1;CHST15;PXYLP1;CHPF;CSPG4;B3GAT2;CHST3;CHST11;CHST9
prerank,muscle cell development (GO:0055001),-0.29492390722475637,-1.014195712921169,0.3722627737226277,0.8746073034534635,1.0,5/30,3.14%,ANK2;NEBL;CXADR;DMD;SGCZ
prerank,protein catabolic process (GO:0030163),0.41958422487031577,1.0136478093045986,0.4978723404255319,0.8359344157818805,1.0,15/59,18.32%,CTSD;MTOR;CLN8;APOE;DDI2;OGA;CHEK2;TRIM24;STT3B;UBE2G2;CAPN3;IDE;HSP90AA1;USE1;FBXO44
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.4648716585239002,1.0134674308986027,0.46153846153846156,0.8358988149624536,1.0,4/19,11.23%,PTPRJ;THY1;LIMS1;NRP1
prerank,regulation of biosynthetic process (GO:0009889),0.5159877661831304,1.0129909436000282,0.4906204906204906,0.8365631823966858,1.0,1/11,3.87%,SNCA
prerank,COPII vesicle coating (GO:0048208),0.41069194177717183,1.0123748986601346,0.4808510638297872,0.8366464663731621,1.0,25/61,24.69%,CTSC;PPP6R1;TRAPPC9;MCFD2;CTSZ;PDCD6;RAB1B;SEC24D;SEC16A;F5;SEC16B;STX5;TRAPPC6A;GRIA1;TRAPPC2L;SEC13;SEC22B;SEC31A;USO1;CUL3;NAPA;TRAPPC10;NSF;SEC24C;TRAPPC4
prerank,vesicle coating (GO:0006901),0.41069194177717183,1.0123748986601346,0.4808510638297872,0.8366464663731621,1.0,25/61,24.69%,CTSC;PPP6R1;TRAPPC9;MCFD2;CTSZ;PDCD6;RAB1B;SEC24D;SEC16A;F5;SEC16B;STX5;TRAPPC6A;GRIA1;TRAPPC2L;SEC13;SEC22B;SEC31A;USO1;CUL3;NAPA;TRAPPC10;NSF;SEC24C;TRAPPC4
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.41069194177717183,1.0123748986601346,0.4808510638297872,0.8366464663731621,1.0,25/61,24.69%,CTSC;PPP6R1;TRAPPC9;MCFD2;CTSZ;PDCD6;RAB1B;SEC24D;SEC16A;F5;SEC16B;STX5;TRAPPC6A;GRIA1;TRAPPC2L;SEC13;SEC22B;SEC31A;USO1;CUL3;NAPA;TRAPPC10;NSF;SEC24C;TRAPPC4
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.4055343602449134,1.012339010202102,0.49594320486815413,0.8362870329000275,1.0,29/100,20.78%,BAG2;CBFA2T3;RNF180;RNF19B;HERPUD1;CEBPA;XPO1;TAF1;HECTD1;GNA12;HFE;USP7;DET1;CSNK1A1;SDCBP;STUB1;RNF144B;LRRK2;PIAS1;GSK3A;RPL11;GIPC1;KEAP1;ELOB;DESI1;TLK2;RAD23B;GSK3B;PRKN
prerank,skin development (GO:0043588),-0.24520198623620165,-1.0122296211013098,0.40540540540540543,0.8769682109219363,1.0,14/65,15.14%,COL5A2;ERRFI1;CLIC4;COL3A1;WNT5A;BCR;ITGB4;COL5A3;COL1A2;MET;JAG1;CASP3;COL1A1;UGCG
prerank,neuron apoptotic process (GO:0051402),-0.33560721290626894,-1.0120058443046498,0.4090909090909091,0.8744216949943148,1.0,5/19,18.04%,APP;BNIP3;ATN1;NAE1;GAPDH
prerank,protein deacetylation (GO:0006476),0.42639235138057086,1.011950407268609,0.4740331491712707,0.8367765463764322,1.0,10/41,13.99%,HDAC5;MTA3;TBL1XR1;RCOR1;MIDEAS;HDAC4;TBL1X;HDAC6;HDAC9;HDAC11
prerank,regulation of G0 to G1 transition (GO:0070316),0.42682008557028794,1.0119338144067709,0.4745575221238938,0.8363488949833762,1.0,9/38,13.05%,UXT;YAF2;APAF1;PCGF6;RING1;PHC1;E2F6;RBBP7;MAX
prerank,response to estrogen (GO:0043627),0.44473750226412956,1.011727592210175,0.4700460829493088,0.8364012169546595,1.0,6/31,15.48%,TRIM25;OCSTAMP;TRIM24;RBBP5;SRA1;NCOA4
prerank,regulation of osteoblast proliferation (GO:0033688),0.4786873580517711,1.0113314290616071,0.48346055979643765,0.8368804072971995,1.0,5/17,19.66%,HPSE;NELL1;RHOA;GREM1;ATRAID
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.45871156265297286,1.0106391120949096,0.4881101376720901,0.8380906303958076,1.0,7/23,16.72%,P2RX7;MLXIPL;PFKFB4;NFKB1;PFKFB3;HIF1A;GAPDHS
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5030360229240665,1.0105055627294603,0.4773371104815864,0.8379345284160706,1.0,2/12,10.11%,TGFB1;TPR
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.4747227913087564,1.0102161800381315,0.47869674185463656,0.8382092715680471,1.0,3/17,3.19%,SCN4B;HCN4;SLC8A1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.4241223962978345,1.009940209783261,0.47420417124039516,0.8384037376794258,1.0,12/43,17.40%,SNX5;PRKCD;PTPN1;PTPRE;PIP4K2A;PRKCB;PRKCQ;SORL1;PID1;GSK3A;ZBTB7B;SIK2
prerank,miRNA mediated inhibition of translation (GO:0035278),0.5099425135342143,1.0097949413137257,0.4789156626506024,0.8378405436435485,1.0,4/11,17.89%,TNRC6A;AGO4;AGO3;AGO2
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.5099425135342143,1.0097949413137257,0.4789156626506024,0.8378405436435485,1.0,4/11,17.89%,TNRC6A;AGO4;AGO3;AGO2
prerank,steroid biosynthetic process (GO:0006694),-0.24740821942453994,-1.0095765703665578,0.4393939393939394,0.8783138624739589,1.0,25/56,33.95%,OSBPL9;OSBPL1A;HMGCR;CYP7B1;CYP51A1;INSIG2;INSIG1;SQLE;AMACR;LSS;CYP39A1;PMVK;LBR;SCP2;HSD17B4;DHCR7;EBP;SLC27A2;SC5D;STAR;TM7SF2;HSD11B1;SRD5A1;OSBPL2;CH25H
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.31662617426964224,-1.0095287123337633,0.48366013071895425,0.8752784615294618,1.0,18/24,35.85%,RFC1;XRCC1;RFC2;LIG1;UBC;POLK;RPA3;UBA52;POLD2;RPA2;RFC3;RPS27A;LIG4;POLE;RFC4;PCNA;POLD4;POLD1
prerank,negative regulation of locomotion (GO:0040013),0.5056091066231928,1.0091311799595102,0.478502080443828,0.838984208359403,1.0,2/12,8.84%,DUSP3;SPINT2
prerank,carbohydrate biosynthetic process (GO:0016051),-0.3218606299759783,-1.008856879402575,0.5026455026455027,0.8740104582157554,1.0,7/21,16.06%,B3GALT5;ST3GAL4;ST6GALNAC6;MPDU1;ST8SIA6;ST3GAL3;B3GALT1
prerank,chromosome organization (GO:0051276),-0.22876799730452413,-1.008663849706674,0.35714285714285715,0.871390925588858,1.0,19/99,10.95%,SMARCA4;COPS5;LATS1;DDB2;TCF7L2;HMG20A;DDB1;EZH1;NUCKS1;ABL1;MSH2;HMGN3;HDAC2;RBX1;EZH2;PWWP3A;TOP2B;SETD7;RAE1
prerank,response to reactive oxygen species (GO:0000302),-0.2529375001338556,-1.008589098258123,0.37681159420289856,0.868472333846587,1.0,16/54,17.20%,MAPK8;EGFR;SOD2;AGAP3;MAPK9;PTPRK;SOD1;PDGFRA;STK25;CHUK;MAPT;AKT1;GLRX2;HYAL1;COA8;ERCC6L2
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.3513274619417273,-1.008221971000317,0.44881889763779526,0.8664552146019381,1.0,7/15,17.54%,NTRK3;F3;VEGFC;CXCL12;IL16;SCG2;PGF
prerank,regulation of programmed cell death (GO:0043067),0.39409678481718935,1.0079232089910224,0.49949849548645936,0.8413747069074358,1.0,34/161,16.74%,CD3E;CTSB;FLT3;NUP62;TNF;TMEM219;TRAF2;CASP1;ANP32A;APAF1;TP53;ACTN4;CRADD;MALT1;TPT1;NTF3;BCAR1;ACER3;ACTN1;LGALS1;NF2;TRIM24;SOX9;SRA1;PRDX2;LRP8;WFS1;LRRK2;PHLPP1;STEAP3;FANK1;RTN4;HSP90AA1;ASAH1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.43719696977385725,1.0078156336779105,0.49174528301886794,0.8411913855317321,1.0,10/28,22.64%,TNF;SPI1;CRADD;ZDHHC3;CASP8;TRADD;SORT1;DEDD;DELE1;BID
prerank,cardiac conduction system development (GO:0003161),-0.3142750349989398,-1.0074883773515275,0.40606060606060607,0.8654330821173564,1.0,7/24,10.26%,BMPR1A;BMP4;CACNA1G;SMAD4;SMAD5;SMAD1;TBX18
prerank,cellular response to catecholamine stimulus (GO:0071870),0.4620254530345844,1.0073504943180436,0.5060827250608273,0.8418741032920581,1.0,13/23,28.04%,SNCA;ADCY6;SLC9A1;GNG2;LRRK2;PRKN;TGM2;GABPA;ATP2B4;MAPK1;MAPK3;PRKACA;APLP1
prerank,regulation of protein modification process (GO:0031399),0.41784467796463254,1.007230426802214,0.5037513397642015,0.8417028829211076,1.0,21/50,24.71%,LYN;FNIP2;ATG7;FNIP1;PLXNB2;FLCN;HPF1;PHIP;PPP2CA;PUM3;CORO1C;ATG14;HSPB1;ABCA2;PIN1;MT3;ATG10;FKTN;PPP1R16B;SPRED3;SPRED1
prerank,establishment of protein localization to organelle (GO:0072594),0.4060306761508857,1.0069203706834988,0.49376299376299376,0.84197701940148,1.0,8/72,10.11%,MMP12;IL10RA;SYK;NUP62;CD68;CSE1L;RAB11A;TPR
prerank,purine nucleotide catabolic process (GO:0006195),0.49669897247040173,1.0068288904458413,0.47956403269754766,0.8417313125261202,1.0,3/13,8.29%,XDH;HINT1;PNP
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.2542114785122382,-1.005909925584365,0.453125,0.866920477969395,1.0,12/53,11.86%,SMCHD1;EYA2;EGFR;FXR2;SPRED2;NACC2;EYA1;FMR1;CEBPG;EYA4;ATM;CCAR2
prerank,acute inflammatory response (GO:0002526),0.4560493300111193,1.0057120402352149,0.4854721549636804,0.8438855469617246,1.0,3/23,7.68%,MYLK3;IL6R;CEBPB
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.4632334932451114,1.0056422081683618,0.4969021065675341,0.8435877291601253,1.0,11/21,27.83%,PPP1R11;YWHAB;ENSA;BOD1L1;PPP4R4;PTPA;GSK3B;PPP1R16B;MFHAS1;TIPRL;CRY2
prerank,regulation of multicellular organismal development (GO:2000026),0.45152215453189826,1.00535203410475,0.485414235705951,0.8437945923127281,1.0,2/25,4.84%,HPSE;RAB14
prerank,cellular senescence (GO:0090398),0.4518559998469835,1.0046415811658889,0.5011764705882353,0.8450419483794642,1.0,3/27,4.97%,PRKCD;MAPK14;SPI1
prerank,positive regulation of protein depolymerization (GO:1901881),0.5048810382822796,1.0045854794243858,0.4808510638297872,0.8447219401105093,1.0,1/11,0.91%,PLEK
prerank,cellular potassium ion homeostasis (GO:0030007),-0.36904773726351175,-1.0041520353342928,0.45955882352941174,0.8687478976012505,1.0,3/13,7.58%,SLC12A2;ATP1B1;ATP1A2
prerank,cytoplasmic microtubule organization (GO:0031122),0.413640415110634,1.004143940836799,0.4984025559105431,0.845314057267954,1.0,13/54,16.11%,HOOK3;CCDC88B;CLIP2;RAB11A;TUBGCP6;TUBGCP4;DYNC1H1;PCM1;KATNA1;HOOK2;DST;CAMSAP2;FIGN
prerank,extracellular matrix assembly (GO:0085029),0.4523928390418483,1.0036719161733478,0.49625,0.845990334217045,1.0,6/23,18.76%,TGFB1;ATP7A;GAS6;PXDN;MFAP4;LTBP3
prerank,regulation of humoral immune response (GO:0002920),0.4138520243396219,1.003288669347686,0.49396267837541163,0.8464017243100647,1.0,6/44,14.89%,FCGR2B;C1QC;C1QA;C1QB;C3AR1;C4B
prerank,regulation of fat cell differentiation (GO:0045598),0.40288578761659805,1.003242171032142,0.5046826222684704,0.8460651720834232,1.0,16/74,18.19%,TGFB1;LPL;TNF;CEBPB;ASXL2;SMAD3;LRP5;CMKLR1;TAF8;CREB1;GPS2;BBS12;SYAP1;WDFY2;PPARD;CREBL2
prerank,cation transport (GO:0006812),0.3870497295593316,1.0032216751465435,0.5150300601202404,0.8456602636597474,1.0,19/167,12.02%,SLC6A3;SCN4B;AQP1;HCN4;KCNN4;FGF13;KCNK6;SLC8A1;SLC7A8;KCNIP2;CLN3;SLC36A1;CNGB1;KCNMA1;NEDD4L;SLC36A4;SLC8B1;SLC66A1;SCN9A
prerank,regulation of epithelial cell migration (GO:0010632),0.41451523710352883,1.0026244034464369,0.49730893433799783,0.8466244610410972,1.0,15/51,17.22%,PLCG2;RREB1;ARSB;MACF1;DUSP10;RAB11A;PFN2;PFN1;SOX9;HDAC6;ADIPOR1;SRC;RTN4;HIF1A;CORO1C
prerank,aortic valve development (GO:0003176),0.42226008192701747,1.002599483349953,0.4919724770642202,0.8462295717511819,1.0,6/34,11.69%,TGFB1;NFATC1;SNAI1;RB1;SOX9;TNFRSF1B
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.4815801807931579,1.0003382770911966,0.4959016393442623,0.8506397954209656,1.0,3/15,11.08%,AP3D1;AP3S1;DTNBP1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.4815801807931579,1.0003382770911966,0.4959016393442623,0.8506397954209656,1.0,3/15,11.08%,AP3D1;AP3S1;DTNBP1
prerank,protein insertion into ER membrane (GO:0045048),-0.2848653400492034,-0.9995516430379622,0.4827586206896552,0.8789503893693332,1.0,13/37,19.11%,APP;EMC7;ALDH3A2;TRAM1;SEC61G;EMC10;EMC4;EMD;SERP1;SEC61B;EMC1;GET4;VAPA
prerank,phasic smooth muscle contraction (GO:0014821),0.5126915815902792,0.9995047121129063,0.4809590973201692,0.8521689116863472,1.0,1/10,2.42%,EDNRB
prerank,tRNA transport (GO:0051031),-0.2841911526564627,-0.9993367114263007,0.4631578947368421,0.8765007281878308,1.0,11/35,11.87%,NUP93;NUP188;RANBP2;SSB;NUP98;NUP42;YBX1;NDC1;RAE1;NUP153;NUP37
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.4879681585525406,0.9986433110436753,0.46016483516483514,0.853766531681408,1.0,2/13,4.54%,CBL;ZFYVE28
prerank,positive regulation of transferase activity (GO:0051347),0.39041316095908507,0.9985452620994058,0.5276381909547738,0.8535589233336532,1.0,12/142,6.29%,TREM2;TGFB1;FLT3;CD74;DBI;CSF1R;DSTYK;PTGES3;PKIB;RPS2;XRCC5;CTNNB1
prerank,muscle cell differentiation (GO:0042692),0.4281251340930537,0.9980539918052379,0.48574686431014824,0.854256372207778,1.0,8/32,13.14%,DUSP29;SYNE1;SPEG;MRTFA;MYOCD;MEF2C;FBXO40;NINJ1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.5028652019669124,0.9979038305418089,0.4714285714285714,0.8541712737346462,1.0,2/11,9.43%,DHX9;PUM2
prerank,myoblast differentiation (GO:0045445),-0.36997744186877046,-0.9978826856964672,0.45384615384615384,0.8773796632552862,1.0,6/14,13.26%,TCF7L2;REST;HINFP;EPAS1;JAG1;MAPK12
prerank,protein import into peroxisome membrane (GO:0045046),0.4621423175508248,0.9978429169667327,0.5061576354679803,0.8538669974193873,1.0,4/22,9.10%,RAB8B;ABCD1;PEX13;PXMP2
prerank,positive regulation of cell development (GO:0010720),0.4285096031334994,0.9974371236979593,0.4774566473988439,0.8543440130110153,1.0,5/31,12.61%,CX3CR1;TYROBP;NAP1L1;ATP6AP1;NUMB
prerank,regulation of protein ubiquitination (GO:0031396),0.39257332316225224,0.9973020492103578,0.5333333333333333,0.85420984408293,1.0,22/108,18.47%,ARRB2;BAG2;IVNS1ABP;LAPTM5;TGFBR1;TNFAIP3;MALT1;DERL1;PRMT3;AMER1;STUB1;HUWE1;WFS1;LRRK2;SOX4;GSK3A;SVBP;HSP90AA1;VPS28;UBE2N;BIRC2;ANGPT1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.46036026601715574,0.9963809300856936,0.4734848484848485,0.8559762005921565,1.0,2/18,3.81%,TGFB1;TNF
prerank,positive regulation of cellular protein localization (GO:1903829),0.39841039008041373,0.9963625474681828,0.5026232948583421,0.8555542985561476,1.0,16/69,20.78%,TGFB1;NUP62;TNF;GPR137B;SNX33;TYROBP;FYN;STX3;KAT7;CENPQ;RTN4;VPS28;ENTR1;TRAPPC12;GSK3B;PRKN
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.23589911986655507,-0.9960762839112481,0.5,0.8793535772092725,1.0,12/85,7.32%,PIEZO2;ROR1;GRM7;NIPBL;DCDC2;GSDME;EML2;COL4A3;EYA1;SOD1;USP53;WDR1
prerank,positive regulation of ossification (GO:0045778),0.42141740316646287,0.9958771173283235,0.4982738780207135,0.8562328135771836,1.0,7/39,11.23%,TGFB1;P2RX7;SLC8A1;FZD9;MEF2C;ATP2B1;NELL1
prerank,establishment of protein localization to membrane (GO:0090150),0.3990788523857156,0.9956432016000734,0.508937960042061,0.8563164928879452,1.0,18/66,17.92%,RFTN1;RAB3GAP2;NPC1;MICALL1;ZDHHC14;AQP11;ZDHHC7;RAB11A;ZDHHC3;VPS37C;SDCBP;BRAF;ZDHHC1;ZDHHC24;RABGEF1;ATG3;MYO1C;SEC63
prerank,spindle assembly (GO:0051225),0.3974433083172569,0.9955393342128144,0.5098445595854922,0.8561380498060714,1.0,18/67,18.47%,HAUS2;NEK6;BCCIP;CEP192;MAPRE1;STARD9;CHEK2;HAUS1;RAB11A;TUBGCP6;TUBGCP4;STAG2;INO80;HAUS8;KIF2A;RHOA;CEP63;MAPRE2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.44753965972404275,0.9954770090671377,0.5067319461444308,0.8558144209161164,1.0,7/22,16.04%,STAC;CACNB4;NOS1AP;CACNB2;CACNB1;STAC3;GNB5
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.4566515805327161,0.9954224186057476,0.5031289111389237,0.8554954896379384,1.0,6/21,20.45%,FRAT2;CTNNB1;AMER1;CSNK1A1;FZD2;GSK3B
prerank,regulation of trophoblast cell migration (GO:1901163),0.47634416377710675,0.9944335647106932,0.473972602739726,0.8573209488814753,1.0,7/14,25.36%,TIMP1;YTHDF3;ARHGDIB;AGO2;VEGFA;GJA1;C1QBP
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.27793598707195866,-0.9943157487127194,0.47674418604651164,0.8813413095815366,1.0,30/42,35.85%,REV1;RFC1;WRNIP1;PRIMPOL;ZBTB1;WRN;USP10;RFC2;POLN;POLA1;UBC;POLK;POLI;UBE2L6;ISG15;FAAP20;RPA3;UBA52;USP43;POLD2;RPA2;RFC3;RPS27A;PCLAF;POLE;RFC4;PCNA;CDKN2D;POLD4;POLD1
prerank,protein import (GO:0017038),0.4010777228752376,0.9941766153637458,0.5143149284253579,0.8574581891815133,1.0,11/84,10.11%,MMP12;SYK;RAB8B;NUP62;APOE;SNX33;ABCD1;CSE1L;PEX13;PXMP2;TPR
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3797639553069679,0.9941090389852799,0.549,0.8571736658785769,1.0,336/1646,18.79%,CD86;RUNX1;BATF3;SPIC;NFE2;IRF5;NPAS4;AHRR;ASCL1;CIITA;MEOX1;SHH;IRF4;IRF8;TGFB1;IKZF1;HCLS1;TOX4;UXT;GATA1;PCID2;CD74;STAT5A;NFE2L2;POU2F2;BASP1;CBFA2T3;SNX5;TGFBR1;NFATC1;HES7;MED17;RREB1;GTF2H1;MAD2L2;BCL11A;NSD1;MLXIPL;SS18L1;ELF4;DHX9;NUP62;ZEB2;MAPK14;MED13L;SP7;CREB3L4;CREB3;BARX2;YAF2;RXRB;FOXD2;CDK14;NR1H4;TNF;SREBF2;RFX1;MLXIP;APOE;UBE2V1;CIR1;BPTF;ZNF326;MITF;ZFP30;PPIE;NFXL1;ATF3;CEBPA;FOXO3;SRCAP;ZMIZ2;LRRFIP1;DDIT3;CXXC1;SPP1;SPI1;MYT1L;ZBTB12;NDP;PGBD1;WWC2;ZBTB39;HIVEP3;MAFG;MAFK;HOXC8;TSC22D4;BHLHE41;HDAC5;HMGB1;XRCC5;RNF111;BRIP1;BACH1;FLI1;PRKCB;TEAD1;PCGF6;CHD7;SBNO1;MAP2K3;CTNNB1;TRPS1;TFEB;MTA3;ZFP69;CDK11B;DNM2;CCAR1;ZNF177;TP53;KLF6;CD80;MEF2A;TBL1XR1;NKX2-1;NRL;TAL1;USF1;MAP3K5;MYOCD;RCOR1;KDM7A;YY1;TCF20;CREB3L1;GCFC2;CDK17;PIM2;STAT4;ZFP90;EPO;CBFA2T2;CEBPB;HINT1;DBX2;FOXN2;TGFBRAP1;ST18;CHEK2;SNAI1;PRKCQ;MEF2C;NKRF;CDC5L;TFAP2B;RB1;METTL4;RBM15B;GMEB2;CIART;BICRA;SMAD3;MMS19;ARID1A;ZFP14;TADA1;GTF2IRD1;IRF2;HSF1;MDFIC;PPARGC1A;ZNF32;ARID3B;QARS1;ATRX;RPL6;CREBRF;RNF4;RING1;ATF7IP;ARID4A;ANXA4;GMEB1;STAT5B;LRP5;MIDEAS;HDAC4;NFX1;NFE2L1;LITAF;CCNL1;ZNF83;TGIF1;ARID1B;HOXA6;RNF10;NFIC;ATAD2;SEC14L2;TBL1X;INHBA;PHC1;MED27;TRIM56;KLF13;CHD1;MAP2K2;CREB3L2;PKN1;BAZ1A;ZMYND15;POLR2L;HCFC2;ZSCAN26;LIMS1;ELF2;OLIG1;SOX9;SRA1;RPS6KA4;HDAC6;NLK;JDP2;DENND4A;NR2C2;DAP;ETV6;ZNF740;E2F6;ZNF628;PHIP;GZF1;CIAO1;HDAC9;HSF5;ATF6B;MTF2;PPP2CA;MBD1;MAP3K12;CREB1;NRG1;BRDT;KAT7;ZSCAN18;BAMBI;SMARCD3;NR4A1;MAX;CAMKK2;SMARCB1;ZFX;ZNF445;FOXN3;GAS6;NFKB1;FOXK1;SAFB2;RFX7;GPATCH3;SOX6;CUX1;HCFC1;CDC6;ZFHX3;IRF1;SOX2;KDM3B;BRD7;HNRNPD;ARHGEF11;LBH;SOX4;SREBF1;MEIS1;CAPN3;ZBTB11;POU6F1;IFRD1;PIAS1;SPTY2D1;TLE5;EID1;NR2C1;MTDH;REXO4;MAF;FOSL2;ERCC6;YWHAH;THRAP3;FANK1;CDK15;USP21;USP16;OGG1;MED29;RBPJ;FADS1;ZBTB7B;HIF1A;SIX5;SBNO2;SUV39H1;PPP3CB;PBXIP1;REL;TRIP4;ZNF568;ZKSCAN2;PPARD;RSF1;ZSCAN2;RPS6KA5;ZGPAT;CDK18;BACH2;VHL;NFYA;PCGF1;CASZ1;KDM4C;NPAS2;CNBP;PROX2;ZNF35;HSF2;CREBL2;PICALM;LOXL3;SFMBT1;RXRA;TESC;JUNB;PHF1;KLF5;CUX2;CIPC;POU2F3;KLF7;CHD4;CTBP2;PER1;MAFB
prerank,regulation of telomere capping (GO:1904353),0.45118736088932926,0.9938903391829333,0.5025062656641605,0.8572234102551092,1.0,5/23,14.36%,PKIB;PRKCQ;USP7;TNKS2;HNRNPD
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.4871773035443272,0.9937984172616378,0.4930939226519337,0.8569957587311675,1.0,4/13,17.20%,TLR2;CCL2;NOD2;IL33
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.43400483598239303,0.9937693344646767,0.5133630289532294,0.8566197149266033,1.0,8/32,17.22%,MMP12;CASK;NF2;THBS1;SRC;RASA1;PTEN;CORO1C
prerank,response to metal ion (GO:0010038),0.4047876353820419,0.9937514467138837,0.5141361256544502,0.8562218404647276,1.0,12/67,12.34%,IL1A;PPP2CB;SNCA;TTN;HAAO;KCNMA1;HFE;PDCD6;ALG2;NEDD4L;THBS1;PPP2CA
prerank,bone morphogenesis (GO:0060349),0.49464786833109387,0.9934005661535291,0.48846675712347354,0.8566030744665183,1.0,2/14,9.91%,SKI;LRP5
prerank,cellular protein metabolic process (GO:0044267),0.38039025321845404,0.9929604005146737,0.536,0.8571615489343933,1.0,89/396,18.78%,KLK3;PCSK9;NAPSA;LGMN;CSF2RB;RPL23;RPL17;RPL10A;SFTPA1;SFTPA2;ST8SIA4;APOE;UBE2D3;DNAJC3;RPS2;SPP1;DMBT1;RRBP1;TIMP1;RPL18A;FARSB;MRPL41;UBE2S;TTF1;RPS15A;SPCS2;GSPT1;P4HB;ATP23;LOX;SEC11C;CHEK2;EIF4EBP2;ST3GAL1;MRPL51;MAN2B1;SPPL3;SPCS1;RPL6;PIGH;MCRS1;VGF;RPLP2;RPL26;FAM20C;RPS20;MSRA;LGALS1;CHGB;YES1;RPS16;CDC34;LMCD1;PARL;F5;RPS14;B4GALT7;UBE2G2;GAS6;DARS1;RPL19;WFS1;IGF2BP3;RPL9;ABCA3;IDE;RPS11;ATG3;RPL11;APLP2;YME1L1;RPS23;ERO1A;FURIN;RPS4X;MRPS21;FDXR;RPS27;FDX1;AGO2;RPL4;MRPS14;PABPC4;CSF2RA;MRPL3;MSRB2;PPP4R2;MXRA8;IGFBP4
prerank,mesenchymal cell differentiation (GO:0048762),0.4070424607659231,0.9929559435398753,0.523704520396913,0.856719090354805,1.0,8/51,11.17%,TGFB1;TGFBR1;CTNNB1;AKNA;SNAI1;MEF2C;LIMS1;SOX9
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.44992871812836005,0.9928107944991758,0.503052503052503,0.8565865656231265,1.0,10/23,25.59%,NLRC5;IFNGR2;TXK;PIAS1;IRGM;SOCS3;IFNGR1;PARP9;HSP90AB1;CDC37
prerank,MAPK cascade (GO:0000165),0.38407711733424277,0.9923253022649597,0.513,0.8572663707419175,1.0,69/295,18.94%,PTPN7;TGFB1;RASAL3;FLT3;SPTBN5;LAT;CSF2RB;TAOK3;GRB2;PIK3CB;FGF13;CCM2;RASA4;TNF;RASA3;IL18;RGL2;SHC2;BCL2L1;YWHAB;MEF2A;PSMB10;MAP3K5;ABHD17B;TNIK;FLT3LG;PRKCQ;MEF2C;RASGRP3;HSF1;MAP2K2;PSMA2;ARTN;SOX9;CCL2;ABHD17C;SYNGAP1;FYN;PSME3;NRG1;RANBP9;IKBKG;CAMKK2;BRAF;NFKB1;PSMB5;LAMTOR3;IL2RG;PSMD8;WDR83;LRRK2;PPP1CC;IL3RA;PTPRA;PSMD7;PSMB9;RASA1;NF1;RASGRP4;RASAL1;KSR1;SPTBN4;PSMD2;PAQR3;ANGPT1;CSF2RA;MINK1;PTPN3;TAOK1
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.3161486966018998,-0.9921002456793662,0.47368421052631576,0.8846518732898311,1.0,12/24,21.11%,NCKAP5;STMN2;MAPT;KIF24;TPPP;STMN4;STMN3;HDGFL3;MAP7D3;KIF18A;TRPV4;STMN1
prerank,membrane organization (GO:0061024),0.3863081843870506,0.9916220757128651,0.525,0.858408086123062,1.0,63/227,21.09%,ARRB2;CBL;VAMP3;GRB2;RABEP1;SNX9;MTCH1;PIP5K1C;LDLRAP1;CLN3;ARPC2;NPC1;STX11;AP3D1;LPCAT2;ACTB;DNM2;GAPVD1;AP2S1;SYT2;ARPC3;SH3KBP1;ATP2C1;STON2;ITSN1;SNAP29;ACTG1;VAPB;SYNGR1;ACTR2;SYNGR2;ACTR3;DYSF;TMCC1;CLTC;TIMM50;ARPC4;SYNJ1;SNAP23;SAR1A;FNBP1L;TOR1AIP2;TOR1A;HUWE1;GAK;EPS15;AP2M1;PDCD6IP;EPN1;CORO1C;BIN1;VPS33B;PICALM;UBXN2A;TMEM170A;DNM1L;FCHO2;FNBP1;USO1;NSFL1C;STAM2;AZIN2;RIMS1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5164275745235354,0.9913004765444526,0.505443234836703,0.8587172776615348,1.0,2/10,7.24%,MLXIPL;ABCD1
prerank,embryonic digit morphogenesis (GO:0042733),0.45428455442546667,0.9911725400956601,0.4937810945273632,0.8585764202553663,1.0,1/18,0.68%,SHH
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.39486976642190624,0.9911648945236382,0.5110876451953538,0.8581410904607629,1.0,21/67,19.19%,TBC1D10C;TBC1D16;P2RX4;TBC1D22A;USP6NL;CAPZB;TBC1D10A;PODXL;TBC1D2;TBC1D17;TBC1D2B;TWF2;TBC1D8;ARF6;TBC1D14;TBC1D22B;ATG3;RABEP2;CDC42;DYNC2LI1;TBC1D5
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3912761908467918,0.9910417760748481,0.541497975708502,0.857948910874581,1.0,23/118,16.34%,GPNMB;TGFB1;CYRIB;LFNG;RAP2A;SEMA4D;TNFAIP3;CTNNB1;CAPZB;TNIK;MEF2C;MYO19;RC3H1;POGLUT1;NEDD4L;PHIP;LZTS3;PID1;TANC2;LRRK2;PDZD8;NF1;EPHA4
prerank,ncRNA processing (GO:0034470),0.38255022343278233,0.9908343629882183,0.5225225225225225,0.8580000364036772,1.0,74/200,25.69%,RPL23;RPL17;EMG1;RPL10A;UTP20;NOB1;TEX10;FBL;RPS2;EXOSC1;LAS1L;RPL18A;ADAR;SMAD3;INTS8;KRR1;AGO4;RPL6;DDX27;RPLP2;RPL26;RPS16;AGO3;METTL3;MDN1;UTP11;HEATR1;RPS14;INTS6;RPL19;PRKRA;IMP3;RPL9;PES1;C1D;PIH1D1;RPL11;TUT7;FARS2;TARBP2;WDR12;RPS27;AGO2;INTS1;RPL4;FCF1;WDR75;RPL7A;RPL15;EXOSC3;RPL29;RRP7A;UTP3;RPL22;IMP4;RPS7;DICER1;LIN28B;SARS1;EXOSC2;RPLP1;ZCCHC8;ADAT1;RPS15;INTS3;RPL41;XRN2;DROSHA;DDX10;RPL10;AGO1;UTP6;RPL5;RPL18
prerank,monocarboxylic acid metabolic process (GO:0032787),0.3888588702914413,0.9903788134144103,0.5267406659939455,0.8585920098120277,1.0,22/117,17.81%,CYP1A1;LPL;SGPL1;ALOX12;MTHFS;ANGPTL3;CKB;NPC1;KYNU;ACSF2;SLC16A1;MCCC2;PDHA1;PDZD11;VDAC1;FASN;ME3;CD36;LDHA;PPARD;ACOT2;PCCA
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.44816385464440983,0.9902969264097472,0.5118203309692672,0.858315896030648,1.0,2/25,3.66%,LYST;VTA1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.47525261512967343,0.990295138507552,0.4967234600262123,0.85786785492468,1.0,3/15,9.59%,HERPUD1;SEL1L;DERL1
prerank,proteasomal protein catabolic process (GO:0010498),0.3852205560723931,0.9898622639731154,0.5355355355355356,0.8584202359586189,1.0,58/201,20.78%,ARRB2;NFE2L2;RFFL;KCTD17;UBE2D3;SEL1L;FBXL22;DDIT3;DDI2;CTNNB1;ATXN3;PSMB10;TBL1XR1;KIF14;GID8;DERL1;RNF4;UBE4B;NEDD4L;APPBP2;TBL1X;PSMA2;MAEA;CDC34;SPOP;PSME3;RNF216;RMND5B;ITCH;STUB1;PSMB5;HUWE1;PSMD8;AREL1;ZNRF1;CCDC47;PSMD7;PSMB9;GSK3A;SMURF1;FAF1;FEM1B;UBE2K;PSMD2;BIRC2;FBXO44;PPP2R5C;UBXN2A;KCTD5;SPSB2;PLAA;ERLEC1;WWP1;RAD23B;FBXW11;NSFL1C;CUL3;PRKN
prerank,cellular response to inorganic substance (GO:0071241),0.45358665619589916,0.9893093226922727,0.4932014833127318,0.8592424570490172,1.0,7/21,24.44%,AQP1;DDI2;ATRX;MTR;SPIDR;MT3;DDX11
prerank,regulation of myotube differentiation (GO:0010830),0.4386931577404135,0.9892482234168001,0.52,0.8589064003323427,1.0,5/24,12.14%,MAPK14;BHLHE41;HDAC5;HDAC4;HDAC9
prerank,polarized epithelial cell differentiation (GO:0030859),0.5050126148867192,0.988567815798147,0.5087719298245614,0.8600481228840202,1.0,5/13,19.31%,RAP2A;ZDHHC7;RHOA;CDC42;SCRIB
prerank,regulation of viral genome replication (GO:0045069),0.39254265082898576,0.9882928305243374,0.5100529100529101,0.8602396401975289,1.0,17/56,24.55%,FAM111A;TNF;PPIE;ADAR;LARP1;VAPB;RNASEL;ADARB1;TARBP2;PPIH;PARP10;IFITM2;CNOT7;ILF3;IFIT1;IFITM1;PPIA
prerank,mRNA methylation (GO:0080009),-0.34915091002572995,-0.9877260013684895,0.4495798319327731,0.8937366222673941,1.0,6/15,14.68%,CBLL1;METTL14;NSUN2;METTL16;TRMT6;CMTR1
prerank,cell cycle G2/M phase transition (GO:0044839),0.3859231439968779,0.9876769118342598,0.5417925478348439,0.8612308600878901,1.0,27/129,18.10%,TUBB;PRKAR2B;HAUS2;CDK14;TUBA4A;FBXL22;CNTRL;CEP192;MAPRE1;DNM2;CEP70;PLK4;CEP76;CHEK2;ENSA;HAUS1;CDK7;DYNC1H1;PCM1;FBXL3;CEP152;HAUS8;AKAP8L;NINL;HSP90AA1;AKAP9;CEP63
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.4462265655340286,0.9873226222817346,0.4903614457831325,0.8615636519933486,1.0,11/21,23.67%,DUSP3;MACF1;SLC9A1;ACTG1;VCL;PTPRA;CORO1C;RHOA;ROCK2;CLASP1;GPM6B
prerank,regulation of AMPA receptor activity (GO:2000311),-0.3080427120668615,-0.9867742545329997,0.46408839779005523,0.8934345856912046,1.0,10/25,26.87%,NLGN1;SHANK3;SHANK1;PRRT1;CACNG8;SHISA9;GSG1L;SHISA7;CACNG2;ADRB2
prerank,negative regulation of viral process (GO:0048525),0.39887372346253636,0.9865393716180236,0.5276595744680851,0.8628988130564926,1.0,17/57,24.55%,FAM111A;TRIM5;TNF;TRIM27;TRIM8;RNASEL;MID2;TRIM35;TRIM62;PARP10;IFITM2;HEXIM1;ILF3;IFIT1;IFITM1;UBP1;PPIA
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.4009958519992543,0.986178812681869,0.5359001040582726,0.8632898405161634,1.0,18/69,19.86%,TRIM25;EDEM1;HERPUD1;SEL1L;ERLIN1;ERLIN2;DERL1;UBE4B;STT3B;UBE2G2;STUB1;WFS1;UBE2J2;FAM8A1;FBXO44;EDEM2;OS9;TMEM67
prerank,negative regulation of neuron projection development (GO:0010977),0.4075089609046386,0.9856221062152054,0.5259259259259259,0.8641724598028506,1.0,18/56,19.41%,MYLIP;THY1;BCL11A;RTN4RL1;APOE;ADCY6;CBFA2T2;PTPRO;ARHGDIA;EFNB3;GAK;RTN4;EPHA4;PTEN;RHOA;DENND5A;PAQR3;RAB29
prerank,cristae formation (GO:0042407),-0.293905204716804,-0.9853841952654017,0.4258064516129032,0.8942079202661212,1.0,10/27,16.24%,AFG3L2;APOOL;IMMT;ATP5PO;ATP5PF;ATP5MC3;SPG7;DMAC2L;SAMM50;ATP5F1D
prerank,nuclear export (GO:0051168),0.39215100261515434,0.9853222106945542,0.5291666666666667,0.8644275710963831,1.0,23/80,19.39%,TGFB1;NUP62;DHX38;XPO1;NXF1;THOC2;CASC3;MALT1;CSE1L;STRADB;WASHC4;TPR;DDX39B;XPO6;POLDIP3;UPF3B;THOC3;STRADA;SMURF1;SLU7;SRSF6;DESI1;SRSF2
prerank,keratan sulfate biosynthetic process (GO:0018146),0.4339860768958511,0.9849085357456985,0.5101553166069295,0.8649155912462132,1.0,4/26,8.51%,PRELP;B4GALT1;FMOD;ST3GAL1
prerank,response to calcium ion (GO:0051592),0.38786271197811784,0.9848593279439538,0.5489795918367347,0.8645756542889309,1.0,15/102,9.11%,SYT17;LGMN;PLCG2;RASA4;PKD2;TTN;KCNIP2;RASGRP2;MEF2A;KCNMA1;SYT2;MEF2C;PDCD6;ALG2;SYT10
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.5057116654075243,0.9847838616128176,0.5371428571428571,0.864298044914387,1.0,4/10,16.89%,ATP5MC2;ATP5F1A;ATP5PD;ATP5MG
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.4527022157133089,0.9845798799111412,0.5166240409207161,0.8638877910859682,1.0,6/20,16.72%,P2RX7;MLXIPL;PFKFB4;PFKFB3;HIF1A;GAPDHS
prerank,positive regulation of glycolytic process (GO:0045821),0.4527022157133089,0.9845798799111412,0.5166240409207161,0.8638877910859682,1.0,6/20,16.72%,P2RX7;MLXIPL;PFKFB4;PFKFB3;HIF1A;GAPDHS
prerank,regulation of cytokinesis (GO:0032465),0.39674531354742426,0.9845790466236513,0.5125260960334029,0.8634397487117634,1.0,20/78,18.00%,ZFYVE26;KLHL21;BCL2L1;PLK4;PLK2;KIF14;FLCN;KIF20B;MYO19;KIF23;UVRAG;RAB11A;SETD2;BECN1;CDC6;PIK3R4;RHOA;GIPC1;CDC42;ENTR1
prerank,response to progesterone (GO:0032570),0.4610429224823348,0.9845091214511756,0.5154241645244216,0.8631723725985571,1.0,3/18,15.27%,TGFB1;THBS1;SRC
prerank,inorganic cation transmembrane transport (GO:0098662),0.38176725828882235,0.9844002411302526,0.552,0.8629686848680047,1.0,22/268,8.01%,SLC6A3;SLC6A4;KCNJ11;SLC11A1;SCN4B;ATP6V0E1;HCN4;SLC9A4;KCNN4;P2RX7;KCNK6;SLC8A1;PKD2;SLC36A1;P2RX4;SLC9A9;CCDC51;SLC9A1;ATP6V0D1;KCNK13;CACNA1A;ATP2C1
prerank,positive regulation of DNA binding (GO:0043388),0.42409323332333393,0.9835564371632508,0.5250875145857643,0.8644428360695139,1.0,4/31,8.46%,TGFB1;SKI;HMGB1;RB1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.38936794229755906,0.9830888220524531,0.5222337125129266,0.8650919812889752,1.0,23/83,20.73%,GPR132;CDK14;BACH1;GSPT1;CDK17;PIM2;PLK2;RB1;CDK7;DBF4;INHBA;CDC34;CDK6;MAX;CDC6;CCNE2;USP29;CDK15;CDK18;CRLF3;CDC45;CUL3;NPAT
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.47748834650986993,0.9829867322598198,0.48770491803278687,0.8648748448082055,1.0,4/14,18.40%,TGFBR1;SOX9;RFLNA;GREM1
prerank,response to ketone (GO:1901654),0.4407683713992323,0.9827495457650929,0.5153751537515375,0.8649594361727939,1.0,3/24,11.24%,TGFB1;ABCB4;THBS1
prerank,energy reserve metabolic process (GO:0006112),-0.32029179521544127,-0.9824918679931871,0.4634146341463415,0.8994644651807999,1.0,10/19,25.51%,LEPR;PHKG2;UGP2;PHKB;PYGM;GFPT1;PPP1R3C;PHKA1;GFPT2;MRAP2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.4223330208627169,0.9823410585770699,0.5064935064935064,0.865426069435677,1.0,5/30,14.28%,KLK3;PKN1;HDAC6;SAFB2;KLK2
prerank,cellular response to interleukin-1 (GO:0071347),0.38469686655806057,0.9823341914930032,0.5581162324649298,0.8649913064033593,1.0,34/143,17.85%,IL1A;SIRPA;IRAK2;CCL8;UBE2V1;MYLK3;TANK;PYCARD;PSMB10;ST18;RC3H1;CCL14;PSMA2;CCL13;SOX9;RPS6KA4;GBP3;CCL2;NOD2;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;TAB3;PSMD7;PSMB9;HIF1A;CD47;CCL25;UBE2N;RPS6KA5;PSMD2
prerank,regulation of lamellipodium assembly (GO:0010591),0.42470321499507385,0.9821148421070292,0.5136054421768708,0.8650342937752462,1.0,8/34,12.18%,ARPC2;CAPZB;WASF2;AKIRIN1;ACTR2;ACTR3;CYFIP1;TWF2
prerank,signal transduction in response to DNA damage (GO:0042770),0.40795788886669004,0.9815398013921346,0.5332606324972737,0.8659023932136466,1.0,9/49,9.48%,MAD2L2;GRB2;MAPK14;BRIP1;TP53;CHEK2;DOT1L;CDC5L;ATRX
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.4375699681708579,0.9812720859551852,0.5210589651022864,0.8660610155305922,1.0,12/24,20.10%,FCER1G;HFE;TAPBPL;TAP1;SEC24D;B2M;ERAP1;IDE;PDIA3;TAP2;SEC13;SEC31A
prerank,sensory perception of chemical stimulus (GO:0007606),-0.34799045013552166,-0.9809742478569303,0.47388059701492535,0.9007885350107828,1.0,7/15,23.15%,GNAS;GNAL;UBR3;BBS4;SLC24A4;DRD2;MKKS
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.24605958094172165,-0.9806124046384892,0.4883720930232558,0.8987168637946461,1.0,28/65,22.47%,FBXL7;FHL1;PSME4;PSMD11;PSMA5;PSMA4;RBX1;PSMD14;PSMC6;NABP2;PINX1;PSMC3;ZFYVE19;PSMB3;VPS4A;PSMC1;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;USP47;PSME2;PSMB4;PSMC4;SKP1;PSMB6;CUL1
prerank,ribosome biogenesis (GO:0042254),0.37937184107648503,0.9802120202179535,0.562374245472837,0.8680191554033417,1.0,50/187,21.04%,RPL23;RPL17;EMG1;RPL10A;UTP20;NOB1;TEX10;FBL;RPS2;EXOSC1;XPO1;LAS1L;URB2;RPL18A;GTF3A;KRR1;SURF6;RPL6;DDX27;RPLP2;RPL26;RPS16;MDN1;UTP11;HEATR1;RPS14;RRS1;RPL19;NOC2L;IMP3;RPL9;PES1;C1D;PIH1D1;RPL11;WDR12;RPS27;RPL4;DDX31;FCF1;WDR75;RPL7A;RPL15;EXOSC3;RPL29;RRP7A;UTP3;RPL22;IMP4;RPS7
prerank,protein localization to Golgi apparatus (GO:0034067),0.42599702265297335,0.9800255090052533,0.5197674418604651,0.8679672376520932,1.0,14/27,23.02%,RIPOR1;ARL5B;BICD2;SORL1;RAB33B;GAK;PAQR3;GOLPH3;OPTN;COG7;VPS13C;GBP5;VPS13A;ARL5A
prerank,microtubule anchoring (GO:0034453),0.4905218965309214,0.9799442885410282,0.5207182320441989,0.8676908447259457,1.0,3/12,12.39%,BCCIP;BICD2;PCM1
prerank,negative regulation of cell cycle process (GO:0010948),0.39808716449111003,0.9797054503264777,0.5214211076280042,0.8677968745096933,1.0,12/61,13.05%,UXT;YAF2;ESPL1;NME6;AURKAIP1;APAF1;PCGF6;RING1;PHC1;E2F6;RBBP7;MAX
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.328379347290207,-0.9792418412211686,0.48130841121495327,0.8996875183964911,1.0,11/18,30.05%,COX16;OXA1L;COX18;COA8;COX14;COX17;TIMM21;COA5;SCO1;COA3;SURF1
prerank,linoleic acid metabolic process (GO:0043651),0.45791048361088627,0.9790125231246849,0.4967741935483871,0.8689375224892486,1.0,4/17,17.83%,ALOX12;ABCD1;FADS1;GSTM2
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.27495079314115856,-0.9789159255059802,0.5210084033613446,0.8976659051858219,1.0,8/33,8.31%,NR2F2;MCC;DAB2IP;SYNJ2BP;ACVRL1;SP100;SLIT2;KRIT1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4040030969719607,0.9786107597962764,0.5289778714436248,0.8693875298997975,1.0,2/53,6.34%,CNR2;ANXA1
prerank,aortic valve morphogenesis (GO:0003180),0.41874942681764177,0.978497263924328,0.5333333333333333,0.8692029257921193,1.0,5/30,11.17%,TGFB1;NFATC1;SNAI1;RB1;SOX9
prerank,regulation of pH (GO:0006885),0.5002866060722847,0.978352732550699,0.5140845070422535,0.8690649923025633,1.0,4/11,20.59%,SLC9A1;ATP6AP1;LACC1;SLC9A7
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.39559044096254603,-0.9779542134240287,0.5136054421768708,0.8972900522637947,1.0,2/10,3.69%,DLGAP1;DLGAP2
prerank,substantia nigra development (GO:0021762),0.41721326500859457,0.9777444345373983,0.5146067415730337,0.8700110016463548,1.0,12/37,23.03%,BASP1;CKB;ACTB;SEC16A;YWHAH;COX6B1;RHOA;CDC42;GNB4;PADI2;RAD1;NDRG2
prerank,ameboidal-type cell migration (GO:0001667),0.4007007219235032,0.9776094259877439,0.5246781115879828,0.86987068326821,1.0,4/51,3.56%,SHH;ITGA4;SGPL1;SEMA4D
prerank,response to hexose (GO:0009746),0.44010891926961354,0.9775718588582376,0.5126353790613718,0.8694995228631319,1.0,4/25,11.24%,LPL;PFKL;EIF2B2;THBS1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.4583363569638239,0.9773715754853095,0.4954128440366973,0.8695024551522805,1.0,6/15,22.43%,TENT4B;TNRC6A;CPEB3;AGO2;CNOT7;CNOT1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.45177009233615373,0.9773424780407027,0.5137844611528822,0.8691171152433524,1.0,6/20,17.33%,DIP2B;PPARGC1A;RPS6KA4;BRD7;SOX4;RPS6KA5
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.3667088552115801,-0.9769593106802162,0.4793103448275862,0.8969666184001437,1.0,3/13,4.82%,ZFPM2;BMPR1A;TGFBR3
prerank,negative regulation of receptor internalization (GO:0002091),0.49141085866606127,0.9765743227357834,0.5230125523012552,0.8704382030190835,1.0,3/12,15.22%,RIN3;SDCBP;ANKRD13A
prerank,negative regulation of histone acetylation (GO:0035067),0.5021978272138199,0.9765599008913219,0.5049786628733998,0.8700196224679508,1.0,3/11,14.67%,SNCA;SPI1;NOC2L
prerank,cell junction organization (GO:0034330),0.39652739702950673,0.9763914503675007,0.553478712357217,0.8699517958974831,1.0,12/71,11.06%,TGFB1;RAB8B;SNCA;ACTB;AGRN;VMP1;C1QA;CAPZA1;RAB39B;SMAD3;ACTG1;LIMS1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.4805880706514916,0.9763029942160817,0.5162200282087447,0.8696995037250973,1.0,4/13,17.60%,FCGR2B;AQP11;WFS1;MANF
prerank,positive regulation of neuron migration (GO:2001224),-0.38591197939711497,-0.976019937921081,0.5051194539249146,0.8965575210829565,1.0,6/11,11.99%,SEMA6A;NIPBL;SEMA3A;DAB2IP;RAPGEF2;NSMF
prerank,sarcomere organization (GO:0045214),0.4237414018419646,0.9758242121967634,0.5181711606096131,0.8703376195307283,1.0,5/27,14.80%,TTN;MYLK3;TNNT3;CSRP1;CAPN3
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.373309373807714,0.9754378691273277,0.595,0.8707697265310471,1.0,77/327,19.05%,HCLS1;TGFBR1;RREB1;NSD1;MLXIPL;YAF2;UBE2V1;MITF;PPIE;NFXL1;CEBPA;DDIT3;CXXC1;SPI1;WWC2;BACH1;CHD7;SBNO1;TFEB;CDK11B;DNM2;CCAR1;TP53;ACTN4;GCFC2;CEBPB;HINT1;FOXN2;TGFBRAP1;CHEK2;PRKCQ;MEF2C;RB1;GTF2IRD1;IRF2;PPARGC1A;ATRX;RPL6;NFX1;HCFC2;ZSCAN26;RPS6KA4;NLK;DENND4A;NR2C2;ZNF628;GZF1;MTF2;PPP2CA;BRDT;KAT7;FOXN3;SOX6;HCFC1;ZFHX3;SOX2;HNRNPD;SOX4;ZBTB11;SPTY2D1;REXO4;OGG1;FADS1;HIF1A;SBNO2;TRIP4;RPS6KA5;VHL;NFYA;PCGF1;CASZ1;CNBP;ZNF35;CREBL2;PHF1;MAFB;TULP3
prerank,neuromuscular process controlling balance (GO:0050885),0.4905945044197739,0.975348272537083,0.5154061624649859,0.8705053295969744,1.0,3/12,13.32%,CLN3;MYO7A;CDH23
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.38827009991058214,0.9748792992829004,0.5468589083419155,0.8711027013845182,1.0,19/78,20.95%,GTF2H1;CCND3;RGCC;PKD2;BCCIP;CEBPA;CCND2;ACTB;MYOCD;CDK7;CDC6;CCNE2;PTEN;CCNYL1;CNPPD1;HHEX;CDK5R1;HEXIM1;TFAP4
prerank,GPI anchor metabolic process (GO:0006505),0.4340254045226628,0.9747740184607909,0.5317647058823529,0.8708939906216341,1.0,11/26,23.18%,PIGM;PIGL;PIGV;PGAP1;PIGH;PGAP2;PIGU;PIGC;PIGN;DPM2;PIGP
prerank,carbohydrate derivative catabolic process (GO:1901136),0.46368001532050057,0.9746117149181251,0.5129533678756477,0.8708196699358972,1.0,5/18,18.32%,SAMHD1;FUCA1;OGA;STT3B;FBXO44
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.3927439229482513,0.97448090905041,0.5485592315901814,0.8706532262931289,1.0,14/59,20.03%,CD84;PCDHB6;PLXNB2;EMB;TRO;NPTN;PTPRT;CADM1;KIRREL3;PECAM1;ITGB1;VSTM2L;PALLD;CNTN4
prerank,membrane depolarization (GO:0051899),0.41591007282493914,0.9739292548885037,0.5365005793742758,0.8714493116240877,1.0,9/32,17.43%,P2RX7;P2RX4;CACNA1A;CACNB4;ATP5IF1;SCN9A;CACNA1B;YWHAH;SCN5A
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.41165314842186107,0.9738827353216812,0.5358361774744027,0.8710958901454511,1.0,2/37,2.20%,ITGAL;CRTAM
prerank,histone modification (GO:0016570),0.3844955250397883,0.9738417027515063,0.5693877551020409,0.8707328918077297,1.0,24/109,17.33%,BRD8;PRKCD;NSD1;ATXN7;HDAC5;MTA3;TBL1XR1;RCOR1;MIDEAS;HDAC4;TBL1X;PHC1;RPS6KA4;HDAC6;HDAC9;MAP3K12;HUWE1;HDAC11;USP21;USP16;INCENP;NAA50;UBE2N;RPS6KA5
prerank,adipose tissue development (GO:0060612),0.49726036383463457,0.9738341245708827,0.5288461538461539,0.8703059613407116,1.0,2/11,9.91%,SH3PXD2B;LRP5
prerank,endocrine system development (GO:0035270),0.4488272872196726,0.9736980944708532,0.5305105853051059,0.8701611055880275,1.0,6/21,16.02%,TGFBR1;MDK;NKX2-1;SOX2;TG;NF1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.5031482892728393,0.9732931115755504,0.5147058823529411,0.8706008003909619,1.0,3/10,13.89%,ATRX;DBF4;INO80
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.44068007257952074,0.9731266776961838,0.5504151838671412,0.870517014636143,1.0,9/25,20.34%,BCAS2;SF3B1;SCAF11;PRPF8;TRA2B;WDR83;SLU7;SF3B3;SRSF10
prerank,cardiocyte differentiation (GO:0035051),0.5020076781311217,0.9729868069082923,0.4957142857142857,0.8703785334700658,1.0,3/10,12.63%,EEF1AKMT4-ECE2;MYOCD;NRG1
prerank,cellular response to glucose stimulus (GO:0071333),0.4218914317758244,0.972539810475134,0.5420991926182238,0.8708878421387706,1.0,7/30,14.60%,MLXIPL;ERN1;TRA2B;RAB11FIP5;GAS6;ADCY8;SOX4
prerank,positive regulation of DNA replication (GO:0045740),0.4729424355847761,0.9724672719101338,0.5273885350318471,0.8705976466547467,1.0,7/16,16.38%,DHX9;BRPF3;STN1;KAT7;DNA2;BCAR3;FAF1
prerank,epithelial cell migration (GO:0010631),-0.2636554205108217,-0.9722863560211041,0.5042016806722689,0.9038058230158473,1.0,10/37,16.08%,FSTL1;STARD13;KANK1;KANK2;ABL1;FAP;ROCK1;NOS3;SCG2;STAT1
prerank,positive regulation of viral genome replication (GO:0045070),0.4169550127013983,0.9714505311718673,0.5242603550295858,0.8723779047535078,1.0,13/29,26.38%,PPIE;ADAR;LARP1;VAPB;ADARB1;TOP2A;TARBP2;PPIH;CNOT7;IFIT1;PPIA;PKN2;HACD3
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.3450486480086349,-0.9708299496144999,0.5243445692883895,0.9048161773318487,1.0,8/16,26.86%,PSIP1;DCPS;SRSF1;SNRPC;NCBP2;DDX23;SRSF12;CACTIN
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.37170971558923976,0.9708257323735167,0.646,0.8733118403073702,1.0,136/807,14.43%,RUNX1;BATF3;ASCL1;CIITA;SHH;IRF8;TGFB1;IKZF1;UXT;GATA1;FNIP2;BASP1;CBFA2T3;RPL23;RREB1;MAD2L2;EDNRB;BCL11A;NSD1;MLXIPL;ZEB2;PRDM12;YAF2;SEMA4D;NR1H4;DNMT3A;TNF;FNIP1;SNCA;SREBF2;CIR1;BPTF;UBE2D3;MITF;CRYM;SKI;ATF3;CEBPA;FOXO3;LRRFIP1;DDIT3;SPI1;MYT1L;WWC2;MAFK;TSC22D4;BHLHE41;HDAC5;HMGB1;XRCC5;TAF1;BACH1;PCGF6;CTNNB1;TRPS1;MTA3;ZFP69;ZNF177;TP53;MEF2A;TBL1XR1;NKX2-1;PHF21A;RCOR1;HSBP1;YY1;CREB3L1;GCFC2;ZFP90;EPO;CBFA2T2;CEBPB;SNAI1;MEF2C;NKRF;FLCN;TFAP2B;RB1;RBM15B;TRIM27;CIART;SMAD3;GTF2IRD1;IRF2;HSF1;MDFIC;QARS1;RING1;ATF7IP;ARID4A;IMPACT;CPEB3;MIDEAS;HDAC4;NFX1;NEDD4L;TPR;TGIF1;NFIC;TBL1X;PHC1;ZMYND15;HCFC2;LIMS1;SOX9;HDAC6;JDP2;NR2C2;DAP;ETV6;NRIP1;E2F6;GZF1;HDAC9;SDCBP;MTF2;MBD1;CREB1;RPS14;NRG1;KAT7;MAX;GPS2;FOXN3;GAS6;NFKB1;FOXK1;CUX1;HCFC1;ZFHX3;IRF1;USP9X;WFS1;SOX2;BRD7;LBH
prerank,protein O-linked glycosylation via serine (GO:0018242),0.49901337155144443,0.9707156716534363,0.5292397660818714,0.8731332606024826,1.0,5/10,17.74%,POGLUT2;POGLUT1;GALNT2;MGAT5B;GALNT1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.48861578849379594,0.9699990292256464,0.5084985835694051,0.8742588319937701,1.0,5/12,17.72%,STX11;SNAP29;STX3;SNAP23;STX2
prerank,positive regulation of protein sumoylation (GO:0033235),0.49580614079932606,0.9698997358420312,0.5248933143669986,0.8740310852018015,1.0,4/10,20.00%,HDAC4;UBA2;PIAS1;RWDD3
prerank,protein lipidation (GO:0006497),0.3981957058107426,0.9698304932741711,0.5548523206751055,0.8737422564207363,1.0,21/59,23.18%,PIGM;ATG7;PIGL;PIGV;ZDHHC14;ZDHHC7;ZDHHC13;ZDHHC16;PIGH;ZDHHC3;ZDHHC1;SELENOK;PGAP2;ZDHHC21;PIGU;PIGC;ZDHHC2;PIGN;ATG10;DPM2;PIGP
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.48757681667011266,0.9696402274270101,0.5363372093023255,0.8737336448705225,1.0,8/13,23.94%,ATG7;UBA2;DESI1;DESI2;SENP6;ATG10;UBA7;UBA5
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.3776983504609973,0.9693739124748384,0.5955955955955956,0.8738527348592425,1.0,38/184,18.10%,TUBB;ANAPC15;PRKAR2B;HAUS2;NEK6;RGCC;CDC23;TUBA4A;CNTRL;CEP192;MAPRE1;UBE2S;PSMB10;CEP70;PLK4;CEP76;KIF14;HAUS1;PSMA2;FZR1;DYNC1H1;PCM1;PSME3;CEP152;PSMB5;CDC6;INO80;HAUS8;PSMD8;PSMD7;PSMB9;NINL;APPL2;HSP90AA1;ANAPC11;AKAP9;PSMD2;CEP63
prerank,ERAD pathway (GO:0036503),0.3882719912902035,0.9691357009270612,0.567926455566905,0.8739177475394835,1.0,23/83,21.28%,TRIM25;EDEM1;HERPUD1;SEL1L;ATXN3;ERLIN1;ERLIN2;DERL1;UBE4B;STT3B;UBE2G2;TOR1A;STUB1;WFS1;UBE2J2;CCDC47;FAM8A1;FBXO44;ERLEC1;OS9;TMEM67;PRKN;DNAJB14
prerank,determination of heart left/right asymmetry (GO:0061371),0.40168591306473667,0.9689424085381452,0.5167037861915368,0.8739282465450742,1.0,4/42,8.10%,SHH;PKD2;TGFBR2;MEF2C
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.4392877653128659,0.9682769293167417,0.5276752767527675,0.8749411038585223,1.0,4/22,10.77%,SPI1;XDH;GADD45B;RELL1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.39975634482248934,0.9680019951497033,0.5464025026068822,0.8751448159495983,1.0,12/63,13.66%,LGALS3;TGFBR1;TNF;ITGA6;TRAF2;PYCARD;CFLAR;THBS1;PHIP;PSME3;CASP8;TRADD
prerank,supramolecular fiber organization (GO:0097435),0.3749391362629431,0.967958081067192,0.605,0.8748015635385754,1.0,75/333,18.76%,MYO1F;HOOK3;ARHGAP25;MYO1G;MYO1E;CORO1A;BFSP2;TGFBR1;MYO5A;MAD2L2;FGF13;ELMO1;SNCA;ITGA6;ATP7A;COLGALT1;TTR;TGFBI;CRTAP;CCDC88B;FLII;CLIP2;P4HB;LOX;MYO7A;KIF14;TSPAN14;MYO19;TPM4;BCAR1;P3H2;TUBGCP6;TUBGCP4;ACTN1;GFAP;BIN3;IAPP;DYNC1H1;ITM2B;PCM1;B4GALT7;TPM3;SORL1;KATNA1;B2M;PXDN;GGA2;DES;USP9X;HOOK2;KIF2A;CAPN3;LAMA3;DST;CAMSAP2;COL22A1;NF1;CD36;FIGN;COL23A1;MFAP4;FURIN;CORO1C;ARHGEF2;MARCKS;MYO1C;DNAJB6;RHOA;CDC42;MYO15A;ELMO2;LOXL3;GREM1;LTBP2;LTBP3
prerank,ether lipid metabolic process (GO:0046485),0.46612412750668336,0.9677916174627768,0.5257301808066759,0.8747163741410289,1.0,7/14,16.78%,DHRS7B;PLA2G7;PEX7;LIPE;AGMO;NCEH1;PLAAT3
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.394891432672576,0.9675201364662012,0.5420765027322404,0.8749002358435608,1.0,15/51,21.76%,PLEK;TGFBR1;RGCC;FHOD1;PFN2;NF2;PFN1;NRP1;SYNPO;CD47;RHOA;CDC42;ROCK2;EVL;CX3CL1
prerank,histone H3-K4 methylation (GO:0051568),0.43028286584816205,0.9673136983729389,0.5179856115107914,0.8749019351611291,1.0,8/26,19.48%,WDR5B;TET3;CXXC1;DPY30;RBBP5;SETD1B;WDR82;TET2
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.4120666507435372,0.967074276272212,0.5509736540664376,0.8750038760931429,1.0,7/35,14.04%,PKIB;XRCC5;CTNNB1;PRKCQ;CCT8;TNKS2;CCT5
prerank,regulation of feeding behavior (GO:0060259),-0.375442442118321,-0.9669470383049901,0.4709897610921502,0.9125202164684313,1.0,5/11,36.28%,LEPR;EIF2AK4;NR4A3;AGRP;CFAP20
prerank,regulation of acrosome reaction (GO:0060046),-0.39260607582224455,-0.9664356701171826,0.49828178694158076,0.9109275347113868,1.0,8/10,60.76%,CACNA1H;PLCB1;SPINK13;SERPINA10;FAM170B;PRSS37;PLA2G10;GLRA1
prerank,cellular response to radiation (GO:0071478),0.4107655396897065,0.9662937249022514,0.5516483516483517,0.8762956322170976,1.0,4/40,6.70%,GRB2;MAPK14;TANK;TP53
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.37429111962179246,0.9660144526110124,0.5793172690763052,0.8764958773449952,1.0,63/168,25.69%,RPL23;RPL17;RPL10A;PNRC2;RPS2;CNOT8;TENT4B;RPL18A;RPS15A;GSPT1;RC3H2;CASC3;RC3H1;SMG1;RPL6;RPLP2;RPL26;CTIF;RPS20;RPS16;PPP2CA;RPS14;RPL19;UPF3B;RPL9;THRAP3;RPS11;RPL11;SMG7;TUT7;RPS23;RPS4X;UPF2;RPS27;RPL4;PYM1;RPL7A;RPL15;RPL29;DIS3L2;RPL22;RPS7;ZFP36L1;DCP1B;RPS13;PNLDC1;CNOT7;CNOT1;EIF3E;RPLP1;RPS15;DCP2;RPS5;CNOT2;RPL41;XRN2;RPL10;AGO1;NCBP1;RPS8;RPL5;DXO;RPL18
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.4223043537625328,0.9658965028788293,0.5351787773933102,0.8763012289086557,1.0,8/30,15.64%,SREBF2;MICALL2;UBE2D3;VPS11;CSNK2A2;HUWE1;UBE2J2;GSK3A
prerank,heart contraction (GO:0060047),0.4071966823044056,0.9657736746485911,0.5361512791991101,0.8761578286097425,1.0,4/41,4.28%,SCN4B;MYL3;SLC8A1;TTN
prerank,detection of mechanical stimulus (GO:0050982),0.4504582358149312,0.9655853798564413,0.5324015247776366,0.8761444578801924,1.0,3/19,6.29%,PKD2;TTN;CTNNB1
prerank,in utero embryonic development (GO:0001701),0.4227153633127112,0.9654094007827876,0.5266343825665859,0.8761001911348695,1.0,3/25,8.33%,TGFBR1;CHD7;FLCN
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.4991721327137408,0.9650026293343155,0.5377906976744186,0.8765476972449517,1.0,1/10,0.91%,PLEK
prerank,protein localization to vacuole (GO:0072665),-0.35532233738197233,-0.9647405687761562,0.5017182130584192,0.9126937129113378,1.0,5/13,20.93%,LMBRD1;KPTN;CD81;LAMTOR5;GLMP
prerank,ion homeostasis (GO:0050801),0.4272910382532571,0.9644426226277943,0.5428571428571428,0.8773292693043078,1.0,5/30,10.05%,HCN4;P2RY2;AP3D1;WNK1;NEDD4L
prerank,negative regulation of catalytic activity (GO:0043086),0.4393317832529443,0.9642337157771984,0.5195121951219512,0.8773420846134757,1.0,5/24,11.27%,CLN3;TIMP1;TP53;ATP5IF1;HDAC6
prerank,regulation of secretion by cell (GO:1903530),0.3983452868841431,0.9639842345280607,0.5608974358974359,0.8774597681264107,1.0,6/54,8.10%,RAB8B;VAMP3;MCTP1;RHBDF2;ANXA1;MEF2C
prerank,axonal transport of mitochondrion (GO:0019896),-0.3846896447324499,-0.9639728351813687,0.5053003533568905,0.9119315813697652,1.0,4/11,11.33%,SPAST;NEFL;SYBU;MAPT
prerank,glucose import (GO:0046323),0.4728873633223091,0.9638663871639233,0.5277777777777778,0.8772895691769194,1.0,2/13,8.19%,SLC2A3;ZDHHC7
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3336615414692462,-0.9637276021217941,0.48031496062992124,0.9096354107535954,1.0,2/15,2.48%,FOXC1;BMP4
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.38964319292709804,0.9636394868724726,0.5511482254697286,0.8773378239982396,1.0,18/62,23.31%,PCID2;GTF2H1;EAF1;LEO1;CDK7;SETD2;POLR2L;ELL;MLLT1;ELOF1;TCEA1;GTF2H5;POLR2E;ELOB;IWS1;ELOC;NELFE;CTR9
prerank,cellular response to estrogen stimulus (GO:0071391),0.477204688981477,0.9635007535505696,0.5426666666666666,0.8771781239037938,1.0,5/14,20.44%,OCSTAMP;TRIM24;SRA1;NCOA4;SFR1
prerank,synapse assembly (GO:0007416),0.3875591133323884,0.9633366790634983,0.5485232067510548,0.8771212023304105,1.0,5/67,4.59%,NPAS4;PCDHB6;FGF13;SLITRK1;PLXNB2
prerank,intracellular protein transmembrane transport (GO:0065002),-0.2700678815579021,-0.9628469182330134,0.5454545454545454,0.9091617879328793,1.0,24/42,33.30%,DNAJC19;TIMM17A;PEX5;GRPEL2;PEX6;SEC61G;C2CD5;PEX14;TOMM70;SEC61B;TIMM23;SEC61A1;PAM16;PEX26;TIMM21;PEX10;ROMO1;GRPEL1;ZFAND2B;HSPD1;PEX16;DNLZ;AIFM1;TOMM40L
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.316800384566021,-0.9628409345963541,0.5071090047393365,0.906255491013928,1.0,5/19,13.22%,BMPR1A;ACVR1;SMAD4;OLFM1;SMAD6
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.41101252704215485,0.9627337104526141,0.5403587443946188,0.8780228264888124,1.0,8/37,12.29%,RPL23;PDCL3;TAF1;HFE;CSNK2A2;CSNK2A1;USP7;SDCBP
prerank,regulation of tau-protein kinase activity (GO:1902947),0.4936516617961024,0.9619973309593203,0.5240875912408759,0.8791670223329149,1.0,3/10,16.71%,RB1;SORL1;HSP90AA1
prerank,response to interferon-alpha (GO:0035455),0.448711503023113,0.9613851207984733,0.5122282608695652,0.8800636461005263,1.0,5/16,14.38%,IFNAR1;ADAR;TPR;GAS6;RO60
prerank,regulation of mitotic cell cycle (GO:0007346),0.3742213234915765,0.9610891256503103,0.6104417670682731,0.8802598914511971,1.0,36/171,17.85%,ANAPC15;TGFB1;LGMN;SMOC2;DUSP3;NEK6;CDC23;CDK11B;UBE2S;PSMB10;TAL1;PIM2;KIF20B;RB1;SMAD3;HSF1;ANGEL2;PSMA2;MAEA;TTLL12;SRA1;FZR1;RNF40;TRIM35;SDCBP;PSME3;PSMB5;PSMD8;CCDC8;INTS13;PSMD7;PSMB9;DYNLT3;IQGAP1;ANAPC11;PSMD2
prerank,protein targeting to lysosome (GO:0006622),0.4465960758842408,0.9609092088078065,0.555,0.8801734217824404,1.0,5/20,16.46%,LAPTM5;RAB7A;SORL1;NCOA4;GNPTAB
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4173716582234652,0.9607981217587173,0.5256257449344458,0.8799796122848685,1.0,3/26,4.54%,CBL;NCK2;ZFYVE28
prerank,skeletal muscle organ development (GO:0060538),0.4185950124209311,0.960713992632743,0.5417170495767836,0.879723106739922,1.0,3/26,8.10%,BASP1;CFLAR;MEF2C
prerank,neurotransmitter transport (GO:0006836),0.38533597037377026,0.9599322461453271,0.5547445255474452,0.8809897648874965,1.0,10/73,15.92%,SLC6A3;SLC6A4;APBA1;STXBP3;SLC6A15;CASK;SYNJ1;PPFIA1;PDZD11;DNAJC5
prerank,negative regulation of glycolytic process (GO:0045820),0.4986132942428979,0.9598601142372675,0.5414847161572053,0.880256984554214,1.0,2/10,9.95%,CBFA2T3;HDAC4
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.4986132942428979,0.9598601142372675,0.5414847161572053,0.880256984554214,1.0,2/10,9.95%,CBFA2T3;HDAC4
prerank,modification-dependent protein catabolic process (GO:0019941),0.3721125905663276,0.9592649281532355,0.6076076076076076,0.8810841735501733,1.0,33/193,13.69%,ANAPC15;CBL;MYLIP;TRIM25;PTTG1;RFFL;RNF149;WDR91;RNF19B;HERPUD1;CDC23;RNF7;PPP1R11;TAF1;RNF111;ATXN3;UBE2S;LONP1;RNF150;RC3H2;RNF114;RC3H1;UBE4B;NEDD4L;UBE2H;FZR1;RNF40;CDC34;WDR81;ITCH;UBE2G2;STUB1;RNF144B
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.4872989011130241,0.9592065263626396,0.5278174037089871,0.8807747141521166,1.0,5/10,25.36%,TSPAN6;GPATCH3;RIOK3;RNF125;C1QBP
prerank,histone methylation (GO:0016571),0.42240159752876877,0.9589419278174356,0.5419198055893074,0.8809187487702808,1.0,5/26,16.48%,NSD1;FBL;SETD6;SMYD3;SUV39H1
prerank,isotype switching (GO:0045190),-0.3960199918447449,-0.9585718900491028,0.48348348348348347,0.9152184199297108,1.0,6/10,36.41%,MSH2;MSH6;BATF;HSPD1;LIG4;RNF8
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.3001779736724116,-0.9585675807037454,0.5028901734104047,0.9123169913085893,1.0,3/23,1.33%,MTM1;SACM1L;MTMR7
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.3587924663946618,-0.9580202753385304,0.5,0.9109822890780861,1.0,9/14,29.63%,IRS1;PPARA;LONP2;AKT1;IRS2;MFSD2A;TWIST1;TYSND1;MTLN
prerank,regulation of axon regeneration (GO:0048679),0.478924563806103,0.957947751776459,0.5242718446601942,0.8826497840487693,1.0,4/12,16.34%,RTN4RL1;GRN;STK24;EPHA4
prerank,negative regulation of viral genome replication (GO:0045071),0.3969161799331949,0.9576842893840409,0.5469798657718121,0.8827993628980644,1.0,12/40,23.80%,FAM111A;TNF;RESF1;RNASEL;TASOR;PARP10;INPP5K;IFITM2;SETDB1;ILF3;IFIT1;IFITM1
prerank,glycerolipid catabolic process (GO:0046503),0.44599462183566624,0.9575802582539829,0.532051282051282,0.8825690716614807,1.0,7/19,23.89%,ABHD12;PRDX6;GDE1;GDPD3;GPCPD1;PLA2G4E;ABHD2
prerank,stress-activated MAPK cascade (GO:0051403),0.38835787500509783,0.9575144092920654,0.5700636942675159,0.882272870954424,1.0,15/61,17.04%,IRAK2;MAPK14;CCM2;UBE2V1;MAP2K3;MAP3K5;NOD2;MAP3K12;TAB2;IKBKG;GPS2;NFKB1;TAB3;MAP3K11;UBE2N
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3946920642256735,0.9575021627291588,0.5573593073593074,0.8818549235519956,1.0,8/48,12.48%,FNIP2;PYCARD;BCL2L1;TP53;CHEK2;BAK1;TNFRSF1B;DDIT4
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3753221047985146,0.9574034241472984,0.5846774193548387,0.8816234112816826,1.0,29/144,15.73%,TGFB1;ITGB2;HCLS1;PRKCD;SREBF2;MICALL2;UBE2D3;AKAP5;YWHAB;TP53;RIPOR1;VPS11;CSNK2A2;KIF20B;SMAD3;ITGAM;TPR;SEC16A;FYN;PCM1;SEC16B;SORL1;CASP8;SAR1A;GAS6;HUWE1;UBE2J2;GSK3A;YWHAH
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.4009214948875603,0.9573208819888316,0.5438786565547129,0.881367236830702,1.0,11/47,18.94%,SCIMP;TAOK3;RAP2A;QARS1;MAP2K2;NOD2;KLHDC10;PHLPP1;GREM1;PER1;TAOK1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.36895080648122147,0.9572449670065086,0.654,0.8811021770679464,1.0,79/341,18.89%,ARRB2;ANAPC15;NFE2L2;CBL;MYLIP;TRIM25;PTTG1;RFFL;RNF149;WDR91;KCTD17;RNF19B;HERPUD1;CDC23;UBE2D3;FBXL22;DDIT3;RNF7;TNFAIP3;PPP1R11;TAF1;RNF111;CTNNB1;ATXN3;UBE2S;PSMB10;TBL1XR1;RNF150;RC3H2;KIF14;RNF114;GID8;RC3H1;RNF4;UBE4B;NEDD4L;UBE2H;APPBP2;TBL1X;PSMA2;MAEA;VPS37C;FZR1;RNF40;CDC34;SPOP;WDR81;PSME3;RNF216;RMND5B;ITCH;UBE2G2;STUB1;RNF144B;PSMB5;HUWE1;USP9X;PSMD8;AREL1;ZNRF1;MVB12B;PSMD7;PSMB9;GSK3A;SMURF1;FAF1;VPS28;FEM1B;ZNRF3;ANAPC11;UBE2K;PSMD2;KEAP1;BIRC2;PPP2R5C;UBXN2A;KCTD5;SPSB2;PLAA
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.48889546015864227,0.9570511703491735,0.550624133148405,0.8810936654393438,1.0,2/12,6.13%,NEK6;PRKCB
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.41220793636943537,0.956767509723071,0.5620022753128555,0.8812936396026795,1.0,8/33,18.54%,GPNMB;PKD2;RB1;CCL2;CDK6;BRD7;PTEN;DACT1
prerank,nucleotide catabolic process (GO:0009166),0.45809226409684156,0.9564113668828013,0.5446194225721784,0.8816211778947077,1.0,3/16,8.29%,XDH;SAMHD1;PNP
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.3751812174697087,-0.9561600777269904,0.4934210526315789,0.9131608252890768,1.0,8/10,41.35%,GAR1;NOP10;TSR3;RPUSD1;NHP2;NAF1;RPUSD2;RPUSD3
prerank,regulation of DNA metabolic process (GO:0051052),0.39361862763490413,0.9560036032545768,0.5678059536934951,0.8820816650252442,1.0,14/44,22.85%,UBE2V2;UBE2V1;XRCC5;POLH;SMG1;KAT7;HNRNPD;SMARCAD1;KPNA1;UBE2N;MPV17;TERF2;WDR70;TERF2IP
prerank,nuclear pore complex assembly (GO:0051292),-0.3914286728663723,-0.9558846717899092,0.5221518987341772,0.91107945977349,1.0,5/10,11.37%,NUP93;NUP98;AHCTF1;NDC1;NUP153
prerank,positive regulation of protein acetylation (GO:1901985),-0.3597066325038645,-0.9554278790572455,0.4968152866242038,0.9094294787516165,1.0,3/12,6.31%,CEP295;RAPGEF3;DIP2A
prerank,positive regulation of protein binding (GO:0032092),0.39477506685550073,0.9554242780646898,0.564755838641189,0.8829094090760228,1.0,23/56,22.54%,PPP2CB;APOE;TAF1;HFE;SPPL3;DERL1;EPB41;PPP2CA;BAMBI;B2M;STK3;LRRK2;LRP1;IDE;RPL11;STK4;ADD1;FLOT1;DACT1;GSK3B;PRKN;PIN1;VTN
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.4499584361833277,0.955103214668454,0.5404699738903395,0.8831749134244566,1.0,4/17,17.70%,SCN4B;NOS1AP;SCN5A;AKAP9
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4387023145243687,0.954967861890968,0.54,0.8830389048342877,1.0,2/20,3.31%,NFE2L2;CREB3
prerank,regulation of catabolic process (GO:0009894),0.4521616578739416,0.9548480267327865,0.5531370038412292,0.8828554910341359,1.0,8/18,21.35%,HPGD;CHEK2;ZDHHC7;NEDD4L;FAF1;FURIN;ITGB1;ZDHHC2
prerank,hepaticobiliary system development (GO:0061008),0.4404889837754028,0.9546437934766246,0.5409836065573771,0.8828790040957035,1.0,3/20,4.57%,PCSK9;PKD2;CEBPA
prerank,fatty acid transmembrane transport (GO:1902001),0.44190505623562937,0.9545224426450193,0.548469387755102,0.8826842297314679,1.0,6/19,17.98%,SLC25A20;ABCD1;ACACA;CD36;CPT2;ABCD2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.3965387844644274,0.954441422979867,0.5420875420875421,0.8824149087338939,1.0,16/38,23.99%,CENPO;ASF1B;ATRX;RBBP7;CENPI;CENPQ;CENPK;RSF1;UBN1;RBBP4;IPO4;ITGB3BP;SMARCA5;H3-3A;KNL1;CENPT
prerank,keratinocyte differentiation (GO:0030216),-0.28154993878538825,-0.9544155992355446,0.5390070921985816,0.9093353236341285,1.0,6/29,15.14%,CLIC4;WNT5A;BCR;JAG1;CASP3;UGCG
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.45902369308830754,0.954411800964475,0.5249343832020997,0.882034305142131,1.0,2/14,9.43%,TLR2;PUM2
prerank,clathrin-dependent endocytosis (GO:0072583),0.4284721426634327,0.9544037507775845,0.5621301775147929,0.8816177531311588,1.0,13/26,23.28%,PIP5K1C;AP2S1;GPR107;ITSN1;CLTC;FNBP1L;SIGLEC1;GAK;AP2M1;PICALM;FCHO2;ITSN2;INPP5F
prerank,nuclear membrane organization (GO:0071763),-0.3165421435706383,-0.9542922972296981,0.5233644859813084,0.9068089345309219,1.0,8/19,23.33%,SPAST;VPS4A;EMD;CHMP4B;TMEM43;TARDBP;CHMP2A;GPER1
prerank,sensory perception of sound (GO:0007605),-0.21464987846910147,-0.9542850519168246,0.5625,0.9039862054566358,1.0,14/88,12.21%,ROR1;GRM7;NIPBL;DCDC2;GSDME;EML2;COL4A3;EYA1;SOD1;USP53;WDR1;CLIC5;ATP6V0A4;TBX1
prerank,positive regulation of developmental growth (GO:0048639),0.39484641926729586,0.9541395299829685,0.5706695005313497,0.8817618284756323,1.0,13/49,21.68%,SYT17;SEMA4D;MACF1;AGRN;SYT2;NEDD4L;TWF2;SMURF1;RASAL1;PLAA;UNC13A;RIMS1;ITSN2
prerank,ATP transport (GO:0015867),0.4911701127372722,0.9535492688022745,0.5512630014858841,0.8825659985554225,1.0,1/10,1.90%,ABCC6
prerank,regulation of neuron projection arborization (GO:0150011),-0.3371563096374291,-0.9533960069820534,0.5098814229249012,0.9033839486877088,1.0,5/15,12.28%,NTNG1;WNT5A;MYO9A;FZD4;GRIP1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.421345943347818,0.95336393957721,0.536144578313253,0.882538190646955,1.0,5/24,13.61%,TGFBR1;MDK;TRPS1;SOX9;SOX6
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.4638695541369498,0.953160956155943,0.5362116991643454,0.8825612637563084,1.0,3/13,14.53%,NFE2L2;GPR37;LRRK2
prerank,regulation of fatty acid oxidation (GO:0046320),0.45223179035183503,0.9527592774749696,0.5401844532279315,0.8829612514649856,1.0,5/16,16.65%,ACADL;ABCD1;PPARGC1A;SOX9;APPL2
prerank,histone H2A monoubiquitination (GO:0035518),-0.32706487348502344,-0.95235277916519,0.4713656387665198,0.903359149125969,1.0,6/17,10.90%,DDB2;RYBP;DDB1;TRIM37;PCGF2;PCGF3
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.4614909251190979,0.9521134456461053,0.5569948186528497,0.8838628468069523,1.0,4/16,15.83%,RMI1;HFM1;SLX4;TOP2A
prerank,response to interleukin-6 (GO:0070741),0.48781223710203997,0.9519134980083931,0.5605633802816902,0.8838198765407881,1.0,5/10,16.43%,NFKB1;PID1;PTPRT;SELPLG;SBNO2
prerank,central nervous system myelination (GO:0022010),0.487711022636535,0.9517605343222972,0.5568022440392707,0.8837136318408754,1.0,6/11,27.98%,PTEN;ABCA2;B4GALT6;TENM4;CNTNAP1;B4GALT5
prerank,positive regulation of cell communication (GO:0010647),0.41361460960591656,0.950789498083894,0.563953488372093,0.8852770246303044,1.0,3/28,6.74%,CLSTN1;TNF;CD80
prerank,regulation of actin filament depolymerization (GO:0030834),0.4787015256677629,0.9506600259540501,0.5489655172413793,0.8851059109464477,1.0,1/12,0.91%,PLEK
prerank,RNA 3'-end processing (GO:0031123),-0.2314916039686836,-0.9504040146896535,0.576271186440678,0.9056824684404087,1.0,18/69,15.25%,WDR33;SARNP;SRRM1;RPRD2;FIP1L1;CPSF7;THOC7;CSTF2;THOC1;PAPOLA;THOC5;U2AF2;SRSF11;RPRD1B;EIF4A3;SRSF1;TUT1;CSTF3
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.3855408574060834,0.9500793939098795,0.566410537870472,0.8859063992826356,1.0,15/44,22.43%,CNOT8;GTPBP1;TNRC6A;YTHDF3;MOV10;RC3H1;CPEB3;METTL3;MEX3D;AGO2;ROCK2;FTO;ZFP36L1;CNOT7;CNOT1
prerank,signal peptide processing (GO:0006465),0.4777801319792604,0.9497959411632023,0.5376044568245125,0.8860872175992036,1.0,6/11,17.02%,SPCS2;SEC11C;SPPL3;SPCS1;PARL;FURIN
prerank,heterocycle biosynthetic process (GO:0018130),0.4568419722280362,0.9494289641250607,0.5670241286863271,0.8864112255949635,1.0,2/14,10.15%,GCH1;PYCR2
prerank,oogenesis (GO:0048477),0.4555115353741244,0.94933561451298,0.5449871465295629,0.8861687445061859,1.0,4/15,17.07%,MDK;TRIP13;METTL3;MARF1
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.4013678611860273,-0.9486680883620856,0.5544217687074829,0.9078359439988305,1.0,5/10,30.15%,MAPT;PPM1F;DNAJA1;TERF1;NDFIP2
prerank,cell differentiation in hindbrain (GO:0021533),0.48147069670996306,0.9485654970026214,0.5368271954674221,0.8873312220996695,1.0,2/11,15.47%,ATP7A;AGTPBP1
prerank,membrane depolarization during action potential (GO:0086010),0.42168284166000053,0.9483910206039569,0.5509964830011723,0.8872737306939894,1.0,7/26,17.43%,SCN4B;HCN4;SLC8A1;SCN9A;YWHAH;CACNA1D;SCN5A
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.3639935353586516,-0.9482939741711967,0.5131578947368421,0.9060217003814257,1.0,7/12,35.79%,BDH2;GSS;OPLAH;CHAC2;GGCT;HAGH;GGT1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.2854004295571434,-0.9476730577087167,0.5126582278481012,0.9048801621737008,1.0,6/26,10.09%,SRI;THADA;ATP1A2;FKBP1A;FMR1;CALM3
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3667526037076588,0.9469500332014128,0.685,0.8898819067687517,1.0,78/314,20.78%,ARRB2;ANAPC15;NFE2L2;TRIM25;EDEM1;PTTG1;RFFL;KCTD17;HERPUD1;CDC23;UBE2D3;SEL1L;FBXL22;DDIT3;DCAF12;FBXL18;TAF1;CTNNB1;ATXN3;ERLIN1;ERLIN2;UBE2S;PSMB10;TBL1XR1;KIF14;RB1;GID8;DERL1;RNF4;UBE4B;NEDD4L;APPBP2;TBL1X;PSMA2;MAEA;FZR1;CDC34;SPOP;PSME3;RNF216;STT3B;FBXL3;RMND5B;ITCH;UBE2G2;STUB1;PSMB5;HUWE1;WFS1;PSMD8;AREL1;UBE2J2;ZNRF1;FAM8A1;PSMD7;PSMB9;GSK3A;SMURF1;FAF1;FEM1B;ANAPC11;UBE2K;PSMD2;BIRC2;FBXO44;PPP2R5C;UBXN2A;KCTD5;SPSB2;PLAA;OS9;TMEM67;WWP1;RAD23B;FBXW11;NSFL1C;CUL3;PRKN
prerank,sulfation (GO:0051923),0.48356556978160103,0.9468739321485297,0.5652777777777778,0.8895881982097813,1.0,1/11,4.99%,SULT4A1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.3928027021482241,0.9463476447829924,0.571584699453552,0.8902429233322179,1.0,7/46,6.51%,TNF;IL6R;IL18;TNFAIP3;XRCC5;CTNNB1;AIF1
prerank,mRNA modification (GO:0016556),-0.297620878565133,-0.9461399464672252,0.5161290322580645,0.9063486734513919,1.0,7/22,14.68%,CBLL1;METTL14;NSUN2;METTL16;TRMT6;TRUB2;CMTR1
prerank,negative regulation of protein secretion (GO:0050709),0.4025336903887212,0.9455726595730171,0.5555555555555556,0.8914145638139948,1.0,3/38,4.68%,KCNJ11;APOE;RHBDF2
prerank,RNA stabilization (GO:0043489),0.4083254187819864,0.9453592188455245,0.5765247410817032,0.8914246271015336,1.0,4/33,8.98%,SLC11A1;CIRBP;LARP1;TENT5C
prerank,potassium ion import across plasma membrane (GO:1990573),0.39788092918403806,0.9452889203943537,0.5734806629834254,0.8911377263321081,1.0,2/41,2.24%,KCNJ11;HCN4
prerank,neuron projection morphogenesis (GO:0048812),0.369049364947814,0.9450672070092294,0.6150753768844222,0.8911553973156056,1.0,19/137,11.42%,NCKAP1L;NEFH;TAOK3;S100B;SLITRK1;ATP7A;CTNNB1;DOCK10;ACTB;DNM2;MEF2A;TNIK;KIF20B;NTF3;IMPACT;FLRT1;MAP1B;DTNBP1;ATL1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.4301628408668501,0.9448939388913782,0.5614906832298137,0.8911102279172006,1.0,5/22,15.61%,NFE2L2;PSMB10;PSMA2;PSMB5;PSMB9
prerank,DNA methylation (GO:0006306),0.4188978311699193,0.9445502725059959,0.5726600985221675,0.8913865407147006,1.0,4/23,9.69%,DNMT3A;METTL4;ATRX;ATF7IP
prerank,positive regulation of response to wounding (GO:1903036),0.42654127147736476,0.944496387146322,0.5765550239234449,0.8910668434651965,1.0,5/24,11.64%,MDK;ARFGEF1;ANXA1;ACTG1;GRN
prerank,cellular glucan metabolic process (GO:0006073),-0.36123256888168553,-0.9441334331917601,0.5211267605633803,0.9090667209138382,1.0,6/11,21.94%,PHKG2;UGP2;PHKB;PYGM;PPP1R3C;PHKA1
prerank,ERBB2 signaling pathway (GO:0038128),0.411057858167574,0.9440557546365397,0.5754060324825986,0.8915470348837983,1.0,8/31,16.79%,GRB2;PTPN18;ERBIN;NRG1;STUB1;SRC;HSP90AA1;PTPN12
prerank,potassium ion export across plasma membrane (GO:0097623),-0.35372725861250665,-0.9439963554984241,0.5185185185185185,0.9066206248241339,1.0,3/13,5.64%,KCNK5;KCND3;KCNT2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.48214289688623013,0.9434130839646715,0.5432624113475177,0.8924268515282011,1.0,2/10,5.36%,PIK3CB;XDH
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.3835072705547664,-0.9434060916615211,0.5033112582781457,0.9054536094065012,1.0,6/10,24.58%,APP;SHANK3;RAB5A;SYP;DRD2;CAMK2B
prerank,regulation of cell cycle process (GO:0010564),0.37366408289675007,0.943204171047304,0.620162932790224,0.8924259387284252,1.0,19/104,12.21%,ZFYVE26;KLHL21;CTNNB1;BCL2L1;SND1;PLK4;PLK2;CSNK2A2;CSNK2A1;FLCN;KIF20B;MYO19;UVRAG;RAB11A;SETD2;DBF4;SOX9;BECN1;DYNC1H1
prerank,zinc ion transport (GO:0006829),-0.3105937546481067,-0.9427374866814909,0.5300546448087432,0.9045152899679982,1.0,7/21,25.80%,SLC39A13;SLC39A8;SLC30A1;SLC39A1;SLC39A14;SLC39A3;TRPM2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.274476919411492,-0.9426700988072093,0.4789915966386555,0.8993004246545774,1.0,10/32,11.87%,NUP93;NUP188;RANBP2;SSB;NUP98;NUP42;NDC1;RAE1;NUP153;NUP37
prerank,tRNA export from nucleus (GO:0006409),-0.274476919411492,-0.9426700988072093,0.4789915966386555,0.8993004246545774,1.0,10/32,11.87%,NUP93;NUP188;RANBP2;SSB;NUP98;NUP42;NDC1;RAE1;NUP153;NUP37
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.39236176878230444,0.9422476331281658,0.5866957470010905,0.8940094235834264,1.0,8/47,11.23%,CASS4;RREB1;MDK;ACTN4;NEDD9;P4HB;LIMS1;NRP1
prerank,connective tissue development (GO:0061448),0.40499129392152095,0.942099426316792,0.5798882681564246,0.8938666231766088,1.0,8/35,13.61%,SH3PXD2B;ATP7A;CD44;SULF2;LRP5;CREB3L2;SOX9;SOX6
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.3884442002700739,0.9419822361468098,0.6004206098843323,0.8936807518187263,1.0,8/55,6.86%,TGFBR1;TNF;TRAF2;PYCARD;DDIT3;BCL2L1;TP53;CRADD
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.34880304248285265,-0.9419301217496723,0.5118110236220472,0.8986483061043135,1.0,3/14,4.70%,ANK2;ATP1B1;ACTN2
prerank,respiratory tube development (GO:0030323),0.41514499220427303,0.9417753399348453,0.5697399527186762,0.89368221121264,1.0,3/28,6.82%,SHH;CEBPA;NKX2-1
prerank,positive regulation of RNA metabolic process (GO:0051254),0.39575593801719566,0.9408983334428482,0.5741360089186176,0.8950387359862556,1.0,8/45,13.46%,TGFB1;ERN1;TP53;GRSF1;ZC3H18;MAP2K2;HEATR1;NFKB1
prerank,regulation of muscle cell differentiation (GO:0051147),0.4090024862764662,0.9406599354021942,0.5515643105446119,0.8950821868090731,1.0,10/31,22.04%,MAPK14;CTNNB1;MEF2A;MYOCD;MEF2C;HDAC9;CDC42;MEGF10;PTBP1;CDH15
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.32500732674250854,-0.9405304682709724,0.5299539170506913,0.8996465237796026,1.0,4/17,15.59%,VEZF1;BMP4;ATOH8;BAD
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.36507820530834767,0.9404319466841313,0.6399197592778335,0.8951156815657506,1.0,57/148,28.29%,RPL23;MTOR;RFFL;MAPK14;MAP2K6;PIP4K2A;RMI1;EXO1;TAF1;BRIP1;TP53;CHEK2;CSNK2A2;CSNK2A1;RPS20;USP7;RBBP7;PIP4P1;RRS1;DNA2;BRD7;NOC2L;TAF3;RPL11;MEAF6;PDPK1;PPP2R5C;CHD4;TAF11;RBBP4;CDK5R1;HEXIM1;TTC5;PHF20;PIN1;RAD1;MDM4;SGK1;NUAK1;RPS15;CHD5;ATR;RPA1;PRKAG1;RPL5;CDK5RAP3;ING5;MTA2;TAF6;TOP3A;PAK1IP1;TAF15;PRKAA1;KAT5;RHNO1;HDAC1;RAD9B
prerank,peptide biosynthetic process (GO:0043043),0.36701453249036575,0.9400924307824479,0.6452261306532663,0.8953577322289279,1.0,59/153,26.26%,RPL23;RPL17;RPL10A;RPS2;RRBP1;RPL18A;FARSB;MRPL41;RPS15A;GSPT1;EIF4EBP2;MRPL51;RPL6;RPLP2;RPL26;RPS20;GGTA1;RPS16;RPS14;DARS1;RPL19;IGF2BP3;RPL9;RPS11;RPL11;RPS23;FURIN;RPS4X;MRPS21;RPS27;AGO2;RPL4;MRPS14;PABPC4;MRPL3;RPL7A;RPL15;MRPL10;RPL29;RPL22;RPS7;RPS13;SARS1;RPLP1;RPS15;MRPL18;MRPL52;RPS5;RPL41;RPL10;MRPL37;MRPS12;ABCF1;RPS8;RPL5;RPL18;EEF1A1;RPL28;MRPS15
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3713366300856056,0.9399958379651899,0.6040609137055838,0.895110767021629,1.0,21/98,17.77%,TREM2;LGALS3;ITGB2;PLS1;TNF;AKAP5;STAC;YWHAB;TP53;PRKCH;ITGAM;FYN;STX3;CASP8;STAC3;ARF6;LRP1;YWHAH;CEMIP;MYO1C;PDPK1
prerank,heme biosynthetic process (GO:0006783),0.42326032042738665,0.9399949182139407,0.5787545787545788,0.8946794130995874,1.0,4/22,10.00%,TSPO;ATP5IF1;SLC25A38;NFE2L1
prerank,modulation by host of symbiont process (GO:0051851),0.4049509607620044,0.9397490218480796,0.570446735395189,0.8947303537000618,1.0,2/31,1.86%,CX3CR1;AQP1
prerank,calcium ion homeostasis (GO:0055074),0.36429412562124913,0.9397168400127853,0.6286008230452675,0.8943673470676133,1.0,18/95,14.21%,CCR2;SLC8A1;CCL8;SNCA;ATP2C1;TPT1;TFAP2B;ATP2B1;CCL14;VAPB;ATP13A1;SLC8B1;CCL13;CHERP;ATP2B3;NPTN;ATP2A3;WFS1
prerank,positive regulation of hormone secretion (GO:0046887),0.4416034782481016,0.9394413539982172,0.5516795865633075,0.8945058737149196,1.0,4/17,14.06%,SPP1;RASL10B;HFE;NMB
prerank,DNA double-strand break processing (GO:0000729),0.44089234288537305,0.9391932869965647,0.5740498034076016,0.8945726330979598,1.0,5/18,17.04%,UBE2V2;DNA2;SLX4;SMARCAD1;UBE2N
prerank,sphingolipid biosynthetic process (GO:0030148),0.37789590569719766,0.9391639490277,0.6035564853556485,0.894218128462832,1.0,20/71,22.59%,CERS6;SGPL1;CLN8;PRKD2;CSNK1G2;HACD4;AGK;ACER3;VAPB;ST8SIA1;LARGE1;DEGS1;ASAH1;SGMS1;SPTSSA;SMPD1;SPTSSB;B4GALT6;PRKD3;CERS4
prerank,protein localization to condensed chromosome (GO:1903083),0.4661973067498854,0.9386822637964664,0.5612535612535613,0.89476172966639,1.0,1/12,2.30%,IK
prerank,protein import into nucleus (GO:0006606),0.38509271570748793,0.9382867594341874,0.6060924369747899,0.8951267219205749,1.0,4/66,2.92%,MMP12;SYK;RPL23;NUP62
prerank,monocyte differentiation (GO:0030224),0.4851412359030344,0.9381699881576109,0.5594512195121951,0.8949223567479063,1.0,2/10,5.26%,CSF1R;MYH9
prerank,positive regulation of histone acetylation (GO:0035066),0.42557126881145596,0.9381655806912239,0.559610705596107,0.8944993695274915,1.0,11/23,27.10%,PPARGC1A;RPS6KA4;KAT7;SMARCB1;BRD7;PIH1D1;RPS6KA5;ARRB1;SPHK2;GLYR1;MAPK3
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.35978432556263623,0.9378963049874883,0.713,0.8946265288401406,1.0,79/366,18.19%,HCLS1;GATA1;ORC3;TGFBR1;RREB1;NSD1;MLXIPL;YAF2;UBE2V1;MITF;PPIE;NFXL1;CEBPA;FOXO3;DDIT3;CXXC1;SPI1;WWC2;BACH1;CHD7;SBNO1;TFEB;CDK11B;DNM2;CCAR1;TP53;GCFC2;CEBPB;HINT1;FOXN2;TGFBRAP1;CHEK2;PRKCQ;MEF2C;RB1;GTF2IRD1;IRF2;PPARGC1A;ATRX;RPL6;NFX1;HCFC2;ZSCAN26;CYFIP1;RPS6KA4;NLK;DENND4A;NR2C2;ZNF628;GZF1;MTF2;PPP2CA;BRDT;KAT7;FOXN3;PCIF1;SOX6;HCFC1;ZFHX3;SOX2;HNRNPD;SOX4;PUM3;ZBTB11;SPTY2D1;REXO4;OGG1;FADS1;HIF1A;SBNO2;TRIP4;RPS6KA5;VHL;NFYA;PCGF1;CASZ1;CNBP;ZNF35;CREBL2
prerank,regulation of monocyte differentiation (GO:0045655),0.45593494600743467,0.9375681505786239,0.5588235294117647,0.8948599158250614,1.0,2/14,3.61%,CD74;ACIN1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.46305259395522386,0.937494651792543,0.5624142661179699,0.8945802847772973,1.0,1/12,2.02%,PLCG2
prerank,histone exchange (GO:0043486),0.3915036897227327,0.9371321059858615,0.5534521158129176,0.8948597071453407,1.0,14/37,23.99%,CENPO;SRCAP;RBBP7;CENPI;SPTY2D1;CENPQ;CENPK;RSF1;RBBP4;ITGB3BP;VPS72;SMARCA5;KNL1;CENPT
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.4646111428112547,0.9370236739610216,0.541095890410959,0.894665400551922,1.0,3/13,6.91%,RENBP;NAGK;OGA
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3793066916864757,0.9369263019211169,0.5759162303664922,0.894443269832064,1.0,13/65,16.48%,AQP1;ADAM8;ANGPT4;MTOR;RGCC;TP53;P4HB;TBL2;STUB1;CPEB4;HIF1A;CPEB2;SUV39H1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.291160701608723,-0.9365397435551895,0.5714285714285714,0.9073601810745044,1.0,6/24,8.55%,SEMA6A;SEMA5A;SEMA3A;SEMA6D;SEMA3C;SEMA3D
prerank,spliceosomal snRNP assembly (GO:0000387),-0.2589001304227327,-0.9364448730923888,0.6101694915254238,0.9048906617052517,1.0,16/38,24.79%,PRPF3;SNRPD3;SNRPD1;TGS1;SNRPC;WDR77;SNRPG;COIL;SNRPF;PRPF19;LSM2;PRPF6;CD2BP2;SRSF12;PRMT7;PRPF31
prerank,potassium ion homeostasis (GO:0055075),-0.2981954149797038,-0.9364037870306853,0.5786516853932584,0.9023233050817844,1.0,3/23,1.49%,SLC12A2;SLC12A7;ATP1B1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.32393382648773683,-0.9363992203697381,0.512,0.8996667992124565,1.0,3/16,8.91%,RBFOX2;AR;TADA3
prerank,rRNA processing (GO:0006364),0.36460628089599817,0.9363647486872768,0.6492462311557788,0.8951393673746518,1.0,46/172,21.04%,RPL23;RPL17;EMG1;RPL10A;UTP20;NOB1;TEX10;FBL;RPS2;EXOSC1;LAS1L;RPL18A;KRR1;RPL6;DDX27;RPLP2;RPL26;RPS16;MDN1;UTP11;HEATR1;RPS14;RPL19;IMP3;RPL9;PES1;C1D;PIH1D1;RPL11;WDR12;RPS27;RPL4;FCF1;RIOK3;WDR75;RPL7A;RPL15;EXOSC3;SART1;RPL29;RRP7A;UTP3;SRFBP1;RPL22;IMP4;RPS7
prerank,lysine catabolic process (GO:0006554),0.4695358979628768,0.9359511113937062,0.5444444444444444,0.8951285863778744,1.0,3/12,12.95%,CRYM;OGDH;ALDH7A1
prerank,lysine metabolic process (GO:0006553),0.4695358979628768,0.9359511113937062,0.5444444444444444,0.8951285863778744,1.0,3/12,12.95%,CRYM;OGDH;ALDH7A1
prerank,regulation of protein localization to nucleus (GO:1900180),0.3901020221032415,0.9358660261373908,0.5890257558790594,0.8948561406633583,1.0,2/43,0.90%,SHH;TGFB1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.42379795811865384,0.9358342406671232,0.5675,0.8944839471840487,1.0,9/21,27.02%,CHSY3;BCAN;CHSY1;CHST15;CHPF;CSPG4;CHST3;CHST11;CHST9
prerank,positive regulation of exosomal secretion (GO:1903543),0.4582217700106873,0.9353065018121074,0.5650406504065041,0.895111228578548,1.0,5/15,19.99%,SMPD3;RAB7A;SDCBP;PDCD6IP;ATP13A2
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.4579838364499531,0.935208864877677,0.5546772068511199,0.8948999136867726,1.0,5/14,20.83%,PKD2;TMSB4X;FAF1;KEAP1;NFKBIE
prerank,protein localization to kinetochore (GO:0034501),0.4600052259880851,0.9346416972473442,0.5595567867036011,0.8956228346622376,1.0,5/14,23.99%,IK;MIS12;KNL1;BUB3;CENPT
prerank,peptide catabolic process (GO:0043171),-0.2943307889078017,-0.9341190227724641,0.5602094240837696,0.9029273035421717,1.0,9/23,23.98%,LTA4H;ECE1;CPQ;ACE;NPEPPS;CHAC2;ENPEP;GGT7;TPP1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.44145995576011177,0.9335984757440933,0.5667963683527886,0.8973016489492506,1.0,2/17,8.05%,TGFB1;SNAI1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.36321985645907173,-0.9335302634929953,0.5461254612546126,0.9016428699389855,1.0,4/12,4.64%,CDH5;STMN2;EML2;DYRK1A
prerank,cellular calcium ion homeostasis (GO:0006874),0.3620974754632397,0.9335242564194103,0.6407669021190716,0.8970274787987456,1.0,33/133,19.99%,CCR2;KCTD17;SLC8A1;CCL8;HERPUD1;CLN3;FZD9;TMEM178A;ATP2C1;TPT1;ATP2B1;BAK1;CCL14;VAPB;ATP13A1;SLC8B1;CCL13;CHERP;ATP2B3;NPTN;CDH23;ATP2A3;ADCY8;WFS1;CCDC47;SELENOK;PDZD8;TMEM165;MICU2;PACS2;CALCA;ATP13A5;ATP13A2
prerank,regulation of cell motility (GO:2000145),0.36777054828677197,0.9333873149835117,0.6329625884732053,0.8968923994144063,1.0,29/121,22.04%,TGFB1;CYRIB;CSF1R;PLXNC1;PLXNB2;ADGRG3;MACF1;DOCK10;TMSB4X;KIF14;SPINT2;PKN1;DIAPH1;CDK6;NRG1;TMSB10;ARHGAP18;KIF2A;SGK3;RHOA;MINK1;ROCK2;CRK;SPATA13;AMOT;MEMO1;PIN1;FLNA;FGF2
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.2517295958012304,-0.933221354746189,0.6141732283464567,0.899859380663278,1.0,17/37,26.84%,KIF3C;IFT46;IFT57;IFT172;KIF3B;IFT81;KIFAP3;IFT74;WDR35;IFT20;IFT43;DYNC2I2;DYNLL2;IFT22;IFT122;WDR19;TRAF3IP1
prerank,regulation of dendrite morphogenesis (GO:0048814),0.4091062579428342,0.9328982956632305,0.5815028901734104,0.8974366041430115,1.0,9/32,20.45%,SS18L1;RAP2A;SEMA4D;TNIK;NEDD4L;CUX1;YWHAH;CUX2;GSK3B
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.4191575871289075,0.9327443948786397,0.591566265060241,0.8973209931667308,1.0,7/24,22.06%,ITGB2;ITGAM;FYN;CEMIP;MYO1C;FIS1;CHP1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.331870035872388,-0.9327040219257967,0.5515873015873016,0.8985784958986809,1.0,3/16,4.82%,ZFPM2;BMPR1A;TGFBR3
prerank,positive regulation of viral life cycle (GO:1903902),0.42994294024746027,0.9323843792749241,0.5707070707070707,0.8976155257141231,1.0,3/22,10.78%,CD74;P4HB;LGALS1
prerank,regulation of osteoblast differentiation (GO:0045667),-0.21492763541783255,-0.9323124941255028,0.5625,0.8968733822900026,1.0,30/82,26.38%,SUCO;CRIM1;BMPR1A;TMEM64;WNT4;PRKD1;BMP4;ACVR1;RORB;REST;CTNNBIP1;CCN1;ATF4;SMAD6;PPARG;TWIST2;HDAC7;FERMT2;RANBP3L;TMEM119;PTK2;PTCH1;CHRD;BMPR2;MEN1;TWIST1;ACVR2B;FGFR2;SMOC1;HGF
prerank,sensory organ development (GO:0007423),0.38386370914506207,0.9320052218634146,0.6212121212121212,0.8979590556058037,1.0,9/51,15.37%,ASCL1;SH3PXD2B;CHD7;MYO7A;ZDHHC16;SOX2;MEIS1;SIPA1L3;AHI1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.44304803391149955,0.9318685504586094,0.5735099337748344,0.8978072734023738,1.0,8/16,21.78%,GPR137B;SEH1L;FLCN;PIP4P1;PIH1D1;TELO2;RRAGA;RRAGB
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.45786677165373924,0.9317633341376512,0.5645161290322581,0.8975776457536783,1.0,2/12,5.36%,PIK3CB;XDH
prerank,axon extension (GO:0048675),-0.30036702024520234,-0.931721459883445,0.5473684210526316,0.895746928780924,1.0,5/23,6.36%,SEMA5A;AUTS2;SEMA3A;ULK2;SLIT2
prerank,response to nitric oxide (GO:0071731),0.4599311994194135,0.9315595946515908,0.5650969529085873,0.897573812838442,1.0,1/13,1.86%,AQP1
prerank,chloride transmembrane transport (GO:1902476),-0.24240584676141408,-0.9313828596237163,0.5274725274725275,0.8939678877661787,1.0,9/48,17.41%,SLC12A2;SLC12A7;GABRB2;GABRB1;GABRA2;GABRB3;ANO4;SLC12A8;GLRB
prerank,cellular response to glucose starvation (GO:0042149),0.3911866997030972,0.9313717280203314,0.5892070484581498,0.8975095988296021,1.0,22/41,28.84%,FOXO3;TP53;MTMR3;IMPACT;BECN1;TBL2;NIM1K;CPEB4;PIK3R4;SIK2;ATG14;BRSK1;NUAK1;PRKAG1;NUAK2;XBP1;SH3GLB1;PRKAA1;ITFG2;SESN1;SESN2;PMAIP1
prerank,rRNA methylation (GO:0031167),0.41566863991433267,0.9311522073628249,0.5682382133995038,0.8975111560803042,1.0,3/22,11.99%,EMG1;FBL;ZCCHC4
prerank,regulation of cellular response to stress (GO:0080135),0.36349794266811974,0.9311149657590314,0.6263846928499497,0.8971580454694033,1.0,33/115,21.26%,BAG2;MTOR;PTGES3;NUP62;NEK6;DNAJC7;ATF3;CLN3;HSBP1;ABCD1;SEH1L;CEBPB;HSF1;SMG1;TPR;NUP205;ADCY8;CHORDC1;BAG1;HSP90AA1;MANF;DNAJB6;NPAS2;CORO2B;RPTOR;SEC13;ROCK2;GSK3B;PRKN;NUP54;BAG4;CRYAB;NEK4
prerank,epidermal cell differentiation (GO:0009913),-0.2564439284905168,-0.9310525474639996,0.5934065934065934,0.8922143842965882,1.0,8/41,15.14%,CLIC4;WNT5A;BCR;HDAC2;GLI1;JAG1;CASP3;UGCG
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.36236522320188425,0.9309967546744884,0.6532258064516129,0.8969608798561988,1.0,31/145,18.10%,TUBB;GPR132;PRKAR2B;HAUS2;TUBA4A;CNTRL;CEP192;MAPRE1;PSMB10;CEP70;PLK4;CEP76;KIF14;HAUS1;RAB11A;PSMA2;DYNC1H1;PCM1;PSME3;CEP152;PSMB5;HAUS8;PSMD8;PSMD7;PSMB9;NINL;RAD51B;HSP90AA1;AKAP9;PSMD2;CEP63
prerank,regulation of dendritic spine development (GO:0060998),-0.31560406627228793,-0.9305045533699815,0.5157894736842106,0.8911796085637916,1.0,7/19,11.45%,NLGN1;GRIN3A;DLG5;FMR1;SHANK3;SHANK1;PPFIA2
prerank,cellular response to UV-A (GO:0071492),0.4764528705475069,0.9304565187015413,0.5611510791366906,0.8976455939854717,1.0,1/11,5.21%,TIMP1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.4232951625702515,0.9299694538378959,0.5784190715181933,0.898192171648887,1.0,2/20,8.46%,TGFB1;RB1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3719056827135781,0.9297391924758087,0.6217616580310881,0.898235647529516,1.0,6/75,7.37%,KCNJ11;HCN4;SLC9A4;SLC8A1;SLC9A9;SLC9A1
prerank,modulation by symbiont of host process (GO:0044003),0.48122275426367633,0.9294640754850879,0.5658465991316932,0.8983543125775085,1.0,3/10,20.10%,TLR2;B2M;ENO1
prerank,regulation of synapse maturation (GO:0090128),-0.3779203712570911,-0.9288330259075508,0.5162241887905604,0.8928860645114892,1.0,5/10,28.16%,DAB2IP;ARHGEF15;ANAPC2;CAMK2B;YWHAZ
prerank,regulation of vacuole organization (GO:0044088),0.42646137114584076,0.9287131746601832,0.5664961636828645,0.899390240999827,1.0,11/20,24.20%,ENO3;MTMR3;RAB1B;TBC1D14;TBC1D12;LAPTM4B;ENO1;SCARB2;NPRL3;ADPRH;IFT88
prerank,regulation of NMDA receptor activity (GO:2000310),0.402843642364732,0.928680250507578,0.5882352941176471,0.8990257736098816,1.0,2/32,1.16%,PTK2B;CCR2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.4107607721628053,0.9284407421758821,0.5801886792452831,0.89905665575275,1.0,3/27,8.05%,CD74;CD44;SNAI1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.45268577293709783,0.9276538172643304,0.5702917771883289,0.9002104373231902,1.0,3/15,12.48%,GRB2;BCAR1;DDIT4
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.4578246128217556,0.9272276562215139,0.594488188976378,0.9006184132193185,1.0,1/13,1.72%,NEIL2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.3805231937748807,0.92654515079891,0.6054852320675106,0.9015409585691812,1.0,17/58,21.90%,UBE2V2;HMGB1;XRCC5;LIG3;ATP23;UVRAG;BABAM2;ERCC6;BABAM1;MDC1;UBE2N;ERCC1;POLM;HERC2;DCLRE1C;NSMCE2;ERCC4
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.3898749297663036,0.9264488769010865,0.5936435868331441,0.9013113027339128,1.0,9/35,16.02%,RGCC;APOE;XDH;MEF2C;ATP5IF1;THBS1;CCL2;ATP5F1A;NF1
prerank,RNA splicing (GO:0008380),0.3639492836548126,0.9263374052021065,0.6156982670744139,0.9011147434439648,1.0,24/95,21.65%,IVNS1ABP;BCAS2;SF3B2;SF3B1;SNRNP25;SCAF11;ZMAT5;SNRPD2;PPARGC1A;DDX39B;LUC7L3;PRPF8;TRA2B;PPP2CA;WDR83;PPIG;NRDE2;SLU7;SNRNP35;SRSF2;SF3B3;SRSF10;PTBP1;PDCD7
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.4206311029436174,0.9262604555766335,0.5780487804878048,0.9008482919917483,1.0,10/22,26.03%,RPL23;RPS20;HEXIM1;RPS7;RPS15;CHD5;SPRED3;ATR;SPRED1;CDK5RAP3
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.3831870472367934,0.9256119774520708,0.5984766050054406,0.901743867905557,1.0,10/51,15.27%,PKIB;TENT4B;XRCC5;CTNNB1;PRKCQ;CCT8;STN1;TNKS2;CCT5;SRC
prerank,regulation of telomerase activity (GO:0051972),0.39033350639481423,0.9253156271135557,0.6147091108671789,0.9019384823408393,1.0,6/45,8.09%,PTGES3;PKIB;XRCC5;CTNNB1;TP53;PRKCQ
prerank,regulation of spindle organization (GO:0090224),0.42665794587254113,0.9252985460443545,0.5844155844155844,0.9015436447636109,1.0,4/18,12.21%,NUP62;RNF4;CLTC;DYNC1H1
prerank,regulation of protein binding (GO:0043393),0.36503504995870273,0.9249049152863961,0.6535353535353535,0.9018891563063267,1.0,29/114,18.54%,BAG2;PRKCD;LDLRAP1;HDAC5;TAF1;ACTB;TFIP11;HFE;DISC1;CTSZ;SPPL3;DERL1;EPB41;HDAC4;PPP2CA;PSME3IP1;SORL1;BAMBI;B2M;STK3;LRRK2;LRP1;TLE5;IDE;RPL11;STK4;ADD1;FLOT1;DACT1
prerank,proton transmembrane transport (GO:1902600),0.3993973706697832,0.9244349976306495,0.5811111111111111,0.9023809180025507,1.0,4/36,7.43%,ATP6V0E1;SLC36A1;SLC9A1;ATP6V0D1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.4505687433158577,0.9240624173591516,0.584516129032258,0.9026813724732249,1.0,4/15,14.15%,TSEN15;ERN1;RTRAF;DDX1
prerank,JNK cascade (GO:0007254),0.3907433111032702,0.924013288812017,0.6013289036544851,0.9023509950152818,1.0,12/40,18.63%,IRAK2;UBE2V1;MAP3K5;NOD2;MAP3K12;TAB2;IKBKG;GPS2;TAB3;MAP3K11;UBE2N;MINK1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.4125636553405408,0.9239868403035862,0.5874704491725768,0.9019795213873969,1.0,9/26,21.21%,SMYD5;TET3;SETD2;ETFBKMT;SUV39H1;SETD1B;WDR82;TET2;SETD5
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3647290799574445,0.923782354989448,0.6503567787971458,0.9019751095518045,1.0,21/95,17.77%,TGFB1;TGFBR1;ZEB2;SKI;RNF111;TGFBR2;NKX2-1;FLCN;FAM89B;SMAD3;THBS1;SNX25;SDCBP;BAMBI;VASN;STUB1;BCL9;SMURF1;LDLRAD4;GIPC1;PDPK1
prerank,regulation of cell-substrate adhesion (GO:0010810),0.3882016721928036,0.9234076152584066,0.6158940397350994,0.902279038148673,1.0,10/42,18.63%,THY1;PIK3CB;ATXN3;LIMS1;PTPRO;NF1;CORO1C;RHOA;CORO2B;MINK1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.3997511731058999,0.9231793401575917,0.5757575757575758,0.9023119920101914,1.0,3/29,4.61%,NT5C3B;CNOT8;EXOSC1
prerank,regulation of exosomal secretion (GO:1903541),0.43376721456117395,0.9231761086894349,0.5767741935483871,0.9019023079499298,1.0,6/19,20.78%,SMPD3;RAB7A;SDCBP;PDCD6IP;ATP13A2;PRKN
prerank,regulation of focal adhesion assembly (GO:0051893),0.3828778721665808,0.9227896015347138,0.6176154672395274,0.9022399474556785,1.0,15/54,17.75%,PTPRJ;THY1;DUSP3;MACF1;SLC9A1;ACTG1;VCL;LIMS1;NRP1;THBS1;SRC;PTPRA;PTEN;CORO1C;RHOA
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.40079436867392715,0.9225988911449122,0.5955188679245284,0.9021821303443971,1.0,4/28,6.55%,LGMN;APOE;AKAP5;TYROBP
prerank,stress granule assembly (GO:0034063),0.4247552707449282,0.922278861477866,0.5732484076433121,0.9023892701868784,1.0,5/20,16.67%,CIRBP;YTHDF3;DYNC1H1;ATXN2L;RPS23
prerank,carnitine shuttle (GO:0006853),0.47057371978701423,0.9220077683666537,0.5778097982708934,0.9024945255617047,1.0,3/11,16.91%,SLC25A20;ACACA;CPT2
prerank,cellular metal ion homeostasis (GO:0006875),0.3585538674830841,0.921878897118514,0.6643002028397565,0.9023417400014258,1.0,20/102,13.76%,CCR2;SLC8A1;CCL8;KCNMA1;SLC9A1;ATP2C1;TPT1;ATP2B1;CCL14;VAPB;NEDD4L;ATP13A1;SLC8B1;CCL13;CHERP;ATP2B3;NPTN;ATP1B3;ATP2A3;ATP1B2
prerank,epithelial cell-cell adhesion (GO:0090136),0.4710623802429039,0.9217695581033511,0.571625344352617,0.9021200894933953,1.0,2/11,9.76%,ITGB5;VCL
prerank,histone H4 deacetylation (GO:0070933),0.4762960692578979,0.9217484853548602,0.5894428152492669,0.9017434510710457,1.0,4/10,16.16%,RCOR1;HDAC4;HDAC9;SMARCAD1
prerank,mitochondrion disassembly (GO:0061726),0.39647325031974695,0.9214692237970176,0.5937846836847946,0.9018588658431105,1.0,10/34,22.33%,CTSK;ATG7;MAP1LC3B;FUNDC1;BECN1;ATG2B;ATG3;FIS1;PRKN;RB1CC1
prerank,RNA processing (GO:0006396),0.3561203577607981,0.9211400586210373,0.688376753507014,0.9020751467797384,1.0,45/176,21.65%,APOBEC1;IVNS1ABP;BCAS2;SF3B2;SF3B1;AURKAIP1;RBM39;TENT4B;SNRNP25;SCAF11;TFIP11;ZMAT5;SNRPD2;ADAR;PPARGC1A;HNRNPL;DDX39B;SON;RNASEL;LUC7L3;METTL3;PRPF8;PPP2CA;ADARB1;HNRNPD;ALKBH5;PPIG;AKAP8L;NUFIP1;NRDE2;TUT7;PABPC4;SLU7;RBMS2;HNRNPF;SNRNP35;SRSF2;PABPN1;SF3B3;TSEN2;DICER1;PTBP1;HNRNPA0;LIN28B;PDCD7
prerank,protein localization to cell-cell junction (GO:0150105),0.4428297655743085,0.9210316696710886,0.5706594885598923,0.901870298249577,1.0,4/15,9.97%,ARHGEF18;ACTB;ACTG1;F11R
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.3716194949297478,0.9207084562106375,0.6318565400843882,0.9020691600973869,1.0,8/62,8.26%,NFE2L2;CREB3;HERPUD1;BCL2L1;CREB3L1;EPO;SNAI1;TPT1
prerank,nuclear transport (GO:0051169),0.4427998139429905,0.9205161314668328,0.583547557840617,0.902003090801713,1.0,4/16,11.71%,XPO1;ANP32A;RBM15B;NUP205
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.44360413311802355,0.9204247590569171,0.6064690026954178,0.9017651266809323,1.0,8/14,24.65%,PIK3CD;VEGFB;NRP1;MYO1C;VEGFD;PIK3CA;VEGFA;KDR
prerank,snRNA metabolic process (GO:0016073),-0.32223167150645915,-0.9202128728205674,0.5528846153846154,0.9122381940242538,1.0,7/17,19.34%,INTS9;INTS10;MTREX;TUT1;INTS4;INTS2;MEPCE
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.43916756329616097,0.9198476756553163,0.6010709504685409,0.9024822527754268,1.0,2/18,6.34%,AQP1;ANXA1
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.2792884465306924,-0.9194856050304154,0.5862068965517241,0.9115807998215247,1.0,13/25,27.03%,ADK;DGUOK;GMPS;MTHFD1;PRPS2;AMPD3;GMPR;AMPD2;PAICS;ADSL;PPAT;PRPS1;PRPS1L1
prerank,endothelial tube morphogenesis (GO:0061154),0.48071283070204673,0.9192663974310779,0.6017441860465116,0.9031815306055535,1.0,3/10,6.29%,CCM2;PRKD2;CTNNB1
prerank,regulation of pseudopodium assembly (GO:0031272),-0.3735602153810963,-0.9189449227197122,0.5650793650793651,0.9078458131111999,1.0,4/10,22.81%,CDC42EP5;CDC42EP4;APC;WASHC1
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.3735602153810963,-0.9189449227197122,0.5650793650793651,0.9078458131111999,1.0,4/10,22.81%,CDC42EP5;CDC42EP4;APC;WASHC1
prerank,transcription by RNA polymerase II (GO:0006366),0.3556786972695773,0.9188677097776213,0.7527527527527528,0.9035500802304869,1.0,68/305,19.13%,ARRB2;PCID2;POU2F2;MED17;RREB1;GTF2H1;TAF1A;MAML3;NABP1;RXRB;NR1H4;EAF1;HDAC5;ELL2;TAF1;BTF3;TEAD1;TBL1XR1;LEO1;CSTF1;TRIP13;GMEB2;LSM11;INTS8;PPARGC1A;CDK7;NFX1;SETD2;RPAP2;NFIC;TBL1X;MED27;KLF13;POLR2L;TRIM24;TAF8;NR2C2;HDAC9;MBD1;PMF1;SNAPC3;ELL;NR4A1;MLLT1;NFKB1;INTS6;ELOF1;INTS13;NR2C1;MAF;ERCC6;TAF3;RBPJ;ZBTB7B;SNAPC4;GTF2B;ICE2;PPARD;NFYA;PCF11;INTS1;TCEA1;GTF2H5;RXRA;POLR2E;TAF11;ELOB;MED4
prerank,DNA replication (GO:0006260),0.36149142578701676,0.9187558448711878,0.6491405460060667,0.9033537944128083,1.0,18/105,13.79%,MCM5;FAM111A;ORC3;RMI1;EXO1;BRIP1;MCM6;MCM2;NAP1L1;DBF4;BAZ1A;ORC4;WDHD1;MCM9;KAT7;DNA2;MCMBP;CDC6
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.38566879122351694,0.9185244632409666,0.6120218579234973,0.9033749958949941,1.0,13/48,20.17%,ADCY7;SLC25A16;GUCY2F;ADCY6;SLC35B3;NPR2;PAPSS1;ADCY3;ADCY8;IMPDH2;PPCDC;ADCY9;NPPC
prerank,histone monoubiquitination (GO:0010390),-0.2826987723676989,-0.9182678676824104,0.6032608695652174,0.9070490922956499,1.0,7/24,12.26%,DDB2;RYBP;DDB1;TRIM37;PAF1;WAC;DTX3L
prerank,pre-replicative complex assembly (GO:0036388),0.37044076436576656,0.9180790864527215,0.6276150627615062,0.9038034340572292,1.0,13/64,15.61%,MCM5;ORC3;PSMB10;MCM6;MCM2;PSMA2;ORC4;PSME3;PSMB5;CDC6;PSMD8;PSMD7;PSMB9
prerank,cellular response to topologically incorrect protein (GO:0035967),0.39533212959572656,0.9179949354578998,0.5899198167239404,0.9035501720786331,1.0,7/31,13.60%,PTPN1;ERN1;ATXN3;BAK1;HSF1;HDAC6;STUB1
prerank,translation (GO:0006412),0.3551008435715834,0.9178209443354612,0.704,0.9034765524949443,1.0,77/208,25.74%,RPL23;RPL17;VARS1;RPL10A;RPS2;RRBP1;RPL18A;FARSB;MRPL41;GTPBP1;RPS15A;GSPT1;GATB;EIF4EBP2;GARS1;PPA2;MRPL51;RARS1;EPRS1;QARS1;RPL6;LARS2;RPLP2;RPL26;RPS20;RPS16;RPS14;DARS1;RPL19;RWDD1;DARS2;IGF2BP3;RPL9;TMA7;RPS11;RPL11;RPS23;FARS2;RPS4X;MRPS21;RPS27;AGO2;RPL4;MRPS14;PABPC4;MRPL3;RPL7A;RPL15;MRPL10;RPL29;AIMP1;RPL22;RPS7;TARS1;YARS1;RPS13;EEF1G;SARS1;SARS2;RPL22L1;RPLP1;RPS15;MRPL18;MRPL52;RPS5;RPL41;DRG2;GATC;RPL10;MRPL37;MRPS34;MRPS12;ABCF1;RPS8;RPL5;RPL18;EEF1A1
prerank,RNA destabilization (GO:0050779),0.42401504763064435,0.9176790671426466,0.5997442455242967,0.9033259445293828,1.0,9/18,25.87%,YTHDF3;ZC3H18;METTL3;MEX3D;ROCK2;FTO;LIN28B;DXO;PUM1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.37001267706111896,-0.9175734445969385,0.5504587155963303,0.9062269814782773,1.0,3/10,11.92%,NEXMIF;ACER2;JAM3
prerank,RNA transport (GO:0050658),0.3673468099727949,0.9173646589826989,0.6268343815513627,0.9035339569776196,1.0,20/71,21.24%,RFTN1;NUP62;DHX38;NXF1;THOC2;TGFBR2;CASC3;TPR;DDX39B;POLDIP3;UPF3B;RTRAF;THOC3;FLOT1;SLU7;SRSF6;SRSF2;SLBP;SRSF3;ZFP36L1
prerank,cellular response to UV (GO:0034644),0.36861662868395867,0.9173309873647331,0.6477857878475798,0.9031795938445251,1.0,15/76,16.44%,AQP1;PRKCD;TIMP1;TAF1;TP53;YY1;BAK1;IMPACT;RPL26;METTL3;INO80;BMF;NOC2L;COPS9;MFAP4
prerank,nucleotide-excision repair (GO:0006289),0.36382868987464806,0.9171601367451802,0.6626262626262627,0.9030787330400767,1.0,23/101,18.79%,COPS6;GTF2H1;PPIE;RNF111;BRIP1;LIG3;UVSSA;ATXN3;TP53;MMS19;CDK7;USP7;POLR2L;COPS4;SLX4;POLD3;ERCC5;ERCC6;OGG1;TCEA1;GTF2H5;ERCC1;POLR2E
prerank,negative regulation of cellular senescence (GO:2000773),-0.3375389031562313,-0.9165920203989087,0.5789473684210527,0.9061742183859197,1.0,6/13,24.19%,ZKSCAN3;YBX1;MAP3K3;HMGA2;TERT;TWIST1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.42696572320873416,0.9161256904523722,0.5863808322824716,0.9046240169092177,1.0,3/17,9.59%,HERPUD1;SEL1L;DERL1
prerank,negative regulation of developmental process (GO:0051093),0.3738413806451406,0.9157312004683531,0.6291666666666667,0.9049373425132626,1.0,18/69,21.54%,SHH;TGFB1;THY1;BCL11A;SPI1;RC3H1;SOX9;CDK6;GAS6;HUWE1;VAT1;SFMBT1;GREM1;KLF7;ROCK2;PRKN;ARPIN;PARP3
prerank,UV protection (GO:0009650),0.4766070834472635,0.9155030739500091,0.5833333333333334,0.9049809544475634,1.0,3/10,16.44%,SDF4;ERCC5;MFAP4
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.4173400013228939,0.9150211601087794,0.5978391356542617,0.9054863160045473,1.0,11/24,23.84%,TENT4B;STN1;TNKS2;SLX4;SRC;TINF2;TERF2;ERCC4;TEN1;PARP1;DCP2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.36028594160676664,-0.9149366964227577,0.5682539682539682,0.9078697588095607,1.0,4/11,18.09%,REST;PINK1;ATF4;PARK7
prerank,protein deacylation (GO:0035601),0.4143683836205789,0.9146893886907334,0.6049382716049383,0.9057258269961422,1.0,5/23,11.66%,HDAC5;ABHD17B;HDAC4;HDAC6;ABHD17C
prerank,regulation of cilium assembly (GO:1902017),0.3694811883250926,0.9138658314204907,0.6417281348788199,0.9069011045871842,1.0,18/62,19.19%,TBC1D10C;KCTD17;TBC1D16;TBC1D22A;USP6NL;TBC1D10A;TBC1D2;TBC1D17;TBC1D2B;TBC1D8;TBC1D14;TBC1D22B;ATG3;RABEP2;ENTR1;DYNC2LI1;TAPT1;TBC1D5
prerank,autophagy of mitochondrion (GO:0000422),0.38878947394425095,0.913339465751107,0.6070252469813392,0.9074768425616894,1.0,11/38,22.33%,CTSK;ATG7;MAP1LC3B;FUNDC1;BECN1;ATG2B;ATG3;ATG14;FIS1;PRKN;RB1CC1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.3523335284812483,-0.9132189943051647,0.564748201438849,0.9097335960846575,1.0,3/12,5.16%,SORBS1;IRS1;EPM2AIP1
prerank,protein palmitoylation (GO:0018345),0.39546606919979743,0.9124451202360211,0.5967365967365967,0.9087656945417448,1.0,8/30,15.36%,ZDHHC14;ZDHHC7;ZDHHC13;ZDHHC16;ZDHHC3;ZDHHC1;ZDHHC24;SELENOK
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.3717200129991636,-0.9120204742751579,0.5607476635514018,0.910171320278395,1.0,3/10,25.44%,FBXW7;HBEGF;EGF
prerank,regulation of exocytosis (GO:0017157),0.3736849606254609,0.911993894324466,0.6109913793103449,0.9092336089100109,1.0,6/46,11.02%,RAB8B;UNC13D;SNCA;ANXA1;SYTL4;ATP6AP1
prerank,regulation of mitochondrial fission (GO:0090140),0.4164637630266993,0.9110640821225527,0.6136363636363636,0.9105875968677647,1.0,8/24,20.78%,CYRIB;DDHD1;MYO19;LRRK2;DNM1L;FIS1;INF2;PRKN
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.3868076138327721,0.9110568029082216,0.6212121212121212,0.9101809012753292,1.0,5/45,12.29%,TGFB1;TGFBR1;HFE;INHBA;SDCBP
prerank,myelin assembly (GO:0032288),0.46614794181467845,0.9109354948931547,0.6125356125356125,0.9099762816385961,1.0,7/10,28.62%,CD9;DICER1;ABCA2;TENM4;CNTNAP1;PMP22;GPC1
prerank,protein complex oligomerization (GO:0051259),0.3630143693875462,0.9107912619305555,0.6363636363636364,0.9098422009467544,1.0,18/85,16.53%,CARD11;LRRC8D;SNCA;PKD2;PYCARD;SLC9A1;AQP11;ATL1;RNF135;NINJ1;TMEM120A;ADCY8;LRRC8C;TWNK;PDCD6IP;ALS2;ZNHIT6;YME1L1
prerank,regulation of centrosome duplication (GO:0010824),-0.26050724573394,-0.9098550450223489,0.625,0.9131331154845144,1.0,15/29,32.21%,CEP295;SPICE1;NAT10;CHMP5;CHMP4B;CENATAC;ALMS1;CEP120;CHMP2A;NPM1;STIL;CHMP4C;CEP295NL;CCNF;CHMP1B
prerank,atrioventricular valve development (GO:0003171),-0.33388783926950394,-0.9098274443336759,0.5800711743772242,0.9106893582924365,1.0,2/14,4.03%,BMPR1A;ACVR1
prerank,Rho protein signal transduction (GO:0007266),0.372015262405315,0.9094612760646066,0.624332977588047,0.9119834241456474,1.0,19/53,23.93%,MYO9B;GNA13;GNA12;RIPOR1;ARHGAP1;ARHGDIB;ADGRG1;ARHGEF3;ARHGDIA;ARHGEF11;RHOA;CDC42;CDC42EP3;RHOD;ROCK2;CFL1;RHOG;PDPN;EPS8L1
prerank,regulation of fibrinolysis (GO:0051917),0.4378039844097909,0.9092061854748013,0.5994318181818182,0.9120641152446342,1.0,2/13,11.24%,USF1;THBS1
prerank,regulation of cardiac conduction (GO:1903779),0.36894911201625896,0.9083739805078082,0.6353944562899787,0.9132494481405865,1.0,10/54,13.76%,KCNJ11;SLC8A1;ASPH;ATP2B1;ITPR2;NPR2;ATP2B3;ATP1B3;ATP2A3;ATP1B2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.44077993409806165,0.9082915422289775,0.5964187327823691,0.9129911034816127,1.0,2/14,9.54%,MAPK14;ANGEL2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4515979865827847,0.9079591055522006,0.5898801597869507,0.9132200751932591,1.0,3/12,16.50%,UBE2S;FZR1;PTEN
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.44473523172738305,0.907868650731373,0.5882352941176471,0.9129681027081452,1.0,3/15,6.91%,RENBP;NAGK;OGA
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.34535504514251447,-0.9075699223506695,0.5976095617529881,0.9137554456423839,1.0,4/14,6.34%,CPSF6;FIP1L1;CPSF7;CSTF2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4389212362093219,0.9075089845972016,0.5918367346938775,0.9132378191960258,1.0,2/14,7.24%,EHHADH;ABCD1
prerank,nucleic acid metabolic process (GO:0090304),-0.21092393635727713,-0.9070988092726121,0.7435897435897436,0.9123412713665023,1.0,27/69,28.29%,RBFOX2;NT5E;TOPBP1;DUSP11;HNRNPR;HNRNPA2B1;DDX24;METTL14;ATXN2;HNRNPA1;WRN;HNRNPU;EXD2;RBMX;HNRNPH2;POLG;RAN;POLR2C;DDX54;NCBP2;GTF2F1;PCBP2;SETMAR;POLR2J;PDE12;POLR2D;KPNA2
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.41505825044141836,0.9068021398870055,0.5893300248138957,0.9141277625652764,1.0,1/20,0.90%,TGFB1
prerank,gliogenesis (GO:0042063),0.42782942365871585,0.9061423312780408,0.5981055480378891,0.9149242595496718,1.0,4/15,12.44%,CD9;ANXA1;METTL3;CDK6
prerank,primary miRNA processing (GO:0031053),-0.36917278740404846,-0.9061034988751872,0.5723076923076923,0.9123141518059521,1.0,4/10,11.19%,DGCR8;HNRNPA2B1;SMAD1;PUS10
prerank,regulation of mRNA stability (GO:0043488),0.3533900441108717,0.9060360877878646,0.7105527638190955,0.9147053360253461,1.0,35/145,20.12%,SLC11A1;PCID2;PRKCD;EXOSC1;XPO1;ANP32A;CIRBP;YWHAB;FASTKD3;PSMB10;YTHDF3;RC3H2;LARP1;TENT5C;RC3H1;PUM2;FASTKD1;PSMA2;METTL3;PSME3;PSMB5;HNRNPD;PSMD8;IGF2BP3;PSMD7;PSMB9;THRAP3;MEX3D;PSMD2;GDNF;SERBP1;ROCK2;FTO;HSPB1;EXOSC3
prerank,tRNA wobble base modification (GO:0002097),-0.33652917402883387,-0.9060009199715037,0.6096654275092936,0.9100689357939719,1.0,5/14,20.80%,ELP3;ELP4;URM1;MTO1;DPH3
prerank,dicarboxylic acid transport (GO:0006835),-0.27678286145415726,-0.9059998791433286,0.589041095890411,0.9075848236953267,1.0,4/28,6.22%,SLC25A12;ARL6IP5;SLC26A7;SLC25A13
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.391538763658421,0.9058867200368933,0.5995260663507109,0.9145692921460223,1.0,5/31,17.14%,GCH1;DHRS11;PYCR2;PRLR;FDXR
prerank,aorta morphogenesis (GO:0035909),-0.3148017363616742,-0.9055921721240409,0.5877192982456141,0.9061763833008138,1.0,5/17,13.17%,BMPR1A;ACVRL1;TBX1;ADAMTS9;JAG1
prerank,regulation of cation channel activity (GO:2001257),0.35376863776442324,0.9052040064848916,0.6601239669421488,0.9154072195365701,1.0,7/89,8.10%,CTSS;PTK2B;FGF13;STAC;EPO;CACNB4;MEF2C
prerank,regulation of dendrite development (GO:0050773),0.392006934877503,0.9051787518141117,0.6095661846496107,0.9150349032935052,1.0,8/37,12.93%,CAMK1D;BCL11A;RAP2A;SEMA4D;TNIK;NEDD4L;CSMD3;LRP8
prerank,cellular response to virus (GO:0098586),0.39272126698185134,0.9051395314119723,0.6063454759106933,0.9146882607648332,1.0,6/30,18.99%,POU2F2;MAPK14;IRGM;HIF1A;HSP90AA1;RIOK3
prerank,lamellipodium organization (GO:0097581),0.4021117106451089,0.9050351997473948,0.6049237983587339,0.914481669391251,1.0,12/29,20.62%,ABLIM2;P2RY12;VCL;PARVB;CYFIP1;PTPRO;SNX2;ARFIP2;GOLPH3;ITGB1;RHOD;SPATA13
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.37050455905372354,0.9050163147759869,0.6407249466950959,0.9141037266996609,1.0,15/57,23.06%,ADCY7;PSAP;ADCY6;AKAP5;P2RY12;GPR37;ADCY3;ADCY8;GNAI3;RGS1;GNAI2;ADCY9;FLNA;MTNR1A;HTR1F
prerank,regulation of translation (GO:0006417),0.35537719426190095,0.9049896744871515,0.7337337337337337,0.9137378418360115,1.0,34/173,14.82%,NIBAN1;MTOR;DHX9;CNOT8;PLXNB2;FOXO3;EIF5B;CIRBP;GSPT1;YTHDF3;TRAP1;LARP4B;EIF1;LARP1;EPRS1;EIF4H;IMPACT;CPEB3;EIF2B2;RPL26;CTIF;EIF4G3;CYFIP1;THBS1;ZCCHC4;METTL3;PCIF1;POLDIP3;UPF3B;DDX1;HNRNPD;SOX4;PUM3;IGF2BP3
prerank,histone deacetylation (GO:0016575),0.38094879627915135,0.9048961822244111,0.6425438596491229,0.9135020000476364,1.0,11/43,16.16%,HDAC5;MTA3;TBL1XR1;RCOR1;MIDEAS;HDAC4;TBL1X;HDAC6;HDAC9;HDAC11;SMARCAD1
prerank,cellular response to pH (GO:0071467),0.420246768558673,0.9047573824303362,0.6028097062579821,0.9133379851233743,1.0,6/17,22.06%,SLC9A1;IMPACT;RAB11FIP5;MCOLN1;HVCN1;CHP1
prerank,cell-cell junction maintenance (GO:0045217),0.45602553224604897,0.9046799053089667,0.6014084507042253,0.9130735360123291,1.0,1/11,2.01%,CSF1R
prerank,regulation of actin filament-based process (GO:0032970),0.3604890037618675,0.9044398059277616,0.6322916666666667,0.9131011229890562,1.0,17/70,20.48%,IQGAP2;CORO1A;FZD10;PRKCD;MTOR;F11R;TWF2;ARHGAP18;LRP1;IQGAP1;RHOA;CORO2B;TAOK1;RHOD;ROCK2;ARHGEF19;CRK
prerank,cellular copper ion homeostasis (GO:0006878),0.44119763365581743,0.9043764423196352,0.611185086551265,0.9128010332921038,1.0,2/14,4.49%,ATP7A;ATOX1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.3675570098691956,0.9041311717924909,0.6232804232804233,0.9128198428030987,1.0,9/62,11.71%,TGFB1;DHX9;NUP62;TNRC6A;SEH1L;PUM2;TPR;POLR2L;NUP205
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.3360903027651715,-0.903268535225827,0.5528169014084507,0.9094401320760226,1.0,7/13,24.79%,PRPF3;PRPF19;LSM2;PRPF6;CD2BP2;SRSF12;PRPF31
prerank,amyloid precursor protein catabolic process (GO:0042987),0.44738891782955736,0.9030666144808102,0.6048714479025711,0.9144034829714913,1.0,2/14,4.53%,ABCG1;CLN3
prerank,response to ionizing radiation (GO:0010212),0.3634477276943261,0.9029008939118457,0.6565762004175365,0.9143104542105278,1.0,18/70,21.95%,GRB2;MAPK14;NABP1;TANK;BRAT1;ANXA1;TP53;BABAM2;INO80;IKBIP;BABAM1;SWI5;SMPD1;SPIDR;CLK2;BRSK1;RAD1;RFWD3
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.4137744999805439,0.9026839298789455,0.5809768637532133,0.9143266838106574,1.0,5/18,20.78%,NFE2L2;TRAP1;HIF1A;HSPB1;PRKN
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.3622002671929791,0.9026258661734553,0.6397058823529411,0.9140267193472645,1.0,9/66,14.04%,TGFB1;HCLS1;PRKCD;SMAD3;CCT8;MCRS1;TPR;KAT7;CCT5
prerank,negative regulation of DNA replication (GO:0008156),-0.3340076383788489,-0.9026125731162281,0.5953177257525084,0.9085397298792456,1.0,5/13,18.91%,RAD17;WAPL;TSPYL2;S100A11;CDAN1
prerank,synaptic vesicle localization (GO:0097479),-0.33218191344855375,-0.9022892385329152,0.5855513307984791,0.9069227349312847,1.0,5/13,15.76%,NLGN1;KIF5B;SYNDIG1;KIF5A;RAB27A
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.4255702988228412,0.9022821922626031,0.6062176165803109,0.9142700680754834,1.0,5/17,23.61%,IK;RB1;MIS12;KNL1;BUB3
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3784536684125844,0.9008930310277609,0.6057585825027686,0.9163838503814719,1.0,11/41,24.89%,ALOX12;DAGLB;ABCD1;DEGS1;FADS1;GSTM2;GPX4;ACOT8;SCD;FADS2;PTGS1
prerank,regulation of striated muscle contraction (GO:0006942),0.403372761003813,0.8994957982611496,0.6215895610913404,0.9185553195095533,1.0,4/27,8.17%,HCN4;MYL3;P2RX4;TNNT3
prerank,mRNA splice site selection (GO:0006376),-0.2509180512293573,-0.899484005044515,0.618421052631579,0.9112897682205573,1.0,16/30,34.39%,PSIP1;YTHDC1;SF3A1;SRSF1;PUF60;SNRPC;SRSF12;CELF4;CELF6;LUC7L;SF3A2;CELF5;LUC7L2;SF3A3;CELF2;SRSF9
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.34785931789134045,0.8990160835663548,0.779,0.9190239028538552,1.0,68/259,20.62%,FGD2;MKS1;RAB8B;P2RX7;RAP2A;EXOC6;ASAP1;IFT52;RAP1B;FGD6;RP2;MTSS1;AIF1;CNGB1;ABLIM2;BBS9;PLK4;ATP6V0D1;TNIK;P2RY12;DISC1;RAP2B;SNAP29;VCL;RAB11A;ACTR2;ACTR3;PARVB;CYFIP1;NRP1;HDAC6;PTPRO;EXOC8;WDR11;DYNC2I1;EXOC7;EXOC1;SDCBP;PCM1;EXOC2;IFT80;TXNDC15;EXOC5;RPGR;FNBP1L;ARF6;EXOC3;RAP1A;CEP162;FXYD5;AHI1;WDR90;ARFIP2;WDPCP;NUDCD3;SNX10;GOLPH3;ITGB1;MINK1;CCDC66;CLUAP1;RHOD;TMEM67;INPP5K;KIF3A;AIF1L;MAP4K4;SPATA13
prerank,diterpenoid metabolic process (GO:0016101),0.36637768051133096,0.8982139088674918,0.635483870967742,0.9201294955237151,1.0,8/55,15.03%,LPL;DHRS3;APOE;TTR;AGRN;ABCA4;LRP8;LRP1
prerank,monocarboxylic acid transport (GO:0015718),0.3704984244552446,0.8981006954087319,0.6413043478260869,0.9199184009515832,1.0,12/51,18.30%,SLCO2B1;ABCC3;NR1H4;ABCB4;SLC16A2;SLC16A1;SLCO1B1;CD36;SLC16A6;SLC16A13;STARD5;RXRA
prerank,mitochondrion transport along microtubule (GO:0047497),0.44077452713954524,0.897850650420309,0.6005398110661269,0.9199455057379575,1.0,1/13,1.14%,UXT
prerank,protein targeting to peroxisome (GO:0006625),0.3949690047048941,0.8969320683208138,0.6247113163972287,0.9212331749592388,1.0,5/29,11.57%,RAB8B;ABCD1;PEX13;PXMP2;PEX7
prerank,peptidyl-threonine modification (GO:0018210),0.36087126408512965,0.8968929766798246,0.649104320337197,0.9208816070399161,1.0,19/66,20.45%,TGFBR1;PRKCD;PRKD2;TAF1;TGFBR2;WNK1;CSNK2A2;CSNK2A1;NLK;MAP3K12;GALNT2;LRRK2;GSK3A;GALNTL6;GALNT1;PDPK1;ROCK2;CDK5R1;GSK3B
prerank,membrane lipid metabolic process (GO:0006643),0.4036855286553265,0.8968572019754968,0.6056511056511057,0.9205317506816265,1.0,5/22,14.79%,CERK;ST6GALNAC4;AGK;AGMO;ARV1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.20532523782163978,-0.8967888420652717,0.75,0.9154646200244615,1.0,29/88,22.47%,FBXL7;PSME4;PSMD11;PSMA5;PSMA4;RBX1;PSMD14;FBXL2;PSMC6;SKP2;PSMC3;FBXW7;PSMB3;PSMC1;PSMD5;CUL2;PSMA3;PSMD3;PSMD6;PSMC5;FBXO31;PSME2;FBXO17;PSMB4;FBXO38;PSMC4;SKP1;PSMB6;CUL1
prerank,muscle contraction (GO:0006936),0.3527747650456145,0.8967342318936768,0.7210473313192346,0.9203441530066094,1.0,18/126,14.40%,ITGB5;HCN4;MYL3;SLC8A1;TTN;KCNIP2;ASPH;MYL12A;TNNT3;TPM4;VCL;DTNA;DYSF;TLN1;TPM3;SMTN;DES;ARHGEF11
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3502201992706011,0.896638330967887,0.7207207207207207,0.9201024600900841,1.0,34/152,15.71%,TGFB1;GPRC5B;TLR2;ZEB2;DKK2;SKI;TNFAIP3;LGR6;FZD9;MACF1;PSMB10;TBL1XR1;WNK1;CSNK1G2;DISC1;CSNK2A1;GID8;SULF2;ATP6AP2;AMER1;TBL1X;PSMA2;TNKS2;PSME3;BAMBI;NFKB1;PSMB5;PSMD8;LRRK2;SOX4;USP8;PSMD7;PSMB9;LGR4
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.33140609607548926,-0.8965953099156097,0.5693430656934306,0.9134084052037337,1.0,3/13,5.16%,SORBS1;IRS1;EPM2AIP1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.4012692114459202,0.8965243602828192,0.6262135922330098,0.919892974184135,1.0,4/24,10.00%,TSPO;ATP5IF1;SLC25A38;NFE2L1
prerank,regulation of protein polymerization (GO:0032271),0.3826543683815059,0.8964467647145735,0.6312785388127854,0.9196262181320686,1.0,9/35,18.71%,HCLS1;PFN2;PFN1;COTL1;ARHGAP18;RASA1;CAMSAP2;HSP90AA1;GBA2
prerank,negative regulation of cell death (GO:0060548),0.354433988638418,0.8962641432800053,0.6885919835560124,0.9195435843218689,1.0,25/88,22.07%,GPNMB;CD200R1;NUP62;SNCA;TRAF2;PPARGC1A;IMPACT;BECN1;PARP16;TNFRSF1B;FYN;SORL1;IKBKG;WFS1;LRRK2;SOX4;NPAS2;TIGAR;SRSF6;NENF;ATP13A2;GSK3B;PRKN;FGF2;MT3
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.36106039725084776,0.8962146389639137,0.670442842430484,0.919222597555131,1.0,16/72,18.79%,COPS6;GTF2H1;PPIE;LIG3;UVSSA;CDK7;USP7;POLR2L;COPS4;POLD3;ERCC5;ERCC6;TCEA1;GTF2H5;ERCC1;POLR2E
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.3432676940745214,-0.8960531601602404,0.5667870036101083,0.9121950993040356,1.0,3/12,7.48%,UNC13B;RIMS2;SYT7
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.389204719325398,0.8959291350761492,0.6564625850340136,0.9193267120465131,1.0,9/35,16.35%,PCDHB6;ATP2C1;CDH8;CDH9;CDH12;CDH23;DCHS1;CDH19;PCDHGB4
prerank,response to UV (GO:0009411),0.3567362781627264,0.8956443691631191,0.6952479338842975,0.9194547849408973,1.0,21/95,16.44%,AQP1;PRKCD;SDF4;TAF1;CIRBP;UVSSA;TP53;USF1;POLH;YY1;BAK1;UBE4B;RPL26;METTL3;INO80;BMF;NOC2L;ERCC5;ERCC6;COPS9;MFAP4
prerank,protein neddylation (GO:0045116),-0.341044819457943,-0.895057378799261,0.5956678700361011,0.9121196662121304,1.0,6/13,18.17%,DCUN1D4;RBX1;NAE1;UBA3;DCUN1D3;UBE2M
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.34532885202204444,-0.8947630200038994,0.6038461538461538,0.9103191337102294,1.0,7/12,25.95%,RAD17;TOPBP1;STK33;NAE1;CLSPN;SETMAR;ORC1
prerank,negative regulation of cellular component movement (GO:0051271),0.4272816846248352,0.8947272288425928,0.6126855600539811,0.9207196339654684,1.0,3/15,10.21%,CD9;SPINT2;ACTN1
prerank,apoptotic nuclear changes (GO:0030262),0.40183277882414753,0.8945946239361716,0.6154776299879081,0.9205234711079945,1.0,11/24,27.66%,ACIN1;HMGB1;TOP2A;KPNA1;DICER1;DNASE2;DFFB;CECR2;CDK5RAP3;KPNB1;HMGB2
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.38380045744153324,0.8944437683164108,0.6129032258064516,0.9203861493635803,1.0,3/31,4.61%,NT5C3B;CNOT8;EXOSC1
prerank,peroxisomal membrane transport (GO:0015919),0.4026075565250563,0.8942816355024933,0.6270983213429256,0.9202646497575849,1.0,5/27,11.57%,RAB8B;ABCD1;PEX13;PXMP2;PEX7
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.3456309154160584,0.8934163563059758,0.789,0.9214188603476962,1.0,100/306,26.26%,MCM5;FAM111A;ORC3;RPL23;RPL17;RPL10A;GCNT1;APOE;RPS2;RMI1;EXO1;RRBP1;RPL18A;BRIP1;FARSB;MRPL41;MEF2A;GTPBP1;RPS15A;GSPT1;EIF4EBP2;MMS19;MRPL51;RPL6;FUT9;MCM6;MCM2;NAP1L1;DBF4;RPLP2;RPL26;INHBA;RPS20;POLR2L;RPS16;ORC4;MCM9;RPS14;KAT7;DNA2;DARS1;RPL19;CDC6;POLD3;IGF2BP3;RPL9;LARGE1;RPS11;RPL11;RPS23;RPS4X;MRPS21;RPS27;AGO2;RPL4;MRPS14;PABPC4;CREBL2;GOLPH3;RNASEH2A;MRPL3;POLR2E;TOP1;FUBP3;RPL7A;RPL15;MRPL10;RPL29;CDC45;RPL22;RPS7;RAD1;RPS13;EEF1G;SARS1;RPLP1;POLR3A;RPS15;MRPL18;MRPL52;RPS5;ATR;RPL41;PAX8;PWP1;RPA1;RPL10;MRPL37;XAB2;MRPS12;ABCF1;RPS8;RPL5;EXT2;RPL18;EEF1A1;ING5;RPL28;PTMA;MRPS15
prerank,circulatory system development (GO:0072359),0.3506413756145039,0.8933571180648381,0.6956521739130435,0.9211120246312094,1.0,24/118,16.50%,SHH;TGFB1;SH3PXD2B;TGFBR1;EEF1AKMT4-ECE2;PKP2;PKD2;ADAP2;TGFBR2;MEF2A;LDB3;MEF2C;ZDHHC16;SMYD4;SOX9;WDR11;HDAC9;TAB2;CASP8;SOX4;PDLIM1;POU6F1;NF1;PTEN
prerank,negative regulation of cartilage development (GO:0061037),0.43878891744653004,0.8931462508543508,0.6104252400548696,0.9210572202242301,1.0,3/13,18.40%,TGFBR1;SOX9;GREM1
prerank,phosphatidylcholine catabolic process (GO:0034638),0.46053792638006796,0.8930999836488303,0.6105417276720352,0.9207314665987819,1.0,4/10,23.25%,PLA2G7;LIPC;PLA2G5;PLA2G6
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.34702708297022594,0.8929187677410048,0.7064220183486238,0.920666287275364,1.0,30/107,22.27%,SLC11A1;CCR2;SLC8A1;CCL8;ATP2C1;TPT1;ATP2B1;CCL14;VAPB;ATP13A1;SLC8B1;CCL13;CHERP;ATP2B3;NPTN;ATP2A3;TMEM165;ATP13A5;ATP13A2;SLC39A6;SLC10A7;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,purine ribonucleotide catabolic process (GO:0009154),0.39949557964966975,0.8925813855826666,0.6063694267515923,0.9208590282653842,1.0,4/21,8.29%,XDH;NUDT4;HINT1;PNP
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.2572537017051857,-0.8924802888899975,0.631578947368421,0.9133439260357405,1.0,11/30,19.98%,OGT;RYBP;N4BP1;USP14;TRIM39;WAC;CCAR2;NOP53;PARK7;UCHL5;DDRGK1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.41795380042254426,0.892196992508714,0.614702154626109,0.921156995519345,1.0,8/17,25.03%,FZD9;BCL2L1;BAK1;TIMM50;DNM1L;FIS1;BID;MFF
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.3857562445021492,0.8921360800741286,0.5889929742388759,0.9204346660952413,1.0,11/29,23.99%,CENPO;RBBP7;CENPI;CENPQ;CENPK;RSF1;RBBP4;ITGB3BP;SMARCA5;KNL1;CENPT
prerank,CENP-A containing chromatin organization (GO:0061641),0.3857562445021492,0.8921360800741286,0.5889929742388759,0.9204346660952413,1.0,11/29,23.99%,CENPO;RBBP7;CENPI;CENPQ;CENPK;RSF1;RBBP4;ITGB3BP;SMARCA5;KNL1;CENPT
prerank,spliceosomal complex assembly (GO:0000245),0.3739286089135663,0.8919018962853545,0.6435643564356436,0.9204272214105536,1.0,12/46,20.34%,SF3B1;SCAF11;GCFC2;SRPK3;SNRPD2;DDX39B;LUC7L3;DDX1;CRNKL1;SNRNP200;SRSF6;SRSF10
prerank,regulation of potassium ion transport (GO:0043266),0.38055060762112325,0.8915636410795064,0.6331018518518519,0.9206306635724024,1.0,2/31,4.32%,PTK2B;KCNIP2
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.45113782923004697,0.8914691799670104,0.6064425770308123,0.9203746954018253,1.0,2/11,5.93%,RENBP;NAGK
prerank,positive regulation of axonogenesis (GO:0050772),0.3726679051889494,0.8914435557689302,0.6428571428571429,0.9200106276402752,1.0,5/43,6.18%,PLXNC1;SLITRK1;SEMA4D;PLXNB2;MACF1
prerank,endoplasmic reticulum organization (GO:0007029),0.35538046544525986,0.8911669762254505,0.668054110301769,0.9200855144539491,1.0,23/72,20.78%,LMAN1L;REEP6;VAPB;TMCC1;BNIP1;ATL1;CYB5A;SEC16A;SEC16B;STX5;TOR1AIP2;LRRK2;GAK;UBE2J2;CCDC47;RTN4;LMAN2;TMEM170A;ATL2;DNM1L;ATL3;SEC31A;SPTSSB
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.3765069897032792,0.8910301174207136,0.648741418764302,0.9199287358372074,1.0,4/37,8.10%,P2RY6;ERN1;LDLRAP1;MEF2C
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.442988134670483,0.8909699195073845,0.6031294452347084,0.9196249495803211,1.0,3/12,16.29%,TNF;UVRAG;IRGM
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.3513811314290625,0.8899448226050242,0.6818181818181818,0.9210250228008628,1.0,19/85,17.93%,ARRB2;FZD3;PSMB10;AP2S1;DAAM1;PSMA2;PFN1;CLTC;PSME3;PSMB5;PSMD8;AP2M1;PSMD7;PSMB9;VANGL1;SMURF1;RHOA;PSMD2;CDC42
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.34552533958624065,0.8899329154987663,0.75678391959799,0.9206353728213487,1.0,24/159,16.35%,CD84;ITGAL;ITGB2;PCDHB6;CRTAM;SLITRK1;PLXNB2;EMB;TGFBR2;TRO;ATP2C1;ITGAM;CDH8;CDH9;CDH12;NPTN;CDH23;PTPRT;CADM1;KIRREL3;MPZ;DCHS1;CDH19;PCDHGB4
prerank,phospholipid biosynthetic process (GO:0008654),-0.24407096054221958,-0.8890101248929357,0.6594202898550725,0.9191377249060875,1.0,12/36,16.30%,FAR1;SAMD8;AGPAT4;AGPAT3;SGMS2;AGPAT5;NUS1;CPNE3;HDHD5;SRD5A3;CRLS1;MBOAT1
prerank,negative regulation of cell aging (GO:0090344),-0.3059372297326701,-0.8882603251131802,0.6036036036036037,0.9184967002565394,1.0,7/16,27.98%,ZKSCAN3;YBX1;MAP3K3;HMGA2;TERT;TWIST1;MIF
prerank,regulation of cellular metabolic process (GO:0031323),0.36932387212373974,0.8879380213667555,0.6518438177874186,0.923779295644444,1.0,14/45,21.23%,NPC2;ABCG1;TBC1D16;PARL;COQ7;STUB1;PID1;FASN;ACACA;LAMTOR1;FLOT1;MPV17;PRKN;ABCA2
prerank,synaptic vesicle exocytosis (GO:0016079),0.3760926975981948,0.8875927455905115,0.6347438752783965,0.9239840815238983,1.0,12/40,21.09%,SNCA;PIP5K1C;STX11;SYT2;SYT10;SNAP29;STX3;SNAP23;DNAJC5;STX2;UNC13A;RIMS1
prerank,oligosaccharide metabolic process (GO:0009311),0.37084677094860014,0.8875158538157245,0.6510869565217391,0.923707976932176,1.0,7/46,10.45%,ST8SIA4;B4GALT1;ST6GALNAC4;MAN2B1;MAN2B2;FUT9;ST8SIA1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.25790965747308325,-0.8873579384645407,0.631578947368421,0.9183475247232158,1.0,19/31,33.30%,DNAJC19;TIMM17A;PEX5;GRPEL2;PEX6;PEX14;TOMM70;TIMM23;PAM16;PEX26;TIMM21;PEX10;ROMO1;GRPEL1;HSPD1;PEX16;DNLZ;AIFM1;TOMM40L
prerank,cellular modified amino acid catabolic process (GO:0042219),0.42494985272086266,0.8870768297317279,0.6174582798459564,0.9240771953689096,1.0,1/15,2.36%,ABHD12
prerank,response to glucose (GO:0009749),0.37045268812041654,0.8870683585573957,0.6805708013172338,0.9236801979769531,1.0,10/46,16.81%,LPL;PFKL;ERN1;EIF2B2;THBS1;TRA2B;GAS6;ADCY8;SOX4;GCK
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.34419229865847467,-0.8869514455158678,0.6062717770034843,0.9169115501956817,1.0,2/11,4.70%,CAV1;ACTN2
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.399292692537698,0.8869242156847877,0.6302021403091558,0.9235448266081424,1.0,1/26,0.31%,PTK2B
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.2609178690887083,-0.8868915658106374,0.631578947368421,0.9146871141596401,1.0,12/29,26.44%,ACSL1;HACD1;ELOVL5;ACSL6;ACLY;PPT1;CBR4;ELOVL1;ACSBG1;HACD2;ACSL4;ACSL3
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.3616674098868282,0.8863640861437384,0.6741693461950696,0.9241336881005858,1.0,16/59,20.45%,TGFBR1;PRKCD;PRKD2;TAF1;TGFBR2;WNK1;CSNK2A2;CSNK2A1;NLK;MAP3K12;LRRK2;GSK3A;PDPK1;ROCK2;CDK5R1;GSK3B
prerank,regulation of mRNA processing (GO:0050684),0.3839918060737897,0.8860093278244908,0.6393063583815028,0.9243500899401054,1.0,15/32,25.80%,DHX9;RBM39;CDK11B;SRPK3;SON;SAFB2;PABPN1;SRSF10;SRSF3;ZFP36L1;IWS1;NCBP1;HNRNPK;CPSF4;JMJD6
prerank,positive regulation of ion transport (GO:0043270),0.36590866606126804,0.8858652957991364,0.6516129032258065,0.9241908808027195,1.0,12/48,19.29%,SCN4B;P2RX7;PKP2;P2RX4;PRSS8;ATP2B1;CACNB2;WFS1;CACNA1D;SCN5A;CNKSR3;GDNF
prerank,pharyngeal system development (GO:0060037),-0.3200676507189906,-0.8858010755449031,0.6514522821576764,0.9149483123679332,1.0,5/15,12.21%,BMPR1A;BMP4;BMP5;HES1;TBX1
prerank,organelle assembly (GO:0070925),0.34103482543203195,0.8856488324019482,0.832,0.9241617606457664,1.0,84/384,19.46%,BIN2;MKS1;RAB8B;SH3PXD2B;CORO1A;RAB32;NUP62;HAUS2;VTA1;NEK6;ATG7;EXOC6;ASAP1;MAP1LC3B;IFT52;RAB7A;CDS2;FLII;CIRBP;RP2;MAPRE1;CNGB1;BBS9;PLK4;YTHDF3;ATP6V0D1;VMP1;STARD9;DISC1;RC3H1;HAUS1;SNAP29;EMC6;RAB11A;TUBGCP6;TUBGCP4;ACTR2;RAB1B;ACTR3;VPS37C;HDAC6;BECN1;EXOC8;WDR11;DYNC2I1;DYNC1H1;EXOC7;EXOC1;PCM1;EXOC2;IFT80;TXNDC15;EXOC5;RPGR;FNBP1L;TRAPPC6A;INO80;SYNPO;EXOC3;HAUS8;CAPN3;CEP162;ATXN2L;ABCA3;AHI1;WDR90;PDCD6IP;ATG2B;IRGM;ATG3;RPS23;VPS28;WDPCP;NUDCD3;MIS12;CEP63;SNX10;MAPRE2;UBXN2A;ATG14;PACS2;TMEM41B;CCDC66;CLUAP1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.40624593555503585,0.8856000474189982,0.6081946222791293,0.9238409852094076,1.0,5/18,19.29%,TNF;ATP7A;NOD2;POR;GDNF
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.4403283022799102,0.8851125080810232,0.6222222222222222,0.9242616736144726,1.0,6/13,19.44%,EDEM1;SVIP;UBE2G2;EDEM2;ERLEC1;OS9
prerank,bicarbonate transport (GO:0015701),0.401290489045627,0.8847660750986054,0.6187050359712231,0.9244488503758114,1.0,3/25,12.09%,AQP1;CYB5R1;CYB5RL
prerank,regulation of organelle organization (GO:0033043),0.3547380023400121,0.8847588896300514,0.6804123711340206,0.9240505455623521,1.0,24/80,21.44%,MYO5A;ZEB2;ARMH3;RBSN;CLN3;USP6NL;VPS11;F11R;DIAPH1;PARL;STX5;SAR1A;RAB33B;CAPN2;CAMSAP2;AKAP9;GOLPH3;TAOK1;DNM1L;FIS1;ATP13A2;PRKN;PDE4DIP;SCARB2
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.28748288904766284,-0.8845759118986187,0.6542553191489362,0.9153992031331014,1.0,6/20,16.06%,B3GALT5;ST3GAL4;ST6GALNAC6;MPDU1;ST3GAL3;B3GALT1
prerank,response to insulin (GO:0032868),0.3518307025529022,0.8845327186130069,0.696875,0.9240479391046573,1.0,21/80,21.24%,PCSK9;RAB8B;LPIN2;MYO5A;HDAC5;USF1;RAB31;EPRS1;DENND4C;HDAC9;GSK3A;SYAP1;ZBTB7B;CPEB2;GCK;PDPK1;SORT1;INPP5K;PKM;LPIN1;ZFP36L1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3554507298735846,0.8840561275892744,0.6838235294117647,0.9244987103028175,1.0,18/69,18.83%,POU2F2;NABP1;ELL2;INTS8;CDK7;RPAP2;POLR2L;TAF8;SNAPC3;ELL;INTS6;INTS13;SNAPC4;GTF2B;ICE2;INTS1;POLR2E;TAF11
prerank,snRNA transcription (GO:0009301),0.3548858688172597,0.883781854992289,0.6812957157784744,0.9245681786359276,1.0,18/70,18.83%,POU2F2;NABP1;ELL2;INTS8;CDK7;RPAP2;POLR2L;TAF8;SNAPC3;ELL;INTS6;INTS13;SNAPC4;GTF2B;ICE2;INTS1;POLR2E;TAF11
prerank,steroid hormone biosynthetic process (GO:0120178),0.38703917211115635,0.8833000651158921,0.6307151230949589,0.9250228621312644,1.0,8/29,26.30%,TSPO;HSD17B11;FDXR;FDX1;STARD3;HSD17B8;MED1;STARD3NL
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.2847605831135184,-0.8830937334780944,0.6310160427807486,0.9165962033147826,1.0,5/20,16.59%,WNT4;NCOR1;SIK1;C1QTNF3;BCKDK
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.39325348116897935,0.8830317541723884,0.6484560570071259,0.9250743250430725,1.0,15/27,31.18%,BRD8;KAT7;NAA50;PHF20;MORF4L2;MORF4L1;TAF6;KAT5;CREBBP;EP300;SGF29;MRGBP;KAT6A;BAG6;KAT8
prerank,"base-excision repair, AP site formation (GO:0006285)",0.42404971163660077,0.8829330052054928,0.6384915474642393,0.9248279623124737,1.0,6/17,22.85%,NEIL2;ERCC5;OGG1;TINF2;TERF2;TERF2IP
prerank,positive regulation of ruffle assembly (GO:1900029),0.4361162112370839,0.8829241513676744,0.6229508196721312,0.9244352626449472,1.0,3/13,11.10%,PLEKHM1;P2RY12;PFN1
prerank,axonemal dynein complex assembly (GO:0070286),0.3873998211588397,0.8827541793655249,0.6390887290167866,0.9243345311889553,1.0,4/27,13.03%,DNAI4;ODAD2;ODAD1;CCDC63
prerank,regulation of peptidase activity (GO:0052547),-0.2969542130206858,-0.8826766225732717,0.6197183098591549,0.915174206930478,1.0,6/19,13.60%,CAV1;NRDC;PINK1;ECM1;MAPK12;PSMA3
prerank,DNA alkylation (GO:0006305),0.402782459691557,0.8820602575110048,0.6350832266325224,0.9247328256875781,1.0,3/19,9.69%,DNMT3A;ATRX;ATF7IP
prerank,DNA methylation or demethylation (GO:0044728),0.402782459691557,0.8820602575110048,0.6350832266325224,0.9247328256875781,1.0,3/19,9.69%,DNMT3A;ATRX;ATF7IP
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.4147130245125903,0.8820317857918654,0.6234979973297731,0.924372115236341,1.0,3/16,8.26%,BCL2L1;SNAI1;TPT1
prerank,ribosomal small subunit assembly (GO:0000028),0.41579376254395134,0.8819438857588449,0.633248730964467,0.9241199259267904,1.0,7/16,23.92%,XRCC5;ERAL1;RPS14;RPS27;RRP7A;RPS15;RPS5
prerank,cellular response to gamma radiation (GO:0071480),0.41661561418860893,0.8812604180535888,0.6253263707571801,0.9249490494220037,1.0,4/17,10.47%,XRCC5;TP53;HSF1;RPL26
prerank,regulation of cellular component biogenesis (GO:0044087),0.368807149927428,0.8808550308777071,0.6475138121546962,0.9252151961831995,1.0,14/39,19.65%,APOE;TRAF2;RAP1B;VPS11;GFAP;RAPGEF1;HCFC1;RAP1A;SPTY2D1;CD36;IRGM;HSP90AA1;PARP10;ROCK2
prerank,regulation of blood circulation (GO:1903522),0.38481686775986923,0.8802902771551003,0.6655172413793103,0.9258269860749908,1.0,2/34,4.32%,TMIGD3;KCNIP2
prerank,cellular response to growth factor stimulus (GO:0071363),0.3420971152102136,0.8801324289006525,0.7449799196787149,0.9257106303765406,1.0,27/151,13.61%,TGFB1;LGMN;TGFBR1;DUSP3;DSTYK;MAPK14;ERN1;PRKD2;CD44;MAP2K3;CTNNB1;ANXA1;TGFBR2;MEF2C;SMAD3;ACAP2;BCAR1;STAT5B;RAPGEF1;LIMS1;SOX9;NRP1;CCL2;VSTM2A;TWF2;NR4A1;SOX6
prerank,protein acetylation (GO:0006473),-0.2600904530874288,-0.8799842000562764,0.6482758620689655,0.9189465215446089,1.0,10/30,22.07%,ESCO1;CLOCK;NAT10;HAT1;MAPT;NAA60;ING4;NAA35;SPHK1;KAT2B
prerank,chromatin remodeling at centromere (GO:0031055),0.375189596787649,0.879480417803369,0.6098964326812428,0.9264165248238572,1.0,11/31,23.99%,CENPO;RBBP7;CENPI;CENPQ;CENPK;RSF1;RBBP4;ITGB3BP;SMARCA5;KNL1;CENPT
prerank,regulation of necroptotic process (GO:0060544),0.40376784244578406,0.8791931647356614,0.6658566221142163,0.9265181007651431,1.0,11/23,20.84%,FZD9;CFLAR;SDCBP;CASP8;STUB1;PDCD6IP;HSP90AA1;ARHGEF2;BIRC2;FLOT1;BIRC3
prerank,tRNA methylation (GO:0030488),-0.24660841597178348,-0.8789559042300487,0.6747967479674797,0.9189541741192431,1.0,17/34,32.91%,NSUN6;METTL6;THADA;THUMPD3;NSUN2;TARBP1;DALRD3;MTO1;TRMT5;LCMT2;WDR6;TRMT44;TRMT13;TRMT10C;TYW3;TRMT12;TRMT112
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.43547726438383705,0.8786966641481583,0.6267409470752089,0.9270203690764232,1.0,2/13,4.79%,LGMN;AKAP5
prerank,heterochromatin assembly (GO:0031507),-0.29031307714899446,-0.8783124431421707,0.6341463414634146,0.9180597016090043,1.0,2/20,4.79%,SMCHD1;EZH1
prerank,regulation of cellular response to heat (GO:1900034),0.35376928973051347,0.8782130044113198,0.7005235602094241,0.9274215922060697,1.0,21/77,21.15%,BAG2;MTOR;PTGES3;NUP62;DNAJC7;HSBP1;SEH1L;HSF1;TPR;NUP205;CHORDC1;BAG1;IER5;HSP90AA1;DNAJB6;RPTOR;SEC13;GSK3B;NUP54;BAG4;CRYAB
prerank,amino sugar biosynthetic process (GO:0046349),0.4383514370421322,0.8779302017069303,0.6269070735090153,0.9275162780779022,1.0,2/12,5.93%,RENBP;NAGK
prerank,cellular response to leucine starvation (GO:1990253),0.4485029587947322,0.8775777719320883,0.6212765957446809,0.9277298745518366,1.0,4/10,21.78%,MTOR;IMPACT;GCN1;RRAGB
prerank,regulation of actomyosin structure organization (GO:0110020),0.43047912900850493,0.8772506899672778,0.6291012838801712,0.9278662412728546,1.0,5/13,19.65%,FHOD1;SLC9A1;ACTG1;CDC42;ROCK2
prerank,protein import into mitochondrial matrix (GO:0030150),-0.292574846707165,-0.8771822881446999,0.6600985221674877,0.9183846226033158,1.0,11/18,33.30%,DNAJC19;TIMM17A;GRPEL2;TOMM70;TIMM23;PAM16;TIMM21;ROMO1;GRPEL1;DNLZ;TOMM40L
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.316784902442962,-0.8771229224200215,0.6111111111111112,0.9161488445007293,1.0,4/15,6.77%,RAPGEF3;TCF7L2;ANP32B;BAG3
prerank,regulation of cell aging (GO:0090342),0.45049936912626776,0.8767055912392544,0.644793152639087,0.9284285079502709,1.0,1/11,3.66%,NEK6
prerank,positive regulation of viral process (GO:0048524),0.3528903793567957,0.8763914081340572,0.6706392199349945,0.9285748007330007,1.0,13/60,18.79%,DHX9;PPIE;RAB7A;ADAR;LARP1;MDFIC;VAPB;POLR2L;ADARB1;TARBP2;RSF1;PPIH;POLR2E
prerank,glutathione metabolic process (GO:0006749),0.3725913637283913,0.8762972628837492,0.6299212598425197,0.9283304149848904,1.0,2/38,3.21%,GSTT4;HPGDS
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.4115892551468604,0.8762545045656998,0.6183310533515732,0.9279967448083584,1.0,6/14,22.06%,ACTN4;WNK1;SLC9A1;WNK4;TESC;CHP1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.3800235298714569,0.8759633714448334,0.648235294117647,0.9280985293033741,1.0,8/32,18.19%,MTOR;MLXIPL;APOE;ADIPOR1;CREB1;ADIPOR2;ASAH1;CREBL2
prerank,mitochondrion localization (GO:0051646),0.41114904244611,0.8757455375114929,0.6043533930857875,0.9280820454492414,1.0,9/19,25.46%,BRAT1;MEF2A;MSTO1;ATCAY;LRRK2;MFN1;MARK1;MARK2;TRAK1
prerank,regulation of neuron projection development (GO:0010975),0.34353084431919284,0.875693672018738,0.7600401606425703,0.9277650929800129,1.0,42/163,22.07%,PTK2B;LYN;MYLIP;CAMK1D;ARSB;MDK;RTN4RL1;ITGA6;APOE;PLXNB2;ADCY6;CBFA2T2;DISC1;FUT9;RAPGEF1;PTPRO;CSMD3;TWF2;NPTN;LZTS3;ATP1B2;TANC2;LRRK2;RAP1A;GAK;GSK3A;CAMSAP2;EPHA4;PTEN;DENND5A;PAQR3;KIDINS220;RAB29;RELN;CDK5R1;GSK3B;MARK1;BRSK1;SCARB2;CX3CL1;CFL1;MT3
prerank,dorsal/ventral pattern formation (GO:0009953),0.409233499136749,0.8755863770285536,0.6290726817042607,0.9275444950356626,1.0,1/20,0.68%,SHH
prerank,cellular amide metabolic process (GO:0043603),0.3454595970012098,0.8754449664735421,0.7182095625635809,0.9273806341180408,1.0,21/102,17.81%,DBI;SGPL1;MTHFS;CLN8;SMPD3;CERK;ST3GAL1;ACSF2;ABHD4;NLN;MCCC2;DNPEP;ORMDL2;PPP2CA;NSMAF;PDZD11;ACOT9;PLAAT3;FPGS;ACOT2;PCCA
prerank,purine-containing compound salvage (GO:0043101),-0.33608873495787717,-0.8749946125215751,0.6095890410958904,0.9187205745932807,1.0,5/12,18.07%,ADK;DGUOK;AMPD3;GMPR;AMPD2
prerank,cellular response to cadmium ion (GO:0071276),-0.2759246545394427,-0.8743331927803166,0.6079545454545454,0.9178920287543215,1.0,4/24,9.25%,MAPK8;EGFR;MAPK9;CHUK
prerank,mucosal immune response (GO:0002385),0.4182730611426736,0.8742091320741371,0.6157826649417852,0.9290865237078202,1.0,2/15,12.29%,FFAR2;DEFA6
prerank,protein modification by small protein conjugation (GO:0032446),0.3382792132412082,0.8735776216540644,0.853,0.9297587811758397,1.0,98/361,23.54%,ARRB2;NFE2L2;CBL;MYLIP;BCL11A;UBE2V2;NUP62;TRIM5;ATG7;MKRN1;CDC23;UBE2D3;OTULIN;MSL2;VPS18;MGRN1;RNF7;HLTF;RNF111;KLHL21;UVSSA;UBE2S;LEO1;KLHL7;SEH1L;VPS11;TRIM27;UBE2E3;PEX13;DERL1;NFX1;NEDD4L;UBE2H;TPR;USP7;TRIM24;RNF40;TRIM35;NUP205;CDC34;DET1;FBXO32;ARRDC4;FBXL3;RNF135;ITCH;UBE2G2;STUB1;HUWE1;UBA2;USP9X;AREL1;UBE2J2;DTX4;RNF152;PIAS1;GAN;SMURF1;HIF1A;ATG3;UBE2N;TRIM62;ZNRF3;ANAPC11;VHL;UBE2Z;UBE2K;KEAP1;DCUN1D5;SPSB2;ELOB;OS9;WWP1;FBXW11;CUL3;LZTR1;PRKN;UBE2R2;NUP54;HERC2;NSMCE2;RRAGA;CDC16;RFWD3;ELOC;UBE2E1;ATG10;TNFAIP1;SPSB1;UBA7;EIPR1;FBXO4;CTR9;RACK1;MYCBP2;NUP85;RNF181;UBE2I
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.38408380553477506,0.8731455509537673,0.6636871508379888,0.9301149387696998,1.0,8/33,16.65%,PLCG2;TAF1;KIF14;PSME3;INO80;PTEN;STXBP4;APPL2
prerank,Rac protein signal transduction (GO:0016601),0.40987303335001835,0.8729930325189227,0.6265984654731458,0.9299654708662234,1.0,3/18,11.18%,ELMO1;AIF1;CYFIP1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.4202869554911199,0.8729242879070045,0.6215469613259669,0.929664785027243,1.0,1/13,1.25%,NRROS
prerank,gene expression (GO:0010467),0.3347360202990583,0.8728198904204872,0.831,0.929433737263212,1.0,125/348,26.36%,APOBEC1;RPL23;RPL17;NUP62;RPL10A;RBM39;RPS2;DHX38;RRBP1;NXF1;THOC2;RPL18A;FARSB;MRPL41;MEF2A;TSPAN32;RPS15A;GSPT1;TFIP11;SEH1L;CASC3;EIF4EBP2;TSPAN14;RBM15B;ADAR;MMS19;MRPL51;SMG1;RPL6;HNRNPL;TPR;DDX39B;RPLP2;RPL26;RPS20;RNASEL;POLR2L;RPS16;NUP205;RPS14;SORL1;ADARB1;DARS1;STUB1;RPL19;POLDIP3;GALNT2;UPF3B;THOC3;HNRNPD;ALKBH5;IGF2BP3;RPL9;NUFIP1;RPS11;RPL11;SMG7;RPS23;RPS4X;MRPS21;UPF2;RPS27;AGO2;RPL4;MRPS14;PABPC4;CREBL2;TESC;SLU7;FYTTD1;GOLPH3;MRPL3;POLR2E;RBMS2;FUBP3;HNRNPF;SRSF6;SRSF2;SEC13;PABPN1;RPL7A;RPL15;HHEX;MRPL10;RPL29;SLBP;SRSF3;RPL22;NUP54;RPS7;RPS13;SARS1;TASP1;RPLP1;POLR3A;NUP85;RPS15;MRPL18;ATXN1;MRPL52;RPS5;NUP155;RPL41;PAX8;PWP1;DDX20;XRN2;DROSHA;RPL10;MRPL37;NCBP1;XAB2;MRPS12;ABCF1;HNRNPK;RPS8;RPL5;RPL18;CPSF4;EEF1A1;MCM3AP;RPL28;PTMA;MRPS15;NOVA1
prerank,embryonic heart tube morphogenesis (GO:0003143),0.3606143248472017,0.8728040767980247,0.639470782800441,0.9290561489164124,1.0,4/43,8.10%,SHH;PKD2;TGFBR2;MEF2C
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4071600235924074,0.872684745092957,0.6463730569948186,0.9288608969639257,1.0,8/19,22.92%,MTOR;CEBPA;ELL;PRDX5;ICE2;RPTOR;ZC3H8;TENM1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3611871958534769,0.8725558136549799,0.6617021276595745,0.9286622395764746,1.0,14/49,19.60%,HERPUD1;PYCARD;DDIT3;BCL2L1;TP53;P4HB;BECN1;BMF;NOC2L;SRC;SGMS1;PTPMT1;DNM1L;FIS1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.3884774256882706,0.8723730359912303,0.6532066508313539,0.9285812640070701,1.0,3/26,5.09%,NLRC3;TRAFD1;TNFAIP3
prerank,regulation of RNA splicing (GO:0043484),0.350470258719665,0.8718970272421674,0.6923076923076923,0.9290139548904541,1.0,13/69,13.39%,RBM38;ERN1;ZNF326;RBM39;GRSF1;METTL4;HNRNPL;SON;PTBP2;TRA2B;PRX;BRDT;FAM50A
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.3860297212852021,0.8718643830732734,0.6522248243559718,0.928657907837354,1.0,5/29,11.24%,TNF;TRAF2;PYCARD;INHBA;THBS1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.4533773924819104,0.8716767244599214,0.6235795454545454,0.9285498208969389,1.0,3/10,9.89%,LEO1;HSF1;CPEB3
prerank,cell-cell junction assembly (GO:0007043),0.350313599198257,0.8715029461586962,0.6750524109014675,0.9284230952578404,1.0,13/63,12.03%,CD9;PKP2;PIP5K1C;CTNNB1;ACTB;GJB6;FLCN;ACTG1;CDH8;VCL;CDH9;CDH12;TLN1
prerank,regulation of viral transcription (GO:0046782),0.36993288731234597,0.8714726521675152,0.6772009029345373,0.9280650958041793,1.0,12/39,24.49%,DHX9;TRIM27;MDFIC;POLR2L;MID2;TARBP2;TRIM62;RSF1;POLR2E;HEXIM1;NELFE;UBP1
prerank,negative regulation of cell projection organization (GO:0031345),0.36500834511636665,0.8710994140441645,0.6843243243243243,0.9282938609432497,1.0,14/48,19.41%,MYLIP;RTN4RL1;APOE;ADCY6;CBFA2T2;PTPRO;FYN;GAK;YWHAH;EPHA4;PTEN;DENND5A;PAQR3;RAB29
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.3455208519167752,-0.8705022541972233,0.5876623376623377,0.9243834830885731,1.0,3/11,10.54%,ATP1B1;KCND3;KCNJ3
prerank,epidermis development (GO:0008544),-0.2224982199771955,-0.8703325517804686,0.7121212121212122,0.9224483028576171,1.0,19/56,32.28%,PLOD1;EMP1;YBX1;HDAC2;ALDH3A2;GLI1;FLOT2;UGCG;GATA6;PTHLH;FGF7;LAMC2;FGFR2;ATP2A2;SCEL;KRTDAP;CCN2;EDAR;DSP
prerank,mitotic metaphase plate congression (GO:0007080),0.36035796122051045,0.8702782039630186,0.6895810955961332,0.9293219899291287,1.0,10/51,17.53%,NUP62;CDC23;SEH1L;KIF14;RAB11A;BECN1;RRS1;PDCD6IP;EML4;MIS12
prerank,maintenance of protein localization in organelle (GO:0072595),-0.2905835806547822,-0.8701783420309772,0.6454545454545455,0.9204827186419259,1.0,10/19,21.39%,PML;HK1;BBS4;TOPORS;PINK1;HNRNPU;AKT1;SUPT7L;BCL3;SKP1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.37280914862958836,0.8701075351862874,0.6757679180887372,0.9291947036613992,1.0,8/34,12.98%,MAPK14;ERN1;PRKD2;MAP2K3;ANXA1;VEGFB;NRP1;NR4A1
prerank,negative regulation of axon extension (GO:0030517),-0.25136427324265453,-0.8700312238089505,0.6573426573426573,0.9185003190009279,1.0,6/30,8.55%,SEMA6A;SEMA5A;SEMA3A;SEMA6D;SEMA3C;SEMA3D
prerank,tetrahydrofolate metabolic process (GO:0046653),0.44572532751513333,0.868927741952229,0.6267217630853994,0.9308036744820319,1.0,1/10,2.77%,MTHFS
prerank,regulation of establishment of planar polarity (GO:0090175),0.3436825806500651,0.8687433056334212,0.7157569515962925,0.9307247893225661,1.0,22/88,20.27%,ARRB2;FZD3;PSMB10;AP2S1;DAAM1;PSMA2;PFN1;CLTC;PSME3;PSMB5;PSMD8;AP2M1;PSMD7;PSMB9;VANGL1;SMURF1;RHOA;PSMD2;CDC42;DACT1;ARHGEF19;FZD2
prerank,dicarboxylic acid catabolic process (GO:0043649),0.4280613914782971,0.8686665961401349,0.6211699164345403,0.9304529881050077,1.0,1/13,2.77%,MTHFS
prerank,nuclear envelope organization (GO:0006998),-0.2851114028520731,-0.8686367515444443,0.66,0.919321740146614,1.0,5/20,16.33%,NUP93;VPS4A;CTDNEP1;EMD;TMEM43
prerank,positive regulation of DNA metabolic process (GO:0051054),0.3481781428265369,0.8685686272568112,0.6867088607594937,0.9302072022976711,1.0,14/61,18.57%,SMOC2;DHX9;RGCC;PRKD2;HMGB1;ATRX;BABAM2;USP7;USP9X;ERCC6;BABAM1;UBE2N;NPAS2;TIGAR
prerank,protein glycosylation (GO:0006486),0.34157773802354485,0.8680331665201142,0.7512639029322548,0.9307377852064886,1.0,35/125,20.62%,MGAT5;MAN1C1;GALNT10;TET3;ST8SIA4;NPC1;B4GALT1;GALNT7;OGA;GALNT6;AQP11;ST3GAL1;ALG2;POGLUT1;FUT9;B3GALNT1;ST8SIA1;POMK;DPAGT1;STT3B;B4GALT7;GALNT2;LARGE1;PMM1;MGAT5B;TMEM165;ALG11;MGAT4B;GALNT1;DDOST;TET2;MGAT1;STT3A;COG7;TUSC3
prerank,regulation of response to oxidative stress (GO:1902882),0.44007270651486563,0.8675964890564516,0.6318051575931232,0.9311089248714368,1.0,2/11,7.24%,MCTP1;ABCD1
prerank,positive regulation of cytokinesis (GO:0032467),0.3723748756052991,0.8675245783324119,0.643348623853211,0.9308281067742779,1.0,8/32,20.56%,KIF14;KIF20B;KIF23;CDC6;RHOA;GIPC1;CDC42;CUL3
prerank,heart trabecula morphogenesis (GO:0061384),-0.28479567091701785,-0.8674120227333458,0.6274509803921569,0.9198510539189407,1.0,8/18,20.15%,BMPR1A;ADGRG6;TGFBR3;BMP5;FKBP1A;S1PR1;TEK;RBP4
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.35949592979437095,0.8672108140275123,0.6611295681063123,0.9309757038165712,1.0,5/40,9.29%,PRKCD;UBE2V2;UBE2V1;POLH;SMG1
prerank,ganglioside biosynthetic process (GO:0001574),0.42202479168792395,0.8671339113621326,0.6464516129032258,0.9307036134548697,1.0,3/15,8.51%,ST8SIA4;ST6GALNAC4;ST3GAL1
prerank,cellular response to unfolded protein (GO:0034620),0.385261902225959,0.8668713265467535,0.6437054631828979,0.9307567100667589,1.0,4/26,9.15%,PTPN1;ERN1;BAK1;HSF1
prerank,lamellipodium assembly (GO:0030032),0.3900703693234944,0.8666029761191952,0.6497641509433962,0.9307933650826092,1.0,13/26,24.54%,ABLIM2;P2RY12;VCL;PARVB;CYFIP1;PTPRO;ARFIP2;GOLPH3;ITGB1;RHOD;SPATA13;ARHGEF7;SRGAP2
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3048605165642005,-0.8665881502894484,0.6637168141592921,0.9193744858944375,1.0,4/15,12.89%,SMARCA4;NUCKS1;CCNT1;SNW1
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.3941477433607119,0.866341257443936,0.6461159062885327,0.9304335786332013,1.0,7/22,21.35%,ZDHHC14;ZDHHC7;ZDHHC3;ZDHHC1;ZDHHC24;ZDHHC21;ZDHHC2
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.3941477433607119,0.866341257443936,0.6461159062885327,0.9304335786332013,1.0,7/22,21.35%,ZDHHC14;ZDHHC7;ZDHHC3;ZDHHC1;ZDHHC24;ZDHHC21;ZDHHC2
prerank,ncRNA transcription (GO:0098781),0.4301917659240232,0.8663394099998504,0.6377204884667571,0.9300326436040646,1.0,3/13,12.43%,GTF3A;RPAP2;SNAPC3
prerank,spinal cord development (GO:0021510),0.4328955388443678,0.865612598114584,0.6510989010989011,0.9308383681221121,1.0,6/12,22.80%,PKD2;SOX4;NF1;LOXL3;RELN;ZPR1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.26903073044195325,-0.8651862035841411,0.6946107784431138,0.9203374713607684,1.0,12/23,27.12%,GLIS2;GLI3;HHIP;GPC3;KCTD21;GPR161;PTCH1;KIF7;RFX4;IFT122;ULK3;PTCH2
prerank,positive regulation of viral transcription (GO:0050434),0.38604119959878047,0.8650861718660491,0.6662591687041565,0.9312914308814672,1.0,5/25,18.79%,DHX9;MDFIC;POLR2L;RSF1;POLR2E
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.33580083855094806,0.864958702318215,0.7853560682046138,0.9310930702645959,1.0,51/173,20.57%,F10;SPTBN5;LMAN1L;CTSC;TMED3;KDELR2;CAPZB;CAPZA1;ACTR10;MCFD2;CTSZ;PDCD6;PGAP1;VAPB;RAB1B;COG6;COPA;YKT6;DCTN5;SEC24D;SEC16A;DYNC1H1;F5;SEC16B;STX5;SAR1A;TRAPPC6A;GAS6;TRAPPC11;VTI1A;GRIA1;LMAN2;ANK1;USE1;SPTBN4;DCTN6;ERGIC1;GOLGB1;TRAPPC2L;ATL2;COG5;RAB29;SEC13;ATL3;TRAPPC12;SEC22B;SEC31A;USO1;ARCN1;CUL3;COG7
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.35648555103676316,0.8649420916640637,0.6520307354555434,0.9307181663687311,1.0,13/44,21.96%,KCNN4;KCNIP2;KCNMA1;WNK1;NOS1AP;ATP1B3;ATP1B2;GNG2;WNK4;AKAP9;KCNJ2;KCNJ10;FLNA
prerank,regulation of protein targeting to membrane (GO:0090313),0.3814594822161428,0.8639908773727764,0.6611764705882353,0.9319116921437727,1.0,8/28,22.06%,ITGB2;ITGAM;FYN;CEMIP;MYO1C;FIS1;INPP5K;CHP1
prerank,antibacterial humoral response (GO:0019731),0.4054781825606813,0.8639718629276402,0.6259842519685039,0.9315451452733925,1.0,5/16,26.04%,DMBT1;DEFA6;RNASE6;PLA2G6;RNASE3
prerank,membrane lipid biosynthetic process (GO:0046467),0.35263161292982015,0.8633179538078224,0.7053191489361702,0.9322598910853589,1.0,7/58,9.81%,CERS6;SGPL1;PRKD2;CSNK1G2;HACD4;ACER3;VAPB
prerank,protein secretion (GO:0009306),0.3490231590067807,0.8629625089062712,0.6932907348242812,0.932455816768526,1.0,11/56,18.76%,RAB8B;ABCA1;SEL1L;ANXA1;PPY;SNX19;STEAP3;SVBP;MON1A;GOLPH3;LTBP2
prerank,histone H4-K16 acetylation (GO:0043984),0.40247063654133847,0.8624640079853142,0.6522842639593909,0.9329262138676274,1.0,8/19,21.52%,MSL2;MCRS1;KAT7;HCFC1;JADE2;MEAF6;MSL1;PHF20
prerank,glycerol metabolic process (GO:0006071),0.4450514129075024,0.8617637643168836,0.6526162790697675,0.9336865911474637,1.0,3/10,19.85%,ANGPTL3;GK;COQ3
prerank,positive regulation of actin nucleation (GO:0051127),-0.3458782092161852,-0.8616581345566905,0.6254071661237784,0.9256250545145658,1.0,3/11,5.31%,GSN;BRK1;WHAMM
prerank,cellular response to ionizing radiation (GO:0071479),0.3605238869142693,0.8616076086310067,0.6880434782608695,0.9335442610487683,1.0,7/47,10.47%,GRB2;MAPK14;TANK;XRCC5;TP53;HSF1;RPL26
prerank,DNA replication checkpoint signaling (GO:0000076),-0.3000151478730112,-0.8615644113300647,0.6497695852534562,0.9235321968486614,1.0,4/16,12.86%,RAD17;TIPIN;TOPBP1;NAE1
prerank,centromere complex assembly (GO:0034508),0.35900404446030587,0.8608603209932983,0.6554433221099888,0.934397054832927,1.0,12/36,23.99%,CENPO;RBBP7;CENPI;CENPQ;CENPK;RSF1;MIS12;RBBP4;ITGB3BP;SMARCA5;KNL1;CENPT
prerank,morphogenesis of an epithelium (GO:0002009),0.384253647320161,0.8606367025530834,0.64,0.9343817238805321,1.0,6/25,15.66%,ACTB;ACTG1;VCL;SOX9;AHI1;LAMA3
prerank,regulation of protein autophosphorylation (GO:0031952),0.36976259117515586,0.8601466459534417,0.6757679180887372,0.934784739335517,1.0,2/36,3.44%,GPNMB;RAP2A
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.3920919683402574,0.859972555150145,0.653416149068323,0.9346685640035768,1.0,9/21,23.21%,ABCD1;TRAP1;HDAC6;ABCD2;PRKN;SIRT5;MT3;AATF;SLC30A10
prerank,positive regulation of synapse assembly (GO:0051965),0.382766524792534,0.8597132051578514,0.6590084643288996,0.9346742327006133,1.0,4/27,10.78%,CLSTN1;SEMA4D;AGRN;SEMA4A
prerank,acylglycerol biosynthetic process (GO:0046463),0.39031469627238674,0.8596512046529219,0.6591179976162098,0.934360949231356,1.0,7/23,20.89%,LPIN2;AGMO;GK;PNPLA3;DGAT2;MOGAT1;LPIN1
prerank,oxoacid metabolic process (GO:0043436),0.3806078249149212,0.8595325553540096,0.6643026004728132,0.9341449829263838,1.0,4/27,11.83%,SULT4A1;BPNT1;PPA2;TPST1
prerank,negative regulation of protein processing (GO:0010955),0.43113180204283796,0.8594654452987149,0.6478494623655914,0.9338637990996959,1.0,4/12,19.16%,CTSZ;THBS1;LRRK2;TMEM59
prerank,gluconeogenesis (GO:0006094),-0.22428967208638145,-0.8593808776466089,0.6666666666666666,0.9261208457004287,1.0,15/39,23.11%,SLC25A12;PGM1;MDH1;SLC25A13;PGK1;GOT1;ATF4;SLC39A14;SLC25A11;PER2;GAPDH;ALDOC;RBP4;ENO2;CRY1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.38537853973360203,0.8588947890312937,0.6880952380952381,0.9343967494961957,1.0,7/26,18.43%,GCNT1;ALG2;LARGE1;RRM2B;GK;ALG11;GOLPH3
prerank,mammary gland epithelium development (GO:0061180),0.4144236160733224,0.8587772316231009,0.6514131897711979,0.9341994653189053,1.0,1/14,2.01%,CSF1R
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.4488075740185148,0.8585980007979247,0.6563814866760168,0.9340650385502344,1.0,5/10,19.95%,PRKCB;PID1;GSK3A;APPL2;INPP5K
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.30930105165441457,-0.8577679602342694,0.6554307116104869,0.9274745177521623,1.0,4/14,16.40%,CAV1;SPRED2;SPRY2;NOTCH4
prerank,glycine metabolic process (GO:0006544),-0.3207129489045891,-0.8571086068288144,0.6245353159851301,0.9265899811187011,1.0,6/12,40.87%,DLD;RIDA;GCSH;SHMT2;GLDC;SHMT1
prerank,motile cilium assembly (GO:0044458),-0.3297798724907199,-0.8564496190898825,0.6241610738255033,0.9258053486906938,1.0,4/12,17.61%,BBOF1;BBS5;CCDC39;E2F4
prerank,aspartate family amino acid catabolic process (GO:0009068),0.40238303417120047,0.8560893050190176,0.6427656850192062,0.9378144310474599,1.0,3/19,12.95%,CRYM;OGDH;ALDH7A1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.33298776912747247,0.8560001689909156,0.833,0.9375633770461996,1.0,48/248,15.71%,DRAXIN;TGFB1;TMEM131L;GPRC5B;MAD2L2;GNAQ;ZEB2;MDK;TLE3;CDK14;DKK2;APOE;OTULIN;TPBGL;DDIT3;LGR6;FZD9;CTNNB1;PSMB10;TBL1XR1;WNK1;CSNK1G2;GID8;SCYL2;ATP6AP2;AMER1;TBL1X;PSMA2;SOX9;PTPRU;PTPRO;CSNK1A1;TNKS2;PSME3;BAMBI;NFKB1;STK3;PSMB5;SOX2;PSMD8;LRRK2;SOX4;USP8;TLE5;PSMD7;PSMB9;GSK3A;LGR4
prerank,protein modification by small protein removal (GO:0070646),0.3327110878676788,0.8559673431571472,0.8508508508508509,0.9372219094553096,1.0,61/252,20.84%,ARRB2;COPS6;OTULINL;TGFBR1;ATXN7;TRAF2;USP35;TNFAIP3;TRAF3;ATXN3;OTUD3;ACTB;TP53;PSMB10;STAMBPL1;YY1;ASXL2;SMAD3;BABAM2;MCRS1;USP7;PSMA2;USP48;USP31;BECN1;USP18;PSME3;IKBKG;COPS4;FOXK1;TOR1A;HCFC1;PSMB5;INO80;USP9X;MBD5;PSMD8;USP8;JOSD2;USP29;PSMD7;PSMB9;USP21;USP16;HIF1A;BABAM1;PTEN;IL33;RHOA;PSMD2;KEAP1;BIRC2;DESI1;DESI2;TOMM20;SENP6;RAD23B;STAM2;SENP7;PRKN;BIRC3
prerank,amino acid import across plasma membrane (GO:0089718),0.3757377895470897,0.8559602091036141,0.6535141800246609,0.9368347825941256,1.0,3/24,7.46%,SLC7A8;SLC36A1;SLC16A2
prerank,homologous chromosome segregation (GO:0045143),0.39004183359113276,0.8544062481986805,0.6704119850187266,0.9389995969307864,1.0,1/20,2.80%,PTTG1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.36771651264703425,0.8541586364872248,0.6553341148886284,0.9389950786079689,1.0,9/29,20.34%,UTP20;RPS16;NOP9;HEATR1;RPS14;RRS1;TSR1;NGDN;UTP3
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3542175428911562,0.853804813209338,0.7167567567567568,0.9391592732966179,1.0,12/52,15.73%,SREBF2;MICALL2;UBE2D3;YWHAB;TP53;VPS11;CSNK2A2;CASP8;HUWE1;UBE2J2;GSK3A;YWHAH
prerank,positive regulation of cellular senescence (GO:2000774),0.4284561914239535,0.8536046234419669,0.6569444444444444,0.939072119641817,1.0,2/10,13.13%,YPEL3;B2M
prerank,sodium ion export across plasma membrane (GO:0036376),0.42127842965336004,0.8532628995106938,0.6418918918918919,0.9392514257748864,1.0,3/13,13.76%,SLC9A1;ATP1B3;ATP1B2
prerank,clathrin coat assembly (GO:0048268),0.41480076339309707,0.8532153086116964,0.6631158455392809,0.938927281576545,1.0,5/15,19.78%,AP2S1;CLTC;EPS15;PICALM;FCHO2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.3575570133879925,0.853166565832318,0.6766666666666666,0.9386003594400837,1.0,9/38,17.70%,SCN4B;HCN4;PKP2;CACNB2;KCNA5;CACNA1D;BIN1;SCN5A;AKAP9
prerank,protein O-linked glycosylation (GO:0006493),0.336590949137117,0.8527591023050766,0.7448979591836735,0.938850728077417,1.0,19/96,16.62%,SDF2L1;GCNT1;GALNT10;TET3;MUC13;GALNT15;GALNT7;OGA;ST6GALNAC4;GALNT6;POGLUT2;ST3GAL1;POGLUT1;TMTC4;POMK;GALNT2;LARGE1;MGAT5B;GALNTL6
prerank,sulfur compound biosynthetic process (GO:0044272),0.33523782786756895,0.8526962473568438,0.7520325203252033,0.9385598651977688,1.0,25/104,21.75%,PRELP;ESD;AKR1A1;HPGDS;SLC35B3;B4GALT1;CHSY3;FMOD;ST3GAL1;BCAN;GGTA1;PAPSS1;CHSY1;CHST15;MGST1;CBS;GSTM2;ANGPT1;CHPF;CSPG4;CNDP2;SLC10A7;B4GALT6;B4GALT2;GCLM
prerank,magnesium ion transport (GO:0015693),-0.3252460148575749,-0.8525563945510826,0.6758620689655173,0.9322799714541792,1.0,5/12,19.16%,SLC41A1;NIPA2;NIPAL2;MRS2;CNNM4
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.43608026321907656,0.8524816266642847,0.6545718432510885,0.9385180734250167,1.0,6/11,21.25%,SH2B3;NF2;ADIPOR1;PTPRT;VHL;SOCS3
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.23130258140876714,-0.8524719804329255,0.7111111111111111,0.9301864166616902,1.0,10/41,11.87%,OGT;NUP93;NUP188;RANBP2;NUP98;NUP42;NDC1;RAE1;NUP153;NUP37
prerank,regulation of isotype switching (GO:0045191),0.41172203970949517,0.8523784054279798,0.6459197786998617,0.9382903235155514,1.0,4/14,21.54%,MAD2L2;SHLD1;SHLD2;PARP3
prerank,negative regulation of catabolic process (GO:0009895),0.3488135282942232,0.851457047640253,0.6889848812095032,0.9393750544237106,1.0,5/47,9.95%,CBFA2T3;MAD2L2;TNF;ZDHHC7;HDAC4
prerank,glycogen biosynthetic process (GO:0005978),0.4309584878277598,0.8511765644972116,0.6497252747252747,0.9389977118133891,1.0,2/12,9.01%,GYG1;GBE1
prerank,glucan biosynthetic process (GO:0009250),0.4309584878277598,0.8511765644972116,0.6497252747252747,0.9389977118133891,1.0,2/12,9.01%,GYG1;GBE1
prerank,regulation of mRNA catabolic process (GO:0061013),0.3308976946565623,0.8509787233370496,0.7679112008072654,0.938914077947421,1.0,22/121,15.61%,PCID2;PRKCD;CNOT8;EXOSC1;XPO1;ANP32A;YWHAB;PSMB10;GTPBP1;YTHDF3;RC3H2;MOV10;RC3H1;PUM2;PSMA2;PSME3;PSMB5;HNRNPD;PSMD8;IGF2BP3;PSMD7;PSMB9
prerank,skeletal muscle tissue development (GO:0007519),0.3584127453341515,0.8509279639679158,0.6590909090909091,0.9385914534050503,1.0,3/32,8.10%,SKI;CFLAR;MEF2C
prerank,contractile actin filament bundle assembly (GO:0030038),0.4077339256676543,0.8509020049731696,0.6705128205128205,0.9378345447920404,1.0,10/15,24.82%,ITGB5;ZYX;PDLIM1;SRC;RHOA;ITGB1;CUL3;TNFAIP1;KCTD13;ARRB1
prerank,stress fiber assembly (GO:0043149),0.4077339256676543,0.8509020049731696,0.6705128205128205,0.9378345447920404,1.0,10/15,24.82%,ITGB5;ZYX;PDLIM1;SRC;RHOA;ITGB1;CUL3;TNFAIP1;KCTD13;ARRB1
prerank,response to prostaglandin E (GO:0034695),0.44611555433728,0.8508654272072541,0.6546242774566474,0.937505408751828,1.0,2/10,14.48%,ADCY6;GNG2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.33162182807484347,0.8503941215640966,0.7935548841893253,0.9378742961184408,1.0,27/138,18.83%,MED17;GTF2H1;MAML3;RXRB;NR1H4;HDAC5;TAF1;TEAD1;TBL1XR1;PPARGC1A;CDK7;TBL1X;MED27;POLR2L;TAF8;NR2C2;HDAC9;NR4A1;NR2C1;TAF3;RBPJ;GTF2B;PPARD;GTF2H5;RXRA;POLR2E;TAF11
prerank,regulation of lamellipodium organization (GO:1902743),0.4139616542603837,0.850160702911569,0.6522911051212938,0.9378499053667475,1.0,4/14,17.93%,CD44;CAPZB;TWF2;CDC42
prerank,protein targeting to mitochondrion (GO:0006626),0.3543392323310498,0.8498952267545239,0.7115384615384616,0.9378606530733273,1.0,18/52,23.68%,TSPO;AIP;CHCHD4;TIMM22;AGK;IMMP2L;TIMM50;TOMM40;PMPCB;HSP90AA1;PITRM1;TOMM20;FIS1;PMPCA;DNAJC15;TIMM29;TIMM8B;HSPA4
prerank,smoothened signaling pathway (GO:0007224),0.3684418762538202,0.8494881130695373,0.6908881199538639,0.938075075341937,1.0,2/32,7.36%,SHH;PTCHD1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.33395183385476324,0.8493411710994423,0.7760891590678825,0.9378972827098866,1.0,26/125,19.41%,ERCC6L;CENPO;ESPL1;NEK6;BCCIP;XPO1;MAPRE1;SEH1L;PLK2;SETD2;DYNC1H1;PMF1;CENPI;KIF2A;PPP1CC;INTS13;CENPQ;PTPA;INCENP;EML4;CENPK;MIS12;RPS27;DCTN6;TAOK1;SEC13
prerank,microtubule bundle formation (GO:0001578),-0.227235545010831,-0.8488711565120427,0.7757009345794392,0.9355990427159266,1.0,19/42,32.13%,NCKAP5;SPAST;CLIP1;MAP1S;CDK5RAP2;MTCL1;TPPP;MARK4;CFAP74;RP1;SPEF1;NUMA1;SPAG16;GAS8;CFAP46;TTLL3;AAAS;LRGUK;CAPN6
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.4019514895294175,0.8488018892406112,0.6670934699103713,0.9383639487412397,1.0,5/18,17.23%,SLC43A2;EPO;NEDD4L;SLC43A1;BIN1
prerank,ether lipid biosynthetic process (GO:0008611),0.44360248876677366,0.84812086843512,0.6757575757575758,0.9390275859423227,1.0,3/10,11.57%,LPCAT2;DHRS7B;PEX7
prerank,negative regulation of metabolic process (GO:0009892),0.34789356855509324,0.8480501334128105,0.7178111587982833,0.938742754864318,1.0,7/54,8.46%,PLCL2;TLE3;MAP2K6;DDIT3;ZDHHC7;FLCN;RB1
prerank,chromatin remodeling (GO:0006338),0.3314274472861573,0.8475958736508826,0.7540983606557377,0.9390865201957114,1.0,28/100,19.97%,NPM3;BPTF;SRCAP;HDAC5;ACTB;RB1;ARID1A;ATRX;HDAC4;ARID1B;BAZ1A;HCFC2;SOX9;BRDT;SMARCD3;SMARCB1;HCFC1;INO80;PIH1D1;ERCC6;SMARCAD1;RSF1;KDM4C;CHD4;TOP1;KDM5A;RBBP4;KDM5B
prerank,ribosomal small subunit biogenesis (GO:0042274),0.3534262946143802,0.8470804083261361,0.6985376827896513,0.939524230356542,1.0,16/39,26.92%,EMG1;NOB1;ERAL1;SURF6;RPS16;RPS14;RPS27;RIOK3;RRP7A;SRFBP1;RPS7;RPS15;RPS5;NOP14;LSM6;RPS6
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3297769134957197,0.8470152702744276,0.8269617706237424,0.9392239951307706,1.0,32/166,19.16%,MED17;GTF2H1;TAF1A;MAML3;POLR1E;RXRB;NR1H4;HDAC5;TAF1;TEAD1;TBL1XR1;PPARGC1A;CDK7;TBL1X;MED27;POLR1B;POLR2L;TAF8;NR2C2;HDAC9;NR4A1;NR2C1;TAF3;RBPJ;GTF2B;PPARD;RSF1;GTF2H5;RXRA;POLR2E;TAF11;CRCP
prerank,neuromuscular process (GO:0050905),0.4091475067845817,0.8470098606199461,0.6382699868938401,0.9388346085927181,1.0,2/16,4.53%,GCH1;CLN3
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.26177046432899664,-0.8468285932215249,0.6989247311827957,0.9379099333721601,1.0,2/23,1.03%,SLC12A2;SLC12A7
prerank,cellular response to acid chemical (GO:0071229),0.38049016800304697,0.8468021992876743,0.6727053140096618,0.9387753880165044,1.0,12/27,25.39%,MTOR;CPEB3;GLRA2;LAMTOR3;CAPN2;CPEB4;LAMTOR1;RPTOR;RRAGA;RRAGB;VEGFA;XBP1
prerank,protein K48-linked ubiquitination (GO:0070936),0.3457553138899568,0.8464450424270042,0.7080213903743315,0.9389470925965355,1.0,19/54,22.14%,RFFL;UBE2D3;TNFAIP3;UBE2E3;RNF4;NEDD4L;UBE2H;CDC34;RNF216;ITCH;UBE2G2;ZNRF1;RNF152;UBE2K;CUL3;PRKN;UBE2R2;RNF146;UBE2E1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.4206393835302311,0.8464419886068157,0.6638418079096046,0.9385535700517132,1.0,4/11,17.98%,ABCD1;TRAP1;FYN;ABCD2
prerank,lung development (GO:0030324),0.36551381857095855,0.8463543645175269,0.6906392694063926,0.9383117228334139,1.0,3/33,6.82%,SHH;CEBPA;NKX2-1
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.44464001283879295,0.8458989935582565,0.6717791411042945,0.9386661486345078,1.0,2/10,6.77%,RXRB;ACTN4
prerank,establishment of vesicle localization (GO:0051650),0.39927434224553293,0.8456910913266416,0.6529032258064517,0.9385877368626881,1.0,5/18,13.52%,DNM2;RAB11A;SYNJ1;IKBKG;TOR1A
prerank,metal ion transport (GO:0030001),0.3309212057537507,0.8456393296479976,0.7510204081632653,0.9382716806968383,1.0,14/86,13.80%,SLC11A1;KCNN4;SLC8A1;CCL8;PKD2;RAMP1;CACNA1A;ATP2C1;TPT1;NIPAL3;FYN;CDH23;ATP2A3;CACNA1B
prerank,peripheral nervous system development (GO:0007422),-0.2610317730233902,-0.8455748030076707,0.7090909090909091,0.9384568085820068,1.0,5/23,11.59%,ADGRG6;NFASC;NGF;ALDH3A2;SCN8A
prerank,female gamete generation (GO:0007292),0.37302319085007324,0.8448709601100005,0.6803760282021152,0.9391396378470652,1.0,6/29,17.07%,MDK;TRIP13;METTL3;MCM9;USP9X;MARF1
prerank,ovarian follicle development (GO:0001541),0.419319244515598,0.8442461227748156,0.6657754010695187,0.9397779602400327,1.0,3/13,10.54%,CEBPB;EIF2B2;INHBA
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.4247421903125766,0.8440272050455135,0.6624113475177305,0.9397232982519503,1.0,5/11,20.84%,FZD9;CASP8;ARHGEF2;BIRC2;BIRC3
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.34394898255716055,-0.8439118206880262,0.6496815286624203,0.9397736521347405,1.0,4/10,11.86%,THOC1;THOC5;WDR76;CCAR2
prerank,regulation of actin nucleation (GO:0051125),0.41934406129917773,0.8434145137479153,0.6638537271448663,0.940283025391522,1.0,1/12,1.76%,CORO1A
prerank,regulation of astrocyte differentiation (GO:0048710),-0.3242262490703115,-0.8426869908467655,0.6387959866220736,0.9400379631871678,1.0,2/12,10.90%,SERPINE2;HES1
prerank,epithelial structure maintenance (GO:0010669),0.42943943041860155,0.8423713225849985,0.6518624641833811,0.9415676681440548,1.0,3/11,20.89%,MUC13;NOD2;STRAP
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.33426755404509384,0.842042486588274,0.7520491803278688,0.9416841441235434,1.0,16/87,16.50%,GPNMB;GPR132;RGCC;PKD2;PSMB10;RB1;PSMA2;CCL2;CDK6;PSME3;PSMB5;BRD7;PSMD8;PSMD7;PSMB9;PTEN
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.4089374193036794,0.8418183713956349,0.6648793565683646,0.941631350498107,1.0,7/14,24.50%,XRCC5;ATRX;TNKS2;TINF2;TERF2;TERF2IP;ATR
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3864978566291632,0.8416265104171914,0.676980198019802,0.9415451243045415,1.0,6/20,20.78%,TGFBR1;ITCH;HIF1A;HSP90AA1;DCUN1D5;PRKN
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.4019195632183912,0.8411680334463499,0.6508795669824087,0.9418626691474339,1.0,5/14,22.04%,CREB3L1;SULF2;THBS1;SPRY4;FGF2
prerank,protein K63-linked deubiquitination (GO:0070536),0.36482692780494874,0.8411394194514927,0.6988372093023256,0.9415109721241905,1.0,8/31,16.40%,TNFAIP3;ATXN3;STAMBPL1;BABAM2;USP7;USP8;USP16;BABAM1
prerank,ketone body metabolic process (GO:1902224),0.42716355041155873,0.8408364969395419,0.6514705882352941,0.9415826482571424,1.0,1/10,3.39%,OXCT1
prerank,potassium ion transmembrane transport (GO:0071805),0.3291351856022431,0.840830852492247,0.7831325301204819,0.9411945143158263,1.0,11/135,7.51%,KCNJ11;HCN4;SLC9A4;KCNN4;KCNK6;PKD2;KCNIP2;SLC9A9;CCDC51;SLC9A1;KCNK13
prerank,myoblast fusion (GO:0007520),-0.3304499223412282,-0.8402070383095843,0.6555555555555556,0.9431699731217856,1.0,7/12,23.87%,ADAMTS5;ADAM12;ADAMTS15;CD81;KCNH1;NOS1;CACNA1H
prerank,apoptotic DNA fragmentation (GO:0006309),0.40042782778816727,0.840123914016,0.6645161290322581,0.9419194087308661,1.0,9/16,29.28%,HMGB1;KPNA1;DICER1;DNASE2;DFFB;CECR2;KPNB1;HMGB2;DFFA
prerank,nervous system development (GO:0007399),0.3253950898899954,0.8400819670520266,0.929,0.94158796955407,1.0,63/429,16.23%,PCDHA6;ASCL1;SHH;TGFB1;PCSK9;PCDHB6;TGFBR1;DAGLB;MYLIP;EDNRB;S100B;FGF13;ZEB2;MDK;NAV2;SLITRK1;PRDM12;CLN8;SREBF2;PKD2;ST8SIA4;CXCR4;NRGN;MYT1L;NDP;FZD9;APAF1;TEAD1;CHD7;ATXN3;APBA1;MEF2C;BPNT1;NTF3;BCAN;HDAC4;EIF2B2;INHBA;ARTN;CHERP;NELL1;SNTG2;NR2C2;PRX;UTP11;ITM2B;NRG1;NAV1;MERTK;NINJ1;SH3GL3;SOX6;MBD5;EFNB3;KIRREL3;IGF2BP3;MPZ;AHI1;ERCC6;DPYSL5;MTR;NF1;DCHS1
prerank,nitric oxide mediated signal transduction (GO:0007263),0.39886237262727336,0.8398279554112112,0.6758530183727034,0.9415940196961355,1.0,3/16,16.03%,APOE;DDAH1;CD36
prerank,regulation of protein localization to centrosome (GO:1904779),0.42862681691655535,0.8395570212637129,0.6808199121522694,0.9416231635749481,1.0,1/10,2.92%,NUP62
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.305147388638996,-0.8389273638759077,0.6532258064516129,0.9436224535782111,1.0,9/14,25.78%,ADK;ADSS2;GMPS;PFAS;RFK;PAICS;ADSL;IMPDH1;PPAT
prerank,sister chromatid segregation (GO:0000819),0.3653922909544321,0.8387932817773562,0.6915887850467289,0.9424505689041556,1.0,8/31,19.63%,ESPL1;NCAPG2;RB1;INO80;TOP2A;CENPK;MIS12;SMC4
prerank,negative regulation of phosphatase activity (GO:0010923),0.374836661421107,0.8385360213495676,0.675,0.9424716376370785,1.0,7/25,22.06%,SEMA4D;PPP1R11;BOD1L1;PPP4R4;PTPA;GSK3B;CHP1
prerank,negative regulation of translational initiation (GO:0045947),0.4106644623528571,0.8382562852054114,0.6532258064516129,0.9425029420596733,1.0,5/13,22.55%,EIF4EBP2;LARP1;TPR;AGO2;EIF3E
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.21278108706867987,-0.8379717569077969,0.8,0.9435280054082535,1.0,18/57,18.76%,RINT1;ATF2;RAD17;TAOK2;TIPIN;TOPBP1;TRIM39;MRE11;WAC;ATM;STK33;NOP53;MRNIP;SDE2;PRKDC;FBXO31;CDK2;HMGA2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.3855400595686166,0.8379286406212009,0.6795366795366795,0.942229530979862,1.0,6/19,22.85%,ATRX;POLR2L;POLR2E;TINF2;TERF2;TERF2IP
prerank,regulation of DNA recombination at telomere (GO:0072695),0.3855400595686166,0.8379286406212009,0.6795366795366795,0.942229530979862,1.0,6/19,22.85%,ATRX;POLR2L;POLR2E;TINF2;TERF2;TERF2IP
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.35617176148361746,0.837888307111454,0.6900921658986175,0.9418866939070728,1.0,3/33,5.09%,NFE2L2;MDK;TNFAIP3
prerank,protein localization to lysosome (GO:0061462),0.3689373447531323,0.8378712400413083,0.6860189573459715,0.9415245231725334,1.0,13/28,27.24%,LAPTM5;RAB7A;SORL1;NCOA4;RTN4;ATP13A2;SCARB2;RNF128;MFSD1;GGA3;HGS;SNX16;NAGPA
prerank,cGMP metabolic process (GO:0046068),0.4179786352939774,0.8378685825593337,0.6676096181046676,0.9411357953203053,1.0,2/12,10.24%,GUCY2F;NPR2
prerank,response to hydroxyurea (GO:0072710),0.4305608272270058,0.8378472395065347,0.673728813559322,0.9407904325593,1.0,3/11,12.85%,DDI2;ATRX;KAT7
prerank,lipid biosynthetic process (GO:0008610),0.3330165801182033,0.8376755509548066,0.7572314049586777,0.9406566410108882,1.0,12/77,17.14%,LPL;LPCAT1;CLN8;DHRS11;LIPC;PDSS1;PRLR;NDUFAB1;SREBF1;ACACA;FADS1;FDXR
prerank,negative regulation of protein catabolic process (GO:0042177),0.35026825061244293,0.836820419282894,0.7109634551495017,0.9415423215351,1.0,4/40,5.21%,CTSA;MAD2L2;SNCA;TIMP1
prerank,embryonic limb morphogenesis (GO:0030326),0.3563431784966881,0.8367089045662105,0.7046223224351748,0.9413219275287049,1.0,3/34,6.29%,SHH;SKI;CTNNB1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.3341128103054855,0.8364680632600631,0.7412513255567338,0.9412918902836428,1.0,13/57,18.07%,EMG1;XPO1;URB2;GTF3A;SURF6;RPL26;RPS16;RRS1;NOC2L;PES1;RPL11;WDR12;DDX31
prerank,NAD biosynthetic process (GO:0009435),0.3860115684229582,0.8363936756348216,0.6711822660098522,0.9410199008190726,1.0,7/20,19.31%,HAAO;KYNU;NMNAT3;PARP16;NAXD;NAXE;PARP10
prerank,endothelial cell proliferation (GO:0001935),0.3959955976735495,0.8363729629968368,0.6833976833976834,0.9406656696360964,1.0,2/17,3.63%,ANGPT4;ERN1
prerank,positive regulation of macroautophagy (GO:0016239),0.34757404956688953,0.8361467236557156,0.7158590308370044,0.940641466103502,1.0,10/48,16.29%,PIP4K2A;RAB3GAP2;SCOC;LARP1;PAFAH1B2;UVRAG;IKBKG;GNAI3;VDAC1;IRGM
prerank,neuron projection extension (GO:1990138),0.3628598231617364,0.8361273548720447,0.7198124267291911,0.9402804653679897,1.0,10/32,17.31%,CTNNB1;IMPACT;FLRT1;MAP1B;CYFIP1;NRP1;USP9X;HSP90AA1;PPP3CB;IQGAP1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.44568846840122267,0.8360815061744776,0.6713483146067416,0.9399668904650572,1.0,3/10,17.93%,RAP2A;RHOA;CDC42
prerank,regulation of gastrulation (GO:0010470),-0.3082035590950671,-0.8360055594026543,0.6612903225806451,0.9453223573898909,1.0,2/14,6.23%,PHLDB2;PHLDB1
prerank,nitric oxide biosynthetic process (GO:0006809),0.4107051055314834,0.8352163525689011,0.6855263157894737,0.9408999969090275,1.0,2/13,11.59%,GCH1;SPR
prerank,response to unfolded protein (GO:0006986),0.350922039658968,0.8352105852562506,0.7164502164502164,0.9405189757721732,1.0,13/48,20.78%,PTPN1;ERN1;HERPUD1;DDIT3;BAK1;HSF1;DERL1;STT3B;HSP90AA1;ERP44;OPTN;HSPB1;PRKN
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.3648033142497167,0.8349498170642579,0.7101947308132875,0.9405377106011938,1.0,10/32,22.80%,CDK14;BACH1;CDK17;RB1;CDC6;CDK15;CDK18;CDC45;NPAT;ZPR1
prerank,protein deubiquitination (GO:0016579),0.3241900653354167,0.8344384396209383,0.8838838838838838,0.9409285778483942,1.0,51/242,18.27%,ARRB2;OTULINL;TGFBR1;ATXN7;OTULIN;TRAF2;USP35;TNFAIP3;TRAF3;ATXN3;OTUD3;ACTB;TP53;PSMB10;STAMBPL1;YY1;ASXL2;SMAD3;BABAM2;MCRS1;USP7;PSMA2;USP48;USP31;BECN1;USP18;PSME3;IKBKG;FOXK1;MINDY1;HCFC1;PSMB5;INO80;USP9X;MBD5;PSMD8;USP8;JOSD2;USP29;PSMD7;PSMB9;USP21;USP16;HIF1A;BABAM1;PTEN;IL33;RHOA;PSMD2;KEAP1;BIRC2
prerank,methylguanosine-cap decapping (GO:0110156),0.4299923161581776,0.8343841003497636,0.6721804511278195,0.9406221625737651,1.0,1/10,4.01%,PNRC2
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2880307138122812,-0.8339838728985909,0.6652542372881356,0.9471925270412905,1.0,10/16,25.78%,ADSS2;GMPS;PFAS;AMPD3;AMPD2;PAICS;ADSL;IMPDH1;NUDT2;PPAT
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.2531521485244265,-0.833951406232541,0.6954022988505747,0.9450214884235578,1.0,4/24,8.48%,SORBS1;IRS1;EPM2AIP1;SELENOS
prerank,oligodendrocyte development (GO:0014003),-0.2888106844997549,-0.8337621451434879,0.6872427983539094,0.9431819936390341,1.0,7/15,30.94%,EIF2B3;TPPP;EIF2B5;EIF2B4;NSUN5;SOX10;EIF2B1
prerank,regulation of telomere maintenance (GO:0032204),0.3707000358038436,0.8335860769960739,0.6930572472594397,0.941455237269781,1.0,10/26,22.85%,XRCC5;SMG1;ATRX;USP7;HNRNPD;ERCC1;TINF2;TERF2;ERCC4;TERF2IP
prerank,protein targeting to membrane (GO:0006612),0.3303963270626451,0.8334446529368033,0.7479423868312757,0.941280937470786,1.0,23/83,21.72%,RAB8B;MICALL1;ABCD1;ZDHHC14;AQP11;ZDHHC7;PEX13;PXMP2;ZDHHC3;VPS37C;SDCBP;ZDHHC1;ZDHHC24;SRP19;RABGEF1;ATG3;MYO1C;SEC63;ABCD2;FIS1;ZDHHC21;ZDHHC2;SRP14
prerank,polyamine metabolic process (GO:0006595),0.4077931184576747,0.8332865780918374,0.6802244039270687,0.9411182070416788,1.0,4/13,15.56%,SMOX;AMD1;HDAC6;PAOX
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.3436466351748424,0.8330489946793219,0.7029702970297029,0.9410960414409792,1.0,6/46,8.46%,PLCL2;TLE3;MAP2K6;DDIT3;FLCN;RB1
prerank,protein auto-ADP-ribosylation (GO:0070213),0.42300609340511947,0.8323421723767059,0.6836158192090396,0.9417554610326831,1.0,7/12,23.59%,PARP8;PARP16;TNKS2;TIPARP;PARP10;PARP3;PARP1
prerank,maturation of LSU-rRNA (GO:0000470),0.3679006418094548,0.832138551260435,0.6856465005931198,0.9416743045448761,1.0,7/26,19.82%,RPL10A;LAS1L;DDX18;PES1;ZNHIT6;WDR12;RPL7A
prerank,heart development (GO:0007507),0.32605311512723156,0.8319972027969376,0.8217522658610272,0.9415133702485087,1.0,25/150,14.97%,SHH;TGFB1;SH3PXD2B;TGFBR1;EEF1AKMT4-ECE2;PKP2;PKD2;ADAP2;CHD7;TGFBR2;MEF2A;MYOCD;LDB3;MEF2C;ZDHHC16;SMYD4;SOX9;WDR11;HDAC9;TAB2;CASP8;MEGF8;SOX4;PDLIM1;POU6F1
prerank,nitric oxide metabolic process (GO:0046209),0.40587104161467447,0.8318950481317715,0.6963350785340314,0.9412807802927607,1.0,2/14,11.59%,GCH1;SPR
prerank,negative regulation of defense response to virus (GO:0050687),0.4338087300570813,0.8318349659031714,0.6849925705794948,0.9409935077567432,1.0,5/10,25.36%,TSPAN6;ITCH;TARBP2;ILRUN;C1QBP
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.36577947974683056,0.8318219796128091,0.6977567886658795,0.940623772430424,1.0,3/27,9.00%,LPIN2;CHKB;ABHD4
prerank,UV-damage excision repair (GO:0070914),-0.3122118843982341,-0.8314961800155729,0.696,0.9457560933125714,1.0,5/12,20.71%,DDB2;DDB1;XPA;POLA1;ACTR5
prerank,microtubule nucleation (GO:0007020),-0.27540515499866447,-0.8313552455943457,0.7015706806282722,0.943842064213098,1.0,6/19,13.94%,SLAIN2;TUBGCP2;NDEL1;NDE1;GOLGA2;TPPP
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.3161277657411482,-0.8308590454593796,0.6891385767790262,0.9426833818380621,1.0,3/12,9.85%,SORBS1;IRS1;PRKCZ
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.30280992609097074,-0.8307944453907303,0.6679245283018868,0.9406046487401355,1.0,8/14,32.76%,ENPP3;AK3;AK4;SMPDL3A;CMPK2;NME2;CMPK1;AK7
prerank,telomere organization (GO:0032200),0.3512637802502954,0.82998376237842,0.7330415754923414,0.9430847931318957,1.0,16/43,24.85%,PTGES3;XRCC5;DOT1L;STN1;DNA2;POLD3;TINF2;RAD51D;TERF2;PARP3;ERCC4;H3-3A;TERF2IP;PARP1;ATR;RPA1
prerank,aorta development (GO:0035904),0.4004217925272959,0.8295399533323006,0.6634349030470914,0.943367964412904,1.0,4/14,15.03%,PKD2;HECTD1;TFAP2B;LRP1
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.42742806046608905,0.8293266214638566,0.6777939042089985,0.9433028131631186,1.0,6/11,26.06%,VPS11;SORL1;PRKN;EIPR1;PTPN23;RAB21
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.3610130295516807,0.8290244880171096,0.7086705202312139,0.9433480810137951,1.0,10/30,22.98%,MGAT5;OSTC;MCFD2;STT3B;DDOST;MGAT1;STT3A;TUSC3;MAGT1;DPM2
prerank,nerve growth factor signaling pathway (GO:0038180),0.4315461887038898,0.8286684696591131,0.6754385964912281,0.9435213165992646,1.0,4/10,19.06%,NTF3;RAPGEF1;RAP1A;KIDINS220
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.3655502334194123,0.8270723300568987,0.6923076923076923,0.9455749724515433,1.0,3/27,3.69%,HCN4;FGF13;PKP2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.3684400524183995,0.8266813604490522,0.7023370233702337,0.9457694486580418,1.0,6/24,21.35%,NFE2L2;TNFAIP3;GAS6;PDPK1;ANGPT1;RAMP2
prerank,gonad development (GO:0008406),0.3456783600162537,0.8258800017949087,0.7013129102844639,0.9466223463948805,1.0,2/41,1.62%,GATA1;BASP1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3614061430946638,0.8251580658765696,0.696969696969697,0.9473227873912607,1.0,7/29,17.38%,MAD2L2;NKX2-1;ADIPOR1;PPP2CA;VASN;PTEN;LDLRAD4
prerank,mRNA processing (GO:0006397),0.3197130556377404,0.8249944794450026,0.897,0.9471809832186997,1.0,75/287,21.68%,IK;SNRNP27;GTF2H1;DHX9;ERN1;BCAS2;SF3B2;SF3B1;AURKAIP1;PPIE;DHX38;SNRNP25;CWF19L1;SCAF11;THOC2;CCAR1;DNAJC8;TFIP11;GCFC2;ZMAT5;CSTF1;CASC3;SNRPD2;CDC5L;RBM15B;CWC27;PPARGC1A;CDK7;HNRNPL;RBMX2;DDX39B;SON;SNIP1;POLR2L;CHERP;METTL3;PRPF8;TRA2B;CTNNBL1;RBM41;POLDIP3;PCBP1;UPF3B;THOC3;HNRNPD;WDR83;ALKBH5;BUD31;AKAP8L;CWF19L2;LSM8;CRNKL1;PCF11;PPIH;DDX41;GTF2H5;SLU7;POLR2E;SNRNP200;HNRNPF;SRSF6;SNRPB2;SNRNP35;PNN;SRSF2;PABPN1;SF3B3;SART1;SRSF10;SRSF3;PTBP1;HNRNPA0;UBL5;PDCD7;PRCC
prerank,regulation of stress fiber assembly (GO:0051492),0.32729667395730944,0.8248851246988056,0.7588357588357588,0.9469573891211276,1.0,13/74,11.23%,TGFBR1;ARHGEF18;ARAP1;RGCC;FHOD1;SLC9A1;WASF2;ACTG1;F11R;PFN2;NF2;PFN1;NRP1
prerank,mitotic cytokinesis (GO:0000281),0.3433206770547052,0.824648030262481,0.7226435536294691,0.9469233353200838,1.0,12/47,17.17%,SNX9;ESPL1;SNX33;CNTROB;KIF23;SON;MYH10;USP8;PDCD6IP;RASA1;INCENP;SNX18
prerank,RNA methylation (GO:0001510),-0.20514781090606135,-0.824532965541215,0.8125,0.9508875587027984,1.0,21/60,23.10%,NSUN6;METTL6;THADA;CBLL1;THUMPD3;METTL14;NSUN2;METTL5;METTL16;TRMT6;TARBP1;TGS1;CMTR1;MTO1;MTERF4;MEPCE;NOP2;TRMT5;LCMT2;WDR6;NSUN5
prerank,calcineurin-mediated signaling (GO:0097720),0.4257556485598921,0.824478036817282,0.6643159379407616,0.9463883902826599,1.0,1/10,2.16%,NFATC1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.4257556485598921,0.824478036817282,0.6643159379407616,0.9463883902826599,1.0,1/10,2.16%,NFATC1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.3892394869360249,0.8243975370971329,0.6849673202614379,0.9461256496010623,1.0,6/16,21.02%,ATP5MC2;ATP5F1E;ATP5F1A;ATP5PD;ATP5MG;ATP5MF
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.37469009287259814,0.8241736636153634,0.699238578680203,0.9460810936981803,1.0,2/23,8.71%,TGFB1;SMAD3
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.37330411466320906,0.823874960934453,0.6857142857142857,0.9461526374697268,1.0,5/19,18.32%,MAD2L2;RGCC;PTPRU;DENND6A;FLOT1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.4228020294888014,0.8237647558567098,0.6706408345752608,0.9459397376174922,1.0,6/11,24.90%,MTOR;SMARCB1;PIH1D1;DDX11;PWP1;SIRT7
prerank,actin filament capping (GO:0051693),0.38178884563148463,0.8235455881362121,0.689171974522293,0.945474703905738,1.0,4/18,12.18%,FLII;CAPZB;CAPZA1;TWF2
prerank,barbed-end actin filament capping (GO:0051016),0.38178884563148463,0.8235455881362121,0.689171974522293,0.945474703905738,1.0,4/18,12.18%,FLII;CAPZB;CAPZA1;TWF2
prerank,protein N-linked glycosylation (GO:0006487),0.33297579483463224,0.8233061376557315,0.7513007284079084,0.9454296684310195,1.0,20/66,21.38%,MGAT5;MAN1C1;B4GALT1;OSTC;ST3GAL1;MCFD2;ALG2;DPAGT1;STT3B;B4GALT7;PMM1;MGAT5B;TMEM165;ALG11;MGAT4B;DDOST;MGAT1;STT3A;TUSC3;MAGT1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.36657992793132044,0.823203445974741,0.6992924528301887,0.9452128121908088,1.0,8/25,21.21%,ZNF326;EAF1;DDX39B;ELL;KAT7;ERCC6;ZMYND11;SETD5
prerank,necroptotic process (GO:0070266),0.40228571582852385,0.8231943984210448,0.681757656458056,0.9448389747598009,1.0,3/16,8.92%,CD14;TICAM1;LY96
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.32044123257229357,0.8230614446804665,0.8128128128128128,0.9446392487873526,1.0,27/129,15.71%,TGFB1;GPRC5B;ZEB2;DKK2;LGR6;FZD9;PSMB10;TBL1XR1;WNK1;CSNK1G2;GID8;ATP6AP2;AMER1;TBL1X;PSMA2;TNKS2;PSME3;BAMBI;NFKB1;PSMB5;PSMD8;LRRK2;SOX4;USP8;PSMD7;PSMB9;LGR4
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.2802081515906014,-0.8227612994776337,0.7333333333333333,0.9523163489172104,1.0,5/18,14.41%,UBTF;EIF2AK3;ATF4;DHX33;UTP15
prerank,ribosomal large subunit biogenesis (GO:0042273),0.34055002691896347,0.8227289489799609,0.7411764705882353,0.9447587574841774,1.0,12/54,17.60%,RPL10A;LAS1L;GTF3A;SURF6;RPL6;RPL26;MDN1;RRS1;NOC2L;PES1;RPL11;WDR12
prerank,protein ubiquitination (GO:0016567),0.3186773545839813,0.822691921721137,0.961,0.9444344057629406,1.0,93/471,18.32%,ARRB2;NFE2L2;CBL;MYLIP;TRIM25;UBE2V2;ZNRF2;RNF19B;TRIM5;MKRN1;CDC23;UBE2V1;UBE2D3;OTULIN;TRAF2;FBXL22;MSL2;VPS18;MGRN1;RNF7;FBXL18;HLTF;TAF1;RNF111;KLHL21;CTNNB1;UVSSA;UBE2S;PSMB10;LEO1;KLHL7;LONRF1;RC3H2;VPS11;TRIM27;RNF114;UBE2E3;PEX13;RC3H1;DERL1;RNF4;UBE4B;NFX1;NEDD4L;UBE2H;RNF10;PHC1;USP7;PSMA2;TRIM24;RNF40;FBXO40;TRIM35;CDC34;SPOP;DET1;FBXO32;TNKS2;ARRDC4;PSME3;FBXL3;RNF135;ITCH;UBE2G2;STUB1;RNF144B;PSMB5;HUWE1;USP9X;PSMD8;AREL1;UBE2J2;DTX4;ZNRF1;RNF152;PSMD7;GAN;PSMB9;SMURF1;HIF1A;ATG3;FANCL;UBE2N;TRIM62;ZNRF3;ANAPC11;VHL;UBE2Z;UBE2K;PSMD2;KEAP1;BIRC2;FBXO44
prerank,DNA modification (GO:0006304),0.37598814977992734,0.8223553690193904,0.6976744186046512,0.9445497276021071,1.0,8/22,23.59%,NEIL2;OGG1;TINF2;EXOSC3;TERF2;PARP3;TERF2IP;PARP1
prerank,negative regulation of anoikis (GO:2000811),-0.2935873126145561,-0.822299566588119,0.7047970479704797,0.9510557613990748,1.0,2/14,6.60%,CAV1;TLE1
prerank,purine-containing compound catabolic process (GO:0072523),0.4021410232118069,0.8219184387679995,0.6712328767123288,0.9448071942452388,1.0,2/13,8.29%,XDH;PNP
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.3714451165415444,0.8216530353869794,0.6921182266009852,0.9448184490782638,1.0,5/21,14.82%,MYH9;PRKCQ;SPPL3;ERAP1;SPPL2A
prerank,regulation of programmed necrotic cell death (GO:0062098),0.3837928974857327,0.8215400585113494,0.7068965517241379,0.9445962963348259,1.0,10/20,20.84%,CFLAR;SDCBP;CASP8;STUB1;PDCD6IP;HSP90AA1;ASAH1;BIRC2;FLOT1;BIRC3
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4223429238607138,0.821474850585122,0.7076023391812866,0.9443105825971876,1.0,7/10,26.03%,NELL1;EPHA4;FURIN;ATRAID;EFNA1;RIC1;CDK5RAP3
prerank,RNA metabolic process (GO:0016070),0.3181596857627972,0.8208079588147216,0.8107287449392713,0.9449017154377355,1.0,33/127,21.19%,APOBEC1;DHX9;RBM39;SND1;TFIP11;ADAR;PCBP3;AGO4;FASTKD1;HNRNPL;DDX39B;RNASEL;POLR2L;AGO3;RNASEH1;METTL3;LAGE3;ADARB1;PCBP1;HNRNPD;NUFIP1;LSM8;AGO2;PABPC4;RNASEH2A;POLR2E;RBMS2;HNRNPF;FTO;PABPN1;DICER1;PTBP1;HNRNPA0
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.38276614011785753,0.8205636976149354,0.6920152091254753,0.9448966788223488,1.0,8/18,27.10%,VPS11;DNAJC13;MAP2K2;SRC;PTPN23;RAB21;MAPK1;MAPK3
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.3467348567263914,0.8203768128543933,0.71875,0.9447730563250251,1.0,17/37,26.63%,SND1;ADPRM;ENTPD1;RNASEH1;HNRNPD;ENTPD2;PABPC4;RNASEH2A;ENTPD3;RNASE6;DNASE1L1;SIDT2;XRN2;NCBP1;DFFB;RNASE3;SUPV3L1
prerank,protein localization to cell surface (GO:0034394),0.3611616767054952,0.8203406134608333,0.716183574879227,0.9444415662420316,1.0,13/26,25.48%,CTNNB1;VCL;PTPRU;GGA2;ARF6;SMURF1;MESD;ANGPT1;PIGU;UNC50;FLNA;PIGK;GGA3
prerank,establishment of apical/basal cell polarity (GO:0035089),0.40855865308687406,0.8201061614247616,0.6865284974093264,0.9443934828798496,1.0,4/14,19.31%,RAP2A;RHOA;CDC42;SCRIB
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.32402186614983874,0.8198672108826577,0.7691521961184883,0.9443637248898061,1.0,20/86,18.91%,NFE2L2;ATF3;DDIT3;BACH1;TP53;PSMB10;EPO;IMPACT;PSMA2;PSME3;PSMB5;INO80;PSMD8;PSMD7;PSMB9;HIF1A;GCN1;VHL;PSMD2;ELOB
prerank,negative regulation by host of viral transcription (GO:0043922),-0.3155435168639921,-0.8198169870384467,0.7175572519083969,0.9539197721257541,1.0,4/12,18.76%,REST;PSMC3;TARDBP;HMGA2
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.37218197358471716,0.8197115153807685,0.6713735558408216,0.944210193007505,1.0,6/17,20.67%,TNF;VCL;F11R;ADD1;ROCK2;ZDHHC21
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.21526337021288608,-0.8193999401421436,0.8192771084337349,0.9525462053545874,1.0,22/44,33.95%,OSBPL9;OSBPL1A;HMGCR;CYP7B1;INSIG2;INSIG1;SQLE;PER2;PARK7;AMACR;CYP39A1;PMVK;LBR;SCP2;HSD17B4;DHCR7;EBP;SLC27A2;SC5D;TM7SF2;OSBPL2;CH25H
prerank,striated muscle cell development (GO:0055002),0.3933512407191042,0.8191638685028929,0.7003994673768309,0.9446456260122303,1.0,2/14,14.80%,FLII;CAPN3
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3273473509310835,0.818054766031941,0.7948453608247422,0.9458780990600673,1.0,14/85,14.24%,TGFB1;NLRC3;MTSS1;AQP11;DUSP10;LIMS1;SOX9;GRN;NOD2;CDK6;NR4A1;B2M;RAB33B;SOX2
prerank,axon guidance (GO:0007411),0.31683187862363715,0.8179362057901659,0.859,0.9456594118056536,1.0,46/201,20.56%,SHH;DRAXIN;SPTBN5;PIK3CD;GRB2;PIK3CB;PLXNC1;SEMA4D;TUBB3;DOK1;CXCR4;PLXNB2;EMB;LGR6;EFNA2;TNR;GAB2;SH3KBP1;PRKCQ;SEMA4A;ARTN;CYFIP1;NRP1;PTPRO;FYN;RANBP9;NPTN;EFNB3;SRC;PTPRA;LAMA3;EPHA4;EPHA8;SEMA4B;RPS6KA5;SPTBN4;VLDLR;TMEFF1;KLF7;VSTM2L;GDNF;PALLD;RELN;CNTN4;CDK5R1;DOK5
prerank,leukotriene metabolic process (GO:0006691),0.3812408254377116,0.8177744844607868,0.6810126582278481,0.9455333924422501,1.0,5/19,23.77%,ALOX12;ABCC1;ABCC10;PLA2G5;DPEP2
prerank,regulation of embryonic development (GO:0045995),-0.22732259788314377,-0.8176809524909837,0.8031496062992126,0.953689228249096,1.0,10/34,20.42%,PHLDB2;NIPBL;PHLDB1;TDG;NPHP3;ZBED3;SOX17;DHX36;RBM19;RPS6KA6
prerank,fatty acid elongation (GO:0030497),0.40145929706614203,0.8176422880749364,0.6887052341597796,0.9453593829063535,1.0,2/13,8.77%,ABCD1;HACD4
prerank,regulation of synapse assembly (GO:0051963),0.34262503027099134,0.8175535464784706,0.7213114754098361,0.9451134050940012,1.0,5/46,8.10%,CLSTN1;TLR2;SLITRK1;SNCA;MEF2C
prerank,L-amino acid transport (GO:0015807),0.3590702305503779,0.8172346175484343,0.7104337631887456,0.9452031711668833,1.0,6/28,15.10%,SLC7A8;SLC36A1;SLC36A4;SLC25A18;CTNS;SLC1A4
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.3956717444770921,0.8170520296516438,0.7094594594594594,0.9450936896065589,1.0,4/14,17.60%,DDX18;PES1;ZNHIT6;WDR12
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.270557099721259,-0.8165896577744554,0.7511737089201878,0.9536320471235691,1.0,10/19,33.39%,DRG1;CEP97;HNRNPU;CHMP5;CHMP4B;CHMP2A;CHMP4C;CHMP1B;HSPA1A;EML3
prerank,myotube differentiation (GO:0014902),0.39111453114908035,0.8165526498793972,0.6912928759894459,0.9454329834948775,1.0,3/17,8.10%,SKI;PLD3;MEF2C
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.3685757489578687,0.8157053839089373,0.7021013597033374,0.9463371862838238,1.0,10/22,28.08%,UTP20;NOP9;RRS1;PES1;WDR12;EXOSC3;EXOSC2;URB1;NOP14;EXOSC10
prerank,protein acylation (GO:0043543),0.3429914423695263,0.8156650369857943,0.6959910913140311,0.9460123159078645,1.0,12/38,21.35%,ZDHHC14;ZDHHC7;ZDHHC13;NAT9;ZDHHC16;ZDHHC3;ZDHHC1;SELENOK;GTF2B;ZDHHC21;NAA80;ZDHHC2
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.40358901561945376,0.8154841352728073,0.6864064602960969,0.945901857588254,1.0,5/13,23.91%,RENBP;NAGK;SLC35A3;GNPNAT1;GNPDA2
prerank,double-strand break repair (GO:0006302),0.3188250638099274,0.8151857804102205,0.8412060301507538,0.9459572014624451,1.0,41/158,21.97%,ZFYVE26;MAD2L2;UBE2V2;NABP1;RMI1;HMGB1;XRCC5;SAMHD1;BRIP1;LIG3;YY1;ATP23;CHEK2;TRIP13;BABAM2;HPF1;APTX;MCM9;DNA2;INO80;SLX4;DDX1;ERCC5;SMARCAD1;RAD51B;BABAM1;MDC1;UBE2N;ERCC1;SWI5;RAD51D;POLM;SPIDR;SFR1;HERC2;DCLRE1C;NSMCE2;PARP3;ERCC4;RFWD3;SMARCA5
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.3002625786064761,-0.8151227016905848,0.7341269841269841,0.9543263495825963,1.0,2/13,3.80%,SORBS1;IRS1
prerank,ATP synthesis coupled proton transport (GO:0015986),0.38216405961887323,0.8149813829048898,0.7065637065637066,0.9458794880629599,1.0,6/17,21.02%,ATP5MC2;ATP5F1E;ATP5F1A;ATP5PD;ATP5MG;ATP5MF
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.3866248913156387,0.8147830203939309,0.6997389033942559,0.9458047277728029,1.0,8/17,25.48%,APOE;SORL1;RTN1;RTN4;BIN1;PIN1;IGF1;GGA3
prerank,positive regulation of DNA recombination (GO:0045911),0.35577052268475606,0.8147784894071369,0.7194679564691656,0.9454328481370772,1.0,6/27,19.13%,MAD2L2;MMS19;ACTR2;ERCC6;SHLD1;SHLD2
prerank,protein localization to chromatin (GO:0071168),-0.2717952423766022,-0.8147117693453482,0.7161572052401747,0.9529095159496835,1.0,3/18,6.33%,NIPBL;WAPL;MSH2
prerank,negative regulation of cellular protein localization (GO:1903828),0.3526008155546636,0.8146972180641261,0.7086614173228346,0.9451619385672342,1.0,11/34,20.55%,SNX33;SPI1;RIPOR2;FLCN;NEDD4L;ANKRD13A;PICALM;ROCK2;LEPROTL1;GSK3B;NSFL1C
prerank,synaptic membrane adhesion (GO:0099560),-0.2938795175758518,-0.8140340971047636,0.7338403041825095,0.9519157506930533,1.0,2/14,2.95%,GPC6;NTNG1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.3811909966022081,0.8137602733336484,0.6871008939974457,0.9461181875753266,1.0,9/18,23.15%,LDLRAP1;CLN3;ACTB;ZDHHC7;STX8;ABCA2;ZDHHC2;VAMP8;STX7
prerank,regulation of neuron differentiation (GO:0045664),0.3269932744663579,0.8134346964447606,0.790356394129979,0.9461947476321979,1.0,17/76,20.23%,ASCL1;GPRC5B;MMD;MEF2C;NTF3;IMPACT;ZFHX3;SOX2;LRRK2;YWHAH;BIN1;ARHGEF2;CASZ1;RHOA;BEND6;CNTN4;CDK5R1
prerank,positive regulation of nervous system development (GO:0051962),0.34078363153928193,0.8133673849645193,0.737885462555066,0.9459016059435525,1.0,2/42,1.58%,CX3CR1;CLSTN1
prerank,regulation of mitochondrial fusion (GO:0010635),0.4186643196922619,0.8132664038534958,0.6950867052023122,0.9456832575251373,1.0,4/11,20.78%,PID1;HUWE1;VAT1;PRKN
prerank,neuron cell-cell adhesion (GO:0007158),-0.29591970461345096,-0.8132458747488898,0.7105263157894737,0.9511738759609041,1.0,3/14,8.33%,NLGN1;ASTN1;NINJ2
prerank,regulation of cellular amide metabolic process (GO:0034248),0.3551681207203139,0.8130953468802349,0.727683615819209,0.9455486706925659,1.0,9/32,18.57%,PRKCD;NR1H4;FOXO3;CYFIP1;PCIF1;PUM3;PGAM1;PICALM;TIGAR
prerank,error-prone translesion synthesis (GO:0042276),-0.270315404239821,-0.8124508352200944,0.7795698924731183,0.950554734187942,1.0,16/21,35.27%,REV3L;REV1;RFC1;PRIMPOL;RFC2;POLE2;UBC;POLK;POLI;RPA3;UBA52;RPA2;RFC3;RPS27A;RFC4;PCNA
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3234850501425149,0.8123604896381312,0.803680981595092,0.9462390139532635,1.0,28/95,24.14%,MCM5;ZFYVE26;NABP1;RMI1;SAMHD1;LIG3;YY1;RAD54L;MCM6;MCM2;MCM9;INO80;SLX4;ERCC5;RAD51B;UBE2N;SWI5;RAD51D;SPIDR;CDC45;SFR1;NSMCE2;ERCC4;RFWD3;SEM1;MORF4L1;PARP1;GINS4
prerank,protein localization to phagophore assembly site (GO:0034497),-0.31621069632426596,-0.8122879560427962,0.7265917602996255,0.9486872260128004,1.0,8/11,44.29%,MFN2;WDR45B;WIPI1;WDR45;ATG9A;STX17;ATG13;WIPI2
prerank,visual system development (GO:0150063),0.34107229182861176,0.8121951161404013,0.7258248009101251,0.9461158317598173,1.0,7/37,15.34%,SH3PXD2B;C1QA;ITGAM;ZDHHC16;SOX2;MEIS1;SIPA1L3
prerank,negative regulation of interleukin-8 production (GO:0032717),0.38349479332874087,0.8121212979044857,0.7251612903225807,0.9458442847599606,1.0,5/17,18.45%,ANXA1;TMSB4X;ANXA4;CD33;MAP2K5
prerank,mitochondrial RNA metabolic process (GO:0000959),0.3946572321176471,0.8121092099300403,0.7004103967168263,0.945478815832801,1.0,5/14,24.33%,FOXO3;FASTKD1;TWNK;TFAM;MRPL12
prerank,mitochondrial transcription (GO:0006390),0.4176315128894107,0.8116562554458613,0.7045790251107829,0.9457723560540725,1.0,4/10,24.33%,FOXO3;TWNK;TFAM;MRPL12
prerank,development of primary male sexual characteristics (GO:0046546),0.35274737125152794,0.8111373961515114,0.7337142857142858,0.9461342579327469,1.0,4/34,11.17%,GATA1;LHFPL2;INHBA;SOX9
prerank,protein localization to chromosome (GO:0034502),0.34920621906529264,0.8110810980616996,0.7347629796839729,0.9458442517670179,1.0,12/34,24.85%,XRCC5;RB1;ATRX;TNKS2;MCM9;SLF2;TINF2;TERF2;PARP3;TERF2IP;ATR;RPA1
prerank,L-serine metabolic process (GO:0006563),0.4128372516618445,0.810755109831119,0.7212643678160919,0.9459710671891742,1.0,5/10,24.97%,CBS;PHGDH;PSAT1;SERINC3;PSPH
prerank,negative regulation of T cell differentiation (GO:0045581),0.41736181972009434,0.8103244091907499,0.6886930983847284,0.9462114252013019,1.0,2/10,13.88%,MDK;IRF1
prerank,myotube cell development (GO:0014904),0.41400111485893765,0.8103151526429284,0.6942496493688639,0.9458466877136944,1.0,1/10,4.36%,SKI
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.3117922858231227,-0.810285901189675,0.7077464788732394,0.9504967447789758,1.0,5/11,22.05%,AHCYL1;PAPOLA;PAF1;DHX36;NCBP2
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.2623820438659089,-0.8099917635571067,0.7386934673366834,0.9489331625951197,1.0,4/22,12.20%,VPS37A;UBAP1;SNF8;VPS4A
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.4098463970805639,0.8096389147154123,0.7013888888888888,0.9464050160145105,1.0,4/11,16.59%,RESF1;ATF7IP;TPR;TASOR
prerank,cellular response to interleukin-7 (GO:0098761),0.38714988135664197,0.8095667237487887,0.7188328912466844,0.9457487630326755,1.0,3/17,14.01%,STAT5A;STAT5B;IL2RG
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.38714988135664197,0.8095667237487887,0.7188328912466844,0.9457487630326755,1.0,3/17,14.01%,STAT5A;STAT5B;IL2RG
prerank,Notch signaling pathway (GO:0007219),0.3339349830639199,0.809437874456404,0.7724358974358975,0.945546525951887,1.0,3/59,3.24%,ASCL1;MDK;MAML3
prerank,atrial septum morphogenesis (GO:0060413),-0.3227704947755981,-0.8088743543250168,0.6818181818181818,0.9488859288348852,1.0,4/10,26.25%,ACVR1;HEY2;BMPR2;TGFB2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.31177849571241484,0.8083180126545346,0.939,0.9467904502089998,1.0,58/336,16.97%,LYN;EID3;FAM111A;FNIP2;TAOK3;GTF2H1;GRB2;MAPK14;MAP2K6;NABP1;TANK;BRAT1;DDIT3;EXO1;VAV3;OARD1;XRCC5;TAF1;SAMHD1;BACH1;BCL2L1;TP53;POLH;YY1;CHEK2;DOT1L;ENDOV;MMS19;BAK1;UVRAG;RAD54L;ZDHHC16;BABAM2;MGMT;HPF1;RBBP5;APTX;BOD1L1;WDHD1;TNFRSF1B;METTL3;PDS5A;MCM9;IKBKG;RNF169;INO80;SLX4;SLF2;REXO4;TOP2A;USP16;OGG1;NRDE2;RAD51B;SUV39H1;STXBP4;FANCL;MACROD1
prerank,protein targeting (GO:0006605),0.3184858934175385,0.8082369921590726,0.8279678068410463,0.9465298633779955,1.0,28/118,19.60%,TSPO;EDEM1;AP1S3;AIP;MICALL1;SPCS2;ZDHHC14;AQP11;ZDHHC7;TIMM22;SPCS1;ZDHHC3;VPS37C;SDCBP;SORL1;TOMM40;ZDHHC1;ZDHHC24;RABGEF1;ATG3;RPL11;PITRM1;MYO1C;GIPC1;SEC63;LTBP2;TOMM20;FIS1
prerank,glutathione biosynthetic process (GO:0006750),-0.3207156690326912,-0.8079000438194286,0.7003154574132492,0.9486149321928821,1.0,6/11,35.79%,GSS;OPLAH;CHAC2;GGCT;HAGH;GGT1
prerank,bile acid biosynthetic process (GO:0006699),-0.2502634018186278,-0.8077681593983552,0.7592592592592593,0.9467629043888954,1.0,12/24,37.87%,OSBPL9;OSBPL1A;CYP7B1;AMACR;CYP39A1;SCP2;HSD17B4;SLC27A2;OSBPL2;CH25H;CYP46A1;HSD3B7
prerank,positive regulation of protein deacetylation (GO:0090312),-0.29101664578009667,-0.8069457559362548,0.7037037037037037,0.9461017442051174,1.0,2/14,4.64%,NIPBL;DYRK1A
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.34044346262248787,0.8069009611672824,0.743847874720358,0.9480177748752407,1.0,8/38,15.14%,NDUFA11;NDUFB8;NDUFA2;NDUFB4;NDUFV1;NDUFS6;NDUFAB1;NDUFB11
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.400057314068363,0.8068695760840837,0.7294964028776978,0.9476886375323774,1.0,6/11,22.83%,ASF1B;ATRX;UBN1;RBBP4;IPO4;H3-3A
prerank,negative regulation of vascular permeability (GO:0043116),0.40438673223331595,0.8066956385478086,0.7198335644937587,0.9475661212441032,1.0,6/12,24.84%,PTPRJ;DDAH1;ANGPT1;RAMP2;VEGFA;SH3GL2
prerank,regulation of glycolytic process (GO:0006110),0.3256432326729741,0.8066482538237228,0.7705943691345151,0.9472607094387002,1.0,14/68,16.87%,CBFA2T3;P2RX7;MLXIPL;NUP62;PFKFB4;SEH1L;HDAC4;TPR;NUP205;PFKFB3;HIF1A;GAPDHS;GCK;PGAM1
prerank,regulation of chromatin organization (GO:1902275),0.3863056908766328,0.806489141486557,0.6941813261163735,0.9471013058966266,1.0,3/14,10.19%,TLK1;METTL4;HPF1
prerank,histone mRNA catabolic process (GO:0071044),-0.2911555806778475,-0.8058487165742789,0.6991869918699187,0.9459480781192874,1.0,5/15,14.46%,SSB;ERI1;ATM;UPF1;TUT1
prerank,sphingolipid catabolic process (GO:0030149),0.3877577592549584,0.8053952586297811,0.7186261558784677,0.9482403274104504,1.0,4/15,19.88%,SGPL1;ACER3;ASAH1;SMPD1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.39629224768200694,0.8049328706727409,0.7016348773841962,0.948536372783931,1.0,5/14,21.96%,TIMP1;LIMS1;CD63;LOXL3;FLNA
prerank,regulation of epithelial cell differentiation (GO:0030856),0.3904465137584605,0.8048879194012749,0.7317073170731707,0.9482290220550016,1.0,3/17,11.17%,MAFG;CEBPB;SOX9
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.2813676205618424,-0.8031880306109614,0.74,0.9486291549227898,1.0,7/16,17.69%,SMCHD1;KMT5B;DTX3L;KMT5C;WRAP53;KDM4D;PRKDC
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.3681114008699482,0.8024131943178722,0.7260765550239234,0.9513706674623335,1.0,1/23,0.90%,TGFB1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.27834735659379145,-0.8022182990073223,0.7394636015325671,0.9482450960960476,1.0,5/16,17.04%,AUTS2;SMAD4;DNMT1;SNW1;PAXIP1
prerank,skeletal system morphogenesis (GO:0048705),0.3384510847835598,0.8021677628384313,0.739514348785872,0.9513273026379044,1.0,8/42,13.95%,TGFBR1;SKI;LRP5;DYNC2I1;MEGF8;RFLNA;RAB33B;ANKRD11
prerank,canonical Wnt signaling pathway (GO:0060070),0.327739901187264,0.8019134517385411,0.7722980062959076,0.9513031168070055,1.0,13/68,16.50%,FZD10;FRAT2;FZD9;FZD3;CTNNB1;SCYL2;LRP5;AMER1;CSNK1A1;LRRK2;BCL9;FZD8;PTEN
prerank,protein polyubiquitination (GO:0000209),0.3115316237566848,0.8017666382874785,0.927,0.9511164904398088,1.0,64/297,18.32%,MYLIP;UBE2V2;RFFL;ZNRF2;RNF19B;TRIM5;MKRN1;CDC23;UBE2V1;UBE2D3;TRAF2;FBXL22;TNFAIP3;TRAF3;FBXL18;TAF1;HECTD1;CTNNB1;UBE2S;PSMB10;LONRF1;RC3H2;TRIM27;RNF114;UBE2E3;RC3H1;RNF4;UBE4B;TRAF5;NEDD4L;UBE2H;TRIM56;PSMA2;FZR1;FBXO40;CDC34;SPOP;FBXO32;TNKS2;PSME3;RNF216;FBXL3;RNF135;ITCH;UBE2G2;STUB1;RNF144B;PSMB5;HUWE1;PSMD8;AREL1;UBE2J2;ZNRF1;RNF152;PSMD7;PSMB9;SMURF1;UBE2N;TRIM62;ANAPC11;UBE2K;PSMD2;BIRC2;FBXO44
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3823938879849283,0.8014430461560703,0.7269279393173198,0.9511786928228863,1.0,2/17,9.11%,UNC13D;SYT10
prerank,negative regulation of double-strand break repair (GO:2000780),0.34664371717090037,0.801198747743712,0.7337962962962963,0.9511578496459148,1.0,8/30,19.13%,MAD2L2;TFIP11;HSF1;RNF169;ERCC6;OGG1;SHLD1;SHLD2
prerank,positive regulation of lyase activity (GO:0051349),-0.292597444582768,-0.8009147088847094,0.7490909090909091,0.9485967108815238,1.0,6/14,21.09%,CACNA1C;NOS3;PARK7;NOS1;FXN;ISCU
prerank,axonogenesis (GO:0007409),0.3104104914625632,0.8008287140397616,0.915,0.9512866820291827,1.0,45/237,17.85%,SHH;DRAXIN;NEFH;SPTBN5;PIK3CD;GRB2;PIK3CB;S100B;SLITRK1;SEMA4D;TUBB3;DOK1;CXCR4;EMB;LGR6;EFNA2;TNR;ACTB;GAB2;SH3KBP1;PRKCQ;MAP1B;SEMA4A;ARTN;CYFIP1;NRP1;PTPRO;ATL1;FYN;RANBP9;NPTN;USP9X;EFNB3;SRC;PTPRA;LAMA3;EPHA4;PTEN;HSP90AA1;EPHA8;PPP3CB;SEMA4B;RPS6KA5;SPTBN4;VLDLR
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.22266776676113434,-0.8008211720552877,0.8076923076923077,0.946676947502287,1.0,20/35,36.19%,RFC1;TDG;XRCC1;SMUG1;RFC2;POLG;LIG1;RPA3;NEIL1;POLD2;RPA2;RFC3;POLE;RFC4;MUTYH;PCNA;NTHL1;POLD4;POLD1;MPG
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.34129756256526517,0.8006856766172075,0.7146118721461188,0.9511101151497403,1.0,5/35,12.10%,RASAL3;ARHGAP24;RIPOR2;FLCN;SYNGAP1
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.2778439183491774,-0.8004883405689662,0.7297297297297297,0.9451644569848193,1.0,9/16,32.04%,DIP2A;ACLY;MLYCD;PPT1;CBR4;ACSS1;PPCS;GCDH;SLC25A1
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.3764457514996015,0.8000515562842514,0.7191867852604829,0.951590771234609,1.0,9/18,25.87%,PUM2;GPATCH3;BIRC2;BIRC3;RNF125;DDX60;C1QBP;USP15;PUM1
prerank,snRNA processing (GO:0016180),-0.27856346080106165,-0.7995859987990034,0.7731481481481481,0.944656254704964,1.0,6/16,18.93%,INTS9;INTS14;INTS10;TUT1;INTS4;INTS2
prerank,interstrand cross-link repair (GO:0036297),-0.20288270078618256,-0.799518337845002,0.8428571428571429,0.9426914623099304,1.0,28/53,34.32%,NUCKS1;FAN1;FANCM;ATRIP;XPA;FANCI;POLN;ERCC6L2;DCLRE1A;MSH6;UBC;DCLRE1B;MUS81;FAAP20;RPA3;FANCB;UBA52;FANCC;FANCD2;FANCG;NEIL3;MCM8;RPA2;EXO5;RPS27A;RAD51;RAD51AP2;CENPX
prerank,regulation of DNA binding (GO:0051101),0.33240302533941907,0.799381340996815,0.7677208287895311,0.9521197895962351,1.0,4/44,8.18%,TGFB1;SKI;HMGB1;DOT1L
prerank,C4-dicarboxylate transport (GO:0015740),0.3896110482758973,0.7981413778475582,0.7135348226018396,0.9534844180184074,1.0,3/14,13.02%,LRRC8D;SLC25A18;SLC25A30
prerank,alpha-amino acid catabolic process (GO:1901606),0.3460563650047465,0.7975556243377037,0.7482517482517482,0.9538872562620809,1.0,5/29,16.85%,HAAO;KYNU;KMO;THNSL2;CBS
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.34448305422198977,0.7973277090995874,0.7465909090909091,0.9538292887372486,1.0,4/32,6.54%,FGF13;SNCA;ATXN7;MAPRE1
prerank,protein methylation (GO:0006479),-0.21989414100626486,-0.7972733075508914,0.8514851485148515,0.9446104894663571,1.0,21/40,32.91%,RAB6A;SETD3;FAM98B;SNRPD3;ATPSCKMT;EZH2;PCMT1;PRMT8;PRMT1;EEF2KMT;LCMT1;METTL22;PRMT7;EEF1AKMT2;N6AMT1;CAMKMT;ICMT;NTMT1;VCPKMT;EHMT1;TRMT112
prerank,neural crest cell migration (GO:0001755),0.3386662379774802,0.7970572186120288,0.7485714285714286,0.9538305780555466,1.0,4/36,11.23%,SHH;SEMA4D;SEMA4A;NRP1
prerank,peptidyl-asparagine modification (GO:0018196),0.345349500088797,0.7967445327834766,0.7468499427262314,0.9538797027930404,1.0,10/31,22.98%,MGAT5;OSTC;MCFD2;STT3B;DDOST;MGAT1;STT3A;TUSC3;MAGT1;DPM2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.2654370450709426,-0.7966479538973203,0.7577092511013216,0.9436629647659612,1.0,5/18,12.45%,KANK1;ARHGAP35;SCAI;MET;HEG1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.37379764273611127,0.7964982679701371,0.7261306532663316,0.9538489577195418,1.0,9/19,25.48%,APOE;SORL1;RTN1;RTN4;BIN1;PICALM;PIN1;IGF1;GGA3
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.2883048574938146,-0.796321334185251,0.6983471074380165,0.9422203428636138,1.0,4/15,15.27%,BMP4;SMO;SIX1;PAX2
prerank,positive regulation of cyclase activity (GO:0031281),0.38936497500564676,0.7961388265508406,0.7105978260869565,0.9539571769199847,1.0,4/14,16.60%,MAPK14;AKAP5;NF1;CACNA1D
prerank,regulation of cartilage development (GO:0061035),0.37106974479463806,0.7955200332164357,0.727979274611399,0.9544268973476273,1.0,4/18,13.61%,MDK;TRPS1;SOX9;SOX6
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.3137502568983795,-0.7953313904638595,0.7372013651877133,0.9418986248328944,1.0,5/11,14.33%,PARP6;PARP14;PARP12;PARP11;PARP4
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.41393403241805765,0.7951340843221902,0.7184466019417476,0.9545692063920544,1.0,5/11,23.67%,SNX33;NEDD4L;PICALM;LEPROTL1;GPM6B
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.38730901888649133,0.7949803480073822,0.702928870292887,0.9544107907934568,1.0,5/13,23.92%,RAMP1;IL33;ABCA2;CHP1;IGF1
prerank,negative regulation of stress fiber assembly (GO:0051497),0.35221553027763125,0.7948935915829799,0.737410071942446,0.9541449213207331,1.0,6/24,13.25%,ARHGEF18;ARAP1;WASF2;F11R;PFN1;PPFIA1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3263328183162099,0.7947867619355128,0.7873254564983888,0.9539297959563338,1.0,7/54,10.47%,RGCC;CNOT8;TP53;CRADD;PLK2;CHEK2;RPL26
prerank,calcium ion transport (GO:0006816),0.31151512078598664,0.7942319616046137,0.8467741935483871,0.9543133321057615,1.0,22/113,17.27%,KCNN4;P2RX7;SLC8A1;CCL8;PKD2;ORAI2;P2RX4;RAMP1;CACNA1A;ATP2C1;TPT1;CACNB2;FYN;CDH23;GAS6;ATP2A3;CACNA1B;TRPV3;SELENOK;CACNA1D;CRACR2B;TMEM165
prerank,regulation of microtubule depolymerization (GO:0031114),0.35401122518216643,0.7940924820262458,0.730814639905549,0.9541176998509845,1.0,6/25,18.94%,FGF13;ATXN7;MAP1B;CAMSAP2;ARHGEF2;TAOK1
prerank,cilium assembly (GO:0060271),0.30505657920364715,0.7939510857093484,0.937,0.9539416040712961,1.0,56/296,18.14%,TUBB;MKS1;RAB8B;PRKAR2B;HAUS2;EXOC6;ASAP1;TUBA4A;IFT52;RP2;CNTRL;CEP192;MAPRE1;CNGB1;CEP70;SPATA6;BBS9;PLK4;ATP6V0D1;CEP76;DISC1;HAUS1;SNAP29;RAB11A;ACTR2;ACTR3;HDAC6;EXOC8;WDR11;DYNC2I1;DYNC1H1;EXOC7;EXOC1;PCM1;EXOC2;IFT80;TXNDC15;EXOC5;RPGR;FNBP1L;CEP152;EXOC3;HAUS8;JHY;CEP162;AHI1;WDR90;NINL;HSP90AA1;WDPCP;IFT27;NUDCD3;AKAP9;DYNC2LI1;CEP63;SNX10
prerank,establishment of epithelial cell polarity (GO:0090162),0.37159057803273493,0.7937888202737757,0.7049382716049383,0.9537797743987416,1.0,6/19,18.43%,RAP2A;CYTH1;SIPA1L3;RHOA;CDC42;GOLPH3
prerank,mitochondrial fission (GO:0000266),0.3881847323428154,0.7935077506451778,0.7330779054916986,0.9537911635285757,1.0,7/16,25.03%,MTFR2;DNM2;DNM1L;FIS1;PRKN;MTFR1;MFF
prerank,neural crest cell development (GO:0014032),0.32934097014812946,0.7934227869207181,0.7431693989071039,0.9535351444601077,1.0,9/44,19.29%,SHH;SEMA4D;PDCD6;SEMA4A;NRG1;SEMA4B;CORO1C;TAPT1;GDNF
prerank,amyloid fibril formation (GO:1990000),0.3279792249179539,0.7933768429399684,0.7851772287862513,0.9532188533263141,1.0,12/51,17.02%,SNCA;TTR;TGFBI;TSPAN14;IAPP;ITM2B;SORL1;B2M;GGA2;USP9X;CD36;FURIN
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.36391948028310456,0.7930924286590365,0.7365853658536585,0.953209493865147,1.0,5/21,18.94%,FGF13;ATXN7;CAMSAP2;ARHGEF2;TAOK1
prerank,phosphatidylserine metabolic process (GO:0006658),0.3468039712621923,0.7930345365699792,0.7373271889400922,0.9529145275671222,1.0,6/32,20.31%,ABHD12;OSBPL10;OSBPL8;ABHD16A;PLAAT3;PLA2G5
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.35961256668862746,0.7925370614184779,0.7302551640340219,0.9532214008993481,1.0,2/22,6.70%,MED17;TP53
prerank,programmed necrotic cell death (GO:0097300),0.37800646297072993,0.7925291287101648,0.7258687258687259,0.9528574277594584,1.0,3/18,8.92%,CD14;TICAM1;LY96
prerank,positive regulation of telomere maintenance (GO:0032206),0.3410525327784693,0.7923351635152523,0.7470588235294118,0.9527544738389522,1.0,6/31,14.36%,PKIB;PRKCQ;ATRX;TNKS2;SLX4;HNRNPD
prerank,acyl-CoA metabolic process (GO:0006637),0.34386949748087525,0.7922222935291963,0.7411225658648339,0.9525470268079198,1.0,6/35,17.49%,DBI;OGDH;ACSF2;ACOT9;ACACA;ACOT2
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.3973047475470832,0.7917684717720839,0.7337931034482759,0.9527908425922087,1.0,5/12,22.41%,SREBF2;SEC14L2;SREBF1;ABCA2;MBTPS2
prerank,mitochondrion organization (GO:0007005),0.3089855883743695,0.7915883781475339,0.8818818818818819,0.9526599036440867,1.0,38/165,19.75%,TSPO;RAB32;MTFR2;AIP;ATP7A;PYROXD2;BCL2L1;DNM2;MEF2A;LONP1;ATP23;CHCHD4;MSTO1;TIMM22;PPARGC1A;ATCAY;IMMP2L;MGME1;TIMM50;PRDX3;WDR81;HCFC1;TOMM40;ATAD3A;PID1;MIGA1;HK2;LRRK2;AGTPBP1;TWNK;YME1L1;PITRM1;RAB29;DNM1L;TOMM20;FIS1;MPV17;MFN1
prerank,dendritic spine morphogenesis (GO:0060997),-0.2912344475568014,-0.7914287261848918,0.7456140350877193,0.9465336134486316,1.0,4/15,11.11%,EPHB2;DIP2A;SHANK3;SHANK1
prerank,cellular response to superoxide (GO:0071451),0.40558597187776607,0.7913826781966049,0.7267441860465116,0.9525656252861698,1.0,3/10,12.89%,ATP7A;PRDX1;PRDX2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.32589317396680517,0.7902628019889054,0.7397107897664071,0.9537082768209205,1.0,13/42,24.67%,MAD2L2;MMS19;ACTR2;SETD2;ERCC6;PPP4C;SHLD1;PPP4R2;SHLD2;SPIDR;TERF2IP;PARP1;KLHL15
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.35162733916642597,0.7901798277762841,0.7360285374554102,0.9534530936335435,1.0,8/27,20.21%,SCN4B;NEDD4L;FXYD5;YWHAH;SCN5A;FXYD6;PTPN3;FXYD1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.3343477044362305,0.7901735553370896,0.7693169092945129,0.953087763527721,1.0,8/40,14.53%,BCL2L1;ABCD1;ATP5IF1;PPA2;BAK1;PRDX3;PID1;LRRK2
prerank,cellular macromolecule catabolic process (GO:0044265),0.3282232620174762,0.7897969968498232,0.7887931034482759,0.9532032429511705,1.0,20/49,26.63%,SND1;OGA;CHEK2;RNASEH1;STT3B;UBE2G2;HNRNPD;IDE;PABPC4;FBXO44;RNASEH2A;PRKN;RNASE6;DNASE1L1;SIDT2;XRN2;NCBP1;DFFB;RNASE3;SUPV3L1
prerank,sensory perception of smell (GO:0007608),-0.3100519175915471,-0.7897033152077261,0.7435897435897436,0.9474969354128229,1.0,5/11,23.15%,UBR3;BBS4;SLC24A4;DRD2;MKKS
prerank,electron transport chain (GO:0022900),0.3820134249312417,0.7892070956861641,0.7135483870967742,0.9536209462587295,1.0,5/15,20.74%,PPARGC1A;POR;SDHB;ETFDH;SDHA
prerank,mitotic nuclear division (GO:0140014),0.31390709936576255,0.7883965890979221,0.7951933124346917,0.9543533437433653,1.0,14/71,17.75%,NUP62;ESPL1;BCCIP;NCAPG2;CEP192;UBE2S;CHEK2;RAB11A;STAG2;INO80;KIF2A;CENPK;MIS12;RHOA
prerank,relaxation of muscle (GO:0090075),0.393461290654046,0.7877786658898213,0.7246575342465753,0.9548199485057882,1.0,2/13,5.57%,SLC8A1;P2RX4
prerank,midbody abscission (GO:0061952),-0.27408571403771087,-0.7876385760393646,0.7475728155339806,0.9489336396496761,1.0,5/17,20.05%,VPS4A;CHMP5;CHMP4B;CHMP4A;CHMP2A
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.2997020160656425,-0.7870618436872738,0.7381818181818182,0.947966017353065,1.0,4/13,14.30%,ADHFE1;D2HGDH;GOT1;DLST
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.2644284176836692,-0.7869407523862109,0.775330396475771,0.9461301895157083,1.0,4/18,10.47%,OTUD7B;LATS1;RAB23;LATS2
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.27385689447804257,-0.7867841100962543,0.7536231884057971,0.9423582335541361,1.0,4/16,15.72%,PHLDB2;ACVRL1;ARHGAP6;DMTN
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.27385689447804257,-0.7867841100962543,0.7536231884057971,0.9423582335541361,1.0,4/16,15.72%,PHLDB2;ACVRL1;ARHGAP6;DMTN
prerank,positive regulation of heart rate (GO:0010460),-0.2728632514204241,-0.7867436225639405,0.7205240174672489,0.9404015830505792,1.0,6/17,29.71%,RYR2;EDN1;EDN3;PDE4D;ATP2A2;SCN3B
prerank,response to amino acid (GO:0043200),0.3460802191146353,0.7867167701884399,0.7590643274853801,0.9558776924228604,1.0,10/31,21.78%,MTOR;CPEB3;GLRA2;LAMTOR3;CAPN2;CPEB4;LAMTOR1;RPTOR;RRAGA;RRAGB
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3442223254505583,0.7864652046538722,0.7306791569086651,0.9558381319852512,1.0,6/31,12.93%,SEMA4D;SKI;LRP5;SOX9;CDK6;BAMBI
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.2849894060344348,-0.7860785320003884,0.7589285714285714,0.9395007313386542,1.0,7/16,29.98%,UPP2;NT5E;CRMP1;DPYSL2;NT5C1A;UPB1;DPYSL3
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.37407521451299475,0.7858448974985606,0.7167553191489362,0.9562731966275511,1.0,2/14,8.96%,PTPN1;BAK1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.3954995251339528,0.7857428245604802,0.6979310344827586,0.9560267087669838,1.0,3/11,11.17%,TGFBR2;LRP5;SOX9
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.379799262502863,0.7854999680543473,0.7313237221494102,0.9559487507767535,1.0,2/14,7.90%,TRAF2;MALT1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.30421003290069154,0.7854414053463467,0.929,0.9556538193138748,1.0,62/241,21.68%,IK;SNRNP27;DHX9;BCAS2;SF3B2;SF3B1;PPIE;DHX38;SNRNP25;CWF19L1;CCAR1;DNAJC8;TFIP11;GCFC2;ZMAT5;CSTF1;CASC3;SNRPD2;CDC5L;RBM15B;CWC27;HNRNPL;RBMX2;DDX39B;SNIP1;POLR2L;CHERP;METTL3;PRPF8;TRA2B;CTNNBL1;RBM41;PCBP1;UPF3B;HNRNPD;WDR83;BUD31;CWF19L2;LSM8;CRNKL1;PCF11;PPIH;DDX41;SLU7;POLR2E;SNRNP200;HNRNPF;SRSF6;SNRPB2;SNRNP35;PNN;SRSF2;PABPN1;SF3B3;SART1;SRSF10;SRSF3;PTBP1;HNRNPA0;UBL5;PDCD7;PRCC
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.3750604424332523,0.7853583462906433,0.7242744063324539,0.9553978733628428,1.0,1/15,2.22%,DAGLB
prerank,histone H3-K9 demethylation (GO:0033169),-0.316282565339725,-0.7849236102647376,0.7553191489361702,0.9393928137520446,1.0,5/11,16.80%,JMJD1C;KDM3A;KDM4B;KDM4A;KDM4D
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.303092980741946,0.7849149185172111,0.933,0.95561060344838,1.0,67/264,21.68%,IK;SNRNP27;DHX9;BCAS2;SF3B2;SF3B1;PPIE;DHX38;SNRNP25;CWF19L1;SCAF11;CCAR1;DNAJC8;TFIP11;GCFC2;ZMAT5;CSTF1;SRPK3;CASC3;SNRPD2;CDC5L;RBM15B;CWC27;HNRNPL;RBMX2;DDX39B;SNIP1;POLR2L;CHERP;METTL3;PRPF8;TRA2B;CTNNBL1;RBM41;PCBP1;UPF3B;DDX1;HNRNPD;WDR83;BUD31;CWF19L2;LSM8;CRNKL1;PCF11;PPIH;DDX41;SLU7;POLR2E;SNRNP200;HNRNPF;SRSF6;SNRPB2;SNRNP35;PNN;SRSF2;CLNS1A;PABPN1;SF3B3;SART1;SRSF10;SRSF3;STRAP;PTBP1;HNRNPA0;UBL5;PDCD7;PRCC
prerank,DNA metabolic process (GO:0006259),0.304039241232192,0.7848619266874534,0.938,0.9553177458609707,1.0,49/270,17.04%,MCM5;EID3;ORC3;GTF2H1;UBE2V2;PTGES3;NABP1;EXO1;HMGB1;XRCC5;SAMHD1;BACH1;LIG3;POLH;LONP1;DOT1L;ENDOV;MMS19;UVRAG;RAD54L;MGMT;MCM6;MCM2;DBF4;USP7;ORC4;WDHD1;STN1;CDC34;RNASEH1;PDS5A;SMARCB1;ZNF445;DNA2;CDC6;INO80;SLX4;POLD3;ERCC5;NOC3L;REXO4;TOP2A;OGG1;SMARCAD1;RAD51B;FANCL;CBS;LRWD1;UBE2N
prerank,activation of protein kinase B activity (GO:0032148),0.3403001918594074,0.7848195960033518,0.7673031026252983,0.9550051630407512,1.0,7/29,17.77%,MTOR;IL18;NTF3;NRG1;GAS6;OSBPL8;PDPK1
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.2873899558475634,-0.7848017763564039,0.7333333333333333,0.9376046088133915,1.0,2/13,6.00%,RANBP2;IPO5
prerank,response to leucine (GO:0043201),0.4054358807606337,0.7845395727875379,0.7325408618127786,0.9546367323953545,1.0,1/10,2.52%,MTOR
prerank,cellular response to leucine (GO:0071233),0.4054358807606337,0.7845395727875379,0.7325408618127786,0.9546367323953545,1.0,1/10,2.52%,MTOR
prerank,monoacylglycerol metabolic process (GO:0046462),0.3897774772038013,0.7838927633062944,0.7270306258322237,0.9551211935851589,1.0,3/13,18.87%,ABHD12;ABHD16A;DGAT2
prerank,mitochondrion morphogenesis (GO:0070584),-0.3084625185000948,-0.7837082051924236,0.768976897689769,0.9374445432075584,1.0,6/11,28.43%,MTM1;NUBPL;WASF1;SLIRP;MYH14;PNPT1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3131923006839224,0.7835946932929982,0.8229273285568065,0.9551398876988748,1.0,15/84,17.85%,ANAPC15;PTTG1;CDC23;UBE2S;PSMB10;RB1;PSMA2;FZR1;PSME3;PSMB5;PSMD8;PSMD7;PSMB9;ANAPC11;PSMD2
prerank,ribosomal subunit export from nucleus (GO:0000054),0.3860461863380601,0.7831053673656267,0.7321178120617111,0.9554333909748335,1.0,3/13,13.02%,XPO1;NOP9;RRS1
prerank,copper ion homeostasis (GO:0055070),0.37177638674248226,0.7829918510980864,0.7310704960835509,0.9552154537695569,1.0,2/17,4.49%,ATP7A;ATOX1
prerank,regulation of rRNA processing (GO:2000232),-0.2654677278294977,-0.7827111372206927,0.756,0.9371890422904882,1.0,8/16,32.91%,RIOK2;SHQ1;UTP15;USP36;KAT2B;RIOK1;NUDT16;TRMT112
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.22042036371963797,-0.7826865402193471,0.8936170212765957,0.9352194715621424,1.0,23/37,35.85%,RFC1;DDB2;DDB1;RBX1;CHD1L;XPA;RFC2;GTF2H3;UBC;POLK;RPA3;GTF2H4;UBA52;POLD2;RPA2;RFC3;RPS27A;CUL4B;RFC4;PCNA;NTHL1;POLD4;POLD1
prerank,GTP metabolic process (GO:0046039),0.37947950762972715,0.7823361372692045,0.7496671105193076,0.9557120700342082,1.0,6/15,23.34%,GTPBP1;GNAI3;LRRK2;IMPDH2;MFN1;EFL1
prerank,positive regulation of cell growth (GO:0030307),0.3073948454810491,0.781395034569747,0.834685598377282,0.9566073246083677,1.0,24/96,22.96%,SYT17;TGFBR1;SEMA4D;BRAT1;MACF1;SYT2;CSNK2A1;NEDD4L;TWF2;SDCBP;INO80;SMURF1;CXCL16;RASAL1;CDC42;PLAA;RPTOR;UNC13A;RIMS1;PABIR1;ITSN2;EXOSC2;H3-3A;GOLGA4
prerank,import into nucleus (GO:0051170),0.3169764046954919,0.7813889139076796,0.8150470219435737,0.9562432381404495,1.0,6/73,10.11%,MMP12;SYK;NUP62;SNRPD2;CSE1L;TPR
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.2154164269068313,-0.7812427082294983,0.8977272727272727,0.9355196416145044,1.0,24/39,35.85%,RFC1;DDB2;DDB1;FAN1;RBX1;CHD1L;XPA;RFC2;GTF2H3;UBC;POLK;RPA3;GTF2H4;UBA52;POLD2;RPA2;RFC3;RPS27A;CUL4B;RFC4;PCNA;NTHL1;POLD4;POLD1
prerank,phospholipid dephosphorylation (GO:0046839),-0.21216576739314255,-0.7800124393456044,0.8455284552845529,0.9356087989521064,1.0,3/37,1.33%,MTM1;SACM1L;MTMR7
prerank,glial cell differentiation (GO:0010001),0.3434778376768791,0.7797725914574173,0.7488262910798122,0.9580232697593822,1.0,4/28,14.60%,SHH;SOX9;SOX2;SOX4
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.30853897631935345,0.7794551509100225,0.8246687054026504,0.9580523101497606,1.0,10/87,13.58%,CBL;GRB2;DSTYK;RAB14;CD44;FLRT1;POLR2L;CCL2;NR4A1;FIBP
prerank,selective autophagy (GO:0061912),0.3189589553185512,0.7794147639527893,0.8,0.9577317802732255,1.0,23/56,27.25%,MAP1LC3B;UBE2V1;RAB7A;HDAC6;BECN1;DYNC1H1;WDR81;TEX264;RETREG1;ATG2B;UBE2N;WDFY3;ATG14;PRKN;RB1CC1;UBA5;IFT88;DYNC1LI1;NBR1;AMBRA1;DYNLL1;ATG2A;UFM1
prerank,inorganic anion transport (GO:0015698),0.31659840508460074,0.7793090833515726,0.7938689217758985,0.9575063962229909,1.0,6/53,15.59%,SLC11A1;PACC1;CLIC1;XPR1;SLC25A30;CLCN4
prerank,cochlea morphogenesis (GO:0090103),-0.3071563634053629,-0.7791580271439993,0.7278688524590164,0.934993069368472,1.0,3/10,15.27%,TBX18;TBX1;PAX2
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.3402067176177852,0.7783452512334412,0.7485172004744959,0.9584099856057092,1.0,7/25,16.53%,ATXN3;LONP1;DERL1;HDAC6;TOR1A;STUB1;YME1L1
prerank,protein-DNA complex assembly (GO:0065004),0.3049112037884452,0.7781623303697163,0.8614457831325302,0.9582904460392438,1.0,23/116,18.25%,MCM5;ORC3;GTF2H1;PSMB10;ATRX;CDK7;MCM6;MCM2;NAP1L1;PSMA2;SOX9;ORC4;PSME3;PSMB5;CDC6;PSMD8;ERCC5;SPTY2D1;PSMD7;PSMB9;RSF1;PSMD2;GTF2H5
prerank,negative regulation of cell growth (GO:0030308),0.3037191175899226,0.7778904156449763,0.8703517587939699,0.9582733213180982,1.0,14/121,12.34%,TGFB1;PTPRJ;FGF13;NME6;DIP2B;CDA;TP53;FLCN;RB1;SMAD3;SIPA1;INHBA;RBBP7;PPP2CA
prerank,transport across blood-brain barrier (GO:0150104),0.3092033198103944,0.7778542017928377,0.8163054695562435,0.9579477763276053,1.0,15/83,17.02%,SLCO2B1;ABCC3;ATP8A1;SLC7A8;SLC2A3;SLC16A2;FABP5;SLC16A1;ABCC1;ATP2A3;ATP1B2;LRP1;SLC1A4;CD36;SLC13A3
prerank,protein modification process (GO:0036211),0.30970348161924743,0.7776801846160479,0.8168574401664932,0.9578245916355151,1.0,23/76,24.58%,ST8SIA4;UBE2D3;UBE2S;LOX;ST3GAL1;MAN2B1;PIGH;MCRS1;MSRA;YES1;CDC34;B4GALT7;ATG3;ERO1A;PPP4R2;CSNK1G3;UBL5;ADPRH;UBA7;UBE2I;PARP1;BAP1;ABL2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.20396460544600084,-0.7770039039942707,0.9285714285714286,0.9364666312702763,1.0,10/48,11.87%,OGT;NUP93;NUP188;RANBP2;NUP98;NUP42;NDC1;RAE1;NUP153;NUP37
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.40343255130477607,0.7769749071082936,0.7478510028653295,0.9583519597109911,1.0,4/10,26.08%,SNCA;NOC2L;CTBP1;KLF15
prerank,aminoglycan metabolic process (GO:0006022),0.40000359156656295,0.776973728649542,0.7405731523378583,0.9579828078793762,1.0,3/10,20.94%,XYLT1;B4GALT7;B3GAT2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3585685572999575,0.7761984498840456,0.7527950310559006,0.9586130187779308,1.0,4/22,12.07%,P2RX4;MEF2A;SLC9A1;LMCD1
prerank,protein K48-linked deubiquitination (GO:0071108),0.3508528504341994,0.775943324905491,0.773561811505508,0.9585748381549744,1.0,5/23,14.78%,TNFAIP3;ATXN3;OTUD3;MINDY1;USP8
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.316160390765728,-0.7753173343399238,0.7589285714285714,0.9372845491561694,1.0,7/10,45.23%,FMR1;CALM3;DRD2;CBARP;GPR35;CRHR1;DRD3
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.384579195368397,0.774874969067543,0.7345505617977528,0.9595575371094368,1.0,4/13,13.26%,SEC16A;SEC16B;SORL1;SAR1A
prerank,replicative senescence (GO:0090399),0.3876308138836546,0.7748356277060453,0.7496617050067659,0.9592387022383293,1.0,2/12,7.97%,TP53;CHEK2
prerank,neuron remodeling (GO:0016322),-0.32595047682352096,-0.7744572348313967,0.7700348432055749,0.9367360298989659,1.0,1/10,0.14%,APP
prerank,negative regulation of cell junction assembly (GO:1901889),0.3503588173328569,0.7741530813288656,0.7408284023668639,0.959734265933959,1.0,7/25,19.65%,TLR2;TNF;THBS1;SRC;PTEN;CORO1C;ROCK2
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.39107875805751224,0.7737677700663114,0.7258297258297258,0.9598727015494575,1.0,1/10,3.78%,DNMT3A
prerank,ribonucleoprotein complex assembly (GO:0022618),0.30298989914880425,0.772675088580561,0.869215291750503,0.960905906921394,1.0,41/132,25.14%,DHX9;PTGES3;SF3B1;SCAF11;XRCC5;GCFC2;SRPK3;SNRPD2;ERAL1;RPL6;EIF4H;DDX39B;LUC7L3;MDN1;RPS14;RRS1;DDX1;RPL11;HSP90AA1;TARBP2;CRNKL1;RPS27;SNRNP200;SRSF6;CLNS1A;SART1;RRP7A;SRSF10;STRAP;DICER1;EIF2S2;SNRPB;RPS15;GEMIN8;RPS5;DDX20;NUDT21;RPL10;NCBP1;XAB2;HSP90AB1
prerank,relaxation of cardiac muscle (GO:0055119),0.38536844688477195,0.771534934166109,0.7405405405405405,0.9619912135279267,1.0,2/13,5.57%,SLC8A1;P2RX4
prerank,neural crest cell differentiation (GO:0014033),0.36318799186174966,0.7714870389289163,0.7378516624040921,0.9616811310581722,1.0,4/18,19.08%,MEF2C;PDCD6;NRG1;TAPT1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3192853364756266,0.7711682309906349,0.8065887353878852,0.9617014489953114,1.0,6/56,12.29%,TGFB1;TGFBR1;HFE;INHBA;SNX25;SDCBP
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.3782848494618585,0.771126935744996,0.7300275482093664,0.9613810707718251,1.0,5/13,23.34%,GTPBP1;GNAI3;LRRK2;MFN1;EFL1
prerank,amide biosynthetic process (GO:0043604),0.3175920587441973,0.7710655832878958,0.7825618945102261,0.9610901066968562,1.0,10/47,20.78%,CERS6;CLN8;AGK;DEGS1;ASAH1;FURIN;SGMS1;SPTSSA;SMPD1;SPTSSB
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.29196981093059504,-0.7710645272110317,0.7802197802197802,0.9400200771688335,1.0,2/12,4.78%,ARHGAP35;EPHB2
prerank,negative regulation of JUN kinase activity (GO:0043508),0.40269944527750845,0.7701856717648593,0.7393103448275862,0.9618667196476133,1.0,2/10,10.57%,DUSP10;DUSP19
prerank,cellular response to hydroxyurea (GO:0072711),0.3979456453387769,0.7701376280139319,0.7382645803698435,0.9615576754714238,1.0,2/10,9.48%,DDI2;ATRX
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.38685784038759374,0.7682467644557348,0.7341954022988506,0.9635874441581108,1.0,4/11,16.52%,PIK3CB;CREB3L1;THBS1;EPN1
prerank,hexose transmembrane transport (GO:0008645),0.3527169786745006,0.7682064912757584,0.7632911392405063,0.9632697115429218,1.0,3/21,17.26%,SLC2A3;SLC2A12;PPARD
prerank,positive regulation of transmembrane transport (GO:0034764),0.36645506261310484,0.7678604969905614,0.7164804469273743,0.963360175739997,1.0,2/13,13.29%,P2RX7;BRAF
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.30589463026395214,0.7677220681805665,0.8302658486707567,0.9631627145237238,1.0,9/86,12.29%,TGFB1;TGFBR1;ZEB2;RNF111;HFE;FLCN;INHBA;THBS1;SDCBP
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.3398405095708243,0.7670206544614174,0.7659327925840093,0.9633604132883007,1.0,6/29,22.16%,DBI;ACSF2;ACOT9;ACOT2;ACOT8;CROT
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.3398405095708243,0.7670206544614174,0.7659327925840093,0.9633604132883007,1.0,6/29,22.16%,DBI;ACSF2;ACOT9;ACOT2;ACOT8;CROT
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.3716608711208317,0.7666762002361155,0.7247579529737206,0.9634338137230427,1.0,7/13,28.33%,TNRC6A;CPEB3;AGO2;CNOT7;CNOT1;BTG2;TNRC6C
prerank,DNA repair (GO:0006281),0.2967859288823483,0.7665101726389312,0.956,0.9632802105381315,1.0,51/284,17.21%,EID3;FAM111A;NEIL2;GTF2H1;MAD2L2;UBE2V2;NABP1;UBE2V1;EXO1;XRCC5;BRIP1;BACH1;LIG3;ATXN3;TP53;POLH;FAAP100;CHEK2;DOT1L;ENDOV;TRIP13;MMS19;UVRAG;RAD54L;BABAM2;MGMT;SETD2;HPF1;MGME1;APTX;WDHD1;PDS5A;TEX264;PMS1;DNA2;INO80;HUWE1;SLX4;POLD3;DDX1;ALKBH5;ERCC5;REXO4;ERCC6;OGG1;RAD51B;BABAM1;FANCL;MDC1;UBE2N;FANCE
prerank,negative regulation of centrosome duplication (GO:0010826),-0.30109386138446026,-0.7663062446574027,0.7581227436823105,0.9453300283871392,1.0,9/11,32.99%,TRIM37;CDK5RAP2;RBM14;CENATAC;NPM1;KAT2B;KAT2A;CCNF;BRCA1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.2457475158505863,-0.7656233159900696,0.788659793814433,0.9443787858647678,1.0,10/21,28.50%,PAN2;CNOT3;SAMD4B;SAMD4A;TNKS1BP1;PAN3;PARN;CNOT6L;CNOT9;ZFP36
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.3967518603659289,0.7655418640098021,0.7433628318584071,0.9641483814344747,1.0,4/10,22.85%,TFIP11;TERF2;DCLRE1C;TERF2IP
prerank,negative regulation of telomere maintenance (GO:0032205),0.36884130070336063,0.7654016362401149,0.7457627118644068,0.9639487181672713,1.0,7/15,23.59%,TNKS2;SLX4;ERCC1;TERF2;ERCC4;TERF2IP;PARP1
prerank,cardiac muscle cell contraction (GO:0086003),0.35637785433526614,0.7651714097903597,0.73625,0.96387157151903,1.0,2/19,3.69%,SCN4B;PKP2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.3720092656294759,0.7649713809541054,0.7633289986996099,0.9637595923257272,1.0,2/15,6.68%,TGFBR1;TGFBR2
prerank,regulation of axon extension (GO:0030516),0.32572411174994853,0.7647673024702792,0.79337899543379,0.9636500502192797,1.0,10/37,22.96%,APOE;DIP2B;MACF1;DNM2;TWF2;RTN4;GSK3B;MT3;NRCAM;GOLGA4
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3507814050739523,0.7643317715498922,0.7561576354679803,0.963819903157064,1.0,7/21,19.95%,MLXIPL;NCK2;DDIT4;PTEN;PAQR3;CNKSR3;INPP5K
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.3996877700888585,0.7643128424885902,0.7361516034985423,0.9634793831289852,1.0,5/10,23.28%,SH2B3;NF2;PPP2CA;SOCS3;INPP5F
prerank,regulation of cilium movement (GO:0003352),0.3888465472925817,0.7642548229841514,0.7434782608695653,0.9631857050400682,1.0,1/10,5.50%,ODAD2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.3343757738151676,0.7640400496443625,0.7663230240549829,0.9630918101762931,1.0,5/29,11.41%,TLE3;CTNNB1;LEO1;RBBP5;PYGO2
prerank,replication fork processing (GO:0031297),0.32544319954191353,0.7638974396442328,0.7853932584269663,0.9628974635631247,1.0,5/38,13.34%,FAM111A;SAMHD1;ATRX;BOD1L1;DNA2
prerank,regulation of DNA repair (GO:0006282),0.31943824612593164,0.7637903912857266,0.7942794279427943,0.9626680760813647,1.0,11/44,18.57%,DHX9;UBE2V2;UBE2V1;POLH;BABAM2;KAT7;ERCC6;BABAM1;UBE2N;NPAS2;TIGAR
prerank,positive regulation of intracellular transport (GO:0032388),0.32469028765300467,0.763267791766511,0.7875417130144605,0.962958294590161,1.0,7/38,12.78%,RIPOR1;KIF20B;PGAP1;TPR;DYNC1H1;PCM1;SORL1
prerank,mitochondrial protein processing (GO:0034982),0.38523980351878884,0.7622503357097733,0.7390691114245416,0.9638808254324747,1.0,5/11,19.72%,ATP23;IMMP2L;PMPCB;YME1L1;PMPCA
prerank,mitochondrial membrane organization (GO:0007006),-0.2151315310797916,-0.7621587085257597,0.8956521739130435,0.9478418379303349,1.0,11/32,22.80%,APOOL;IMMT;SLC25A4;BNIP3;SPG7;SAMM50;BAD;MFN2;MTX3;SLC25A5;APOO
prerank,cellular response to amino acid stimulus (GO:0071230),0.33068852254224035,0.7619687004577135,0.7992998833138857,0.9638751076731142,1.0,11/33,21.78%,MTOR;CPEB3;GLRA2;FYN;LAMTOR3;CAPN2;CPEB4;LAMTOR1;RPTOR;RRAGA;RRAGB
prerank,negative regulation of synaptic transmission (GO:0050805),-0.23375935834116443,-0.7619610169861255,0.8579881656804734,0.9461616208348346,1.0,8/23,25.87%,ATAD1;SLC24A2;SLC30A1;PRRT1;SHANK2;DRD2;ARF1;STXBP1
prerank,actomyosin structure organization (GO:0031032),0.3004812860944936,0.7618974113594345,0.8379772961816305,0.9635945553744227,1.0,15/75,15.27%,ITGB5;TTN;MYLK3;MYH9;FLII;TNNT3;EPB41;F11R;EPB41L2;ZYX;MYH10;CSRP1;PDLIM1;CAPN3;SRC
prerank,cell part morphogenesis (GO:0032990),-0.28382177313440576,-0.7618003256851998,0.7832699619771863,0.9444296929262971,1.0,6/13,28.43%,MTM1;NUBPL;WASF1;SLIRP;MYH14;PNPT1
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.34792567858299217,0.7615889531626433,0.752851711026616,0.9636119757056566,1.0,2/19,10.02%,APOE;RAPSN
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3304950287143787,0.7615748386044361,0.8002257336343115,0.9632658108568052,1.0,11/35,25.52%,ALOX12;HPGD;GGTA1;FASN;ACACA;PPT2;FAR2;HMGCL;SCD;ACSS3;HSD17B8
prerank,hemidesmosome assembly (GO:0031581),0.3868627624522652,0.7611128409933312,0.7464183381088825,0.9635060046006847,1.0,3/11,15.77%,ITGA6;LAMA3;DST
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.375383738232845,0.7603854005419463,0.7224489795918367,0.9640387563381856,1.0,2/13,9.02%,PTPN1;PDCD6
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.37494795770603445,0.760035725960444,0.7447988904299584,0.9640855946909105,1.0,1/12,1.96%,SLAMF8
prerank,tRNA wobble uridine modification (GO:0002098),0.37407165541134896,0.759518119165807,0.7600554785020804,0.9643372769492804,1.0,3/14,11.46%,ELP1;TRMU;CTU1
prerank,protein monoubiquitination (GO:0006513),0.32671694480499985,0.7594615334564536,0.7924311926605505,0.9640409428740407,1.0,12/36,23.31%,TRIM25;UBE2D3;MGRN1;LEO1;RNF40;HUWE1;FANCL;CUL3;PRKN;UBE2R2;UBE2E1;CTR9
prerank,regulation of protein kinase C signaling (GO:0090036),-0.2803950892636014,-0.7590484210822758,0.8015267175572519,0.9464491914964945,1.0,3/14,6.35%,WNT5A;ULK4;MYADM
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.3527029048818487,0.7588655455957661,0.7584059775840598,0.964431787413248,1.0,3/19,12.48%,PYCARD;TP53;DDIT4
prerank,mitotic sister chromatid cohesion (GO:0007064),0.36688049470379586,0.7585409198573116,0.7601043024771839,0.9644585630747662,1.0,6/16,25.05%,RB1;PDS5A;NAA50;MAU2;SMC1A;PDS5B
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.36274896889980185,0.758253890666353,0.7557251908396947,0.964453816445326,1.0,6/16,21.48%,ST8SIA4;ST6GALNAC4;ST8SIA1;LARGE1;B4GALNT1;B4GALT6
prerank,protein localization to cilium (GO:0061512),-0.21937911027749007,-0.7581932547865525,0.8601398601398601,0.9457428767616883,1.0,15/32,26.97%,ZNF423;ATP6V1D;ARL3;BBS4;ARL6;EHD1;WDR35;IFT20;TCTN2;BBS1;TUB;IFT122;WDR19;TULP2;NPHP4
prerank,dendrite self-avoidance (GO:0070593),0.36254461865983545,0.7581209492925585,0.7667525773195877,0.9642535245305428,1.0,6/16,24.11%,EMB;NPTN;VSTM2L;PALLD;CNTN4;BSG
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.35632926479645854,0.7578616495894839,0.7509578544061303,0.9642123292942758,1.0,2/17,3.69%,SLC8A1;PKP2
prerank,synapse organization (GO:0050808),0.2975488082634634,0.7578186187276797,0.8920282542885973,0.9639031209480584,1.0,17/125,14.72%,CX3CR1;PCDHB6;ARHGAP39;C1QC;SLITRK1;SNCA;AGRN;C1QA;CACNB4;RAB39B;C1QB;CACNB2;CYFIP1;CACNB1;PPFIA1;LRRK2;KIRREL3
prerank,cellular response to arsenic-containing substance (GO:0071243),0.3663786806623372,0.7578144406758337,0.7530201342281879,0.9635432769269096,1.0,3/15,16.45%,ATF3;HSF1;CPEB2
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.3395171202303689,0.7577574352409665,0.7808716707021792,0.9632462020776431,1.0,6/23,19.44%,HERPUD1;SEL1L;DERL1;SEC16A;SEC13;OS9
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.24545150050742537,-0.7570389081280515,0.84375,0.9455424819276353,1.0,5/20,12.28%,AFG3L2;MICU1;SLC8A3;SPG7;MCUR1
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.23291272615434633,-0.7568827586911739,0.8342857142857143,0.9438388136988721,1.0,10/24,30.49%,DACH1;ACVRL1;MSH2;MSH6;H1-0;CDKN1A;BMPR2;NIBAN2;MSH3;RTEL1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.29291623940701594,-0.7568377445071699,0.7774086378737541,0.9419715315350218,1.0,2/11,5.70%,GSN;CAAP1
prerank,cilium movement (GO:0003341),0.3108982772716434,0.7565345177527604,0.8070175438596491,0.9643850572936985,1.0,5/47,13.03%,DNAI4;ODAD2;TTC29;ODAD1;CCDC63
prerank,peptidyl-lysine monomethylation (GO:0018026),0.3943808881638472,0.7561868273823994,0.7678832116788321,0.9644773214330536,1.0,2/10,10.14%,SETD6;SETD2
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.37657854188525486,0.7561209477324358,0.7229916897506925,0.9641903114578229,1.0,3/13,12.13%,MMS19;CIAO2A;CIAO1
prerank,synaptic vesicle cycle (GO:0099504),0.33472628700454055,0.7554417850290822,0.7894736842105263,0.9647003988559628,1.0,4/30,9.11%,SNCA;PIP5K1C;PLD2;SYT10
prerank,C-terminal protein amino acid modification (GO:0018410),-0.29564511185891607,-0.7553158646875164,0.7483870967741936,0.9424267259940049,1.0,8/11,28.45%,AGBL4;FOLH1;GPLD1;TTL;LCMT1;AGBL1;ATG5;ICMT
prerank,protein O-linked mannosylation (GO:0035269),-0.2540466239958321,-0.7552969808743911,0.8253275109170306,0.940530201872805,1.0,9/18,23.47%,DPM1;POMT2;RXYLT1;TMTC1;TMTC3;CRPPA;FKRP;DPM3;TMTC2
prerank,mRNA export from nucleus (GO:0006406),0.29747039422866933,0.7552945200561251,0.8655030800821355,0.964522392593956,1.0,28/102,20.94%,PCID2;NUP62;DHX38;NXF1;THOC2;SEH1L;CASC3;RBM15B;SMG1;TPR;DDX39B;NUP205;POLDIP3;UPF3B;THOC3;ALKBH5;SMG7;UPF2;SLU7;FYTTD1;SRSF6;SRSF2;SEC13;PABPN1;HHEX;SLBP;SRSF3;NUP54
prerank,cytoplasmic sequestering of protein (GO:0051220),0.3704090147798964,0.7551603891938226,0.7510148849797023,0.9643189596105133,1.0,5/13,21.96%,PKD2;YWHAB;KEAP1;NFKBIE;FLNA
prerank,mitochondrial transport (GO:0006839),0.3105136494904652,0.7546751611394564,0.8198294243070362,0.9645709663063565,1.0,6/53,8.96%,TSPO;SLC25A16;AIP;BCL2L1;TIMM22;BAK1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.298691738892997,0.7543182871858588,0.8646998982706002,0.9646273467335978,1.0,20/94,17.85%,IL1A;IRAK2;UBE2V1;PSMB10;ST18;PSMA2;RPS6KA4;NOD2;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;TAB3;PSMD7;PSMB9;UBE2N;RPS6KA5;PSMD2
prerank,histone H3-K4 trimethylation (GO:0080182),0.37992042323850067,0.75430380646984,0.7629009762900977,0.9642805814711688,1.0,5/11,23.31%,TET3;SETD1B;WDR82;TET2;CTR9
prerank,neuromuscular synaptic transmission (GO:0007274),0.35360605875081924,0.7540763337844658,0.7730138713745272,0.9642012941401574,1.0,4/18,18.37%,RIMBP2;DTNA;STAC3;KIF1B
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.33164946834494496,0.7539880103417728,0.7716627634660421,0.9639388358456823,1.0,6/28,18.71%,GAS2L1;MAPRE1;MAP1B;CAMSAP2;MAPRE2;GBA2
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.29959663297423217,0.7538336514943647,0.8540816326530613,0.9637612010401111,1.0,14/88,16.28%,EDNRB;CLN8;APOE;CNOT8;CLN3;LARP1;EPRS1;CPEB3;NELL1;HDAC6;PCIF1;NFKB1;IGF2BP3;PUS7
prerank,photoperiodism (GO:0009648),-0.21960265170702833,-0.752995827210572,0.8819444444444444,0.941904661545814,1.0,10/28,23.11%,PPP1CB;CLOCK;PML;SIK1;RBM4B;USP2;PER2;PPP1CA;RBM4;CRY1
prerank,protein mannosylation (GO:0035268),-0.2405204911700643,-0.7529404891156085,0.8324873096446701,0.940060131105361,1.0,10/22,24.25%,DPM1;POMT2;RXYLT1;TMTC1;TMTC3;CRPPA;FKRP;DPM3;TMTC2;DPY19L4
prerank,protein heterotetramerization (GO:0051290),0.3760321869468457,0.752726338201531,0.7870879120879121,0.9647324709221475,1.0,2/13,6.09%,PKD2;FARSB
prerank,regulation of cell growth (GO:0001558),0.2911552080909397,0.7518562074527546,0.948,0.9654122555322131,1.0,31/204,16.17%,TGFB1;TGFBR1;PTPRJ;MAD2L2;MTOR;NME6;BRAT1;RASGRP2;CDA;CDK11B;TP53;PRKCQ;KIF14;CSNK2A1;FLCN;RB1;SMAD3;SIPA1;BCAR1;INHBA;RBBP7;SDCBP;PPP2CA;ITCH;RAB33B;INO80;ATAD3A;ARHGEF11;SGK3;CXCL16;RTN4
prerank,zinc ion homeostasis (GO:0055069),0.32941542888598524,0.7518094938702753,0.7828638497652582,0.9651053487897444,1.0,13/28,23.21%,ATP13A2;SLC39A6;PRKN;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;SLC30A10
prerank,ERK1 and ERK2 cascade (GO:0070371),0.34433213230989496,0.7510000676797536,0.7716049382716049,0.9657073134991623,1.0,10/21,27.71%,MAP2K2;SOX9;ZFP36L1;MT3;IGF1;KDR;PTGER4;MAPK1;MAPK3;CTSH
prerank,DNA duplex unwinding (GO:0032508),0.3120582775799807,0.7507475208457026,0.812972972972973,0.965646982165371,1.0,8/50,15.51%,GTF2H1;DHX9;ANXA1;MCM6;MCM2;MCM9;DDX1;TWNK
prerank,chromatin organization (GO:0006325),0.29110889231481246,0.7503013847877494,0.8731117824773413,0.9658130104801497,1.0,34/132,19.97%,NPM3;BPTF;SPI1;HDAC5;SNAI1;RB1;ARID1A;ATRX;HDAC4;SETD2;CHD1;BAZ1A;HCFC2;SOX9;MTF2;BRDT;SMARCD3;SMARCB1;FAM50A;HCFC1;INO80;HDAC11;SOX2;PIH1D1;SMARCAD1;SUV39H1;LRWD1;RSF1;KDM4C;PHF1;TOP1;KDM5A;RBBP4;KDM5B
prerank,mitotic spindle organization (GO:0007052),0.2920082344486879,0.7493181048174553,0.9173387096774194,0.9666217586792618,1.0,30/153,19.41%,ERCC6L;CENPO;NEK6;BCCIP;XPO1;CEP192;MAPRE1;SEH1L;PLK2;CHEK2;KIF23;RAB11A;DYNC1H1;PMF1;CENPI;STAG2;KIF2A;PPP1CC;INTS13;CENPQ;PTPA;INCENP;EML4;CENPK;MIS12;RPS27;RHOA;DCTN6;TAOK1;SEC13
prerank,nucleotide metabolic process (GO:0009117),-0.24304974662268064,-0.7489009030394331,0.8555555555555555,0.9439002294469693,1.0,11/23,28.82%,ME1;NUDT5;RNASEH2B;ENPP3;NMNAT1;PARK7;GUK1;AK4;CMPK2;NME2;CMPK1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.30254706621350413,0.7486455721150814,0.851890756302521,0.9670870224294014,1.0,17/68,23.34%,DBI;SULT4A1;GTPBP1;HINT1;BPNT1;ACSF2;TPST1;GNAI3;LRRK2;ACOT9;ACOT2;MFN1;GMPR2;ACOT8;CROT;TPST2;EFL1
prerank,glycolipid biosynthetic process (GO:0009247),0.3201859592516746,0.748264275027677,0.8246392896781354,0.9672007170206058,1.0,13/38,23.18%,PIGM;PIGL;PIGV;PIGH;ST8SIA1;LARGE1;PGAP2;PIGU;PIGC;B4GALT6;PIGN;DPM2;PIGP
prerank,nucleosome assembly (GO:0006334),0.3173335909284787,0.7478214632523228,0.7981330221703618,0.9673843895067743,1.0,11/31,22.83%,ASF1B;ATRX;NAP1L1;SOX9;SPTY2D1;RSF1;UBN1;RBBP4;IPO4;SMARCA5;H3-3A
prerank,postsynaptic membrane organization (GO:0001941),0.36066991692193945,0.7477726818800959,0.7825520833333334,0.9670784340265078,1.0,2/17,4.47%,APOE;CEL
prerank,cellular response to exogenous dsRNA (GO:0071360),0.3744355013902551,0.747532584225587,0.7648725212464589,0.9670038978539076,1.0,1/12,2.82%,DHX9
prerank,sulfur amino acid metabolic process (GO:0000096),0.33435754929708056,0.7469605655150993,0.7929354445797807,0.9673135631089005,1.0,5/24,16.85%,TXN2;MSRA;MMUT;MTR;CBS
prerank,protein destabilization (GO:0031648),0.32917955561726125,0.7466877832733615,0.8020361990950227,0.9672789707188443,1.0,16/32,29.05%,SNCA;DERL1;FBXL3;CAPN3;IRGM;FBXW11;CUL3;PRKN;HTT;GGA3;CTSH;PRNP;CREBBP;SENP2;EP300;CDC73
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.34060353976706037,0.7456255191309851,0.7783191230207065,0.9681738839342448,1.0,11/23,29.28%,HMGB1;REXO4;KPNA1;DICER1;DNASE2;DNASE1L1;DFFB;CECR2;KPNB1;HMGB2;DFFA
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.36522409888680873,0.7454340944723551,0.7607843137254902,0.9680195404874327,1.0,5/14,21.53%,HDAC5;THBS1;RHOA;MAP2K5;MMRN2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.37868999526149283,0.7454022179939541,0.7517433751743375,0.9676944537340311,1.0,2/11,15.64%,P2RX4;GSK3A
prerank,negative regulation of TOR signaling (GO:0032007),0.31490559610861246,0.7453088374975397,0.8242009132420092,0.967438696394917,1.0,7/36,15.64%,FNIP1;FLCN;PDCD6;DDIT4;TMEM127;RNF152;GSK3A
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.32834787401941357,0.7447678905480415,0.8,0.9677237150410778,1.0,6/28,15.93%,HCLS1;PFN2;PFN1;COTL1;ARHGAP18;RASA1
prerank,cellular response to hypoxia (GO:0071456),0.29213347496651115,0.7444595574826558,0.896969696969697,0.9677320011456014,1.0,25/126,18.91%,AQP1;ADAM8;ANGPT4;MTOR;RGCC;BACH1;TP53;PSMB10;P4HB;EPO;PSMA2;PSME3;TBL2;STUB1;PSMB5;PSMD8;PSMD7;PSMB9;HIF1A;CPEB2;SUV39H1;VHL;PSMD2;TIGAR;ELOB
prerank,response to gamma radiation (GO:0010332),0.3332070903306832,0.744225284234793,0.7946537059538274,0.9676486537472564,1.0,4/24,10.47%,XRCC5;TP53;HSF1;RPL26
prerank,organelle disassembly (GO:1903008),-0.20765556145470215,-0.7442060256213068,0.8717948717948718,0.9484616378572203,1.0,11/33,25.32%,KIF5B;GFM2;ULK2;EIF2D;GOLGA2;KIF9;DDRGK1;PLK5;KLC1;UFL1;MRRF
prerank,response to growth factor (GO:0070848),0.3118891299552239,0.7429648746384724,0.813692480359147,0.9687591435224884,1.0,7/41,14.24%,TGFBR1;CTNNB1;TGFBR2;STAT5B;HDAC6;TWF2;SOX2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.2809497069411621,-0.7427260740014584,0.8131868131868132,0.9486601906242506,1.0,5/13,18.42%,SP100;RAB23;NUP153;PARK7;CABP1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.33670474306830467,0.741334349270702,0.7994987468671679,0.9703089734774942,1.0,10/23,27.37%,NABP1;PLK2;PABIR1;PRCC;INTS3;ZWINT;BUB1B;CDK5RAP3;ZWILCH;WEE1
prerank,determination of bilateral symmetry (GO:0009855),0.33397524254041344,0.7407058458591868,0.7855392156862745,0.9706655281544436,1.0,2/24,5.50%,PKD2;ODAD2
prerank,"DNA-templated transcription, termination (GO:0006353)",0.29530075936444294,0.7406960440004862,0.8517745302713987,0.9703186046163752,1.0,9/68,10.96%,GTF2H1;TAF1A;POLR1E;TTF1;CSTF1;LSM11;CDK7;POLR1B;POLR2L
prerank,dicarboxylic acid metabolic process (GO:0043648),0.30888708342890253,0.7406625148953431,0.8394396551724138,0.9699941348107861,1.0,4/52,6.93%,DGLUCY;MTHFS;HAAO;OGDH
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.29620745144913374,0.7405052057042671,0.8655030800821355,0.9698099091759317,1.0,19/76,20.84%,LAPTM5;TANK;MALT1;DERL1;HDAC4;AMER1;STUB1;HUWE1;UBA2;WFS1;LRRK2;PIAS1;GSK3A;BIRC2;ANGPT1;DCUN1D5;RWDD3;CUL3;BIRC3
prerank,protein homotetramerization (GO:0051289),0.30160802896599836,0.7404369084258134,0.8378672470076169,0.9695306097208881,1.0,11/49,21.77%,ALDH9A1;PKD2;SAMHD1;B2M;ACACA;USP16;APPL2;MCOLN1;KCNJ2;HCN1;GBP5
prerank,sprouting angiogenesis (GO:0002040),0.2998474073004436,0.7400153049502384,0.809575625680087,0.9696559208830476,1.0,11/51,18.59%,PTK2B;OTULIN;VEGFB;NRP1;THBS1;CCBE1;NR4A1;NAXE;GREM1;ANGPT1;VEGFD
prerank,regulation of cell cycle phase transition (GO:1901987),0.29209975695126317,0.7397553934152186,0.8929663608562691,0.969607287606218,1.0,16/91,17.85%,ANAPC15;CDC23;TAF1;UBE2S;TP53;PSMB10;DBF4;PSMA2;FZR1;PSME3;PSMB5;PSMD8;PSMD7;PSMB9;ANAPC11;PSMD2
prerank,brain development (GO:0007420),0.28672266758311715,0.7394902573451035,0.8991935483870968,0.9695483780459534,1.0,30/136,20.41%,SLC6A4;CX3CR1;EEF1AKMT4-ECE2;BPTF;CXCR4;PLXNB2;TGFBR2;NKX2-1;PAFAH1B2;SCYL2;QARS1;POMK;ADGRG1;DDIT4;SYNJ1;CTNS;SOX6;ZFHX3;MEIS1;JHY;POU6F1;NF1;PTEN;TBC1D23;PHGDH;RELN;CNTN4;CDK5R1;UTP3;FBXW11
prerank,negative regulation of protein transport (GO:0051224),0.3323778128899597,0.7391738590856445,0.7973462002412546,0.9695590009105343,1.0,2/25,4.68%,APOE;RHBDF2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.3255198065663819,0.7391259251979879,0.7847953216374269,0.9692600875897067,1.0,7/27,23.58%,CTPS1;TXNRD1;RRM2B;AK8;GSR;AK5;AK1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3252914848970826,0.7388006211229232,0.797153024911032,0.9692681393448958,1.0,8/28,21.54%,MAD2L2;TFIP11;HSF1;ACTR2;ERCC6;SHLD1;SHLD2;PARP3
prerank,cellular response to hexose stimulus (GO:0071331),0.3316275318504214,0.7376346869547609,0.7752403846153846,0.9702281047692866,1.0,5/23,14.60%,ERN1;TRA2B;GAS6;ADCY8;SOX4
prerank,endothelial cell development (GO:0001885),-0.22491405388977068,-0.7374415190083454,0.8514285714285714,0.9539131788749208,1.0,8/25,17.19%,RAPGEF3;MYADM;RDX;MET;RAPGEF2;EZR;PDE2A;ROBO4
prerank,protein ADP-ribosylation (GO:0006471),0.3289348547087703,0.7373162904751944,0.8046783625730994,0.970258282924983,1.0,6/28,13.24%,ART4;PARP8;HPF1;PARP16;TNKS2;TIPARP
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.3435975707850497,0.7373062908272578,0.7766497461928934,0.9699088688885799,1.0,7/18,21.09%,VPS18;RAP1B;DTNBP1;LRRK2;RAP1A;GSK3B;RIMS1
prerank,calcium ion transmembrane transport (GO:0070588),0.289326952788371,0.7370772593037028,0.8365878725590956,0.9698279053269506,1.0,21/86,19.72%,P2RX7;SLC8A1;PKD2;P2RX4;CACNA1A;ATP2C1;ATP2B1;SLC8B1;ATP2B3;PARL;GAS6;ATP2A3;TRPV3;PMPCB;YME1L1;CACNA1D;TMEM165;MICU2;MCOLN1;NALCN;PMPCA
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.37639360463234983,0.7369822947915611,0.7521994134897361,0.9688578074001062,1.0,1/11,3.26%,SLC25A16
prerank,coenzyme A biosynthetic process (GO:0015937),0.37639360463234983,0.7369822947915611,0.7521994134897361,0.9688578074001062,1.0,1/11,3.26%,SLC25A16
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.37639360463234983,0.7369822947915611,0.7521994134897361,0.9688578074001062,1.0,1/11,3.26%,SLC25A16
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.26638716447164873,-0.736585161919979,0.8566037735849057,0.9532427634053287,1.0,4/15,14.17%,REST;HNRNPU;UBE2L3;BCL2L11
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.2927044661278494,0.7359091508469694,0.8640576725025747,0.9697454371591645,1.0,9/75,11.42%,NEFH;S100B;SLITRK1;ACTB;MEF2A;MEF2C;RB1;MAP1B;ATL1
prerank,negative regulation of dephosphorylation (GO:0035305),0.3445171971531483,0.7357833076616418,0.7748091603053435,0.9695228534106985,1.0,7/18,26.12%,YWHAB;ENSA;PTPA;INPP5K;CHP1;PPP1R16B;MFHAS1
prerank,regulation of autophagosome maturation (GO:1901096),0.3686335838506303,0.7355116605713081,0.782246879334258,0.9694722417532036,1.0,3/13,16.29%,CLN3;UVRAG;IRGM
prerank,regulation of insulin secretion (GO:0050796),0.29134109682116466,0.7349061306160896,0.889795918367347,0.9697909911369345,1.0,16/101,16.82%,KCNJ11;NR1H4;TNF;CACNA1A;TFAP2B;ITPR2;ENSA;LRP5;SLC8B1;KCNA5;RAP1A;SOX4;STXBP4;CACNA1D;GCK;PPP3CB
prerank,organelle transport along microtubule (GO:0072384),0.32826161908221707,0.7348789726563596,0.8190255220417634,0.9694630479026419,1.0,5/31,11.77%,UXT;CLN3;ARHGAP21;BORCS5;BICD2
prerank,negative chemotaxis (GO:0050919),0.3133824439189572,0.7339718630008586,0.8120728929384966,0.9701768116819035,1.0,3/33,5.21%,ITGB3;SEMA4D;LGR6
prerank,positive regulation of catalytic activity (GO:0043085),0.30955637528631513,0.7336706209660615,0.8152295632698768,0.970167781986029,1.0,4/37,6.62%,MAPK14;ATP7A;XRCC5;YWHAB
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.301665973371984,0.7334322583401819,0.8274760383386581,0.9700828791656405,1.0,13/56,17.75%,SNX9;ESPL1;SNX33;KIF23;SON;BIN3;MYH10;USP8;PDCD6IP;RASA1;INCENP;SNX18;RHOA
prerank,positive regulation of cell aging (GO:0090343),0.36347578697645255,0.7330022536703902,0.7854137447405329,0.9702312832495991,1.0,2/11,13.13%,YPEL3;B2M
prerank,regulation of tube diameter (GO:0035296),-0.27372235138152506,-0.7328761704153006,0.8356643356643356,0.9542528976135458,1.0,4/13,12.61%,SCPEP1;ROCK1;ACE;NOS3
prerank,vascular process in circulatory system (GO:0003018),-0.27372235138152506,-0.7328761704153006,0.8356643356643356,0.9542528976135458,1.0,4/13,12.61%,SCPEP1;ROCK1;ACE;NOS3
prerank,peptidyl-lysine acetylation (GO:0018394),-0.3009816199970745,-0.7328566368100667,0.7938144329896907,0.9523671375288446,1.0,1/10,1.29%,ESCO1
prerank,positive regulation of insulin secretion (GO:0032024),-0.20089705593619445,-0.7324933951831056,0.9401709401709402,0.9509238030678832,1.0,18/36,41.00%,MYRIP;TCF7L2;GPLD1;BAD;IRS2;RBP4;GPER1;ACSL4;CAPN10;CFTR;AACS;GLUD1;C2CD2L;ANO1;PSMD9;DOC2B;LRRC8A;NLGN2
prerank,regulation of presynapse organization (GO:0099174),0.3438171754970342,0.7322973117113901,0.7733160621761658,0.9702692989666752,1.0,2/18,3.87%,SLITRK1;SNCA
prerank,regulation of presynapse assembly (GO:1905606),0.3438171754970342,0.7322973117113901,0.7733160621761658,0.9702692989666752,1.0,2/18,3.87%,SLITRK1;SNCA
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.33785733275547275,0.7319181903009133,0.7917737789203085,0.9703242752772328,1.0,5/19,19.92%,SS18L1;LRP8;CUX1;CUX2;RELN
prerank,embryonic organ development (GO:0048568),0.29708873928804047,0.7307967851440268,0.8523206751054853,0.9712721790950006,1.0,6/61,7.98%,TGFB1;TNF;TEAD1;TGFBR2;TAL1;FLT3LG
prerank,regulation of chromosome organization (GO:0033044),0.327087559901303,0.7307277839905705,0.7678132678132679,0.9709909635930464,1.0,4/22,14.36%,XRCC5;RB1;SMG1;HNRNPD
prerank,DNA-dependent DNA replication (GO:0006261),0.2862284868643198,0.7303898927722747,0.918429003021148,0.9710107977526794,1.0,23/128,15.61%,MCM5;ORC3;PSMB10;MCM6;MCM2;DBF4;MGME1;BAZ1A;PSMA2;ORC4;WDHD1;CDC34;PSME3;DNA2;MCMBP;PSMB5;CDC6;POLD3;PSMD8;NOC3L;PSMD7;TWNK;PSMB9
prerank,positive regulation of reproductive process (GO:2000243),0.3137159957266341,0.7303582354709608,0.8093607305936074,0.97069357205585,1.0,5/31,17.89%,LHFPL2;INHBA;TACR1;PGAM4;AGO2
prerank,negative regulation of protein depolymerization (GO:1901880),0.3298117080141298,0.7302250513841055,0.8086124401913876,0.9705066601012601,1.0,7/24,22.70%,FGF13;ATXN7;CAMSAP2;ARHGEF2;TAOK1;PIK3CA;CLASP1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.3196169746262342,0.7301141908148515,0.8222477064220184,0.9702817083868833,1.0,5/35,11.17%,AQP1;APOE;NUDT4;CAP1;SOX9
prerank,fatty acid beta-oxidation (GO:0006635),0.29540682712987226,0.7299077950276986,0.8479913137893594,0.9701544102494963,1.0,11/51,18.65%,EHHADH;ACAD10;ACADL;ABCD1;ECHS1;ECI1;CPT2;PPARD;ABCD2;ETFDH;ECHDC1
prerank,positive regulation of binding (GO:0051099),0.2923736374191445,0.7295292775379221,0.8783505154639175,0.9702126661345751,1.0,29/84,25.12%,DHX9;APOE;SKI;HMGB1;TAF1;HFE;SPPL3;DERL1;EPB41;BAMBI;B2M;STK3;LRRK2;LRP1;IDE;RPL11;STK4;ADD1;FLOT1;DACT1;GSK3B;PRKN;PIN1;VTN;AMFR;IGF1;DDX11;PARP9;NCBP1
prerank,positive regulation of chromosome organization (GO:2001252),-0.26453430547330736,-0.7285940748812516,0.8489795918367347,0.9539110617307536,1.0,4/15,17.71%,PML;MRE11;GNL3;DHX36
prerank,vascular transport (GO:0010232),0.2897549891027999,0.7285009477053845,0.865979381443299,0.970999985571118,1.0,12/81,15.10%,SLCO2B1;ABCC3;ATP8A1;SLC7A8;SLC2A3;SLC16A2;SLC16A1;ABCC1;ATP2A3;ATP1B2;LRP1;SLC1A4
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.38295229696599375,0.7284918135977829,0.8063583815028902,0.9706551576472838,1.0,3/10,15.10%,HDAC5;SMARCB1;PIH1D1
prerank,kidney development (GO:0001822),0.2921066237965023,0.7281647692976646,0.8359621451104101,0.9706814712213517,1.0,3/65,2.10%,SHH;PCSK9;TGFBR1
prerank,positive regulation of tissue remodeling (GO:0034105),0.3754985402198279,0.7279391138518719,0.7956521739130434,0.9705836789756714,1.0,1/10,5.08%,IL18
prerank,cardiolipin metabolic process (GO:0032048),0.35684882930737555,0.7271292460044566,0.7674094707520891,0.9711619618670969,1.0,7/13,25.79%,PGS1;LCLAT1;PTPMT1;PLA2G5;PLA2G6;HADHA;HADHB
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.35076490102801183,0.7270904588316741,0.7893296853625171,0.9708515017719073,1.0,2/15,9.18%,MLXIPL;PPARGC1A
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.2850819847662022,0.7270903478240067,0.9369369369369369,0.9704945537104329,1.0,33/161,18.78%,DRAXIN;TMEM131L;MAD2L2;MDK;TLE3;DKK2;APOE;TPBGL;DDIT3;PSMB10;SCYL2;AMER1;PSMA2;SOX9;PTPRU;PTPRO;CSNK1A1;PSME3;STK3;PSMB5;SOX2;PSMD8;TLE5;PSMD7;PSMB9;GSK3A;INVS;STK4;ZNRF3;PSMD2;GREM1;DACT1;IGFBP4
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.30472212647078817,0.7270760588878357,0.8205128205128205,0.9701578284928498,1.0,17/42,26.65%,SRCAP;ACTB;ARID1A;ARID1B;SMARCB1;INO80;SPTY2D1;ERCC6;SMARCAD1;CHD4;RBBP4;VPS72;SMARCA5;MBD2;SMARCC1;CECR2;MTA2
prerank,androgen receptor signaling pathway (GO:0030521),-0.2816813860932175,-0.7267860629616836,0.8131487889273357,0.9544195769856735,1.0,5/11,25.09%,AR;KDM3A;RNF14;PMEPA1;PLPP1
prerank,regulation of cell death (GO:0010941),0.2895650061948337,0.7265967978042458,0.884263959390863,0.9703310897531647,1.0,22/94,22.07%,CALCR;SNCA;CTSZ;ACER3;IMPACT;BECN1;PARP16;TNFRSF1B;RRAS2;LRRK2;SOX4;LRP1;CD36;FAF1;NPAS2;SRSF6;RAB29;PRKN;CRYAB;FGF2;CHP1;MT3
prerank,telomere capping (GO:0016233),0.34853272483638903,0.7264766866949615,0.7862694300518135,0.9701117109858028,1.0,7/16,22.93%,TFIP11;STN1;TINF2;TERF2;DCLRE1C;TERF2IP;TEN1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.29417042809419514,-0.7256103100901373,0.825,0.9540175608168224,1.0,5/10,28.01%,FOXC1;TRIM16;NUMA1;NME2;ETV4
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.32355032691345437,0.7255144888180519,0.8117505995203836,0.9708231927611668,1.0,5/27,13.46%,CCM2;MAP3K5;IKBKG;KAT7;NFKB1
prerank,cardiac ventricle development (GO:0003231),-0.24348728037967574,-0.725157489123991,0.8369565217391305,0.9527174481944988,1.0,10/20,33.77%,SALL1;HES1;STRA6;PDE2A;HEY2;MATR3;DAND5;TMEM65;HEY1;DLL4
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.31618864578831296,0.7249650385007398,0.8183990442054958,0.9710731096772551,1.0,3/29,4.14%,MTOR;MLXIPL;APOE
prerank,establishment of spindle localization (GO:0051293),0.34746140026694927,0.7247962233519378,0.7912087912087912,0.9709025691594131,1.0,4/14,22.70%,ESPL1;DYNC1H1;CFL1;CLASP1
prerank,peptide metabolic process (GO:0006518),0.291166804640679,0.724773662693592,0.8549222797927462,0.9705701936199956,1.0,16/75,18.38%,GSTT4;HPGDS;SPCS2;SEC11C;SPPL3;SPCS1;NLN;NAALADL1;DNPEP;PARL;CTNS;ERAP1;IDE;FURIN;GSTM2;GSR
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.35625605313839326,0.724766599827712,0.7806788511749347,0.970224538989275,1.0,3/14,14.15%,TSEN15;RTRAF;DDX1
prerank,response to cadmium ion (GO:0046686),0.3196301932786013,0.7245811996735332,0.7978468899521531,0.9700781540742506,1.0,11/26,22.27%,HAAO;HSF1;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,histone deubiquitination (GO:0016578),0.3339153328331202,0.7245512162416745,0.7840616966580977,0.9697550798816891,1.0,4/18,16.00%,ATXN7;USP7;USP21;USP16
prerank,regulation of axonogenesis (GO:0050770),0.30121973470719887,0.7244958779752494,0.844994617868676,0.9694566322899039,1.0,10/51,17.75%,THY1;PLXNC1;SLITRK1;PLXNB2;ARHGDIA;EFNB3;RTN4;EPHA4;PTEN;RHOA
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3045701418020348,0.7239432433780613,0.8362255965292842,0.9697135356106257,1.0,19/45,26.62%,FOXO3;LARP1;RC3H1;TDRD7;PUM2;CYFIP1;PCIF1;PUM3;MEX3D;PER1;ATG14;ZC3H7A;NUDT21;RPL10;ZC3H7B;EIF2A;PARP9;PUM1;TSC1
prerank,protein homooligomerization (GO:0051260),0.28241508068408583,0.723821077079227,0.9056795131845842,0.9694981862541756,1.0,22/114,20.98%,CARD11;ALDH9A1;PKD2;PYCARD;SAMHD1;AQP11;ATL1;RNF135;B2M;NINJ1;TMEM120A;ADCY8;PDCD6IP;ACACA;USP16;ALS2;APPL2;ATL2;MCOLN1;ATL3;KCNJ2;HCN1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.35293120156857166,0.7237909041760144,0.7827926657263752,0.9691791709533424,1.0,2/12,8.10%,DOCK4;MEF2C
prerank,reticulophagy (GO:0061709),0.36507038154238514,0.7235223674727905,0.7880512091038406,0.9691451440412571,1.0,7/12,27.25%,TEX264;RETREG1;ATG2B;RB1CC1;UBA5;ATG2A;UFM1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3017747047123423,0.723069343165892,0.8294314381270903,0.9692931686347326,1.0,10/44,19.65%,TGFBR1;RGCC;FHOD1;PFN2;NF2;NRP1;CD47;RHOA;CDC42;ROCK2
prerank,regulation of cytoskeleton organization (GO:0051493),0.2829903805809827,0.7230060716707946,0.8932926829268293,0.9690090234832096,1.0,23/108,20.48%,IQGAP2;CORO1A;FZD10;PRKCD;P2RX7;MTOR;CLN3;F11R;DIAPH1;BICD2;TWF2;ARHGAP18;CAPN2;LRP1;IQGAP1;RHOA;CORO2B;TAOK1;RHOD;ROCK2;ARHGEF19;GSK3B;CRK
prerank,negative regulation by host of viral process (GO:0044793),0.38055646749338834,0.7224324700177776,0.7959479015918958,0.9692898541923829,1.0,1/10,3.44%,CCL8
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.3518847279454249,0.7222385298076925,0.7858117326057299,0.9691424752862087,1.0,3/14,15.69%,MMS19;ACTR2;ERCC6
prerank,production of siRNA involved in RNA interference (GO:0030422),0.3707774805463992,0.7219663110640075,0.7896995708154506,0.9690658887442765,1.0,5/10,24.76%,PRKRA;TARBP2;AGO2;DICER1;DROSHA
prerank,chromatin assembly or disassembly (GO:0006333),0.3713909807578842,0.7218591995537039,0.8008595988538681,0.9688237397729489,1.0,3/11,19.59%,TP53;NOC2L;RBBP4
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.28668268136883895,-0.7212959697025857,0.8172043010752689,0.9554954611553464,1.0,6/12,22.20%,WAC;SDE2;PRKDC;FBXO31;CDK2;PLK5
prerank,Wnt signaling pathway (GO:0016055),0.28764625724660414,0.721273053717472,0.8969387755102041,0.9691083389257463,1.0,15/92,16.50%,FZD10;PLCG2;FZD9;FZD3;CTNNB1;CSNK1G2;STRN;LRP5;AMER1;CSNK1A1;VPS29;LRRK2;BCL9;FZD8;PTEN
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3170669681275279,0.7212270233237638,0.8033573141486811,0.9688058306882887,1.0,6/26,18.66%,NR1H4;LRP5;ADCY8;STXBP4;PPP3CB;KLF7
prerank,recombinational repair (GO:0000725),0.28746991522992554,0.7205182034887441,0.8713991769547325,0.9692429686145851,1.0,22/77,23.59%,ZFYVE26;NABP1;RMI1;SAMHD1;LIG3;YY1;MCM9;INO80;SLX4;ERCC5;RAD51B;UBE2N;SWI5;RAD51D;SPIDR;SFR1;NSMCE2;ERCC4;RFWD3;SEM1;MORF4L1;PARP1
prerank,intestinal absorption (GO:0050892),0.3504942276284694,0.7204067744549743,0.7916102841677943,0.9690123076368444,1.0,2/13,16.03%,F11R;CD36
prerank,motor neuron axon guidance (GO:0008045),-0.24709133342766235,-0.720317543229365,0.8346456692913385,0.9547565595718666,1.0,2/15,6.36%,SEMA3A;SLIT2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.282059923241318,-0.7189248032046388,0.8215613382899628,0.9545401082738681,1.0,4/13,17.10%,PTGIS;NAMPT;PTGS2;NNMT
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.31430842176750284,0.7178966620769782,0.8256772673733804,0.9714470299659063,1.0,6/27,13.25%,ARHGEF18;ARAP1;WASF2;F11R;PFN1;PPFIA1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.28095810126708776,0.7177206785665476,0.891260162601626,0.9712787774534672,1.0,22/95,21.70%,PRELP;HEXA;B4GALT1;CHSY3;FMOD;AGRN;ST3GAL1;NDST1;BCAN;XYLT1;CHSY1;B4GALT7;CHST15;PXYLP1;NDST2;CEMIP;ANGPT1;CHPF;CSPG4;SLC10A7;B4GALT6;B4GALT2
prerank,positive regulation of histone deacetylation (GO:0031065),0.34948545969303435,0.7172332595198126,0.7893296853625171,0.9714264963739762,1.0,5/12,23.95%,PRKD2;AKAP8L;ZBTB7B;CTBP1;VEGFA
prerank,mitochondrial translation (GO:0032543),0.2820574351664728,0.717145232231425,0.9036511156186613,0.9711748740288229,1.0,31/104,25.21%,MRPL46;GFM1;AURKAIP1;CHCHD1;MRPL41;GATB;ERAL1;MRPL51;MTRF1L;LARS2;MRPL19;MRPL15;MRPS25;MRPS9;MRPS21;MRPL39;MRPS14;MRPL30;MRPL3;MTIF3;MRPS26;MRPL10;MRPL54;MRPL21;MRPL18;MRPL52;MRPL12;GATC;MRPL37;MRPS34;MRPS12
prerank,signal transduction by p53 class mediator (GO:0072331),0.3093614349081009,0.7165189210683464,0.839677047289504,0.9715151737129297,1.0,4/30,9.48%,PYCARD;TP53;HINT1;ATRX
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.24705157513908677,-0.7159511673722146,0.8495575221238938,0.9562297826116383,1.0,6/17,18.67%,MPDU1;NUS1;ALG9;SRD5A3;ALG12;ALG1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.32125527880676863,0.7149893908893359,0.799265605875153,0.9728270675421065,1.0,3/22,12.34%,PPP2CB;DUSP10;PPP2CA
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.33344670867992215,0.7149828317341014,0.8080301129234629,0.9724806307677852,1.0,7/19,23.84%,TENT4B;STN1;SRC;TINF2;TERF2;TEN1;DCP2
prerank,regulation of DNA replication (GO:0006275),0.29847114935537794,0.7148784625953583,0.8516949152542372,0.9722416467471313,1.0,11/49,16.38%,ORC3;DHX9;BRPF3;STN1;PDS5A;PPP2CA;KAT7;DNA2;CDC6;BCAR3;FAF1
prerank,spermatid development (GO:0007286),-0.20490731844376814,-0.7133524926202982,0.9180327868852459,0.9574734687486126,1.0,8/32,24.01%,BBS4;RFX2;CEP57;ACRBP;NECTIN2;TDRD5;MKKS;NME5
prerank,myelination (GO:0042552),0.2982275962134351,0.7130914276809895,0.8679245283018868,0.9738740755381697,1.0,10/46,17.98%,SKI;CXCR4;ABCD1;ACER3;EIF2B2;TNFRSF21;MPZ;DEGS1;NF1;ABCD2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.329576984083479,0.7118881776082021,0.8177014531043593,0.9748350559865288,1.0,1/16,2.40%,MAD2L2
prerank,meiosis I (GO:0007127),0.3161069334409286,0.7115669465416338,0.8147239263803681,0.974840877959204,1.0,2/23,12.70%,PTTG1;BRDT
prerank,positive regulation of double-strand break repair (GO:2000781),0.3013397957416954,0.7108248954205566,0.845464725643897,0.9752666990385508,1.0,13/39,25.10%,MAD2L2;MMS19;MGMT;ACTR2;SLF2;ERCC6;SHLD1;SHLD2;SPIDR;PARP3;PARP1;DDX11;PARP9
prerank,positive regulation of cell junction assembly (GO:1901890),0.2917724228527533,0.7106813699276315,0.8582251082251082,0.975075810447169,1.0,3/56,2.38%,CLSTN1;PTPRJ;THY1
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.26835348458788616,-0.7103275603718613,0.8288973384030418,0.9591230347879754,1.0,7/12,27.03%,MTHFD1;PRPS2;AMPD2;ADSL;PPAT;PRPS1;PRPS1L1
prerank,cellular zinc ion homeostasis (GO:0006882),0.31532265297876894,0.7100881830328226,0.8223289315726291,0.975395384096384,1.0,12/26,23.21%,ATP13A2;SLC39A6;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;SLC30A10
prerank,aerobic electron transport chain (GO:0019646),0.28474330420927946,0.7100596118679879,0.8784067085953878,0.9750698126929198,1.0,15/68,19.51%,NDUFA11;NDUFB8;COX6C;NDUFA2;NDUFB4;NDUFV1;COX7C;NDUFS6;NDUFAB1;UQCRB;NDUFB11;COX6B1;SDHD;NDUFB9;COX4I1
prerank,regulation of multicellular organism growth (GO:0040014),0.344697452237992,0.7100355751042366,0.7979002624671916,0.9747385390569904,1.0,3/15,14.18%,STAT5A;STAT5B;MBD5
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2718671510128748,0.7097890495311974,0.993,0.9746531146988994,1.0,88/417,21.25%,ASCL1;CIITA;TGFB1;IKZF1;BASP1;CBFA2T3;MLXIPL;YAF2;TNF;CIR1;CEBPA;DDIT3;SPI1;TSC22D4;BHLHE41;HDAC5;XRCC5;PCGF6;CTNNB1;MTA3;TP53;NKX2-1;RCOR1;CREB3L1;GCFC2;CBFA2T2;NKRF;TFAP2B;RB1;RBM15B;CIART;MDFIC;QARS1;RING1;ATF7IP;ARID4A;MIDEAS;HDAC4;PHC1;ZMYND15;LIMS1;SOX9;HDAC6;DAP;GZF1;HDAC9;MBD1;NRG1;KAT7;FOXN3;GAS6;FOXK1;IRF1;BRD7;LBH;CAPN3;TLE5;EID1;RBPJ;SBNO2;SUV39H1;PBXIP1;ZNF568;PPARD;RSF1;RPS6KA5;ZGPAT;LOXL3;SFMBT1;CIPC;CTBP2;PER1;CALCA;WWP1;INPP5K;HHEX;ENO1;ZMYND11;CDK5R1;FBXW11;POU2F1;YEATS2;HEXIM1;EED;SCMH1;TFAP4;CRYAB;PHC2
prerank,mitochondrial translational elongation (GO:0070125),0.2808831863994099,0.7092078629241326,0.9037871033776868,0.9749319528255661,1.0,26/88,25.21%,MRPL46;GFM1;AURKAIP1;CHCHD1;MRPL41;ERAL1;MRPL51;MRPL19;MRPL15;MRPS25;MRPS9;MRPS21;MRPL39;MRPS14;MRPL30;MRPL3;MRPS26;MRPL10;MRPL54;MRPL21;MRPL18;MRPL52;MRPL12;MRPL37;MRPS34;MRPS12
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.3652803553194471,0.7090900099563506,0.7964860907759883,0.9747097164853791,1.0,1/10,6.29%,CTNNB1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.3636194195776418,0.7088612823960947,0.7840909090909091,0.9745928936849204,1.0,2/10,13.14%,WDFY1;NINJ1
prerank,regulation of ossification (GO:0030278),0.30278658038989553,0.7087625865204782,0.8289623717217788,0.9743546400834117,1.0,5/36,12.22%,BMP2K;MDK;MEF2C;SOX9;CHSY1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.2842543809858308,0.7087451342272645,0.8774869109947644,0.9740210112541772,1.0,15/69,19.51%,NDUFA11;NDUFB8;COX6C;NDUFA2;NDUFB4;NDUFV1;COX7C;NDUFS6;NDUFAB1;UQCRB;NDUFB11;COX6B1;SDHD;NDUFB9;COX4I1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.29595729636319795,0.7085983219633389,0.8572961373390557,0.973821638209372,1.0,3/50,5.02%,SHH;RAB34;MGRN1
prerank,response to steroid hormone (GO:0048545),0.30677185441056387,0.7083412554387675,0.831002331002331,0.9737534147605198,1.0,1/31,0.90%,TGFB1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.2990024053356286,0.7082984855909512,0.8650707290533188,0.9734455207294722,1.0,10/46,19.60%,TSPO;AIP;CHCHD4;TIMM22;TIMM50;TOMM40;HK2;PITRM1;TOMM20;FIS1
prerank,ESCRT complex disassembly (GO:1904896),0.37006475335087363,0.7081986873465346,0.7936507936507936,0.9728440776503355,1.0,1/10,3.66%,VTA1
prerank,ESCRT III complex disassembly (GO:1904903),0.37006475335087363,0.7081986873465346,0.7936507936507936,0.9728440776503355,1.0,1/10,3.66%,VTA1
prerank,icosanoid biosynthetic process (GO:0046456),-0.28971987810361965,-0.7081358343008832,0.8129032258064516,0.9598753178677567,1.0,1/10,2.21%,LTA4H
prerank,positive regulation of behavior (GO:0048520),-0.29252853694115233,-0.7081105951684686,0.8024316109422492,0.9580316362672674,1.0,1/10,0.39%,NLGN1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.3151101282636017,0.708079066826356,0.8195754716981132,0.9726159263741571,1.0,10/26,22.80%,DUSP3;STAT5B;SOX9;SYAP1;PTPN12;IQGAP1;PDPK1;INPP5K;ZFP36L1;ZPR1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.3652281075925011,0.7079587265457608,0.8177966101694916,0.9723835069195567,1.0,2/11,9.58%,TIMM22;AGK
prerank,regulation of cellular senescence (GO:2000772),0.31060223906600826,0.7076153111487279,0.8382180539273154,0.9724071598424237,1.0,10/28,26.35%,NEK6;YPEL3;CDK6;B2M;TERF2;NEK4;NUAK1;SLC30A10;AKT3;FBXO5
prerank,camera-type eye morphogenesis (GO:0048593),0.36182887907468503,0.7075325543114079,0.7918486171761281,0.9721443448773539,1.0,4/10,23.95%,SKI;NF1;KDM2B;VEGFA
prerank,telomere maintenance via recombination (GO:0000722),0.35764532857487463,0.7070888577818912,0.7975206611570248,0.9722654841756043,1.0,5/11,21.90%,TEP1;ERCC1;RAD51D;NSMCE2;ERCC4
prerank,negative regulation of ATPase activity (GO:0032780),0.34150109311796645,0.7069606369046023,0.8104575163398693,0.9720593470389434,1.0,2/16,8.60%,TP53;ATP5IF1
prerank,mitochondrion distribution (GO:0048311),0.35927216076565255,0.7068891864751784,0.8021828103683493,0.971778504451527,1.0,5/12,19.49%,MEF2A;MSTO1;ATCAY;LRRK2;DNM1L
prerank,axoneme assembly (GO:0035082),-0.20085491131543892,-0.7062833574147532,0.9219858156028369,0.9582110723282072,1.0,12/30,31.01%,SPAG1;TTC12;CCDC39;CFAP74;RP1;SPEF1;SPAG16;GAS8;CFAP46;TTLL3;DNAAF3;LRGUK
prerank,cell junction assembly (GO:0034329),0.2796163692138642,0.7060979279182804,0.9080694586312564,0.9722446597992551,1.0,22/100,19.64%,PCDHB6;SLITRK1;PKP2;ITGA6;ACTB;VMP1;CAPZA1;FLCN;ACTG1;CDH8;LIMS1;CDH9;CDH12;TLN1;KIRREL3;DCHS1;CDH19;PTEN;RHOA;CDC42;RAB29;FBLIM1
prerank,insulin secretion (GO:0030073),0.32884639569412694,0.7049395801844396,0.8382165605095542,0.9731559637265401,1.0,3/19,12.59%,ANXA1;SNX19;RAB11FIP5
prerank,photoreceptor cell development (GO:0042461),-0.2567603831996372,-0.7048965829458489,0.8353413654618473,0.957942697355139,1.0,5/14,21.11%,RORB;ARL3;TOPORS;RP1;MFSD2A
prerank,eye photoreceptor cell differentiation (GO:0001754),0.34812193303403915,0.7046503862312258,0.8031609195402298,0.973127343072385,1.0,6/12,23.95%,MYO7A;AGTPBP1;NKD1;PROM1;STAT3;VEGFA
prerank,positive regulation of growth (GO:0045927),0.2855940310657536,0.7041574295849753,0.8689727463312369,0.9732949979697675,1.0,14/64,22.83%,RFTN1;TGFBR1;BRAT1;CSNK2A1;SDCBP;INO80;WFS1;CXCL16;CDC42;RPTOR;PABIR1;EXOSC2;ZPR1;H3-3A
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.2784663366930283,-0.7040672603635867,0.8772563176895307,0.9570059976265538,1.0,3/12,16.06%,B3GNT2;B3GALT5;B3GALT1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.3021245114700837,0.703251292460995,0.8408304498269896,0.9738854513677293,1.0,10/33,24.18%,FZD9;BCL2L1;FLCN;IAPP;HUWE1;VAT1;GHITM;PRKN;IGF1;PRELID1
prerank,telomere maintenance (GO:0000723),0.29303842703486926,0.7026055018891368,0.8483870967741935,0.9742190236825804,1.0,17/50,24.85%,PTGES3;XRCC5;STN1;DNA2;POLD3;TEP1;TINF2;RAD51D;TERF2;NSMCE2;PARP3;ERCC4;TERF2IP;TEN1;PARP1;ATR;RPA1
prerank,nucleus organization (GO:0006997),0.29479630448273586,0.7018445082740464,0.8648648648648649,0.9746329069427737,1.0,10/47,18.86%,ATXN7;SYNE1;SEH1L;IRAG2;TPR;NUP205;TOR1A;PDCD6IP;BIN1;TMEM170A
prerank,regulation of complement activation (GO:0030449),0.29283179619483346,0.7010847591528604,0.8488241881298992,0.9750582586057591,1.0,5/40,14.89%,C1QC;C1QA;C1QB;C3AR1;C4B
prerank,regulation of developmental growth (GO:0048638),0.3068095361016025,0.7007351664221942,0.8507109004739336,0.9750562150490178,1.0,4/29,9.89%,STAT5A;APOE;DNM2;STAT5B
prerank,cytoplasmic translational initiation (GO:0002183),-0.239763959151959,-0.700622909583222,0.8870967741935484,0.959091233457958,1.0,4/17,12.41%,EIF2B3;EIF4B;EIF2D;DHX29
prerank,membrane repolarization (GO:0086009),0.3398473351557015,0.70047935973477,0.8170563961485557,0.9749597472529455,1.0,3/15,13.76%,KCNIP2;ATP1B3;ATP1B2
prerank,response to X-ray (GO:0010165),0.34144800606607156,0.7000362333305609,0.8237650200267023,0.9750712310701485,1.0,3/14,14.22%,XRCC5;ANXA1;IKBIP
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.333642048261688,0.699453520857953,0.796221322537112,0.9749713482989567,1.0,5/15,22.43%,CPEB3;AGO2;ZFP36L1;CNOT7;CNOT1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.333642048261688,0.699453520857953,0.796221322537112,0.9749713482989567,1.0,5/15,22.43%,CPEB3;AGO2;ZFP36L1;CNOT7;CNOT1
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.34159896127371703,0.6992367886811005,0.8312020460358056,0.9748368928284336,1.0,1/15,2.02%,PLCG2
prerank,histone H4 acetylation (GO:0043967),0.29014707219553704,0.6988171168210408,0.8657205240174672,0.97490388329229,1.0,16/47,24.76%,BRD8;MSL2;EP400;MCRS1;NAA40;KAT7;HCFC1;JADE2;MEAF6;PER1;MSL1;PHF20;MORF4L2;MORF4L1;CHD5;KANSL1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.3331200961187629,0.6976946425945598,0.8087649402390438,0.9757205751730452,1.0,5/15,24.18%,BCL2L1;GHITM;PRKN;IGF1;PRELID1
prerank,nucleocytoplasmic transport (GO:0006913),0.2935323450878527,0.6976067832380403,0.8566739606126915,0.9754613877890509,1.0,6/40,11.71%,XPO1;ANP32A;SNRPD2;MALT1;RBM15B;NUP205
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.259368269726985,-0.6971477395257422,0.8875502008032129,0.961041885845047,1.0,9/13,42.87%,CACNA1G;SYT4;CACNA1H;CACNA1I;KCNB1;SYT1;DOC2B;HYAL3;SCAMP5
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.3473851228121365,0.6969013429146873,0.819327731092437,0.9754833955458825,1.0,5/12,27.95%,RCAN1;GSK3B;CHP1;ATP2B4;PRNP
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.3473851228121365,0.6969013429146873,0.819327731092437,0.9754833955458825,1.0,5/12,27.95%,RCAN1;GSK3B;CHP1;ATP2B4;PRNP
prerank,cellular response to estradiol stimulus (GO:0071392),-0.22825101961659194,-0.6961959743423429,0.8888888888888888,0.96011315995651,1.0,2/18,7.36%,EGFR;CCDC62
prerank,negative regulation of lipid catabolic process (GO:0050995),0.3263747697100078,0.6959086054712893,0.8204787234042553,0.9761595933624367,1.0,2/17,12.78%,TNF;SORL1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.3589804380344579,0.694473736189313,0.8286118980169972,0.9772667865692922,1.0,2/10,10.48%,NOS1AP;CACNB2
prerank,negative regulation of viral transcription (GO:0032897),0.34340444248545715,0.6939930236195729,0.8243430152143845,0.9774102989585609,1.0,5/13,24.49%,TRIM27;MID2;TRIM62;HEXIM1;UBP1
prerank,histone H4-K5 acetylation (GO:0043981),0.3327220352819504,0.6937609649893814,0.821664464993395,0.9769643976504446,1.0,7/15,24.76%,MCRS1;KAT7;HCFC1;JADE2;MEAF6;PHF20;KANSL1
prerank,histone H4-K8 acetylation (GO:0043982),0.3327220352819504,0.6937609649893814,0.821664464993395,0.9769643976504446,1.0,7/15,24.76%,MCRS1;KAT7;HCFC1;JADE2;MEAF6;PHF20;KANSL1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.3054770365517845,0.6936154686899866,0.8424737456242707,0.9767606890623587,1.0,4/26,16.74%,GCH1;ACER3;SPR;ASAH1
prerank,secondary palate development (GO:0062009),0.33687828233215167,0.6932585131549558,0.8076923076923077,0.9767701057942141,1.0,2/14,6.68%,CHD7;TGFBR2
prerank,cilium organization (GO:0044782),0.26811087131271244,0.6929824920595131,0.97,0.9766940620836218,1.0,34/209,15.62%,MKS1;RAB8B;EXOC6;ASAP1;PKD2;IFT52;TTC29;RP2;CNGB1;BBS9;PLK4;ATP6V0D1;DISC1;SNAP29;RAB11A;ACTR2;ACTR3;HDAC6;EXOC8;WDR11;DYNC2I1;EXOC7;EXOC1;PCM1;EXOC2;IFT80;TXNDC15;EXOC5;RPGR;FNBP1L;EXOC3;CEP162;AHI1;WDR90
prerank,7-methylguanosine RNA capping (GO:0009452),0.29767282964046926,0.6911986501759573,0.856,0.977830692686216,1.0,5/31,18.79%,GTF2H1;CDK7;POLR2L;GTF2H5;POLR2E
prerank,7-methylguanosine mRNA capping (GO:0006370),0.29767282964046926,0.6911986501759573,0.856,0.977830692686216,1.0,5/31,18.79%,GTF2H1;CDK7;POLR2L;GTF2H5;POLR2E
prerank,lipid droplet formation (GO:0140042),0.3571681183789996,0.6911657266525174,0.8241430700447094,0.9775124922811148,1.0,1/10,5.78%,CDS2
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.30241088849201964,0.6905469068839498,0.8615384615384616,0.9777860075895453,1.0,4/29,10.01%,APOE;CLN3;MCTP1;SYNGR1
prerank,Golgi ribbon formation (GO:0090161),-0.26265595089457044,-0.6904602603617452,0.909433962264151,0.9642240727782484,1.0,3/13,11.76%,VAMP4;GCC2;GOLGA2
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.2339052999703958,-0.6893729168475564,0.8962655601659751,0.9634474831678255,1.0,5/17,17.47%,EMC7;EMC10;EMC4;EMC1;GET4
prerank,neuron migration (GO:0001764),0.28202667802630377,0.6893023747637554,0.878021978021978,0.9787114840472447,1.0,10/48,14.17%,FGF13;LRP12;DISC1;MEF2C;PEX13;MAP1B;NRP1;DDIT4;NAV1;USP9X
prerank,peptidyl-proline modification (GO:0018208),0.3044359401132372,0.6892205486568935,0.8415366146458584,0.9784308438204132,1.0,9/25,25.25%,PPIE;CWC27;P3H2;PPIG;PPIH;NKTR;PIN1;PPIA;PPIL3
prerank,male gonad development (GO:0008584),0.2991150976549179,0.6876174054488181,0.8605990783410138,0.9796563250096396,1.0,4/34,15.48%,GATA1;INHBA;SOX9;NCOA4
prerank,tRNA 5'-leader removal (GO:0001682),0.33377822345640196,0.6873491448675842,0.8248974008207934,0.9795820199905079,1.0,3/13,15.01%,RPP38;RPP14;PRORP
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.3367327602601087,0.6872124247980578,0.8180555555555555,0.9793796334675413,1.0,2/13,10.01%,CLN3;SYNGR1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.3457514143073832,0.6870147751105145,0.8214783821478382,0.9792250602502475,1.0,3/10,20.94%,XYLT1;PXYLP1;B3GAT2
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.35168093310360127,0.6861369876791191,0.839541547277937,0.9797380952584493,1.0,3/11,10.18%,RAP2B;F11R;RAB1B
prerank,neuron maturation (GO:0042551),0.31809511010961766,0.6859936704965867,0.8394437420986094,0.9795300508968875,1.0,5/18,21.76%,MTCH1;C1QA;EPHA8;B4GALT6;CX3CL1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.32611992950059754,0.6850650995907366,0.8136246786632391,0.9800898683540958,1.0,6/16,26.35%,PHIP;IGFBP4;CDH3;IGFBP2;IGF1;IGFBP3
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2771654223760216,0.6847881125177268,0.8905263157894737,0.9800253787389154,1.0,7/63,10.47%,RGCC;CNOT8;TP53;CRADD;PLK2;CHEK2;RPL26
prerank,regulation of phospholipid metabolic process (GO:1903725),0.34302222911699776,0.6846397759770709,0.8168604651162791,0.9798283512020531,1.0,3/10,22.41%,MTMR3;ABCA3;MTMR9
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.3474932837090455,0.6838271211141524,0.8528610354223434,0.9802770803826882,1.0,5/12,21.23%,APOE;RANBP9;PICALM;ROCK2;ABCA2
prerank,alpha-amino acid metabolic process (GO:1901605),0.2857141623684907,0.6836825968905843,0.8711395101171459,0.9800721176476006,1.0,8/45,16.85%,ATP7A;ASPG;KMO;PYCR2;MMUT;DDAH1;OAT;CBS
prerank,iron ion transmembrane transport (GO:0034755),0.3533295853607298,0.6829979969108059,0.8371104815864022,0.9804286395373069,1.0,1/10,4.91%,SLC25A37
prerank,mitotic spindle assembly (GO:0090307),0.28574546372641046,0.6829430987010392,0.8723640399556049,0.9801388899771298,1.0,7/42,14.30%,BCCIP;CEP192;CHEK2;KIF23;RAB11A;STAG2;KIF2A
prerank,glucose transmembrane transport (GO:1904659),0.32140987443854657,0.6816983644301736,0.8290816326530612,0.9810267066831615,1.0,3/18,19.71%,SLC2A3;PPARD;SORT1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3004235010134802,0.6816245662799555,0.8583850931677018,0.9807528992819178,1.0,4/26,14.53%,NFE2L2;GPR37;FYN;LRRK2
prerank,inositol phosphate-mediated signaling (GO:0048016),0.3145752158738006,0.6814888207716973,0.8496332518337408,0.9805452321379107,1.0,1/19,2.16%,NFATC1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3295963180150984,0.6814548749040729,0.8403247631935047,0.98023520520232,1.0,2/14,12.34%,PPP2CB;PPP2CA
prerank,protein alkylation (GO:0008213),-0.21296300282288572,-0.6811359740529789,0.9329608938547486,0.9699555096495571,1.0,11/22,30.42%,FAM98B;SNRPD3;PCMT1;PRMT8;PRMT1;EEF2KMT;LCMT1;METTL22;EEF1AKMT2;CAMKMT;VCPKMT
prerank,endodermal cell fate commitment (GO:0001711),0.35579238813456887,0.6808139372558322,0.8283687943262411,0.9805228404477871,1.0,2/10,14.24%,LEO1;SOX2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.3185301428209857,0.6807543404439924,0.8294270833333334,0.9802289668609993,1.0,1/16,2.22%,DAGLB
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.29539642860160276,0.6806210802222882,0.8591065292096219,0.9800073053200783,1.0,7/31,18.67%,RPS2;UBE2S;FZR1;ARRDC4;PTEN;UBE2N;DCUN1D5
prerank,N-terminal protein amino acid modification (GO:0031365),0.3281595988218317,0.6802447733006285,0.8413978494623656,0.9800227157233767,1.0,4/14,20.75%,NAA40;METAP2;NAA50;NAA15
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.2662006511428761,0.6792224883760204,0.971,0.980649176943008,1.0,36/186,18.78%,DRAXIN;TMEM131L;NFATC1;MAD2L2;MDK;TLE3;DKK2;APOE;TPBGL;DDIT3;PSMB10;SCYL2;AMER1;PSMA2;SOX9;PTPRU;PTPRO;NLK;CSNK1A1;PSME3;STK3;PSMB5;SOX2;PSMD8;LRP1;TLE5;PSMD7;PSMB9;GSK3A;INVS;STK4;ZNRF3;PSMD2;GREM1;DACT1;IGFBP4
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.26238179829410935,-0.6788449267219824,0.9011406844106464,0.9702851135300614,1.0,3/13,16.06%,B3GNT2;B3GALT5;B3GALT1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.26778209466097413,0.6781861392796312,0.9248971193415638,0.9812972440316742,1.0,26/96,20.94%,NUP62;DHX38;NXF1;THOC2;SEH1L;CASC3;RBM15B;SMG1;TPR;DDX39B;NUP205;POLDIP3;UPF3B;THOC3;ALKBH5;SMG7;UPF2;SLU7;FYTTD1;SRSF6;SRSF2;SEC13;HHEX;SLBP;SRSF3;NUP54
prerank,Golgi to endosome transport (GO:0006895),0.3201248782175181,0.6780252362222138,0.8375838926174497,0.9811145409071429,1.0,6/16,22.22%,RAB14;EPS15;MON2;SORT1;VPS13C;VPS13A
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.34664883282209125,0.6778244349565588,0.8316970546984572,0.9809662799799231,1.0,2/11,11.23%,BCAR1;NRP1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.2945753464970547,0.6777877198148441,0.8680555555555556,0.9806487842483554,1.0,4/32,12.48%,PYCARD;TP53;HINT1;DDIT4
prerank,metal ion homeostasis (GO:0055065),0.28424617732057544,0.6776456161535793,0.8690744920993227,0.980443763982822,1.0,4/40,8.42%,SLC8A1;SLC7A8;SNCA;TFAP2B
prerank,negative regulation of histone modification (GO:0031057),0.32826671106089317,0.6768099247768256,0.8360215053763441,0.9809071088774345,1.0,6/14,29.48%,SNCA;NOC2L;CTBP1;SPHK2;JARID2;PRMT6
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.2768793824836859,0.6766314290235421,0.8840425531914894,0.9807356856025073,1.0,12/54,21.96%,KCNN4;KCNIP2;KCNMA1;NOS1AP;NEDD4L;CD63;GNG2;CACNA1D;BIN1;KCNJ2;KCNJ10;FLNA
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.32084630191889735,0.6765927253850981,0.836340206185567,0.9804198000976193,1.0,4/17,19.51%,COX6C;COX7C;COX6B1;COX4I1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.27650096445319494,-0.6759068185476759,0.9085365853658537,0.9712252630624987,1.0,8/10,31.34%,IVD;ACAD11;ETFA;ETFB;ACADS;ACADVL;GCDH;ACADM
prerank,early endosome to Golgi transport (GO:0034498),0.34841275029169616,0.6758421266589396,0.8297567954220315,0.9808037300005714,1.0,3/11,14.53%,RBSN;STX5;SNX2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.25892335029465047,0.6757962356358814,0.997,0.9804963298732917,1.0,78/497,17.35%,ASCL1;CIITA;TGFB1;IKZF1;DBI;BASP1;CBFA2T3;MLXIPL;YAF2;TNF;CIR1;CNOT8;CEBPA;DDIT3;SPI1;TSC22D4;BHLHE41;HDAC5;XRCC5;PCGF6;CTNNB1;MTA3;TP53;NKX2-1;RCOR1;CREB3L1;GCFC2;CBFA2T2;NKRF;TFAP2B;RB1;RBM15B;LARP1;CIART;MDFIC;EPRS1;QARS1;RING1;ATF7IP;ARID4A;CPEB3;MIDEAS;HDAC4;PHC1;ZMYND15;LIMS1;SOX9;HDAC6;DAP;GZF1;HDAC9;PDS5A;MBD1;NRG1;KAT7;FOXN3;GAS6;PCIF1;FOXK1;CDC6;IRF1;BRD7;LBH;CAPN3;IGF2BP3;TLE5;EID1;GSK3A;RBPJ;PUS7;SBNO2;SUV39H1;PBXIP1;ZNF568;PPARD;RSF1;RPS6KA5;ZGPAT
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.25175363037304166,-0.6757938128401452,0.8791208791208791,0.9694881721608506,1.0,3/12,14.87%,GMDS;UGP2;GFPT1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.260221265606895,-0.6756160132091147,0.8643410852713178,0.9677930550559453,1.0,4/11,21.73%,ENPP3;SLC19A2;SLC19A3;SLC25A19
prerank,nuclear pore organization (GO:0006999),0.3352227383002294,0.6755761970419647,0.841313269493844,0.9803793187321089,1.0,6/14,20.94%,SEH1L;TPR;NUP205;RTN4;TMEM170A;NUP54
prerank,calcium ion import across plasma membrane (GO:0098703),0.3309252828055457,0.6750414828842622,0.8319444444444445,0.9805713117790766,1.0,2/14,13.91%,SLC8A1;TRPV3
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.26949365731826586,0.6745916796618707,0.8974093264248705,0.9806512340045593,1.0,15/74,18.91%,NFE2L2;BACH1;PSMB10;EPO;PSMA2;PSME3;PSMB5;PSMD8;PSMD7;PSMB9;RBPJ;HIF1A;VHL;PSMD2;ELOB
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.32357257394813255,0.674398132578183,0.8290366350067843,0.9804770842864257,1.0,3/14,15.03%,AIF1;MEF2C;LRP1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.3319019957847717,0.6742200053920203,0.8326300984528833,0.9803113293436291,1.0,2/12,12.85%,METTL4;KAT7
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.2638244103386208,0.6741402205950464,0.9382591093117408,0.980032075274012,1.0,18/104,18.40%,TGFB1;TGFBR1;UBE2D3;SKI;TGFBR2;NKX2-1;FAM89B;SMAD3;SNX25;SORL1;BAMBI;VASN;STUB1;SMURF1;LDLRAD4;PDPK1;RBPMS2;GREM1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.3116050037240277,0.6739990316383193,0.8574969021065675,0.9798241818153421,1.0,2/20,8.05%,TGFBR1;SNAI1
prerank,divalent inorganic cation homeostasis (GO:0072507),0.29738201968346395,0.6739277748051536,0.8438661710037175,0.9795442168996136,1.0,3/25,8.42%,SLC8A1;SNCA;TFAP2B
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.286425578095353,0.6736759683234248,0.8710407239819005,0.9794515731406703,1.0,3/33,8.10%,TNFAIP3;AIF1;MEF2C
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.24999329580446805,-0.6735460381247498,0.8937728937728938,0.9677478466104943,1.0,3/12,16.07%,DSE;VCAN;DCN
prerank,histone H3-K36 demethylation (GO:0070544),0.35105378149225636,0.6726973605308504,0.8308823529411765,0.9800081359694046,1.0,4/10,21.86%,KDM7A;RIOX2;KDM4C;KDM2B
prerank,blood vessel diameter maintenance (GO:0097746),0.28834038834853526,0.6721482774611122,0.8740068104426788,0.9801971409077164,1.0,2/34,4.66%,EDNRB;ADCY6
prerank,synaptic vesicle transport (GO:0048489),0.3496518972917858,0.6719671890265347,0.8238636363636364,0.9800300968426782,1.0,3/11,13.52%,DNM2;SYNJ1;TOR1A
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.33077460478340076,0.6719498425494488,0.8474358974358974,0.979703565652857,1.0,7/16,25.15%,CIRBP;TRA2B;PRDX6;THRAP3;RBMXL1;NCBP1;TRA2A
prerank,cobalamin metabolic process (GO:0009235),0.3183704985545681,0.6711846845093498,0.8497474747474747,0.9800835780683906,1.0,6/17,24.52%,ABCC1;MMUT;CUBN;MTR;MMAA;MMAB
prerank,mismatch repair (GO:0006298),0.29588151801072254,0.6701034172185552,0.857487922705314,0.9807428841105208,1.0,7/27,18.75%,EXO1;SETD2;MCM9;PMS1;POLD3;RNASEH2A;ERCC1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.3440240701335878,0.6698992700672194,0.837037037037037,0.9805834068731819,1.0,1/10,3.87%,SNCA
prerank,positive regulation of mRNA processing (GO:0050685),0.3155704113608731,0.6694684532781153,0.8514492753623188,0.9806468162050851,1.0,6/21,19.27%,CIRBP;LEO1;TRA2B;PRDX6;THRAP3;RBMXL1
prerank,translational elongation (GO:0006414),0.2647402476671782,0.6694014253044761,0.9501525940996948,0.9803668267273679,1.0,29/101,25.21%,MRPL46;GFM1;AURKAIP1;CHCHD1;MRPL41;GTPBP1;ERAL1;MRPL51;MRPL19;MRPL15;MRPS25;MRPS9;MRPS21;MRPL39;MRPS14;MRPL30;MRPL3;MRPS26;MRPL10;MRPL54;EEF1G;MRPL21;RACK1;MRPL18;MRPL52;MRPL12;MRPL37;MRPS34;MRPS12
prerank,central nervous system development (GO:0007417),0.2595039491033706,0.6693697139041614,0.988,0.980053747541789,1.0,49/250,20.34%,SHH;CX3CR1;S100B;EEF1AKMT4-ECE2;PKD2;BPTF;CXCR4;PLXNB2;CHD7;TGFBR2;NKX2-1;C1QA;PAFAH1B2;BCAN;SCYL2;ITGAM;QARS1;ATP6AP2;EIF2B2;SOX9;SNTG2;POMK;ADGRG1;DDIT4;SYNJ1;CTNS;SH3GL3;SOX6;ZFHX3;SOX4;MEIS1;JHY;POU6F1;AHI1;NF1;PTEN;TBC1D23;MARCKS;PHGDH;NPAS2;LOXL3;GBA2;ZIC4;WWP1;RELN;CNTN4;ANKLE2;CDK5R1;UTP3
prerank,pigment granule transport (GO:0051904),0.31110051101748176,0.6685377538338169,0.8482142857142857,0.9801231760678583,1.0,2/18,9.82%,MYO5A;RAB11A
prerank,melanosome transport (GO:0032402),0.31110051101748176,0.6685377538338169,0.8482142857142857,0.9801231760678583,1.0,2/18,9.82%,MYO5A;RAB11A
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.3236195223921514,0.6680187048311187,0.8513513513513513,0.9802767338832762,1.0,6/15,23.58%,ENTPD1;ENTPD2;AK8;ENTPD3;AK5;AK1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.34040495089967837,0.6679273627559883,0.8402366863905325,0.9800252403175524,1.0,2/10,14.04%,CCT8;CCT5
prerank,synaptonemal complex organization (GO:0070193),0.3211454301974983,0.6674717085546641,0.8493333333333334,0.9797706482913288,1.0,1/15,8.32%,TRIP13
prerank,synaptonemal complex assembly (GO:0007130),0.3211454301974983,0.6674717085546641,0.8493333333333334,0.9797706482913288,1.0,1/15,8.32%,TRIP13
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.2719684136421751,0.6674634998667062,0.8977635782747604,0.9794356912309504,1.0,5/52,8.99%,NT5C3B;CNOT8;EXOSC1;RC3H2;RC3H1
prerank,base-excision repair (GO:0006284),0.2760665650634089,0.6662676464115311,0.8956989247311828,0.9802109587926833,1.0,8/48,16.00%,NEIL2;LIG3;DNA2;HUWE1;POLD3;ERCC5;ERCC6;OGG1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3165840878411195,0.6661704081226236,0.8504551365409623,0.979967418951811,1.0,9/17,25.12%,HSF1;CPEB3;RNF40;VIRMA;ZC3H3;NELFE;CTR9;NUDT21;NCBP1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.32645800998224583,0.6653681840066477,0.8405172413793104,0.9803699629540998,1.0,5/12,20.21%,WNK1;ATP1B3;ATP1B2;WNK4;FXYD1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.28801651650653487,0.665205431661685,0.877030162412993,0.9801867921984607,1.0,5/32,14.53%,MCTP1;VPS18;MEF2C;DTNBP1;LRRK2
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.3174980629828965,0.6646482934403979,0.8563685636856369,0.9803330748075223,1.0,4/15,18.96%,ATL1;RTN4;TMEM170A;ATL2
prerank,hexose biosynthetic process (GO:0019319),0.28024519540624615,0.6645649297512244,0.8760964912280702,0.9800730859455068,1.0,8/42,16.87%,ALDOB;SORD;ENO3;PPARGC1A;GPI;CHST15;GAPDHS;PGAM1
prerank,peptidyl-arginine modification (GO:0018195),0.31914701448853294,0.6642112431309992,0.8431105047748977,0.9800622374737611,1.0,1/15,3.91%,ART4
prerank,negative regulation of hemostasis (GO:1900047),0.32328962583622173,0.6641045672233816,0.8500687757909215,0.9798231740734373,1.0,1/12,4.14%,APOE
prerank,autophagy of nucleus (GO:0044804),0.3166606150544352,0.663789424803612,0.8479087452471483,0.9797604560856291,1.0,3/16,16.36%,ATG7;ATG2B;ATG3
prerank,postreplication repair (GO:0006301),0.27622703499789725,0.6632092691781565,0.8756756756756757,0.9799614248990883,1.0,4/45,6.94%,TRIM25;UBE2V2;UBE2V1;POLH
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.19558831778237729,-0.6630854877755566,0.9620253164556962,0.975075975207597,1.0,5/30,10.66%,ABCD4;ACSL1;HACD1;ELOVL5;ACSL6
prerank,covalent chromatin modification (GO:0016569),0.3223499263949714,0.6630502987451963,0.8624338624338624,0.9797596354224712,1.0,7/14,28.18%,CHD1;SETD5;MT3;MBD2;SIRT7;HELLS;HDAC1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.24318457683768688,-0.6617682090289557,0.8964285714285715,0.974350865694311,1.0,6/12,36.41%,HNRNPU;LARP7;NELFB;NELFA;EAPP;RNF8
prerank,neuromuscular junction development (GO:0007528),0.2971065136080098,0.6614803581511686,0.8739595719381689,0.9808418650056393,1.0,5/24,14.53%,AGRN;CACNB4;CACNB2;CACNB1;LRRK2
prerank,glycoprotein biosynthetic process (GO:0009101),0.2615584022690871,0.6611635286526732,0.9356486210418795,0.9807909648019997,1.0,15/79,20.57%,GCNT1;ATP7A;ST8SIA4;NPC1;XYLT1;FUT9;B3GALNT1;ST8SIA1;B4GALT7;TMEM106A;LARGE1;DDOST;GOLPH3;MGAT1;COG7
prerank,calcium ion import into cytosol (GO:1902656),0.32160338686249756,0.6611104006081321,0.8435374149659864,0.9805006278629077,1.0,2/15,13.91%,SLC8A1;TRPV3
prerank,protein polyglutamylation (GO:0018095),0.3310262596183449,0.6610657484392073,0.8563134978229318,0.9802055199354137,1.0,4/11,25.34%,TPGS1;TTLL1;TTLL7;TTLL4
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.33099935768974265,0.660991767253973,0.8493894165535957,0.979930499717135,1.0,1/12,3.05%,DHRS3
prerank,membrane repolarization during action potential (GO:0086011),0.3260448364797865,0.6605813476701231,0.8614958448753463,0.9799460031379683,1.0,1/13,4.32%,KCNIP2
prerank,smooth muscle contraction (GO:0006939),0.3215408164931943,0.6596665836465677,0.8617021276595744,0.9804653220227212,1.0,3/14,19.65%,SLC8A1;SMTN;ROCK2
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.28749693606230836,0.6595952633012203,0.8988505747126436,0.9801915617194831,1.0,11/32,25.24%,HDAC5;ANXA1;THBS1;HDAC9;RHOA;MAP2K5;MMRN2;FGF2;VEGFA;KDR;AKT3
prerank,mRNA transport (GO:0051028),0.25889107651487603,0.6589639288742125,0.9375,0.9804179226332139,1.0,27/101,21.24%,NUP62;DHX38;NXF1;THOC2;SEH1L;CASC3;RBM15B;SMG1;TPR;DDX39B;NUP205;POLDIP3;UPF3B;THOC3;ALKBH5;SMG7;UPF2;SLU7;FYTTD1;SRSF6;SRSF2;SEC13;HHEX;SLBP;SRSF3;NUP54;ZFP36L1
prerank,tRNA metabolic process (GO:0006399),-0.2294530306924929,-0.6585369771847954,0.88,0.9753227932633007,1.0,8/17,32.59%,SSB;DTD2;KARS1;RPP21;YARS2;POP5;RPP30;POP1
prerank,autophagy of peroxisome (GO:0030242),0.33188208497977933,0.6581675913612706,0.865546218487395,0.9808323336967527,1.0,4/12,25.45%,MAP1LC3B;PIK3R4;RB1CC1;NBR1
prerank,histone mRNA metabolic process (GO:0008334),-0.1981088425624517,-0.6578890789002737,0.9230769230769231,0.9740329191961005,1.0,9/27,22.05%,SSB;SNRPD3;ERI1;ATM;UPF1;TUT1;SNRPG;SNRPF;NCBP2
prerank,mitochondrial translational termination (GO:0070126),0.25942197807919665,0.6578778506302778,0.9366700715015321,0.9807621079832741,1.0,26/88,25.21%,MRPL46;AURKAIP1;CHCHD1;MRPL41;ERAL1;MRPL51;MTRF1L;MRPL19;MRPL15;MRPS25;MRPS9;MRPS21;MRPL39;MRPS14;MRPL30;MRPL3;MRPS26;MRPL10;MRPL54;MRPL21;MRPL18;MRPL52;MRPL12;MRPL37;MRPS34;MRPS12
prerank,histone H2B ubiquitination (GO:0033523),0.3442325369965406,0.6574131059125461,0.8455988455988456,0.9808477759376001,1.0,4/10,23.31%,LEO1;RNF40;UBE2E1;CTR9
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.18624811869091307,-0.6565662565207067,0.96875,0.9731640558079853,1.0,20/33,34.86%,RFC1;MRE11;PINX1;CTC1;SHQ1;TNKS1BP1;WRAP53;CDK2;TERT;DCLRE1B;GAR1;PPP6R3;TERF1;NOP10;RTEL1;ZBTB48;ACD;RAD51;PPP6C;NHP2
prerank,skeletal system development (GO:0001501),0.255875484155247,0.6564302916255379,0.9679358717434869,0.9813936766953648,1.0,20/148,14.60%,SH3PXD2B;TGFBR1;PRELP;ATP7A;CD44;CHD7;TRPS1;SULF2;BCAN;XYLT1;PRDX1;CMKLR1;CREB3L2;PAPSS1;SOX9;SOX6;RFLNA;RAB33B;ANKRD11;SOX4
prerank,nucleotide biosynthetic process (GO:0009165),0.30913071645618523,0.6553034808009758,0.87375,0.9820652055555823,1.0,5/18,16.30%,GART;PNP;NMNAT3;PRPSAP1;RRM2B
prerank,negative regulation of wound healing (GO:0061045),0.2848044687066705,0.6552791937725326,0.8648960739030023,0.9817498031598744,1.0,8/28,22.70%,TNF;APOE;CASK;PTEN;CRK;FGF2;VTN;CLASP1
prerank,regulation of ATP metabolic process (GO:1903578),0.26988343816906196,0.6547422003924441,0.9100642398286938,0.9818802855000253,1.0,13/54,20.94%,NUP62;ATP7A;ABCD1;SEH1L;ATP5IF1;TPR;NUP205;HIF1A;GCK;PGAM1;SEC13;FIS1;NUP54
prerank,pore complex assembly (GO:0046931),0.30537488274288654,0.654616002570726,0.8765903307888041,0.9816659356320008,1.0,6/19,18.86%,P2RX7;TPR;NUP205;PDZD11;RTN4;TMEM170A
prerank,protein heterooligomerization (GO:0051291),0.31015820546743617,0.6545340614546267,0.8618925831202046,0.9813997752473939,1.0,3/17,13.25%,PKD2;FARSB;TMEM120A
prerank,cellular response to dsRNA (GO:0071359),0.3112231552147396,0.6543789597706383,0.8575197889182058,0.981197399362327,1.0,1/15,2.82%,DHX9
prerank,renal system development (GO:0072001),0.26572733263233045,0.6541433860132576,0.9036402569593148,0.9810721641392824,1.0,6/52,11.41%,PCSK9;TGFBR1;MYOCD;TFAP2B;SULF2;PYGO2
prerank,water-soluble vitamin metabolic process (GO:0006767),0.26458475843861873,0.6536806958233061,0.9292403746097815,0.9811355673712773,1.0,12/68,17.81%,SLC52A1;MTHFS;SLC2A3;ABCC1;MCCC2;CYB5A;MMUT;CUBN;PDZD11;MTR;FPGS;PCCA
prerank,regulation of protein neddylation (GO:2000434),0.33881110207740317,0.6534568664485865,0.8389458272327965,0.9809987917633355,1.0,4/10,18.67%,COPS9;HIF1A;RPL11;DCUN1D5
prerank,RNA export from nucleus (GO:0006405),0.25733943365763523,0.6534442601348242,0.9385875127942682,0.9806712184336684,1.0,26/100,20.94%,NUP62;DHX38;NXF1;THOC2;SEH1L;CASC3;RBM15B;SMG1;TPR;DDX39B;NUP205;POLDIP3;UPF3B;THOC3;ALKBH5;SMG7;UPF2;SLU7;FYTTD1;SRSF6;SRSF2;SEC13;HHEX;SLBP;SRSF3;NUP54
prerank,regulation of cell morphogenesis (GO:0022604),0.2832653303727666,0.6529866500896581,0.8739693757361602,0.9807318724534084,1.0,5/30,11.87%,CD44;MACF1;CAPZB;MOV10;PHIP
prerank,detection of calcium ion (GO:0005513),0.3254745060902747,0.6529803484218915,0.8782849239280774,0.980398975033498,1.0,1/13,4.32%,KCNIP2
prerank,central nervous system neuron development (GO:0021954),0.31311832412067475,0.6525862583457749,0.850383631713555,0.9804103330170222,1.0,8/15,28.35%,ATP7A;PTEN;HSP90AA1;GBA2;B4GALT6;HSP90AB1;B4GALT5;MAP2
prerank,positive regulation of developmental process (GO:0051094),0.25367475951936597,0.6522501088248809,0.963855421686747,0.9803536768407971,1.0,28/164,19.92%,SHH;BASP1;RREB1;MAD2L2;DDHD1;MDK;TNF;APOE;CEBPB;CPEB3;SOX9;NR2C2;SORL1;LRP8;SOX6;SRC;RTN4;CORO1C;VHL;VLDLR;AGO2;SHLD1;TAPT1;SHLD2;GDNF;DNM1L;FIS1;RELN
prerank,apoptotic mitochondrial changes (GO:0008637),0.27892023063043636,0.6514462348735082,0.894374282433984,0.9807003781240599,1.0,8/32,19.60%,FZD9;BCL2L1;BAK1;TIMM50;HK2;ATG3;DNM1L;FIS1
prerank,negative regulation of binding (GO:0051100),0.2579956019369193,0.6508653736671232,0.9261538461538461,0.9808581034696643,1.0,20/81,24.72%,BAG2;PRKCD;ACTB;TFIP11;DISC1;CTSZ;PSME3IP1;SORL1;LRRK2;TLE5;RSF1;DACT1;GSK3B;TFAP4;PIN1;MITD1;RACK1;IFIT1;DDX11;ILRUN
prerank,regulation of keratinocyte proliferation (GO:0010837),0.29254949309230704,0.6508144995519922,0.8771289537712895,0.9805707911445457,1.0,8/22,25.94%,MDK;CASK;STXBP4;SRSF6;ZFP36L1;CDH3;EPB41L4B;MED1
prerank,regulation of phosphatase activity (GO:0010921),0.29430459514714835,0.6496001264273357,0.8866103739445115,0.981284422903351,1.0,8/24,26.62%,PPP6R1;PTPA;CHP1;MTMR9;HTT;CDK5RAP3;TIPRL;TSC1
prerank,peptidyl-lysine modification (GO:0018205),0.2557834819079141,0.6495712729756625,0.9369918699186992,0.9809732419289006,1.0,22/99,21.50%,BCL11A;NUP62;ATP7A;SEH1L;LOX;HDAC4;TPR;HDAC6;NUP205;HDAC9;NDUFAB1;ETFBKMT;UBA2;PIAS1;VPS33B;LOXL3;SENP6;SENP7;NUP54;SIRT5;NSMCE2;EEF1AKMT1
prerank,tetrapyrrole metabolic process (GO:0033013),0.3050280816102936,0.6493215505567592,0.8647642679900744,0.980856730665494,1.0,6/18,24.52%,ABCC1;MMUT;CUBN;MTR;MMAA;MMAB
prerank,sulfur compound transport (GO:0072348),0.29102487793441734,0.6489722655393184,0.888755980861244,0.9808295848499502,1.0,4/27,13.56%,LRRC8D;SLC36A1;SLC25A30;MGST1
prerank,diol metabolic process (GO:0034311),0.3007579673250117,0.6489023245343871,0.865979381443299,0.9805547229599954,1.0,3/19,16.71%,GCH1;SPR;HSP90AA1
prerank,positive regulation of axon extension (GO:0045773),0.2894753627332292,0.6483765958779726,0.8688725490196079,0.9806959606993535,1.0,4/22,13.51%,MACF1;NRP1;TWF2;MEGF8
prerank,ncRNA 3'-end processing (GO:0043628),0.32018483627013083,0.6481509499146212,0.8689839572192514,0.9805561770072185,1.0,5/14,21.18%,ELAC2;INTS8;INTS6;INTS6L;TOE1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.25794586192879293,0.6470738832762921,0.9306418219461697,0.9811750763325406,1.0,8/72,10.47%,RGCC;CNOT8;TP53;CRADD;PLK2;CHEK2;ATRX;RPL26
prerank,vitamin transport (GO:0051180),0.27924203304691103,0.647017730102502,0.8725146198830409,0.9808920509548096,1.0,1/29,1.98%,SLC52A1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.31727188763308456,0.646886156582049,0.8629737609329446,0.9806730641866218,1.0,3/11,21.23%,ITM2B;AGO2;ABCA2
prerank,global genome nucleotide-excision repair (GO:0070911),0.2892246954219932,0.6468621480533308,0.8764705882352941,0.9803595453567483,1.0,8/26,24.19%,GTF2H1;RNF111;GTF2H5;ERCC1;RAD23B;ERCC4;PARP1;XPC
prerank,Notch signaling involved in heart development (GO:0061314),0.32740293887518257,0.646859954991879,0.852112676056338,0.9800259091126124,1.0,2/11,16.11%,SNAI1;RBPJ
prerank,maturation of 5.8S rRNA (GO:0000460),0.30962185806280357,0.6467034053773608,0.8771021992238034,0.9798253159282061,1.0,4/17,17.60%,LAS1L;PES1;C1D;WDR12
prerank,DNA conformation change (GO:0071103),0.3084501289591528,0.6458341292212356,0.8809831824062095,0.9802284517947423,1.0,7/17,27.66%,HMGB1;TOP2A;TOP1;HHEX;NAA10;TOP3A;HMGB2
prerank,protein sumoylation (GO:0016925),0.265982519096088,0.645481254974293,0.9052744886975242,0.9802068759976871,1.0,7/49,15.15%,BCL11A;NUP62;SEH1L;TPR;NUP205;UBA2;PIAS1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.32854183667064213,0.6454003141563107,0.8611500701262272,0.9799441134137472,1.0,11/11,67.17%,RTP4;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;RTP3;LPO;PKD1L3;PKD2L1
prerank,negative regulation of growth (GO:0045926),0.2524768454450357,0.6453756773294566,0.9575757575757575,0.9796265875415826,1.0,12/121,12.34%,TGFB1;PTPRJ;NME6;CDA;TP53;FLCN;RB1;SMAD3;SIPA1;INHBA;RBBP7;PPP2CA
prerank,negative regulation of histone methylation (GO:0031061),0.32714257645784384,0.6453011243816164,0.8558823529411764,0.9793547573251974,1.0,5/10,28.11%,MTF2;PHF1;DNMT3B;BCOR;JARID2
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.27224317492406663,0.6452757196991906,0.8938053097345132,0.9790407972120191,1.0,12/40,25.03%,PYCARD;BCL2L1;TP53;BMF;TNFSF10;GHITM;DNM1L;PRKN;BID;IGF1;PRELID1;MFF
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.3046572511979454,0.6447615388168703,0.8712998712998713,0.9791483154150787,1.0,1/16,2.82%,DHX9
prerank,xenobiotic transport (GO:0042908),0.30251740412828176,0.6443620543909295,0.8731241473396999,0.9791463738352403,1.0,3/17,15.26%,ABCC3;ABCC1;ABCA3
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.2800235233979923,0.6443209558493923,0.880648899188876,0.9788502742002744,1.0,6/30,17.43%,SCN4B;PKP2;NEDD4L;KCNA5;CACNA1D;SCN5A
prerank,DNA integrity checkpoint signaling (GO:0031570),0.27652590745780387,0.6441977659808529,0.8818897637795275,0.9786252720763426,1.0,10/36,21.92%,BRIP1;CHEK2;DOT1L;CDC5L;DNA2;CDC6;ERCC6;CEP63;CDC45;RAD1
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.2717149446822576,0.6438827792465066,0.9070548712206047,0.9785742850070089,1.0,7/39,16.11%,BMP2K;MAML3;TSPAN14;POGLUT1;NOD2;SRC;RBPJ
prerank,folic acid metabolic process (GO:0046655),0.3030406438216521,0.6437655011782264,0.8817480719794345,0.9783331273809797,1.0,1/18,2.77%,MTHFS
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.2900822554324144,0.6432621820531941,0.8679950186799502,0.97844031802503,1.0,8/20,25.25%,PPIE;CWC27;PPIG;PPIH;NKTR;PIN1;PPIA;PPIL3
prerank,peptidyl-glutamic acid modification (GO:0018200),0.2823212527433798,0.6425057022941442,0.8791469194312796,0.9787308848460655,1.0,9/24,26.38%,TPGS1;AGBL5;AGTPBP1;TTLL1;NAA80;TTLL7;PARP1;TTLL4;NAA10
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2738176918377918,0.6419475268891476,0.9148936170212766,0.9788824934263617,1.0,4/40,12.53%,FAM111A;ATRX;BOD1L1;MCM9
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.31998987201580564,0.6415692079119854,0.8667582417582418,0.9788924975026396,1.0,4/12,14.16%,RBM15B;METTL3;CDYL;LRIF1
prerank,chromatin assembly (GO:0031497),0.26881338106444197,0.641321572047654,0.8986486486486487,0.9787620868876123,1.0,11/38,22.83%,TP53;ATRX;NAP1L1;SOX9;NOC2L;SPTY2D1;RSF1;RBBP4;LIN54;SMARCA5;H3-3A
prerank,sensory perception of taste (GO:0050909),0.328521215164449,0.641174754816042,0.8705547652916074,0.9785638488365976,1.0,10/10,67.17%,CD36;ASIC2;TAS1R3;GNAT3;TAS1R2;TAS1R1;ASIC3;ASIC1;PKD1L3;PKD2L1
prerank,tRNA 5'-end processing (GO:0099116),0.30382924713768333,0.6411537100759324,0.8841544607190412,0.9782480643024989,1.0,3/15,15.01%,RPP38;RPP14;PRORP
prerank,purine nucleotide metabolic process (GO:0006163),0.285348654472176,0.6407978485913286,0.8755924170616114,0.9782032783926655,1.0,4/24,14.45%,XDH;GART;PNP;PRPSAP1
prerank,aggrephagy (GO:0035973),0.2834329289132428,0.6406164694229689,0.8719153936545241,0.9780151745522403,1.0,9/27,24.32%,UBE2V1;HDAC6;DYNC1H1;WDR81;UBE2N;WDFY3;PRKN;IFT88;DYNC1LI1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.2993471351490915,0.6402937815519223,0.8646616541353384,0.9779419774036521,1.0,3/19,17.43%,MTHFS;GGH;FPGS
prerank,cell-cell junction organization (GO:0045216),0.25349621105423564,0.6402121923435065,0.9422084623323014,0.9776897662400404,1.0,13/79,16.24%,TGFB1;CSF1R;PKP2;FLCN;SMAD3;CDH8;LIMS1;CDH9;CDH12;TLN1;CADM1;DCHS1;CDH19
prerank,membrane assembly (GO:0071709),0.2789989013952099,0.6401692398526824,0.9001135073779796,0.9773908032569137,1.0,8/34,18.49%,RFTN1;CEL;GAK;PTEN;STX2;PICALM;FLOT1;UBXN2A
prerank,modified amino acid transport (GO:0072337),0.300836773373781,0.6395082468457789,0.8753351206434317,0.9776069797539323,1.0,3/15,15.10%,CTNS;MGST1;SLC1A4
prerank,female gonad development (GO:0008585),0.2984205149280761,0.6394363277432352,0.8890258939580764,0.9773381192223377,1.0,3/19,10.54%,CEBPB;EIF2B2;INHBA
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.31404368560568185,0.6392617560047963,0.8523489932885906,0.9771493027995604,1.0,1/13,3.19%,SLC8A1
prerank,receptor recycling (GO:0001881),0.3253393495306206,0.6391329757039028,0.8746438746438746,0.9769248624032123,1.0,2/10,12.78%,ARFGEF2;SORL1
prerank,dermatan sulfate metabolic process (GO:0030205),-0.227441294305807,-0.6382269265969758,0.9253731343283582,0.9855620586130394,1.0,2/13,6.53%,DSE;VCAN
prerank,cellular response to alkaloid (GO:0071312),0.3033903415200445,0.6372939151642847,0.8890274314214464,0.9781294765422932,1.0,5/17,22.31%,SLC8A1;CASP7;GSTM2;SPIDR;TGM2
prerank,cellular response to misfolded protein (GO:0071218),0.2863267068634416,0.6369515026710427,0.8948019801980198,0.9780730889413288,1.0,9/20,27.32%,ATXN3;DERL1;TOR1A;STUB1;CUL3;DNAJB14;KLHL15;UGGT2;VCP
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.2670604532327912,0.6367220131443305,0.9065934065934066,0.977934212015669,1.0,10/43,21.51%,TAOK3;NABP1;BABAM2;FZR1;FOXN3;CDC6;BABAM1;TAOK1;BRSK1;PABIR1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.29894437524694406,0.6366751146931292,0.8753148614609572,0.9776366694509584,1.0,2/19,5.93%,RENBP;NAGK
prerank,translational termination (GO:0006415),0.24944795948830495,0.6364947001205259,0.9461382113821138,0.9774616497375337,1.0,27/95,25.21%,MRPL46;AURKAIP1;CHCHD1;MRPL41;GSPT1;ERAL1;MRPL51;MTRF1L;MRPL19;MRPL15;MRPS25;MRPS9;MRPS21;MRPL39;MRPS14;MRPL30;MRPL3;MRPS26;MRPL10;MRPL54;MRPL21;MRPL18;MRPL52;MRPL12;MRPL37;MRPS34;MRPS12
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.3034901964958442,0.6361981483268134,0.8655126498002663,0.9773757738675327,1.0,7/16,23.28%,SH2B3;NF2;ADIPOR1;PPP2CA;VHL;SOCS3;INPP5F
prerank,protein tetramerization (GO:0051262),0.2550548980039856,0.6357372920442438,0.9378947368421052,0.9774326255602385,1.0,5/67,6.09%,ALDH9A1;SNCA;PKD2;SAMHD1;FARSB
prerank,kinetochore organization (GO:0051383),0.3133906711030197,0.6355982035103803,0.8874824191279888,0.9772235817842885,1.0,13/13,68.69%,MIS12;CENPT;CDT1;POGZ;CENPC;CENPW;NUF2;DLGAP5;CENPA;CENPF;NDC80;CENPH;CENPE
prerank,neuron projection regeneration (GO:0031102),0.3279184905670555,0.6354132461603471,0.8684603886397608,0.9770354424073752,1.0,1/10,3.71%,RTN4RL1
prerank,regulation of neurotransmitter transport (GO:0051588),0.29736177626066207,0.6353621817820401,0.855683269476373,0.9767394987823367,1.0,2/16,8.10%,MCTP1;MEF2C
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2854881114105613,0.6349324561611698,0.8866103739445115,0.9767781602975905,1.0,6/25,23.09%,EAF1;LEO1;ELL;ZMYND11;HEXIM1;NELFE
prerank,mitotic DNA replication (GO:1902969),0.3342585956954509,0.6342915332966942,0.8646288209606987,0.9769654468510174,1.0,2/10,10.17%,MCM6;MCM2
prerank,regulation of Notch signaling pathway (GO:0008593),0.2524338979365222,0.6339403381615962,0.9266528925619835,0.9769283231614716,1.0,8/76,12.24%,LFNG;BMP2K;MAML3;SREBF2;TSPAN14;POGLUT1;METTL3;NOD2
prerank,positive regulation of mitochondrial fission (GO:0090141),0.29966927447283226,0.633773411242831,0.89,0.9767323097061201,1.0,7/18,27.11%,DDHD1;DNM1L;FIS1;PRKN;KDR;MFF;MCU
prerank,muscle tissue morphogenesis (GO:0060415),0.2982510308046677,0.6333579879708833,0.8698453608247423,0.9767439841366155,1.0,1/16,4.28%,TTN
prerank,inositol phosphate catabolic process (GO:0071545),0.3121693936116203,0.6327753340576567,0.8849315068493151,0.9768820063284648,1.0,5/12,23.28%,SYNJ1;PTEN;INPP5K;NUDT3;OCRL
prerank,histone acetylation (GO:0016573),0.2527112591082771,0.6320374035362587,0.9386694386694386,0.9771534959547615,1.0,17/69,24.01%,BRD8;SPI1;EP400;TADA1;BRPF3;NAA40;KAT7;JADE2;NAA50;MEAF6;PER1;BRD1;YEATS2;PHF20;MORF4L2;MORF4L1;CHD5
prerank,establishment of mitotic spindle localization (GO:0040001),-0.1876499822744114,-0.6318229498668488,0.972027972027972,0.988309957407828,1.0,5/28,11.09%,PAFAH1B1;GPSM2;NDEL1;NDE1;CDK5RAP2
prerank,positive regulation of protein ubiquitination (GO:0031398),0.2490132610414333,0.6315882320856797,0.9379450661241099,0.9771888217111683,1.0,19/80,21.61%,LAPTM5;RPS2;MALT1;PDCD6;DERL1;AMER1;ARRDC4;STUB1;HUWE1;WFS1;LRRK2;GSK3A;UBE2N;BIRC2;ANGPT1;DCUN1D5;CUL3;BIRC3;PIN1
prerank,calcium ion import (GO:0070509),0.27569719987985486,0.6314784584234913,0.8925619834710744,0.9769451116799888,1.0,6/28,17.73%,SLC8A1;CACNA1A;CACNB2;CACNA1B;CACNA1D;MICU2
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.30166435592236956,0.6314561701436241,0.8794701986754967,0.9766329568153562,1.0,2/15,7.37%,MEF2A;SLC9A1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.32475426414638897,0.6313113220264104,0.8830409356725146,0.9761026469546644,1.0,2/10,18.45%,WNK1;MAP2K5
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.32475426414638897,0.6313113220264104,0.8830409356725146,0.9761026469546644,1.0,2/10,18.45%,WNK1;MAP2K5
prerank,negative regulation of lipid metabolic process (GO:0045833),0.28488328063310775,0.6312762169703534,0.8682266009852216,0.9758038342242665,1.0,1/22,3.81%,TNF
prerank,sphingosine biosynthetic process (GO:0046512),0.32200534439862594,0.6312330606325228,0.8914616497829233,0.9751820299896388,1.0,4/11,25.07%,ACER3;ASAH1;ABCA2;SPHK2
prerank,sphingoid biosynthetic process (GO:0046520),0.32200534439862594,0.6312330606325228,0.8914616497829233,0.9751820299896388,1.0,4/11,25.07%,ACER3;ASAH1;ABCA2;SPHK2
prerank,DNA damage checkpoint signaling (GO:0000077),0.278751457646401,0.630740020311778,0.9008363201911589,0.9752426967240868,1.0,4/28,8.23%,BRIP1;CHEK2;DOT1L;CDC5L
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.30622691695643,0.6303771756555803,0.8866396761133604,0.9752046067670838,1.0,4/14,20.51%,ADPRM;ENTPD1;ENTPD2;ENTPD3
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.20270120640598238,-0.6302389494592384,0.9685863874345549,0.9876112491582411,1.0,10/20,32.04%,FAR1;ACLY;PPT1;CBR4;ACSL4;ACSL3;HSD17B4;FITM2;GCDH;SLC25A1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.32717708588907346,0.6296464234289726,0.8672438672438673,0.975464309895239,1.0,3/10,16.40%,PIH1D1;NUFIP1;ZNHIT6
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.316061509103478,0.6282261584130252,0.8760683760683761,0.9762772389387258,1.0,2/12,17.53%,SEH1L;MIS12
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.3112919709126968,0.6282060662763218,0.8769017980636238,0.9759653252842804,1.0,3/13,16.11%,TGFBR2;GSK3A;RBPJ
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.2909955795250906,0.6277388908212107,0.8877551020408163,0.9759878427935275,1.0,4/19,16.12%,NDST1;XYLT1;EXTL3;NDST2
prerank,post-translational protein modification (GO:0043687),0.2414442534925836,0.6273257471685187,0.996,0.9759790975248598,1.0,55/332,18.91%,PCSK9;WDTC1;COPS6;APOE;DNAJC3;FBXL22;SPP1;RNF7;TIMP1;FBXL18;PTP4A2;KLHL21;PSMB10;P4HB;CHML;RAB11A;RAB1B;VGF;FAM20C;LGALS1;CHGB;PSMA2;RBBP5;FBXO40;KLHL11;RBBP7;FBXO32;F5;PSME3;STT3B;SUMF2;FBXL3;COPS4;GAS6;PSMB5;WFS1;PSMD8;CCDC8;DCAF17;PSMD7;GAN;PSMB9;HIF1A;APLP2;WSB2;DCAF5;FEM1B;VHL;PSMD2;KEAP1;FBXO44;MXRA8;SPSB2;IGFBP4;ELOB
prerank,negative regulation of coagulation (GO:0050819),0.30011924612429897,0.6272898670927816,0.8807588075880759,0.9756761792932996,1.0,1/14,4.14%,APOE
prerank,protein localization to nucleus (GO:0034504),0.2489778394457249,0.6269735045348016,0.950253807106599,0.9756044046262589,1.0,14/102,16.65%,MMP12;SYK;NUP62;MORC3;CSE1L;TPR;TAF8;RRS1;TOR1AIP2;TOR1A;INTS13;TAF3;RPL11;APPL2
prerank,regulation of TORC1 signaling (GO:1903432),0.26901243629341753,0.626593645433937,0.9228149829738933,0.9755796739664654,1.0,9/33,21.78%,GPR137B;SEH1L;FLCN;PIP4P1;RNF152;PIH1D1;TELO2;RRAGA;RRAGB
prerank,organophosphate ester transport (GO:0015748),0.2767482823753786,0.6263157397287076,0.8930412371134021,0.9754620283254243,1.0,4/24,15.26%,NPC2;PRELID3B;OSBPL8;ABCA3
prerank,peptidyl-lysine dimethylation (GO:0018027),0.2966920156861436,0.6259111397020642,0.88375,0.9754524453757693,1.0,4/18,18.41%,ASH1L;SETD2;SUV39H1;SETD1B
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.22798287426745814,-0.6253769384325778,0.9259259259259259,0.9890613138163192,1.0,6/13,36.41%,HNRNPU;LARP7;NELFB;NELFA;EAPP;RNF8
prerank,regulation of gene silencing by RNA (GO:0060966),0.25696837284552543,0.6252159815097118,0.9196141479099679,0.9753325812121287,1.0,7/50,11.71%,NUP62;TNRC6A;SEH1L;PUM2;TPR;POLR2L;NUP205
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.25696837284552543,0.6252159815097118,0.9196141479099679,0.9753325812121287,1.0,7/50,11.71%,NUP62;TNRC6A;SEH1L;PUM2;TPR;POLR2L;NUP205
prerank,response to UV-A (GO:0070141),0.30489944820553233,0.6237320853696262,0.8844086021505376,0.9761939319087446,1.0,1/14,5.21%,TIMP1
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.31280638773508873,0.6231518017580703,0.882525697503671,0.976312839620279,1.0,3/10,19.03%,GABRA5;GABRA4;GABRG1
prerank,cranial nerve development (GO:0021545),0.3194411807911998,0.6230234933046466,0.862116991643454,0.9760914882714335,1.0,1/11,6.22%,CHD7
prerank,epithelial cell development (GO:0002064),-0.20054541799819492,-0.6225939294737209,0.9487179487179487,0.9890184962625475,1.0,13/20,49.97%,WNT5B;ACTA2;PDZD7;EXPH5;RILPL2;TMEM79;WNT7A;PKHD1;POF1B;GRHL2;WNT7B;RAB25;ROS1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.26547222703698325,0.622375522235459,0.9118942731277533,0.9762709057244024,1.0,12/39,21.76%,ACTN4;CASK;NF2;THBS1;PTPRO;RASA1;CORO1C;RHOA;SPRY4;CORO2B;MAP4K4;CX3CL1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.2944974361133914,0.6221994311752632,0.8901515151515151,0.9760804966822031,1.0,1/17,3.24%,MAML3
prerank,positive regulation of DNA repair (GO:0045739),0.2610466365959878,0.6220693464063064,0.9260485651214128,0.9758467948000771,1.0,11/46,20.14%,DHX9;HMGB1;BABAM2;MGMT;SLF2;ERCC6;BABAM1;UBE2N;NPAS2;TIGAR;SPIDR
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.315828164541639,0.6220399074494342,0.8844011142061281,0.975539767166109,1.0,1/11,6.29%,CTNNB1
prerank,regulation of autophagosome assembly (GO:2000785),0.2645602119628291,0.6219392328025176,0.9222096956031567,0.9752838520984026,1.0,11/33,24.20%,PIP4K2A;RAB3GAP2;MTMR3;RAB1B;LRRK2;TBC1D14;TBC1D12;SEC22B;NPRL3;ADPRH;IFT88
prerank,maturation of SSU-rRNA (GO:0030490),0.2672065070903365,0.6215962181835913,0.9060324825986079,0.9752101527871532,1.0,9/34,20.88%,NOB1;RPS16;HEATR1;RPS14;TSR1;NGDN;RIOK3;UTP3;SRFBP1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.28873139129332465,0.6213522363086594,0.899746192893401,0.9750934819737505,1.0,5/21,23.51%,OSBPL10;OSBPL8;PLAAT3;PLA2G5;PLA2G4E
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.3175172782982243,0.621313855481161,0.8947368421052632,0.9747987199152239,1.0,4/10,21.27%,EMC6;EMC2;MMGT1;EMC3
prerank,establishment of endothelial barrier (GO:0061028),0.2713141544034745,0.6209133669857998,0.9085580304806565,0.9747771193638439,1.0,7/29,17.17%,RAP1B;RAP2B;F11R;RAB1B;RAPGEF1;RAP1A;PECAM1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.3172854240418249,0.6204786009334814,0.8755304101838756,0.9747841849823481,1.0,4/10,19.44%,SVIP;UBE2G2;ERLEC1;OS9
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.2566899452500216,-0.6204376088626975,0.9351535836177475,0.9886301759531729,1.0,2/10,8.81%,ATP1A2;FKBP1A
prerank,positive regulation of cartilage development (GO:0061036),0.2883276663287895,0.6196487308221832,0.9078104993597952,0.9750793730890885,1.0,3/17,13.61%,MDK;SOX9;SOX6
prerank,acidic amino acid transport (GO:0015800),0.2938366208079534,0.6195003725551234,0.8983268983268984,0.974884541044262,1.0,5/17,24.22%,LRRC8D;SLC25A18;GIPC1;SLC6A6;GJA1
prerank,coenzyme A metabolic process (GO:0015936),0.3103813957308289,0.6192312795014421,0.8907563025210085,0.9747692339102413,1.0,1/14,3.26%,SLC25A16
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.2878493762352778,0.6191391879544625,0.9006451612903226,0.9745129791732763,1.0,5/18,22.64%,FZD9;BAK1;GSK3A;GSK3B;BID
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.21239721730232575,-0.6185626746038028,0.94,0.9879475680163775,1.0,4/17,26.87%,AKAP13;RAPGEF2;DRD2;ADRB2
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.24157677539799138,-0.6183009594906885,0.9127272727272727,0.9862753516631083,1.0,3/11,23.11%,SIK1;C1QTNF3;CRY1
prerank,positive regulation of histone modification (GO:0031058),0.2648139721796077,0.6182022248654178,0.9147465437788018,0.9748974228301672,1.0,12/33,27.10%,PPARGC1A;RPS6KA4;BRD7;AKAP8L;ZBTB7B;UBE2N;RPS6KA5;CTBP1;ARRB1;GLYR1;SART3;MAPK3
prerank,snRNA 3'-end processing (GO:0034472),0.2872192236120846,0.6179305149202111,0.9054054054054054,0.9747873326302389,1.0,7/19,22.63%,INTS8;INTS6;INTS6L;INTS1;EXOSC3;TOE1;EXOSC2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.2890209754833203,0.617497068411434,0.8987179487179487,0.9747678351055132,1.0,2/17,10.05%,PKP2;NEDD4L
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.22053761371823022,-0.6174707550163473,0.9338842975206612,0.9850218189589985,1.0,2/15,6.53%,DSE;VCAN
prerank,regulation of endocytic recycling (GO:2001135),0.3143629344292118,0.616486111286297,0.875,0.9752140647523461,1.0,5/11,23.51%,ARHGAP1;SORL1;EIPR1;INPP5F;PLA2G4E
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.2860642638493866,0.616385098055372,0.8869123252858958,0.9749747514643607,1.0,4/20,20.45%,BCL2L1;BAK1;GSK3A;GSK3B
prerank,axon development (GO:0061564),0.24445728171287956,0.6162857925348483,0.9550102249488752,0.9747253983438203,1.0,15/78,20.23%,NEFH;S100B;SLITRK1;RTN4RL1;ACTB;MAP1B;ATL1;SVBP;MTR;CAMSAP2;RTN4;SPTBN4;KLF7;CNTN4;CDK5R1
prerank,regulation of lipid metabolic process (GO:0019216),0.24435583243489223,0.6161883847762774,0.9554404145077721,0.9744758709495398,1.0,15/88,18.30%,PSAP;NPC2;SREBF2;ZFP69;TBL1XR1;TBL1X;ADIPOR1;SMARCD3;GPS2;SREBF1;FASN;ACACA;PPARD;NFYA;RXRA
prerank,histone H3 acetylation (GO:0043966),0.2571826395118516,0.6161856123720135,0.9115341545352743,0.974153466364505,1.0,9/40,20.73%,SPI1;TADA1;BRPF3;KAT7;JADE2;MEAF6;PER1;BRD1;YEATS2
prerank,body fluid secretion (GO:0007589),0.2945871796328029,0.6158245841537956,0.889487870619946,0.974105689767681,1.0,4/15,26.25%,PRLR;ZBTB7B;VEGFA;ERBB4
prerank,organelle fusion (GO:0048284),0.2807665202867418,0.6155075041385613,0.8993939393939394,0.9740260310451547,1.0,7/22,25.03%,VPS18;VPS11;MIGA1;FIS1;MFN1;EEA1;MFF
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.3142932800486641,0.6150253001622981,0.8951149425287356,0.9737308192795608,1.0,1/11,4.10%,PKD2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.3142932800486641,0.6150253001622981,0.8951149425287356,0.9737308192795608,1.0,1/11,4.10%,PKD2
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.27788222501621207,0.6145769266952462,0.8965952080706179,0.9737480277503587,1.0,4/22,15.10%,MTOR;HEATR1;SMARCB1;PIH1D1
prerank,maintenance of protein location in nucleus (GO:0051457),0.28151407803720574,0.6144714096014325,0.9032663316582915,0.9735092353696609,1.0,4/20,15.91%,MORC3;SYNE1;TAF8;TAF3
prerank,ncRNA metabolic process (GO:0034660),0.2601738366461606,0.6139087773304298,0.9339305711086227,0.9735946340838515,1.0,9/37,24.76%,TENT4B;BCDIN3D;PRKRA;TUT7;TARBP2;AGO2;DICER1;ZCCHC8;DROSHA
prerank,regulation of glucose transmembrane transport (GO:0010827),0.28709284508358923,0.6136922496743019,0.9116915422885572,0.9734421145068868,1.0,3/18,19.95%,PRKCB;BRAF;INPP5K
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.28264801451976057,0.6125179143891287,0.8962386511024644,0.9739894961111736,1.0,6/19,21.79%,CDA;PNP;POLD3;DCK;APRT;GMPR2
prerank,histone ubiquitination (GO:0016574),0.2807520059089661,0.612417200376839,0.8937728937728938,0.9737394270727766,1.0,7/21,23.31%,LEO1;PHC1;RNF40;HUWE1;UBE2N;UBE2E1;CTR9
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.26616691193144726,0.6121188104732572,0.9214780600461894,0.9736211992481777,1.0,9/31,22.64%,YWHAB;TP53;BAK1;CASP8;GSK3A;YWHAH;NMT1;GSK3B;BID
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.3062346828145822,0.61159809014683,0.8949640287769784,0.9736938994992027,1.0,2/11,14.04%,CCT8;CCT5
prerank,response to peptide hormone (GO:0043434),0.2579565641073504,0.6108809666758254,0.9269102990033222,0.9738961108472094,1.0,10/43,19.71%,STAT5A;ANXA1;STAT4;STAT5B;EIF2B2;CREB1;SRC;ZBTB7B;ROCK2;SORT1
prerank,cellular amino acid catabolic process (GO:0009063),0.24163097157195773,0.6103607240783037,0.9673469387755103,0.973958527360375,1.0,10/87,13.61%,CRYM;HAAO;OGDH;KYNU;KMO;QDPR;ECHS1;MCCC2;ALDH7A1;DDAH1
prerank,DNA biosynthetic process (GO:0071897),-0.21421184296209325,-0.6100253649755446,0.9551020408163265,0.9877153774212313,1.0,11/16,35.85%,WRNIP1;WRN;POLA1;TERT;TYMS;POLD2;RFC3;POLE;CDKN2D;POLD4;POLD1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.2362990000191342,0.6100145201265162,0.992992992992993,0.9738927812784254,1.0,27/224,15.78%,PCDHB6;PRKAR2B;SNCA;KCNIP2;CEL;AKAP5;NRGN;ATXN3;APBA1;PTCHD1;CACNA1A;CACNB4;GABRA5;SYT10;DTNA;RAPSN;CACNB2;GLRA2;PRKACB;SDCBP;CACNB1;CAMKK2;GABRA4;CACNA1B;MPZ;GRIA1;RPS6KA2
prerank,amino sugar metabolic process (GO:0006040),0.31713520959492336,0.6098191865178558,0.8905325443786982,0.9737179241489335,1.0,3/10,19.34%,ST3GAL1;SLC35A3;FN3K
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.24918231312119365,-0.6094713261679593,0.9206349206349206,0.9861833113536486,1.0,7/10,39.13%,SACS;DNAJB2;DNAJA4;DNAJB1;HSPA1A;HSPA1B;HSPA2
prerank,intraciliary retrograde transport (GO:0035721),-0.23098779032481573,-0.6091467594069718,0.9424460431654677,0.9845624745422804,1.0,6/12,29.57%,WDR35;IFT43;DYNC2I2;IFT122;WDR19;DYNC2H1
prerank,regulation of nuclear division (GO:0051783),0.2780796369773255,0.6090396987730475,0.8793324775353016,0.9739536434192584,1.0,5/20,26.48%,KIF20B;CCDC8;PIN1;FBXO5;DAPK3
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3030110001427879,0.6085693803848964,0.8919667590027701,0.9739632748043794,1.0,2/12,11.45%,IREB2;ACO1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.2900099443942754,0.6084183918205718,0.8916776750330251,0.9737585205803659,1.0,4/15,18.08%,LDLRAP1;PPARD;ADM;PPM1K
prerank,negative regulation of endopeptidase activity (GO:0010951),0.24969808054967976,0.6074940740697267,0.933695652173913,0.9741030038140691,1.0,2/47,5.21%,PCID2;TIMP1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.3067774656981751,0.6070845874414055,0.8825174825174825,0.9740602821470209,1.0,1/11,6.22%,LIG3
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.2598573911624288,0.606926423299662,0.9267734553775744,0.9738486156533699,1.0,4/36,8.53%,RAB34;RAB7A;MACF1;RAB31
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.26255513193058155,0.6068466618363594,0.9088785046728972,0.9735902233122886,1.0,5/30,13.78%,RAB34;MACF1;RAB31;SEC16A;GGA2
prerank,microtubule polymerization (GO:0046785),0.26463874126288,0.606349541419918,0.9366197183098591,0.9736326491163171,1.0,4/28,12.77%,FGF13;TUBGCP6;TUBGCP4;RANBP9
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.29310219591140824,0.6048130414644959,0.8870748299319728,0.9743977797787935,1.0,6/14,25.82%,SEC24D;SAR1A;SEC13;SEC31A;SEC24C;SEC24A
prerank,retinal metabolic process (GO:0042574),-0.22876725296568484,-0.6047917839280985,0.9298245614035088,0.9852597302240458,1.0,1/12,5.92%,RDH10
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.29169423483818296,0.6044770095675811,0.9169960474308301,0.9743142752766105,1.0,3/16,15.51%,MCM6;MCM2;TWNK
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.24159179423240412,0.6044276831516967,0.964509394572025,0.9740308159959709,1.0,14/79,18.40%,PTPN1;UBE2D3;SKI;CREB3L1;SULF2;PDCD6;CASK;THBS1;SORL1;BAMBI;SMURF1;RBPMS2;SPRY4;GREM1
prerank,arachidonic acid secretion (GO:0050482),0.3104649871591053,0.6033095369997542,0.902158273381295,0.9741737886489027,1.0,1/10,6.34%,ANXA1
prerank,arachidonate transport (GO:1903963),0.3104649871591053,0.6033095369997542,0.902158273381295,0.9741737886489027,1.0,1/10,6.34%,ANXA1
prerank,axonal transport (GO:0098930),0.25642532034922944,0.6026209609452937,0.9405714285714286,0.9743158452934161,1.0,9/36,20.41%,AP3D1;AP3S1;DTNBP1;DYNC1H1;DST;HIF1A;KIF1B;KIF3A;FBXW11
prerank,DNA packaging (GO:0006323),0.2908740708594113,0.6024208447326665,0.9156939040207522,0.9741366667157402,1.0,3/16,19.59%,TP53;NOC2L;RBBP4
prerank,peptidyl-lysine methylation (GO:0018022),0.26773613322959144,0.6020947716016776,0.9184397163120568,0.9740567741437847,1.0,5/26,16.48%,SETD6;SETD2;ETFBKMT;SMYD3;SUV39H1
prerank,regulation of cation transmembrane transport (GO:1904062),0.25796548306479805,0.6013969091145134,0.925531914893617,0.974228301994561,1.0,5/29,17.43%,KCNIP2;WNK1;CD63;CACNA1D;SCN5A
prerank,signal release from synapse (GO:0099643),0.24909295285561617,0.60109309593762,0.9467969598262758,0.9741138296454344,1.0,9/43,21.32%,SNCA;PIP5K1C;STXBP3;SYT10;PDZD11;DNAJC5;UNC13A;RIMS1;BRSK1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.29886186076190313,0.600046888137957,0.9030390738060782,0.9745176226082454,1.0,2/12,9.18%,ABCD1;PPARGC1A
prerank,establishment of melanosome localization (GO:0032401),0.2764454072240839,0.5992677564185012,0.9176029962546817,0.9747287815508009,1.0,2/19,9.82%,MYO5A;RAB11A
prerank,icosanoid secretion (GO:0032309),0.2988352061016456,0.5988736465340238,0.898236092265943,0.9746884281133141,1.0,3/12,21.31%,ANXA1;PLA2G5;ABCC4
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.2617521771729232,0.5981514497729796,0.9302884615384616,0.9748473897339682,1.0,5/27,15.10%,SLC7A8;SLC25A38;SLC36A4;SLC25A18;SLC1A4
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.28489231748198385,0.5981219531713791,0.9124487004103967,0.9745474298707874,1.0,4/16,23.95%,THBS1;FGF2;PPP1R16B;VEGFA
prerank,negative regulation of DNA recombination (GO:0045910),0.24615926868545182,0.5979704231392454,0.9289740698985344,0.9743288049753158,1.0,12/43,25.84%,MAD2L2;ATRX;POLR2L;SHLD1;POLR2E;SHLD2;TINF2;TERF2;PARP3;TERF2IP;KLHL15;ZRANB3
prerank,translesion synthesis (GO:0019985),0.25133988677065155,0.5977738990672937,0.9406593406593406,0.9741458516047088,1.0,3/42,6.94%,TRIM25;MAD2L2;POLH
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.26538478965311807,0.5976907321820806,0.9336437718277066,0.9738842781035871,1.0,9/30,23.84%,TENT4B;TP53;STN1;SRC;TINF2;TERF2;ERCC4;TEN1;DCP2
prerank,regulation of steroid biosynthetic process (GO:0050810),0.30632490810906904,0.5974922926742839,0.924791086350975,0.9737056093725656,1.0,1/11,3.77%,NR1H4
prerank,sulfur amino acid catabolic process (GO:0000098),0.30742347032025863,0.5971182938560031,0.9183673469387755,0.9736553028651064,1.0,2/10,16.85%,TXN2;CBS
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.23705316026636417,0.5969874194105319,0.9576008273009308,0.9734252767193418,1.0,19/80,20.57%,KLC2;TMED3;KDELR2;KIF23;UVRAG;RAB1B;BNIP1;COPA;SCYL1;BICD2;KIF2A;LMAN2;USE1;ERGIC1;GOLPH3;SEC22B;KIF3A;ARCN1;COG7
prerank,mitochondrial gene expression (GO:0140053),0.24986950157684448,0.5960710658326686,0.9331103678929766,0.9737157432847044,1.0,15/42,27.37%,FOXO3;GATB;MRPL51;LARS2;TWNK;MRPS21;MRPS14;TFAM;MRPL12;GATC;MRPS34;MRPS12;MRPS15;MRPL16;MRPS24
prerank,innate immune response in mucosa (GO:0002227),0.3043613951826713,0.5959445256020798,0.9028169014084507,0.9734828370876822,1.0,1/10,12.29%,DEFA6
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.21066320402747785,-0.5959057336950995,0.9461538461538461,0.9881049989064784,1.0,4/15,16.36%,CCT3;CCT6A;SHQ1;RUVBL1
prerank,toxin transport (GO:1901998),0.3029885500494849,0.5956821650579712,0.8854166666666666,0.973349401841379,1.0,3/10,24.51%,ANTXR2;RAB29;ANTXR1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.2803950521234345,0.5949880362024589,0.918954248366013,0.9735112383859926,1.0,2/16,7.37%,MEF2A;SLC9A1
prerank,positive regulation of histone methylation (GO:0031062),0.2670050521309739,0.5949373973798463,0.9268004722550177,0.9732281646384465,1.0,3/24,12.31%,PRDM12;CTNNB1;MTF2
prerank,regulation of supramolecular fiber organization (GO:1902903),0.27464398388600003,0.5939739219918339,0.90920245398773,0.9735609836773164,1.0,6/22,21.63%,APOE;MAP1B;CAMSAP2;GBA2;AEBP1;PIK3CA
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.2911473615255572,0.5937351210701678,0.9087078651685393,0.9734036512188227,1.0,2/12,14.04%,CCT8;CCT5
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.2754266673795903,0.5927505218692743,0.9230769230769231,0.9737568953188911,1.0,7/20,23.64%,CEBPA;MYOCD;PTEN;HHEX;HEXIM1;TFAP4;IPO7
prerank,melanosome localization (GO:0032400),0.26953963338436643,0.5922529887052479,0.9183922046285018,0.9737628065253432,1.0,4/21,18.15%,MYO5A;RAB11A;RAB27B;VPS33B
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.19285449041935637,-0.5921794480761188,0.9308510638297872,0.9882023217264869,1.0,6/21,22.53%,ATAD5;BRD4;CDK4;CDC7;NPM1;RAD51C
prerank,tyrosine metabolic process (GO:0006570),-0.2365197716942122,-0.5909523253749843,0.954225352112676,0.9870194808609505,1.0,5/11,41.93%,FAH;GSTZ1;TYR;HGD;IL4I1
prerank,negative regulation of reproductive process (GO:2000242),0.2791706647708877,0.5907759162475787,0.9187096774193548,0.974416316220988,1.0,2/17,9.88%,TIMP1;ARHGDIB
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.26364984592261476,0.5893457690151483,0.923728813559322,0.9750417166382479,1.0,8/25,27.53%,NDST1;FUT9;B3GALNT1;NDST2;NDST4;B3GALT2;EXT2;B3GNT9
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.3034950920655906,0.5892015735031465,0.9055555555555556,0.974817139411433,1.0,2/12,8.13%,ATIC;GART
prerank,cognition (GO:0050890),0.24630634605265408,0.5885753861176501,0.9438325991189427,0.9748966942104736,1.0,12/42,21.38%,TNF;CHD7;PTCHD1;LINS1;CYFIP1;CTNS;SLC1A4;NF1;CUX2;TUSC3;SETD5;MAGT1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.29574009803492557,0.587812516622663,0.9082969432314411,0.9747405351254669,1.0,2/11,14.04%,CCT8;CCT5
prerank,regulation of protein localization to Cajal body (GO:1904869),0.29574009803492557,0.587812516622663,0.9082969432314411,0.9747405351254669,1.0,2/11,14.04%,CCT8;CCT5
prerank,regulation of primary metabolic process (GO:0080090),0.2297697455066688,0.5874717954578529,0.9837067209775967,0.9746432182216499,1.0,25/126,19.67%,PSAP;SREBF2;APOE;ZFP69;PSMB10;TBL1XR1;TBL1X;PSMA2;ADIPOR1;PSME3;SMARCD3;GPS2;PSMB5;PSMD8;SREBF1;FASN;PSMD7;PSMB9;ACACA;PPARD;NFYA;PSMD2;RXRA;ROCK2;C1QTNF2
prerank,protein autoubiquitination (GO:0051865),0.2396245419752265,0.5856818383039573,0.9538300104931794,0.9754777073359442,1.0,8/61,13.60%,RNF19B;UBE2D3;TRAF2;RNF4;NFX1;RNF10;ITCH;STUB1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.2708955615025447,0.5855943027538486,0.927360774818402,0.9748978875247751,1.0,7/21,24.85%,GTF2H1;ERCC5;GTF2H5;ERCC1;ERCC4;PARP1;RPA1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.2708955615025447,0.5855943027538486,0.927360774818402,0.9748978875247751,1.0,7/21,24.85%,GTF2H1;ERCC5;GTF2H5;ERCC1;ERCC4;PARP1;RPA1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.2795815141296123,0.5853259923766105,0.9182879377431906,0.9747520922513039,1.0,8/16,28.88%,NAA40;NAA50;NAA25;NAA15;NAA80;NAA10;CREBBP;EP300
prerank,aminoglycan biosynthetic process (GO:0006023),0.24048312986187564,0.5840121795284611,0.9494505494505494,0.9752609890540617,1.0,8/49,16.12%,HEXA;AGRN;NDST1;XYLT1;B3GALNT1;B4GALT7;PXYLP1;NDST2
prerank,hippo signaling (GO:0035329),0.2584360642454801,0.5839188890632165,0.9401408450704225,0.9750084882193377,1.0,8/26,20.79%,TEAD1;YWHAB;STK3;MOB1B;DCHS1;STK4;MOB1A;AMOT
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.2885887160724895,0.5838828331799462,0.9245810055865922,0.9747096382697606,1.0,4/12,27.56%,ADCY8;PPP3CB;PLA2G6;STX4
prerank,serine family amino acid biosynthetic process (GO:0009070),0.28676242147668946,0.5838140682150731,0.9110169491525424,0.9744395452676565,1.0,6/12,24.97%,CBS;PHGDH;PSAT1;SERINC3;SEPHS2;PSPH
prerank,chemical synaptic transmission (GO:0007268),0.22575449066352454,0.5836897462446223,0.999,0.9742001733523824,1.0,35/284,15.92%,PCDHB6;PRKAR2B;SNCA;APOE;KCNIP2;CEL;AKAP5;NRGN;ATXN3;RIMBP2;APBA1;PTCHD1;STXBP3;CACNA1A;CACNB4;GABRA5;SYT10;CDH8;DTNA;RAPSN;CACNB2;GLRA2;PRKACB;SDCBP;CACNB1;CAMKK2;STAC3;GABRA4;CACNA1B;PDZD11;SLC1A4;MPZ;GRIA1;RPS6KA2;DNAJC5
prerank,negative regulation of translation (GO:0017148),0.2324502241729219,0.5831260644139539,0.9722792607802875,0.9742404271597129,1.0,23/87,23.64%,CNOT8;YTHDF3;EIF4EBP2;LARP1;EPRS1;CPEB3;TPR;METTL3;PCIF1;IGF2BP3;CPEB4;PUS7;MEX3D;CPEB2;AGO2;ROCK2;FTO;LSM14A;CNOT7;CNOT1;EIF3E;RACK1;ILF3
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.2837872935394262,0.5829386410766951,0.9375,0.9740298102117485,1.0,3/13,17.56%,ALG2;DPAGT1;ALG11
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.23063401972173098,0.5826915404330092,0.9703779366700716,0.9738760500491287,1.0,13/87,15.14%,NDUFA11;NDUFB8;NDUFA2;NDUFB4;FASTKD3;UQCC1;CHCHD4;NDUFV1;NDUFS6;IMMP2L;NDUFAB1;COX20;NDUFB11
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.2335499574491931,0.5815564999205715,0.9648033126293996,0.9742923929463807,1.0,6/72,13.58%,CBL;GRB2;RAB14;FLRT1;POLR2L;FIBP
prerank,regulation of double-strand break repair (GO:2000779),0.2457344088347408,0.5806786002553771,0.9407158836689038,0.974539078503822,1.0,13/39,26.32%,MGMT;ACTR2;SETD2;RNF169;SLF2;PPP4C;PPP4R2;SHLD2;SPIDR;TERF2IP;DDX11;SIRT7;TRIP12
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.29681831973473727,0.5796683892538506,0.9127906976744186,0.9748346479082659,1.0,2/11,12.33%,P4HB;FYN
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.2716050108904092,0.5793204476784348,0.913375796178344,0.974730516553074,1.0,2/18,8.96%,BCL2L1;BAK1
prerank,ribosome assembly (GO:0042255),0.24122577026216926,0.5790641335051562,0.9555796316359697,0.9745681682335661,1.0,15/47,25.61%,ERAL1;RPL6;MDN1;RPS14;RRS1;RPL11;RPS27;RRP7A;EFL1;RPS15;RPS5;RPL10;EIF2A;C1QBP;RPL5
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.2458216306629769,0.5790614635898741,0.9410456062291435,0.9742546332806229,1.0,10/37,23.38%,DDIT3;BCL2L1;TP53;BECN1;BMF;DNM1L;FIS1;RPS7;BID;RACK1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.25046843737923163,0.5785790806664811,0.9492502883506344,0.9742229368738512,1.0,6/32,18.94%,TAOK3;BABAM2;FZR1;FOXN3;BABAM1;TAOK1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.2673575984972053,0.5784895097412638,0.9360902255639098,0.973955372085195,1.0,1/20,2.77%,MTHFS
prerank,myelination in peripheral nervous system (GO:0022011),0.2863519627157071,0.5780071642969085,0.9232914923291492,0.9739350377758047,1.0,6/13,26.45%,SKI;PRX;NF1;DICER1;CNTNAP1;LGI4
prerank,transport along microtubule (GO:0010970),0.2879667959359484,0.5776286441652474,0.9181692094313454,0.9738482607340312,1.0,3/13,11.51%,APBA1;ARHGAP21;BORCS5
prerank,positive regulation of RNA splicing (GO:0033120),0.2576534711569595,0.5774531010762614,0.9309133489461359,0.9736352813005437,1.0,5/29,15.79%,ERN1;CIRBP;TRA2B;PRDX6;THRAP3
prerank,regulation of membrane repolarization (GO:0060306),-0.2102670237523071,-0.5773981279258887,0.9694656488549618,0.9915557104823354,1.0,1/13,1.12%,CAV1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.2504629691371841,0.5762879152133473,0.9327146171693735,0.9740399808200462,1.0,4/31,13.51%,TGFBR1;TGFBR2;DYNC2I1;MEGF8
prerank,inorganic anion transmembrane transport (GO:0098661),0.23122240515021053,0.5760904947757496,0.96,0.9738472256467479,1.0,7/63,13.67%,SLC37A2;GABRA5;XPR1;GLRA2;SLC20A2;SLC25A30;GABRA4
prerank,rRNA modification (GO:0000154),0.26001402458677214,0.5755226716080284,0.9349693251533743,0.9738956405364833,1.0,3/21,18.54%,FBL;ZCCHC4;NSUN4
prerank,adherens junction organization (GO:0034332),0.23853836311197846,0.5729043232094966,0.9606126914660832,0.9751581066743368,1.0,15/48,22.05%,PIP5K1C;CTNNB1;ACTB;CDH8;VCL;CDH9;CDH12;CADM1;DCHS1;CDH19;CSK;CDH20;RAMP2;CDH15;CDH3
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.2939340453805915,0.5727664032703623,0.9127906976744186,0.974616669077098,1.0,3/10,19.67%,MGMT;ALKBH5;FTO
prerank,DNA dealkylation (GO:0035510),0.2939340453805915,0.5727664032703623,0.9127906976744186,0.974616669077098,1.0,3/10,19.67%,MGMT;ALKBH5;FTO
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.18859134620393542,-0.5725574668773866,0.9696969696969697,0.9918474700622602,1.0,7/18,28.40%,CCT3;CCT6A;SHQ1;RUVBL1;PARN;NOP10;RUVBL2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.28919451408098273,0.5704743851817771,0.9170243204577968,0.9756029809485479,1.0,1/10,6.70%,TP53
prerank,mesenchymal cell development (GO:0014031),-0.19395205187864534,-0.5694133403441259,0.9805825242718447,0.9913715796654334,1.0,9/18,35.43%,FOXC1;PEF1;CDH2;HEY2;SOX8;TCOF1;KBTBD8;SOX11;KLHL12
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.25449265410242167,0.5690729573399469,0.935064935064935,0.9761033864049196,1.0,1/23,2.04%,COPS6
prerank,negative regulation of cation channel activity (GO:2001258),0.25385976250691145,0.5685980213618828,0.9365853658536586,0.9760702387566552,1.0,4/26,17.83%,PKD2;EPO;GNB5;GSTM2
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.24509911432377274,0.5656870013206502,0.9595505617977528,0.9774181905873967,1.0,1/37,0.90%,TGFB1
prerank,neurotransmitter secretion (GO:0007269),0.23386825491922641,0.5634837191854998,0.9695982627578719,0.9782979278411872,1.0,9/44,21.32%,SNCA;PIP5K1C;STXBP3;SYT10;PDZD11;DNAJC5;UNC13A;RIMS1;BRSK1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.2485741850934731,0.5618908101408406,0.9518348623853211,0.978865305356287,1.0,13/31,26.40%,LRP8;LZTS3;TANC2;LRRK2;EPHA4;PTEN;CUX2;RELN;CDK5R1;CFL1;EFNA1;DBNL;NGEF
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.25107981891309505,0.5616010977283715,0.9456264775413712,0.9787101895320977,1.0,5/25,19.49%,PYCARD;TP53;BMF;TNFSF10;DNM1L
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.24639100753818122,0.5587874595523136,0.9494712103407755,0.9799051919815086,1.0,8/29,24.85%,GTF2H1;CDK7;ERCC5;GTF2H5;RAD23B;PARP1;XPC;RPA1
prerank,DNA catabolic process (GO:0006308),0.28583935632245555,0.5573784136229715,0.9305555555555556,0.9803567107757638,1.0,4/11,25.84%,REXO4;DNASE1L1;XRN2;DFFB
prerank,RNA modification (GO:0009451),0.23104320267177436,0.5571435197330457,0.9647435897435898,0.980193373651264,1.0,10/54,18.54%,RBM15B;ADAR;CDKAL1;TRMT1;CTU1;METTL3;ADARB1;BCDIN3D;PUS7;NSUN4
prerank,gastrulation (GO:0007369),0.26986176807179996,0.5571409247663118,0.9343832020997376,0.9798795899269829,1.0,3/15,16.59%,LRP5;MEGF8;TASOR
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.25271356506033493,0.5549429194657832,0.9306569343065694,0.9807358576651538,1.0,1/22,2.37%,GTF2H1
prerank,regulation of mitotic spindle organization (GO:0060236),0.24019504936116048,0.5543815304262283,0.9539170506912442,0.9807243250096648,1.0,5/35,15.82%,NUP62;TPR;CLTC;DYNC1H1;PDCD6IP
prerank,male meiosis I (GO:0007141),-0.1932898803187122,-0.5541116331650014,0.9821428571428571,0.9954869990352578,1.0,7/16,41.60%,ZSCAN21;MYBL1;FOXJ2;HSF2BP;SYCP3;TDRD9;DDX4
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.2541672727373187,0.5537580064182918,0.9469790382244143,0.9807367728590899,1.0,7/22,23.64%,CEBPA;MYOCD;PTEN;HHEX;HEXIM1;TFAP4;IPO7
prerank,leukotriene biosynthetic process (GO:0019370),-0.20820003147042304,-0.5530126009581954,0.9798387096774194,0.9940742933781666,1.0,1/14,2.21%,LTA4H
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.2725057974482271,0.5524943730761719,0.9309859154929577,0.9810968754092874,1.0,4/12,23.86%,ABCD1;FADS1;ACOT8;FADS2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.23140733224449722,0.5522033909839287,0.9563794983642312,0.9809303333058348,1.0,10/41,20.94%,NUP62;SEH1L;TPR;NUP205;LACC1;HIF1A;GCK;PGAM1;SEC13;NUP54
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.20229412867842428,-0.5503759631907595,0.9669117647058824,0.9931446145033107,1.0,5/13,29.04%,SPRED2;ATM;EEF1E1;HIC1;PLA2R1
prerank,protein prenylation (GO:0018342),0.2891085706958044,0.549698663818844,0.932761087267525,0.9819121882208107,1.0,1/10,9.21%,CHML
prerank,metallo-sulfur cluster assembly (GO:0031163),0.24844426459902874,0.5476431908259506,0.9538653366583542,0.9826398870957374,1.0,4/22,13.87%,MMS19;CIAO2A;CIAO1;HSCB
prerank,inositol phosphate dephosphorylation (GO:0046855),0.2753715649201249,0.5459843347359057,0.9545454545454546,0.9828706574502136,1.0,4/11,23.28%,SYNJ1;PTEN;INPP5K;OCRL
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.2753715649201249,0.5459843347359057,0.9545454545454546,0.9828706574502136,1.0,4/11,23.28%,SYNJ1;PTEN;INPP5K;OCRL
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.24426581148232368,0.5458553902664111,0.9660194174757282,0.9826212430690144,1.0,7/23,23.68%,TIMM22;AGK;BMF;HSP90AA1;TIMM29;TIMM8B;HSPA4
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.25860143462246266,0.5453527968911601,0.9550858652575958,0.9825622995103972,1.0,2/17,16.94%,NOS1AP;KCNRG
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.23198913360534257,0.5428285714612466,0.9564719358533792,0.983437945136063,1.0,8/36,19.70%,HFE;AQP11;USP7;SDCBP;PSME3IP1;RPL11;GIPC1;TLK2
prerank,aerobic respiration (GO:0009060),0.2462995444193382,0.5418347609917755,0.952088452088452,0.9836079220468119,1.0,4/20,17.69%,MTFR2;UQCRB;ME3;SDHB
prerank,DNA recombination (GO:0006310),0.22798055946898044,0.5406073553119974,0.9709497206703911,0.9838690913093817,1.0,7/37,21.43%,EXO1;HMGB1;RAD54L;RAD51B;ERCC1;RAD51D;RPAIN
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.24359271085830936,0.5403566355908813,0.9550295857988166,0.9836678458619649,1.0,5/27,18.77%,FBXL22;TP53;FBXL3;PPP1CC;PER1
prerank,histone H3 deacetylation (GO:0070932),0.2611578121452117,0.5397406144775085,0.9454061251664447,0.9836344978292217,1.0,4/15,18.77%,HDAC4;HDAC9;SMARCAD1;PER1
prerank,protein import into peroxisome matrix (GO:0016558),0.270445523560883,0.5380736717265239,0.9583911234396671,0.9840977782130335,1.0,2/12,11.57%,PEX13;PEX7
prerank,multivesicular body assembly (GO:0036258),0.23670390989072299,0.5380459467550772,0.9638273045507585,0.9837972974368988,1.0,5/30,16.97%,VTA1;RAB11A;VPS37C;PDCD6IP;VPS28
prerank,protein hydroxylation (GO:0018126),0.2580958083347214,0.53769816866935,0.9578392621870883,0.9836476271311633,1.0,2/15,9.78%,ASPH;P3H2
prerank,Golgi inheritance (GO:0048313),-0.21004639882163875,-0.5367075889930103,0.959375,0.9958751807238739,1.0,6/11,37.39%,STK25;GOLGA2;PLK5;YWHAZ;GBF1;PLK3
prerank,positive regulation of phospholipase activity (GO:0010518),0.24236330338815537,0.5365214004964802,0.9488139825218477,0.9838743155161604,1.0,7/22,24.58%,GNA13;NTF3;PDPK1;PLAA;PLA2G5;FGF2;ABL2
prerank,respiratory electron transport chain (GO:0022904),0.2643883311752129,0.5355271507497824,0.9415670650730412,0.9840136802704954,1.0,5/14,20.74%,PPARGC1A;SLC25A18;SDHB;ETFDH;SDHA
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.25827383249404245,0.53457658590253,0.9483870967741935,0.9841441431001913,1.0,1/16,3.66%,VTA1
prerank,response to interleukin-4 (GO:0070670),0.27912377604820493,0.5331248068650164,0.9388038942976356,0.9844631270360096,1.0,10/10,72.11%,SHPK;XBP1;TCF7;DCSTAMP;XCL1;CITED1;RUFY4;GATA3;JAK3;LEF1
prerank,negative regulation of mRNA processing (GO:0050686),-0.1909336347083569,-0.5328745774499678,0.9801587301587301,0.9951940569301334,1.0,15/15,80.93%,U2AF2;RBMX;SRSF12;RNPS1;SAP18;SRSF9;SRSF7;BARD1;SFSWAP;SRSF4;PCBP4;C1QBP;PTBP1;SRSF10;SRSF6
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.2272910889961325,0.5307573074580321,0.96878612716763,0.9852170598055324,1.0,5/35,13.57%,SEMA4D;PLXNB2;SEMA4A;NRP1;ARHGDIA
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.24768612082239502,0.5286581648315967,0.9556714471968709,0.9858042026972815,1.0,6/18,25.24%,ANXA1;HDAC9;FGF2;VEGFA;KDR;AKT3
prerank,regulation of smooth muscle cell migration (GO:0014910),0.24180339597913494,0.5261685289071041,0.9641975308641976,0.9865308227089449,1.0,8/20,26.95%,NRP1;SORL1;LRP1;VTN;IGF1;CCN4;IGFBP3;NDRG4
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.19092164741336015,-0.5253532189397603,0.9962121212121212,0.9954358554385595,1.0,14/14,80.93%,U2AF2;RBMX;SRSF12;RNPS1;SAP18;SRSF9;SRSF7;SFSWAP;SRSF4;PCBP4;C1QBP;PTBP1;SRSF10;SRSF6
prerank,iron-sulfur cluster assembly (GO:0016226),0.23468280673880654,0.5236488640668449,0.9631449631449631,0.9872498104848714,1.0,4/24,13.87%,MMS19;CIAO2A;CIAO1;HSCB
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.25021939096496754,0.5234697582931351,0.9596879063719116,0.9869948928532374,1.0,6/16,23.59%,TNKS2;SLX4;TINF2;TERF2;ERCC4;PARP1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.20850824617826327,0.5206788993770968,0.9845837615621789,0.9877647332274059,1.0,16/72,21.10%,TRAF2;MAP3K14;PSMB10;MALT1;PSMA2;PSME3;PSMB5;PSMD8;PSMD7;PSMB9;REL;PSMD2;BIRC2;FBXW11;BIRC3;DICER1
prerank,RNA biosynthetic process (GO:0032774),-0.14878232943203507,-0.5206105737240633,0.9863945578231292,0.9948833317891101,1.0,7/31,21.89%,TBP;TAF13;POLA1;POLA2;TERT;PRIM1;TAF7
prerank,tRNA processing (GO:0008033),0.21100995124964497,0.5198859940099043,0.9821989528795811,0.987770602341507,1.0,8/61,14.15%,TSEN15;ELAC2;CDKAL1;TRMT1;TRMT10A;CTU1;RTRAF;DDX1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.19730760954592613,-0.5189097714565531,0.982078853046595,0.993529668083299,1.0,4/13,24.84%,HACD1;ELOVL5;ELOVL1;HACD2
prerank,amide transport (GO:0042886),0.2227314386958113,0.5173409283143129,0.9683313032886723,0.9884658236868276,1.0,3/26,10.46%,AQP11;SLC14A2;TAP1
prerank,anion transmembrane transport (GO:0098656),0.2100945834680058,0.5172880662233413,0.9790575916230366,0.9881708229501353,1.0,10/67,17.02%,LRRC8D;SLC7A8;SLC25A38;SLC36A4;ABCC1;SLC25A18;SLC25A30;SLC35A3;LRRC8C;SLC13A3
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2100614524176218,0.516256748980652,0.9892933618843683,0.9882608018698665,1.0,13/59,26.42%,LPL;LIPC;NDUFAB1;OSBP;ACACA;OSBPL7;ACOT8;GATM;CYP27A1;OSBPL3;XBP1;HSD17B8;HOGA1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.2640992649555377,0.5160098098239279,0.948936170212766,0.988039540923528,1.0,2/11,13.52%,DERL1;TOR1A
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.24454304810971098,0.5119651697747698,0.9654714475431607,0.9892226862990184,1.0,1/15,4.36%,SKI
prerank,inner mitochondrial membrane organization (GO:0007007),0.21085324647776357,0.5103315427264837,0.9893617021276596,0.989507870515695,1.0,12/47,23.66%,ATP5MC2;ATP5F1E;TIMM22;AGK;ATP5F1A;ATP5PD;ATP5MG;GHITM;ATP5MF;LETM1;TIMM29;TIMM8B
prerank,multivesicular body organization (GO:0036257),0.22338552256805738,0.5101335489820015,0.9733178654292344,0.9892685574218247,1.0,5/31,16.97%,VTA1;RAB11A;VPS37C;PDCD6IP;VPS28
prerank,positive regulation of rRNA processing (GO:2000234),-0.20568195135222325,-0.5093829958676346,0.9742765273311897,0.9940008435159801,1.0,2/10,14.41%,RIOK2;UTP15
prerank,positive regulation of embryonic development (GO:0040019),-0.17096938994092759,-0.5085847149936367,0.9908675799086758,0.9924073587674362,1.0,8/19,37.44%,WNT4;ZBED3;RBM19;NIBAN2;PLCB1;OSR1;TLE6;LHX1
prerank,serine family amino acid catabolic process (GO:0009071),0.2556146205400551,0.5068760413691424,0.9603960396039604,0.9901117950604374,1.0,2/10,16.85%,THNSL2;CBS
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.2551475518592825,0.5064461741638783,0.9538239538239538,0.9899383460031081,1.0,2/10,17.51%,IMPACT;VHL
prerank,P-body assembly (GO:0033962),0.25520973486268644,0.5054253129966161,0.9578651685393258,0.9899850492629464,1.0,2/12,12.21%,RC3H1;DYNC1H1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.2152956702067491,0.49799061046443316,0.9732868757259001,0.9922012755504729,1.0,29/29,78.51%,TRIP13;SIRT7;RAD21;BAG6;RNF212;KASH5;SYCE1;SYCE3;SYCP1;TERB2;HORMAD1;ANKRD31;RNF212B;RAD21L1;IHO1;STAG3;TEX12;MEIOB;MAJIN;SYCE2;REC8;TEX11;ZCWPW1;SYCP2;FANCD2;MEI4;TERB1;P3H4;PRDM9
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.20136196594549022,0.4969560798675155,0.9906832298136646,0.9922131764324703,1.0,19/72,25.64%,GTF2H1;PNRC2;DNA2;POLD3;DDX1;ERCC5;REXO4;OGG1;GTF2H5;ERCC1;DICER1;DCP1B;ERCC4;RNASE6;PARP1;DNASE1L1;XRN2;RPA1;DXO
prerank,ribosomal large subunit assembly (GO:0000027),0.22313805034340595,0.4953074578556082,0.9717314487632509,0.9924196124573972,1.0,4/24,16.37%,RPL6;MDN1;RRS1;RPL11
prerank,exit from mitosis (GO:0010458),0.2407113083582328,0.49388047606339985,0.967032967032967,0.9925568769607638,1.0,1/12,6.58%,UBE2S
prerank,homocysteine metabolic process (GO:0050667),0.24981500584854982,0.4935910298333137,0.9597701149425287,0.9923356745876487,1.0,2/11,16.85%,MMUT;CBS
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.19816962064537402,0.49345198152553843,0.9896587383660806,0.9920631073487195,1.0,20/84,23.92%,APOE;CNOT8;LARP1;EPRS1;CPEB3;ORMDL2;SORL1;PCIF1;RTN1;IGF2BP3;RTN4;PUS7;BIN1;LSM14A;PIN1;CNOT7;CNOT1;RACK1;ILF3;IGF1
prerank,positive regulation of transporter activity (GO:0032411),-0.18312511770983741,-0.49151020617239355,0.9925093632958801,0.9939077172302703,1.0,13/13,81.71%,NR1H3;KCTD7;STK39;SYNGR3;SGK2;TRPC6;PDZK1;PON1;ADIPOQ;KMT2A;WNK3;SGK1;RXRA
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.2220856712498842,0.48639824056200265,0.9828641370869033,0.9935404770122389,1.0,4/23,15.73%,YWHAB;TP53;CASP8;YWHAH
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.2220856712498842,0.48639824056200265,0.9828641370869033,0.9935404770122389,1.0,4/23,15.73%,YWHAB;TP53;CASP8;YWHAH
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.21365678440554536,0.48361059218539004,0.9799528301886793,0.9939920550955685,1.0,1/28,2.51%,LFNG
prerank,regulation of endopeptidase activity (GO:0052548),0.19429130509957132,0.4832817668562132,0.9925611052072264,0.9937597489918415,1.0,12/59,24.51%,VSIR;TIMP1;PSME3;PSMB9;FURIN;PICALM;BIRC2;ATP13A2;BIRC3;VTN;PRELID1;SERPINA2
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.22477727185240218,0.4817521733172442,0.9823008849557522,0.9938487440026913,1.0,1/18,4.59%,SEL1L
prerank,engulfment of apoptotic cell (GO:0043652),0.22678189480721794,0.48078841216303725,0.9770992366412213,0.9938112662024343,1.0,4/15,22.16%,THBS1;XKR4;MEGF10;RHOG
prerank,negative regulation of transferase activity (GO:0051348),0.21272858682294807,0.4795450274044121,0.9846878680800942,0.9938329602323759,1.0,7/28,21.90%,TP53;PRDX3;SRC;GSK3A;INPP5K;GSK3B;ERCC4
prerank,nucleoside phosphate catabolic process (GO:1901292),0.23548009336121975,0.4777132147474286,0.9810040705563093,0.9939845315817918,1.0,4/13,25.17%,ENTPD1;ENTPD2;ENTPD3;ITPA
prerank,nucleic acid-templated transcription (GO:0097659),0.2000848822832067,0.476130634609017,0.9899665551839465,0.9940633300183973,1.0,11/42,26.24%,MEF2A;MMS19;POLR2L;CREBL2;POLR2E;FUBP3;POLR3A;PAX8;PWP1;XAB2;PTMA
prerank,peptidyl-methionine modification (GO:0018206),0.23302674626892067,0.47494948760833516,0.9787234042553191,0.9940468208439189,1.0,3/12,20.75%,METAP2;NAA25;NAA15
prerank,positive regulation of mitochondrial translation (GO:0070131),0.2340723354563642,0.4743616058976115,0.9670184696569921,0.993880539963323,1.0,2/14,13.93%,FASTKD3;RCC1L
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.15550810199723653,-0.47073727916249053,1.0,0.9950991879687896,1.0,20/20,84.47%,AKAP13;RAPGEF2;DRD2;PDE4D;ADRB2;ADRB1;GPR101;DRD3;ADRB3;ADRA2C;ADRA2B;DRD5;DRD1;ADRA2A;ADRA1A;ADRA1D;ADRA1B;ZDHHC21;ADCY9;LMBRD2
prerank,lipid droplet organization (GO:0034389),0.20907094124414888,0.46674654242509955,0.9846350832266325,0.9953537029020099,1.0,1/22,5.78%,CDS2
prerank,regulation of histone deacetylation (GO:0031063),0.22670076478073617,0.4664522674882698,0.981081081081081,0.9951064642505469,1.0,6/13,29.48%,AKAP8L;ZBTB7B;CTBP1;SPHK2;SAP30BP;PRMT6
prerank,regulation of response to stress (GO:0080134),0.24243799938684094,0.46573564257324596,0.9777448071216617,0.9949419416912224,1.0,2/10,18.50%,ADCY8;CORO2B
prerank,bile acid metabolic process (GO:0008206),0.2032757746838915,0.45980765192239076,0.9883585564610011,0.9959004405932255,1.0,7/27,23.87%,NPC1;OSBP;GBA2;OSBPL7;ACOT8;CYP27A1;OSBPL3
prerank,response to light stimulus (GO:0009416),0.18771336698965596,0.4558701090314049,0.9936373276776246,0.9963813347273279,1.0,6/55,15.69%,CIRBP;UVSSA;USF1;UBE4B;ERCC5;ERCC6
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.22405172222348196,0.4530404770108299,0.9850543478260869,0.9966305889343401,1.0,5/14,23.58%,PNP;NMNAT3;AK8;AK5;AK1
prerank,proteoglycan biosynthetic process (GO:0030166),0.1945401570469789,0.45149637322941927,0.9964871194379391,0.9965898005421064,1.0,12/31,29.16%,XYLT1;EXTL3;B4GALT7;PXYLP1;B3GAT2;IGF1;EXT2;CHST11;BMPR1B;CHST9;HS3ST3B1;CHST12
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.21480427560308024,0.44644908026775787,0.9906666666666667,0.9972065494438183,1.0,4/16,21.44%,ADIPOR1;FOXK1;PRKN;SCARB2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.22837788943086892,0.44509605360470583,0.9844192634560907,0.9971141027549842,1.0,1/10,8.24%,DGKD
prerank,regulation of mitochondrial translation (GO:0070129),0.2080015821232015,0.4439244049445628,0.9887920298879203,0.9970062681986677,1.0,4/21,21.55%,FASTKD3;RCC1L;MTG2;RPUSD4
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.1924687419171063,0.4391396742983709,0.9953325554259043,0.9974575992774226,1.0,10/29,26.36%,PTGES3;HSP90AA1;TINF2;TERF2;TELO2;TERF2IP;PPIA;RPA1;HSP90AB1;ANKRD28
prerank,regulation of spindle assembly (GO:0090169),0.1977625352923664,0.43802173257140636,0.9904420549581839,0.9973239974175742,1.0,5/25,19.79%,RNF4;TPR;DYNC1H1;PDCD6IP;SENP6
prerank,regulation of phosphate metabolic process (GO:0019220),0.2069103014765294,0.4325212808316321,0.9919893190921228,0.9978675338379309,1.0,3/16,18.57%,SMG7;PGAM1;TIGAR
prerank,regulation of DNA recombination (GO:0000018),0.18582437695232515,0.4313409266046159,0.9977116704805492,0.9977162108597444,1.0,8/32,22.85%,SETD2;SMARCAD1;KPNA1;PPP4C;PPP4R2;SHLD2;SPIDR;TERF2IP
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.20558563691757636,0.43037725549888706,0.9898477157360406,0.997535424517234,1.0,2/18,14.07%,LIG3;POLD3
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.2198719558122018,0.4245288199398237,0.9858356940509915,0.9979906992638544,1.0,10/10,78.03%,TUT7;DIS3L2;CHFR;NEDD8;UBB;TUT4;RPS27A;UBA52;ISG15;UBC
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.17456517525820298,0.41222998300607294,0.998898678414097,0.9990104767789416,1.0,4/39,16.81%,RASL10B;HFE;SOX4;GCK
prerank,mitotic cytokinetic process (GO:1902410),0.19278739361991554,0.41114923101291995,0.9913151364764268,0.9988005660732795,1.0,5/20,24.66%,CNTROB;PDCD6IP;RHOA;MITD1;CHMP1A
prerank,telomere maintenance via telomerase (GO:0007004),0.18000539218619702,0.4102163612998641,0.9988358556461001,0.9985830857662042,1.0,9/28,26.36%,PTGES3;HSP90AA1;TINF2;TERF2;TELO2;TERF2IP;RPA1;HSP90AB1;ANKRD28
prerank,cellular response to interleukin-4 (GO:0071353),0.2141427579509395,0.4064953778179935,0.9943262411347518,0.9986198019517533,1.0,1/10,13.18%,SHPK
prerank,negative regulation of RNA splicing (GO:0033119),0.1853522727267236,0.4003241958812022,0.9948914431673053,0.9988588458305251,1.0,8/19,27.70%,PTBP2;SRSF6;SRSF10;PTBP1;RPS13;C1QBP;PCBP4;SRSF4
prerank,mitotic recombination (GO:0006312),0.18795231721327998,0.3940951623981738,0.9933949801849405,0.9990156709536125,1.0,4/15,21.33%,TEP1;ERCC1;RAD51D;NSMCE2
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.19628836916854428,0.3933900257366412,0.9972027972027973,0.9987564125502741,1.0,5/12,27.46%,SOX9;GDNF;VEGFA;PAX8;SIX4
prerank,sphingosine metabolic process (GO:0006670),0.17986252751993814,0.3794258558298408,0.9920844327176781,0.9993370362288725,1.0,4/17,25.07%,ACER3;ASAH1;ABCA2;SPHK2
prerank,monosaccharide transmembrane transport (GO:0015749),0.17518523169659667,0.37099109997740826,0.9973544973544973,0.9994452020601851,1.0,16/16,82.50%,SLC2A12;SLC45A3;SLC2A7;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC2A6;SLC2A10;SLC23A2;SLC23A1;SLC2A2;SLC2A9;SLC2A8;SLC5A3;SLC50A1
prerank,epithelial cell morphogenesis (GO:0003382),0.17261778159708585,0.3645544903870106,0.9987146529562982,0.9994133811151602,1.0,2/17,15.95%,SIPA1L3;COL22A1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.18196083354255566,0.35157820898270115,1.0,0.9995573044896486,1.0,10/10,81.82%,CDC42;ECT2;SIRT2;NEK2;CCNB1;RCC2;SPAG5;KNSTRN;RACGAP1;APC
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.15016953556445364,0.3207861532594816,0.9987113402061856,0.9997993720055792,1.0,2/18,16.33%,RAB11A;RAD51B
